data_1vj6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1vj6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.399 0 CA-C-O 121.678 0.752 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.18 118.1 33.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.963 1.305 . . . . 0.0 109.093 174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.23 92.06 7.05 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.051 1.405 . . . . 0.0 110.078 170.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.2 t -89.45 127.91 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 126.315 1.846 . . . . 0.0 112.454 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 0.0 OUTLIER -108.35 122.54 47.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.012 -2.305 . . . . 0.0 110.238 174.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.84 157.64 37.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.005 -173.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.05 113.22 22.89 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 163.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -56.41 132.45 51.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.262 1.425 . . . . 0.0 113.953 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.5 t -97.74 110.13 22.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.605 -1.31 . . . . 0.0 109.138 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 46.07 55.43 7.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.896 2.478 . . . . 0.0 115.457 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.98 51.22 19.72 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.714 -1.241 . . . . 0.0 114.828 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 p -178.24 111.57 0.07 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.3 mt -66.63 -53.51 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.408 2.283 . . . . 0.0 108.15 166.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 133.96 26.73 0.56 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.911 174.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 pt -126.27 137.61 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.306 1.05 . . . . 0.0 111.171 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -87.27 119.82 27.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.982 1.713 . . . . 0.0 111.649 164.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 m -84.63 140.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.02 178.25 7.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.463 1.905 . . . . 0.0 109.291 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 -118.2 4.73 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.27 1.414 . . . . 0.0 113.105 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.79 162.2 36.01 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 121.432 -1.04 . . . . 0.0 112.502 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.274 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -107.25 156.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.94 157.54 46.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.877 -1.764 . . . . 0.0 106.416 -170.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.6 t -87.32 131.29 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.141 -1.599 . . . . 0.0 111.9 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -41.48 9.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.367 -1.458 . . . . 0.0 110.816 171.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.45 136.03 25.7 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.032 -1.042 . . . . 0.0 111.102 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mm -97.43 137.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 127.017 2.127 . . . . 0.0 108.597 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.43 -1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 110.151 171.353 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.73 54.19 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.181 2.192 . . . . 0.0 115.104 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.53 -26.93 68.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.923 -1.736 . . . . 0.0 112.292 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -70.11 -18.73 63.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.033 -1.667 . . . . 0.0 115.066 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.74 -71.57 0.24 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.036 -2.29 . . . . 0.0 107.368 157.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.0 5.63 62.4 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 161.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -80.75 -19.37 45.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 110.115 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.08 149.29 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.298 1.839 . . . . 0.0 114.253 162.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.44 -161.23 1.11 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.62 1.568 . . . . 0.0 107.464 157.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.3 45.45 1.28 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.959 -2.338 . . . . 0.0 112.549 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.73 -20.13 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 O-C-N 120.609 -1.307 . . . . 0.0 114.807 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -78.76 161.06 27.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -166.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -104.07 124.65 49.44 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.64 1.576 . . . . 0.0 110.411 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.26 117.24 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 107.248 166.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 -36.19 9.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.824 -1.797 . . . . 0.0 112.754 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.26 154.22 38.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.82 -1.175 . . . . 0.0 111.401 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.04 121.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.065 -1.022 . . . . 0.0 111.259 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.8 t30 63.77 21.33 12.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.643 -1.285 . . . . 0.0 113.389 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.94 20.38 63.34 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.665 -1.272 . . . . 0.0 113.492 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.9 110.67 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 121.079 -1.248 . . . . 0.0 107.99 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.7 m -58.13 141.18 51.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.383 1.873 . . . . 0.0 114.543 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mt -81.08 47.62 1.03 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.284 1.516 . . . . 0.0 111.889 170.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.76 117.03 21.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.196 1.799 . . . . 0.0 109.707 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.86 72.02 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 114.734 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.21 132.76 36.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.529 1.633 . . . . 0.0 112.639 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -110.46 -164.92 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.006 2.523 . . . . 0.0 105.517 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -58.18 -52.17 66.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.557 -1.965 . . . . 0.0 112.947 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -70.53 -44.63 67.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.121 0.968 . . . . 0.0 112.583 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -38.83 92.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.05 1.34 . . . . 0.0 113.807 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.32 97.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 0.0 114.312 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.37 -54.51 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 118.127 0.421 . . . . 0.0 110.247 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.77 -37.12 40.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 126.085 1.754 . . . . 0.0 115.351 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.7 m -72.22 -31.46 65.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.68 2.392 . . . . 0.0 113.898 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -89.02 -37.94 14.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.242 1.817 . . . . 0.0 114.102 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -82.97 -45.45 14.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.624 1.97 . . . . 0.0 113.378 -166.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -90.88 37.32 0.92 Allowed 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.038 1.399 . . . . 0.0 112.623 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.8 p -90.1 173.51 8.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.949 2.1 . . . . 0.0 114.058 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.71 51.39 4.45 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.673 -1.892 . . . . 0.0 113.972 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 68.27 -51.78 0.54 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.299 3.04 . . . . 0.0 115.673 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.6 t -76.86 128.46 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 123.144 1.449 . . . . 0.0 109.844 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.03 100.22 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -82.26 98.49 8.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.875 1.67 . . . . 0.0 107.987 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -87.51 112.75 22.55 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.322 1.449 . . . . 0.0 109.878 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.26 100.52 12.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.84 136.97 44.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.413 1.885 . . . . 0.0 110.881 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.28 158.23 17.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.134 1.774 . . . . 0.0 109.37 171.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.6 tp . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.51 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.419 16.0 m 33.12 89.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 129.934 3.294 . . . . 0.0 116.775 171.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 64.5 m -125.11 121.83 35.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.0 p -71.62 121.1 18.18 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.574 1.15 . . . . 0.0 109.779 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.636 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.911 0.862 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.58 121.54 37.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.517 1.127 . . . . 0.0 108.599 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -88.74 87.63 7.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.965 1.364 . . . . 0.0 111.021 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.9 t -85.82 110.77 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.941 1.696 . . . . 0.0 111.493 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.58 123.21 40.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.621 -1.924 . . . . 0.0 108.24 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.11 172.36 12.48 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.13 128.77 55.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 158.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.3 137.17 52.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.578 1.151 . . . . 0.0 110.565 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -89.35 92.2 9.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.015 -1.678 . . . . 0.0 110.67 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.5 -18.82 0.11 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.52 61.07 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 119.983 -1.698 . . . . 0.0 110.028 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -179.97 119.64 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.875 1.797 . . . . 0.0 107.266 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.413 ' CD2' HG23 ' A' ' 92' ' ' VAL . 16.9 mt -74.87 -47.54 29.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.001 1.857 . . . . 0.0 106.575 162.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.01 39.94 1.23 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.426 1.489 . . . . 0.0 111.4 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.9 pt -124.85 136.65 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.812 0.815 . . . . 0.0 109.713 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 m -88.31 121.57 30.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.342 1.457 . . . . 0.0 111.398 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.11 138.41 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -174.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.2 t -138.6 175.9 9.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.16 2.584 . . . . 0.0 108.581 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 -128.34 9.02 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 113.123 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.8 163.49 39.44 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.796 -1.414 . . . . 0.0 114.525 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.431 -1.401 0 C-N-CA 126.697 1.999 . . . . 0.0 114.615 -175.145 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -105.57 160.33 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.9 160.31 38.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.926 -1.734 . . . . 0.0 107.017 -171.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.07 134.46 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.429 -1.42 . . . . 0.0 112.219 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -99.56 -36.64 9.46 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.72 -1.237 . . . . 0.0 111.441 171.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.05 129.95 16.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.216 -1.553 . . . . 0.0 111.654 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mm -95.25 136.86 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 108.816 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.4 mt . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 119.919 -1.738 . . . . 0.0 110.176 172.305 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 121.687 0.756 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.87 63.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.081 1.753 . . . . 0.0 114.656 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.73 -28.37 67.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.44 -1.412 . . . . 0.0 112.956 171.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -14.54 63.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.69 -70.52 0.34 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.163 -1.586 . . . . 0.0 108.685 159.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.47 6.64 56.42 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 114.206 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -78.83 -27.62 44.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.301 -1.705 . . . . 0.0 109.102 164.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.27 143.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.873 1.669 . . . . 0.0 114.198 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -132.61 172.81 12.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.696 -1.252 . . . . 0.0 110.049 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -82.62 58.39 4.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.686 -1.884 . . . . 0.0 113.458 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.55 31.4 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -103.75 159.19 15.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -100.73 130.22 46.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.713 1.205 . . . . 0.0 109.772 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.21 114.35 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.98 -34.11 11.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.575 -1.328 . . . . 0.0 112.225 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.08 165.34 37.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.217 1.371 . . . . 0.0 113.327 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.9 t -134.27 119.17 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 110.552 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.89 27.1 8.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 121.101 1.773 . . . . 0.0 115.247 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.67 17.82 74.55 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 120.88 -1.137 . . . . 0.0 114.5 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.9 98.29 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 t -68.64 137.12 53.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.277 1.431 . . . . 0.0 114.642 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.93 30.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.855 2.062 . . . . 0.0 111.702 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 10.49 1.19 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -167.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.62 36.59 0.39 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.829 -1.17 . . . . 0.0 110.401 166.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.32 37.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.059 0.943 . . . . 0.0 113.31 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -108.73 -161.59 0.77 Allowed 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.415 2.286 . . . . 0.0 106.859 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -55.09 -55.97 25.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.637 1.975 . . . . 0.0 114.09 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -64.64 -54.45 31.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.082 0.944 . . . . 0.0 112.724 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -41.09 71.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.132 1.773 . . . . 0.0 114.256 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.51 89.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.208 -1.558 . . . . 0.0 114.844 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.1 t -57.52 -52.5 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 119.196 0.907 . . . . 0.0 110.333 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.03 -35.9 74.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.6 m -64.58 -34.65 78.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.966 1.706 . . . . 0.0 113.772 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.98 -39.48 14.66 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.258 -1.526 . . . . 0.0 113.481 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -50.81 10.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.409 2.284 . . . . 0.0 113.986 -173.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.59 43.03 0.94 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 124.023 1.868 . . . . 0.0 112.044 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.4 p -99.08 174.64 6.24 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.93 2.892 . . . . 0.0 108.35 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.24 -131.22 0.76 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.646 -1.284 . . . . 0.0 112.743 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -97.19 -49.78 4.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.023 -1.281 . . . . 0.0 110.45 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.6 129.88 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.184 1.468 . . . . 0.0 110.977 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.413 HG23 ' CD2' ' A' ' 25' ' ' LEU . 13.9 m -121.37 110.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.821 1.648 . . . . 0.0 107.062 170.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -82.84 96.15 8.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 161.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.38 122.42 24.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.748 -1.22 . . . . 0.0 110.817 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.8 103.58 15.48 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 108.664 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -112.83 144.54 42.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.155 1.382 . . . . 0.0 110.219 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -119.29 133.63 55.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.013 1.325 . . . . 0.0 109.519 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.403 0 C-N-CA 125.068 1.347 . . . . 0.0 114.386 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.517 17.4 m 61.92 98.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.001 2.521 . . . . 0.0 116.531 171.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.2 m -129.43 120.99 26.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.4 p -71.36 135.72 47.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.168 0.987 . . . . 0.0 109.796 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.259 1.604 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -166.062 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.375 0.607 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 134.42 54.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.77 1.228 . . . . 0.0 107.947 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.21 68.49 0.71 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.94 1.352 . . . . 0.0 108.819 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.4 t -75.97 112.77 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.522 2.329 . . . . 0.0 112.21 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.29 3.0 pm0 -100.74 120.84 40.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.879 -1.763 . . . . 0.0 111.708 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 mt -133.73 174.34 10.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.56 1.144 . . . . 0.0 108.802 -171.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.03 125.52 52.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 160.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 143.82 41.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 113.117 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -91.15 87.28 6.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.965 1.364 . . . . 0.0 110.69 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 67.58 6.88 5.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.947 2.099 . . . . 0.0 115.404 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.47 72.88 0.53 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.8 t 167.97 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.332 1.853 . . . . 0.0 108.447 -166.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.14 -45.13 67.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 154.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.12 40.67 0.95 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 124.848 1.213 . . . . 0.0 110.68 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -127.84 134.22 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.962 0.887 . . . . 0.0 109.862 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.5 m -85.07 120.46 26.6 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 123.677 0.791 . . . . 0.0 111.553 163.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.54 142.35 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -142.8 170.72 15.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.316 1.446 . . . . 0.0 110.0 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 -130.96 10.55 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.053 1.311 . . . . 0.0 112.368 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.32 157.62 31.56 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.598 1.094 . . . . 0.0 111.421 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.43 -1.469 0 C-N-CA 126.391 1.877 . . . . 0.0 113.193 173.49 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.724 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -143.31 160.93 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.289 -1.712 . . . . 0.0 106.79 160.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -125.56 166.74 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.092 -1.63 . . . . 0.0 107.291 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.4 t -83.89 141.35 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.085 -1.634 . . . . 0.0 110.216 170.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -97.09 -57.69 2.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.803 -1.185 . . . . 0.0 109.535 160.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.69 145.11 49.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.879 0.872 . . . . 0.0 111.135 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.1 mm -101.07 131.94 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.279 1.831 . . . . 0.0 106.706 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt . . . . . 0 N--CA 1.431 -1.381 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.339 179.115 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.517 0 CA-C-O 121.667 0.746 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.18 59.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 126.213 1.805 . . . . 0.0 114.443 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.7 -32.54 67.48 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.032 -1.668 . . . . 0.0 113.06 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -70.54 -0.62 8.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.69 -96.98 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.209 -2.182 . . . . 0.0 107.553 156.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.93 -14.42 0.77 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.75 -1.219 . . . . 0.0 113.067 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -84.63 -23.45 29.52 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.939 -1.33 . . . . 0.0 110.733 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.39 135.22 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.181 2.592 . . . . 0.0 113.965 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 4.1 t-80 -143.98 -173.72 4.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.419 1.58 . . . . 0.0 114.343 167.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.606 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 78.4 mttt -89.22 81.16 6.76 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.185 1.794 . . . . 0.0 111.348 -164.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.98 -14.28 0.77 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.17 -0.956 . . . . 0.0 113.029 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.84 170.26 8.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -106.3 143.83 33.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.232 1.413 . . . . 0.0 109.643 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 p -110.48 129.38 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 164.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.05 -32.84 8.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.878 -1.764 . . . . 0.0 112.211 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.03 156.89 42.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.729 -1.232 . . . . 0.0 112.441 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 t -136.15 120.77 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.083 -1.01 . . . . 0.0 110.784 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.3 t30 65.3 19.21 11.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.892 1.277 . . . . 0.0 112.736 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.17 46.25 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.601 -1.312 . . . . 0.0 113.284 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.95 104.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.3 p -65.56 138.51 58.1 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.323 1.449 . . . . 0.0 114.32 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -80.71 49.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.31 1.844 . . . . 0.0 111.247 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.44 107.96 6.91 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.584 1.554 . . . . 0.0 110.643 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 29.61 62.48 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 114.025 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.84 137.25 33.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.567 1.651 . . . . 0.0 113.555 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.6 p -93.66 -165.74 1.38 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.365 1.866 . . . . 0.0 108.341 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -64.71 -50.07 68.38 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 119.547 -1.971 . . . . 0.0 111.371 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -64.28 -49.04 73.38 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.393 1.077 . . . . 0.0 113.194 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -67.69 -30.95 70.6 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.603 -1.311 . . . . 0.0 114.332 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.14 93.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.126 -1.609 . . . . 0.0 114.48 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.4 t -53.68 -51.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.609 1.163 . . . . 0.0 111.574 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -58.4 -43.4 88.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.512 -1.368 . . . . 0.0 114.463 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.0 m -65.53 -30.79 71.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.551 1.54 . . . . 0.0 114.508 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -88.62 -49.23 7.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.946 1.298 . . . . 0.0 112.096 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.22 44.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -91.63 37.75 0.97 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.071 -1.643 . . . . 0.0 110.898 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 p -94.06 170.09 9.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.053 2.141 . . . . 0.0 108.125 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.1 -79.24 1.04 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 119.83 -1.794 . . . . 0.0 112.693 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -137.75 -57.7 0.68 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.653 -0.91 . . . . 0.0 108.979 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.5 t -78.07 130.47 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 123.114 1.435 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 m -115.26 117.88 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.464 1.106 . . . . 0.0 108.157 167.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -85.72 97.54 10.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.258 -1.527 . . . . 0.0 107.349 161.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 mt -85.19 112.57 20.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 110.762 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.07 105.19 17.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.168 0.987 . . . . 0.0 108.719 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mt -117.9 144.26 45.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.589 1.555 . . . . 0.0 111.352 -165.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.07 138.67 54.61 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.462 1.505 . . . . 0.0 109.637 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp . . . . . 0 N--CA 1.43 -1.443 0 C-N-CA 124.731 1.212 . . . . 0.0 113.735 -172.362 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.592 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 5.5 tp . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.592 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.411 1.9 t 38.22 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 129.81 3.244 . . . . 0.0 116.281 152.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 46.7 m -138.04 122.61 18.52 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 102.941 -2.985 . . . . 0.0 102.941 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -83.52 127.91 34.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.006 0.908 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.261 1.678 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -163.097 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 122.525 1.155 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.04 120.01 33.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.85 74.41 3.58 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.359 1.064 . . . . 0.0 108.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.94 153.12 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 127.187 2.195 . . . . 0.0 110.02 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -130.33 123.03 29.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.945 -1.722 . . . . 0.0 109.501 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -122.89 174.85 6.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.516 1.126 . . . . 0.0 109.29 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.51 136.87 54.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 153.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HB2' ' H ' ' A' ' 24' ' ' SER . 7.7 ptpt -66.85 130.25 42.54 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.067 1.747 . . . . 0.0 113.365 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 101.52 13.3 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.527 -1.358 . . . . 0.0 109.649 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 51.37 64.95 1.64 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.733 2.013 . . . . 0.0 114.01 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.48 72.64 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.869 -1.144 . . . . 0.0 115.234 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.448 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 35.9 t -172.75 99.01 0.14 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.62 -41.99 95.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.363 2.265 . . . . 0.0 107.075 164.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.29 46.32 1.16 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.359 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -123.36 136.9 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 124.358 0.681 . . . . 0.0 110.108 165.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.3 m -84.72 120.0 25.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.3 1.04 . . . . 0.0 110.677 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -90.01 129.82 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -126.54 165.33 19.35 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.232 -2.167 . . . . 0.0 110.958 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 -130.58 10.37 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.333 1.444 . . . . 0.0 113.221 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.2 158.69 24.15 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.756 1.646 . . . . 0.0 110.897 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.429 -1.475 0 C-N-CA 125.098 1.359 . . . . 0.0 114.12 -177.245 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -115.99 151.03 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 167.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.14 153.69 46.59 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.282 -2.137 . . . . 0.0 105.512 -168.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.69 127.03 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.593 -1.942 . . . . 0.0 111.535 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -84.43 -54.49 4.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.497 -1.377 . . . . 0.0 109.977 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 137.82 34.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.292 0.637 . . . . 0.0 110.321 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.9 mm -90.62 144.98 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.271 1.828 . . . . 0.0 107.582 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 119.725 -1.859 . . . . 0.0 108.326 164.559 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.43 0 CA-C-O 121.858 0.837 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -46.88 60.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.824 -1.798 . . . . 0.0 113.072 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.11 -32.87 56.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.803 1.287 . . . . 0.0 113.576 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 p -59.24 -20.98 58.72 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.18 -79.35 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.435 1.094 . . . . 0.0 110.939 167.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.88 -19.32 6.15 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 121.463 -0.773 . . . . 0.0 113.913 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -30.16 60.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.816 -1.402 . . . . 0.0 112.319 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.81 140.79 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -134.83 -164.08 1.47 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -73.42 150.73 41.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.479 -2.013 . . . . 0.0 110.725 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.38 74.75 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 120.57 -1.331 . . . . 0.0 115.445 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.09 148.86 41.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 118.896 1.348 . . . . 0.0 111.891 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.45 112.33 25.18 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.88 1.272 . . . . 0.0 110.036 -168.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.26 3.5 p -84.47 116.03 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 119.963 -1.71 . . . . 0.0 108.36 173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 -37.18 12.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.181 -1.574 . . . . 0.0 111.436 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.14 28.31 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.166 0.984 . . . . 0.0 112.906 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.35 128.94 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.75 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 52.61 18.97 1.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.86 -2.4 . . . . 0.0 117.408 -170.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.1 6.15 63.4 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.425 -1.422 . . . . 0.0 114.945 -171.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -108.03 101.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 125.726 1.611 . . . . 0.0 109.786 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.8 m -68.72 145.02 54.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -82.16 43.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.033 2.533 . . . . 0.0 112.848 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.55 117.33 23.06 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.928 -1.733 . . . . 0.0 110.72 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.5 86.55 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 123.926 0.774 . . . . 0.0 113.436 -170.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.87 133.96 33.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.939 1.37 . . . . 0.0 113.434 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.482 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 44.6 p -97.14 -160.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.402 2.681 . . . . 0.0 108.228 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -63.77 -55.96 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.045 -1.659 . . . . 0.0 111.771 164.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -64.98 -38.76 92.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.482 ' HB3' ' H ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -70.86 -37.31 73.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.789 -1.819 . . . . 0.0 114.149 174.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.62 76.42 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.2 -1.563 . . . . 0.0 114.22 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.3 t -58.93 -56.37 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.729 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.97 -43.23 63.46 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 m -56.18 -45.55 79.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.188 2.195 . . . . 0.0 114.629 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.91 -32.38 15.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.746 -1.846 . . . . 0.0 115.26 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -79.34 -50.08 11.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.488 1.515 . . . . 0.0 113.145 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -92.19 52.23 1.92 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.126 -1.609 . . . . 0.0 111.922 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.1 p -95.04 -164.96 1.23 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.303 2.241 . . . . 0.0 110.656 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.25 -75.43 1.19 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.089 -1.632 . . . . 0.0 112.365 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -150.6 -60.21 0.19 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.822 -1.399 . . . . 0.0 110.225 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -72.35 125.04 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.219 1.485 . . . . 0.0 110.614 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.97 103.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -73.85 110.35 8.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.917 -1.114 . . . . 0.0 110.38 165.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.2 mt -91.79 110.67 22.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.367 0.985 . . . . 0.0 108.681 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.66 95.41 10.25 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.906 0.86 . . . . 0.0 108.769 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.14 138.91 40.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.102 1.761 . . . . 0.0 110.273 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.91 137.02 46.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.59 1.956 . . . . 0.0 108.088 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 tptt . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.416 2.3 t 67.79 104.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 124.395 2.045 . . . . 0.0 113.484 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 59.5 m -135.84 123.82 22.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -70.44 121.64 18.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.627 1.171 . . . . 0.0 108.549 167.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.259 1.589 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -166.567 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 121.183 0.516 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.94 116.97 24.48 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.615 1.166 . . . . 0.0 109.39 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.71 86.61 7.31 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.273 1.035 . . . . 0.0 110.279 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.12 121.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.874 2.069 . . . . 0.0 109.722 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.07 116.8 24.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.547 -1.971 . . . . 0.0 111.448 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.13 167.79 27.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.223 -1.548 . . . . 0.0 112.279 -167.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.22 138.8 40.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.378 1.071 . . . . 0.0 110.212 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -75.67 160.91 29.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.717 -1.24 . . . . 0.0 112.539 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 m -92.6 71.8 5.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.276 -1.515 . . . . 0.0 109.343 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 53.57 63.58 2.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.158 2.183 . . . . 0.0 114.959 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.45 38.57 14.25 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -177.54 108.59 0.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.201 1.4 . . . . 0.0 107.932 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -66.0 -48.04 72.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.279 2.632 . . . . 0.0 108.2 169.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.07 34.41 0.78 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.094 1.33 . . . . 0.0 112.645 172.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 pt -121.76 129.66 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 121.454 0.645 . . . . 0.0 110.514 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.257 5.5 m -78.68 122.9 26.56 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 111.81 162.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.19 134.29 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -130.61 168.08 17.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.115 1.366 . . . . 0.0 109.069 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.59 -146.99 21.06 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.237 0.923 . . . . 0.0 113.28 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.69 169.65 43.98 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 121.314 -1.11 . . . . 0.0 112.02 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -171.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.289 2.7 tp -112.61 151.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.804 -1.41 . . . . 0.0 107.459 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.98 155.13 50.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -167.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.52 136.7 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 119.48 -2.012 . . . . 0.0 111.387 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -92.59 -51.71 4.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.025 0.93 . . . . 0.0 110.507 166.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.82 141.78 38.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.594 -0.691 . . . . 0.0 111.574 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.2 mm -103.66 128.63 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.259 1.823 . . . . 0.0 109.676 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 pt . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.498 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.86 88.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.5 -40.06 65.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.16 1.457 . . . . 0.0 112.889 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 t -79.58 -16.14 56.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.25 -54.05 14.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.753 2.524 . . . . 0.0 111.365 -164.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.58 -77.78 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 118.925 -1.607 . . . . 0.0 113.476 153.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -81.74 -7.8 59.63 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -164.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mt -73.29 126.47 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.039 -1.663 . . . . 0.0 114.196 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 74.9 t60 -128.81 -160.1 1.0 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 163.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 20.6 pttp -92.95 67.09 4.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.349 -2.72 . . . . 0.0 114.442 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.35 42.83 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.461 -2.649 . . . . 0.0 116.717 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -116.17 174.67 5.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.987 1.393 . . . . 0.0 111.213 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 129.7 56.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.868 1.667 . . . . 0.0 107.435 176.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.269 9.4 p -100.13 119.86 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.061 1.3 . . . . 0.0 107.892 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -39.01 10.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.524 -1.36 . . . . 0.0 111.547 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.23 150.36 42.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.03 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.0 t -133.14 116.94 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.19 31.1 20.39 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.974 1.31 . . . . 0.0 112.92 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.16 30.92 54.18 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.192 -0.943 . . . . 0.0 112.939 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -129.12 100.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 t -70.37 137.31 50.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 112.814 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.12 57.1 3.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.515 1.526 . . . . 0.0 112.562 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.23 94.69 9.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.538 -1.976 . . . . 0.0 110.729 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.04 45.58 4.12 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 121.349 -0.844 . . . . 0.0 111.521 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.18 147.56 37.17 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.592 1.187 . . . . 0.0 109.202 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -126.21 -165.35 1.43 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -52.58 -55.16 24.2 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.216 -1.553 . . . . 0.0 114.292 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -62.5 -50.55 70.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.672 1.225 . . . . 0.0 113.491 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -42.58 99.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.546 1.138 . . . . 0.0 113.426 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.98 89.36 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 120.442 -1.411 . . . . 0.0 114.431 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.1 t -54.94 -56.59 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.328 0.967 . . . . 0.0 110.676 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.41 -27.38 65.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -65.78 -26.6 67.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.78 2.032 . . . . 0.0 112.623 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.93 -46.46 8.52 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.14 1.376 . . . . 0.0 112.587 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.4 ' HB3' ' CG2' ' B' ' 210' ' ' VAL 0.45 0.0 OUTLIER -71.74 -45.78 60.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.048 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -93.7 45.4 1.15 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.323 1.535 . . . . 0.0 110.344 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.4 p -98.13 157.23 16.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.512 2.325 . . . . 0.0 108.256 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -63.53 4.19 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.21 -0.931 . . . . 0.0 115.418 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -155.22 -59.93 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.687 -0.89 . . . . 0.0 109.03 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.83 124.72 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.212 1.482 . . . . 0.0 110.6 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.5 t -112.27 104.83 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.24 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -78.33 104.81 9.16 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mt -90.83 107.37 19.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.401 1.481 . . . . 0.0 107.783 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.35 95.92 10.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 173.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.22 142.9 32.73 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.068 2.147 . . . . 0.0 110.362 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -115.07 136.58 52.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.436 1.094 . . . . 0.0 109.029 167.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 125.918 1.687 . . . . 0.0 113.543 179.484 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.425 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.434 2.6 t 69.93 96.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 124.969 2.318 . . . . 0.0 113.393 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 79.6 m -149.1 121.8 8.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 -165.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -72.41 139.67 47.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.952 0.901 . . . . 0.0 111.169 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 86' ' ' ARG . 7.7 p . . . . . 0 C--O 1.26 1.639 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 122.419 1.104 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.275 0.1 OUTLIER -114.96 113.81 24.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.712 -1.243 . . . . 0.0 108.697 174.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.29 81.85 5.47 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.108 0.956 . . . . 0.0 109.342 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.68 143.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.769 2.028 . . . . 0.0 109.466 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.52 130.49 55.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.413 -2.054 . . . . 0.0 110.643 166.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.57 157.58 33.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.225 1.01 . . . . 0.0 108.314 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.77 105.78 13.43 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.957 0.884 . . . . 0.0 109.181 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.37 135.12 45.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.509 1.924 . . . . 0.0 112.992 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -101.88 108.62 20.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.791 -1.193 . . . . 0.0 108.869 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 42.76 49.12 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.619 2.368 . . . . 0.0 116.162 -166.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 45.84 26.81 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.808 -1.183 . . . . 0.0 115.248 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -161.06 117.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.899 1.809 . . . . 0.0 106.138 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.08 -36.05 66.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.292 1.837 . . . . 0.0 107.732 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.03 2.14 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.478 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.4 pt -127.67 135.36 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.674 1.226 . . . . 0.0 109.566 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -78.94 112.02 15.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.937 1.695 . . . . 0.0 112.507 172.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.86 131.67 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -132.88 174.05 10.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.956 2.502 . . . . 0.0 108.325 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.87 45.18 76.05 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 118.608 2.203 . . . . 0.0 118.608 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.54 169.81 47.67 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 120.592 -1.534 . . . . 0.0 111.227 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.31 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.776 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -145.79 162.15 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 159.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.9 165.62 27.02 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.41 -1.431 . . . . 0.0 108.642 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -80.31 138.19 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.574 1.95 . . . . 0.0 110.643 167.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -95.24 -57.47 2.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.395 -1.441 . . . . 0.0 109.542 159.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.78 134.74 52.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.879 1.272 . . . . 0.0 111.301 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mm -93.33 133.46 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 pt . . . . . 0 N--CA 1.431 -1.403 0 O-C-N 121.113 -0.992 . . . . 0.0 111.637 172.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.53 -42.0 65.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.41 -36.8 61.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.942 1.829 . . . . 0.0 112.535 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -74.56 6.49 3.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.12 -79.26 0.09 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.894 -2.379 . . . . 0.0 106.357 152.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.51 -31.6 1.66 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.271 -0.893 . . . . 0.0 111.179 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -89.07 -20.87 23.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.533 -0.98 . . . . 0.0 111.335 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mt -66.46 130.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 124.859 1.264 . . . . 0.0 110.106 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -155.34 169.79 23.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -161.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -80.03 77.04 6.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.74 -1.225 . . . . 0.0 111.864 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.78 60.05 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.376 0.989 . . . . 0.0 110.839 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.57 -151.52 0.34 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.895 2.078 . . . . 0.0 110.222 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -160.04 121.04 3.08 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 149.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.56 122.73 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.034 -1.667 . . . . 0.0 107.728 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -30.3 9.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.888 -1.133 . . . . 0.0 113.275 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.26 159.01 41.07 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 120.244 1.383 . . . . 0.0 113.64 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 t -137.19 119.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 123.997 0.919 . . . . 0.0 111.856 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.99 34.4 22.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.876 -1.765 . . . . 0.0 113.473 -167.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.17 -5.13 73.33 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.627 1.584 . . . . 0.0 113.834 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.61 106.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 121.008 -1.289 . . . . 0.0 108.297 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.8 p -60.71 137.21 58.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.244 1.018 . . . . 0.0 113.612 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.27 -48.8 55.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.4 1.08 . . . . 0.0 111.143 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 34.5 41.83 0.06 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.248 3.425 . . . . 0.0 120.248 160.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.37 -16.85 2.49 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.129 -1.607 . . . . 0.0 111.88 -165.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.29 132.35 44.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.042 1.877 . . . . 0.0 115.119 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -175.45 2.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -48.03 -52.77 18.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.585 -1.947 . . . . 0.0 115.455 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -74.16 -43.95 55.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.309 -0.869 . . . . 0.0 112.161 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -57.58 -43.6 84.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.11 1.364 . . . . 0.0 114.328 172.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -40.68 95.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.452 -1.405 . . . . 0.0 114.292 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.4 -42.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 121.076 -1.015 . . . . 0.0 111.593 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.91 -44.22 97.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.943 -1.723 . . . . 0.0 114.697 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.8 m -58.93 -26.51 64.44 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.688 1.995 . . . . 0.0 114.83 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -91.24 -46.52 8.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.634 1.574 . . . . 0.0 112.679 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -79.35 -34.9 41.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.999 -1.688 . . . . 0.0 114.569 -172.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.82 35.22 0.68 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.455 1.598 . . . . 0.0 111.888 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.4 p -99.67 -176.81 3.38 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.564 3.146 . . . . 0.0 108.203 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.42 -115.02 0.57 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.264 -1.522 . . . . 0.0 112.069 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.62 -44.88 4.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.246 1.018 . . . . 0.0 110.868 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.48 125.01 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.041 1.4 . . . . 0.0 110.462 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.8 t -114.0 106.49 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -83.36 101.66 11.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.575 1.55 . . . . 0.0 109.155 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.27 115.91 26.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 99.52 12.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.08 148.62 25.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.696 1.999 . . . . 0.0 111.776 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.32 1.448 . . . . 0.0 109.608 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? . . . . . 0 CA--C 1.489 -1.371 0 O-C-N 120.179 -1.575 . . . . 0.0 110.982 176.662 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.46 3.5 t 64.26 106.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 162.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 88.4 m -143.92 120.82 11.31 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 103.039 -2.948 . . . . 0.0 103.039 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -76.39 119.91 20.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.604 1.093 . . . . 0.0 109.62 173.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.26 1.634 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -167.082 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.259 0.1 OUTLIER -132.56 115.14 15.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.88 91.41 8.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.591 1.186 . . . . 0.0 110.282 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.12 154.1 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.71 2.004 . . . . 0.0 108.494 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -130.99 113.24 13.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.212 -2.18 . . . . 0.0 110.322 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.5 mt -119.62 152.15 37.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.587 -1.32 . . . . 0.0 111.001 -170.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.96 117.87 35.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 165.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.54 138.01 54.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.952 -1.092 . . . . 0.0 112.581 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -89.83 103.34 16.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.648 1.213 . . . . 0.0 109.075 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 51.71 44.62 29.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.788 2.435 . . . . 0.0 115.248 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 48.72 26.9 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 119.888 -1.757 . . . . 0.0 114.398 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -161.81 111.55 1.56 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.2 mt -73.44 -45.19 55.83 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 167.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.52 31.65 0.76 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.089 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.43 124.98 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 122.278 1.037 . . . . 0.0 110.647 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 114.44 17.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.385 1.074 . . . . 0.0 111.481 166.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 127.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -128.16 -179.7 5.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.834 2.453 . . . . 0.0 108.702 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -125.22 7.05 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.346 -1.471 . . . . 0.0 111.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.51 162.64 35.05 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.477 -1.014 . . . . 0.0 114.164 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.431 -1.414 0 C-N-CA 125.399 1.48 . . . . 0.0 113.667 -177.516 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.56 161.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -133.94 162.08 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.299 -2.125 . . . . 0.0 106.646 -170.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.98 132.57 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.391 -1.443 . . . . 0.0 110.61 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -90.37 -53.44 4.44 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.44 -1.413 . . . . 0.0 109.161 163.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.96 135.68 31.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.897 0.879 . . . . 0.0 109.49 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.82 128.66 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 pt . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.749 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.44 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.25 86.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.674 1.589 . . . . 0.0 114.226 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -60.3 -38.19 82.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.906 -1.121 . . . . 0.0 111.253 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -70.95 0.52 7.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.45 -74.23 0.19 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.524 -2.61 . . . . 0.0 108.205 156.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.61 -26.22 3.5 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 121.638 -0.664 . . . . 0.0 111.518 167.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -80.52 -24.84 39.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.739 -0.859 . . . . 0.0 112.149 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 132.6 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.011 1.324 . . . . 0.0 112.392 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 41.5 t60 -138.28 -178.44 5.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 173.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 27.0 mttm -78.35 69.21 4.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.573 -1.329 . . . . 0.0 113.157 -168.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 3.31 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -80.37 171.76 14.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.197 1.999 . . . . 0.0 114.005 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.3 ttt-85 -108.24 139.11 43.39 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.843 1.257 . . . . 0.0 109.942 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.28 115.27 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.384 1.874 . . . . 0.0 107.662 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.45 -34.41 10.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.832 -1.792 . . . . 0.0 113.846 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.11 152.68 39.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.773 1.17 . . . . 0.0 113.696 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.0 t -135.72 122.75 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.43 0.692 . . . . 0.0 111.129 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 58.98 28.04 17.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.25 1.02 . . . . 0.0 113.409 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.35 46.06 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.737 1.636 . . . . 0.0 114.015 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.95 96.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 118.761 1.28 . . . . 0.0 110.275 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.3 p -67.49 142.49 56.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.78 68.39 10.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.28 128.01 33.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 109.247 162.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.99 -2.28 65.57 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.754 1.862 . . . . 0.0 117.754 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 135.96 33.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.422 2.111 . . . . 0.0 113.586 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.0 t -109.35 -169.61 1.51 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.5 2.72 . . . . 0.0 106.143 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -49.16 -58.89 4.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.933 2.093 . . . . 0.0 115.103 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -72.23 -42.09 66.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.165 1.46 . . . . 0.0 111.077 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -59.19 -47.34 85.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.954 1.702 . . . . 0.0 113.84 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.55 79.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.94 -51.85 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 121.134 -0.979 . . . . 0.0 111.221 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -56.8 -36.65 70.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 m -69.43 -24.24 63.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.309 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mt -89.82 -44.41 9.97 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.534 -1.978 . . . . 0.0 111.877 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -78.6 -44.17 24.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 127.743 2.417 . . . . 0.0 116.037 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -81.31 13.35 2.96 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 123.941 1.829 . . . . 0.0 114.503 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -84.15 -176.37 6.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.457 3.103 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.33 -123.88 2.1 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 120.131 -1.605 . . . . 0.0 112.762 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -95.33 -60.26 1.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 111.091 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.26 120.99 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 123.051 1.405 . . . . 0.0 112.109 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.13 110.68 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.054 1.742 . . . . 0.0 107.816 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.55 102.82 7.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.929 -1.107 . . . . 0.0 110.312 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 113.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.899 1.279 . . . . 0.0 109.132 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.92 105.36 17.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.359 -0.838 . . . . 0.0 109.197 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.78 145.78 29.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.457 1.503 . . . . 0.0 111.403 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.71 145.96 42.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.48 1.912 . . . . 0.0 106.694 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.632 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 121.201 0.524 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.412 2.3 t 79.8 112.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 124.221 1.962 . . . . 0.0 113.319 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 38.9 m -145.02 124.99 13.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.515 -3.143 . . . . 0.0 102.515 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -80.83 131.42 35.39 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.257 0.935 . . . . 0.0 110.865 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 25' ' ' LEU . 7.2 p . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 -160.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.431 -1.413 0 CA-C-O 122.519 1.152 . . . . 0.0 113.636 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.14 119.6 12.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.432 1.493 . . . . 0.0 107.871 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.42 66.88 1.5 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.576 1.15 . . . . 0.0 111.265 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.32 111.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.113 2.165 . . . . 0.0 114.426 -168.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.31 0.2 OUTLIER -96.31 111.95 23.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.781 -1.824 . . . . 0.0 112.86 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.75 159.75 22.5 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.546 1.138 . . . . 0.0 107.984 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.38 24.08 10.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.398 1.094 . . . . 0.0 111.142 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HB3' ' H ' ' A' ' 24' ' ' SER . 30.3 mttt 52.29 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.984 2.914 . . . . 0.0 114.515 -171.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -122.42 81.3 1.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.35 -2.094 . . . . 0.0 106.506 159.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 55.73 64.05 1.86 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.938 2.095 . . . . 0.0 115.15 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.47 46.79 9.53 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.85 -1.156 . . . . 0.0 114.987 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.544 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 47.7 t 178.53 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mt -75.54 -38.34 59.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.426 1.89 . . . . 0.0 107.368 169.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.22 14.83 4.38 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.941 168.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.22 125.32 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.263 1.03 . . . . 0.0 110.732 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.9 m -78.35 109.27 12.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.717 1.207 . . . . 0.0 110.504 169.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.35 127.19 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -125.31 167.9 14.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.424 1.49 . . . . 0.0 110.406 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 -125.6 7.07 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.564 1.554 . . . . 0.0 113.183 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.3 167.34 30.12 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 120.163 -1.787 . . . . 0.0 113.554 179.026 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.42 167.31 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -136.14 156.5 48.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.559 -1.963 . . . . 0.0 107.12 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.57 130.46 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.262 -1.524 . . . . 0.0 112.015 165.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -91.89 -38.68 12.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.417 -1.427 . . . . 0.0 112.531 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.3 136.08 22.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.7 -1.25 . . . . 0.0 112.129 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mm -96.75 143.32 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.026 2.131 . . . . 0.0 108.008 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 120.72 -1.238 . . . . 0.0 113.827 176.075 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.52 78.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.66 -35.6 81.07 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.6 -1.938 . . . . 0.0 111.741 170.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.27 2.58 24.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.15 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.859 -1.776 . . . . 0.0 108.476 160.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 -41.79 0.29 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.783 -1.198 . . . . 0.0 111.186 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.9 mtm-85 -87.42 -17.35 32.46 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.58 133.45 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.676 -1.265 . . . . 0.0 112.293 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 21.9 t-80 -129.24 -165.18 1.48 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.939 0.896 . . . . 0.0 108.604 170.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.529 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 43.2 pttt -102.71 44.79 0.99 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.852 -1.78 . . . . 0.0 112.229 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.68 33.97 0.16 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -97.74 178.19 5.23 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.358 1.063 . . . . 0.0 109.667 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -114.33 128.63 56.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.745 -1.847 . . . . 0.0 108.698 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.36 110.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.378 -1.452 . . . . 0.0 107.27 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -48.58 7.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.507 -1.996 . . . . 0.0 112.348 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -136.79 160.87 37.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.882 -1.136 . . . . 0.0 113.479 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.0 112.94 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 123.964 0.905 . . . . 0.0 111.285 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 58.74 26.82 15.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.138 -1.601 . . . . 0.0 113.536 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 12.98 83.66 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.702 -1.249 . . . . 0.0 113.705 -171.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.85 100.27 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -68.14 148.46 50.88 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 121.109 -0.995 . . . . 0.0 110.091 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.561 2.059 . . . . 0.0 116.561 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 61.29 51.63 4.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.334 1.54 . . . . 0.0 112.314 169.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.58 35.0 80.03 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.087 -1.633 . . . . 0.0 115.617 -173.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.65 151.99 23.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.541 1.639 . . . . 0.0 113.13 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 64.5 p -104.2 -158.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.161 2.585 . . . . 0.0 109.381 -169.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -60.21 -51.3 70.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.191 -1.568 . . . . 0.0 112.471 161.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -70.69 -46.14 63.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.126 0.971 . . . . 0.0 111.983 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.489 ' HB2' ' H ' ' A' ' 77' ' ' THR . 65.9 mt-30 -66.57 -34.38 77.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.993 -1.067 . . . . 0.0 113.454 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.11 93.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.313 1.87 . . . . 0.0 114.288 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.8 -50.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.909 0.884 . . . . 0.0 111.596 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -59.26 -40.53 86.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.346 -1.471 . . . . 0.0 113.874 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -59.78 -30.36 68.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.623 1.969 . . . . 0.0 113.428 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -89.96 -42.05 11.4 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.342 1.857 . . . . 0.0 113.78 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -24.87 24.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -90.05 24.5 2.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.276 -2.14 . . . . 0.0 112.907 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 p -94.38 162.39 13.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.655 2.782 . . . . 0.0 112.409 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.37 65.02 3.44 Favored Glycine 0 N--CA 1.431 -1.695 0 O-C-N 120.528 -1.358 . . . . 0.0 113.718 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.271 28.1 tt0 68.33 -55.24 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.0 115.368 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.75 132.6 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.381 1.086 . . . . 0.0 110.625 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.3 108.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 172.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -77.35 108.04 10.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.906 -1.121 . . . . 0.0 108.445 163.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.0 105.29 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.538 -1.351 . . . . 0.0 109.486 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.07 93.96 8.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mt -98.59 139.71 33.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.877 2.071 . . . . 0.0 109.703 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -109.47 135.96 49.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 106.798 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.429 -1.502 0 C-N-CA 124.755 1.222 . . . . 0.0 112.021 -179.571 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.4 ' H ' ' CD2' ' B' ' 206' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.418 2.1 t 76.02 106.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.56 2.124 . . . . 0.0 113.358 172.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -141.31 122.26 14.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.795 -3.039 . . . . 0.0 102.795 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 41.5 m -78.0 129.26 35.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.261 1.684 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -163.213 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.429 -1.486 0 CA-C-O 123.091 1.424 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.82 116.51 18.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -89.57 83.99 6.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.911 1.339 . . . . 0.0 109.741 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -80.84 110.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 126.947 2.099 . . . . 0.0 112.99 -173.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.64 121.67 41.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.101 -2.249 . . . . 0.0 109.531 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -122.04 172.81 7.96 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.089 0.956 . . . . 0.0 109.9 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.23 122.17 23.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 161.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -67.02 160.46 26.48 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.442 1.897 . . . . 0.0 114.805 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -115.75 106.94 14.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.163 1.385 . . . . 0.0 108.924 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.88 55.0 9.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.641 2.376 . . . . 0.0 114.503 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.62 48.55 61.63 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 119.974 -1.704 . . . . 0.0 114.982 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 m -172.01 111.05 0.28 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 -172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -72.73 -36.68 67.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.876 2.07 . . . . 0.0 108.101 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.04 38.15 1.73 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.425 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.45 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 121.838 0.828 . . . . 0.0 110.222 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -85.27 114.11 22.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.16 129.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 t -121.25 164.27 17.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.769 2.428 . . . . 0.0 111.023 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.51 -145.85 18.22 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 125.397 1.475 . . . . 0.0 111.854 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.64 153.87 23.71 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.062 1.315 . . . . 0.0 111.929 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.779 1.631 . . . . 0.0 115.315 -173.866 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.783 0 N-CA-C 104.577 -3.409 . . . . 0.0 104.577 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.256 4.4 tp -129.13 163.0 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -138.84 160.94 38.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.69 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.302 -1.499 . . . . 0.0 110.393 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -88.13 -55.85 3.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.136 -1.602 . . . . 0.0 110.208 166.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.42 139.64 25.72 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.103 0.954 . . . . 0.0 110.782 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mm -91.23 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.552 1.541 . . . . 0.0 107.042 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 121.435 -0.79 . . . . 0.0 112.505 -178.933 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.44 83.52 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -48.09 -36.85 13.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.716 1.606 . . . . 0.0 114.172 167.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 t -73.14 4.25 4.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.66 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.462 -2.024 . . . . 0.0 108.249 155.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.37 -23.69 2.04 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.323 -0.86 . . . . 0.0 112.562 164.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mtt85 -77.56 -31.78 53.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.806 1.242 . . . . 0.0 112.18 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.49 143.72 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.244 1.818 . . . . 0.0 113.966 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 44.6 t60 -142.44 -167.03 2.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.975 -1.078 . . . . 0.0 109.628 170.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.533 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 58.3 mttp -80.06 53.97 1.82 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.859 -1.776 . . . . 0.0 113.255 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.28 -35.08 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.823 -1.798 . . . . 0.0 114.998 -169.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.38 156.29 32.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -167.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 117.37 33.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.292 1.437 . . . . 0.0 110.19 -170.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.46 125.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.255 1.503 . . . . 0.0 109.504 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -37.16 9.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.967 1.307 . . . . 0.0 112.214 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.12 157.11 44.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.68 115.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 124.36 1.064 . . . . 0.0 111.541 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.94 23.13 6.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -168.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.8 12.7 68.36 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.795 -1.19 . . . . 0.0 113.859 -171.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.33 99.27 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.6 p -61.95 139.12 58.42 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 125.832 1.653 . . . . 0.0 113.573 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.26 47.32 1.32 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.708 -1.245 . . . . 0.0 112.66 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -74.59 115.04 13.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.663 -1.898 . . . . 0.0 110.695 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.85 84.92 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.793 -1.192 . . . . 0.0 115.07 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.98 136.3 33.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.847 1.823 . . . . 0.0 112.95 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -95.44 -161.37 0.86 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.087 2.155 . . . . 0.0 109.836 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -64.3 -56.25 15.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.008 -1.682 . . . . 0.0 111.628 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -66.96 -38.73 86.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -67.12 -36.17 81.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.971 -1.706 . . . . 0.0 113.908 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.23 90.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.487 -2.008 . . . . 0.0 113.782 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -55.93 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 124.0 0.92 . . . . 0.0 110.461 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.06 -33.48 57.56 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.5 m -68.67 -36.47 78.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.827 2.051 . . . . 0.0 112.006 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.4 mt -89.29 -34.57 16.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.808 1.643 . . . . 0.0 114.934 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -45.29 17.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.965 1.706 . . . . 0.0 112.445 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -90.0 47.48 1.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.858 -1.777 . . . . 0.0 112.227 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.6 p -107.31 -166.62 1.17 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.988 2.115 . . . . 0.0 110.524 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.73 -93.92 1.25 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.078 -1.639 . . . . 0.0 114.647 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -132.91 -53.01 0.92 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.072 1.349 . . . . 0.0 109.519 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.06 139.84 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.472 -1.392 . . . . 0.0 110.89 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.21 121.82 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -86.46 105.82 17.04 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.66 1.184 . . . . 0.0 109.969 166.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mt -87.24 110.8 20.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.333 -1.48 . . . . 0.0 109.652 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 97.94 11.16 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.728 -1.232 . . . . 0.0 108.44 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -101.54 141.33 34.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.075 2.15 . . . . 0.0 110.901 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -108.27 141.09 40.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.461 1.904 . . . . 0.0 107.488 166.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tptp . . . . . 0 N--CA 1.429 -1.496 0 C-N-CA 126.236 1.814 . . . . 0.0 113.917 179.451 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.417 2.1 t 70.82 104.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 124.553 2.12 . . . . 0.0 114.633 164.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.8 m -142.48 121.99 13.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.325 -2.842 . . . . 0.0 103.325 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 7.4 m -76.21 126.43 30.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.626 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.702 0.763 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 121.4 35.49 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.823 1.249 . . . . 0.0 108.353 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -98.7 79.36 2.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.317 1.532 . . . . 0.0 108.836 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.91 115.55 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.323 2.249 . . . . 0.0 111.581 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.266 3.1 pt-20 -105.87 115.45 30.25 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.221 -2.174 . . . . 0.0 110.276 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -117.28 160.66 20.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.885 1.274 . . . . 0.0 109.568 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.92 105.3 11.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 145.88 55.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -173.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 t -99.48 110.64 23.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.563 1.545 . . . . 0.0 109.068 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t70 58.11 20.41 6.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.57 1.948 . . . . 0.0 116.017 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 57.6 2.02 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.008 -1.682 . . . . 0.0 112.654 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -173.93 112.72 0.19 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 126.207 1.803 . . . . 0.0 106.823 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.6 mt -74.88 -40.15 61.09 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.413 1.885 . . . . 0.0 106.219 165.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.45 40.63 1.11 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.474 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.8 pt -131.68 127.92 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.298 1.047 . . . . 0.0 110.585 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -80.41 123.28 27.9 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.644 1.177 . . . . 0.0 111.515 167.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.72 145.79 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.98 170.74 15.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.349 1.46 . . . . 0.0 109.074 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.12 -133.29 11.71 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.882 1.229 . . . . 0.0 113.615 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.47 161.57 34.82 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 124.753 1.168 . . . . 0.0 112.551 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.43 -1.469 0 O-C-N 120.45 -1.618 . . . . 0.0 115.03 -179.34 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.78 0 N-CA-C 105.153 -3.179 . . . . 0.0 105.153 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.262 3.8 tp -118.73 158.09 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 166.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.94 158.05 45.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.76 138.6 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.227 -1.546 . . . . 0.0 110.732 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -101.51 -74.05 0.63 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.509 -1.369 . . . . 0.0 109.955 167.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.21 124.82 50.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.142 0.972 . . . . 0.0 111.534 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 mm -90.21 133.92 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.274 1.83 . . . . 0.0 108.562 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 116.047 -1.93 . . . . 0.0 109.771 170.662 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.45 0 CA-C-O 121.782 0.801 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 -45.71 69.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -56.15 -36.08 67.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.132 -1.605 . . . . 0.0 111.933 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -71.31 3.04 4.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.67 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.982 1.719 . . . . 0.0 108.83 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.77 -41.49 0.19 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.562 -1.336 . . . . 0.0 111.903 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -84.92 -26.82 27.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.9 mt -65.69 129.09 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 125.174 1.39 . . . . 0.0 114.6 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -132.95 177.71 7.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.731 2.013 . . . . 0.0 110.683 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -71.01 77.03 0.66 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.376 -1.452 . . . . 0.0 113.463 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.81 19.18 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -85.58 165.0 17.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 119.175 1.488 . . . . 0.0 112.147 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 120.72 43.32 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.679 1.191 . . . . 0.0 110.598 -171.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 p -95.84 122.63 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.178 -1.577 . . . . 0.0 110.658 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.0 -36.42 11.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.304 -1.497 . . . . 0.0 111.366 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 155.82 43.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.993 -1.067 . . . . 0.0 113.049 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -131.42 118.52 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.328 -0.857 . . . . 0.0 111.504 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.34 30.78 20.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.266 1.426 . . . . 0.0 112.77 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.51 79.82 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.444 -1.41 . . . . 0.0 114.251 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.35 104.91 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.462 1.505 . . . . 0.0 107.661 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.8 p -64.27 144.76 56.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.21 40.22 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.217 1.407 . . . . 0.0 112.793 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.54 118.48 16.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.117 -1.615 . . . . 0.0 111.305 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.24 88.64 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.063 -1.023 . . . . 0.0 114.846 -174.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.17 140.81 29.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.736 1.732 . . . . 0.0 113.262 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.04 -174.17 2.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -45.93 -50.9 14.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.086 2.154 . . . . 0.0 114.863 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -70.04 -44.31 69.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.787 0.835 . . . . 0.0 112.428 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.89 -37.75 76.11 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.005 -1.059 . . . . 0.0 112.459 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.4 97.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.702 -1.249 . . . . 0.0 113.71 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.3 t -57.0 -53.63 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 123.45 0.7 . . . . 0.0 111.388 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.37 -31.39 67.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.8 m -71.6 -26.21 62.5 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.774 2.029 . . . . 0.0 112.896 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.52 -46.65 8.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.007 1.723 . . . . 0.0 114.275 168.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -32.9 22.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.31 1.844 . . . . 0.0 115.064 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -91.4 41.66 1.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.999 -2.313 . . . . 0.0 111.589 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.9 p -102.84 160.86 14.23 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.681 1.992 . . . . 0.0 108.975 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.5 -70.36 1.11 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.31 -1.494 . . . . 0.0 113.906 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -153.57 -52.73 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.968 -0.724 . . . . 0.0 109.407 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.14 130.53 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.658 1.218 . . . . 0.0 112.049 171.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.24 109.8 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.425 1.09 . . . . 0.0 108.063 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -83.02 109.75 17.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.777 -1.202 . . . . 0.0 109.418 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -89.54 110.1 20.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.55 1.14 . . . . 0.0 108.506 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.15 93.49 9.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.96 144.13 28.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.335 1.854 . . . . 0.0 110.577 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -111.54 144.02 41.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.901 1.68 . . . . 0.0 107.075 164.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 pptt? . . . . . 0 N--CA 1.43 -1.444 0 C-N-CA 126.482 1.913 . . . . 0.0 115.089 172.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.8 tp . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.5 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.443 29.4 m 53.74 82.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.159 2.184 . . . . 0.0 116.667 166.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 94.6 m -118.7 114.31 22.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -170.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.3 m -83.09 124.52 30.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 122.907 0.483 . . . . 0.0 110.118 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.628 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 122.558 1.17 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.48 116.49 14.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.859 1.263 . . . . 0.0 109.107 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.52 81.61 5.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.311 1.529 . . . . 0.0 112.677 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.63 114.68 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 126.651 1.98 . . . . 0.0 112.219 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.55 113.05 26.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.762 -1.836 . . . . 0.0 110.744 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.24 161.49 25.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.78 -1.2 . . . . 0.0 110.28 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.89 117.04 29.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 163.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -49.27 130.76 19.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.33 1.852 . . . . 0.0 114.711 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -96.95 109.9 22.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.775 1.63 . . . . 0.0 107.955 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.57 26.84 11.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.21 2.204 . . . . 0.0 115.3 -171.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.71 64.74 2.09 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.115 -1.616 . . . . 0.0 112.437 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 174.58 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' B' ' 210' ' ' VAL . 9.8 mt -75.72 -45.52 36.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.347 2.022 . . . . 0.0 106.472 169.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.0 32.02 0.89 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 113.672 -1.604 . . . . 0.0 111.568 169.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.0 pt -113.0 129.93 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.884 0.849 . . . . 0.0 109.74 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -83.07 112.45 19.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.286 1.035 . . . . 0.0 110.031 161.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.93 138.32 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.3 t -131.26 167.83 18.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.111 -1.618 . . . . 0.0 108.763 172.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.52 -140.49 18.96 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 124.641 1.115 . . . . 0.0 113.62 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.2 155.43 31.69 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 124.476 1.036 . . . . 0.0 110.56 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.43 -1.47 0 C-N-CA 126.853 2.061 . . . . 0.0 114.959 -178.046 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 CA-C-O 121.533 0.519 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 tp -124.95 160.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.55 153.89 43.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -168.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.5 t -84.37 138.28 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.159 -2.213 . . . . 0.0 111.789 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -94.47 -58.48 2.19 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.778 -1.201 . . . . 0.0 109.603 166.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.17 51.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.377 -0.827 . . . . 0.0 111.647 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.4 mm -96.17 125.43 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.074 1.35 . . . . 0.0 108.439 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 120.733 -1.23 . . . . 0.0 112.772 -179.355 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -45.73 75.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.062 -1.649 . . . . 0.0 113.451 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -19.63 65.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.524 -1.36 . . . . 0.0 112.977 172.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 t -69.11 -22.18 63.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.5 -89.94 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.199 -1.563 . . . . 0.0 110.32 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.84 -3.79 9.22 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.916 -1.115 . . . . 0.0 113.197 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -84.57 -27.94 26.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.013 -1.287 . . . . 0.0 108.399 161.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.13 128.6 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.619 1.567 . . . . 0.0 112.761 166.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -133.74 -155.82 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -90.36 81.73 6.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.201 -2.187 . . . . 0.0 112.894 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.06 39.97 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 118.854 2.301 . . . . 0.0 118.854 164.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -98.19 163.57 12.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.539 1.536 . . . . 0.0 110.943 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -89.26 125.48 35.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.569 -1.332 . . . . 0.0 108.395 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.26 2.9 p -102.48 120.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 -28.93 11.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.796 -1.19 . . . . 0.0 112.124 -173.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.46 161.69 42.26 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 121.635 -0.666 . . . . 0.0 112.459 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.6 122.82 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 121.269 -0.895 . . . . 0.0 110.54 -176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 60.61 26.8 16.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.439 1.927 . . . . 0.0 113.353 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.04 -0.57 89.39 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 125.713 1.625 . . . . 0.0 114.085 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.03 101.88 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.805 1.242 . . . . 0.0 108.132 -172.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -62.6 136.92 58.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.852 -1.155 . . . . 0.0 113.659 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.85 -43.81 91.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.065 0.946 . . . . 0.0 113.512 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 28.22 79.6 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.361 2.664 . . . . 0.0 117.939 158.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.66 -22.32 30.55 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.021 1.296 . . . . 0.0 114.69 -170.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.37 141.43 57.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -98.93 -153.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.814 2.046 . . . . 0.0 110.061 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -73.28 -50.68 20.88 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.8 -1.813 . . . . 0.0 110.918 167.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -64.32 -44.74 90.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.531 0.732 . . . . 0.0 112.757 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -31.87 72.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.641 -1.287 . . . . 0.0 114.25 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.09 94.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.319 -2.113 . . . . 0.0 114.756 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.408 HG11 ' HG2' ' A' ' 86' ' ' ARG . 73.3 t -55.08 -56.24 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.197 0.999 . . . . 0.0 110.049 170.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.04 -46.99 33.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.5 m -62.47 -31.92 72.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.821 2.448 . . . . 0.0 113.58 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.25 -40.78 13.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.53 -1.981 . . . . 0.0 113.668 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.408 ' HG2' HG11 ' A' ' 82' ' ' VAL . 4.4 ppt_? -80.01 -38.74 31.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -166.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.64 29.7 1.12 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.87 -1.769 . . . . 0.0 111.705 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 60.7 p -96.43 151.47 19.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.748 2.819 . . . . 0.0 109.854 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.25 -58.12 4.44 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.687 -1.258 . . . . 0.0 114.643 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -150.93 -67.52 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.651 -0.911 . . . . 0.0 112.297 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.96 128.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.643 1.211 . . . . 0.0 111.086 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -124.11 103.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.92 1.688 . . . . 0.0 106.977 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -81.37 103.61 11.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.768 -1.207 . . . . 0.0 109.379 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.04 115.8 22.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.461 -1.4 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.25 95.1 9.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.09 151.31 19.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.825 2.05 . . . . 0.0 110.708 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.37 147.67 49.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.522 1.129 . . . . 0.0 108.402 164.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm . . . . . 0 N--CA 1.43 -1.458 0 C-N-CA 125.814 1.646 . . . . 0.0 114.511 170.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.624 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 15.2 tp . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.624 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.341 8.8 m 21.72 80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 130.948 3.699 . . . . 0.0 117.636 160.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 44.2 m -118.94 121.38 39.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.8 p -79.14 127.89 32.6 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.563 1.145 . . . . 0.0 110.508 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' LEU . 14.9 p . . . . . 0 C--O 1.26 1.655 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -160.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.119 0.962 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 121.48 16.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.398 1.079 . . . . 0.0 108.908 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -98.88 77.83 2.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.278 1.031 . . . . 0.0 109.729 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.4 t -84.4 132.24 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.871 2.868 . . . . 0.0 113.316 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -110.51 124.75 52.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.886 -2.384 . . . . 0.0 111.8 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.52 150.87 48.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.576 -1.327 . . . . 0.0 110.375 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.11 104.97 12.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 122.181 0.991 . . . . 0.0 108.74 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 140.51 49.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.257 1.576 . . . . 0.0 115.257 -172.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 t -99.38 95.19 6.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.412 1.577 . . . . 0.0 110.138 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t70 56.73 58.11 4.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.753 2.021 . . . . 0.0 113.936 -174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.94 52.21 49.75 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 114.392 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -167.73 98.08 0.47 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.491 1.615 . . . . 0.0 107.647 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.53 -42.22 62.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.364 1.866 . . . . 0.0 106.753 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.7 43.65 0.95 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.295 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.3 pt -125.4 136.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 121.754 0.788 . . . . 0.0 109.462 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 m -82.25 118.09 22.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.941 -1.1 . . . . 0.0 111.716 161.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.48 120.46 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -119.21 163.23 17.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.694 2.798 . . . . 0.0 109.796 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.1 -147.75 19.8 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 124.627 1.108 . . . . 0.0 112.412 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.27 158.48 19.67 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.104 1.335 . . . . 0.0 111.01 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 120.425 -1.633 . . . . 0.0 114.752 -177.68 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 tp -118.3 162.41 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -141.81 165.1 28.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.02 135.93 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.494 -1.379 . . . . 0.0 112.338 172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -73.04 0.55 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.98 -1.075 . . . . 0.0 108.929 164.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.57 126.01 51.72 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.444 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.9 mm -82.69 125.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 161.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt . . . . . 0 N--CA 1.429 -1.511 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.248 175.269 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 121.135 0.493 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.6 57.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.469 1.908 . . . . 0.0 115.753 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -53.6 -43.28 68.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.864 1.316 . . . . 0.0 111.353 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -69.02 5.91 1.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 -78.15 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.385 -1.447 . . . . 0.0 108.944 156.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -39.51 0.45 Allowed Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -93.86 -19.6 20.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 mt -72.57 127.49 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.109 -1.619 . . . . 0.0 113.018 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -125.64 -178.32 4.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.949 1.3 . . . . 0.0 109.045 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -79.06 82.98 5.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 0.0 112.114 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.12 -8.71 0.33 Allowed Glycine 0 N--CA 1.431 -1.655 0 O-C-N 120.122 -1.611 . . . . 0.0 115.815 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.12 157.03 36.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 119.205 1.503 . . . . 0.0 114.266 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.65 132.51 36.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.911 1.284 . . . . 0.0 109.374 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 t -92.39 117.47 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 160.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -31.53 11.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.666 -1.896 . . . . 0.0 112.218 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.56 160.51 43.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.341 -0.849 . . . . 0.0 112.13 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.62 118.58 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 111.037 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.52 26.77 14.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.178 -1.577 . . . . 0.0 113.946 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.59 85.46 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.165 -0.959 . . . . 0.0 113.765 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.04 101.23 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 121.25 -1.147 . . . . 0.0 108.205 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 p -56.97 124.1 17.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.748 2.019 . . . . 0.0 112.759 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.12 -46.29 78.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.934 -1.104 . . . . 0.0 113.664 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 6.01 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.922 3.689 . . . . 0.0 117.68 167.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.8 -23.05 5.08 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.562 -1.336 . . . . 0.0 113.461 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.77 141.82 39.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.1 p -98.13 -161.6 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.789 1.635 . . . . 0.0 108.422 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -59.62 -48.0 83.37 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 119.874 -1.766 . . . . 0.0 112.511 164.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -71.04 -45.1 64.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.285 1.434 . . . . 0.0 111.68 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.52 -33.35 72.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.366 -1.459 . . . . 0.0 114.262 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.85 88.89 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.663 -1.898 . . . . 0.0 114.402 172.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.7 t -54.48 -54.3 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.919 0.888 . . . . 0.0 111.047 171.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -59.06 -37.56 77.34 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 m -61.97 -27.72 69.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.358 1.863 . . . . 0.0 112.204 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.25 -41.93 10.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.473 1.509 . . . . 0.0 114.525 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.293 0.0 OUTLIER -88.7 -32.25 18.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -165.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -88.6 39.54 0.92 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.666 1.222 . . . . 0.0 111.647 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.0 p -105.81 170.81 7.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.696 1.999 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.22 -92.17 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 114.101 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -133.44 -48.22 0.83 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.552 -1.558 . . . . 0.0 109.263 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.31 121.12 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.976 1.37 . . . . 0.0 111.242 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.61 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -87.16 99.97 12.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.769 2.027 . . . . 0.0 107.486 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.06 124.59 31.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.363 -1.461 . . . . 0.0 109.892 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.39 100.55 13.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 146.32 26.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.47 1.908 . . . . 0.0 111.431 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -124.02 144.1 50.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.244 1.417 . . . . 0.0 108.807 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.251 0.548 . . . . 0.0 112.394 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.405 3.8 t 71.33 114.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 124.22 1.962 . . . . 0.0 113.567 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 54.2 m -153.3 129.18 10.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 81.1 p -74.54 129.08 37.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.864 1.266 . . . . 0.0 110.079 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.26 1.608 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -161.443 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.429 -1.483 0 CA-C-O 123.024 1.392 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.4 113.23 16.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 173.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -87.14 85.68 7.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 123.265 1.507 . . . . 0.0 109.949 170.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.16 152.91 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.133 2.173 . . . . 0.0 109.844 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.32 131.67 48.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.103 -1.623 . . . . 0.0 108.716 164.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 167.99 16.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.64 134.47 51.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 157.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HB3' ' H ' ' A' ' 24' ' ' SER . 24.0 mttt -61.61 136.49 58.03 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.077 1.351 . . . . 0.0 113.848 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -84.68 84.37 7.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.417 -1.427 . . . . 0.0 110.047 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.16 60.09 2.18 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.358 2.263 . . . . 0.0 114.602 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.72 48.72 60.11 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.714 -1.241 . . . . 0.0 115.044 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.572 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 40.3 t 176.96 106.7 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -166.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.02 -47.27 74.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.898 2.285 . . . . 0.0 106.283 164.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.34 38.02 0.7 Allowed Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.296 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.15 127.87 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.796 0.808 . . . . 0.0 110.52 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -78.36 104.91 9.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.632 1.973 . . . . 0.0 113.149 165.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.08 125.11 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t -118.57 161.43 20.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.757 2.423 . . . . 0.0 111.457 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.3 21.59 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.129 1.347 . . . . 0.0 113.453 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.68 169.5 20.18 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 124.602 1.096 . . . . 0.0 111.017 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -179.381 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -116.17 157.17 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -131.57 161.7 32.03 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.649 -1.907 . . . . 0.0 106.562 -170.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -86.67 128.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.962 1.305 . . . . 0.0 111.512 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -99.17 -35.6 9.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.735 -1.853 . . . . 0.0 111.739 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.02 133.85 11.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.569 0.699 . . . . 0.0 110.446 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -100.44 115.78 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.771 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.94 85.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.068 -1.645 . . . . 0.0 113.102 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.07 -33.85 76.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.702 -1.249 . . . . 0.0 112.516 168.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.75 -20.43 65.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.78 -76.16 0.1 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.552 -1.342 . . . . 0.0 109.429 162.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.15 7.91 56.96 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.317 -0.864 . . . . 0.0 113.788 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -88.55 -18.69 27.57 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.91 -1.347 . . . . 0.0 109.711 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 153.34 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.634 1.574 . . . . 0.0 112.632 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -147.89 176.59 10.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 166.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -81.16 57.06 3.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.48 0.94 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.552 -1.342 . . . . 0.0 114.841 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -80.11 166.47 21.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 118.982 1.391 . . . . 0.0 114.415 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -103.87 132.08 50.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.95 1.3 . . . . 0.0 109.234 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 p -105.37 125.0 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 107.809 167.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 -28.69 9.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.468 -1.395 . . . . 0.0 113.401 -175.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.22 161.0 42.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 120.007 1.276 . . . . 0.0 112.777 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -133.63 116.76 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.264 1.026 . . . . 0.0 110.532 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 58.77 24.0 11.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.197 -1.564 . . . . 0.0 114.164 -173.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.71 4.93 84.78 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 124.573 1.083 . . . . 0.0 114.132 -171.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.29 102.21 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 p -55.35 135.27 50.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.761 2.024 . . . . 0.0 115.168 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -74.74 -54.51 7.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.837 -1.165 . . . . 0.0 110.8 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -5.07 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.262 3.825 . . . . 0.0 117.897 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.02 6.46 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -163.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.26 138.98 37.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 120.675 -1.486 . . . . 0.0 114.748 -176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -110.71 -161.0 0.73 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.279 2.231 . . . . 0.0 106.391 177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -61.57 -51.83 66.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.466 -2.021 . . . . 0.0 112.793 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -66.51 -49.97 64.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.015 -1.053 . . . . 0.0 112.239 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.22 93.67 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.291 -2.13 . . . . 0.0 114.4 173.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.45 -50.72 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.03 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -47.22 -47.58 24.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.594 1.543 . . . . 0.0 115.03 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 m -62.99 -36.45 83.57 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.456 2.702 . . . . 0.0 114.533 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -90.98 -44.36 9.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.817 1.247 . . . . 0.0 113.73 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.12 13.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.81 2.044 . . . . 0.0 112.599 -170.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -89.17 38.31 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.489 1.614 . . . . 0.0 112.531 -166.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.5 p -91.57 -168.91 2.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.097 2.959 . . . . 0.0 108.944 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -89.6 -116.89 1.63 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.122 -1.611 . . . . 0.0 110.542 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -105.65 -47.7 3.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.72 -0.871 . . . . 0.0 109.951 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.61 129.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.111 -0.993 . . . . 0.0 111.77 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.6 t -122.64 108.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -78.99 109.78 13.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.786 -1.196 . . . . 0.0 108.585 163.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -89.02 120.23 30.25 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.643 -1.286 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.33 97.26 11.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.23 142.14 35.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.544 1.938 . . . . 0.0 110.52 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -115.34 140.4 49.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.786 1.634 . . . . 0.0 108.912 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.45 0 C-N-CA 125.858 1.663 . . . . 0.0 113.853 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.356 4.9 t 74.46 120.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 123.936 1.826 . . . . 0.0 114.813 167.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.3 m -143.15 132.17 22.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.9 p -82.93 129.99 35.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.882 1.273 . . . . 0.0 109.244 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.642 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -164.653 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE2' HD11 ' A' ' 96' ' ' LEU 0.299 0.1 OUTLIER -136.25 129.15 31.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.648 1.179 . . . . 0.0 108.681 171.384 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -105.97 79.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.626 1.203 . . . . 0.0 109.64 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.21 159.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.986 2.114 . . . . 0.0 110.796 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 0.1 OUTLIER -125.74 129.91 50.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 119.949 -1.72 . . . . 0.0 108.386 164.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -125.88 164.95 19.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.102 1.761 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.15 112.92 14.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.274 1.03 . . . . 0.0 109.587 167.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -56.51 144.71 30.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.225 2.21 . . . . 0.0 115.849 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -113.08 117.94 33.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.992 1.317 . . . . 0.0 108.253 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 36.05 51.73 0.79 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.422 2.689 . . . . 0.0 117.522 -166.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.86 48.05 22.97 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.276 -1.515 . . . . 0.0 114.565 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -172.48 111.25 0.25 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.082 1.42 . . . . 0.0 107.298 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.32 -45.3 73.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.322 2.249 . . . . 0.0 108.057 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.68 41.0 0.44 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.176 167.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.64 135.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.983 0.896 . . . . 0.0 110.646 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -85.68 114.21 22.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.263 1.025 . . . . 0.0 109.666 163.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.408 HG21 ' CE1' ' A' ' 78' ' ' HIS . 27.2 m -83.02 137.2 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -176.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 45' ' ' LYS . 15.0 t -127.98 165.77 19.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.652 1.981 . . . . 0.0 110.075 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.84 -149.11 39.2 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.888 1.233 . . . . 0.0 112.893 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.66 168.11 13.31 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 120.837 -1.39 . . . . 0.0 113.759 -178.55 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 N-CA-C 119.998 2.759 . . . . 0.0 119.998 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 tp -94.08 167.51 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 0.0 109.768 -170.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -136.4 158.79 43.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.228 -2.17 . . . . 0.0 107.722 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.5 128.82 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.813 -1.179 . . . . 0.0 111.12 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 21.6 tptp -88.51 -63.08 1.35 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 170.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.21 133.83 54.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.206 1.402 . . . . 0.0 110.125 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.4 mm -97.83 135.89 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.281 1.832 . . . . 0.0 108.274 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.429 -1.477 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.213 174.251 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.77 60.93 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.55 -34.4 70.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.057 1.408 . . . . 0.0 111.71 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -72.09 1.27 7.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.51 -74.15 0.17 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.615 -1.928 . . . . 0.0 107.541 156.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.79 -18.5 2.58 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 113.486 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -92.99 -15.73 25.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.474 0.71 . . . . 0.0 112.48 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -80.86 133.79 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.048 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.29 177.45 8.61 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.188 0.994 . . . . 0.0 111.031 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.91 104.15 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.932 1.693 . . . . 0.0 112.441 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.44 -31.31 2.34 Favored Glycine 0 N--CA 1.429 -1.818 0 O-C-N 120.696 -1.253 . . . . 0.0 115.191 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.73 161.18 31.06 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 118.507 1.154 . . . . 0.0 113.71 -170.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -98.69 134.44 41.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.48 1.112 . . . . 0.0 110.894 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.38 114.11 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.771 1.628 . . . . 0.0 107.072 171.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -27.86 12.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.699 -1.876 . . . . 0.0 113.973 -173.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.35 166.68 30.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 119.073 0.851 . . . . 0.0 112.501 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -146.31 135.35 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 112.077 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.0 m120 56.41 20.22 4.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.382 -2.074 . . . . 0.0 115.93 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.1 79.35 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.255 -1.528 . . . . 0.0 115.383 -168.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 t -109.43 106.26 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.107 1.763 . . . . 0.0 109.485 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.8 p -62.16 141.51 58.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.41 34.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.227 -1.546 . . . . 0.0 113.214 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.74 103.19 3.56 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.5 -2.0 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.1 13.58 58.72 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.376 -0.827 . . . . 0.0 114.079 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 140.03 29.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.673 -1.486 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -95.05 -163.62 1.07 Allowed 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.131 1.772 . . . . 0.0 110.408 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.408 ' CE1' HG21 ' A' ' 29' ' ' VAL . 86.5 t60 -59.97 -54.42 46.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.973 -1.704 . . . . 0.0 112.749 164.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -67.35 -44.79 78.18 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 111.951 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -68.2 -33.89 75.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.32 93.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.695 -1.878 . . . . 0.0 113.727 170.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.4 -53.98 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 122.995 0.518 . . . . 0.0 111.135 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -69.45 -20.13 63.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.7 m -63.81 -36.08 82.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.686 1.595 . . . . 0.0 110.756 168.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.27 -40.0 12.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.312 1.445 . . . . 0.0 114.717 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.459 0.0 OUTLIER -72.83 -43.42 62.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.874 -2.391 . . . . 0.0 116.546 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -87.87 47.41 1.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.007 1.384 . . . . 0.0 111.102 -174.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.0 p -102.09 175.29 5.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.39 2.676 . . . . 0.0 111.417 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.34 75.51 0.21 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 124.802 1.191 . . . . 0.0 111.654 175.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 69.22 -50.61 0.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.068 2.547 . . . . 0.0 117.382 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.86 135.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 125.631 1.572 . . . . 0.0 109.772 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.32 107.31 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 75.5 m80 -79.02 103.03 8.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 109.329 162.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -85.39 117.36 24.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.386 1.474 . . . . 0.0 109.343 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.78 102.94 15.64 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.694 0.759 . . . . 0.0 109.39 167.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -104.82 145.32 30.55 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.521 1.928 . . . . 0.0 110.862 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.76 120.79 43.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 163.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.6 tptt . . . . . 0 N--CA 1.431 -1.404 0 O-C-N 120.73 -1.231 . . . . 0.0 107.691 169.577 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 8.3 tp . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.441 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.461 19.5 m 46.68 91.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 128.12 2.568 . . . . 0.0 117.023 170.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.5 m -128.88 126.58 40.06 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 42.4 m -62.78 123.36 18.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.868 2.467 . . . . 0.0 109.239 170.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--O 1.26 1.651 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 -172.544 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 122.549 1.166 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 111.4 16.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.169 1.388 . . . . 0.0 108.94 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.96 75.0 8.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.344 1.458 . . . . 0.0 110.842 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.42 121.26 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.397 -1.439 . . . . 0.0 114.033 -171.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -100.89 132.41 46.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.758 -1.839 . . . . 0.0 112.192 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.61 178.57 8.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.56 43.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.53 -1.356 . . . . 0.0 109.845 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 146.29 24.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 113.021 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -96.63 85.2 3.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.911 1.338 . . . . 0.0 108.91 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 55.71 72.96 0.45 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.253 1.821 . . . . 0.0 115.015 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.0 50.54 60.96 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.267 1.413 . . . . 0.0 114.324 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 t -169.96 98.08 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -169.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.16 -47.05 30.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.054 1.883 . . . . 0.0 105.956 164.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.11 46.39 0.55 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.114 171.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 pt -118.09 134.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.003 0.921 . . . . 0.0 109.429 166.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -88.99 112.66 23.63 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.574 1.15 . . . . 0.0 109.951 166.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 m -79.23 143.65 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -138.08 171.33 14.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.699 -1.876 . . . . 0.0 109.001 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.98 -133.4 11.78 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 125.011 1.291 . . . . 0.0 112.815 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.36 154.71 29.89 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 123.985 0.803 . . . . 0.0 112.566 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.431 -1.415 0 C-N-CA 125.402 1.481 . . . . 0.0 113.751 -176.581 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.818 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.281 2.4 tp -111.54 159.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.257 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -139.48 157.45 45.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.9 t -82.33 137.9 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.552 -1.967 . . . . 0.0 110.592 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -100.31 -53.29 3.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.941 -1.1 . . . . 0.0 109.851 165.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.65 48.3 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.939 0.876 . . . . 0.0 111.231 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.1 mm -110.79 133.63 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.465 1.906 . . . . 0.0 109.21 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.3 mt . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.762 174.175 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 120.574 0.226 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.62 -45.11 72.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.936 1.694 . . . . 0.0 115.513 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.62 -33.64 68.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.927 -1.733 . . . . 0.0 111.737 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t -72.7 6.33 2.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.84 -88.55 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.001 -1.687 . . . . 0.0 106.888 149.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.33 -21.78 0.95 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.893 -1.129 . . . . 0.0 112.122 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -85.82 -35.56 20.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 121.365 -1.079 . . . . 0.0 111.145 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 mt -60.4 125.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.524 1.53 . . . . 0.0 113.102 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -177.06 4.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.586 1.154 . . . . 0.0 109.412 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -76.62 89.89 3.35 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.086 -1.634 . . . . 0.0 111.434 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.95 -21.17 0.37 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.707 -1.246 . . . . 0.0 114.964 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -68.2 155.32 39.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 114.71 29.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.711 2.004 . . . . 0.0 109.43 -168.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.27 112.68 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.225 -1.547 . . . . 0.0 108.743 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.61 -31.75 11.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.451 -1.406 . . . . 0.0 112.962 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.76 160.25 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.637 1.108 . . . . 0.0 112.553 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 t -137.2 127.32 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.85 27.02 12.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.027 1.74 . . . . 0.0 114.608 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.1 18.73 79.78 Favored Glycine 0 N--CA 1.43 -1.766 0 O-C-N 120.598 -1.314 . . . . 0.0 113.644 -172.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.35 102.22 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 t -60.76 138.06 58.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -86.19 82.12 8.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -110.09 42.09 1.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.315 2.007 . . . . 0.0 110.308 -170.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.17 55.44 0.18 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.01 141.94 43.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.013 0.911 . . . . 0.0 108.581 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.8 p -96.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.572 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.04 -54.67 38.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.47 -1.394 . . . . 0.0 111.713 165.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -67.8 -42.9 80.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.417 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.6 tt0 -63.97 -46.49 84.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.8 77.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.91 -53.74 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 121.709 -0.619 . . . . 0.0 111.285 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.41 -30.87 71.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.4 m -60.3 -28.92 68.49 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.465 1.506 . . . . 0.0 112.303 171.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.0 mt -88.34 -47.0 8.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.02 -1.675 . . . . 0.0 113.355 168.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -88.07 -27.88 21.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -162.097 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -86.9 18.98 3.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.627 -1.296 . . . . 0.0 113.217 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.0 p -88.29 170.49 10.94 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.978 2.511 . . . . 0.0 111.396 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.15 -90.13 0.21 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.373 -1.455 . . . . 0.0 115.238 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -129.44 -57.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.531 . . . . 0.0 110.321 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.24 136.82 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 122.041 0.924 . . . . 0.0 111.028 173.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.69 109.66 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 168.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -85.54 102.67 13.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.644 1.178 . . . . 0.0 109.284 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.65 120.03 28.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.769 -1.832 . . . . 0.0 110.439 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.85 97.72 11.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.911 -1.118 . . . . 0.0 108.663 169.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.38 145.8 28.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.466 1.906 . . . . 0.0 110.41 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.62 144.18 46.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.769 1.228 . . . . 0.0 108.971 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 tptt . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -172.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.4 tp . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.559 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.359 13.5 m 29.27 101.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.781 3.232 . . . . 0.0 119.071 157.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -132.57 123.68 26.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.0 p -75.5 119.93 20.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.692 1.597 . . . . 0.0 110.793 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.566 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.06 126.12 51.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.385 2.674 . . . . 0.0 109.147 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.24 67.16 1.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.222 1.409 . . . . 0.0 110.83 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.38 112.64 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -165.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 5.5 tt0 -93.1 118.81 31.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.432 -2.043 . . . . 0.0 111.418 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.6 169.65 17.18 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.612 1.165 . . . . 0.0 109.351 175.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.31 150.13 32.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.783 1.633 . . . . 0.0 110.006 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.96 174.2 9.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.163 -0.961 . . . . 0.0 112.101 -170.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.8 t -110.89 103.87 12.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.124 -1.61 . . . . 0.0 107.361 168.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t70 34.42 67.48 0.22 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.523 2.729 . . . . 0.0 117.18 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.36 48.35 45.7 Favored Glycine 0 N--CA 1.429 -1.808 0 O-C-N 119.961 -1.712 . . . . 0.0 115.069 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 m -175.98 111.15 0.1 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.56 -45.56 68.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.153 1.781 . . . . 0.0 108.094 167.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.01 45.13 1.31 Allowed Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.774 1.178 . . . . 0.0 110.799 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -125.8 141.96 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 163.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 m -90.37 126.17 35.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 164.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.47 148.83 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -149.38 167.8 25.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.341 -1.475 . . . . 0.0 108.743 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.19 -138.21 14.21 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.854 -1.154 . . . . 0.0 112.704 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.86 167.57 28.3 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.43 -1.469 0 C-N-CA 126.609 1.964 . . . . 0.0 113.3 171.931 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.647 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 tp -107.93 156.86 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -131.7 161.09 33.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 t -91.87 134.17 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.577 -1.327 . . . . 0.0 109.497 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -85.48 -57.26 3.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.586 172.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.85 129.23 25.76 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 123.919 0.888 . . . . 0.0 110.628 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.0 mm -91.7 122.86 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.698 1.599 . . . . 0.0 109.181 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.018 176.152 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 120.814 0.34 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.46 -48.19 67.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.503 1.921 . . . . 0.0 115.876 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.32 -30.47 66.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.126 -1.608 . . . . 0.0 112.344 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t -71.34 3.94 3.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.41 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.438 -1.414 . . . . 0.0 109.378 155.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.67 -45.81 0.26 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.174 -0.953 . . . . 0.0 111.551 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -86.54 -39.9 15.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.68 130.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -163.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.528 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 53.0 t60 -127.38 175.17 8.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.543 1.937 . . . . 0.0 110.833 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 51.0 mttp -86.11 40.96 0.9 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.058 1.743 . . . . 0.0 113.558 -169.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.26 38.58 0.09 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.258 -1.526 . . . . 0.0 110.864 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -103.45 158.1 16.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.07 1.348 . . . . 0.0 109.719 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.69 134.07 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 123.79 0.836 . . . . 0.0 109.229 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.12 110.54 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 163.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.75 -27.86 15.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.96 -1.713 . . . . 0.0 112.187 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.21 41.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 111.39 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -137.37 121.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.938 -1.101 . . . . 0.0 110.297 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.373 0.8 OUTLIER 43.02 34.29 0.61 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -173.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.34 60.64 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.284 0.945 . . . . 0.0 114.008 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.83 98.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.629 1.572 . . . . 0.0 107.225 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -62.36 142.52 57.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.854 -1.154 . . . . 0.0 113.352 173.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.9 mt -87.28 30.74 0.76 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.56 -1.337 . . . . 0.0 112.726 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.38 97.43 2.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.489 1.916 . . . . 0.0 109.061 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.16 -3.21 33.28 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.337 0.97 . . . . 0.0 114.986 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.73 140.95 29.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.943 1.872 . . . . 0.0 114.378 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 80.6 p -101.99 -163.0 0.97 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.503 2.321 . . . . 0.0 109.863 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.01 -53.21 53.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.214 -1.554 . . . . 0.0 111.343 166.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.1 -45.19 82.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.605 -0.684 . . . . 0.0 112.727 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.439 ' HB2' ' H ' ' A' ' 77' ' ' THR . 1.6 mm-40 -61.05 -43.07 99.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.79 -1.194 . . . . 0.0 113.253 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.22 94.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.956 -1.715 . . . . 0.0 115.411 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.43 -48.67 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 121.481 -0.762 . . . . 0.0 111.365 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.05 -36.69 84.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.643 -1.286 . . . . 0.0 114.104 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 m -63.59 -26.56 68.74 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.897 1.679 . . . . 0.0 113.351 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.33 -42.58 11.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.974 -1.704 . . . . 0.0 113.596 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -22.77 23.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.054 -1.654 . . . . 0.0 115.291 -169.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.71 37.51 1.92 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.61 -1.931 . . . . 0.0 111.28 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.5 p -87.76 -171.58 3.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.627 2.371 . . . . 0.0 111.207 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.42 62.54 0.3 Allowed Glycine 0 N--CA 1.431 -1.693 0 O-C-N 120.508 -1.37 . . . . 0.0 112.52 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 72.88 -54.05 0.7 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.301 2.641 . . . . 0.0 114.567 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 t -82.49 132.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 123.071 1.415 . . . . 0.0 109.98 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.76 109.72 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.438 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 8.4 m80 -84.62 102.01 12.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.902 -1.123 . . . . 0.0 108.434 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.5 110.89 21.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.424 -1.422 . . . . 0.0 111.56 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.9 89.31 7.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.398 1.094 . . . . 0.0 108.318 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.9 mt -103.79 148.61 25.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.88 2.472 . . . . 0.0 111.633 -173.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -135.37 140.69 45.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.824 -1.173 . . . . 0.0 109.528 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 120.358 -1.464 . . . . 0.0 113.134 -174.034 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.456 ' CG ' ' H ' ' B' ' 207' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.456 ' H ' ' CG ' ' B' ' 206' ' ' LEU 0.52 33.4 m 66.65 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 127.823 2.449 . . . . 0.0 117.543 174.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 99.6 m -152.55 118.45 5.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 91.1 p -78.65 128.62 33.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.403 1.097 . . . . 0.0 109.935 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.261 1.658 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 -156.386 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.429 -1.523 0 CA-C-O 122.128 0.966 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.05 129.38 56.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.5 1.52 . . . . 0.0 107.483 170.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.46 84.44 3.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.929 1.292 . . . . 0.0 108.815 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.8 107.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.215 2.206 . . . . 0.0 111.662 -171.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.27 112.75 24.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.826 -1.796 . . . . 0.0 109.643 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.8 mt -122.94 150.75 42.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.43 110.5 20.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 148.34 37.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.544 1.138 . . . . 0.0 113.709 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -102.33 97.18 7.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.427 -1.421 . . . . 0.0 109.96 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 60.49 50.12 6.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.787 2.035 . . . . 0.0 112.57 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.81 55.69 25.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 120.352 -1.467 . . . . 0.0 113.934 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -165.87 112.33 0.89 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.236 1.493 . . . . 0.0 107.005 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD22 HG21 ' A' ' 92' ' ' VAL . 6.9 mt -67.33 -49.61 63.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.482 1.913 . . . . 0.0 106.258 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.96 39.06 0.66 Allowed Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.562 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.9 132.28 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.673 0.749 . . . . 0.0 109.817 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -77.22 117.4 18.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.443 -0.785 . . . . 0.0 111.742 159.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.36 128.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -130.19 169.69 15.04 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.379 1.471 . . . . 0.0 108.898 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.82 58.87 7.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.472 2.149 . . . . 0.0 118.472 169.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.52 -176.63 34.18 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.34 -1.683 . . . . 0.0 109.604 172.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.663 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.797 0 CA-C-O 121.911 0.728 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -148.05 161.35 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 161.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -135.71 161.24 36.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.528 -1.982 . . . . 0.0 106.739 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -92.44 129.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.031 -1.668 . . . . 0.0 111.643 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.67 -49.31 6.94 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.808 -1.182 . . . . 0.0 111.429 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.47 126.92 28.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.845 -1.159 . . . . 0.0 110.626 -170.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.3 mm -96.07 119.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt . . . . . 0 N--CA 1.431 -1.407 0 O-C-N 120.841 -1.162 . . . . 0.0 112.735 -177.188 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.57 -50.96 65.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.715 1.606 . . . . 0.0 114.454 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.96 -34.43 68.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.683 -1.26 . . . . 0.0 111.915 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 t -72.51 -6.33 43.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.54 -75.45 0.15 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.632 -1.918 . . . . 0.0 108.552 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.76 -10.19 12.43 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.399 -0.813 . . . . 0.0 114.238 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 -81.74 -23.74 36.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.78 -0.835 . . . . 0.0 111.395 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.99 139.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.165 1.786 . . . . 0.0 112.868 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -138.32 -167.91 2.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.248 1.023 . . . . 0.0 108.758 166.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -80.78 75.95 7.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.328 -1.483 . . . . 0.0 111.967 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.38 13.3 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.747 -1.221 . . . . 0.0 116.126 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -81.97 158.95 23.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.488 1.644 . . . . 0.0 113.18 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.65 114.17 27.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.236 1.415 . . . . 0.0 110.616 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.96 117.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.383 -1.448 . . . . 0.0 108.075 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -97.21 -39.46 9.26 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.003 -1.061 . . . . 0.0 112.163 173.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.2 166.21 34.12 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.118 1.326 . . . . 0.0 114.279 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.16 122.56 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 110.644 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 49.13 30.77 3.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -167.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.85 27.79 57.97 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 120.503 -1.373 . . . . 0.0 113.813 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.83 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.7 m -60.53 136.76 58.15 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.123 1.369 . . . . 0.0 114.59 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.97 53.11 1.9 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.169 1.788 . . . . 0.0 113.446 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.44 117.95 23.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.654 1.582 . . . . 0.0 108.198 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 9.53 86.51 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 120.87 -1.144 . . . . 0.0 115.727 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.76 140.29 29.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.865 1.317 . . . . 0.0 112.659 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 p -100.6 -164.89 1.15 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.968 1.707 . . . . 0.0 109.222 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -60.17 -57.33 13.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.446 -1.409 . . . . 0.0 112.651 163.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.61 -43.82 95.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 112.968 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -37.04 86.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.759 -1.213 . . . . 0.0 113.471 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.87 89.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.314 -1.491 . . . . 0.0 114.986 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.3 t -57.84 -53.21 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 121.69 -0.631 . . . . 0.0 112.108 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.3 m -64.23 -30.17 71.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.53 2.332 . . . . 0.0 113.294 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.8 mt -88.47 -43.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.99 -1.694 . . . . 0.0 113.771 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -48.46 11.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.784 1.634 . . . . 0.0 114.976 -162.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -81.12 18.98 0.96 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.719 1.208 . . . . 0.0 113.723 -169.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.1 p -85.02 177.1 8.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.182 2.593 . . . . 0.0 112.08 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.87 -77.82 0.28 Allowed Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.167 -1.583 . . . . 0.0 115.217 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -154.29 -54.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.982 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.44 128.08 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.846 1.308 . . . . 0.0 111.006 170.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 25' ' ' LEU . 2.7 m -118.42 112.2 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.977 1.711 . . . . 0.0 107.53 166.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -78.85 95.22 5.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.685 -1.259 . . . . 0.0 107.71 164.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 117.3 15.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.791 -1.193 . . . . 0.0 113.063 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.495 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 7.1 mt -86.04 95.64 9.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.8 mt -104.19 130.64 51.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.902 2.881 . . . . 0.0 111.688 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -105.94 140.24 39.25 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.778 -1.202 . . . . 0.0 110.24 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.1 tptt . . . . . 0 N--CA 1.43 -1.439 0 C-N-CA 125.111 1.364 . . . . 0.0 113.121 -175.316 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.424 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.521 30.1 m 66.46 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 127.571 2.348 . . . . 0.0 116.932 171.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 80.3 m -152.82 125.6 8.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 78.7 p -76.91 126.43 30.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.592 1.157 . . . . 0.0 108.404 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.613 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 -161.575 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 121.436 0.636 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.312 0.0 OUTLIER -106.62 136.88 45.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.591 1.556 . . . . 0.0 110.075 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -117.64 76.72 1.08 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.068 1.347 . . . . 0.0 108.423 -173.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.68 137.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 126.851 2.06 . . . . 0.0 111.233 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 127.64 53.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.354 2.343 . . . . 0.0 110.093 167.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.5 128.8 49.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.207 1.003 . . . . 0.0 110.156 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.1 90.88 6.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.219 1.009 . . . . 0.0 109.313 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 137.52 58.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -104.05 105.19 15.28 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.82 1.295 . . . . 0.0 109.413 -160.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 54.78 37.33 28.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.198 2.199 . . . . 0.0 114.958 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.62 88.62 0.25 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.794 -1.191 . . . . 0.0 112.371 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.284 51.9 p 149.32 112.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.727 2.411 . . . . 0.0 109.519 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.0 mt -73.28 -43.16 61.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 156.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.94 17.81 3.31 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.545 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.3 pt -105.8 126.22 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 122.013 0.911 . . . . 0.0 111.09 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -79.31 109.68 13.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.06 1.344 . . . . 0.0 111.469 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.64 127.62 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -134.07 178.93 6.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.697 2.399 . . . . 0.0 108.699 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.11 39.94 35.96 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 119.881 -1.762 . . . . 0.0 117.26 168.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.48 -179.88 49.31 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.092 -1.828 . . . . 0.0 113.606 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.425 0 C-N-CA 126.288 1.835 . . . . 0.0 114.345 179.868 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.704 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 tp -136.32 156.18 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 155.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -137.12 154.56 50.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -171.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 t -84.08 131.94 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 119.694 -1.879 . . . . 0.0 111.067 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.33 -52.66 5.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 109.956 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.43 140.43 41.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 111.696 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -97.61 127.57 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.503 1.921 . . . . 0.0 106.789 169.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 pt . . . . . 0 N--CA 1.429 -1.5 0 O-C-N 121.194 -0.941 . . . . 0.0 112.092 176.782 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.42 0 CA-C-O 121.583 0.706 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.73 72.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.121 -1.612 . . . . 0.0 113.228 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.68 -26.84 64.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.618 1.567 . . . . 0.0 112.424 165.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -80.93 -9.49 59.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.437 -2.039 . . . . 0.0 115.788 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -76.22 -62.45 1.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.748 2.067 . . . . 0.0 106.049 156.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.62 -9.68 62.45 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 121.499 -0.75 . . . . 0.0 112.935 162.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -74.23 -28.77 61.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 123.66 0.784 . . . . 0.0 109.174 166.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.7 mt -61.71 128.08 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 126.938 2.095 . . . . 0.0 110.716 165.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.616 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 70.9 t60 -127.7 -161.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.109 0.963 . . . . 0.0 109.665 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 95.1 mttt -92.45 66.27 4.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.555 -2.59 . . . . 0.0 111.12 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.92 53.5 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.45 -0.781 . . . . 0.0 114.911 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -109.83 173.68 6.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.778 1.231 . . . . 0.0 108.898 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -103.89 136.43 43.56 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.034 0.934 . . . . 0.0 110.377 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.63 119.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.41 -34.21 8.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.864 -1.772 . . . . 0.0 113.161 177.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.58 153.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.119 1.327 . . . . 0.0 112.9 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -133.92 111.96 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 112.102 -174.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.74 31.19 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.437 -1.415 . . . . 0.0 113.744 -166.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.42 80.7 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.123 1.344 . . . . 0.0 113.921 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.75 102.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.992 -1.299 . . . . 0.0 107.584 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -65.75 137.1 57.04 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 126.136 1.774 . . . . 0.0 114.359 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.2 mt -86.99 26.39 1.16 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.561 1.544 . . . . 0.0 113.009 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -68.21 118.16 10.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.573 -1.955 . . . . 0.0 110.023 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.28 6.53 86.1 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 120.954 -1.091 . . . . 0.0 115.201 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.37 137.94 32.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 118.945 1.372 . . . . 0.0 111.744 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -113.64 -168.15 1.3 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -54.62 -52.0 63.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.603 -1.936 . . . . 0.0 114.647 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.31 -46.24 74.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.242 -0.912 . . . . 0.0 112.978 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.99 -46.44 90.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.497 1.519 . . . . 0.0 114.809 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.29 -34.63 78.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.371 -1.456 . . . . 0.0 114.404 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.12 -54.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.151 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -55.48 -47.71 75.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.2 m -52.56 -33.16 44.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 126.283 1.833 . . . . 0.0 115.182 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 mt -92.2 -46.7 7.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.176 1.79 . . . . 0.0 115.449 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -37.05 55.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.592 2.357 . . . . 0.0 114.586 -172.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.54 30.49 0.71 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.157 -1.59 . . . . 0.0 112.363 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.6 p -106.19 176.78 5.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.761 2.424 . . . . 0.0 109.361 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.42 -74.63 1.28 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 119.444 -2.035 . . . . 0.0 113.954 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -139.91 -66.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.966 -1.314 . . . . 0.0 110.068 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.59 115.35 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.17 1.462 . . . . 0.0 110.605 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.74 103.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.23 97.77 8.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.594 1.158 . . . . 0.0 109.133 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.29 114.01 22.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.829 1.652 . . . . 0.0 108.993 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 103.85 16.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mt -108.97 142.84 39.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.317 1.847 . . . . 0.0 110.408 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -114.04 129.45 56.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.564 1.146 . . . . 0.0 108.034 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tptm . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 126.539 1.936 . . . . 0.0 113.264 -171.408 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.41 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.389 2.7 t 66.86 91.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 124.943 2.306 . . . . 0.0 113.016 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 90.4 m -136.61 128.62 29.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.193 -2.891 . . . . 0.0 103.193 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.7 m -72.89 120.03 17.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' LEU . 2.9 m . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.036 0.922 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.72 126.57 54.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.8 1.64 . . . . 0.0 107.739 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -99.69 85.39 3.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.979 1.371 . . . . 0.0 108.312 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -81.1 115.52 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.668 1.987 . . . . 0.0 111.594 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 118.53 36.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.289 -2.132 . . . . 0.0 110.761 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.4 mt -126.02 -178.86 4.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.557 1.143 . . . . 0.0 108.973 -170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.43 126.86 30.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 162.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.57 53.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.9 -1.125 . . . . 0.0 112.755 -174.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 t -97.23 92.8 6.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.439 1.59 . . . . 0.0 109.543 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.38 25.82 12.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.004 1.722 . . . . 0.0 114.31 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.3 65.46 1.32 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 124.677 1.132 . . . . 0.0 112.662 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.3 t 179.33 113.94 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.3 mt -78.58 -36.26 44.64 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.357 2.027 . . . . 0.0 106.466 162.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.82 43.93 2.02 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 173.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -128.3 133.64 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.5 m -89.34 108.03 19.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.683 1.593 . . . . 0.0 111.736 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 m -77.89 137.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -171.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 t -133.07 166.32 22.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.316 -1.49 . . . . 0.0 110.37 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.49 -130.86 10.27 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 125.106 1.336 . . . . 0.0 112.645 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.52 160.68 30.35 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.529 1.061 . . . . 0.0 112.049 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 119.808 -1.995 . . . . 0.0 115.729 -177.0 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.765 0 N-CA-C 105.936 -2.865 . . . . 0.0 105.936 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.34 154.94 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 119.489 1.645 . . . . 0.0 106.936 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -138.79 148.75 44.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.315 -2.116 . . . . 0.0 105.853 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.9 t -73.39 127.56 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 120.622 -1.299 . . . . 0.0 111.505 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -88.23 -66.05 0.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.725 -1.235 . . . . 0.0 108.722 166.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 133.53 53.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.527 1.131 . . . . 0.0 111.711 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.0 mm -93.44 137.1 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 116.525 -1.703 . . . . 0.0 110.726 176.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 120.786 1.63 . . . . 0.0 113.314 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 p -55.18 -27.28 44.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.17 -73.8 0.06 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.872 1.269 . . . . 0.0 111.173 170.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.44 -9.92 14.8 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 121.667 -0.646 . . . . 0.0 112.95 164.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -79.17 -27.69 42.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.135 -1.215 . . . . 0.0 110.557 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.98 146.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.549 1.939 . . . . 0.0 114.434 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -148.58 -171.59 3.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.833 -1.167 . . . . 0.0 109.317 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -78.12 93.74 4.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.902 -2.373 . . . . 0.0 112.569 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.38 -19.24 0.26 Allowed Glycine 0 N--CA 1.429 -1.782 0 O-C-N 121.023 -1.048 . . . . 0.0 114.467 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -70.05 153.43 43.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -172.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -105.51 121.3 43.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.407 1.575 . . . . 0.0 111.325 -172.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.22 109.48 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.418 2.687 . . . . 0.0 106.232 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.09 -37.07 9.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.192 -0.943 . . . . 0.0 112.488 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.93 166.5 33.35 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.979 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.54 123.57 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 121.311 -0.868 . . . . 0.0 113.023 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.24 30.89 3.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.82 22.4 66.45 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.608 -1.308 . . . . 0.0 114.329 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.81 98.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -67.0 137.59 56.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 125.106 1.362 . . . . 0.0 112.554 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -75.63 61.16 1.32 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.069 1.748 . . . . 0.0 113.679 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.1 110.18 5.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.192 1.397 . . . . 0.0 111.56 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.65 30.53 78.18 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.717 1.151 . . . . 0.0 115.6 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.54 140.45 29.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.762 1.281 . . . . 0.0 112.821 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.5 p -97.96 -157.44 0.6 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.698 1.999 . . . . 0.0 109.934 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.421 -2.049 . . . . 0.0 109.754 168.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -53.21 55.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.327 1.051 . . . . 0.0 111.645 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.07 -26.9 64.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.07 78.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.481 -2.012 . . . . 0.0 113.644 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.88 -52.56 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.16 -0.963 . . . . 0.0 110.184 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 62.1 mt-10 -54.02 -41.19 67.73 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.5 m -57.25 -39.31 75.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.905 2.082 . . . . 0.0 114.452 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mt -92.21 -28.4 17.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.842 1.257 . . . . 0.0 113.252 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.405 ' HG3' ' HA ' ' A' ' 83' ' ' GLU . 4.4 ppt_? -86.6 -47.98 8.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.02 43.98 1.17 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.667 1.699 . . . . 0.0 110.473 -171.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.8 p -95.94 -152.8 0.38 Allowed 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.103 2.961 . . . . 0.0 109.609 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.14 -137.42 9.56 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.144 -1.598 . . . . 0.0 110.43 172.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -92.9 -51.48 5.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.522 1.129 . . . . 0.0 109.055 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.76 132.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.976 1.37 . . . . 0.0 110.139 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -124.01 111.76 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.66 103.55 10.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.126 1.371 . . . . 0.0 107.772 160.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -83.27 108.77 16.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.716 2.007 . . . . 0.0 108.284 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.7 102.57 11.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 110.722 169.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -109.6 147.97 32.1 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.392 2.277 . . . . 0.0 110.228 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.88 152.21 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.172 1.789 . . . . 0.0 106.425 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -171.392 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.0 tp . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.548 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.394 10.9 m 31.71 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 130.308 3.443 . . . . 0.0 118.213 164.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 82.2 m -119.47 124.15 45.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 36.9 t -67.98 112.43 4.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.519 1.128 . . . . 0.0 108.562 164.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 25' ' ' LEU . 13.1 p . . . . . 0 C--O 1.26 1.624 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 -167.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 122.303 1.049 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -133.87 133.43 41.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -111.4 76.03 0.95 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.967 1.307 . . . . 0.0 108.939 -177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.72 118.91 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 125.712 1.605 . . . . 0.0 114.543 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.268 6.3 pm0 -99.68 126.39 45.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.466 -2.021 . . . . 0.0 111.977 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 169.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.62 148.17 33.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.697 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 146.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 111.005 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -94.45 93.07 7.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.528 -1.357 . . . . 0.0 108.244 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 45.81 67.72 0.7 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.257 2.623 . . . . 0.0 115.861 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.82 42.7 77.97 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 121.507 -0.746 . . . . 0.0 113.862 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 p -167.89 106.18 0.51 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.848 1.785 . . . . 0.0 108.49 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' B' ' 210' ' ' VAL . 11.6 mt -71.13 -47.23 59.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 162.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 27.77 1.67 Allowed Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.186 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 pt -109.13 122.93 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 122.998 1.38 . . . . 0.0 109.541 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -84.51 110.54 18.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.176 1.39 . . . . 0.0 109.209 171.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -80.9 138.43 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -133.51 171.63 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.017 1.727 . . . . 0.0 108.281 169.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.42 -143.73 18.05 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 124.985 1.279 . . . . 0.0 113.163 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.6 159.39 28.82 Favored Glycine 0 N--CA 1.431 -1.661 0 O-C-N 121.562 -0.963 . . . . 0.0 111.808 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.43 -1.46 0 C-N-CA 126.052 1.741 . . . . 0.0 114.503 -174.739 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 tp -102.88 158.8 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 167.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -133.94 158.73 42.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.576 -1.952 . . . . 0.0 105.914 -171.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 t -89.7 134.49 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.578 -1.951 . . . . 0.0 109.873 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -39.16 10.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.356 -1.465 . . . . 0.0 110.923 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.67 20.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.555 -0.716 . . . . 0.0 111.265 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.9 mm -99.01 135.02 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.6 1.96 . . . . 0.0 107.3 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.425 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.69 82.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.141 -1.599 . . . . 0.0 115.114 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.36 -29.77 70.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.496 -1.378 . . . . 0.0 111.583 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.35 -0.86 15.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 115.405 1.632 . . . . 0.0 115.405 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.73 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 108.447 158.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.57 -1.54 15.81 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 113.353 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -95.05 -31.9 13.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.023 -1.281 . . . . 0.0 110.237 169.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.36 139.54 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.131 -1.605 . . . . 0.0 114.594 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -127.54 177.47 6.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.982 0.896 . . . . 0.0 109.213 160.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.63 50.78 0.44 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.25 -1.53 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.154 -2.216 . . . . 0.0 115.666 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -76.01 161.73 28.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 118.567 1.183 . . . . 0.0 114.175 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -96.0 131.9 41.9 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.736 1.214 . . . . 0.0 109.869 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.48 115.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 168.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.35 -35.83 12.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.196 -1.565 . . . . 0.0 111.915 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.98 156.8 41.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.009 0.822 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.16 119.94 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 121.007 -1.058 . . . . 0.0 109.948 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.74 28.12 16.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.119 -1.613 . . . . 0.0 114.186 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.7 90.41 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 125.035 1.302 . . . . 0.0 113.486 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.6 t -97.33 104.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.155 -1.203 . . . . 0.0 109.163 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -53.4 137.17 36.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.357 2.263 . . . . 0.0 115.697 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.24 25.55 1.6 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.736 -1.227 . . . . 0.0 112.584 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.7 111.57 11.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.011 -1.68 . . . . 0.0 110.574 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.45 -1.67 72.92 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.777 -0.577 . . . . 0.0 113.039 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.22 138.66 31.4 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.552 1.644 . . . . 0.0 111.59 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.471 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 3.8 t -117.57 -171.7 2.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.677 2.391 . . . . 0.0 104.836 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -48.96 -52.65 23.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.844 1.658 . . . . 0.0 114.856 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.42 -47.74 59.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.755 1.161 . . . . 0.0 113.188 -175.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.471 ' HB2' ' H ' ' A' ' 77' ' ' THR . 5.1 mm100 -50.67 -49.35 57.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.554 1.542 . . . . 0.0 114.474 168.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.61 84.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.436 -1.415 . . . . 0.0 114.5 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.1 t -62.53 -48.19 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 111.512 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -58.14 -39.0 77.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.212 -1.555 . . . . 0.0 113.592 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.5 m -64.56 -26.81 68.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.518 2.327 . . . . 0.0 113.715 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.46 -47.02 7.67 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.349 1.459 . . . . 0.0 114.087 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.269 0.1 OUTLIER -79.62 -35.09 39.98 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.361 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.75 40.31 1.03 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.436 -2.04 . . . . 0.0 111.61 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.1 p -101.2 159.07 15.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.75 2.42 . . . . 0.0 111.663 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.09 65.09 4.17 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 121.165 -0.959 . . . . 0.0 112.103 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 67.46 -48.09 0.5 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 129.319 3.048 . . . . 0.0 116.133 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.2 t -80.5 131.66 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.775 1.274 . . . . 0.0 110.874 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -117.73 109.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -88.4 101.15 13.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.935 -1.103 . . . . 0.0 109.153 171.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -90.37 122.62 33.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.864 -1.148 . . . . 0.0 111.627 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.07 102.95 14.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.7 mt -112.47 142.52 44.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.507 1.923 . . . . 0.0 110.583 -171.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.65 142.09 50.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.207 2.203 . . . . 0.0 108.512 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.764 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 10.5 tp . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.406 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.491 5.9 m 52.82 100.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.103 2.961 . . . . 0.0 117.827 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 53.5 m -130.62 118.93 21.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 76.2 p -77.67 122.83 25.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.575 1.15 . . . . 0.0 109.244 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.633 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -175.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.37 1.081 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 114.74 26.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 174.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -92.29 83.45 5.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.24 153.39 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 127.761 2.425 . . . . 0.0 110.339 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.52 50.96 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.513 -1.992 . . . . 0.0 108.321 167.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.8 mt -128.75 161.72 29.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 123.998 0.919 . . . . 0.0 109.689 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.74 117.13 26.67 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.032 0.92 . . . . 0.0 108.863 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 1.2 ptmm? -62.84 126.25 26.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.051 1.74 . . . . 0.0 113.087 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 23' ' ' GLY . 12.6 t -96.48 118.27 32.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.989 -1.069 . . . . 0.0 108.709 -171.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.34 -19.93 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.29 2.236 . . . . 0.0 117.006 -171.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 21' ' ' THR . . . 128.75 53.26 0.11 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.971 1.748 . . . . 0.0 110.682 178.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 m -177.81 126.87 0.13 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 -173.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.2 mt -84.02 -39.4 19.68 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.393 2.277 . . . . 0.0 106.724 172.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.97 6.17 3.28 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 124.298 0.951 . . . . 0.0 113.22 170.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 pt -102.0 127.55 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 122.428 1.108 . . . . 0.0 111.13 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -81.49 109.8 16.29 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.075 1.35 . . . . 0.0 112.102 168.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.91 125.95 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -172.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.5 t -120.22 160.84 22.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.938 2.095 . . . . 0.0 110.843 175.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.08 -125.14 8.24 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.668 1.604 . . . . 0.0 112.441 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.15 140.72 11.43 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 177.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 124.898 1.279 . . . . 0.0 114.28 -167.939 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.701 0 N-CA-C 107.354 -2.298 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.287 2.3 tp -114.61 157.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.043 1.421 . . . . 0.0 108.701 175.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -140.6 157.25 45.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.892 -1.755 . . . . 0.0 106.614 -171.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.2 t -88.73 127.37 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.305 -1.497 . . . . 0.0 112.2 174.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -83.27 -50.42 8.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.656 -1.277 . . . . 0.0 109.907 171.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.06 138.87 37.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -174.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.03 145.58 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.121 1.768 . . . . 0.0 107.184 171.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 N--CA 1.43 -1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 110.776 169.066 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.498 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.13 72.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.322 -1.486 . . . . 0.0 113.916 -177.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.74 -32.99 72.26 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.274 1.43 . . . . 0.0 112.195 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -61.62 -28.54 69.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.32 -75.04 0.05 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.932 1.242 . . . . 0.0 111.797 176.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.16 -30.71 2.42 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 112.1 168.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -86.58 -20.97 27.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 113.644 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -71.75 133.89 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.159 1.784 . . . . 0.0 112.073 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -150.33 -159.75 1.08 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.638 -1.288 . . . . 0.0 110.557 165.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.76 129.03 36.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.215 -1.553 . . . . 0.0 112.1 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.75 23.24 56.42 Favored Glycine 0 N--CA 1.428 -1.839 0 O-C-N 120.151 -1.593 . . . . 0.0 114.965 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.85 148.14 22.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.289 -1.124 . . . . 0.0 109.821 168.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -90.99 129.8 36.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.04 -1.038 . . . . 0.0 109.976 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 p -104.19 119.91 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.87 -31.57 11.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.754 -1.216 . . . . 0.0 112.852 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.2 43.48 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 119.04 0.836 . . . . 0.0 112.418 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.49 120.86 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 121.189 -0.945 . . . . 0.0 111.027 -177.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 54.94 29.79 12.82 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.412 1.485 . . . . 0.0 114.44 -170.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.77 22.36 77.15 Favored Glycine 0 N--CA 1.431 -1.659 0 O-C-N 121.037 -1.039 . . . . 0.0 114.117 -173.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.48 101.94 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.619 1.567 . . . . 0.0 107.86 177.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -66.19 143.49 57.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.843 -1.16 . . . . 0.0 113.915 177.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.39 62.0 3.61 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.902 1.681 . . . . 0.0 112.783 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.33 123.33 37.67 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.837 1.655 . . . . 0.0 108.539 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.5 -7.6 57.11 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.626 -1.296 . . . . 0.0 114.487 -171.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.93 129.26 34.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.128 1.918 . . . . 0.0 114.755 -169.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.478 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.1 p -96.17 -163.48 1.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.471 1.909 . . . . 0.0 108.415 -175.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.4 -51.66 66.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.986 -1.696 . . . . 0.0 112.374 163.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.61 -42.19 87.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.122 -0.986 . . . . 0.0 112.723 -177.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.478 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.9 tt0 -69.84 -34.32 73.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.43 75.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.217 -2.177 . . . . 0.0 114.097 171.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.59 -53.01 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.429 -0.794 . . . . 0.0 110.832 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.13 -41.36 62.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.418 1.463 . . . . 0.0 114.837 175.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.7 m -62.41 -29.95 70.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.65 2.38 . . . . 0.0 114.542 178.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.47 -40.95 9.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -50.55 15.06 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.534 2.334 . . . . 0.0 112.73 -171.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -91.44 42.55 1.11 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.977 1.37 . . . . 0.0 110.622 -168.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.1 p -102.44 164.7 11.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.51 2.324 . . . . 0.0 111.341 -174.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.04 58.23 4.77 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.759 -1.213 . . . . 0.0 113.125 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 71.16 -48.23 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.945 2.898 . . . . 0.0 116.858 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.49 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.596 1.188 . . . . 0.0 109.478 171.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -117.63 99.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -78.92 105.89 10.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.807 -1.183 . . . . 0.0 107.964 166.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -88.89 125.49 34.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.187 -1.571 . . . . 0.0 110.544 -177.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.42 102.09 14.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 108.567 166.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.32 148.29 24.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.2 1.8 . . . . 0.0 111.713 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -116.37 138.75 51.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 162.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.0 tptt . . . . . 0 N--CA 1.429 -1.515 0 C-N-CA 123.618 0.767 . . . . 0.0 112.982 176.432 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 20.2 tp . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 111.087 0.032 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.41 2.2 t 78.92 122.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.077 1.894 . . . . 0.0 114.565 166.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.1 m -147.21 125.11 11.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 176.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.7 p -75.52 128.99 36.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.013 0.925 . . . . 0.0 109.61 169.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.3 p . . . . . 0 C--O 1.259 1.588 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -162.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.429 -1.476 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.66 113.69 14.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.75 71.55 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.867 1.317 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.95 121.58 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.702 2.401 . . . . 0.0 111.721 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -105.24 115.34 30.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.423 -2.048 . . . . 0.0 109.398 -174.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -115.83 146.4 42.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.836 0.827 . . . . 0.0 110.003 -171.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.81 109.58 21.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 165.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' HB2' ' H ' ' A' ' 24' ' ' SER . 8.9 ptpt -53.7 151.99 5.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.842 2.057 . . . . 0.0 112.77 175.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -110.12 104.74 13.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 56.73 5.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.133 2.173 . . . . 0.0 116.086 -175.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.62 61.2 5.19 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 120.49 -1.381 . . . . 0.0 115.897 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 37.6 t 175.08 112.64 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.792 1.637 . . . . 0.0 106.77 -173.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.42 -41.93 45.93 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 126.233 1.813 . . . . 0.0 107.388 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.45 33.76 1.28 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.034 171.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.19 133.74 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 121.845 -0.797 . . . . 0.0 111.062 175.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -82.95 113.13 20.34 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.245 1.018 . . . . 0.0 111.088 164.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 78' ' ' HIS . 21.0 m -85.26 128.98 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -124.11 167.15 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.448 1.899 . . . . 0.0 110.865 176.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 -137.65 15.6 Favored Glycine 0 N--CA 1.428 -1.846 0 C-N-CA 125.103 1.335 . . . . 0.0 112.915 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.11 161.88 21.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 124.433 1.015 . . . . 0.0 111.293 177.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.465 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 CA-C-O 121.041 0.245 . . . . 0.0 113.491 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.7 tp -116.59 164.39 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.189 0.995 . . . . 0.0 110.093 -166.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -140.72 156.75 46.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.028 -1.67 . . . . 0.0 106.786 -172.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.37 119.87 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.644 -1.285 . . . . 0.0 111.782 177.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -83.71 -40.49 18.81 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.732 -1.23 . . . . 0.0 111.065 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.42 131.8 17.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.964 0.905 . . . . 0.0 109.988 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.33 120.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.9 pt . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 121.163 -0.961 . . . . 0.0 113.018 -175.517 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.24 -40.53 67.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.81 -28.7 69.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.469 -1.394 . . . . 0.0 111.796 168.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.7 t -73.33 -12.9 60.99 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.92 -85.03 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.923 2.147 . . . . 0.0 110.403 176.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.82 -30.22 0.82 Allowed Glycine 0 N--CA 1.431 -1.697 0 O-C-N 120.622 -1.299 . . . . 0.0 111.469 172.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -83.87 -43.08 15.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.55 -0.971 . . . . 0.0 111.287 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 134.83 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 124.765 1.226 . . . . 0.0 114.046 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -133.5 -172.69 3.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 164.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -84.52 122.3 28.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.308 -2.12 . . . . 0.0 112.084 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.71 -30.71 2.73 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 112.395 -169.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -73.12 162.88 28.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.279 1.514 . . . . 0.0 113.768 -172.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -105.01 129.9 53.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.98 0.912 . . . . 0.0 109.884 -173.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.34 114.72 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.12 1.438 . . . . 0.0 107.984 167.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.41 -32.02 11.71 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 120.231 -1.543 . . . . 0.0 113.176 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.14 159.32 43.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.611 1.096 . . . . 0.0 111.867 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.0 126.2 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 110.415 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 m120 58.59 22.14 9.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.919 1.691 . . . . 0.0 114.828 -174.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.69 -2.72 80.61 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.629 1.109 . . . . 0.0 114.267 -172.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.81 103.01 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.115 1.366 . . . . 0.0 108.53 -172.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -62.77 141.39 58.62 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.599 1.56 . . . . 0.0 113.18 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.56 72.46 7.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.475 1.131 . . . . 0.0 111.098 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -91.65 111.18 22.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.769 1.228 . . . . 0.0 108.621 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.3 -3.86 85.15 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.988 -1.07 . . . . 0.0 115.349 -176.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.41 133.35 38.69 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 123.942 1.83 . . . . 0.0 114.745 -172.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.434 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 80.0 p -99.53 -155.82 0.52 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.558 2.343 . . . . 0.0 109.881 -169.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.519 ' CE1' HG23 ' A' ' 29' ' ' VAL . 85.2 t60 -72.4 -50.47 26.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.612 -1.93 . . . . 0.0 111.19 168.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -42.82 80.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.434 ' HB3' ' H ' ' A' ' 77' ' ' THR . 17.8 tt0 -65.68 -35.87 82.01 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.12 -1.612 . . . . 0.0 113.902 174.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.78 96.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.671 -1.893 . . . . 0.0 115.05 172.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.03 -56.39 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 123.594 0.757 . . . . 0.0 110.406 172.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -51.28 -46.49 62.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.06 1.344 . . . . 0.0 113.602 177.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 m -59.58 -30.39 68.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.384 1.874 . . . . 0.0 114.422 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.6 mt -89.34 -38.65 14.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.161 -1.587 . . . . 0.0 113.366 173.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.44 39.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.575 2.35 . . . . 0.0 114.863 -172.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 15.13 0.58 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.5 p -91.68 158.86 16.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.287 2.635 . . . . 0.0 111.013 -169.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.55 -61.67 3.08 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 121.414 -0.804 . . . . 0.0 114.286 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.52 -64.84 0.18 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.236 -1.155 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.09 129.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.153 1.454 . . . . 0.0 111.541 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -115.58 105.3 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.834 1.654 . . . . 0.0 107.749 172.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -78.74 106.17 10.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.572 -1.33 . . . . 0.0 109.284 169.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mt -87.41 110.37 20.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.067 1.747 . . . . 0.0 108.677 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.9 101.86 13.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 172.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.89 143.26 34.28 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 -175.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.16 143.16 45.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.888 2.075 . . . . 0.0 106.226 171.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 N--CA 1.429 -1.511 0 C-N-CA 123.564 0.746 . . . . 0.0 110.892 178.943 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.419 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.412 5.7 m 45.23 92.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 162.925 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -128.34 125.05 37.93 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 -171.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.3 m -74.23 123.84 25.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.293 1.837 . . . . 0.0 108.575 177.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.657 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -163.15 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -125.22 120.94 32.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.52 74.83 1.91 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.893 1.277 . . . . 0.0 107.734 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.99 151.23 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.302 2.241 . . . . 0.0 109.355 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -128.27 128.68 45.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.435 -2.041 . . . . 0.0 111.165 168.266 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -126.0 141.16 52.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 124.553 1.141 . . . . 0.0 109.058 -171.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.66 111.47 23.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.65 124.06 18.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.45 1.1 . . . . 0.0 111.7 -177.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -94.37 108.58 20.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.92 1.343 . . . . 0.0 108.982 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 60.23 34.86 20.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.823 2.049 . . . . 0.0 114.686 -179.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.46 60.57 2.47 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.742 -1.224 . . . . 0.0 114.367 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m 172.34 120.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.868 2.067 . . . . 0.0 105.574 -175.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.85 -41.44 78.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.217 1.484 . . . . 0.0 107.966 161.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.11 22.95 3.08 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.471 170.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.7 pt -111.39 130.24 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.213 -1.169 . . . . 0.0 111.224 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -79.67 112.53 17.03 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.201 1.0 . . . . 0.0 110.576 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 m -84.15 131.15 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -123.11 166.73 14.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.618 -1.927 . . . . 0.0 109.824 176.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.69 -150.83 31.61 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.787 1.185 . . . . 0.0 113.857 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.49 166.05 16.16 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 125.49 1.519 . . . . 0.0 110.556 -177.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.551 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.268 1.8 tp -115.3 162.04 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.776 0.798 . . . . 0.0 109.454 -172.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -142.69 154.07 43.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -169.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -90.1 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.965 -1.709 . . . . 0.0 111.988 179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -90.47 -48.37 7.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.519 -1.363 . . . . 0.0 111.169 176.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.05 128.72 18.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.003 0.906 . . . . 0.0 112.217 -172.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.7 mm -92.68 134.24 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.205 2.202 . . . . 0.0 109.175 178.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.6 mt . . . . . 0 N--CA 1.43 -1.429 0 C-N-CA 125.132 1.373 . . . . 0.0 109.911 175.323 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 121.132 0.491 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.55 -41.31 72.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.93 -31.36 71.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.152 -2.217 . . . . 0.0 110.862 170.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.04 5.79 6.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -72.52 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.296 -2.128 . . . . 0.0 105.9 149.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.0 1.0 Allowed Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.862 163.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -79.55 -17.48 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 117.172 0.486 . . . . 0.0 112.309 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.49 133.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.174 2.19 . . . . 0.0 111.67 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.93 -178.94 5.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.895 -1.128 . . . . 0.0 108.763 169.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -86.23 60.42 6.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.923 -2.361 . . . . 0.0 113.258 -174.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.91 -7.52 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 121.086 -1.009 . . . . 0.0 114.787 176.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -76.05 154.12 35.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.399 1.571 . . . . 0.0 114.92 -172.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -102.64 105.83 16.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.406 1.882 . . . . 0.0 108.79 -173.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.37 113.14 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.8 -1.813 . . . . 0.0 108.949 -179.391 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.42 -29.0 13.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.137 1.375 . . . . 0.0 113.41 -173.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 155.18 38.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 119.984 1.266 . . . . 0.0 112.745 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -132.98 119.0 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.595 -0.691 . . . . 0.0 111.175 -177.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 56.09 31.98 19.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 120.409 1.459 . . . . 0.0 114.027 -168.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.29 9.9 85.62 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.809 -1.182 . . . . 0.0 114.301 -173.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -100.26 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.4 p -60.42 138.1 58.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.83 31.77 0.84 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.76 -1.213 . . . . 0.0 112.15 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.72 76.13 1.55 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.201 2.201 . . . . 0.0 110.941 -177.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.99 5.79 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 125.047 1.308 . . . . 0.0 114.44 -170.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.59 139.08 31.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.021 1.911 . . . . 0.0 112.587 177.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t -112.13 -165.26 0.98 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.458 2.303 . . . . 0.0 105.95 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -53.9 -57.68 10.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.391 1.876 . . . . 0.0 113.641 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -69.62 -46.99 64.96 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 111.987 -174.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -48.64 66.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.918 1.687 . . . . 0.0 113.572 173.272 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.61 86.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.208 -1.558 . . . . 0.0 114.609 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.79 -47.97 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.35 1.06 . . . . 0.0 112.193 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -68.47 -29.23 67.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.251 -1.531 . . . . 0.0 114.158 177.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.6 m -68.55 -26.3 65.35 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.948 1.699 . . . . 0.0 113.194 174.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.51 -48.66 6.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.341 1.457 . . . . 0.0 113.58 172.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -82.61 -36.97 25.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -172.103 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.01 29.26 1.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.31 1.868 . . . . 0.0 112.594 -172.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.4 p -88.76 -168.35 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.373 3.069 . . . . 0.0 109.933 175.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.52 -110.85 3.02 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.211 -1.555 . . . . 0.0 111.547 175.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -102.12 -61.17 1.42 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.863 0.831 . . . . 0.0 112.567 -176.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.64 125.86 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.765 1.269 . . . . 0.0 110.45 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 t -109.92 111.51 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 125.395 1.478 . . . . 0.0 107.833 165.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 17' ' ' GLU . 78.5 m80 -79.87 112.26 16.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.773 -1.204 . . . . 0.0 108.643 166.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mt -94.28 112.96 24.79 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.054 1.342 . . . . 0.0 109.015 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.45 101.01 13.69 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.05 143.61 34.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.489 2.315 . . . . 0.0 110.182 -175.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -122.66 143.57 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.197 1.399 . . . . 0.0 109.95 173.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 119.807 3.262 . . . . 0.0 119.807 -175.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.466 6.9 m 43.57 87.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 128.789 2.836 . . . . 0.0 117.439 170.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 77.1 m -129.37 120.82 26.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -176.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -78.86 121.98 25.51 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.314 1.446 . . . . 0.0 109.501 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 -171.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.35 132.69 48.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.562 1.145 . . . . 0.0 108.489 174.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 84.86 2.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.207 1.003 . . . . 0.0 109.569 175.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.96 155.0 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.479 1.911 . . . . 0.0 109.644 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -130.54 118.82 21.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.287 -2.133 . . . . 0.0 110.097 165.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.3 mt -122.36 154.47 37.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.937 -1.102 . . . . 0.0 109.975 -174.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.95 119.64 39.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.1 0.952 . . . . 0.0 109.223 162.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 123.43 19.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.992 1.317 . . . . 0.0 113.025 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -90.1 115.12 27.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.777 -1.202 . . . . 0.0 109.501 -175.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 52.43 42.63 31.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.317 1.847 . . . . 0.0 114.915 -172.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.57 43.17 53.41 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.271 0.938 . . . . 0.0 115.342 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -166.74 113.49 0.82 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -170.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' B' ' 210' ' ' VAL . 6.0 mt -75.07 -28.79 60.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.118 -1.614 . . . . 0.0 107.443 169.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.35 13.09 11.02 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.988 168.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.0 pt -114.75 125.76 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 118.226 1.013 . . . . 0.0 110.454 -171.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -80.86 121.77 26.38 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.509 1.124 . . . . 0.0 113.536 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.19 132.47 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -127.96 170.57 12.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.509 1.524 . . . . 0.0 109.045 169.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.43 -123.08 6.31 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.291 1.424 . . . . 0.0 113.734 178.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.15 155.17 27.53 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 121.681 -0.893 . . . . 0.0 112.993 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.43 -1.441 0 O-C-N 120.881 -1.364 . . . . 0.0 112.794 -177.968 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 CA-C-O 122.023 0.791 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -123.32 161.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 170.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -132.71 152.03 51.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.78 -1.825 . . . . 0.0 106.647 -171.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.27 119.43 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 120.04 -1.663 . . . . 0.0 108.973 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -82.91 -60.33 2.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.605 -1.309 . . . . 0.0 110.833 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.91 132.28 56.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.26 1.029 . . . . 0.0 110.838 -176.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -94.6 131.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 164.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 111.685 179.202 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 121.962 0.886 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.9 64.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.48 -41.43 80.68 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.306 -1.496 . . . . 0.0 111.468 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -73.6 6.27 3.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.348 2.259 . . . . 0.0 116.496 -177.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.55 -82.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.405 -2.06 . . . . 0.0 107.742 152.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.55 -32.64 1.11 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 170.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -83.92 -15.8 46.6 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.072 0.949 . . . . 0.0 113.162 -172.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.87 133.01 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.941 1.696 . . . . 0.0 110.989 173.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 61' ' ' LYS . 4.3 t-160 -131.55 -172.71 2.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.285 1.434 . . . . 0.0 109.936 173.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' H ' ' CD2' ' A' ' 60' ' ' HIS . 55.5 mtmt -85.95 113.06 21.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.876 -1.765 . . . . 0.0 109.898 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.23 10.8 12.98 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.354 0.978 . . . . 0.0 114.946 -175.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.25 164.09 20.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.465 1.506 . . . . 0.0 112.826 176.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -116.3 121.39 41.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.668 2.387 . . . . 0.0 111.647 -173.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.07 122.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.512 1.525 . . . . 0.0 107.895 174.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 -39.88 8.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 120.255 -1.528 . . . . 0.0 112.309 175.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.98 159.94 42.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.787 1.176 . . . . 0.0 113.783 -176.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.01 119.8 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 124.378 1.071 . . . . 0.0 110.126 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 56.82 25.11 9.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.258 -1.527 . . . . 0.0 115.034 -171.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.74 -2.98 84.88 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.12 1.343 . . . . 0.0 114.6 -171.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.6 t -93.86 100.46 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 0.0 108.361 -174.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t -70.29 137.37 50.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.315 1.446 . . . . 0.0 113.497 -178.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.92 52.16 1.45 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.099 2.16 . . . . 0.0 112.403 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -79.25 119.06 21.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.005 1.322 . . . . 0.0 109.925 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 14.03 75.31 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.886 -1.134 . . . . 0.0 114.959 -175.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.51 138.78 31.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.855 1.312 . . . . 0.0 112.299 -177.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.3 p -101.11 -162.55 0.95 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.682 1.993 . . . . 0.0 109.699 -174.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -59.84 -54.07 50.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.977 -1.702 . . . . 0.0 112.001 164.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -71.59 -41.13 69.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.498 -0.751 . . . . 0.0 112.869 -176.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -40.5 96.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 175.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.37 95.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.888 -1.758 . . . . 0.0 114.584 173.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -53.8 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 119.123 0.874 . . . . 0.0 111.189 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -64.58 -36.73 85.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.878 2.471 . . . . 0.0 113.643 176.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.94 -26.96 18.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.305 1.842 . . . . 0.0 115.269 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -83.97 -52.8 6.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.423 1.889 . . . . 0.0 112.489 -176.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -93.68 63.77 3.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 110.695 -175.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.447 ' HG1' HG22 ' A' ' 92' ' ' VAL . 73.2 p -96.14 -129.65 0.16 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.006 1.322 . . . . 0.0 111.815 177.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.29 57.36 0.43 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 64.08 -54.4 0.25 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.785 3.234 . . . . 0.0 114.47 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.35 124.99 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.572 1.177 . . . . 0.0 110.156 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.447 HG22 ' HG1' ' A' ' 88' ' ' THR . 85.0 t -110.92 106.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 168.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -77.97 102.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.942 -1.099 . . . . 0.0 108.952 166.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.43 118.31 24.88 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.577 -1.327 . . . . 0.0 110.475 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.96 100.92 13.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 148.86 25.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.481 1.512 . . . . 0.0 109.991 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -164.04 1.08 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.038 2.135 . . . . 0.0 107.562 173.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.429 -1.512 0 O-C-N 119.259 -2.151 . . . . 0.0 112.282 159.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.656 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.3 tp . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.656 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.38 2.4 t 25.52 101.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.188 4.195 . . . . 0.0 118.568 163.604 . . . . . . . . 4 3 . 1 . 024 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 2.6 p -144.92 116.02 7.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -172.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.4 p -75.25 130.2 38.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.382 1.073 . . . . 0.0 110.424 174.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 25' ' ' LEU . 2.8 p . . . . . 0 C--O 1.261 1.682 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -171.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 122.489 1.137 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.26 1.6 m-30 -107.67 144.01 35.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -118.51 77.41 1.17 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 158.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.47 112.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.917 2.087 . . . . 0.0 107.098 -168.42 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.71 135.36 54.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.935 -1.728 . . . . 0.0 112.719 -175.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.15 178.3 9.42 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.344 -0.847 . . . . 0.0 108.9 -171.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.05 139.2 52.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.841 -1.162 . . . . 0.0 111.461 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 144.22 28.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.18 -1.575 . . . . 0.0 111.305 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -96.89 102.22 13.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.771 -1.206 . . . . 0.0 109.317 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.32 61.98 2.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -171.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.53 49.74 63.14 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.845 -1.159 . . . . 0.0 114.201 178.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.4 t -168.3 96.58 0.41 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.732 1.73 . . . . 0.0 107.319 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.02 -46.52 56.85 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.048 2.139 . . . . 0.0 106.514 166.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.66 39.93 0.96 Allowed Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.708 175.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.52 130.0 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.946 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -84.65 113.76 21.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.09 1.356 . . . . 0.0 112.072 170.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.81 125.65 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -175.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -122.71 164.04 19.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.656 1.982 . . . . 0.0 109.367 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.41 17.26 Favored Glycine 0 N--CA 1.431 -1.683 0 C-N-CA 124.71 1.148 . . . . 0.0 112.547 178.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.93 165.26 34.14 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.246 0.926 . . . . 0.0 111.565 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.429 -1.476 0 O-C-N 120.467 -1.607 . . . . 0.0 113.492 -179.169 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.754 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.274 4.0 tp -110.3 163.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.973 -1.31 . . . . 0.0 108.181 173.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -137.39 161.91 35.02 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.915 -1.74 . . . . 0.0 107.0 -174.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.91 125.86 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.296 -1.503 . . . . 0.0 111.841 173.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -82.13 -51.84 7.58 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.732 -1.23 . . . . 0.0 109.948 166.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.62 32.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.763 1.225 . . . . 0.0 110.443 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.51 121.57 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.431 -1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 110.229 179.216 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 121.388 0.614 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -51.49 57.5 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.741 2.016 . . . . 0.0 115.119 -176.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.72 -41.87 82.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.276 1.036 . . . . 0.0 111.373 173.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -69.19 -5.52 23.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -178.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.89 -101.22 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.329 2.331 . . . . 0.0 110.457 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.31 -97.71 0.96 Allowed Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.211 -1.556 . . . . 0.0 112.805 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -133.99 26.08 3.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.999 -0.706 . . . . 0.0 112.744 -156.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 mt -87.11 127.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.86 -1.775 . . . . 0.0 113.427 -170.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -143.85 155.02 43.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 163.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -62.78 148.76 45.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -153.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.73 23.61 7.07 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -103.02 172.95 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.725 1.762 . . . . 0.0 112.693 174.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -98.34 136.5 38.41 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.368 1.067 . . . . 0.0 110.738 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.35 101.89 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.034 2.934 . . . . 0.0 105.01 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.253 0.9 OUTLIER -98.02 -38.18 9.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.235 -2.166 . . . . 0.0 114.827 -173.946 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 145.21 27.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.236 1.38 . . . . 0.0 113.49 -176.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.23 116.02 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 O-C-N 120.994 -1.066 . . . . 0.0 111.914 -171.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 55.59 33.99 22.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.222 1.409 . . . . 0.0 113.677 -170.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.42 25.71 62.82 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 113.495 -176.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.9 t -123.63 100.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.82 38.34 0.7 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.913 1.685 . . . . 0.0 114.189 -173.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -82.81 111.1 18.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.486 -2.009 . . . . 0.0 110.718 175.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 8.95 68.87 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.947 -1.095 . . . . 0.0 113.083 -175.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.12 155.02 17.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.985 1.374 . . . . 0.0 110.067 171.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.567 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 71.2 p -106.87 -170.34 1.7 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.426 1.89 . . . . 0.0 108.718 -172.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -57.29 -49.95 74.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.762 -1.211 . . . . 0.0 112.903 161.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -69.9 -43.8 71.0 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 112.215 -176.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.567 ' HB2' ' H ' ' A' ' 77' ' ' THR . 4.7 mp0 -67.19 -34.3 77.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.633 -1.292 . . . . 0.0 112.947 175.177 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.92 87.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.9 -1.75 . . . . 0.0 114.475 172.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -57.47 -49.19 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.379 -0.825 . . . . 0.0 111.923 172.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.9 -31.28 71.56 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.012 -1.68 . . . . 0.0 114.901 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.6 m -74.93 -27.75 60.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.558 1.943 . . . . 0.0 112.714 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.89 -43.69 10.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.297 1.839 . . . . 0.0 112.892 174.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -84.24 -34.38 23.88 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -172.612 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -86.1 35.31 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.512 -1.992 . . . . 0.0 112.309 -176.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.6 p -93.69 163.25 13.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.142 2.577 . . . . 0.0 113.483 -176.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.75 59.57 4.9 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 125.065 1.317 . . . . 0.0 114.268 -176.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.259 46.4 tt0 68.09 -53.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.617 2.767 . . . . 0.0 114.634 -174.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -76.37 136.33 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.169 1.388 . . . . 0.0 110.721 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.15 101.39 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.65 1.98 . . . . 0.0 107.165 171.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -82.29 97.61 8.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.815 2.446 . . . . 0.0 108.58 170.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.04 113.24 21.97 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.913 0.863 . . . . 0.0 111.462 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.47 102.73 13.03 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 163.347 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.16 152.8 24.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.991 1.316 . . . . 0.0 108.053 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.0 125.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tptt . . . . . 0 N--CA 1.429 -1.486 0 C-N-CA 124.849 1.26 . . . . 0.0 112.148 -178.124 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.397 2.7 t 72.58 115.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.768 2.223 . . . . 0.0 115.511 164.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 73.0 m -141.53 123.23 15.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -77.14 124.06 27.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.26 1.615 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -162.566 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 122.488 1.137 . . . . 0.0 113.802 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -132.02 118.86 20.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.874 1.27 . . . . 0.0 108.921 173.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 86.45 5.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.268 1.427 . . . . 0.0 109.146 173.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.97 156.85 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.211 2.204 . . . . 0.0 109.982 178.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.85 132.77 50.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.616 -1.927 . . . . 0.0 107.159 166.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.6 mt -129.46 153.37 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.013 -1.054 . . . . 0.0 109.572 -177.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.52 110.01 17.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.434 1.094 . . . . 0.0 109.067 166.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HB2' ' H ' ' A' ' 24' ' ' SER . 15.5 ptpt -60.04 141.31 55.92 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 127.77 2.428 . . . . 0.0 114.746 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 t -101.57 113.76 27.17 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.698 -1.251 . . . . 0.0 109.344 -174.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 58.76 -18.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 129.189 2.995 . . . . 0.0 118.171 -169.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.19 59.32 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.847 1.689 . . . . 0.0 109.27 -178.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.539 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 95.4 p -178.2 120.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -173.783 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' B' ' 210' ' ' VAL . 9.8 mt -79.45 -40.02 30.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.436 1.894 . . . . 0.0 106.586 168.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.06 29.3 2.02 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.035 1.303 . . . . 0.0 111.988 171.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 pt -114.78 131.03 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.632 174.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 m -83.91 117.07 23.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.236 0.614 . . . . 0.0 111.04 162.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.67 132.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -128.28 163.55 24.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.102 2.161 . . . . 0.0 109.608 174.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.35 -137.36 13.26 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 125.279 1.419 . . . . 0.0 111.788 -177.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 155.63 28.07 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.429 -1.478 0 O-C-N 120.546 -1.561 . . . . 0.0 114.06 -178.148 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.255 2.2 tp -120.49 162.1 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 118.049 0.924 . . . . 0.0 109.078 -166.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -142.08 162.11 36.31 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 -171.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 t -88.36 132.31 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.679 -1.263 . . . . 0.0 111.769 172.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -88.52 -46.85 8.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.529 -1.357 . . . . 0.0 110.554 170.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.02 134.02 24.08 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.067 -1.021 . . . . 0.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.3 mm -93.84 128.92 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.433 1.493 . . . . 0.0 108.725 173.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 121.184 -0.948 . . . . 0.0 110.836 172.916 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.78 66.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.009 1.323 . . . . 0.0 113.84 -178.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -56.76 -34.17 67.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.968 1.307 . . . . 0.0 112.504 167.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -70.27 -5.46 27.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.97 -79.27 0.06 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 118.643 -2.536 . . . . 0.0 108.061 159.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.33 -20.14 3.36 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 169.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -85.31 -32.99 22.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.887 -0.772 . . . . 0.0 111.537 177.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.6 mt -65.86 125.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.735 1.614 . . . . 0.0 113.097 178.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.471 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 17.3 t60 -136.71 177.9 7.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.319 1.056 . . . . 0.0 109.954 171.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 30.1 pttt -79.74 58.9 2.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.852 -1.78 . . . . 0.0 115.347 -172.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.32 -10.32 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.188 1.375 . . . . 0.0 113.238 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -78.62 154.35 30.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 118.611 1.206 . . . . 0.0 113.427 -173.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 138.74 32.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.408 1.483 . . . . 0.0 107.465 175.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.42 115.68 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 161.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.76 -30.53 11.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 113.412 -172.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 153.52 38.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.02 0.827 . . . . 0.0 112.584 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 t -135.75 120.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.453 0.701 . . . . 0.0 112.173 -175.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 55.5 33.87 21.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.432 -1.417 . . . . 0.0 114.203 -168.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.67 11.72 85.06 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 120.68 -1.263 . . . . 0.0 113.538 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.64 100.3 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -60.75 135.2 57.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.078 1.751 . . . . 0.0 113.306 174.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.6 mt -68.96 -49.35 58.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.445 -0.785 . . . . 0.0 112.476 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 46.39 27.79 0.64 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.939 2.94 . . . . 0.0 118.939 166.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.61 27.91 0.93 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.268 -1.52 . . . . 0.0 112.885 -169.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.86 146.05 26.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.803 -1.41 . . . . 0.0 110.702 175.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.424 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 72.5 p -94.83 -167.7 1.69 Allowed 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.719 1.608 . . . . 0.0 109.148 -178.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -61.52 -50.2 73.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.029 -1.669 . . . . 0.0 112.151 165.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.19 -49.41 74.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.424 ' HB3' ' H ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -62.76 -38.11 89.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.1 -1.0 . . . . 0.0 113.286 179.833 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.23 96.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.034 -1.666 . . . . 0.0 114.983 172.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.55 -54.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.465 173.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -49.72 -43.11 47.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.245 1.384 . . . . 0.0 114.555 175.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.6 m -68.22 -27.45 66.38 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.272 2.229 . . . . 0.0 114.882 -178.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.3 -41.43 10.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.87 -1.769 . . . . 0.0 113.78 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -53.89 6.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.557 2.343 . . . . 0.0 114.214 -169.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.51 36.43 0.75 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.509 1.623 . . . . 0.0 111.96 -168.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.2 p -93.44 -172.48 2.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.588 2.755 . . . . 0.0 109.636 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.11 -90.48 0.48 Allowed Glycine 0 N--CA 1.429 -1.818 0 O-C-N 119.86 -1.775 . . . . 0.0 112.599 174.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -142.99 -50.15 0.34 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.747 1.219 . . . . 0.0 110.013 -175.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.64 131.52 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.173 -1.579 . . . . 0.0 110.129 172.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.3 112.54 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -76.52 113.28 13.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.647 -1.283 . . . . 0.0 108.806 163.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mt -94.83 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.978 -1.077 . . . . 0.0 108.766 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.43 102.77 15.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.07 150.67 23.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.049 2.139 . . . . 0.0 111.358 -177.458 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -127.38 136.35 51.74 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.261 1.024 . . . . 0.0 108.878 169.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 127.234 2.214 . . . . 0.0 114.445 -175.115 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 N--CA 1.429 -1.475 0 CA-C-O 121.588 0.708 . . . . 0.0 112.572 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.422 1.4 t 77.6 102.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 124.584 2.135 . . . . 0.0 113.311 171.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 89.4 m -136.72 119.68 16.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -171.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.5 p -75.1 129.23 37.21 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.984 1.313 . . . . 0.0 109.253 174.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 25' ' ' LEU . 8.5 p . . . . . 0 C--O 1.26 1.63 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 -162.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 122.139 0.971 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.69 137.79 53.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.744 1.618 . . . . 0.0 107.823 176.046 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -114.44 82.9 1.79 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.216 1.484 . . . . 0.0 108.802 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.12 142.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.0 2.12 . . . . 0.0 109.083 -178.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.34 123.53 44.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.037 -2.289 . . . . 0.0 109.2 170.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.35 162.06 19.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.064 0.946 . . . . 0.0 108.778 -176.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 125.0 53.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 157.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HB2' ' H ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -61.48 136.69 58.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.038 1.335 . . . . 0.0 112.025 169.224 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -90.71 95.45 10.15 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.354 1.55 . . . . 0.0 108.682 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 62.54 -17.71 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.724 2.861 . . . . 0.0 118.724 -171.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.2 62.56 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.846 -1.784 . . . . 0.0 109.919 -178.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.502 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 45.7 t 167.8 104.46 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -162.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.8 mt -75.17 -41.59 57.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 161.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 41.44 1.09 Allowed Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.676 171.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.5 pt -119.45 129.04 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 121.653 0.74 . . . . 0.0 110.297 171.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -82.29 113.95 20.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.294 1.037 . . . . 0.0 110.481 167.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.38 129.78 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -128.82 166.37 19.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.004 1.722 . . . . 0.0 110.373 176.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.35 -157.35 46.21 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 125.118 1.342 . . . . 0.0 111.463 -170.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.35 151.68 8.95 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.869 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -170.042 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.714 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 tp -125.26 155.84 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -139.14 156.43 47.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -166.073 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.6 137.87 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 119.096 -2.252 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.08 -64.65 1.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.414 -1.429 . . . . 0.0 108.529 160.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.44 136.62 50.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.245 1.018 . . . . 0.0 110.785 -175.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.5 mm -89.81 118.99 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.667 1.587 . . . . 0.0 107.424 169.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 N--CA 1.429 -1.49 0 CA-C-O 117.728 -1.13 . . . . 0.0 111.776 -177.673 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -48.86 36.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.463 1.905 . . . . 0.0 114.639 -174.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.22 -39.51 56.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.071 1.415 . . . . 0.0 111.789 169.07 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -67.83 -2.76 7.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -67.72 -90.99 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.2 2.273 . . . . 0.0 109.145 164.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.79 -35.34 0.5 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 111.615 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.61 -25.85 35.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.791 -0.829 . . . . 0.0 113.113 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.06 131.26 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.068 -1.645 . . . . 0.0 112.339 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -136.58 179.25 6.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.983 -1.073 . . . . 0.0 108.795 167.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -84.54 49.15 1.63 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.231 -1.543 . . . . 0.0 114.905 -167.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.41 19.64 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.899 -1.75 . . . . 0.0 114.057 176.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.33 179.99 4.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.028 -1.277 . . . . 0.0 112.425 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -113.01 142.54 45.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.768 2.027 . . . . 0.0 109.088 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.78 133.9 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.324 -1.485 . . . . 0.0 108.126 165.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.59 -30.48 5.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.556 -1.34 . . . . 0.0 113.93 -173.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 157.25 42.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.162 1.346 . . . . 0.0 113.452 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.8 t -137.99 123.27 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 123.821 0.848 . . . . 0.0 110.955 -177.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 52.67 33.89 14.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.61 1.564 . . . . 0.0 114.641 -173.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.89 23.46 69.29 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.065 -1.022 . . . . 0.0 113.512 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.12 100.07 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 124.333 1.053 . . . . 0.0 108.392 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.09 142.61 41.75 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.928 2.091 . . . . 0.0 115.468 173.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.45 -56.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.624 -1.297 . . . . 0.0 111.555 176.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 43.24 43.97 4.3 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 169.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 45.16 0.97 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 120.819 -1.176 . . . . 0.0 110.679 -168.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.57 144.69 28.37 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.443 -1.033 . . . . 0.0 108.918 171.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.6 p -97.01 -160.98 0.84 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.481 1.512 . . . . 0.0 109.946 -175.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.42 -49.9 65.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.951 -1.718 . . . . 0.0 110.802 167.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -66.5 -46.93 74.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 112.775 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.71 -33.01 71.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.48 91.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.465 -2.022 . . . . 0.0 113.533 170.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.59 -52.38 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 118.885 -0.579 . . . . 0.0 111.314 172.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -47.24 -45.16 23.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 171.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -73.64 -27.47 61.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.95 1.3 . . . . 0.0 112.368 -171.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.27 -48.12 7.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.077 1.751 . . . . 0.0 114.51 172.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -48.24 17.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.956 2.103 . . . . 0.0 113.402 -173.287 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.38 31.41 0.82 Allowed 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.859 -1.776 . . . . 0.0 112.426 -166.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.3 p -83.04 -168.06 1.92 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.283 3.433 . . . . 0.0 109.388 171.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.5 -108.08 0.53 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.383 -1.448 . . . . 0.0 110.723 170.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -120.18 -44.87 2.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.567 1.147 . . . . 0.0 110.436 174.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -72.72 129.89 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.449 1.119 . . . . 0.0 112.116 173.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.8 t -129.76 99.87 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 126.415 1.886 . . . . 0.0 108.116 179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -78.02 98.62 5.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.552 1.941 . . . . 0.0 110.312 168.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -84.79 113.16 21.14 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.455 1.902 . . . . 0.0 109.911 -175.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 98.36 11.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 168.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.06 147.97 25.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.364 1.865 . . . . 0.0 109.717 -177.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.97 132.97 56.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.702 1.239 . . . . 0.0 108.236 167.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? . . . . . 0 N--CA 1.43 -1.429 0 C-N-CA 124.862 1.265 . . . . 0.0 109.79 176.56 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 tp . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.398 2.2 t 67.86 104.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 124.924 2.297 . . . . 0.0 114.378 169.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 34.1 m -140.24 122.76 16.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.612 -3.107 . . . . 0.0 102.612 -171.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.3 p -80.55 121.29 25.62 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.984 0.914 . . . . 0.0 109.986 175.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.0 m . . . . . 0 C--O 1.259 1.579 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -169.488 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 122.521 1.153 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.38 128.25 41.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.725 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -103.25 81.24 1.92 Allowed 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.609 1.195 . . . . 0.0 108.316 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.95 109.11 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 126.926 2.091 . . . . 0.0 112.543 -173.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 124.64 44.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.92 -1.738 . . . . 0.0 109.384 -177.061 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.1 mt -134.93 158.73 43.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 109.045 -171.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.28 43.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 162.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -63.18 146.51 53.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.885 -1.134 . . . . 0.0 113.37 -175.136 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -92.41 88.66 6.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.963 1.364 . . . . 0.0 107.381 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 t0 44.99 64.98 1.2 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.18 2.592 . . . . 0.0 117.108 -177.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 52.8 6.02 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.634 -1.291 . . . . 0.0 114.119 179.154 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.42 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 3.9 m 177.33 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.166 1.386 . . . . 0.0 108.618 -169.354 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.7 mt -74.39 -45.68 45.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.248 1.819 . . . . 0.0 107.426 163.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.88 47.06 0.85 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 125.444 1.497 . . . . 0.0 111.054 177.1 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 pt -128.8 131.65 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.39 0.614 . . . . 0.0 109.429 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.1 m -91.05 113.03 25.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.434 1.094 . . . . 0.0 111.95 171.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.6 m -80.85 140.13 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -172.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -130.67 168.18 17.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.098 1.759 . . . . 0.0 109.602 172.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.85 -150.23 34.02 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.977 1.275 . . . . 0.0 114.08 -177.1 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 161.44 21.76 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 125.439 1.495 . . . . 0.0 109.602 -179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 120.094 -1.827 . . . . 0.0 115.136 -171.562 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 CA-C-O 121.415 0.453 . . . . 0.0 113.584 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.287 3.9 tp -124.33 156.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 120.103 -1.821 . . . . 0.0 106.826 170.659 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.09 151.63 52.01 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -170.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 t -85.87 130.91 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.403 -2.061 . . . . 0.0 110.524 176.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -90.23 -45.96 8.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.035 -1.666 . . . . 0.0 110.379 168.192 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 143.87 33.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.605 1.193 . . . . 0.0 112.784 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.8 mm -105.02 116.97 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.513 2.725 . . . . 0.0 108.001 -176.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 120.539 -1.351 . . . . 0.0 112.653 -177.007 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 -49.0 50.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.955 1.702 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.17 -29.98 70.74 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.454 -1.403 . . . . 0.0 111.929 173.023 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 m -69.72 -2.36 11.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 176.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.95 -80.9 0.05 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 120.872 1.669 . . . . 0.0 107.427 157.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.62 -33.94 0.82 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.25 -0.906 . . . . 0.0 111.413 165.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -72.25 -26.49 62.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -169.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.02 141.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.706 1.202 . . . . 0.0 114.125 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.421 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 3.6 t-80 -134.21 -166.93 1.87 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.607 -1.308 . . . . 0.0 110.783 165.046 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 53.1 mtpt -80.84 135.34 35.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.041 -1.662 . . . . 0.0 110.337 -176.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.65 2.34 72.8 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.076 -1.64 . . . . 0.0 114.642 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.21 151.52 39.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.437 1.119 . . . . 0.0 111.682 176.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -106.19 114.46 28.6 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.419 1.087 . . . . 0.0 109.357 -167.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -92.89 120.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.132 -1.605 . . . . 0.0 108.814 173.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.04 -39.84 9.95 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.651 -1.281 . . . . 0.0 111.544 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.63 149.23 34.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 t -129.59 117.73 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 O-C-N 120.804 -1.185 . . . . 0.0 113.061 -173.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 0.4 OUTLIER 46.62 37.54 4.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.277 2.231 . . . . 0.0 115.754 -169.863 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.24 5.88 57.93 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 114.201 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -121.87 105.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 118.346 1.073 . . . . 0.0 110.366 -168.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 t -60.74 139.24 57.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.759 172.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.84 60.33 2.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.911 2.084 . . . . 0.0 111.614 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.01 105.26 10.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.081 2.153 . . . . 0.0 111.796 -169.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.93 21.03 79.15 Favored Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.813 -1.179 . . . . 0.0 114.026 -175.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.27 141.07 29.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.161 -1.2 . . . . 0.0 113.165 -175.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -104.57 -156.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.591 2.356 . . . . 0.0 109.66 -174.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.97 -50.94 44.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.707 -1.871 . . . . 0.0 111.384 168.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.72 -51.76 68.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 112.337 174.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.83 -36.07 82.71 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.006 -1.059 . . . . 0.0 113.846 -175.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.15 92.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.156 -1.59 . . . . 0.0 114.953 171.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.05 -49.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 110.764 174.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.36 -26.12 67.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.891 -1.756 . . . . 0.0 114.902 178.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -75.97 -27.98 57.7 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.158 1.783 . . . . 0.0 113.172 176.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.6 mt -89.63 -47.72 7.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.227 -1.545 . . . . 0.0 113.963 173.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 -37.1 22.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.695 1.598 . . . . 0.0 114.072 -170.277 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.55 37.58 0.92 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.979 -1.701 . . . . 0.0 111.274 -172.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.5 p -100.17 179.41 4.49 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.132 3.373 . . . . 0.0 111.555 -179.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.94 -136.68 4.22 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.611 -1.306 . . . . 0.0 112.871 173.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -85.06 -62.42 1.54 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.802 -1.411 . . . . 0.0 111.869 -177.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -75.75 124.28 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.89 1.329 . . . . 0.0 111.787 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.5 t -114.99 114.94 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 167.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -87.35 110.66 20.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.12 111.14 20.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.585 -1.322 . . . . 0.0 110.253 174.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 98.36 10.97 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.4 mt -104.97 137.92 41.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.968 2.507 . . . . 0.0 110.759 -173.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.6 148.05 42.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.235 1.814 . . . . 0.0 108.545 170.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 176.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.477 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 7.8 tp . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.477 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.452 5.7 m 46.06 76.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 128.058 2.543 . . . . 0.0 117.311 171.107 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.1 m -117.78 117.86 30.48 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 69.3 p -78.86 117.98 20.47 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.017 1.327 . . . . 0.0 111.323 178.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.4 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -171.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 122.439 1.114 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 117.46 33.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.218 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.53 89.05 7.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.985 1.85 . . . . 0.0 109.513 170.4 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.36 150.77 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.388 1.875 . . . . 0.0 108.358 176.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.79 130.7 34.45 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.799 -1.813 . . . . 0.0 109.164 168.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.08 165.42 36.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.223 1.011 . . . . 0.0 111.718 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.18 132.77 45.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.578 1.151 . . . . 0.0 110.355 170.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -70.49 164.27 25.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 0.0 112.374 177.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 t -114.64 96.94 5.99 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.532 -1.355 . . . . 0.0 109.36 -179.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 53.08 55.08 9.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.011 2.125 . . . . 0.0 115.399 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.74 48.75 16.06 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 114.001 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 p -178.58 119.32 0.08 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.66 -38.19 62.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.91 2.084 . . . . 0.0 106.449 164.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.52 18.25 4.11 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.253 1.406 . . . . 0.0 110.864 168.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 pt -107.93 129.19 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.715 1.245 . . . . 0.0 110.541 -176.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.0 m -85.96 113.61 22.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.513 1.125 . . . . 0.0 110.864 173.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.13 131.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -171.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -126.24 164.96 19.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.118 2.167 . . . . 0.0 110.83 177.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -136.18 13.69 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 125.877 1.703 . . . . 0.0 114.009 174.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.52 176.84 49.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 124.662 1.125 . . . . 0.0 114.457 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.429 -1.49 0 C-N-CA 127.521 2.328 . . . . 0.0 115.343 -172.263 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.765 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.264 3.1 tp -145.52 164.53 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 161.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -145.53 157.49 43.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -168.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.8 t -90.06 130.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.015 -1.678 . . . . 0.0 113.208 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -87.73 -53.56 4.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.896 -1.128 . . . . 0.0 111.375 170.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.76 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.035 0.921 . . . . 0.0 111.472 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.6 mm -98.39 137.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.522 2.329 . . . . 0.0 107.787 172.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 116.827 -1.559 . . . . 0.0 108.426 176.31 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.58 -33.68 75.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.459 2.762 . . . . 0.0 118.459 -171.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.0 -35.25 80.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.088 -2.882 . . . . 0.0 111.014 171.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -74.34 0.54 14.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -72.48 -51.72 18.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.672 -1.893 . . . . 0.0 109.941 168.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.09 -73.76 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.798 158.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.96 -19.24 63.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -166.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.5 133.06 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 121.748 2.067 . . . . 0.0 115.575 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -129.49 178.71 6.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.555 1.542 . . . . 0.0 111.718 172.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -83.03 124.75 30.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.213 -1.555 . . . . 0.0 109.523 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.15 52.98 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 121.118 -0.989 . . . . 0.0 113.933 -173.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -81.83 165.04 21.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.588 1.185 . . . . 0.0 111.896 176.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -107.69 131.15 54.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.678 -172.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.43 120.49 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.092 -1.63 . . . . 0.0 107.541 163.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.24 -37.59 9.61 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.618 -1.301 . . . . 0.0 112.308 -179.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.13 156.87 43.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 119.467 1.03 . . . . 0.0 113.217 -177.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.71 123.34 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 111.646 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 53.46 32.8 14.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.218 1.372 . . . . 0.0 114.566 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.4 20.65 76.72 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.899 -1.126 . . . . 0.0 114.49 -175.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -115.23 102.61 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.7 m -59.46 135.83 57.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.883 -1.136 . . . . 0.0 112.457 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.95 70.71 2.69 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.0 111.897 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.82 101.26 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.387 1.875 . . . . 0.0 112.349 -174.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.49 38.02 95.65 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.119 -0.988 . . . . 0.0 112.978 -175.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.05 140.52 35.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.417 -1.049 . . . . 0.0 109.706 176.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -114.48 -168.78 1.42 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 103.892 -2.632 . . . . 0.0 103.892 174.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -56.45 -52.88 63.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.91 -1.744 . . . . 0.0 114.168 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -74.14 -41.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.707 1.14 . . . . 0.0 112.315 -174.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -59.45 -47.1 86.77 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 119.957 -1.714 . . . . 0.0 114.449 172.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.41 -29.9 70.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.459 -1.401 . . . . 0.0 114.597 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.5 -56.86 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.43 166.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -51.56 -42.4 61.83 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -61.17 -29.81 70.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.933 2.093 . . . . 0.0 115.012 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -97.74 -33.43 11.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.104 2.162 . . . . 0.0 115.263 173.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -49.44 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.168 2.587 . . . . 0.0 114.147 -169.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -92.91 30.92 1.48 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.564 1.65 . . . . 0.0 111.548 -169.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -87.14 -174.57 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.628 2.771 . . . . 0.0 111.175 -176.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.37 173.44 51.22 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.337 158.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -61.53 -41.22 97.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.691 1.596 . . . . 0.0 113.07 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.23 126.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.939 1.352 . . . . 0.0 111.043 169.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -120.51 105.22 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.607 1.563 . . . . 0.0 107.394 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -77.83 103.55 7.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.605 -1.309 . . . . 0.0 109.542 165.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -89.17 118.4 28.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.744 -1.222 . . . . 0.0 110.429 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.38 95.34 10.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.12 145.61 26.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.885 2.074 . . . . 0.0 110.196 -177.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.62 139.23 52.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.772 1.273 . . . . 0.0 110.048 163.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? . . . . . 0 N--CA 1.429 -1.497 0 C-N-CA 126.686 1.994 . . . . 0.0 113.267 177.195 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.395 2.3 t 77.09 121.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 163.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 20.5 m -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 10.8 p -80.99 122.95 27.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.795 1.638 . . . . 0.0 110.661 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.261 1.664 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 -170.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 121.764 0.792 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.01 121.8 44.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.449 1.5 . . . . 0.0 108.806 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -101.32 75.14 1.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.511 1.524 . . . . 0.0 111.375 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.58 121.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.193 -1.567 . . . . 0.0 114.817 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.72 122.24 39.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.774 -1.829 . . . . 0.0 111.328 175.22 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.23 170.64 16.33 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.439 1.096 . . . . 0.0 108.578 175.079 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.0 133.49 55.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.423 1.089 . . . . 0.0 109.501 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 155.03 34.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.992 -1.068 . . . . 0.0 111.42 -174.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 t -100.9 100.03 10.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.838 -1.164 . . . . 0.0 109.052 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.265 2.4 m-20 37.81 60.23 1.2 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.536 2.735 . . . . 0.0 117.141 -172.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.6 54.66 5.37 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.969 -1.082 . . . . 0.0 114.198 178.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 m 179.22 109.91 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.237 1.415 . . . . 0.0 107.354 -172.148 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.9 mt -76.84 -44.86 30.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.39 45.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.806 1.193 . . . . 0.0 110.768 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.16 136.94 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 121.553 0.692 . . . . 0.0 110.793 169.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.1 m -80.09 110.52 15.57 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.091 1.757 . . . . 0.0 112.442 167.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.8 123.47 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -172.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -121.72 171.08 9.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.574 2.349 . . . . 0.0 109.98 176.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.63 -131.01 10.29 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.238 1.399 . . . . 0.0 112.606 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.65 168.73 44.84 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.271 0.939 . . . . 0.0 111.895 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.468 0 C-N-CA 126.161 1.784 . . . . 0.0 115.006 -171.824 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.706 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -110.15 157.71 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -137.01 153.1 50.75 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.016 -1.678 . . . . 0.0 108.056 -169.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 t -90.85 117.89 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.41 -1.431 . . . . 0.0 112.074 178.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -81.66 -33.98 31.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.844 -1.16 . . . . 0.0 112.102 177.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.93 146.15 18.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.803 0.811 . . . . 0.0 109.776 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.2 mm -100.76 121.67 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 120.55 -1.344 . . . . 0.0 112.547 -176.069 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.502 0.668 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.72 72.74 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.946 1.698 . . . . 0.0 113.625 -176.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.91 -36.19 62.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.4 -1.437 . . . . 0.0 113.424 165.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 t -75.36 2.31 11.59 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.325 -2.11 . . . . 0.0 107.923 153.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.71 -28.12 1.46 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 170.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.8 mtt85 -81.77 -27.61 33.66 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mt -67.02 133.82 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 119.235 0.925 . . . . 0.0 113.436 178.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.23 -178.43 4.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.734 -1.229 . . . . 0.0 109.424 166.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -76.6 103.34 6.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.517 -1.989 . . . . 0.0 111.132 174.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.7 -17.72 1.82 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.783 -1.198 . . . . 0.0 115.505 -173.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.49 156.65 36.69 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 119.918 1.859 . . . . 0.0 115.226 -172.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.19 122.31 45.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.655 1.582 . . . . 0.0 109.513 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.48 114.39 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.94 -38.89 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.403 -1.435 . . . . 0.0 112.939 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.16 160.18 44.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.022 1.283 . . . . 0.0 114.147 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.0 t -134.3 113.32 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 111.49 -175.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 10.2 p30 43.44 33.98 0.7 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 -163.708 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.07 22.29 59.51 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.575 -1.328 . . . . 0.0 113.383 -177.032 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.99 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 172.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -70.38 144.26 51.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.475 1.131 . . . . 0.0 113.248 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.79 56.38 3.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.727 1.211 . . . . 0.0 110.037 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.27 24.56 0.18 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 128.588 2.755 . . . . 0.0 114.654 -163.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.1 40.21 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.085 1.802 . . . . 0.0 111.173 -176.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.47 148.39 25.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.287 -1.125 . . . . 0.0 111.81 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.608 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 46.6 p -95.91 -159.7 0.74 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.727 2.811 . . . . 0.0 109.872 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -63.96 -54.88 27.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.831 -1.793 . . . . 0.0 112.228 163.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -68.05 -38.7 82.78 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 114.446 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.608 ' HB2' ' H ' ' A' ' 77' ' ' THR . 35.2 mt-30 -68.52 -38.84 81.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.975 -1.703 . . . . 0.0 113.128 174.391 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.41 87.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.79 -1.819 . . . . 0.0 113.597 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.634 1.173 . . . . 0.0 110.751 175.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -51.93 -41.07 61.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 174.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -70.64 -24.66 62.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.705 1.602 . . . . 0.0 113.984 -175.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.85 -40.18 11.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.008 -1.683 . . . . 0.0 114.141 167.288 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -46.76 44.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.181 1.792 . . . . 0.0 114.786 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.88 34.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.935 -1.728 . . . . 0.0 113.496 -170.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.0 p -103.03 153.35 20.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.416 2.286 . . . . 0.0 114.158 -170.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.31 62.08 4.52 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.321 1.439 . . . . 0.0 115.888 -175.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.321 9.8 tt0 64.63 -50.68 0.31 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.354 3.462 . . . . 0.0 116.929 178.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.19 127.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.263 1.506 . . . . 0.0 109.8 173.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.11 104.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -79.09 102.78 8.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 165.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.59 113.85 23.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 110.39 -175.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.12 95.78 10.28 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.7 141.21 36.46 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.543 2.337 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.79 139.02 45.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.813 1.245 . . . . 0.0 109.287 167.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? . . . . . 0 N--CA 1.43 -1.455 0 C-N-CA 127.467 2.307 . . . . 0.0 114.387 178.393 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.374 15.6 t 67.59 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 124.352 2.025 . . . . 0.0 114.732 171.108 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 98.3 m -138.29 133.65 33.34 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 43.7 m -74.47 118.87 17.92 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.436 1.494 . . . . 0.0 109.509 171.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.572 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -176.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.277 0.0 OUTLIER -131.2 132.61 44.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.749 1.22 . . . . 0.0 108.247 170.473 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -106.71 87.18 2.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.217 1.007 . . . . 0.0 109.102 175.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.4 t -90.68 122.84 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.205 2.202 . . . . 0.0 113.044 -174.73 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -105.73 118.36 36.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.005 -2.309 . . . . 0.0 113.22 -179.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 mt -120.12 160.85 22.04 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.943 -1.098 . . . . 0.0 111.161 -173.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.26 102.65 8.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.001 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.86 143.83 57.22 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -173.045 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 t -104.39 93.99 5.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.425 1.49 . . . . 0.0 109.627 -168.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.62 56.44 7.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.674 2.39 . . . . 0.0 114.156 -173.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.39 60.01 7.17 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.792 -1.193 . . . . 0.0 114.231 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -175.81 104.47 0.08 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.33 -49.98 30.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 164.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.03 37.63 0.3 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 113.307 -1.77 . . . . 0.0 111.605 165.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.05 130.69 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.324 1.059 . . . . 0.0 112.127 179.814 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -73.32 111.22 8.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.217 1.007 . . . . 0.0 111.954 160.575 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.8 m -84.12 124.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.44 169.7 9.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.459 1.904 . . . . 0.0 110.04 175.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.46 -121.51 5.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.481 1.515 . . . . 0.0 113.613 178.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.31 147.71 22.13 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -175.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -171.363 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.776 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -108.85 155.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 168.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.002 -1.686 . . . . 0.0 107.292 -171.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 t -79.9 130.68 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.375 -1.453 . . . . 0.0 110.432 173.384 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -90.3 -49.47 6.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.235 -1.541 . . . . 0.0 110.327 168.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.99 37.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.128 0.971 . . . . 0.0 109.824 -173.097 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mm -95.15 137.45 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 170.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 N--CA 1.43 -1.431 0 O-C-N 120.869 -1.145 . . . . 0.0 113.215 -179.118 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 118.989 2.959 . . . . 0.0 118.989 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 -28.89 61.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.184 -1.572 . . . . 0.0 114.991 179.07 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.14 -37.3 83.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.179 -1.576 . . . . 0.0 110.942 168.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -69.93 -1.7 10.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -178.373 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -71.56 -83.4 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.062 -2.274 . . . . 0.0 109.793 165.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.88 -41.08 0.93 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.957 -1.089 . . . . 0.0 111.561 174.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -84.94 -18.6 34.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.31 127.22 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.843 1.257 . . . . 0.0 110.836 176.303 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.8 -179.42 5.07 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.634 1.574 . . . . 0.0 110.359 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -76.52 70.55 3.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.326 1.45 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.68 -13.03 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.384 -1.447 . . . . 0.0 116.561 179.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -71.34 157.4 38.15 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -92.92 130.33 38.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.392 1.477 . . . . 0.0 110.216 -177.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.26 122.3 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.123 1.369 . . . . 0.0 107.754 167.809 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -32.84 8.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.993 -1.067 . . . . 0.0 113.155 175.101 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 159.72 44.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.763 -1.211 . . . . 0.0 112.811 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 t -141.08 123.66 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 111.863 -174.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.09 30.43 19.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.28 -1.512 . . . . 0.0 112.687 -178.26 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.84 78.06 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 125.73 1.633 . . . . 0.0 114.557 -174.245 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.92 109.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -177.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 m -60.57 146.21 45.98 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.124 1.44 . . . . 0.0 113.677 175.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -79.28 65.01 4.33 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.52 -1.362 . . . . 0.0 110.303 172.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.38 98.77 9.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.242 -1.536 . . . . 0.0 111.019 -176.307 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.93 66.43 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.361 -0.837 . . . . 0.0 112.896 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.82 129.15 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.955 1.836 . . . . 0.0 115.087 -170.178 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.491 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.5 p -93.4 -165.19 1.29 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.645 2.378 . . . . 0.0 107.741 -179.745 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.6 -49.99 75.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.085 -1.635 . . . . 0.0 112.737 164.735 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -69.83 -45.38 67.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.491 ' HB3' ' H ' ' A' ' 77' ' ' THR . 58.9 tt0 -69.22 -32.86 72.4 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.979 -1.076 . . . . 0.0 112.97 177.7 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.1 89.97 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.394 -1.441 . . . . 0.0 114.312 173.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.89 -52.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.398 -0.811 . . . . 0.0 110.146 171.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.24 -40.81 78.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.2 m -62.4 -28.78 70.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 175.054 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.27 -40.79 11.94 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.824 1.65 . . . . 0.0 115.057 172.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -75.69 -44.33 42.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.912 2.885 . . . . 0.0 113.483 -173.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -87.93 38.61 0.85 Allowed 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.336 -1.477 . . . . 0.0 111.471 -169.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.0 p -109.26 166.45 10.85 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.722 2.009 . . . . 0.0 112.125 -173.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.13 -89.09 0.19 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.199 -1.563 . . . . 0.0 115.564 -172.699 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.64 -62.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.602 -0.94 . . . . 0.0 110.177 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.2 t -75.09 125.79 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 122.961 1.362 . . . . 0.0 110.707 172.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.7 t -114.37 103.99 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -83.12 103.88 12.88 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 108.622 172.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.73 118.76 26.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.025 -1.047 . . . . 0.0 111.483 178.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 102.53 15.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.75 144.49 30.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.588 1.955 . . . . 0.0 110.427 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.98 132.15 54.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 163.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 tptt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 123.961 0.905 . . . . 0.0 112.258 179.738 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.507 28.0 m 54.41 98.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 169.314 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 31.2 m -133.76 124.51 26.75 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 -174.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -69.83 128.78 37.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.488 1.115 . . . . 0.0 110.672 171.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.259 1.594 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -170.744 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.431 -1.396 0 CA-C-O 122.055 0.931 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -131.11 137.55 49.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.558 1.143 . . . . 0.0 108.004 178.22 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.39 76.36 0.97 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.032 1.333 . . . . 0.0 109.364 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.74 121.71 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.044 1.738 . . . . 0.0 114.942 -169.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -99.54 116.56 31.95 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.512 -1.992 . . . . 0.0 110.46 174.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.29 170.68 15.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.51 141.06 49.53 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.967 -1.083 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -63.99 145.98 54.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.573 1.949 . . . . 0.0 112.593 174.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -101.73 101.65 12.18 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.392 1.091 . . . . 0.0 109.495 179.708 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.95 -20.77 0.06 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.704 2.802 . . . . 0.0 117.522 -173.226 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.16 43.81 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.799 -1.813 . . . . 0.0 111.97 179.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.9 p -174.12 129.07 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.3 mt -78.99 -40.55 31.31 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.716 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.56 43.19 0.59 Allowed Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.39 169.235 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 pt -120.21 134.73 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.695 0.76 . . . . 0.0 109.886 167.238 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.6 m -96.12 117.13 30.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.162 0.985 . . . . 0.0 111.042 169.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.67 142.09 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -167.339 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 159.51 40.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.855 1.662 . . . . 0.0 109.448 168.384 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.98 -141.79 16.3 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.839 1.209 . . . . 0.0 114.593 173.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -175.54 48.6 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.668 1.127 . . . . 0.0 115.252 -178.689 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 N--CA 1.429 -1.478 0 C-N-CA 127.634 2.374 . . . . 0.0 114.085 178.126 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 N-CA-C 112.779 -0.128 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -107.64 162.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.338 -170.479 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.852 -1.78 . . . . 0.0 107.777 -173.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.2 t -96.68 125.16 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 120.558 -1.339 . . . . 0.0 111.469 176.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 -33.55 14.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.373 -1.454 . . . . 0.0 112.261 175.049 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.14 137.58 24.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 110.977 177.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.23 140.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.581 1.952 . . . . 0.0 107.411 173.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.1 mt . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 116.853 -1.546 . . . . 0.0 109.521 169.249 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 121.524 0.678 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.05 66.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.267 -1.521 . . . . 0.0 114.729 -175.16 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.56 -32.91 69.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.114 -1.616 . . . . 0.0 111.343 167.665 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -73.76 5.69 3.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 177.323 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.64 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.101 -2.249 . . . . 0.0 107.733 151.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.77 -42.14 0.6 Allowed Glycine 0 N--CA 1.431 -1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 112.712 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 2.5 mpt_? -79.7 -17.85 52.64 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.067 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -72.59 143.8 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.013 1.725 . . . . 0.0 112.457 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.13 -178.87 5.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.376 -1.452 . . . . 0.0 109.278 159.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.25 135.25 36.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.1 -1.625 . . . . 0.0 111.861 177.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.22 -21.53 17.39 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.619 1.104 . . . . 0.0 112.725 -170.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -71.55 159.65 34.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.217 1.407 . . . . 0.0 114.232 -172.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -101.53 134.88 43.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.753 1.263 . . . . 0.0 110.916 -177.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 t -112.6 111.75 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.063 2.545 . . . . 0.0 105.055 178.215 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.82 -33.66 9.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.422 -1.424 . . . . 0.0 113.64 -175.266 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.64 158.05 39.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.75 1.159 . . . . 0.0 113.361 -179.198 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.2 t -129.9 129.5 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.043 -1.036 . . . . 0.0 110.606 174.996 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.385 0.5 OUTLIER 39.25 43.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.927 2.491 . . . . 0.0 116.081 -171.879 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.87 12.26 81.54 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.452 1.501 . . . . 0.0 114.649 178.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.9 t -109.32 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.606 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 p -71.36 153.77 42.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.314 1.53 . . . . 0.0 113.301 174.038 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.56 74.15 7.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.452 1.12 . . . . 0.0 112.253 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -84.28 107.95 16.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.016 1.389 . . . . 0.0 110.052 176.242 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.84 11.18 84.8 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.339 -1.476 . . . . 0.0 116.373 -177.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.95 141.78 34.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 123.478 1.609 . . . . 0.0 114.909 -169.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.48 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 66.9 p -99.22 -156.74 0.56 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.067 2.147 . . . . 0.0 109.455 -175.555 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -53.48 19.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.129 -1.607 . . . . 0.0 110.563 164.458 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -69.8 -38.63 76.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.251 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.48 ' HB3' ' H ' ' A' ' 77' ' ' THR . 10.5 tt0 -65.42 -37.5 87.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.957 -1.714 . . . . 0.0 113.79 171.371 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.34 -36.22 83.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.678 -1.889 . . . . 0.0 114.397 172.747 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.11 -57.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.028 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -48.46 -38.89 21.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 175.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.4 m -65.3 -33.3 75.66 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.879 2.471 . . . . 0.0 113.759 177.077 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mt -90.87 -29.62 17.41 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.702 -1.874 . . . . 0.0 114.577 171.846 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.15 -48.62 7.91 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.676 2.39 . . . . 0.0 114.739 -168.738 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -87.2 37.92 0.79 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.034 -1.666 . . . . 0.0 111.531 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 35.7 p -95.59 159.47 14.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.435 2.694 . . . . 0.0 112.087 -175.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.03 63.32 3.77 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.796 -1.19 . . . . 0.0 114.251 -174.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.289 28.3 tt0 68.69 -51.51 0.57 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.377 2.671 . . . . 0.0 115.423 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.34 125.97 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.673 1.225 . . . . 0.0 110.513 170.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.67 107.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -89.53 96.63 10.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 124.26 34.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 111.825 -169.023 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.14 100.89 13.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.3 1.048 . . . . 0.0 108.286 165.372 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.9 147.54 26.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.221 2.208 . . . . 0.0 109.378 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.62 138.43 54.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.521 1.153 . . . . 0.0 108.481 166.206 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 tptt . . . . . 0 N--CA 1.431 -1.397 0 O-C-N 120.968 -1.083 . . . . 0.0 112.2 -178.281 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.454 1.1 t 69.68 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 125.051 2.358 . . . . 0.0 115.69 154.313 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.0 m -130.5 122.3 27.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -170.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.8 p -74.27 130.03 38.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.609 1.563 . . . . 0.0 110.319 176.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 25' ' ' LEU . 11.7 p . . . . . 0 C--O 1.259 1.579 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -164.178 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 122.148 0.975 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.62 122.47 24.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.369 1.468 . . . . 0.0 109.088 176.734 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -88.35 86.41 7.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.384 1.564 . . . . 0.0 110.34 168.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.17 143.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.3 1.44 . . . . 0.0 108.876 176.177 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 117.92 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.894 -1.754 . . . . 0.0 109.65 174.668 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.1 mt -120.84 161.23 21.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.513 1.125 . . . . 0.0 109.916 -173.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.13 117.43 26.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 166.318 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.488 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -63.9 145.33 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.1 1.36 . . . . 0.0 114.303 -173.96 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.6 t -97.62 104.09 16.08 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 120.511 -1.368 . . . . 0.0 110.474 178.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 49.83 39.82 19.08 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.157 2.183 . . . . 0.0 115.28 -174.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 65.54 1.98 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 121.107 -0.996 . . . . 0.0 115.004 -173.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 46.6 t 177.98 114.01 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -175.305 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.8 mt -76.52 -38.25 55.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.5 27.65 2.32 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.122 169.067 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 pt -124.37 127.36 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.684 0.754 . . . . 0.0 109.96 -174.232 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -79.12 110.69 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.028 1.331 . . . . 0.0 114.003 173.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.46 129.39 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -176.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -124.27 167.88 13.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.727 . . . . 0.0 109.939 172.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.7 -152.03 42.06 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.975 1.274 . . . . 0.0 113.61 -177.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.0 165.7 19.65 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.288 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.43 -1.447 0 O-C-N 120.634 -1.509 . . . . 0.0 114.372 -171.332 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 CA-C-O 121.554 0.53 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.4 tp -140.92 163.0 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -135.72 155.32 50.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.292 -1.505 . . . . 0.0 107.356 -173.177 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.96 121.39 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.758 -1.214 . . . . 0.0 111.611 -178.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.31 -34.48 18.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.246 -1.534 . . . . 0.0 113.21 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.21 132.68 18.64 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -177.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mm -93.48 126.3 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 166.561 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 121.631 -0.668 . . . . 0.0 111.859 179.442 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.439 0 CA-C-O 121.07 0.462 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.8 -41.1 79.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.668 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.77 -30.5 56.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.234 -1.541 . . . . 0.0 112.996 174.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -72.29 2.22 6.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 175.762 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.13 -99.86 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.874 -2.391 . . . . 0.0 109.045 162.519 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 -47.36 0.14 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.654 -1.904 . . . . 0.0 113.404 175.475 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 mtm-85 -69.2 -33.83 73.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.92 1.288 . . . . 0.0 113.143 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -52.13 129.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.062 2.945 . . . . 0.0 116.016 -175.386 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.87 177.79 8.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.57 -1.331 . . . . 0.0 110.93 167.38 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -72.16 121.26 19.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.475 -2.641 . . . . 0.0 112.445 175.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.06 0.95 11.55 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -176.264 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.95 158.69 29.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.528 2.164 . . . . 0.0 112.836 176.206 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -100.62 129.92 46.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.244 1.418 . . . . 0.0 108.971 178.453 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.52 117.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.03 -39.12 8.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.875 -1.765 . . . . 0.0 113.332 176.442 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.55 159.18 44.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 119.993 1.269 . . . . 0.0 113.721 -177.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG12 HG11 ' A' ' 92' ' ' VAL . 67.0 t -133.28 115.78 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 123.881 0.872 . . . . 0.0 111.271 179.905 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 52.49 27.11 4.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.066 -1.646 . . . . 0.0 115.305 -168.184 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 4.52 72.97 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 114.25 -173.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.39 93.5 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -177.636 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.5 p -71.42 135.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.34 1.067 . . . . 0.0 113.634 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.2 mt -80.12 56.67 2.48 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.081 2.152 . . . . 0.0 112.354 -174.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -73.35 82.04 1.4 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.289 2.236 . . . . 0.0 112.643 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.27 29.41 19.79 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 120.711 -1.243 . . . . 0.0 113.446 -178.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.29 149.85 35.32 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.687 1.232 . . . . 0.0 112.238 176.037 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -104.66 -163.27 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.503 1.921 . . . . 0.0 109.121 -176.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -66.72 -54.11 26.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 111.511 169.24 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -64.35 -46.54 82.98 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.499 1.12 . . . . 0.0 112.659 177.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -63.38 -41.76 98.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.417 -1.427 . . . . 0.0 113.654 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.21 -38.4 87.88 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.295 -1.503 . . . . 0.0 114.918 174.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.79 -56.34 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 118.7 0.682 . . . . 0.0 110.494 170.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 36.0 mt-10 -64.18 -25.45 68.08 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -65.13 -35.05 79.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.357 1.863 . . . . 0.0 111.186 173.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.95 -40.85 13.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.241 1.816 . . . . 0.0 114.507 174.123 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 83' ' ' GLU 0.356 0.0 OUTLIER -82.33 -35.59 27.75 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -174.457 . . . . . . . . 4 4 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -81.33 41.58 0.62 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.559 -1.963 . . . . 0.0 113.333 178.101 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -105.42 -169.02 1.53 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.087 2.155 . . . . 0.0 110.488 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.86 -117.02 3.99 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.194 1.378 . . . . 0.0 110.736 176.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -66.35 0.93 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.877 -1.367 . . . . 0.0 111.438 178.098 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.46 129.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.907 -174.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 68' ' ' VAL . 30.1 t -121.28 105.99 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 172.277 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -77.43 100.43 5.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.653 1.581 . . . . 0.0 108.844 165.368 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -84.6 111.83 19.89 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.462 1.505 . . . . 0.0 108.065 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 99.61 12.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 171.596 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.5 144.1 32.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.286 1.434 . . . . 0.0 109.802 -177.672 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.62 125.26 53.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 166.301 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptm . . . . . 0 N--CA 1.429 -1.491 0 C-N-CA 124.808 1.243 . . . . 0.0 113.567 -171.306 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 120.351 0.119 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER 85.8 112.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 123.981 1.848 . . . . 0.0 113.466 165.823 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.6 m -139.4 118.8 12.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 -172.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 85.8 p -73.14 129.1 37.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.383 0.992 . . . . 0.0 109.426 170.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.0 p . . . . . 0 C--O 1.261 1.697 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -161.306 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.244 1.021 . . . . 0.0 108.842 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 124.58 31.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.18 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.01 82.23 3.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.687 1.232 . . . . 0.0 108.567 176.27 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.54 153.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.301 1.44 . . . . 0.0 109.709 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -129.31 122.35 29.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.177 -1.577 . . . . 0.0 107.807 166.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -119.89 153.25 36.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.936 -1.103 . . . . 0.0 108.336 -173.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.07 8.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.63 123.9 15.61 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.85 1.66 . . . . 0.0 113.303 -168.873 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.259 11.1 t -85.7 104.45 15.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.303 -1.498 . . . . 0.0 110.978 -169.815 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.61 16.71 9.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 127.2 2.2 . . . . 0.0 116.019 -173.835 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.99 84.58 1.35 Allowed Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.262 -1.524 . . . . 0.0 111.041 -175.566 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.254 79.2 p 151.51 109.31 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.346 2.658 . . . . 0.0 107.447 -169.023 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.7 mt -68.13 -40.94 82.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.239 2.216 . . . . 0.0 107.369 161.047 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.74 32.23 2.73 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 124.953 1.263 . . . . 0.0 110.765 173.038 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 pt -121.37 130.7 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 121.86 -0.788 . . . . 0.0 109.484 174.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -87.04 119.33 27.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.026 0.917 . . . . 0.0 111.096 168.249 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 m -86.08 133.65 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -126.22 170.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.534 1.534 . . . . 0.0 110.83 176.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.91 -121.73 5.69 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 125.23 1.395 . . . . 0.0 113.461 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.39 155.05 30.78 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.624 1.107 . . . . 0.0 112.236 -177.884 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.488 -1.418 0 C-N-CA 126.312 1.845 . . . . 0.0 114.154 -175.462 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.693 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 tp -116.13 155.87 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.488 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -132.66 152.3 51.72 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.236 -1.54 . . . . 0.0 107.904 -169.308 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.36 107.42 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.846 -1.158 . . . . 0.0 111.397 -170.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -86.93 -42.09 13.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.631 -1.918 . . . . 0.0 113.416 -177.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.55 133.13 47.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 113.576 176.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.9 128.93 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.884 2.474 . . . . 0.0 109.777 175.622 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.429 -1.502 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.692 174.779 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.57 -40.5 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.509 1.924 . . . . 0.0 113.652 -176.545 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -62.6 -33.57 75.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.286 -1.508 . . . . 0.0 111.227 170.122 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.35 1.66 7.45 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 174.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.25 -70.98 0.28 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.636 -1.915 . . . . 0.0 108.751 157.097 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -11.46 5.74 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 123.462 0.553 . . . . 0.0 112.984 164.278 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -94.78 -12.71 26.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.25 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -86.32 138.0 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.935 1.694 . . . . 0.0 112.746 -173.835 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -128.24 -171.95 2.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.858 1.263 . . . . 0.0 110.65 170.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -94.78 36.07 1.21 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.397 -2.064 . . . . 0.0 115.182 -163.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.9 16.85 1.07 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.372 -1.455 . . . . 0.0 111.749 175.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -92.62 151.5 20.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.894 0.854 . . . . 0.0 111.949 -162.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -96.64 124.67 40.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.073 0.949 . . . . 0.0 110.526 -176.242 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.2 108.67 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 167.488 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -39.69 11.51 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.949 -1.72 . . . . 0.0 112.09 178.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.63 38.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 119.509 1.049 . . . . 0.0 113.47 -176.355 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.36 118.21 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 123.58 0.752 . . . . 0.0 111.432 -175.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 61.72 29.6 18.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.049 1.295 . . . . 0.0 111.808 -173.549 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.18 4.35 89.78 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.509 -1.37 . . . . 0.0 115.278 -171.523 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.8 107.33 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 118.639 1.219 . . . . 0.0 108.081 -172.501 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 m -70.41 138.22 51.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.206 -0.934 . . . . 0.0 113.333 -178.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.46 37.95 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.298 1.839 . . . . 0.0 111.727 -178.055 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -84.53 74.29 10.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.669 1.988 . . . . 0.0 110.227 -169.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.63 9.6 6.94 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 124.175 0.893 . . . . 0.0 112.985 -170.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.49 140.46 32.3 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.147 1.473 . . . . 0.0 112.953 177.763 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.514 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.2 p -92.12 -160.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.706 2.002 . . . . 0.0 109.912 -178.735 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -66.5 -56.42 10.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.031 -1.668 . . . . 0.0 111.317 165.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -69.38 -38.4 77.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 121.355 -0.841 . . . . 0.0 112.673 -177.127 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.514 ' HB3' ' H ' ' A' ' 77' ' ' THR . 9.0 tt0 -65.96 -36.91 84.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 174.867 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.24 96.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.563 -1.96 . . . . 0.0 113.929 171.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 t -56.21 -49.8 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.74 1.216 . . . . 0.0 111.933 174.827 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.006 -1.684 . . . . 0.0 114.029 176.163 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.2 m -66.31 -24.72 66.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.303 1.841 . . . . 0.0 113.216 -179.313 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.44 -46.39 8.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.848 1.259 . . . . 0.0 114.138 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -85.47 -33.62 21.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.045 -1.66 . . . . 0.0 115.376 -169.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.53 34.23 0.98 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.901 -1.75 . . . . 0.0 111.032 -174.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.3 p -88.48 -166.15 1.52 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.368 2.667 . . . . 0.0 110.429 177.404 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.89 -123.92 3.79 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.019 -1.676 . . . . 0.0 110.138 170.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.8 -50.61 4.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.184 -1.186 . . . . 0.0 109.8 177.142 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.19 123.63 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 123.22 1.486 . . . . 0.0 110.776 176.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 t -114.58 112.48 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.833 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -78.51 116.11 18.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.72 110.08 22.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.027 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.72 99.91 12.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.532 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.55 142.89 36.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.37 1.868 . . . . 0.0 110.207 -173.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -121.81 151.61 40.41 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.004 1.722 . . . . 0.0 109.514 177.329 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 174.483 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 16.1 tp . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.427 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.45 2.9 m 52.61 88.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.132 2.173 . . . . 0.0 115.077 170.302 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 61.7 m -126.77 118.21 24.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -168.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.3 p -79.59 120.45 23.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.4 1.08 . . . . 0.0 110.304 -179.37 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 2.8 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -169.155 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.43 -1.454 0 CA-C-O 122.461 1.124 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.2 117.28 14.37 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.562 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.53 76.65 3.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.887 1.327 . . . . 0.0 109.601 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.03 116.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.706 2.402 . . . . 0.0 112.472 -169.211 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.332 0.2 OUTLIER -104.56 118.36 36.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.834 -1.791 . . . . 0.0 112.078 -173.999 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 mt -127.72 178.38 6.18 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.768 -1.207 . . . . 0.0 109.216 -171.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.28 119.33 22.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 162.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HB3' ' H ' ' A' ' 24' ' ' SER . 2.1 mtpt -62.31 128.6 36.83 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.576 -1.328 . . . . 0.0 113.09 -174.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -88.72 121.02 30.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.505 -1.372 . . . . 0.0 109.392 179.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.26 4.59 3.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.845 2.058 . . . . 0.0 114.743 178.182 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.93 86.24 0.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 125.527 1.537 . . . . 0.0 110.581 -164.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.55 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 37.3 m 163.57 119.81 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 128.192 2.597 . . . . 0.0 106.584 -169.697 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' CD2' HG21 ' A' ' 92' ' ' VAL . 23.6 mt -72.7 -37.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.785 1.755 . . . . 0.0 109.095 162.778 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.58 34.66 4.05 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.141 178.726 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.9 pt -119.99 136.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 122.031 -0.688 . . . . 0.0 109.683 173.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.2 m -84.46 122.35 28.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 123.307 0.643 . . . . 0.0 109.754 160.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 m -85.13 132.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.617 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -122.85 161.83 23.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.538 -1.976 . . . . 0.0 109.691 174.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.72 -148.62 30.69 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.764 1.174 . . . . 0.0 113.998 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.83 146.91 5.46 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.431 -1.419 0 C-N-CA 126.525 1.93 . . . . 0.0 114.996 -178.242 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.683 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.27 2.1 tp -116.04 157.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 119.644 1.722 . . . . 0.0 110.7 -173.976 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -140.5 152.79 45.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -170.511 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 t -87.99 131.66 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.698 -1.877 . . . . 0.0 111.506 -178.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -96.98 -52.38 3.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.908 -1.12 . . . . 0.0 111.213 175.75 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.81 118.07 17.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.074 -1.016 . . . . 0.0 111.163 -171.671 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.92 129.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 126.28 1.832 . . . . 0.0 109.346 177.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.9 mt . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.449 174.51 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.515 0 CA-C-O 120.643 0.259 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.05 80.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.352 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -51.72 -35.83 44.61 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.107 1.363 . . . . 0.0 113.548 167.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 -16.18 46.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.97 -77.15 0.07 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.019 0.927 . . . . 0.0 110.281 164.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.36 -20.95 3.9 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 114.804 160.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.76 -13.62 60.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 118.778 1.289 . . . . 0.0 113.479 178.002 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 141.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 125.082 1.353 . . . . 0.0 113.542 -176.328 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.69 -174.24 3.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.697 -1.252 . . . . 0.0 110.372 169.055 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -81.69 56.25 2.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.388 -1.445 . . . . 0.0 112.914 -175.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -172.56 -8.91 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.248 -0.908 . . . . 0.0 114.58 -176.443 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.68 157.67 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.663 1.732 . . . . 0.0 114.855 -177.1 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -93.7 123.8 37.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.42 1.088 . . . . 0.0 110.412 -176.722 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.78 110.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.588 -1.32 . . . . 0.0 107.983 174.104 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.45 -26.59 12.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.64 172.0 17.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.62 2.009 . . . . 0.0 113.239 176.336 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.89 120.51 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 177.019 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.501 0.0 OUTLIER 30.22 43.77 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.0 2.963 . . . . 0.0 119.0 -151.501 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.48 10.31 86.03 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 126.452 1.977 . . . . 0.0 115.366 -175.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.16 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.472 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -63.72 130.43 44.21 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.063 1.745 . . . . 0.0 115.576 -170.318 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mt -89.42 -6.65 56.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.969 2.108 . . . . 0.0 110.366 171.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.94 108.74 9.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.988 -1.695 . . . . 0.0 109.202 172.047 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.62 28.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.181 -0.95 . . . . 0.0 113.421 -163.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 142.07 34.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.791 -1.417 . . . . 0.0 113.08 -179.506 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.568 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 60.4 p -91.1 -162.0 0.87 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.868 2.467 . . . . 0.0 109.746 -177.89 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -62.87 -51.62 66.3 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.647 -1.908 . . . . 0.0 111.47 167.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -65.26 -50.62 65.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.339 1.055 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HB2' ' H ' ' A' ' 77' ' ' THR . 2.3 mp0 -63.03 -33.37 75.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.607 -1.308 . . . . 0.0 113.856 177.471 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.85 89.61 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 120.263 1.392 . . . . 0.0 114.185 174.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -59.12 -51.21 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 121.58 -0.7 . . . . 0.0 111.212 176.058 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -63.44 -32.58 74.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.346 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.4 m -60.72 -45.18 95.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.886 1.674 . . . . 0.0 112.332 172.27 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.6 -41.3 12.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 113.323 -174.476 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -44.12 56.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -88.47 42.32 1.06 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.654 -1.904 . . . . 0.0 112.421 -169.711 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 p -99.5 -171.0 1.99 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.407 3.483 . . . . 0.0 109.496 177.13 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.93 -132.95 4.53 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.533 -1.354 . . . . 0.0 111.681 175.106 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -93.37 -52.17 4.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.403 -1.645 . . . . 0.0 112.563 178.136 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.59 130.98 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 122.0 0.905 . . . . 0.0 111.308 176.596 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' A' ' 25' ' ' LEU . 3.9 m -122.23 113.45 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.405 1.082 . . . . 0.0 108.086 172.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -81.57 94.26 6.87 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.552 -1.343 . . . . 0.0 108.826 160.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mt -73.3 110.49 7.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.034 1.333 . . . . 0.0 110.053 178.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.38 100.43 11.84 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.455 -0.778 . . . . 0.0 110.358 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.71 149.07 28.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.986 1.714 . . . . 0.0 109.585 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -124.44 147.49 48.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.94 1.296 . . . . 0.0 108.36 167.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 176.093 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' B' B ' 206' ' ' LEU . . . . . 0.636 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.636 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.378 15.4 m 23.14 100.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.155 3.782 . . . . 0.0 119.663 161.87 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -130.55 123.05 28.71 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 -176.42 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.5 p -72.17 129.02 37.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.093 0.949 . . . . 0.0 110.068 169.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.26 1.619 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 -158.466 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.949 0.881 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -139.77 146.97 49.63 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.553 -1.342 . . . . 0.0 108.891 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.72 163.37 35.91 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.657 1.985 . . . . 0.0 111.618 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.47 30.67 76.93 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.786 1.184 . . . . 0.0 115.353 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.18 131.19 54.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.955 -1.32 . . . . 0.0 110.786 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.78 133.86 52.99 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.177 1.791 . . . . 0.0 110.143 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.18 118.1 33.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.963 1.305 . . . . 0.0 109.093 174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.23 92.06 7.05 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.051 1.405 . . . . 0.0 110.078 170.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.2 t -89.45 127.91 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 126.315 1.846 . . . . 0.0 112.454 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 0.0 OUTLIER -108.35 122.54 47.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.012 -2.305 . . . . 0.0 110.238 174.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.84 157.64 37.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.005 -173.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.05 113.22 22.89 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 163.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -56.41 132.45 51.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.262 1.425 . . . . 0.0 113.953 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.5 t -97.74 110.13 22.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.605 -1.31 . . . . 0.0 109.138 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 46.07 55.43 7.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.896 2.478 . . . . 0.0 115.457 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.98 51.22 19.72 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.714 -1.241 . . . . 0.0 114.828 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 p -178.24 111.57 0.07 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.3 mt -66.63 -53.51 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.408 2.283 . . . . 0.0 108.15 166.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 133.96 26.73 0.56 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.911 174.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 pt -126.27 137.61 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.306 1.05 . . . . 0.0 111.171 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -87.27 119.82 27.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.982 1.713 . . . . 0.0 111.649 164.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 m -84.63 140.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.02 178.25 7.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.463 1.905 . . . . 0.0 109.291 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 -118.2 4.73 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.27 1.414 . . . . 0.0 113.105 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.79 162.2 36.01 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 121.432 -1.04 . . . . 0.0 112.502 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -61.6 -20.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.66 -22.4 60.93 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.467 1.507 . . . . 0.0 112.346 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 m -100.28 158.29 15.98 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.25 2.22 . . . . 0.0 106.114 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 p -78.35 67.53 4.17 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.691 -2.505 . . . . 0.0 114.958 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.75 -160.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.049 2.14 . . . . 0.0 110.397 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -81.03 43.85 0.73 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.236 -2.165 . . . . 0.0 113.588 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 m170 53.56 33.13 15.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.45 115.97 1.15 Allowed Glycine 0 N--CA 1.43 -1.739 0 O-C-N 119.883 -1.76 . . . . 0.0 110.939 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.51 140.7 3.02 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -107.25 156.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.94 157.54 46.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.877 -1.764 . . . . 0.0 106.416 -170.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.6 t -87.32 131.29 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.141 -1.599 . . . . 0.0 111.9 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -41.48 9.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.367 -1.458 . . . . 0.0 110.816 171.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.45 136.03 25.7 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.032 -1.042 . . . . 0.0 111.102 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.2 mm -97.43 137.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 127.017 2.127 . . . . 0.0 108.597 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.1 mt -77.22 132.67 69.69 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 110.151 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.04 93.88 0.46 Allowed 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.968 2.445 . . . . 0.0 112.192 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.256 30.4 mmtp 82.57 53.32 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.938 2.495 . . . . 0.0 113.725 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.92 -179.08 30.53 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 151.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.9 -39.11 68.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.056 1.742 . . . . 0.0 115.348 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.73 54.19 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.181 2.192 . . . . 0.0 115.104 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.53 -26.93 68.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.923 -1.736 . . . . 0.0 112.292 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -70.11 -18.73 63.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.033 -1.667 . . . . 0.0 115.066 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.74 -71.57 0.24 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.036 -2.29 . . . . 0.0 107.368 157.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.0 5.63 62.4 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 161.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -80.75 -19.37 45.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 110.115 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.08 149.29 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.298 1.839 . . . . 0.0 114.253 162.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.44 -161.23 1.11 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.62 1.568 . . . . 0.0 107.464 157.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.3 45.45 1.28 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.959 -2.338 . . . . 0.0 112.549 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.73 -20.13 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 O-C-N 120.609 -1.307 . . . . 0.0 114.807 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -78.76 161.06 27.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -166.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -104.07 124.65 49.44 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.64 1.576 . . . . 0.0 110.411 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.26 117.24 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 107.248 166.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 -36.19 9.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.824 -1.797 . . . . 0.0 112.754 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.26 154.22 38.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.82 -1.175 . . . . 0.0 111.401 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.04 121.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.065 -1.022 . . . . 0.0 111.259 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.8 t30 63.77 21.33 12.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.643 -1.285 . . . . 0.0 113.389 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.94 20.38 63.34 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.665 -1.272 . . . . 0.0 113.492 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.9 110.67 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 121.079 -1.248 . . . . 0.0 107.99 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.7 m -58.13 141.18 51.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.383 1.873 . . . . 0.0 114.543 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mt -81.08 47.62 1.03 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.284 1.516 . . . . 0.0 111.889 170.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.76 117.03 21.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.196 1.799 . . . . 0.0 109.707 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.86 72.02 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 114.734 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.21 132.76 36.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.529 1.633 . . . . 0.0 112.639 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -110.46 -164.92 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.006 2.523 . . . . 0.0 105.517 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -58.18 -52.17 66.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.557 -1.965 . . . . 0.0 112.947 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -70.53 -44.63 67.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.121 0.968 . . . . 0.0 112.583 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -38.83 92.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.05 1.34 . . . . 0.0 113.807 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.32 97.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 0.0 114.312 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.37 -54.51 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 118.127 0.421 . . . . 0.0 110.247 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.77 -37.12 40.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 126.085 1.754 . . . . 0.0 115.351 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.7 m -72.22 -31.46 65.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.68 2.392 . . . . 0.0 113.898 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -89.02 -37.94 14.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.242 1.817 . . . . 0.0 114.102 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -82.97 -45.45 14.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.624 1.97 . . . . 0.0 113.378 -166.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -90.88 37.32 0.92 Allowed 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.038 1.399 . . . . 0.0 112.623 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.8 p -90.1 173.51 8.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.949 2.1 . . . . 0.0 114.058 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.71 51.39 4.45 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.673 -1.892 . . . . 0.0 113.972 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 68.27 -51.78 0.54 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.299 3.04 . . . . 0.0 115.673 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.6 t -76.86 128.46 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 123.144 1.449 . . . . 0.0 109.844 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.03 100.22 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -82.26 98.49 8.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.875 1.67 . . . . 0.0 107.987 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -87.51 112.75 22.55 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.322 1.449 . . . . 0.0 109.878 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.26 100.52 12.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.84 136.97 44.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.413 1.885 . . . . 0.0 110.881 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.28 158.23 17.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.134 1.774 . . . . 0.0 109.37 171.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 131.71 31.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.98 14.3 64.7 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.624 -1.923 . . . . 0.0 113.961 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -111.73 121.66 45.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.392 1.877 . . . . 0.0 109.997 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 m -75.04 154.94 86.64 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.327 -1.483 . . . . 0.0 113.531 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.3 -1.983 0 C-N-CA 122.546 2.164 . . . . 0.0 113.369 169.78 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 N--CA 1.431 -1.416 0 CA-C-O 121.328 0.585 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.6 tp 61.37 179.8 0.11 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.634 2.374 . . . . 0.0 114.819 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.51 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.419 16.0 m 33.12 89.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 129.934 3.294 . . . . 0.0 116.775 171.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 64.5 m -125.11 121.83 35.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.0 p -71.62 121.1 18.18 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.574 1.15 . . . . 0.0 109.779 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.636 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 33.5 ttm . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -119.69 140.26 29.2 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 120.119 -1.613 . . . . 0.0 107.156 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -68.96 115.26 3.89 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 123.888 2.424 . . . . 0.0 113.057 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.69 50.44 42.5 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 115.185 0.834 . . . . 0.0 115.185 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.52 128.14 33.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.354 -1.086 . . . . 0.0 109.238 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 p -91.68 130.63 37.44 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.911 0.862 . . . . 0.0 110.566 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.58 121.54 37.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.517 1.127 . . . . 0.0 108.599 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -88.74 87.63 7.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.965 1.364 . . . . 0.0 111.021 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.9 t -85.82 110.77 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.941 1.696 . . . . 0.0 111.493 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.58 123.21 40.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.621 -1.924 . . . . 0.0 108.24 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.11 172.36 12.48 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.13 128.77 55.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 158.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.3 137.17 52.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.578 1.151 . . . . 0.0 110.565 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -89.35 92.2 9.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.015 -1.678 . . . . 0.0 110.67 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.5 -18.82 0.11 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.52 61.07 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 119.983 -1.698 . . . . 0.0 110.028 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -179.97 119.64 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.875 1.797 . . . . 0.0 107.266 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.413 ' CD2' HG23 ' A' ' 92' ' ' VAL . 16.9 mt -74.87 -47.54 29.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.001 1.857 . . . . 0.0 106.575 162.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.01 39.94 1.23 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.426 1.489 . . . . 0.0 111.4 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.9 pt -124.85 136.65 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.812 0.815 . . . . 0.0 109.713 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 m -88.31 121.57 30.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.342 1.457 . . . . 0.0 111.398 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.11 138.41 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -174.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.2 t -138.6 175.9 9.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.16 2.584 . . . . 0.0 108.581 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 -128.34 9.02 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 113.123 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.8 163.49 39.44 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.796 -1.414 . . . . 0.0 114.525 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -59.94 -24.08 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 126.697 1.999 . . . . 0.0 114.615 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.36 6.8 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.133 -1.604 . . . . 0.0 114.297 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 p -123.16 174.66 7.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.231 -1.543 . . . . 0.0 107.907 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.4 m -87.98 60.08 5.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.581 -1.95 . . . . 0.0 114.257 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.1 -164.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.213 1.805 . . . . 0.0 110.937 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -77.26 63.61 2.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.127 -2.233 . . . . 0.0 111.841 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.31 30.7 p80 30.64 31.0 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 132.316 4.246 . . . . 0.0 120.647 -179.694 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.92 111.98 0.45 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 119.801 -1.812 . . . . 0.0 110.29 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.01 147.08 4.45 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -105.57 160.33 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.9 160.31 38.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.926 -1.734 . . . . 0.0 107.017 -171.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.07 134.46 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.429 -1.42 . . . . 0.0 112.219 177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -99.56 -36.64 9.46 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.72 -1.237 . . . . 0.0 111.441 171.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.05 129.95 16.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.216 -1.553 . . . . 0.0 111.654 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mm -95.25 136.86 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 108.816 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.4 mt -80.46 134.55 54.59 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 119.919 -1.738 . . . . 0.0 110.176 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -59.18 96.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 123.683 2.922 . . . . 0.0 114.667 168.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 37.5 mmtm 65.0 57.88 0.95 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.152 2.181 . . . . 0.0 114.429 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.19 -113.13 0.53 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 158.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.45 -44.99 3.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.16 -1.2 . . . . 0.0 110.71 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.87 63.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.081 1.753 . . . . 0.0 114.656 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 50' ' ' LYS . 5.9 tp10 -59.73 -28.37 67.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.44 -1.412 . . . . 0.0 112.956 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -14.54 63.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.69 -70.52 0.34 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.163 -1.586 . . . . 0.0 108.685 159.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.47 6.64 56.42 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 114.206 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -78.83 -27.62 44.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.301 -1.705 . . . . 0.0 109.102 164.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.27 143.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.873 1.669 . . . . 0.0 114.198 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -132.61 172.81 12.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.696 -1.252 . . . . 0.0 110.049 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -82.62 58.39 4.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.686 -1.884 . . . . 0.0 113.458 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.55 31.4 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -103.75 159.19 15.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -100.73 130.22 46.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.713 1.205 . . . . 0.0 109.772 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.21 114.35 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.98 -34.11 11.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.575 -1.328 . . . . 0.0 112.225 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.08 165.34 37.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.217 1.371 . . . . 0.0 113.327 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.9 t -134.27 119.17 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 110.552 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.89 27.1 8.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 121.101 1.773 . . . . 0.0 115.247 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.67 17.82 74.55 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 120.88 -1.137 . . . . 0.0 114.5 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.9 98.29 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 t -68.64 137.12 53.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.277 1.431 . . . . 0.0 114.642 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.93 30.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.855 2.062 . . . . 0.0 111.702 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 10.49 1.19 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -167.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.62 36.59 0.39 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.829 -1.17 . . . . 0.0 110.401 166.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.32 37.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.059 0.943 . . . . 0.0 113.31 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -108.73 -161.59 0.77 Allowed 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.415 2.286 . . . . 0.0 106.859 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -55.09 -55.97 25.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.637 1.975 . . . . 0.0 114.09 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -64.64 -54.45 31.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.082 0.944 . . . . 0.0 112.724 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -41.09 71.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.132 1.773 . . . . 0.0 114.256 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.51 89.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.208 -1.558 . . . . 0.0 114.844 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.1 t -57.52 -52.5 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 119.196 0.907 . . . . 0.0 110.333 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.03 -35.9 74.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.6 m -64.58 -34.65 78.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.966 1.706 . . . . 0.0 113.772 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.98 -39.48 14.66 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.258 -1.526 . . . . 0.0 113.481 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -50.81 10.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.409 2.284 . . . . 0.0 113.986 -173.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.59 43.03 0.94 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 124.023 1.868 . . . . 0.0 112.044 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.4 p -99.08 174.64 6.24 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.93 2.892 . . . . 0.0 108.35 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.24 -131.22 0.76 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.646 -1.284 . . . . 0.0 112.743 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -97.19 -49.78 4.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.023 -1.281 . . . . 0.0 110.45 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.6 129.88 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.184 1.468 . . . . 0.0 110.977 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.413 HG23 ' CD2' ' A' ' 25' ' ' LEU . 13.9 m -121.37 110.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.821 1.648 . . . . 0.0 107.062 170.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -82.84 96.15 8.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 161.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.38 122.42 24.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.748 -1.22 . . . . 0.0 110.817 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.8 103.58 15.48 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 108.664 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -112.83 144.54 42.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.155 1.382 . . . . 0.0 110.219 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -119.29 133.63 55.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.013 1.325 . . . . 0.0 109.519 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.21 119.58 11.74 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.068 1.347 . . . . 0.0 114.386 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.99 73.54 0.7 Allowed Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 125.731 1.634 . . . . 0.0 111.282 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -135.64 160.28 39.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.473 -1.016 . . . . 0.0 109.828 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.52 139.69 26.64 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.819 -1.563 . . . . 0.0 110.222 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo . . . . . 0 N--CA 1.434 -2.029 0 C-N-CA 123.027 2.485 . . . . 0.0 116.845 178.32 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 120.94 0.4 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.19 172.65 12.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.885 1.274 . . . . 0.0 114.371 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.517 17.4 m 61.92 98.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.001 2.521 . . . . 0.0 116.531 171.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.2 m -129.43 120.99 26.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.4 p -71.36 135.72 47.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.168 0.987 . . . . 0.0 109.796 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.259 1.604 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -166.062 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.546 ' N ' ' HZ3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.387 1.089 . . . . 0.0 109.963 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -121.83 153.12 60.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 C-N-CA 125.326 1.45 . . . . 0.0 107.773 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.9 126.57 12.69 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.527 2.151 . . . . 0.0 112.148 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.15 77.92 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 123.778 0.704 . . . . 0.0 113.619 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.1 88.96 5.96 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.996 -1.297 . . . . 0.0 109.526 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -75.84 132.47 40.38 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 125.328 1.451 . . . . 0.0 112.15 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 134.42 54.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.77 1.228 . . . . 0.0 107.947 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.21 68.49 0.71 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.94 1.352 . . . . 0.0 108.819 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.4 t -75.97 112.77 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.522 2.329 . . . . 0.0 112.21 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.29 3.0 pm0 -100.74 120.84 40.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.879 -1.763 . . . . 0.0 111.708 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 mt -133.73 174.34 10.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.56 1.144 . . . . 0.0 108.802 -171.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.03 125.52 52.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 160.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.93 143.82 41.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 113.117 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -91.15 87.28 6.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.965 1.364 . . . . 0.0 110.69 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 67.58 6.88 5.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.947 2.099 . . . . 0.0 115.404 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.47 72.88 0.53 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.8 t 167.97 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.332 1.853 . . . . 0.0 108.447 -166.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -70.14 -45.13 67.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 154.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.12 40.67 0.95 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 124.848 1.213 . . . . 0.0 110.68 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -127.84 134.22 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.962 0.887 . . . . 0.0 109.862 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.5 m -85.07 120.46 26.6 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 123.677 0.791 . . . . 0.0 111.553 163.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.54 142.35 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -142.8 170.72 15.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.316 1.446 . . . . 0.0 110.0 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 -130.96 10.55 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.053 1.311 . . . . 0.0 112.368 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.32 157.62 31.56 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.598 1.094 . . . . 0.0 111.421 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.2 t -45.19 -40.72 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.391 1.877 . . . . 0.0 113.193 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -68.28 -26.23 65.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.596 1.958 . . . . 0.0 115.006 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.9 m -80.88 -33.31 34.44 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.656 -1.278 . . . . 0.0 111.481 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.268 3.8 t 96.04 87.62 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.959 2.904 . . . . 0.0 110.208 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 m -119.75 -156.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.729 2.012 . . . . 0.0 109.334 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -83.36 79.38 9.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.401 -2.062 . . . . 0.0 110.77 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 71.8 -80.05 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.311 1.844 . . . . 0.0 112.047 -169.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -151.65 -121.3 0.94 Allowed Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 126.378 1.942 . . . . 0.0 108.677 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.35 -170.18 53.67 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.013 -1.287 . . . . 0.0 111.946 -168.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -143.31 160.93 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.289 -1.712 . . . . 0.0 106.79 160.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -125.56 166.74 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.092 -1.63 . . . . 0.0 107.291 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.4 t -83.89 141.35 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.085 -1.634 . . . . 0.0 110.216 170.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -97.09 -57.69 2.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.803 -1.185 . . . . 0.0 109.535 160.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.69 145.11 49.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.879 0.872 . . . . 0.0 111.135 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.1 mm -101.07 131.94 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.279 1.831 . . . . 0.0 106.706 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -88.92 163.86 33.37 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.339 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.38 103.5 0.66 Allowed 'Trans proline' 0 C--N 1.298 -2.082 0 C-N-CA 122.923 2.416 . . . . 0.0 114.279 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 50.5 70.72 0.48 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 170.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.65 -92.4 0.76 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 164.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.06 -36.82 1.74 Allowed 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 124.811 1.244 . . . . 0.0 109.981 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.18 59.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 126.213 1.805 . . . . 0.0 114.443 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.7 -32.54 67.48 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.032 -1.668 . . . . 0.0 113.06 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -70.54 -0.62 8.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.69 -96.98 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.209 -2.182 . . . . 0.0 107.553 156.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.93 -14.42 0.77 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.75 -1.219 . . . . 0.0 113.067 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -84.63 -23.45 29.52 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.939 -1.33 . . . . 0.0 110.733 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.39 135.22 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.181 2.592 . . . . 0.0 113.965 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.606 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 4.1 t-80 -143.98 -173.72 4.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.419 1.58 . . . . 0.0 114.343 167.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.606 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 78.4 mttt -89.22 81.16 6.76 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.185 1.794 . . . . 0.0 111.348 -164.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.98 -14.28 0.77 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.17 -0.956 . . . . 0.0 113.029 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.84 170.26 8.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -106.3 143.83 33.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.232 1.413 . . . . 0.0 109.643 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 p -110.48 129.38 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 164.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.05 -32.84 8.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.878 -1.764 . . . . 0.0 112.211 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.03 156.89 42.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.729 -1.232 . . . . 0.0 112.441 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 t -136.15 120.77 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.083 -1.01 . . . . 0.0 110.784 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.3 t30 65.3 19.21 11.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.892 1.277 . . . . 0.0 112.736 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.17 46.25 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.601 -1.312 . . . . 0.0 113.284 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.95 104.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.3 p -65.56 138.51 58.1 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.323 1.449 . . . . 0.0 114.32 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -80.71 49.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.31 1.844 . . . . 0.0 111.247 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.44 107.96 6.91 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.584 1.554 . . . . 0.0 110.643 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 29.61 62.48 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 114.025 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.84 137.25 33.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.567 1.651 . . . . 0.0 113.555 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.6 p -93.66 -165.74 1.38 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.365 1.866 . . . . 0.0 108.341 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -64.71 -50.07 68.38 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 119.547 -1.971 . . . . 0.0 111.371 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -64.28 -49.04 73.38 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.393 1.077 . . . . 0.0 113.194 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -67.69 -30.95 70.6 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.603 -1.311 . . . . 0.0 114.332 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.14 93.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.126 -1.609 . . . . 0.0 114.48 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.4 t -53.68 -51.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.609 1.163 . . . . 0.0 111.574 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -58.4 -43.4 88.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.512 -1.368 . . . . 0.0 114.463 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.0 m -65.53 -30.79 71.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.551 1.54 . . . . 0.0 114.508 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -88.62 -49.23 7.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.946 1.298 . . . . 0.0 112.096 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.22 44.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -91.63 37.75 0.97 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.071 -1.643 . . . . 0.0 110.898 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 p -94.06 170.09 9.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.053 2.141 . . . . 0.0 108.125 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.1 -79.24 1.04 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 119.83 -1.794 . . . . 0.0 112.693 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -137.75 -57.7 0.68 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.653 -0.91 . . . . 0.0 108.979 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.5 t -78.07 130.47 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 123.114 1.435 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 m -115.26 117.88 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.464 1.106 . . . . 0.0 108.157 167.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -85.72 97.54 10.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.258 -1.527 . . . . 0.0 107.349 161.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.8 mt -85.19 112.57 20.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 110.762 -176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.07 105.19 17.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.168 0.987 . . . . 0.0 108.719 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mt -117.9 144.26 45.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.589 1.555 . . . . 0.0 111.352 -165.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.07 138.67 54.61 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.462 1.505 . . . . 0.0 109.637 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.546 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 27.1 mmtp -75.0 136.02 41.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.731 1.212 . . . . 0.0 113.735 -172.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.96 61.34 3.39 Favored Glycine 0 N--CA 1.431 -1.651 0 O-C-N 120.772 -1.205 . . . . 0.0 111.555 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -126.01 -172.65 2.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.103 1.761 . . . . 0.0 110.687 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.41 156.62 79.28 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.89 1.676 . . . . 0.0 108.953 -168.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo . . . . . 0 N--CA 1.433 -2.045 0 C-N-CA 122.822 2.348 . . . . 0.0 114.887 167.258 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 N--CA 1.429 -1.496 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.592 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 5.5 tp 54.73 -148.69 0.47 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.76 2.024 . . . . 0.0 113.35 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.592 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.411 1.9 t 38.22 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 129.81 3.244 . . . . 0.0 116.281 152.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 46.7 m -138.04 122.61 18.52 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 102.941 -2.985 . . . . 0.0 102.941 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -83.52 127.91 34.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.006 0.908 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.261 1.678 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -163.097 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 121.418 0.628 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.1 151.07 41.45 Favored Pre-proline 0 N--CA 1.429 -1.478 0 C-N-CA 125.109 1.364 . . . . 0.0 111.388 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.06 114.35 3.95 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.922 2.415 . . . . 0.0 114.332 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.37 28.65 61.37 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 121.481 -0.762 . . . . 0.0 114.702 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.66 133.67 34.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.502 -0.999 . . . . 0.0 110.485 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.3 p -91.0 138.19 31.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.724 -1.235 . . . . 0.0 112.559 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.04 120.01 33.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.85 74.41 3.58 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.359 1.064 . . . . 0.0 108.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.94 153.12 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 127.187 2.195 . . . . 0.0 110.02 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -130.33 123.03 29.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.945 -1.722 . . . . 0.0 109.501 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -122.89 174.85 6.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.516 1.126 . . . . 0.0 109.29 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.51 136.87 54.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 153.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HB2' ' H ' ' A' ' 24' ' ' SER . 7.7 ptpt -66.85 130.25 42.54 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.067 1.747 . . . . 0.0 113.365 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 101.52 13.3 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.527 -1.358 . . . . 0.0 109.649 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 51.37 64.95 1.64 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.733 2.013 . . . . 0.0 114.01 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.48 72.64 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.869 -1.144 . . . . 0.0 115.234 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.448 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 35.9 t -172.75 99.01 0.14 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.62 -41.99 95.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.363 2.265 . . . . 0.0 107.075 164.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.29 46.32 1.16 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.359 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -123.36 136.9 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 124.358 0.681 . . . . 0.0 110.108 165.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.3 m -84.72 120.0 25.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.3 1.04 . . . . 0.0 110.677 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -90.01 129.82 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -126.54 165.33 19.35 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.232 -2.167 . . . . 0.0 110.958 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 -130.58 10.37 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.333 1.444 . . . . 0.0 113.221 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.2 158.69 24.15 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.756 1.646 . . . . 0.0 110.897 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.3 p -60.42 -20.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.098 1.359 . . . . 0.0 114.12 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -55.35 -49.63 71.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.654 1.982 . . . . 0.0 114.379 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -166.1 164.21 18.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.318 10.5 p 85.74 -21.02 0.23 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.5 -170.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.024 -1.672 . . . . 0.0 110.238 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -76.49 -62.54 1.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.444 -1.41 . . . . 0.0 110.22 171.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.83 5.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.98 107.14 0.2 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.527 -2.608 . . . . 0.0 113.657 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.79 171.35 26.63 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 tp -115.99 151.03 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 167.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.14 153.69 46.59 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.282 -2.137 . . . . 0.0 105.512 -168.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.69 127.03 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.593 -1.942 . . . . 0.0 111.535 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -84.43 -54.49 4.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.497 -1.377 . . . . 0.0 109.977 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 137.82 34.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.292 0.637 . . . . 0.0 110.321 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.9 mm -90.62 144.98 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.271 1.828 . . . . 0.0 107.582 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 59.8 mt -87.2 117.15 68.2 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 119.725 -1.859 . . . . 0.0 108.326 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 86.2 Cg_endo -80.3 65.93 8.86 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 CA-C-N 124.161 2.522 . . . . 0.0 111.938 174.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 0.7 OUTLIER 152.29 45.76 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 131.45 3.9 . . . . 0.0 111.342 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -108.15 -121.38 4.58 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.777 -2.452 . . . . 0.0 110.383 167.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.61 -31.1 2.5 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.972 1.709 . . . . 0.0 110.362 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -46.88 60.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.824 -1.798 . . . . 0.0 113.072 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 9.0 tp10 -54.11 -32.87 56.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.803 1.287 . . . . 0.0 113.576 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 p -59.24 -20.98 58.72 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.18 -79.35 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.435 1.094 . . . . 0.0 110.939 167.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.88 -19.32 6.15 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 121.463 -0.773 . . . . 0.0 113.913 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -30.16 60.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.816 -1.402 . . . . 0.0 112.319 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.81 140.79 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -134.83 -164.08 1.47 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -73.42 150.73 41.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.479 -2.013 . . . . 0.0 110.725 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.38 74.75 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 120.57 -1.331 . . . . 0.0 115.445 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.09 148.86 41.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 118.896 1.348 . . . . 0.0 111.891 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.45 112.33 25.18 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.88 1.272 . . . . 0.0 110.036 -168.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.26 3.5 p -84.47 116.03 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 119.963 -1.71 . . . . 0.0 108.36 173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 -37.18 12.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.181 -1.574 . . . . 0.0 111.436 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.14 28.31 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.166 0.984 . . . . 0.0 112.906 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.35 128.94 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.75 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 52.61 18.97 1.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.86 -2.4 . . . . 0.0 117.408 -170.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.1 6.15 63.4 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.425 -1.422 . . . . 0.0 114.945 -171.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -108.03 101.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 125.726 1.611 . . . . 0.0 109.786 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.8 m -68.72 145.02 54.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -82.16 43.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.033 2.533 . . . . 0.0 112.848 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.55 117.33 23.06 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.928 -1.733 . . . . 0.0 110.72 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.5 86.55 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 123.926 0.774 . . . . 0.0 113.436 -170.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.87 133.96 33.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.939 1.37 . . . . 0.0 113.434 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.482 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 44.6 p -97.14 -160.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.402 2.681 . . . . 0.0 108.228 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -63.77 -55.96 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.045 -1.659 . . . . 0.0 111.771 164.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -64.98 -38.76 92.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.482 ' HB3' ' H ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -70.86 -37.31 73.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.789 -1.819 . . . . 0.0 114.149 174.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.62 76.42 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.2 -1.563 . . . . 0.0 114.22 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.3 t -58.93 -56.37 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.729 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.97 -43.23 63.46 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 m -56.18 -45.55 79.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.188 2.195 . . . . 0.0 114.629 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.91 -32.38 15.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.746 -1.846 . . . . 0.0 115.26 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -79.34 -50.08 11.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.488 1.515 . . . . 0.0 113.145 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -92.19 52.23 1.92 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.126 -1.609 . . . . 0.0 111.922 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.1 p -95.04 -164.96 1.23 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.303 2.241 . . . . 0.0 110.656 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.25 -75.43 1.19 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.089 -1.632 . . . . 0.0 112.365 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -150.6 -60.21 0.19 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.822 -1.399 . . . . 0.0 110.225 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -72.35 125.04 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.219 1.485 . . . . 0.0 110.614 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.97 103.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -73.85 110.35 8.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.917 -1.114 . . . . 0.0 110.38 165.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.2 mt -91.79 110.67 22.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.367 0.985 . . . . 0.0 108.681 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.66 95.41 10.25 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.906 0.86 . . . . 0.0 108.769 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.14 138.91 40.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.102 1.761 . . . . 0.0 110.273 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.91 137.02 46.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.59 1.956 . . . . 0.0 108.088 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -79.75 126.2 30.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 56.58 5.01 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 113.859 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.0 151.15 28.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.983 1.713 . . . . 0.0 110.902 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.94 145.05 31.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 116.125 -1.893 . . . . 0.0 107.432 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--N 1.3 -2.018 0 CA-C-N 124.381 2.6 . . . . 0.0 115.285 -176.53 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 121.918 0.866 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.53 -149.57 0.31 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.337 -1.477 . . . . 0.0 109.355 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.416 2.3 t 67.79 104.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 124.395 2.045 . . . . 0.0 113.484 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 59.5 m -135.84 123.82 22.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -70.44 121.64 18.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.627 1.171 . . . . 0.0 108.549 167.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.259 1.589 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -166.567 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 121.31 0.576 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -147.86 147.75 28.01 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.1 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.79 137.9 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 123.484 2.28 . . . . 0.0 112.442 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.54 76.67 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 116.285 1.274 . . . . 0.0 116.285 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -82.72 130.83 35.19 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.777 -1.425 . . . . 0.0 110.773 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 129.68 45.12 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.754 -1.217 . . . . 0.0 110.748 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.94 116.97 24.48 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.615 1.166 . . . . 0.0 109.39 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.71 86.61 7.31 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.273 1.035 . . . . 0.0 110.279 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.12 121.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.874 2.069 . . . . 0.0 109.722 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.07 116.8 24.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.547 -1.971 . . . . 0.0 111.448 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.13 167.79 27.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.223 -1.548 . . . . 0.0 112.279 -167.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.22 138.8 40.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.378 1.071 . . . . 0.0 110.212 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -75.67 160.91 29.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.717 -1.24 . . . . 0.0 112.539 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 m -92.6 71.8 5.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.276 -1.515 . . . . 0.0 109.343 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 53.57 63.58 2.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.158 2.183 . . . . 0.0 114.959 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.45 38.57 14.25 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -177.54 108.59 0.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.201 1.4 . . . . 0.0 107.932 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -66.0 -48.04 72.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.279 2.632 . . . . 0.0 108.2 169.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.07 34.41 0.78 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.094 1.33 . . . . 0.0 112.645 172.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 pt -121.76 129.66 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 121.454 0.645 . . . . 0.0 110.514 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.257 5.5 m -78.68 122.9 26.56 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 111.81 162.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.19 134.29 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -130.61 168.08 17.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.115 1.366 . . . . 0.0 109.069 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.59 -146.99 21.06 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.237 0.923 . . . . 0.0 113.28 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.69 169.65 43.98 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 121.314 -1.11 . . . . 0.0 112.02 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.73 -21.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -71.76 -20.78 61.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -111.39 166.51 11.06 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.509 -1.369 . . . . 0.0 109.976 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.8 m -84.51 99.17 10.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.991 -1.068 . . . . 0.0 108.716 172.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 p -146.21 54.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 123.987 1.851 . . . . 0.0 107.586 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 70.73 -72.41 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.119 2.168 . . . . 0.0 112.655 -168.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -138.23 -85.25 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.569 1.147 . . . . 0.0 109.657 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.95 16.6 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -168.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.69 176.2 54.76 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 119.056 1.428 . . . . 0.0 110.296 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.289 2.7 tp -112.61 151.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.804 -1.41 . . . . 0.0 107.459 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.98 155.13 50.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -167.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.52 136.7 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 119.48 -2.012 . . . . 0.0 111.387 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -92.59 -51.71 4.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.025 0.93 . . . . 0.0 110.507 166.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.82 141.78 38.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.594 -0.691 . . . . 0.0 111.574 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.2 mm -103.66 128.63 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.259 1.823 . . . . 0.0 109.676 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.6 139.74 41.07 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.35 68.84 7.64 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.523 2.149 . . . . 0.0 112.233 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -117.28 -87.12 0.62 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.158 0.983 . . . . 0.0 109.11 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.04 45.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.46 -77.07 0.6 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.006 1.903 . . . . 0.0 109.112 157.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.86 88.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.5 -40.06 65.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.16 1.457 . . . . 0.0 112.889 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 t -79.58 -16.14 56.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.25 -54.05 14.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.753 2.524 . . . . 0.0 111.365 -164.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.58 -77.78 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 118.925 -1.607 . . . . 0.0 113.476 153.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -81.74 -7.8 59.63 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -164.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mt -73.29 126.47 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.039 -1.663 . . . . 0.0 114.196 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 74.9 t60 -128.81 -160.1 1.0 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 163.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 20.6 pttp -92.95 67.09 4.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.349 -2.72 . . . . 0.0 114.442 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.35 42.83 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.461 -2.649 . . . . 0.0 116.717 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -116.17 174.67 5.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.987 1.393 . . . . 0.0 111.213 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 129.7 56.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.868 1.667 . . . . 0.0 107.435 176.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.269 9.4 p -100.13 119.86 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.061 1.3 . . . . 0.0 107.892 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -39.01 10.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.524 -1.36 . . . . 0.0 111.547 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.23 150.36 42.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.03 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.0 t -133.14 116.94 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.19 31.1 20.39 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.974 1.31 . . . . 0.0 112.92 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.16 30.92 54.18 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.192 -0.943 . . . . 0.0 112.939 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -129.12 100.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 t -70.37 137.31 50.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 112.814 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.12 57.1 3.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.515 1.526 . . . . 0.0 112.562 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.23 94.69 9.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.538 -1.976 . . . . 0.0 110.729 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.04 45.58 4.12 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 121.349 -0.844 . . . . 0.0 111.521 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.18 147.56 37.17 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.592 1.187 . . . . 0.0 109.202 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -126.21 -165.35 1.43 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -52.58 -55.16 24.2 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.216 -1.553 . . . . 0.0 114.292 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -62.5 -50.55 70.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.672 1.225 . . . . 0.0 113.491 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -42.58 99.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.546 1.138 . . . . 0.0 113.426 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.98 89.36 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 120.442 -1.411 . . . . 0.0 114.431 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.1 t -54.94 -56.59 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.328 0.967 . . . . 0.0 110.676 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.41 -27.38 65.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -65.78 -26.6 67.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.78 2.032 . . . . 0.0 112.623 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.93 -46.46 8.52 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.14 1.376 . . . . 0.0 112.587 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.4 ' HB3' ' CG2' ' B' ' 210' ' ' VAL 0.45 0.0 OUTLIER -71.74 -45.78 60.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.048 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -93.7 45.4 1.15 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.323 1.535 . . . . 0.0 110.344 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.4 p -98.13 157.23 16.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.512 2.325 . . . . 0.0 108.256 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -63.53 4.19 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.21 -0.931 . . . . 0.0 115.418 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -155.22 -59.93 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.687 -0.89 . . . . 0.0 109.03 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.83 124.72 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.212 1.482 . . . . 0.0 110.6 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.5 t -112.27 104.83 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.24 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -78.33 104.81 9.16 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mt -90.83 107.37 19.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.401 1.481 . . . . 0.0 107.783 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.35 95.92 10.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 173.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.22 142.9 32.73 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.068 2.147 . . . . 0.0 110.362 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -115.07 136.58 52.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.436 1.094 . . . . 0.0 109.029 167.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -62.56 117.88 6.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.918 1.687 . . . . 0.0 113.543 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.42 61.56 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.789 -1.194 . . . . 0.0 114.095 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -117.4 152.31 35.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.697 1.599 . . . . 0.0 109.64 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.1 m -86.76 149.91 49.38 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 121.305 -0.872 . . . . 0.0 112.367 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 C--N 1.299 -2.073 0 C-N-CA 122.729 2.286 . . . . 0.0 116.226 179.033 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.3 -156.28 0.69 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.398 -0.813 . . . . 0.0 109.807 174.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.434 2.6 t 69.93 96.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 124.969 2.318 . . . . 0.0 113.393 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 79.6 m -149.1 121.8 8.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 -165.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -72.41 139.67 47.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.952 0.901 . . . . 0.0 111.169 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 86' ' ' ARG . 7.7 p . . . . . 0 C--O 1.26 1.639 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 122.415 1.103 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -106.71 111.28 63.95 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 164.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -72.04 119.45 6.19 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 123.272 2.204 . . . . 0.0 111.977 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 16.41 61.27 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.91 126.57 31.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.216 1.008 . . . . 0.0 111.841 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -94.64 130.41 41.12 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.419 1.104 . . . . 0.0 110.627 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.275 0.1 OUTLIER -114.96 113.81 24.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.712 -1.243 . . . . 0.0 108.697 174.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.29 81.85 5.47 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.108 0.956 . . . . 0.0 109.342 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.68 143.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.769 2.028 . . . . 0.0 109.466 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.52 130.49 55.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.413 -2.054 . . . . 0.0 110.643 166.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.57 157.58 33.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.225 1.01 . . . . 0.0 108.314 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.77 105.78 13.43 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.957 0.884 . . . . 0.0 109.181 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.37 135.12 45.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.509 1.924 . . . . 0.0 112.992 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -101.88 108.62 20.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.791 -1.193 . . . . 0.0 108.869 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 42.76 49.12 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.619 2.368 . . . . 0.0 116.162 -166.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 45.84 26.81 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.808 -1.183 . . . . 0.0 115.248 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -161.06 117.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.899 1.809 . . . . 0.0 106.138 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.08 -36.05 66.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.292 1.837 . . . . 0.0 107.732 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.03 2.14 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.478 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.4 pt -127.67 135.36 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.674 1.226 . . . . 0.0 109.566 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -78.94 112.02 15.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.937 1.695 . . . . 0.0 112.507 172.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.86 131.67 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -132.88 174.05 10.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.956 2.502 . . . . 0.0 108.325 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.87 45.18 76.05 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 118.608 2.203 . . . . 0.0 118.608 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.54 169.81 47.67 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 120.592 -1.534 . . . . 0.0 111.227 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 m -55.74 -19.42 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -48.89 -64.76 0.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -170.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -143.97 -70.19 0.31 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m -42.22 -49.19 4.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.89 2.876 . . . . 0.0 117.67 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -92.34 -1.22 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.943 -1.098 . . . . 0.0 113.769 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 64.65 49.93 2.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.317 1.447 . . . . 0.0 111.745 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 72.12 164.99 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.495 2.318 . . . . 0.0 113.07 -164.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.92 -96.7 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.206 -2.808 . . . . 0.0 118.965 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.59 -117.5 0.68 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -145.79 162.15 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 159.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.9 165.62 27.02 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.41 -1.431 . . . . 0.0 108.642 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -80.31 138.19 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.574 1.95 . . . . 0.0 110.643 167.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -95.24 -57.47 2.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.395 -1.441 . . . . 0.0 109.542 159.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.78 134.74 52.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.879 1.272 . . . . 0.0 111.301 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.7 mm -93.33 133.46 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.25 147.22 33.36 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 121.113 -0.992 . . . . 0.0 111.637 172.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 111.79 3.2 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.952 2.434 . . . . 0.0 112.156 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 67.98 64.2 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.43 -96.92 2.21 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 166.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.61 -38.34 0.66 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 110.342 171.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.53 -42.0 65.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.41 -36.8 61.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.942 1.829 . . . . 0.0 112.535 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -74.56 6.49 3.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.12 -79.26 0.09 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.894 -2.379 . . . . 0.0 106.357 152.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.51 -31.6 1.66 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.271 -0.893 . . . . 0.0 111.179 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -89.07 -20.87 23.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.533 -0.98 . . . . 0.0 111.335 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mt -66.46 130.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 124.859 1.264 . . . . 0.0 110.106 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -155.34 169.79 23.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -161.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -80.03 77.04 6.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.74 -1.225 . . . . 0.0 111.864 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.78 60.05 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.376 0.989 . . . . 0.0 110.839 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.57 -151.52 0.34 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.895 2.078 . . . . 0.0 110.222 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -160.04 121.04 3.08 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 149.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.56 122.73 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.034 -1.667 . . . . 0.0 107.728 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -30.3 9.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.888 -1.133 . . . . 0.0 113.275 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.26 159.01 41.07 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 120.244 1.383 . . . . 0.0 113.64 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 t -137.19 119.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 123.997 0.919 . . . . 0.0 111.856 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.99 34.4 22.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.876 -1.765 . . . . 0.0 113.473 -167.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.17 -5.13 73.33 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.627 1.584 . . . . 0.0 113.834 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.61 106.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 121.008 -1.289 . . . . 0.0 108.297 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.8 p -60.71 137.21 58.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.244 1.018 . . . . 0.0 113.612 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.27 -48.8 55.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.4 1.08 . . . . 0.0 111.143 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 34.5 41.83 0.06 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.248 3.425 . . . . 0.0 120.248 160.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.37 -16.85 2.49 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.129 -1.607 . . . . 0.0 111.88 -165.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.29 132.35 44.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.042 1.877 . . . . 0.0 115.119 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -175.45 2.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -48.03 -52.77 18.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.585 -1.947 . . . . 0.0 115.455 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -74.16 -43.95 55.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.309 -0.869 . . . . 0.0 112.161 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -57.58 -43.6 84.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.11 1.364 . . . . 0.0 114.328 172.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -40.68 95.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.452 -1.405 . . . . 0.0 114.292 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.4 -42.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 121.076 -1.015 . . . . 0.0 111.593 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.91 -44.22 97.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.943 -1.723 . . . . 0.0 114.697 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.8 m -58.93 -26.51 64.44 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.688 1.995 . . . . 0.0 114.83 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -91.24 -46.52 8.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.634 1.574 . . . . 0.0 112.679 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -79.35 -34.9 41.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.999 -1.688 . . . . 0.0 114.569 -172.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.82 35.22 0.68 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.455 1.598 . . . . 0.0 111.888 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.4 p -99.67 -176.81 3.38 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.564 3.146 . . . . 0.0 108.203 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.42 -115.02 0.57 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.264 -1.522 . . . . 0.0 112.069 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.62 -44.88 4.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.246 1.018 . . . . 0.0 110.868 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.48 125.01 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.041 1.4 . . . . 0.0 110.462 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.8 t -114.0 106.49 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -83.36 101.66 11.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.575 1.55 . . . . 0.0 109.155 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.27 115.91 26.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 99.52 12.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.08 148.62 25.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.696 1.999 . . . . 0.0 111.776 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.32 1.448 . . . . 0.0 109.608 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -78.26 99.42 6.27 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.179 -1.575 . . . . 0.0 110.982 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.18 64.57 4.29 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.781 1.182 . . . . 0.0 114.134 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -135.99 137.39 41.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.967 1.307 . . . . 0.0 108.2 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.77 158.61 82.58 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 120.832 -1.168 . . . . 0.0 112.024 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo . . . . . 0 N--CA 1.434 -1.994 0 C-N-CA 122.801 2.334 . . . . 0.0 115.433 -179.5 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 49.9 p90 . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.88 0.847 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 9.3 tp -145.58 159.5 43.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.46 3.5 t 64.26 106.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 162.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 88.4 m -143.92 120.82 11.31 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 103.039 -2.948 . . . . 0.0 103.039 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -76.39 119.91 20.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.604 1.093 . . . . 0.0 109.62 173.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.26 1.634 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -167.082 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 122.999 1.38 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -63.65 138.71 97.45 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.533 1.933 . . . . 0.0 115.184 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -71.27 112.47 3.34 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 123.693 2.355 . . . . 0.0 116.629 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 33.32 9.84 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 123.679 0.657 . . . . 0.0 113.363 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.72 14.81 0.07 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -142.15 128.63 20.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.774 -1.204 . . . . 0.0 108.171 155.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.259 0.1 OUTLIER -132.56 115.14 15.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.88 91.41 8.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.591 1.186 . . . . 0.0 110.282 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.12 154.1 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.71 2.004 . . . . 0.0 108.494 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -130.99 113.24 13.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.212 -2.18 . . . . 0.0 110.322 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.5 mt -119.62 152.15 37.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.587 -1.32 . . . . 0.0 111.001 -170.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.96 117.87 35.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 165.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.54 138.01 54.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.952 -1.092 . . . . 0.0 112.581 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -89.83 103.34 16.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.648 1.213 . . . . 0.0 109.075 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 51.71 44.62 29.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.788 2.435 . . . . 0.0 115.248 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 48.72 26.9 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 119.888 -1.757 . . . . 0.0 114.398 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -161.81 111.55 1.56 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.2 mt -73.44 -45.19 55.83 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 167.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.52 31.65 0.76 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.089 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.43 124.98 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 122.278 1.037 . . . . 0.0 110.647 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 114.44 17.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.385 1.074 . . . . 0.0 111.481 166.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 127.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -128.16 -179.7 5.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.834 2.453 . . . . 0.0 108.702 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -125.22 7.05 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.346 -1.471 . . . . 0.0 111.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.51 162.64 35.05 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.477 -1.014 . . . . 0.0 114.164 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.03 -32.25 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.399 1.48 . . . . 0.0 113.667 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -72.92 -19.75 61.2 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.53 -1.356 . . . . 0.0 114.569 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.4 p -100.21 -6.09 26.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.763 -1.211 . . . . 0.0 111.803 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t 67.24 83.8 0.16 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.695 2.398 . . . . 0.0 113.817 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.22 27.32 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.671 -1.268 . . . . 0.0 112.708 -167.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.274 32.5 ttp180 73.92 71.43 0.11 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.933 1.693 . . . . 0.0 110.874 -168.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 79.75 -61.35 0.3 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.931 2.093 . . . . 0.0 113.299 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.75 -149.28 6.52 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.18 155.84 22.7 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -157.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.56 161.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -133.94 162.08 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.299 -2.125 . . . . 0.0 106.646 -170.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.98 132.57 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.391 -1.443 . . . . 0.0 110.61 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -90.37 -53.44 4.44 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.44 -1.413 . . . . 0.0 109.161 163.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.96 135.68 31.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.897 0.879 . . . . 0.0 109.49 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.82 128.66 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 pt -76.32 156.87 83.4 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.749 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.38 95.41 0.86 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 122.237 1.958 . . . . 0.0 113.346 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.252 46.9 mtmt 83.88 77.89 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.612 2.365 . . . . 0.0 114.287 166.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.5 -157.68 8.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 168.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.32 1.048 . . . . 0.0 113.719 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.25 86.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.674 1.589 . . . . 0.0 114.226 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -60.3 -38.19 82.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.906 -1.121 . . . . 0.0 111.253 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -70.95 0.52 7.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.45 -74.23 0.19 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.524 -2.61 . . . . 0.0 108.205 156.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.61 -26.22 3.5 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 121.638 -0.664 . . . . 0.0 111.518 167.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -80.52 -24.84 39.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.739 -0.859 . . . . 0.0 112.149 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 132.6 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.011 1.324 . . . . 0.0 112.392 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 41.5 t60 -138.28 -178.44 5.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 173.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 27.0 mttm -78.35 69.21 4.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.573 -1.329 . . . . 0.0 113.157 -168.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 3.31 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -80.37 171.76 14.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.197 1.999 . . . . 0.0 114.005 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.3 ttt-85 -108.24 139.11 43.39 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.843 1.257 . . . . 0.0 109.942 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.28 115.27 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.384 1.874 . . . . 0.0 107.662 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.45 -34.41 10.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.832 -1.792 . . . . 0.0 113.846 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.11 152.68 39.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.773 1.17 . . . . 0.0 113.696 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.0 t -135.72 122.75 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.43 0.692 . . . . 0.0 111.129 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 58.98 28.04 17.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.25 1.02 . . . . 0.0 113.409 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.35 46.06 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.737 1.636 . . . . 0.0 114.015 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.95 96.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 118.761 1.28 . . . . 0.0 110.275 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.3 p -67.49 142.49 56.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.78 68.39 10.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.28 128.01 33.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 109.247 162.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.99 -2.28 65.57 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.754 1.862 . . . . 0.0 117.754 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 135.96 33.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.422 2.111 . . . . 0.0 113.586 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.0 t -109.35 -169.61 1.51 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.5 2.72 . . . . 0.0 106.143 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -49.16 -58.89 4.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.933 2.093 . . . . 0.0 115.103 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -72.23 -42.09 66.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.165 1.46 . . . . 0.0 111.077 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -59.19 -47.34 85.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.954 1.702 . . . . 0.0 113.84 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.55 79.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.94 -51.85 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 121.134 -0.979 . . . . 0.0 111.221 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -56.8 -36.65 70.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 m -69.43 -24.24 63.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.309 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mt -89.82 -44.41 9.97 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.534 -1.978 . . . . 0.0 111.877 171.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -78.6 -44.17 24.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 127.743 2.417 . . . . 0.0 116.037 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -81.31 13.35 2.96 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 123.941 1.829 . . . . 0.0 114.503 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -84.15 -176.37 6.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.457 3.103 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.33 -123.88 2.1 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 120.131 -1.605 . . . . 0.0 112.762 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -95.33 -60.26 1.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 111.091 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.26 120.99 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 123.051 1.405 . . . . 0.0 112.109 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.13 110.68 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.054 1.742 . . . . 0.0 107.816 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.55 102.82 7.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.929 -1.107 . . . . 0.0 110.312 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 113.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.899 1.279 . . . . 0.0 109.132 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.92 105.36 17.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.359 -0.838 . . . . 0.0 109.197 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.78 145.78 29.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.457 1.503 . . . . 0.0 111.403 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.71 145.96 42.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.48 1.912 . . . . 0.0 106.694 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -72.64 143.48 48.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -71.62 0.74 Allowed Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 126.126 1.822 . . . . 0.0 113.428 167.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -163.91 -35.41 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 169.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.6 m -78.81 152.57 77.57 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 120.648 -1.283 . . . . 0.0 114.171 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 C--N 1.299 -2.033 0 C-N-CA 122.757 2.305 . . . . 0.0 113.121 178.369 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.92 -161.32 0.83 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.663 1.585 . . . . 0.0 112.372 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.412 2.3 t 79.8 112.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 124.221 1.962 . . . . 0.0 113.319 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 38.9 m -145.02 124.99 13.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.515 -3.143 . . . . 0.0 102.515 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -80.83 131.42 35.39 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.257 0.935 . . . . 0.0 110.865 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 25' ' ' LEU . 7.2 p . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 -160.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 122.42 1.105 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.89 131.9 22.9 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.681 -1.262 . . . . 0.0 107.739 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 135.4 22.76 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 123.461 2.272 . . . . 0.0 111.947 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.77 16.63 80.53 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.58 123.31 27.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.865 1.266 . . . . 0.0 111.942 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -90.04 141.92 28.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.519 1.152 . . . . 0.0 113.636 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.14 119.6 12.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.432 1.493 . . . . 0.0 107.871 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.42 66.88 1.5 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.576 1.15 . . . . 0.0 111.265 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.32 111.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.113 2.165 . . . . 0.0 114.426 -168.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.31 0.2 OUTLIER -96.31 111.95 23.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.781 -1.824 . . . . 0.0 112.86 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.75 159.75 22.5 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.546 1.138 . . . . 0.0 107.984 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.38 24.08 10.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.398 1.094 . . . . 0.0 111.142 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' HB3' ' H ' ' A' ' 24' ' ' SER . 30.3 mttt 52.29 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.984 2.914 . . . . 0.0 114.515 -171.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -122.42 81.3 1.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.35 -2.094 . . . . 0.0 106.506 159.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 55.73 64.05 1.86 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.938 2.095 . . . . 0.0 115.15 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.47 46.79 9.53 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.85 -1.156 . . . . 0.0 114.987 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.544 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 47.7 t 178.53 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mt -75.54 -38.34 59.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.426 1.89 . . . . 0.0 107.368 169.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.22 14.83 4.38 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.941 168.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.22 125.32 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.263 1.03 . . . . 0.0 110.732 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.9 m -78.35 109.27 12.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.717 1.207 . . . . 0.0 110.504 169.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.35 127.19 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -125.31 167.9 14.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.424 1.49 . . . . 0.0 110.406 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 -125.6 7.07 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.564 1.554 . . . . 0.0 113.183 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.3 167.34 30.12 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.71 -12.87 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.163 -1.787 . . . . 0.0 113.554 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -60.27 -31.54 70.33 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.83 2.052 . . . . 0.0 113.969 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 m -100.2 -33.14 10.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.217 -1.552 . . . . 0.0 109.633 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.288 8.1 t 97.47 119.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.408 2.683 . . . . 0.0 109.474 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 t -126.41 70.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -168.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.4 ttt-85 69.85 -68.78 0.19 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.491 1.916 . . . . 0.0 113.32 -172.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -136.92 -11.79 1.73 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.351 1.461 . . . . 0.0 111.202 172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.59 130.13 1.99 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 -162.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.82 170.49 33.52 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.42 167.31 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -136.14 156.5 48.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.559 -1.963 . . . . 0.0 107.12 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.57 130.46 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.262 -1.524 . . . . 0.0 112.015 165.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -91.89 -38.68 12.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.417 -1.427 . . . . 0.0 112.531 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.3 136.08 22.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.7 -1.25 . . . . 0.0 112.129 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mm -96.75 143.32 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.026 2.131 . . . . 0.0 108.008 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 pt -107.59 146.5 33.47 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 120.72 -1.238 . . . . 0.0 113.827 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.64 69.22 8.05 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -103.76 -68.77 0.83 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 110.753 170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.6 23.19 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.741 0 O-C-N 120.845 -1.159 . . . . 0.0 115.422 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.38 -82.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.29 -1.123 . . . . 0.0 109.047 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.52 78.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.66 -35.6 81.07 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.6 -1.938 . . . . 0.0 111.741 170.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.27 2.58 24.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.15 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.859 -1.776 . . . . 0.0 108.476 160.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 -41.79 0.29 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.783 -1.198 . . . . 0.0 111.186 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.9 mtm-85 -87.42 -17.35 32.46 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.58 133.45 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.676 -1.265 . . . . 0.0 112.293 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 21.9 t-80 -129.24 -165.18 1.48 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.939 0.896 . . . . 0.0 108.604 170.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.529 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 43.2 pttt -102.71 44.79 0.99 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.852 -1.78 . . . . 0.0 112.229 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.68 33.97 0.16 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -97.74 178.19 5.23 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.358 1.063 . . . . 0.0 109.667 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -114.33 128.63 56.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.745 -1.847 . . . . 0.0 108.698 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.36 110.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.378 -1.452 . . . . 0.0 107.27 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -48.58 7.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.507 -1.996 . . . . 0.0 112.348 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -136.79 160.87 37.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.882 -1.136 . . . . 0.0 113.479 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.0 112.94 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 123.964 0.905 . . . . 0.0 111.285 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 58.74 26.82 15.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.138 -1.601 . . . . 0.0 113.536 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 12.98 83.66 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.702 -1.249 . . . . 0.0 113.705 -171.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.85 100.27 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -68.14 148.46 50.88 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 121.109 -0.995 . . . . 0.0 110.091 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.561 2.059 . . . . 0.0 116.561 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 61.29 51.63 4.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.334 1.54 . . . . 0.0 112.314 169.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.58 35.0 80.03 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.087 -1.633 . . . . 0.0 115.617 -173.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.65 151.99 23.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.541 1.639 . . . . 0.0 113.13 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.489 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 64.5 p -104.2 -158.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.161 2.585 . . . . 0.0 109.381 -169.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -60.21 -51.3 70.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.191 -1.568 . . . . 0.0 112.471 161.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -70.69 -46.14 63.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.126 0.971 . . . . 0.0 111.983 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.489 ' HB2' ' H ' ' A' ' 77' ' ' THR . 65.9 mt-30 -66.57 -34.38 77.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.993 -1.067 . . . . 0.0 113.454 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.11 93.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.313 1.87 . . . . 0.0 114.288 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.8 -50.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.909 0.884 . . . . 0.0 111.596 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -59.26 -40.53 86.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.346 -1.471 . . . . 0.0 113.874 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -59.78 -30.36 68.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.623 1.969 . . . . 0.0 113.428 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -89.96 -42.05 11.4 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.342 1.857 . . . . 0.0 113.78 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -24.87 24.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -90.05 24.5 2.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.276 -2.14 . . . . 0.0 112.907 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 p -94.38 162.39 13.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.655 2.782 . . . . 0.0 112.409 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.37 65.02 3.44 Favored Glycine 0 N--CA 1.431 -1.695 0 O-C-N 120.528 -1.358 . . . . 0.0 113.718 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.271 28.1 tt0 68.33 -55.24 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.0 115.368 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.75 132.6 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.381 1.086 . . . . 0.0 110.625 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.3 108.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 172.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -77.35 108.04 10.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.906 -1.121 . . . . 0.0 108.445 163.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.0 105.29 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.538 -1.351 . . . . 0.0 109.486 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.07 93.96 8.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mt -98.59 139.71 33.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.877 2.071 . . . . 0.0 109.703 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -109.47 135.96 49.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 106.798 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -69.1 115.27 8.2 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.755 1.222 . . . . 0.0 112.021 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.89 37.23 3.43 Favored Glycine 0 N--CA 1.432 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 115.041 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -115.03 151.93 33.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.801 1.24 . . . . 0.0 111.221 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.72 140.11 33.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 125.561 1.544 . . . . 0.0 110.501 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo . . . . . 0 N--CA 1.434 -2.024 0 C-N-CA 122.919 2.413 . . . . 0.0 115.273 -179.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 122.896 1.331 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.4 ' H ' ' CD2' ' B' ' 206' ' ' LEU . 0.3 OUTLIER -83.94 -143.18 0.08 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.093 1.757 . . . . 0.0 112.721 178.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.418 2.1 t 76.02 106.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.56 2.124 . . . . 0.0 113.358 172.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -141.31 122.26 14.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.795 -3.039 . . . . 0.0 102.795 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 41.5 m -78.0 129.26 35.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.261 1.684 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -163.213 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 122.465 1.126 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -106.86 119.41 51.48 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.378 -1.451 . . . . 0.0 109.765 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -64.79 124.17 12.77 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.462 2.108 . . . . 0.0 113.568 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.21 19.97 50.92 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.394 1.473 . . . . 0.0 115.082 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.78 116.77 17.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 119.444 1.622 . . . . 0.0 111.89 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 p -90.42 142.08 28.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.091 1.424 . . . . 0.0 112.715 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.82 116.51 18.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -89.57 83.99 6.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.911 1.339 . . . . 0.0 109.741 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -80.84 110.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 126.947 2.099 . . . . 0.0 112.99 -173.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.64 121.67 41.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.101 -2.249 . . . . 0.0 109.531 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -122.04 172.81 7.96 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.089 0.956 . . . . 0.0 109.9 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.23 122.17 23.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 161.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -67.02 160.46 26.48 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.442 1.897 . . . . 0.0 114.805 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -115.75 106.94 14.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.163 1.385 . . . . 0.0 108.924 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.88 55.0 9.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.641 2.376 . . . . 0.0 114.503 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.62 48.55 61.63 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 119.974 -1.704 . . . . 0.0 114.982 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 m -172.01 111.05 0.28 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 -172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -72.73 -36.68 67.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.876 2.07 . . . . 0.0 108.101 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.04 38.15 1.73 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.425 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.45 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 121.838 0.828 . . . . 0.0 110.222 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -85.27 114.11 22.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.16 129.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 t -121.25 164.27 17.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.769 2.428 . . . . 0.0 111.023 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.51 -145.85 18.22 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 125.397 1.475 . . . . 0.0 111.854 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.64 153.87 23.71 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.062 1.315 . . . . 0.0 111.929 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.05 -2.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.779 1.631 . . . . 0.0 115.315 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.42 -20.97 63.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.766 -1.834 . . . . 0.0 111.869 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -123.07 172.48 8.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 p -86.72 68.47 10.14 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.919 -1.738 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.46 -39.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 124.821 1.248 . . . . 0.0 109.339 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -162.34 -101.58 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -128.32 -12.31 5.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.637 -1.289 . . . . 0.0 112.914 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.17 115.58 0.6 Allowed Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.82 168.4 34.76 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 104.577 -3.409 . . . . 0.0 104.577 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.256 4.4 tp -129.13 163.0 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -138.84 160.94 38.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.69 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.302 -1.499 . . . . 0.0 110.393 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -88.13 -55.85 3.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.136 -1.602 . . . . 0.0 110.208 166.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.42 139.64 25.72 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.103 0.954 . . . . 0.0 110.782 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mm -91.23 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.552 1.541 . . . . 0.0 107.042 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 pt -85.75 166.83 27.64 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 121.435 -0.79 . . . . 0.0 112.505 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.12 93.71 1.08 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.58 2.187 . . . . 0.0 113.457 166.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.334 48.6 mtmt 74.12 84.33 0.11 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.354 2.262 . . . . 0.0 116.59 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -110.01 -107.35 3.05 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 158.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.36 -40.44 0.73 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.746 1.219 . . . . 0.0 112.606 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.44 83.52 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -48.09 -36.85 13.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.716 1.606 . . . . 0.0 114.172 167.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 t -73.14 4.25 4.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.66 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.462 -2.024 . . . . 0.0 108.249 155.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.37 -23.69 2.04 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.323 -0.86 . . . . 0.0 112.562 164.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mtt85 -77.56 -31.78 53.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.806 1.242 . . . . 0.0 112.18 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.49 143.72 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.244 1.818 . . . . 0.0 113.966 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 44.6 t60 -142.44 -167.03 2.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.975 -1.078 . . . . 0.0 109.628 170.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 58.3 mttp -80.06 53.97 1.82 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.859 -1.776 . . . . 0.0 113.255 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.28 -35.08 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.823 -1.798 . . . . 0.0 114.998 -169.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.38 156.29 32.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -167.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 117.37 33.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.292 1.437 . . . . 0.0 110.19 -170.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.46 125.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.255 1.503 . . . . 0.0 109.504 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -37.16 9.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.967 1.307 . . . . 0.0 112.214 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.12 157.11 44.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.68 115.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 124.36 1.064 . . . . 0.0 111.541 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.94 23.13 6.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -168.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.8 12.7 68.36 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.795 -1.19 . . . . 0.0 113.859 -171.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.33 99.27 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.6 p -61.95 139.12 58.42 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 125.832 1.653 . . . . 0.0 113.573 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.26 47.32 1.32 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.708 -1.245 . . . . 0.0 112.66 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -74.59 115.04 13.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.663 -1.898 . . . . 0.0 110.695 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.85 84.92 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.793 -1.192 . . . . 0.0 115.07 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.98 136.3 33.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.847 1.823 . . . . 0.0 112.95 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -95.44 -161.37 0.86 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.087 2.155 . . . . 0.0 109.836 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' B' ' 205' ' ' TYR . 79.3 t60 -64.3 -56.25 15.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.008 -1.682 . . . . 0.0 111.628 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -66.96 -38.73 86.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -67.12 -36.17 81.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.971 -1.706 . . . . 0.0 113.908 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.23 90.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.487 -2.008 . . . . 0.0 113.782 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -55.93 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 124.0 0.92 . . . . 0.0 110.461 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.06 -33.48 57.56 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.5 m -68.67 -36.47 78.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.827 2.051 . . . . 0.0 112.006 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.4 mt -89.29 -34.57 16.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.808 1.643 . . . . 0.0 114.934 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -45.29 17.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.965 1.706 . . . . 0.0 112.445 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -90.0 47.48 1.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.858 -1.777 . . . . 0.0 112.227 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.6 p -107.31 -166.62 1.17 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.988 2.115 . . . . 0.0 110.524 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.73 -93.92 1.25 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.078 -1.639 . . . . 0.0 114.647 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -132.91 -53.01 0.92 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.072 1.349 . . . . 0.0 109.519 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.06 139.84 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.472 -1.392 . . . . 0.0 110.89 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.21 121.82 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -86.46 105.82 17.04 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.66 1.184 . . . . 0.0 109.969 166.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mt -87.24 110.8 20.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.333 -1.48 . . . . 0.0 109.652 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 97.94 11.16 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.728 -1.232 . . . . 0.0 108.44 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -101.54 141.33 34.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.075 2.15 . . . . 0.0 110.901 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -108.27 141.09 40.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.461 1.904 . . . . 0.0 107.488 166.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -59.42 119.58 7.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.236 1.814 . . . . 0.0 113.917 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 65.5 4.12 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 120.671 -1.268 . . . . 0.0 114.457 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.34 151.44 44.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.199 1.399 . . . . 0.0 111.83 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.6 m -92.39 157.4 40.44 Favored Pre-proline 0 N--CA 1.431 -1.419 0 C-N-CA 124.734 1.214 . . . . 0.0 109.323 164.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.3 -2.008 0 C-N-CA 122.624 2.216 . . . . 0.0 114.022 -179.429 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 41.5 p90 . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 122.251 1.024 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp -99.34 155.8 17.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.907 -1.121 . . . . 0.0 109.145 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.417 2.1 t 70.82 104.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 124.553 2.12 . . . . 0.0 114.633 164.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.8 m -142.48 121.99 13.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.325 -2.842 . . . . 0.0 103.325 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 7.4 m -76.21 126.43 30.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.626 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.431 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -122.74 151.71 60.99 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 121.069 -1.019 . . . . 0.0 111.991 -171.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.61 154.73 27.36 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 122.913 2.076 . . . . 0.0 113.109 171.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.72 53.02 41.83 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 125.654 1.597 . . . . 0.0 114.544 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.91 98.5 6.52 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 121.569 -0.959 . . . . 0.0 108.433 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -94.81 131.5 40.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.222 -0.923 . . . . 0.0 109.762 168.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 121.4 35.49 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.823 1.249 . . . . 0.0 108.353 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -98.7 79.36 2.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.317 1.532 . . . . 0.0 108.836 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.91 115.55 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.323 2.249 . . . . 0.0 111.581 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.266 3.1 pt-20 -105.87 115.45 30.25 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.221 -2.174 . . . . 0.0 110.276 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -117.28 160.66 20.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.885 1.274 . . . . 0.0 109.568 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.92 105.3 11.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 145.88 55.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -173.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 t -99.48 110.64 23.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.563 1.545 . . . . 0.0 109.068 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t70 58.11 20.41 6.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.57 1.948 . . . . 0.0 116.017 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 57.6 2.02 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.008 -1.682 . . . . 0.0 112.654 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -173.93 112.72 0.19 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 126.207 1.803 . . . . 0.0 106.823 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.6 mt -74.88 -40.15 61.09 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.413 1.885 . . . . 0.0 106.219 165.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.45 40.63 1.11 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.474 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.8 pt -131.68 127.92 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.298 1.047 . . . . 0.0 110.585 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -80.41 123.28 27.9 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.644 1.177 . . . . 0.0 111.515 167.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.72 145.79 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.98 170.74 15.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.349 1.46 . . . . 0.0 109.074 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.12 -133.29 11.71 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.882 1.229 . . . . 0.0 113.615 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.47 161.57 34.82 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 124.753 1.168 . . . . 0.0 112.551 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.15 -14.36 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.45 -1.618 . . . . 0.0 115.03 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -63.69 -47.48 81.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.724 1.609 . . . . 0.0 114.447 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 m -161.73 120.15 2.33 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.375 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t 69.08 77.25 0.23 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 164.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 m -137.11 -165.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.285 1.834 . . . . 0.0 108.386 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -76.64 -63.26 1.38 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.969 -1.707 . . . . 0.0 109.298 162.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -157.35 -15.0 0.09 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.43 94.66 0.1 Allowed Glycine 0 N--CA 1.431 -1.639 0 O-C-N 119.273 -2.142 . . . . 0.0 112.69 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.64 41.92 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 105.153 -3.179 . . . . 0.0 105.153 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.262 3.8 tp -118.73 158.09 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 166.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.94 158.05 45.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.76 138.6 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.227 -1.546 . . . . 0.0 110.732 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -101.51 -74.05 0.63 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.509 -1.369 . . . . 0.0 109.955 167.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.21 124.82 50.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.142 0.972 . . . . 0.0 111.534 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 mm -90.21 133.92 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.274 1.83 . . . . 0.0 108.562 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 73.4 mt -79.88 136.47 54.6 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 116.047 -1.93 . . . . 0.0 109.771 170.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -59.98 107.41 0.4 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.181 2.587 . . . . 0.0 112.853 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.256 83.0 mttt 31.52 73.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.97 -76.96 1.02 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.56 -45.33 0.49 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.435 1.094 . . . . 0.0 109.649 166.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 -45.71 69.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -56.15 -36.08 67.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.132 -1.605 . . . . 0.0 111.933 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -71.31 3.04 4.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.67 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.982 1.719 . . . . 0.0 108.83 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.77 -41.49 0.19 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.562 -1.336 . . . . 0.0 111.903 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -84.92 -26.82 27.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.9 mt -65.69 129.09 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 125.174 1.39 . . . . 0.0 114.6 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -132.95 177.71 7.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.731 2.013 . . . . 0.0 110.683 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -71.01 77.03 0.66 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.376 -1.452 . . . . 0.0 113.463 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.81 19.18 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -85.58 165.0 17.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 119.175 1.488 . . . . 0.0 112.147 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 120.72 43.32 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.679 1.191 . . . . 0.0 110.598 -171.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 p -95.84 122.63 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.178 -1.577 . . . . 0.0 110.658 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.0 -36.42 11.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.304 -1.497 . . . . 0.0 111.366 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 155.82 43.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.993 -1.067 . . . . 0.0 113.049 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -131.42 118.52 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.328 -0.857 . . . . 0.0 111.504 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.34 30.78 20.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.266 1.426 . . . . 0.0 112.77 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.51 79.82 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.444 -1.41 . . . . 0.0 114.251 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.35 104.91 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.462 1.505 . . . . 0.0 107.661 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.8 p -64.27 144.76 56.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.21 40.22 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.217 1.407 . . . . 0.0 112.793 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.54 118.48 16.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.117 -1.615 . . . . 0.0 111.305 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.24 88.64 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.063 -1.023 . . . . 0.0 114.846 -174.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.17 140.81 29.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.736 1.732 . . . . 0.0 113.262 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.04 -174.17 2.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -45.93 -50.9 14.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.086 2.154 . . . . 0.0 114.863 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -70.04 -44.31 69.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.787 0.835 . . . . 0.0 112.428 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.89 -37.75 76.11 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.005 -1.059 . . . . 0.0 112.459 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.4 97.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.702 -1.249 . . . . 0.0 113.71 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.3 t -57.0 -53.63 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 123.45 0.7 . . . . 0.0 111.388 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.37 -31.39 67.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.8 m -71.6 -26.21 62.5 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.774 2.029 . . . . 0.0 112.896 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.52 -46.65 8.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.007 1.723 . . . . 0.0 114.275 168.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -32.9 22.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.31 1.844 . . . . 0.0 115.064 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -91.4 41.66 1.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.999 -2.313 . . . . 0.0 111.589 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.9 p -102.84 160.86 14.23 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.681 1.992 . . . . 0.0 108.975 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.5 -70.36 1.11 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.31 -1.494 . . . . 0.0 113.906 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -153.57 -52.73 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.968 -0.724 . . . . 0.0 109.407 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.14 130.53 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.658 1.218 . . . . 0.0 112.049 171.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.24 109.8 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.425 1.09 . . . . 0.0 108.063 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -83.02 109.75 17.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.777 -1.202 . . . . 0.0 109.418 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -89.54 110.1 20.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.55 1.14 . . . . 0.0 108.506 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.15 93.49 9.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.96 144.13 28.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.335 1.854 . . . . 0.0 110.577 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -111.54 144.02 41.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.901 1.68 . . . . 0.0 107.075 164.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 100' ' ' GLN . 1.1 pptt? -53.64 130.39 36.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.482 1.913 . . . . 0.0 115.089 172.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.64 43.76 3.2 Favored Glycine 0 N--CA 1.428 -1.842 0 O-C-N 118.807 -2.433 . . . . 0.0 112.003 171.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' H ' ' HD2' ' A' ' 98' ' ' LYS . 4.2 tp-100 -118.11 143.33 46.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.995 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -82.9 126.88 71.71 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 125.233 1.413 . . . . 0.0 110.727 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.3 -2.003 0 C-N-CA 122.467 2.111 . . . . 0.0 114.795 171.158 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 123.068 1.413 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.8 tp -161.59 -154.39 0.34 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 176.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.5 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.443 29.4 m 53.74 82.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.159 2.184 . . . . 0.0 116.667 166.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 94.6 m -118.7 114.31 22.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -170.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.3 m -83.09 124.52 30.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 122.907 0.483 . . . . 0.0 110.118 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.628 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -136.76 161.84 59.4 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 149.43 64.7 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 CA-C-N 121.913 1.719 . . . . 0.0 111.534 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.06 9.29 60.88 Favored Glycine 0 N--CA 1.429 -1.785 0 O-C-N 121.523 -0.735 . . . . 0.0 114.831 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -86.76 104.75 16.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.62 -1.518 . . . . 0.0 110.252 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p -96.1 147.09 24.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.56 1.544 . . . . 0.0 112.785 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.48 116.49 14.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.859 1.263 . . . . 0.0 109.107 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.52 81.61 5.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.311 1.529 . . . . 0.0 112.677 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.63 114.68 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 126.651 1.98 . . . . 0.0 112.219 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.55 113.05 26.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.762 -1.836 . . . . 0.0 110.744 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.24 161.49 25.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.78 -1.2 . . . . 0.0 110.28 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.89 117.04 29.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 163.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -49.27 130.76 19.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.33 1.852 . . . . 0.0 114.711 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -96.95 109.9 22.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.775 1.63 . . . . 0.0 107.955 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.57 26.84 11.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.21 2.204 . . . . 0.0 115.3 -171.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.71 64.74 2.09 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.115 -1.616 . . . . 0.0 112.437 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 174.58 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' B' ' 210' ' ' VAL . 9.8 mt -75.72 -45.52 36.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.347 2.022 . . . . 0.0 106.472 169.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.0 32.02 0.89 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 113.672 -1.604 . . . . 0.0 111.568 169.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.0 pt -113.0 129.93 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.884 0.849 . . . . 0.0 109.74 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -83.07 112.45 19.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.286 1.035 . . . . 0.0 110.031 161.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.93 138.32 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.3 t -131.26 167.83 18.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.111 -1.618 . . . . 0.0 108.763 172.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.52 -140.49 18.96 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 124.641 1.115 . . . . 0.0 113.62 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.2 155.43 31.69 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 124.476 1.036 . . . . 0.0 110.56 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 t -43.19 -38.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 126.853 2.061 . . . . 0.0 114.959 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.59 -41.19 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.811 2.044 . . . . 0.0 114.697 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -87.62 -13.64 42.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.404 1.882 . . . . 0.0 112.335 -165.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.305 22.4 m 84.65 80.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.581 1.952 . . . . 0.0 112.762 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.89 57.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.814 1.246 . . . . 0.0 110.393 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.44 -67.09 0.23 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.747 1.619 . . . . 0.0 112.532 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -131.41 -79.23 0.52 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.351 1.86 . . . . 0.0 106.784 171.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.38 -126.86 1.41 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 173.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.31 168.75 24.15 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.574 -0.956 . . . . 0.0 112.014 -164.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 tp -124.95 160.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.55 153.89 43.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -168.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.5 t -84.37 138.28 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.159 -2.213 . . . . 0.0 111.789 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -94.47 -58.48 2.19 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.778 -1.201 . . . . 0.0 109.603 166.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.17 51.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.377 -0.827 . . . . 0.0 111.647 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.4 mm -96.17 125.43 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.074 1.35 . . . . 0.0 108.439 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.0 pt -85.37 154.58 59.78 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 120.733 -1.23 . . . . 0.0 112.772 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 70.69 7.26 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 C-N-CA 122.479 2.119 . . . . 0.0 112.641 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -115.82 -86.76 0.61 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.469 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.29 48.79 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.86 -63.41 1.27 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 118.946 1.373 . . . . 0.0 108.554 153.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -45.73 75.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.062 -1.649 . . . . 0.0 113.451 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -19.63 65.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.524 -1.36 . . . . 0.0 112.977 172.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 t -69.11 -22.18 63.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.5 -89.94 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.199 -1.563 . . . . 0.0 110.32 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.84 -3.79 9.22 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.916 -1.115 . . . . 0.0 113.197 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -84.57 -27.94 26.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.013 -1.287 . . . . 0.0 108.399 161.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.13 128.6 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.619 1.567 . . . . 0.0 112.761 166.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -133.74 -155.82 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -90.36 81.73 6.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.201 -2.187 . . . . 0.0 112.894 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.06 39.97 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 118.854 2.301 . . . . 0.0 118.854 164.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -98.19 163.57 12.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.539 1.536 . . . . 0.0 110.943 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -89.26 125.48 35.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.569 -1.332 . . . . 0.0 108.395 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.26 2.9 p -102.48 120.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 -28.93 11.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.796 -1.19 . . . . 0.0 112.124 -173.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.46 161.69 42.26 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 121.635 -0.666 . . . . 0.0 112.459 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.6 122.82 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 121.269 -0.895 . . . . 0.0 110.54 -176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 60.61 26.8 16.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.439 1.927 . . . . 0.0 113.353 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.04 -0.57 89.39 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 125.713 1.625 . . . . 0.0 114.085 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.03 101.88 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.805 1.242 . . . . 0.0 108.132 -172.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -62.6 136.92 58.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.852 -1.155 . . . . 0.0 113.659 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.85 -43.81 91.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.065 0.946 . . . . 0.0 113.512 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 28.22 79.6 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.361 2.664 . . . . 0.0 117.939 158.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.66 -22.32 30.55 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.021 1.296 . . . . 0.0 114.69 -170.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.37 141.43 57.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -98.93 -153.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.814 2.046 . . . . 0.0 110.061 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -73.28 -50.68 20.88 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.8 -1.813 . . . . 0.0 110.918 167.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -64.32 -44.74 90.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.531 0.732 . . . . 0.0 112.757 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -31.87 72.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.641 -1.287 . . . . 0.0 114.25 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.09 94.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.319 -2.113 . . . . 0.0 114.756 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.408 HG11 ' HG2' ' A' ' 86' ' ' ARG . 73.3 t -55.08 -56.24 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.197 0.999 . . . . 0.0 110.049 170.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.04 -46.99 33.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.5 m -62.47 -31.92 72.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.821 2.448 . . . . 0.0 113.58 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.25 -40.78 13.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.53 -1.981 . . . . 0.0 113.668 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.408 ' HG2' HG11 ' A' ' 82' ' ' VAL . 4.4 ppt_? -80.01 -38.74 31.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -166.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.64 29.7 1.12 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.87 -1.769 . . . . 0.0 111.705 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 60.7 p -96.43 151.47 19.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.748 2.819 . . . . 0.0 109.854 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.25 -58.12 4.44 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.687 -1.258 . . . . 0.0 114.643 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -150.93 -67.52 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.651 -0.911 . . . . 0.0 112.297 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.96 128.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.643 1.211 . . . . 0.0 111.086 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -124.11 103.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.92 1.688 . . . . 0.0 106.977 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -81.37 103.61 11.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.768 -1.207 . . . . 0.0 109.379 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.04 115.8 22.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.461 -1.4 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.25 95.1 9.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.09 151.31 19.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.825 2.05 . . . . 0.0 110.708 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.37 147.67 49.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.522 1.129 . . . . 0.0 108.402 164.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -50.02 117.78 2.52 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.814 1.646 . . . . 0.0 114.511 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.36 70.46 3.15 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.803 -1.186 . . . . 0.0 113.073 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -124.75 158.85 32.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.646 1.178 . . . . 0.0 110.382 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.06 143.62 43.01 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 117.718 -1.134 . . . . 0.0 109.749 168.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo . . . . . 0 N--CA 1.433 -2.057 0 CA-C-N 123.293 2.212 . . . . 0.0 114.913 176.23 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.624 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 15.2 tp 78.74 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.238 2.615 . . . . 0.0 109.343 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.624 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.341 8.8 m 21.72 80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 130.948 3.699 . . . . 0.0 117.636 160.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 44.2 m -118.94 121.38 39.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.8 p -79.14 127.89 32.6 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.563 1.145 . . . . 0.0 110.508 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' LEU . 14.9 p . . . . . 0 C--O 1.26 1.655 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -160.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 121.532 0.682 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -129.06 163.06 48.34 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 126.778 2.031 . . . . 0.0 109.055 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.05 159.36 47.92 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.047 2.124 . . . . 0.0 113.175 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.71 0.16 87.87 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.06 98.83 9.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.038 1.419 . . . . 0.0 113.618 -164.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p -91.51 155.58 18.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.474 -1.392 . . . . 0.0 110.948 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 121.48 16.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.398 1.079 . . . . 0.0 108.908 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -98.88 77.83 2.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.278 1.031 . . . . 0.0 109.729 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.4 t -84.4 132.24 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.871 2.868 . . . . 0.0 113.316 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -110.51 124.75 52.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.886 -2.384 . . . . 0.0 111.8 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.52 150.87 48.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.576 -1.327 . . . . 0.0 110.375 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.11 104.97 12.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 122.181 0.991 . . . . 0.0 108.74 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 140.51 49.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.257 1.576 . . . . 0.0 115.257 -172.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 t -99.38 95.19 6.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.412 1.577 . . . . 0.0 110.138 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t70 56.73 58.11 4.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.753 2.021 . . . . 0.0 113.936 -174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.94 52.21 49.75 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 114.392 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -167.73 98.08 0.47 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.491 1.615 . . . . 0.0 107.647 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -73.53 -42.22 62.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.364 1.866 . . . . 0.0 106.753 168.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.7 43.65 0.95 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.295 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.3 pt -125.4 136.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 121.754 0.788 . . . . 0.0 109.462 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 m -82.25 118.09 22.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.941 -1.1 . . . . 0.0 111.716 161.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.48 120.46 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -119.21 163.23 17.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.694 2.798 . . . . 0.0 109.796 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.1 -147.75 19.8 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 124.627 1.108 . . . . 0.0 112.412 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.27 158.48 19.67 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.104 1.335 . . . . 0.0 111.01 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.6 -18.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.425 -1.633 . . . . 0.0 114.752 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -70.77 -26.87 63.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.365 -0.835 . . . . 0.0 112.298 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.15 12.45 30.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.242 1.017 . . . . 0.0 110.792 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.279 99.2 p 47.08 79.55 0.06 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 117.784 2.512 . . . . 0.0 117.784 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -110.23 116.43 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 120.643 -1.286 . . . . 0.0 108.206 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 36.97 -103.36 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.875 2.07 . . . . 0.0 115.167 -163.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -132.16 38.74 3.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.786 -1.196 . . . . 0.0 112.145 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.78 107.51 3.06 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-O 122.926 1.292 . . . . 0.0 116.263 166.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -175.83 179.77 46.78 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 tp -118.3 162.41 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -141.81 165.1 28.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.02 135.93 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.494 -1.379 . . . . 0.0 112.338 172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -73.04 0.55 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.98 -1.075 . . . . 0.0 108.929 164.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.57 126.01 51.72 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.444 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.9 mm -82.69 125.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 161.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -88.91 153.74 49.62 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.248 175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.34 106.6 1.05 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.592 2.195 . . . . 0.0 113.754 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.322 30.4 pttt 45.5 62.8 2.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.241 3.016 . . . . 0.0 117.893 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.06 -81.9 0.82 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 120.822 -1.174 . . . . 0.0 111.064 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 -38.58 0.4 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.347 1.059 . . . . 0.0 110.365 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.6 57.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.469 1.908 . . . . 0.0 115.753 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -53.6 -43.28 68.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.864 1.316 . . . . 0.0 111.353 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -69.02 5.91 1.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 -78.15 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.385 -1.447 . . . . 0.0 108.944 156.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -39.51 0.45 Allowed Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -93.86 -19.6 20.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 mt -72.57 127.49 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.109 -1.619 . . . . 0.0 113.018 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -125.64 -178.32 4.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.949 1.3 . . . . 0.0 109.045 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -79.06 82.98 5.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 0.0 112.114 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.12 -8.71 0.33 Allowed Glycine 0 N--CA 1.431 -1.655 0 O-C-N 120.122 -1.611 . . . . 0.0 115.815 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.12 157.03 36.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 119.205 1.503 . . . . 0.0 114.266 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.65 132.51 36.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.911 1.284 . . . . 0.0 109.374 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 t -92.39 117.47 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 160.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -31.53 11.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.666 -1.896 . . . . 0.0 112.218 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.56 160.51 43.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.341 -0.849 . . . . 0.0 112.13 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.62 118.58 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 111.037 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.52 26.77 14.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.178 -1.577 . . . . 0.0 113.946 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.59 85.46 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.165 -0.959 . . . . 0.0 113.765 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.04 101.23 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 121.25 -1.147 . . . . 0.0 108.205 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 p -56.97 124.1 17.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.748 2.019 . . . . 0.0 112.759 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.12 -46.29 78.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.934 -1.104 . . . . 0.0 113.664 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 6.01 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.922 3.689 . . . . 0.0 117.68 167.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.8 -23.05 5.08 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.562 -1.336 . . . . 0.0 113.461 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.77 141.82 39.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.1 p -98.13 -161.6 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.789 1.635 . . . . 0.0 108.422 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -59.62 -48.0 83.37 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 119.874 -1.766 . . . . 0.0 112.511 164.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -71.04 -45.1 64.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.285 1.434 . . . . 0.0 111.68 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.52 -33.35 72.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.366 -1.459 . . . . 0.0 114.262 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.85 88.89 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.663 -1.898 . . . . 0.0 114.402 172.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.7 t -54.48 -54.3 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.919 0.888 . . . . 0.0 111.047 171.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -59.06 -37.56 77.34 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 m -61.97 -27.72 69.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.358 1.863 . . . . 0.0 112.204 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.25 -41.93 10.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.473 1.509 . . . . 0.0 114.525 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.293 0.0 OUTLIER -88.7 -32.25 18.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -165.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -88.6 39.54 0.92 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.666 1.222 . . . . 0.0 111.647 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.0 p -105.81 170.81 7.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.696 1.999 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.22 -92.17 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 114.101 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -133.44 -48.22 0.83 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.552 -1.558 . . . . 0.0 109.263 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.31 121.12 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.976 1.37 . . . . 0.0 111.242 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.61 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -87.16 99.97 12.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.769 2.027 . . . . 0.0 107.486 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.06 124.59 31.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.363 -1.461 . . . . 0.0 109.892 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.39 100.55 13.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 146.32 26.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.47 1.908 . . . . 0.0 111.431 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -124.02 144.1 50.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.244 1.417 . . . . 0.0 108.807 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 130.52 15.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 72.05 2.46 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 119.767 -1.833 . . . . 0.0 113.538 168.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -162.14 157.76 23.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.75 152.46 37.81 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.176 -1.578 . . . . 0.0 110.418 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.3 -2.016 0 CA-C-N 123.527 2.295 . . . . 0.0 113.973 166.407 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 50.0 t80 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.57 -173.41 3.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.224 -0.923 . . . . 0.0 112.394 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.405 3.8 t 71.33 114.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 124.22 1.962 . . . . 0.0 113.567 -177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 54.2 m -153.3 129.18 10.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 81.1 p -74.54 129.08 37.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.864 1.266 . . . . 0.0 110.079 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.26 1.608 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -161.443 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.431 -1.419 0 CA-C-O 121.296 0.57 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -148.54 158.36 40.44 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.61 135.9 22.66 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 C-N-CA 122.721 2.281 . . . . 0.0 112.867 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.2 73.01 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 125.133 1.349 . . . . 0.0 114.516 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.69 114.13 20.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.962 1.305 . . . . 0.0 111.268 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.8 p -88.33 145.67 25.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.024 1.392 . . . . 0.0 112.41 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.4 113.23 16.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 173.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -87.14 85.68 7.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 123.265 1.507 . . . . 0.0 109.949 170.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.16 152.91 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.133 2.173 . . . . 0.0 109.844 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.32 131.67 48.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.103 -1.623 . . . . 0.0 108.716 164.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 167.99 16.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.64 134.47 51.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 157.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HB3' ' H ' ' A' ' 24' ' ' SER . 24.0 mttt -61.61 136.49 58.03 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.077 1.351 . . . . 0.0 113.848 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -84.68 84.37 7.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.417 -1.427 . . . . 0.0 110.047 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.16 60.09 2.18 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.358 2.263 . . . . 0.0 114.602 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.72 48.72 60.11 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.714 -1.241 . . . . 0.0 115.044 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.572 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 40.3 t 176.96 106.7 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -166.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.02 -47.27 74.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.898 2.285 . . . . 0.0 106.283 164.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.34 38.02 0.7 Allowed Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.296 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.15 127.87 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.796 0.808 . . . . 0.0 110.52 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -78.36 104.91 9.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.632 1.973 . . . . 0.0 113.149 165.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.08 125.11 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t -118.57 161.43 20.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.757 2.423 . . . . 0.0 111.457 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.3 21.59 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.129 1.347 . . . . 0.0 113.453 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.68 169.5 20.18 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 124.602 1.096 . . . . 0.0 111.017 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.95 -7.81 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -61.8 -27.2 68.59 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -138.76 -163.28 1.44 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 110.474 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 m -85.16 92.31 8.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.942 1.697 . . . . 0.0 111.673 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.48 -129.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -88.54 -99.71 0.09 Allowed 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.774 -1.829 . . . . 0.0 107.19 162.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -134.19 22.8 3.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.891 -1.755 . . . . 0.0 112.148 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.77 129.25 3.2 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.438 -1.414 . . . . 0.0 110.934 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.7 176.79 31.15 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -116.17 157.17 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 166.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -131.57 161.7 32.03 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.649 -1.907 . . . . 0.0 106.562 -170.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 85.4 t -86.67 128.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.962 1.305 . . . . 0.0 111.512 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -99.17 -35.6 9.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.735 -1.853 . . . . 0.0 111.739 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.02 133.85 11.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.569 0.699 . . . . 0.0 110.446 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -100.44 115.78 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.7 pt -81.45 144.22 52.9 Favored Pre-proline 0 N--CA 1.43 -1.45 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.4 71.4 6.81 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.95 2.433 . . . . 0.0 112.189 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -111.86 -89.06 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 123.58 0.752 . . . . 0.0 108.973 164.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 50.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.724 -0.61 . . . . 0.0 113.855 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.03 -72.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.895 -1.356 . . . . 0.0 108.479 164.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.94 85.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.068 -1.645 . . . . 0.0 113.102 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.07 -33.85 76.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.702 -1.249 . . . . 0.0 112.516 168.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.75 -20.43 65.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.78 -76.16 0.1 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.552 -1.342 . . . . 0.0 109.429 162.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.15 7.91 56.96 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.317 -0.864 . . . . 0.0 113.788 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -88.55 -18.69 27.57 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.91 -1.347 . . . . 0.0 109.711 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 153.34 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.634 1.574 . . . . 0.0 112.632 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -147.89 176.59 10.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 166.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -81.16 57.06 3.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.48 0.94 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.552 -1.342 . . . . 0.0 114.841 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -80.11 166.47 21.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 118.982 1.391 . . . . 0.0 114.415 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -103.87 132.08 50.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.95 1.3 . . . . 0.0 109.234 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 p -105.37 125.0 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 107.809 167.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 -28.69 9.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.468 -1.395 . . . . 0.0 113.401 -175.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.22 161.0 42.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 120.007 1.276 . . . . 0.0 112.777 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -133.63 116.76 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.264 1.026 . . . . 0.0 110.532 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 58.77 24.0 11.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.197 -1.564 . . . . 0.0 114.164 -173.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.71 4.93 84.78 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 124.573 1.083 . . . . 0.0 114.132 -171.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.29 102.21 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 p -55.35 135.27 50.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.761 2.024 . . . . 0.0 115.168 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -74.74 -54.51 7.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.837 -1.165 . . . . 0.0 110.8 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -5.07 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.262 3.825 . . . . 0.0 117.897 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.02 6.46 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -163.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.26 138.98 37.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 120.675 -1.486 . . . . 0.0 114.748 -176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -110.71 -161.0 0.73 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.279 2.231 . . . . 0.0 106.391 177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -61.57 -51.83 66.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.466 -2.021 . . . . 0.0 112.793 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -66.51 -49.97 64.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.015 -1.053 . . . . 0.0 112.239 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.22 93.67 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.291 -2.13 . . . . 0.0 114.4 173.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.45 -50.72 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.03 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -47.22 -47.58 24.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.594 1.543 . . . . 0.0 115.03 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 m -62.99 -36.45 83.57 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.456 2.702 . . . . 0.0 114.533 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -90.98 -44.36 9.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.817 1.247 . . . . 0.0 113.73 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.12 13.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.81 2.044 . . . . 0.0 112.599 -170.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -89.17 38.31 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.489 1.614 . . . . 0.0 112.531 -166.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.5 p -91.57 -168.91 2.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.097 2.959 . . . . 0.0 108.944 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -89.6 -116.89 1.63 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.122 -1.611 . . . . 0.0 110.542 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -105.65 -47.7 3.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.72 -0.871 . . . . 0.0 109.951 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.61 129.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.111 -0.993 . . . . 0.0 111.77 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.6 t -122.64 108.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -78.99 109.78 13.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.786 -1.196 . . . . 0.0 108.585 163.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -89.02 120.23 30.25 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.643 -1.286 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.33 97.26 11.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.23 142.14 35.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.544 1.938 . . . . 0.0 110.52 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -115.34 140.4 49.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.786 1.634 . . . . 0.0 108.912 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.07 115.44 4.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.858 1.663 . . . . 0.0 113.853 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.44 48.32 3.56 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.321 -1.487 . . . . 0.0 112.428 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -120.02 137.71 53.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.079 1.351 . . . . 0.0 109.179 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -84.35 156.91 62.57 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 124.965 1.306 . . . . 0.0 111.765 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 N--CA 1.434 -2.021 0 C-N-CA 123.065 2.51 . . . . 0.0 114.458 178.766 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.0 tp 75.98 155.3 0.16 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.831 2.453 . . . . 0.0 115.026 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.356 4.9 t 74.46 120.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 123.936 1.826 . . . . 0.0 114.813 167.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.3 m -143.15 132.17 22.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.9 p -82.93 129.99 35.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.882 1.273 . . . . 0.0 109.244 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.642 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -164.653 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.431 -1.412 0 CA-C-O 121.1 0.476 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -127.32 -159.1 0.03 OUTLIER Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -63.71 112.47 1.81 Allowed 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 124.359 2.592 . . . . 0.0 111.536 155.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 137.34 57.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.0 163.06 36.77 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -68.82 152.65 45.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.951 -1.718 . . . . 0.0 113.824 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE2' HD11 ' A' ' 96' ' ' LEU 0.299 0.1 OUTLIER -136.25 129.15 31.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.648 1.179 . . . . 0.0 108.681 171.384 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -105.97 79.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.626 1.203 . . . . 0.0 109.64 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.21 159.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.986 2.114 . . . . 0.0 110.796 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 0.1 OUTLIER -125.74 129.91 50.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 119.949 -1.72 . . . . 0.0 108.386 164.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -125.88 164.95 19.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.102 1.761 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.15 112.92 14.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.274 1.03 . . . . 0.0 109.587 167.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -56.51 144.71 30.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.225 2.21 . . . . 0.0 115.849 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -113.08 117.94 33.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.992 1.317 . . . . 0.0 108.253 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 36.05 51.73 0.79 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.422 2.689 . . . . 0.0 117.522 -166.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.86 48.05 22.97 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.276 -1.515 . . . . 0.0 114.565 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -172.48 111.25 0.25 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.082 1.42 . . . . 0.0 107.298 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.32 -45.3 73.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.322 2.249 . . . . 0.0 108.057 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.68 41.0 0.44 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.176 167.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.64 135.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.983 0.896 . . . . 0.0 110.646 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -85.68 114.21 22.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.263 1.025 . . . . 0.0 109.666 163.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.408 HG21 ' CE1' ' A' ' 78' ' ' HIS . 27.2 m -83.02 137.2 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -176.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 45' ' ' LYS . 15.0 t -127.98 165.77 19.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.652 1.981 . . . . 0.0 110.075 176.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.84 -149.11 39.2 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.888 1.233 . . . . 0.0 112.893 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 37' ' ' VAL . . . 121.66 168.11 13.31 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 177.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.77 -21.71 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.837 -1.39 . . . . 0.0 113.759 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -71.34 -29.22 64.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.577 -1.327 . . . . 0.0 113.64 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 m -117.51 74.6 0.94 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.5 m -25.09 106.81 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.072 2.949 . . . . 0.0 118.366 -167.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -92.91 -98.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.975 1.71 . . . . 0.0 111.34 -166.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -123.08 -79.55 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 163.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -125.9 144.05 50.83 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 158.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 24.8 -69.44 0.0 OUTLIER Glycine 0 N--CA 1.43 -1.712 1 C-N-CA 132.742 4.973 . . . . 0.0 121.267 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -30.24 141.28 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 130.038 3.685 . . . . 0.0 119.998 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 tp -94.08 167.51 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 0.0 109.768 -170.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -136.4 158.79 43.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.228 -2.17 . . . . 0.0 107.722 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.5 128.82 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.813 -1.179 . . . . 0.0 111.12 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 21.6 tptp -88.51 -63.08 1.35 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 170.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.21 133.83 54.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.206 1.402 . . . . 0.0 110.125 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.4 mm -97.83 135.89 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.281 1.832 . . . . 0.0 108.274 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.8 mt -75.34 132.36 76.24 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.213 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -61.66 94.4 0.12 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.409 2.739 . . . . 0.0 114.575 168.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 74.4 51.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.871 2.069 . . . . 0.0 113.983 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.82 -119.33 0.74 Allowed Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 161.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.44 -40.73 4.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.228 -1.16 . . . . 0.0 111.221 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.77 60.93 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.55 -34.4 70.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.057 1.408 . . . . 0.0 111.71 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -72.09 1.27 7.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.51 -74.15 0.17 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.615 -1.928 . . . . 0.0 107.541 156.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.79 -18.5 2.58 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 113.486 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -92.99 -15.73 25.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.474 0.71 . . . . 0.0 112.48 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -80.86 133.79 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.048 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.29 177.45 8.61 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.188 0.994 . . . . 0.0 111.031 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.91 104.15 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.932 1.693 . . . . 0.0 112.441 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.44 -31.31 2.34 Favored Glycine 0 N--CA 1.429 -1.818 0 O-C-N 120.696 -1.253 . . . . 0.0 115.191 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.73 161.18 31.06 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 118.507 1.154 . . . . 0.0 113.71 -170.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -98.69 134.44 41.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.48 1.112 . . . . 0.0 110.894 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.38 114.11 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.771 1.628 . . . . 0.0 107.072 171.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -27.86 12.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.699 -1.876 . . . . 0.0 113.973 -173.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.35 166.68 30.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 119.073 0.851 . . . . 0.0 112.501 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -146.31 135.35 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 112.077 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.0 m120 56.41 20.22 4.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.382 -2.074 . . . . 0.0 115.93 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.1 79.35 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.255 -1.528 . . . . 0.0 115.383 -168.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 t -109.43 106.26 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.107 1.763 . . . . 0.0 109.485 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.8 p -62.16 141.51 58.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.41 34.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.227 -1.546 . . . . 0.0 113.214 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.74 103.19 3.56 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.5 -2.0 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.1 13.58 58.72 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.376 -0.827 . . . . 0.0 114.079 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 140.03 29.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.673 -1.486 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -95.05 -163.62 1.07 Allowed 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.131 1.772 . . . . 0.0 110.408 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.408 ' CE1' HG21 ' A' ' 29' ' ' VAL . 86.5 t60 -59.97 -54.42 46.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.973 -1.704 . . . . 0.0 112.749 164.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -67.35 -44.79 78.18 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 111.951 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -68.2 -33.89 75.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.32 93.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.695 -1.878 . . . . 0.0 113.727 170.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.4 -53.98 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 122.995 0.518 . . . . 0.0 111.135 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -69.45 -20.13 63.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 95.7 m -63.81 -36.08 82.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.686 1.595 . . . . 0.0 110.756 168.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.27 -40.0 12.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.312 1.445 . . . . 0.0 114.717 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.459 0.0 OUTLIER -72.83 -43.42 62.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.874 -2.391 . . . . 0.0 116.546 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -87.87 47.41 1.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.007 1.384 . . . . 0.0 111.102 -174.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.0 p -102.09 175.29 5.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.39 2.676 . . . . 0.0 111.417 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.34 75.51 0.21 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 124.802 1.191 . . . . 0.0 111.654 175.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 69.22 -50.61 0.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.068 2.547 . . . . 0.0 117.382 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.86 135.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 125.631 1.572 . . . . 0.0 109.772 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.32 107.31 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 75.5 m80 -79.02 103.03 8.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 109.329 162.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -85.39 117.36 24.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.386 1.474 . . . . 0.0 109.343 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.78 102.94 15.64 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.694 0.759 . . . . 0.0 109.39 167.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -104.82 145.32 30.55 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.521 1.928 . . . . 0.0 110.862 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.76 120.79 43.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 163.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -76.65 126.18 30.53 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.73 -1.231 . . . . 0.0 107.691 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -46.58 -76.25 0.14 Allowed Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.291 13.5 pt20 178.34 45.21 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.844 1.657 . . . . 0.0 111.837 149.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -95.31 118.95 66.21 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 120.202 -1.561 . . . . 0.0 110.844 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo . . . . . 0 N--CA 1.434 -2.011 0 C-N-CA 123.141 2.561 . . . . 0.0 111.613 160.699 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 8.3 tp 70.38 172.03 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.625 1.97 . . . . 0.0 113.831 -176.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.441 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.461 19.5 m 46.68 91.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 128.12 2.568 . . . . 0.0 117.023 170.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.5 m -128.88 126.58 40.06 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 42.4 m -62.78 123.36 18.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.868 2.467 . . . . 0.0 109.239 170.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--O 1.26 1.651 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 -172.544 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.43 -1.468 0 CA-C-O 122.39 1.091 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -124.78 150.46 65.75 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 126.632 1.973 . . . . 0.0 106.729 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -67.56 112.02 2.5 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-N 123.829 2.403 . . . . 0.0 116.082 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.08 18.99 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.231 0.919 . . . . 0.0 114.162 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.4 123.19 22.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.207 1.403 . . . . 0.0 111.799 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -96.67 132.97 41.79 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.508 -1.37 . . . . 0.0 111.299 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 111.4 16.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.169 1.388 . . . . 0.0 108.94 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.96 75.0 8.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.344 1.458 . . . . 0.0 110.842 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.42 121.26 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.397 -1.439 . . . . 0.0 114.033 -171.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -100.89 132.41 46.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.758 -1.839 . . . . 0.0 112.192 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.61 178.57 8.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.56 43.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.53 -1.356 . . . . 0.0 109.845 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 146.29 24.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 113.021 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -96.63 85.2 3.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.911 1.338 . . . . 0.0 108.91 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 55.71 72.96 0.45 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.253 1.821 . . . . 0.0 115.015 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.0 50.54 60.96 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.267 1.413 . . . . 0.0 114.324 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 t -169.96 98.08 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -169.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.16 -47.05 30.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.054 1.883 . . . . 0.0 105.956 164.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.11 46.39 0.55 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.114 171.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 pt -118.09 134.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.003 0.921 . . . . 0.0 109.429 166.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -88.99 112.66 23.63 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.574 1.15 . . . . 0.0 109.951 166.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 m -79.23 143.65 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -138.08 171.33 14.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.699 -1.876 . . . . 0.0 109.001 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.98 -133.4 11.78 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 125.011 1.291 . . . . 0.0 112.815 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.36 154.71 29.89 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 123.985 0.803 . . . . 0.0 112.566 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -58.81 -28.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.402 1.481 . . . . 0.0 113.751 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -79.5 -15.36 57.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.814 -1.179 . . . . 0.0 112.276 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 m -91.14 -23.58 20.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.716 -1.24 . . . . 0.0 109.379 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.0 m 74.01 93.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.228 2.611 . . . . 0.0 111.402 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.01 49.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.123 0.969 . . . . 0.0 110.542 -168.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 72.02 -52.24 0.7 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.531 2.333 . . . . 0.0 113.396 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.505 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 38.4 t-80 -114.07 -140.92 0.38 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.241 1.416 . . . . 0.0 107.328 160.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.505 ' H ' ' CG ' ' A' ' 39' ' ' HIS . . . -140.5 43.18 1.14 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.086 -1.634 . . . . 0.0 113.378 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 -175.69 31.11 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 124.0 0.81 . . . . 0.0 111.972 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.281 2.4 tp -111.54 159.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.257 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -139.48 157.45 45.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.9 t -82.33 137.9 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.552 -1.967 . . . . 0.0 110.592 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -100.31 -53.29 3.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.941 -1.1 . . . . 0.0 109.851 165.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.65 48.3 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.939 0.876 . . . . 0.0 111.231 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.1 mm -110.79 133.63 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.465 1.906 . . . . 0.0 109.21 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.71 133.65 76.39 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.762 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.75 95.67 0.24 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 123.543 2.829 . . . . 0.0 114.047 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp 63.23 47.33 4.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 127.743 2.417 . . . . 0.0 116.008 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.24 -70.25 1.33 Allowed Glycine 0 N--CA 1.431 -1.657 0 O-C-N 120.932 -1.105 . . . . 0.0 112.34 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.31 -48.43 0.27 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.659 -0.906 . . . . 0.0 110.86 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.62 -45.11 72.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.936 1.694 . . . . 0.0 115.513 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.62 -33.64 68.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.927 -1.733 . . . . 0.0 111.737 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t -72.7 6.33 2.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.84 -88.55 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.001 -1.687 . . . . 0.0 106.888 149.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.33 -21.78 0.95 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.893 -1.129 . . . . 0.0 112.122 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -85.82 -35.56 20.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 121.365 -1.079 . . . . 0.0 111.145 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 mt -60.4 125.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.524 1.53 . . . . 0.0 113.102 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -177.06 4.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.586 1.154 . . . . 0.0 109.412 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -76.62 89.89 3.35 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.086 -1.634 . . . . 0.0 111.434 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.95 -21.17 0.37 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.707 -1.246 . . . . 0.0 114.964 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -68.2 155.32 39.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 114.71 29.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.711 2.004 . . . . 0.0 109.43 -168.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.27 112.68 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.225 -1.547 . . . . 0.0 108.743 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.61 -31.75 11.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.451 -1.406 . . . . 0.0 112.962 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.76 160.25 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.637 1.108 . . . . 0.0 112.553 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 t -137.2 127.32 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.85 27.02 12.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.027 1.74 . . . . 0.0 114.608 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.1 18.73 79.78 Favored Glycine 0 N--CA 1.43 -1.766 0 O-C-N 120.598 -1.314 . . . . 0.0 113.644 -172.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.35 102.22 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 t -60.76 138.06 58.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -86.19 82.12 8.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -110.09 42.09 1.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.315 2.007 . . . . 0.0 110.308 -170.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.17 55.44 0.18 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.01 141.94 43.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.013 0.911 . . . . 0.0 108.581 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.417 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.8 p -96.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.572 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.04 -54.67 38.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.47 -1.394 . . . . 0.0 111.713 165.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -67.8 -42.9 80.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.417 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.6 tt0 -63.97 -46.49 84.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.8 77.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.91 -53.74 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 121.709 -0.619 . . . . 0.0 111.285 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.41 -30.87 71.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.4 m -60.3 -28.92 68.49 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.465 1.506 . . . . 0.0 112.303 171.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.0 mt -88.34 -47.0 8.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.02 -1.675 . . . . 0.0 113.355 168.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -88.07 -27.88 21.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -162.097 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -86.9 18.98 3.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.627 -1.296 . . . . 0.0 113.217 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.0 p -88.29 170.49 10.94 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.978 2.511 . . . . 0.0 111.396 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.15 -90.13 0.21 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.373 -1.455 . . . . 0.0 115.238 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -129.44 -57.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.531 . . . . 0.0 110.321 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.24 136.82 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 122.041 0.924 . . . . 0.0 111.028 173.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.69 109.66 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 168.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -85.54 102.67 13.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.644 1.178 . . . . 0.0 109.284 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.65 120.03 28.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.769 -1.832 . . . . 0.0 110.439 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.85 97.72 11.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.911 -1.118 . . . . 0.0 108.663 169.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.38 145.8 28.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.466 1.906 . . . . 0.0 110.41 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.62 144.18 46.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.769 1.228 . . . . 0.0 108.971 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.97 120.0 11.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.94 56.72 5.07 Favored Glycine 0 N--CA 1.429 -1.798 0 O-C-N 120.77 -1.206 . . . . 0.0 113.643 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -139.74 158.39 44.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.356 1.862 . . . . 0.0 108.299 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.67 171.39 4.84 Favored Pre-proline 0 N--CA 1.429 -1.475 0 C-N-CA 125.517 1.527 . . . . 0.0 110.433 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 C--N 1.299 -2.034 0 C-N-CA 123.122 2.548 . . . . 0.0 113.645 164.237 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.4 tp 64.78 -157.17 0.3 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.897 2.079 . . . . 0.0 111.871 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.559 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.359 13.5 m 29.27 101.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.781 3.232 . . . . 0.0 119.071 157.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -132.57 123.68 26.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.0 p -75.5 119.93 20.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.692 1.597 . . . . 0.0 110.793 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.566 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.431 -1.399 0 CA-C-O 121.737 0.78 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -119.91 177.53 1.37 Allowed Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 163.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -68.02 94.21 0.4 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 CA-C-N 124.799 2.75 . . . . 0.0 112.186 168.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.87 50.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.607 1.563 . . . . 0.0 108.821 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p -78.33 125.94 30.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -173.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.06 126.12 51.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.385 2.674 . . . . 0.0 109.147 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.24 67.16 1.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.222 1.409 . . . . 0.0 110.83 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.38 112.64 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -165.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 5.5 tt0 -93.1 118.81 31.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.432 -2.043 . . . . 0.0 111.418 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.6 169.65 17.18 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.612 1.165 . . . . 0.0 109.351 175.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.31 150.13 32.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.783 1.633 . . . . 0.0 110.006 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.96 174.2 9.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.163 -0.961 . . . . 0.0 112.101 -170.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.8 t -110.89 103.87 12.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.124 -1.61 . . . . 0.0 107.361 168.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t70 34.42 67.48 0.22 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.523 2.729 . . . . 0.0 117.18 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.36 48.35 45.7 Favored Glycine 0 N--CA 1.429 -1.808 0 O-C-N 119.961 -1.712 . . . . 0.0 115.069 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 m -175.98 111.15 0.1 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.56 -45.56 68.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.153 1.781 . . . . 0.0 108.094 167.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.01 45.13 1.31 Allowed Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.774 1.178 . . . . 0.0 110.799 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -125.8 141.96 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 163.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 m -90.37 126.17 35.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 164.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.47 148.83 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -149.38 167.8 25.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.341 -1.475 . . . . 0.0 108.743 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.19 -138.21 14.21 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.854 -1.154 . . . . 0.0 112.704 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.86 167.57 28.3 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -49.85 -37.45 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.609 1.964 . . . . 0.0 113.3 171.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -55.02 -40.99 70.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.819 2.448 . . . . 0.0 116.289 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -93.71 -6.31 46.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.545 -1.347 . . . . 0.0 110.923 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m 64.62 90.8 0.08 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.288 1.835 . . . . 0.0 112.862 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -93.25 -142.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.029 1.331 . . . . 0.0 107.791 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 ttm-85 -88.77 91.38 8.79 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.627 -1.921 . . . . 0.0 108.46 166.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 66.58 -65.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.188 2.595 . . . . 0.0 115.524 -171.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.34 118.49 0.62 Allowed Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 106.529 -2.628 . . . . 0.0 106.529 -162.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.7 150.24 8.69 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 tp -107.93 156.86 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -131.7 161.09 33.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.4 t -91.87 134.17 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.577 -1.327 . . . . 0.0 109.497 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -85.48 -57.26 3.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.586 172.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.85 129.23 25.76 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 123.919 0.888 . . . . 0.0 110.628 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.0 mm -91.7 122.86 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.698 1.599 . . . . 0.0 109.181 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.2 mt -67.49 133.98 92.9 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.018 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.31 91.45 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 123.314 2.676 . . . . 0.0 112.166 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.268 10.8 mmmm 68.48 78.85 0.22 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.13 2.572 . . . . 0.0 115.203 -173.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.15 -134.16 8.25 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 148.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.655 -1.497 . . . . 0.0 111.468 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.46 -48.19 67.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.503 1.921 . . . . 0.0 115.876 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.32 -30.47 66.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.126 -1.608 . . . . 0.0 112.344 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t -71.34 3.94 3.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.41 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.438 -1.414 . . . . 0.0 109.378 155.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.67 -45.81 0.26 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.174 -0.953 . . . . 0.0 111.551 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -86.54 -39.9 15.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.68 130.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -163.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.528 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 53.0 t60 -127.38 175.17 8.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.543 1.937 . . . . 0.0 110.833 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 51.0 mttp -86.11 40.96 0.9 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.058 1.743 . . . . 0.0 113.558 -169.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.26 38.58 0.09 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.258 -1.526 . . . . 0.0 110.864 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -103.45 158.1 16.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.07 1.348 . . . . 0.0 109.719 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.69 134.07 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 123.79 0.836 . . . . 0.0 109.229 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.12 110.54 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 163.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.75 -27.86 15.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.96 -1.713 . . . . 0.0 112.187 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.21 41.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 111.39 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -137.37 121.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.938 -1.101 . . . . 0.0 110.297 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.373 0.8 OUTLIER 43.02 34.29 0.61 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -173.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.34 60.64 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.284 0.945 . . . . 0.0 114.008 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.83 98.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.629 1.572 . . . . 0.0 107.225 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -62.36 142.52 57.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.854 -1.154 . . . . 0.0 113.352 173.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.9 mt -87.28 30.74 0.76 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.56 -1.337 . . . . 0.0 112.726 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.38 97.43 2.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.489 1.916 . . . . 0.0 109.061 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.16 -3.21 33.28 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.337 0.97 . . . . 0.0 114.986 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.73 140.95 29.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.943 1.872 . . . . 0.0 114.378 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.439 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 80.6 p -101.99 -163.0 0.97 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.503 2.321 . . . . 0.0 109.863 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.01 -53.21 53.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.214 -1.554 . . . . 0.0 111.343 166.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.1 -45.19 82.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.605 -0.684 . . . . 0.0 112.727 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.439 ' HB2' ' H ' ' A' ' 77' ' ' THR . 1.6 mm-40 -61.05 -43.07 99.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.79 -1.194 . . . . 0.0 113.253 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.22 94.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.956 -1.715 . . . . 0.0 115.411 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.43 -48.67 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 121.481 -0.762 . . . . 0.0 111.365 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.05 -36.69 84.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.643 -1.286 . . . . 0.0 114.104 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 m -63.59 -26.56 68.74 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.897 1.679 . . . . 0.0 113.351 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.33 -42.58 11.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.974 -1.704 . . . . 0.0 113.596 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -22.77 23.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.054 -1.654 . . . . 0.0 115.291 -169.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.71 37.51 1.92 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.61 -1.931 . . . . 0.0 111.28 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.5 p -87.76 -171.58 3.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.627 2.371 . . . . 0.0 111.207 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.42 62.54 0.3 Allowed Glycine 0 N--CA 1.431 -1.693 0 O-C-N 120.508 -1.37 . . . . 0.0 112.52 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 72.88 -54.05 0.7 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.301 2.641 . . . . 0.0 114.567 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 t -82.49 132.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 123.071 1.415 . . . . 0.0 109.98 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.76 109.72 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.438 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 8.4 m80 -84.62 102.01 12.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.902 -1.123 . . . . 0.0 108.434 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.5 110.89 21.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.424 -1.422 . . . . 0.0 111.56 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.9 89.31 7.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.398 1.094 . . . . 0.0 108.318 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.9 mt -103.79 148.61 25.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.88 2.472 . . . . 0.0 111.633 -173.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -135.37 140.69 45.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.824 -1.173 . . . . 0.0 109.528 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -82.7 61.8 5.98 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.358 -1.464 . . . . 0.0 113.134 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.2 -88.34 0.15 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.069 -1.644 . . . . 0.0 113.135 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 179.2 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.457 2.303 . . . . 0.0 110.393 163.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.5 m -93.06 165.45 18.5 Favored Pre-proline 0 N--CA 1.43 -1.473 0 C-N-CA 124.696 1.198 . . . . 0.0 111.656 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 N--CA 1.434 -1.998 0 C-N-CA 122.502 2.135 . . . . 0.0 115.762 -179.466 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 47.5 p90 . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 121.705 0.764 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.456 ' CG ' ' H ' ' B' ' 207' ' ' VAL . 3.3 tp -88.4 -156.96 0.4 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.353 1.461 . . . . 0.0 110.161 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.456 ' H ' ' CG ' ' B' ' 206' ' ' LEU 0.52 33.4 m 66.65 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 127.823 2.449 . . . . 0.0 117.543 174.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 99.6 m -152.55 118.45 5.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 91.1 p -78.65 128.62 33.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.403 1.097 . . . . 0.0 109.935 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.261 1.658 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 -156.386 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.1 mmt . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 138.94 33.27 Favored Pre-proline 0 N--CA 1.429 -1.484 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.55 121.01 5.78 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.552 2.168 . . . . 0.0 112.204 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.1 79.55 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 121.438 -0.789 . . . . 0.0 114.3 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.51 129.88 34.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.849 1.26 . . . . 0.0 111.138 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -82.97 124.31 30.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 120.943 -1.098 . . . . 0.0 112.654 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.05 129.38 56.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.5 1.52 . . . . 0.0 107.483 170.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.46 84.44 3.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.929 1.292 . . . . 0.0 108.815 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.8 107.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.215 2.206 . . . . 0.0 111.662 -171.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.27 112.75 24.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.826 -1.796 . . . . 0.0 109.643 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.8 mt -122.94 150.75 42.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.43 110.5 20.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 148.34 37.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.544 1.138 . . . . 0.0 113.709 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -102.33 97.18 7.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.427 -1.421 . . . . 0.0 109.96 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 60.49 50.12 6.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.787 2.035 . . . . 0.0 112.57 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.81 55.69 25.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 120.352 -1.467 . . . . 0.0 113.934 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -165.87 112.33 0.89 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.236 1.493 . . . . 0.0 107.005 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD22 HG21 ' A' ' 92' ' ' VAL . 6.9 mt -67.33 -49.61 63.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.482 1.913 . . . . 0.0 106.258 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.96 39.06 0.66 Allowed Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.562 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.9 132.28 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.673 0.749 . . . . 0.0 109.817 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -77.22 117.4 18.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.443 -0.785 . . . . 0.0 111.742 159.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.36 128.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -130.19 169.69 15.04 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.379 1.471 . . . . 0.0 108.898 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.82 58.87 7.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.472 2.149 . . . . 0.0 118.472 169.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.52 -176.63 34.18 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.34 -1.683 . . . . 0.0 109.604 172.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.43 -29.95 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -68.6 -34.57 76.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.4 p -94.68 14.76 20.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.478 -1.389 . . . . 0.0 113.58 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m 67.82 63.27 0.4 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.216 1.806 . . . . 0.0 114.244 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.8 m -87.52 -133.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 124.339 1.056 . . . . 0.0 111.343 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -82.92 -57.15 3.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.577 -1.952 . . . . 0.0 110.258 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -136.3 -89.66 0.29 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 156.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.54 -131.71 6.88 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 164.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.71 -172.27 34.01 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-O 121.911 0.728 . . . . 0.0 111.904 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -148.05 161.35 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 161.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -135.71 161.24 36.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.528 -1.982 . . . . 0.0 106.739 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -92.44 129.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.031 -1.668 . . . . 0.0 111.643 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.67 -49.31 6.94 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.808 -1.182 . . . . 0.0 111.429 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.47 126.92 28.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.845 -1.159 . . . . 0.0 110.626 -170.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.3 mm -96.07 119.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -84.37 145.66 45.84 Favored Pre-proline 0 N--CA 1.431 -1.407 0 O-C-N 120.841 -1.162 . . . . 0.0 112.735 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.94 77.83 3.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.877 2.385 . . . . 0.0 113.254 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -125.34 -89.43 0.57 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.25 58.54 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.72 0 O-C-N 120.306 -1.496 . . . . 0.0 116.262 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.64 -62.45 1.02 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 153.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.57 -50.96 65.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.715 1.606 . . . . 0.0 114.454 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.96 -34.43 68.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.683 -1.26 . . . . 0.0 111.915 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 t -72.51 -6.33 43.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.54 -75.45 0.15 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.632 -1.918 . . . . 0.0 108.552 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.76 -10.19 12.43 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.399 -0.813 . . . . 0.0 114.238 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 -81.74 -23.74 36.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.78 -0.835 . . . . 0.0 111.395 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.99 139.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.165 1.786 . . . . 0.0 112.868 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -138.32 -167.91 2.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.248 1.023 . . . . 0.0 108.758 166.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -80.78 75.95 7.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.328 -1.483 . . . . 0.0 111.967 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.38 13.3 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.747 -1.221 . . . . 0.0 116.126 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -81.97 158.95 23.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.488 1.644 . . . . 0.0 113.18 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.65 114.17 27.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.236 1.415 . . . . 0.0 110.616 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.96 117.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.383 -1.448 . . . . 0.0 108.075 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -97.21 -39.46 9.26 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.003 -1.061 . . . . 0.0 112.163 173.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.2 166.21 34.12 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.118 1.326 . . . . 0.0 114.279 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.16 122.56 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 110.644 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 49.13 30.77 3.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -167.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.85 27.79 57.97 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 120.503 -1.373 . . . . 0.0 113.813 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.83 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.7 m -60.53 136.76 58.15 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.123 1.369 . . . . 0.0 114.59 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.97 53.11 1.9 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.169 1.788 . . . . 0.0 113.446 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.44 117.95 23.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.654 1.582 . . . . 0.0 108.198 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 9.53 86.51 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 120.87 -1.144 . . . . 0.0 115.727 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.76 140.29 29.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.865 1.317 . . . . 0.0 112.659 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 p -100.6 -164.89 1.15 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.968 1.707 . . . . 0.0 109.222 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -60.17 -57.33 13.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.446 -1.409 . . . . 0.0 112.651 163.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.61 -43.82 95.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 112.968 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -37.04 86.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.759 -1.213 . . . . 0.0 113.471 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.87 89.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.314 -1.491 . . . . 0.0 114.986 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.3 t -57.84 -53.21 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 121.69 -0.631 . . . . 0.0 112.108 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.3 m -64.23 -30.17 71.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.53 2.332 . . . . 0.0 113.294 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.8 mt -88.47 -43.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.99 -1.694 . . . . 0.0 113.771 170.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -48.46 11.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.784 1.634 . . . . 0.0 114.976 -162.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -81.12 18.98 0.96 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.719 1.208 . . . . 0.0 113.723 -169.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.1 p -85.02 177.1 8.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.182 2.593 . . . . 0.0 112.08 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.87 -77.82 0.28 Allowed Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.167 -1.583 . . . . 0.0 115.217 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -154.29 -54.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.982 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.44 128.08 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.846 1.308 . . . . 0.0 111.006 170.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 25' ' ' LEU . 2.7 m -118.42 112.2 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.977 1.711 . . . . 0.0 107.53 166.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -78.85 95.22 5.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.685 -1.259 . . . . 0.0 107.71 164.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 117.3 15.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.791 -1.193 . . . . 0.0 113.063 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.495 ' HB3' ' HG ' ' A' ' 66' ' ' LEU . 7.1 mt -86.04 95.64 9.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.8 mt -104.19 130.64 51.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.902 2.881 . . . . 0.0 111.688 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -105.94 140.24 39.25 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.778 -1.202 . . . . 0.0 110.24 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -70.89 111.35 6.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.111 1.364 . . . . 0.0 113.121 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.82 70.43 2.55 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 120.708 -1.245 . . . . 0.0 113.394 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.97 164.47 28.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.286 -1.126 . . . . 0.0 110.766 -177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.3 t -79.27 140.25 56.59 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 126.737 2.015 . . . . 0.0 112.328 -175.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 N--CA 1.433 -2.078 0 C-N-CA 123.934 3.089 . . . . 0.0 115.116 169.408 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 0.7 OUTLIER -125.01 -121.6 0.26 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.266 1.027 . . . . 0.0 110.831 -176.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.424 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.521 30.1 m 66.46 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 127.571 2.348 . . . . 0.0 116.932 171.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 80.3 m -152.82 125.6 8.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 78.7 p -76.91 126.43 30.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.592 1.157 . . . . 0.0 108.404 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.613 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 -161.575 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.597 ' N ' ' HZ2' ' A' ' 98' ' ' LYS . 63.5 ttp . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -99.03 144.21 27.79 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 124.88 1.272 . . . . 0.0 108.412 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.5 116.52 3.81 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 123.389 2.246 . . . . 0.0 115.494 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.1 36.48 40.52 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 124.062 0.839 . . . . 0.0 114.671 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -76.17 130.52 38.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.892 -1.358 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.48 117.14 31.07 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 120.139 -1.6 . . . . 0.0 112.019 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.312 0.0 OUTLIER -106.62 136.88 45.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.591 1.556 . . . . 0.0 110.075 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -117.64 76.72 1.08 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.068 1.347 . . . . 0.0 108.423 -173.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.68 137.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 126.851 2.06 . . . . 0.0 111.233 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 127.64 53.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.354 2.343 . . . . 0.0 110.093 167.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.5 128.8 49.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.207 1.003 . . . . 0.0 110.156 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.1 90.88 6.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.219 1.009 . . . . 0.0 109.313 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 137.52 58.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -104.05 105.19 15.28 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.82 1.295 . . . . 0.0 109.413 -160.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 54.78 37.33 28.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.198 2.199 . . . . 0.0 114.958 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.62 88.62 0.25 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.794 -1.191 . . . . 0.0 112.371 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.284 51.9 p 149.32 112.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.727 2.411 . . . . 0.0 109.519 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.0 mt -73.28 -43.16 61.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 156.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.94 17.81 3.31 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.545 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.3 pt -105.8 126.22 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 122.013 0.911 . . . . 0.0 111.09 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -79.31 109.68 13.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.06 1.344 . . . . 0.0 111.469 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.64 127.62 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -134.07 178.93 6.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.697 2.399 . . . . 0.0 108.699 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.11 39.94 35.96 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 119.881 -1.762 . . . . 0.0 117.26 168.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.48 -179.88 49.31 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.092 -1.828 . . . . 0.0 113.606 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.81 -8.69 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.288 1.835 . . . . 0.0 114.345 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -65.51 -33.18 75.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.764 -1.835 . . . . 0.0 114.314 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -99.23 -166.7 1.38 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.931 -1.106 . . . . 0.0 108.685 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.8 m -103.25 92.32 4.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.871 -1.768 . . . . 0.0 109.354 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -104.9 179.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -53.97 -64.34 0.86 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -161.28 59.89 0.28 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.684 -1.26 . . . . 0.0 110.009 167.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.16 130.44 4.3 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-O 123.295 1.497 . . . . 0.0 110.728 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 179.04 -169.98 41.54 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 169.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 tp -136.32 156.18 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 155.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -137.12 154.56 50.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -171.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 t -84.08 131.94 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 119.694 -1.879 . . . . 0.0 111.067 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.33 -52.66 5.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 109.956 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.43 140.43 41.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 111.696 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -97.61 127.57 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.503 1.921 . . . . 0.0 106.789 169.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 pt -78.74 157.15 77.17 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 121.194 -0.941 . . . . 0.0 112.092 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.61 84.59 0.62 Allowed 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 121.922 1.748 . . . . 0.0 115.575 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 86.29 82.71 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.506 2.322 . . . . 0.0 112.978 165.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.96 -116.12 3.09 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.57 -37.55 4.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.462 1.105 . . . . 0.0 112.282 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.73 72.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.121 -1.612 . . . . 0.0 113.228 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.68 -26.84 64.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.618 1.567 . . . . 0.0 112.424 165.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -80.93 -9.49 59.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.437 -2.039 . . . . 0.0 115.788 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -76.22 -62.45 1.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.748 2.067 . . . . 0.0 106.049 156.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.62 -9.68 62.45 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 121.499 -0.75 . . . . 0.0 112.935 162.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -74.23 -28.77 61.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 123.66 0.784 . . . . 0.0 109.174 166.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.7 mt -61.71 128.08 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 126.938 2.095 . . . . 0.0 110.716 165.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.616 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 70.9 t60 -127.7 -161.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.109 0.963 . . . . 0.0 109.665 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.616 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 95.1 mttt -92.45 66.27 4.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.555 -2.59 . . . . 0.0 111.12 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.92 53.5 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.45 -0.781 . . . . 0.0 114.911 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -109.83 173.68 6.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.778 1.231 . . . . 0.0 108.898 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -103.89 136.43 43.56 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.034 0.934 . . . . 0.0 110.377 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.63 119.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.41 -34.21 8.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.864 -1.772 . . . . 0.0 113.161 177.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.58 153.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.119 1.327 . . . . 0.0 112.9 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -133.92 111.96 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 112.102 -174.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.74 31.19 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.437 -1.415 . . . . 0.0 113.744 -166.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.42 80.7 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.123 1.344 . . . . 0.0 113.921 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.75 102.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.992 -1.299 . . . . 0.0 107.584 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -65.75 137.1 57.04 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 126.136 1.774 . . . . 0.0 114.359 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.2 mt -86.99 26.39 1.16 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.561 1.544 . . . . 0.0 113.009 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -68.21 118.16 10.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.573 -1.955 . . . . 0.0 110.023 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.28 6.53 86.1 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 120.954 -1.091 . . . . 0.0 115.201 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.37 137.94 32.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 118.945 1.372 . . . . 0.0 111.744 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -113.64 -168.15 1.3 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -54.62 -52.0 63.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.603 -1.936 . . . . 0.0 114.647 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.31 -46.24 74.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.242 -0.912 . . . . 0.0 112.978 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.99 -46.44 90.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.497 1.519 . . . . 0.0 114.809 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.29 -34.63 78.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.371 -1.456 . . . . 0.0 114.404 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.12 -54.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.151 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -55.48 -47.71 75.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.2 m -52.56 -33.16 44.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 126.283 1.833 . . . . 0.0 115.182 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 mt -92.2 -46.7 7.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.176 1.79 . . . . 0.0 115.449 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -37.05 55.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.592 2.357 . . . . 0.0 114.586 -172.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.54 30.49 0.71 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.157 -1.59 . . . . 0.0 112.363 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.6 p -106.19 176.78 5.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.761 2.424 . . . . 0.0 109.361 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.42 -74.63 1.28 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 119.444 -2.035 . . . . 0.0 113.954 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -139.91 -66.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.966 -1.314 . . . . 0.0 110.068 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.59 115.35 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.17 1.462 . . . . 0.0 110.605 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.74 103.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.23 97.77 8.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.594 1.158 . . . . 0.0 109.133 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.29 114.01 22.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.829 1.652 . . . . 0.0 108.993 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 103.85 16.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mt -108.97 142.84 39.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.317 1.847 . . . . 0.0 110.408 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -114.04 129.45 56.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.564 1.146 . . . . 0.0 108.034 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.597 ' HZ2' ' N ' ' A' ' 8' ' ' MET . 17.3 tptm -71.76 122.81 21.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.539 1.936 . . . . 0.0 113.264 -171.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.94 66.88 3.04 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 117.196 1.638 . . . . 0.0 117.196 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -127.88 154.3 45.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.261 1.424 . . . . 0.0 109.278 166.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.12 144.4 28.56 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.117 1.367 . . . . 0.0 110.28 -172.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo . . . . . 0 N--CA 1.434 -1.992 0 C-N-CA 122.346 2.031 . . . . 0.0 114.903 171.854 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 123.081 1.42 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.72 -156.06 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.389 2.7 t 66.86 91.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 124.943 2.306 . . . . 0.0 113.016 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 90.4 m -136.61 128.62 29.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.193 -2.891 . . . . 0.0 103.193 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.7 m -72.89 120.03 17.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' LEU . 2.9 m . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 17.0 ptm . . . . . 0 N--CA 1.431 -1.384 0 CA-C-O 122.307 1.051 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.59 159.01 72.93 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.271 -1.518 . . . . 0.0 109.845 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 147.12 25.65 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.478 2.118 . . . . 0.0 111.694 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.31 61.53 2.78 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 124.566 1.079 . . . . 0.0 113.496 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -142.42 99.28 3.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.881 1.273 . . . . 0.0 108.198 -169.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -84.01 132.32 34.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.558 -1.339 . . . . 0.0 111.93 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.72 126.57 54.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.8 1.64 . . . . 0.0 107.739 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -99.69 85.39 3.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.979 1.371 . . . . 0.0 108.312 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -81.1 115.52 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.668 1.987 . . . . 0.0 111.594 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 118.53 36.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.289 -2.132 . . . . 0.0 110.761 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.4 mt -126.02 -178.86 4.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.557 1.143 . . . . 0.0 108.973 -170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.43 126.86 30.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 162.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.57 53.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.9 -1.125 . . . . 0.0 112.755 -174.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 t -97.23 92.8 6.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.439 1.59 . . . . 0.0 109.543 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.38 25.82 12.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.004 1.722 . . . . 0.0 114.31 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.3 65.46 1.32 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 124.677 1.132 . . . . 0.0 112.662 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.3 t 179.33 113.94 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.3 mt -78.58 -36.26 44.64 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.357 2.027 . . . . 0.0 106.466 162.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.82 43.93 2.02 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 173.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -128.3 133.64 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.5 m -89.34 108.03 19.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.683 1.593 . . . . 0.0 111.736 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 m -77.89 137.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -171.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 t -133.07 166.32 22.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.316 -1.49 . . . . 0.0 110.37 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.49 -130.86 10.27 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 125.106 1.336 . . . . 0.0 112.645 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.52 160.68 30.35 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.529 1.061 . . . . 0.0 112.049 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.87 11.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.808 -1.995 . . . . 0.0 115.729 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.08 -39.37 75.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.312 -1.492 . . . . 0.0 111.367 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.2 p -99.55 -155.53 0.51 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.883 1.273 . . . . 0.0 110.101 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -119.06 81.99 1.79 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.008 -1.683 . . . . 0.0 108.069 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.03 81.61 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 123.757 1.741 . . . . 0.0 110.305 -167.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 67.41 -109.4 0.12 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.788 1.635 . . . . 0.0 109.267 -168.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -146.83 52.24 1.1 Allowed 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.58 -1.325 . . . . 0.0 111.264 160.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.37 122.82 4.45 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-O 122.845 1.247 . . . . 0.0 114.921 166.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.11 177.24 36.69 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 105.936 -2.865 . . . . 0.0 105.936 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.34 154.94 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 119.489 1.645 . . . . 0.0 106.936 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -138.79 148.75 44.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.315 -2.116 . . . . 0.0 105.853 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.9 t -73.39 127.56 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 120.622 -1.299 . . . . 0.0 111.505 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -88.23 -66.05 0.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.725 -1.235 . . . . 0.0 108.722 166.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 133.53 53.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.527 1.131 . . . . 0.0 111.711 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.0 mm -93.44 137.1 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 54.5 mt -78.59 143.09 62.74 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.525 -1.703 . . . . 0.0 110.726 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.4 94.66 0.17 Allowed 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.486 2.79 . . . . 0.0 112.946 166.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.325 48.9 mtmt 43.84 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.446 2.698 . . . . 0.0 117.346 -169.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.22 -136.18 9.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 151.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.52 -44.69 18.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.255 -1.733 . . . . 0.0 113.732 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 120.786 1.63 . . . . 0.0 113.314 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 p -55.18 -27.28 44.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.17 -73.8 0.06 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.872 1.269 . . . . 0.0 111.173 170.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.44 -9.92 14.8 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 121.667 -0.646 . . . . 0.0 112.95 164.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -79.17 -27.69 42.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.135 -1.215 . . . . 0.0 110.557 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.98 146.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.549 1.939 . . . . 0.0 114.434 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -148.58 -171.59 3.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.833 -1.167 . . . . 0.0 109.317 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -78.12 93.74 4.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.902 -2.373 . . . . 0.0 112.569 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.38 -19.24 0.26 Allowed Glycine 0 N--CA 1.429 -1.782 0 O-C-N 121.023 -1.048 . . . . 0.0 114.467 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -70.05 153.43 43.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -172.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -105.51 121.3 43.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.407 1.575 . . . . 0.0 111.325 -172.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.22 109.48 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.418 2.687 . . . . 0.0 106.232 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.09 -37.07 9.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.192 -0.943 . . . . 0.0 112.488 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.93 166.5 33.35 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.979 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.54 123.57 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 121.311 -0.868 . . . . 0.0 113.023 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.24 30.89 3.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.82 22.4 66.45 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.608 -1.308 . . . . 0.0 114.329 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.81 98.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -67.0 137.59 56.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 125.106 1.362 . . . . 0.0 112.554 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -75.63 61.16 1.32 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.069 1.748 . . . . 0.0 113.679 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.1 110.18 5.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.192 1.397 . . . . 0.0 111.56 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.65 30.53 78.18 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.717 1.151 . . . . 0.0 115.6 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.54 140.45 29.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.762 1.281 . . . . 0.0 112.821 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.5 p -97.96 -157.44 0.6 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.698 1.999 . . . . 0.0 109.934 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.421 -2.049 . . . . 0.0 109.754 168.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -53.21 55.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.327 1.051 . . . . 0.0 111.645 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.07 -26.9 64.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.07 78.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.481 -2.012 . . . . 0.0 113.644 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.88 -52.56 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.16 -0.963 . . . . 0.0 110.184 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 62.1 mt-10 -54.02 -41.19 67.73 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.5 m -57.25 -39.31 75.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.905 2.082 . . . . 0.0 114.452 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mt -92.21 -28.4 17.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.842 1.257 . . . . 0.0 113.252 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.405 ' HG3' ' HA ' ' A' ' 83' ' ' GLU . 4.4 ppt_? -86.6 -47.98 8.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.02 43.98 1.17 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.667 1.699 . . . . 0.0 110.473 -171.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.8 p -95.94 -152.8 0.38 Allowed 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.103 2.961 . . . . 0.0 109.609 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.14 -137.42 9.56 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.144 -1.598 . . . . 0.0 110.43 172.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -92.9 -51.48 5.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.522 1.129 . . . . 0.0 109.055 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.76 132.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.976 1.37 . . . . 0.0 110.139 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -124.01 111.76 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.66 103.55 10.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.126 1.371 . . . . 0.0 107.772 160.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -83.27 108.77 16.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.716 2.007 . . . . 0.0 108.284 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.7 102.57 11.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 110.722 169.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -109.6 147.97 32.1 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.392 2.277 . . . . 0.0 110.228 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.88 152.21 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.172 1.789 . . . . 0.0 106.425 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.64 141.53 46.51 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.87 -6.36 85.29 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 125.975 1.75 . . . . 0.0 113.243 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -80.14 65.52 5.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.805 1.642 . . . . 0.0 110.381 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.91 164.12 49.87 Favored Pre-proline 0 N--CA 1.431 -1.422 0 C-N-CA 126.678 1.991 . . . . 0.0 113.001 -172.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo . . . . . 0 C--N 1.3 -1.984 0 CA-C-N 121.782 1.672 . . . . 0.0 115.586 -173.342 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 43.1 t80 . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.442 0.639 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.0 tp -138.89 -162.13 1.28 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.104 0.962 . . . . 0.0 109.331 -172.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.548 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.394 10.9 m 31.71 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 130.308 3.443 . . . . 0.0 118.213 164.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 82.2 m -119.47 124.15 45.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 36.9 t -67.98 112.43 4.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.519 1.128 . . . . 0.0 108.562 164.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 25' ' ' LEU . 13.1 p . . . . . 0 C--O 1.26 1.624 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 -167.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 121.074 0.464 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -101.92 139.02 19.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 CA-C-O 116.968 -1.491 . . . . 0.0 107.479 166.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -58.57 115.55 2.62 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 123.472 2.276 . . . . 0.0 116.835 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.36 2.49 6.39 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.214 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -89.63 109.72 20.66 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 120.079 1.94 . . . . 0.0 110.121 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -96.69 155.81 16.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 111.575 172.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -133.87 133.43 41.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -111.4 76.03 0.95 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.967 1.307 . . . . 0.0 108.939 -177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.72 118.91 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 125.712 1.605 . . . . 0.0 114.543 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.268 6.3 pm0 -99.68 126.39 45.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.466 -2.021 . . . . 0.0 111.977 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 169.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.62 148.17 33.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.697 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 146.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 111.005 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -94.45 93.07 7.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.528 -1.357 . . . . 0.0 108.244 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 45.81 67.72 0.7 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.257 2.623 . . . . 0.0 115.861 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.82 42.7 77.97 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 121.507 -0.746 . . . . 0.0 113.862 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 p -167.89 106.18 0.51 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.848 1.785 . . . . 0.0 108.49 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' B' ' 210' ' ' VAL . 11.6 mt -71.13 -47.23 59.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 162.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 27.77 1.67 Allowed Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.186 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 pt -109.13 122.93 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 122.998 1.38 . . . . 0.0 109.541 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -84.51 110.54 18.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.176 1.39 . . . . 0.0 109.209 171.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -80.9 138.43 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -133.51 171.63 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.017 1.727 . . . . 0.0 108.281 169.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.42 -143.73 18.05 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 124.985 1.279 . . . . 0.0 113.163 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.6 159.39 28.82 Favored Glycine 0 N--CA 1.431 -1.661 0 O-C-N 121.562 -0.963 . . . . 0.0 111.808 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.33 -32.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.052 1.741 . . . . 0.0 114.503 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.59 -11.43 42.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.492 -1.38 . . . . 0.0 113.253 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 m -88.82 -96.24 0.1 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.93 -1.106 . . . . 0.0 110.01 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 t -159.82 80.81 0.72 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.74 -1.85 . . . . 0.0 109.528 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.38 -167.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.807 -1.183 . . . . 0.0 108.834 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -72.92 -69.06 0.44 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.005 1.322 . . . . 0.0 110.875 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.03 -1.64 0.24 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.276 -1.515 . . . . 0.0 114.289 165.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.51 117.52 0.48 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.555 -1.966 . . . . 0.0 109.667 -175.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.05 145.44 4.3 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 tp -102.88 158.8 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 167.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -133.94 158.73 42.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.576 -1.952 . . . . 0.0 105.914 -171.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 t -89.7 134.49 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.578 -1.951 . . . . 0.0 109.873 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -39.16 10.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.356 -1.465 . . . . 0.0 110.923 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.67 20.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.555 -0.716 . . . . 0.0 111.265 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.9 mm -99.01 135.02 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.6 1.96 . . . . 0.0 107.3 171.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt -100.71 147.47 33.69 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.6 73.08 6.19 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 123.101 2.534 . . . . 0.0 113.189 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -110.17 -85.91 0.54 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.065 -1.022 . . . . 0.0 111.732 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.53 38.66 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.311 -1.493 . . . . 0.0 114.236 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.23 -75.66 0.52 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.69 82.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.141 -1.599 . . . . 0.0 115.114 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.36 -29.77 70.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.496 -1.378 . . . . 0.0 111.583 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.35 -0.86 15.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 115.405 1.632 . . . . 0.0 115.405 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.73 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 108.447 158.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.57 -1.54 15.81 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 113.353 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -95.05 -31.9 13.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.023 -1.281 . . . . 0.0 110.237 169.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.36 139.54 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.131 -1.605 . . . . 0.0 114.594 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -127.54 177.47 6.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.982 0.896 . . . . 0.0 109.213 160.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.63 50.78 0.44 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.25 -1.53 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.154 -2.216 . . . . 0.0 115.666 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -76.01 161.73 28.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 118.567 1.183 . . . . 0.0 114.175 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -96.0 131.9 41.9 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.736 1.214 . . . . 0.0 109.869 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.48 115.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 168.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.35 -35.83 12.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.196 -1.565 . . . . 0.0 111.915 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.98 156.8 41.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.009 0.822 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.16 119.94 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 121.007 -1.058 . . . . 0.0 109.948 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.74 28.12 16.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.119 -1.613 . . . . 0.0 114.186 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.7 90.41 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 125.035 1.302 . . . . 0.0 113.486 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.6 t -97.33 104.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.155 -1.203 . . . . 0.0 109.163 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -53.4 137.17 36.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.357 2.263 . . . . 0.0 115.697 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.24 25.55 1.6 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.736 -1.227 . . . . 0.0 112.584 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.7 111.57 11.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.011 -1.68 . . . . 0.0 110.574 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.45 -1.67 72.92 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.777 -0.577 . . . . 0.0 113.039 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.22 138.66 31.4 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.552 1.644 . . . . 0.0 111.59 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.471 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 3.8 t -117.57 -171.7 2.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.677 2.391 . . . . 0.0 104.836 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -48.96 -52.65 23.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.844 1.658 . . . . 0.0 114.856 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.42 -47.74 59.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.755 1.161 . . . . 0.0 113.188 -175.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.471 ' HB2' ' H ' ' A' ' 77' ' ' THR . 5.1 mm100 -50.67 -49.35 57.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.554 1.542 . . . . 0.0 114.474 168.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.61 84.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.436 -1.415 . . . . 0.0 114.5 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.1 t -62.53 -48.19 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 111.512 175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -58.14 -39.0 77.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.212 -1.555 . . . . 0.0 113.592 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.5 m -64.56 -26.81 68.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.518 2.327 . . . . 0.0 113.715 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.46 -47.02 7.67 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.349 1.459 . . . . 0.0 114.087 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.269 0.1 OUTLIER -79.62 -35.09 39.98 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.361 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.75 40.31 1.03 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.436 -2.04 . . . . 0.0 111.61 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.1 p -101.2 159.07 15.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.75 2.42 . . . . 0.0 111.663 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.09 65.09 4.17 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 121.165 -0.959 . . . . 0.0 112.103 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 67.46 -48.09 0.5 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 129.319 3.048 . . . . 0.0 116.133 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.2 t -80.5 131.66 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.775 1.274 . . . . 0.0 110.874 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -117.73 109.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -88.4 101.15 13.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.935 -1.103 . . . . 0.0 109.153 171.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.2 mt -90.37 122.62 33.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.864 -1.148 . . . . 0.0 111.627 -173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.07 102.95 14.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.7 mt -112.47 142.52 44.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.507 1.923 . . . . 0.0 110.583 -171.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.65 142.09 50.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.207 2.203 . . . . 0.0 108.512 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -67.79 127.12 31.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.4 69.69 1.5 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.154 1.359 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -130.42 166.21 20.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.944 1.298 . . . . 0.0 110.164 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.24 160.41 42.77 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.362 1.465 . . . . 0.0 110.479 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 N--CA 1.434 -2.006 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 176.798 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 10.5 tp 77.15 173.43 0.21 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.288 2.635 . . . . 0.0 114.2 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.406 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.491 5.9 m 52.82 100.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.103 2.961 . . . . 0.0 117.827 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 53.5 m -130.62 118.93 21.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 76.2 p -77.67 122.83 25.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.575 1.15 . . . . 0.0 109.244 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.633 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -175.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 121.764 0.793 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -138.2 147.45 55.9 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 175.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.71 105.23 1.27 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.66 2.343 . . . . 0.0 116.19 -168.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.47 39.81 97.82 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 124.762 1.172 . . . . 0.0 113.739 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.01 135.75 44.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.146 0.978 . . . . 0.0 111.727 -172.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -89.52 120.68 31.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.37 1.081 . . . . 0.0 111.23 174.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 114.74 26.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 174.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -92.29 83.45 5.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.24 153.39 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 127.761 2.425 . . . . 0.0 110.339 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.52 50.96 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.513 -1.992 . . . . 0.0 108.321 167.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.8 mt -128.75 161.72 29.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 123.998 0.919 . . . . 0.0 109.689 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.74 117.13 26.67 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.032 0.92 . . . . 0.0 108.863 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 1.2 ptmm? -62.84 126.25 26.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.051 1.74 . . . . 0.0 113.087 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 23' ' ' GLY . 12.6 t -96.48 118.27 32.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.989 -1.069 . . . . 0.0 108.709 -171.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.34 -19.93 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.29 2.236 . . . . 0.0 117.006 -171.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 21' ' ' THR . . . 128.75 53.26 0.11 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.971 1.748 . . . . 0.0 110.682 178.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 m -177.81 126.87 0.13 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 -173.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.2 mt -84.02 -39.4 19.68 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.393 2.277 . . . . 0.0 106.724 172.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.97 6.17 3.28 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 124.298 0.951 . . . . 0.0 113.22 170.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 pt -102.0 127.55 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 122.428 1.108 . . . . 0.0 111.13 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -81.49 109.8 16.29 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.075 1.35 . . . . 0.0 112.102 168.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.91 125.95 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -172.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.5 t -120.22 160.84 22.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.938 2.095 . . . . 0.0 110.843 175.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.08 -125.14 8.24 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.668 1.604 . . . . 0.0 112.441 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.15 140.72 11.43 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 177.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 m -56.5 -27.56 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.898 1.279 . . . . 0.0 114.28 -167.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -47.22 -55.34 8.76 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 128.064 2.545 . . . . 0.0 116.275 -167.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 p -140.96 -77.75 0.29 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -41.82 -46.75 4.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.575 3.15 . . . . 0.0 117.648 -171.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.31 -6.9 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 O-C-N 119.934 -1.729 . . . . 0.0 112.854 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 61.34 52.75 3.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.031 2.132 . . . . 0.0 112.751 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.367 17.9 m-70 59.51 132.46 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.395 2.278 . . . . 0.0 116.174 -164.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.23 -107.09 0.21 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.976 -2.328 . . . . 0.0 113.776 -162.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.92 -157.03 13.65 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 107.354 -2.298 . . . . 0.0 107.354 -177.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.287 2.3 tp -114.61 157.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.043 1.421 . . . . 0.0 108.701 175.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -140.6 157.25 45.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.892 -1.755 . . . . 0.0 106.614 -171.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.2 t -88.73 127.37 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.305 -1.497 . . . . 0.0 112.2 174.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -83.27 -50.42 8.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.656 -1.277 . . . . 0.0 109.907 171.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.06 138.87 37.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -174.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.03 145.58 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.121 1.768 . . . . 0.0 107.184 171.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.05 138.97 20.69 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 110.776 169.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.3 67.31 8.63 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.491 2.127 . . . . 0.0 110.895 171.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.16 73.63 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.866 2.066 . . . . 0.0 110.098 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 177.04 164.98 31.7 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 118.628 -2.545 . . . . 0.0 109.453 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.14 84.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.746 2.019 . . . . 0.0 114.475 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.13 72.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.322 -1.486 . . . . 0.0 113.916 -177.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.74 -32.99 72.26 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.274 1.43 . . . . 0.0 112.195 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -61.62 -28.54 69.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.32 -75.04 0.05 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.932 1.242 . . . . 0.0 111.797 176.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.16 -30.71 2.42 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 112.1 168.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -86.58 -20.97 27.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 113.644 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -71.75 133.89 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.159 1.784 . . . . 0.0 112.073 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -150.33 -159.75 1.08 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.638 -1.288 . . . . 0.0 110.557 165.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.76 129.03 36.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.215 -1.553 . . . . 0.0 112.1 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.75 23.24 56.42 Favored Glycine 0 N--CA 1.428 -1.839 0 O-C-N 120.151 -1.593 . . . . 0.0 114.965 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.85 148.14 22.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.289 -1.124 . . . . 0.0 109.821 168.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -90.99 129.8 36.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.04 -1.038 . . . . 0.0 109.976 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 p -104.19 119.91 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.87 -31.57 11.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.754 -1.216 . . . . 0.0 112.852 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.2 43.48 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 119.04 0.836 . . . . 0.0 112.418 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.49 120.86 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 121.189 -0.945 . . . . 0.0 111.027 -177.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 54.94 29.79 12.82 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.412 1.485 . . . . 0.0 114.44 -170.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.77 22.36 77.15 Favored Glycine 0 N--CA 1.431 -1.659 0 O-C-N 121.037 -1.039 . . . . 0.0 114.117 -173.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.48 101.94 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.619 1.567 . . . . 0.0 107.86 177.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -66.19 143.49 57.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.843 -1.16 . . . . 0.0 113.915 177.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.39 62.0 3.61 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.902 1.681 . . . . 0.0 112.783 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.33 123.33 37.67 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.837 1.655 . . . . 0.0 108.539 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.5 -7.6 57.11 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.626 -1.296 . . . . 0.0 114.487 -171.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.93 129.26 34.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.128 1.918 . . . . 0.0 114.755 -169.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.478 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.1 p -96.17 -163.48 1.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.471 1.909 . . . . 0.0 108.415 -175.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.4 -51.66 66.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.986 -1.696 . . . . 0.0 112.374 163.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.61 -42.19 87.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.122 -0.986 . . . . 0.0 112.723 -177.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.478 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.9 tt0 -69.84 -34.32 73.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.43 75.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.217 -2.177 . . . . 0.0 114.097 171.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.59 -53.01 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.429 -0.794 . . . . 0.0 110.832 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.13 -41.36 62.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.418 1.463 . . . . 0.0 114.837 175.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.7 m -62.41 -29.95 70.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.65 2.38 . . . . 0.0 114.542 178.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.47 -40.95 9.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -50.55 15.06 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.534 2.334 . . . . 0.0 112.73 -171.262 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -91.44 42.55 1.11 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.977 1.37 . . . . 0.0 110.622 -168.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.1 p -102.44 164.7 11.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.51 2.324 . . . . 0.0 111.341 -174.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.04 58.23 4.77 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.759 -1.213 . . . . 0.0 113.125 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 71.16 -48.23 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.945 2.898 . . . . 0.0 116.858 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.49 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.596 1.188 . . . . 0.0 109.478 171.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -117.63 99.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -78.92 105.89 10.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.807 -1.183 . . . . 0.0 107.964 166.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -88.89 125.49 34.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.187 -1.571 . . . . 0.0 110.544 -177.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.42 102.09 14.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 108.567 166.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.32 148.29 24.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.2 1.8 . . . . 0.0 111.713 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -116.37 138.75 51.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 162.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -67.86 126.1 28.38 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.618 0.767 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -21.57 76.0 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 124.883 1.23 . . . . 0.0 114.497 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -84.32 104.89 14.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.149 1.78 . . . . 0.0 109.641 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.2 105.12 49.45 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 121.258 -0.901 . . . . 0.0 111.637 -173.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--N 1.299 -2.042 0 N-CA-C 118.04 2.284 . . . . 0.0 118.04 162.98 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 20.2 tp -86.82 157.55 19.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.301 -1.499 . . . . 0.0 111.087 172.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.41 2.2 t 78.92 122.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.077 1.894 . . . . 0.0 114.565 166.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.1 m -147.21 125.11 11.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 176.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.7 p -75.52 128.99 36.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.013 0.925 . . . . 0.0 109.61 169.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.3 p . . . . . 0 C--O 1.259 1.588 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -162.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -87.09 156.43 54.72 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 120.042 -1.661 . . . . 0.0 110.692 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -58.3 129.73 34.25 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 120.045 3.056 . . . . 0.0 120.045 -155.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.73 12.65 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 125.733 1.635 . . . . 0.0 112.727 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.55 16.39 0.65 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.493 3.516 . . . . 0.0 120.493 -160.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.17 114.59 7.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 156.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.66 113.69 14.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.75 71.55 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.867 1.317 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.95 121.58 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.702 2.401 . . . . 0.0 111.721 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -105.24 115.34 30.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.423 -2.048 . . . . 0.0 109.398 -174.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -115.83 146.4 42.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.836 0.827 . . . . 0.0 110.003 -171.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.81 109.58 21.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 165.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' HB2' ' H ' ' A' ' 24' ' ' SER . 8.9 ptpt -53.7 151.99 5.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.842 2.057 . . . . 0.0 112.77 175.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -110.12 104.74 13.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 56.73 5.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.133 2.173 . . . . 0.0 116.086 -175.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.62 61.2 5.19 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 120.49 -1.381 . . . . 0.0 115.897 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 37.6 t 175.08 112.64 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.792 1.637 . . . . 0.0 106.77 -173.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.42 -41.93 45.93 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 126.233 1.813 . . . . 0.0 107.388 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.45 33.76 1.28 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.034 171.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.19 133.74 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 121.845 -0.797 . . . . 0.0 111.062 175.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -82.95 113.13 20.34 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.245 1.018 . . . . 0.0 111.088 164.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 HG23 ' CE1' ' A' ' 78' ' ' HIS . 21.0 m -85.26 128.98 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -124.11 167.15 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.448 1.899 . . . . 0.0 110.865 176.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 -137.65 15.6 Favored Glycine 0 N--CA 1.428 -1.846 0 C-N-CA 125.103 1.335 . . . . 0.0 112.915 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.11 161.88 21.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 124.433 1.015 . . . . 0.0 111.293 177.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 t -56.05 -32.7 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -70.48 -27.84 64.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -171.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 p -103.95 3.37 33.49 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.454 -1.404 . . . . 0.0 112.433 -175.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t 68.11 84.68 0.15 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.011 1.725 . . . . 0.0 113.094 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.04 -159.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.848 1.659 . . . . 0.0 110.014 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -56.29 -66.93 0.35 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.1 -1.625 . . . . 0.0 112.852 175.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -167.07 116.75 0.86 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 156.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.36 105.59 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.415 2.126 . . . . 0.0 118.415 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -167.96 21.34 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.513 -0.993 . . . . 0.0 113.491 162.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.7 tp -116.59 164.39 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.189 0.995 . . . . 0.0 110.093 -166.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -140.72 156.75 46.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.028 -1.67 . . . . 0.0 106.786 -172.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.37 119.87 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.644 -1.285 . . . . 0.0 111.782 177.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -83.71 -40.49 18.81 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.732 -1.23 . . . . 0.0 111.065 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.42 131.8 17.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.964 0.905 . . . . 0.0 109.988 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -97.33 120.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.9 pt -77.56 152.46 80.88 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 121.163 -0.961 . . . . 0.0 113.018 -175.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.77 92.54 0.96 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 122.159 1.906 . . . . 0.0 113.243 -177.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.308 46.7 mtpt 92.64 88.33 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 127.129 2.172 . . . . 0.0 110.641 169.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.41 -172.96 20.8 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 103.284 -3.926 . . . . 0.0 103.284 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.72 82.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.24 -40.53 67.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.81 -28.7 69.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.469 -1.394 . . . . 0.0 111.796 168.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.7 t -73.33 -12.9 60.99 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.92 -85.03 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.923 2.147 . . . . 0.0 110.403 176.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.82 -30.22 0.82 Allowed Glycine 0 N--CA 1.431 -1.697 0 O-C-N 120.622 -1.299 . . . . 0.0 111.469 172.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -83.87 -43.08 15.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.55 -0.971 . . . . 0.0 111.287 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 134.83 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 124.765 1.226 . . . . 0.0 114.046 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -133.5 -172.69 3.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 164.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -84.52 122.3 28.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.308 -2.12 . . . . 0.0 112.084 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.71 -30.71 2.73 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 112.395 -169.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -73.12 162.88 28.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.279 1.514 . . . . 0.0 113.768 -172.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -105.01 129.9 53.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.98 0.912 . . . . 0.0 109.884 -173.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.34 114.72 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.12 1.438 . . . . 0.0 107.984 167.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.41 -32.02 11.71 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 120.231 -1.543 . . . . 0.0 113.176 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.14 159.32 43.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.611 1.096 . . . . 0.0 111.867 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.0 126.2 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 110.415 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 m120 58.59 22.14 9.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.919 1.691 . . . . 0.0 114.828 -174.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.69 -2.72 80.61 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.629 1.109 . . . . 0.0 114.267 -172.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.81 103.01 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.115 1.366 . . . . 0.0 108.53 -172.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -62.77 141.39 58.62 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.599 1.56 . . . . 0.0 113.18 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.56 72.46 7.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.475 1.131 . . . . 0.0 111.098 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -91.65 111.18 22.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.769 1.228 . . . . 0.0 108.621 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.3 -3.86 85.15 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.988 -1.07 . . . . 0.0 115.349 -176.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.41 133.35 38.69 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 123.942 1.83 . . . . 0.0 114.745 -172.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.434 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 80.0 p -99.53 -155.82 0.52 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.558 2.343 . . . . 0.0 109.881 -169.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.519 ' CE1' HG23 ' A' ' 29' ' ' VAL . 85.2 t60 -72.4 -50.47 26.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.612 -1.93 . . . . 0.0 111.19 168.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -42.82 80.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.434 ' HB3' ' H ' ' A' ' 77' ' ' THR . 17.8 tt0 -65.68 -35.87 82.01 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.12 -1.612 . . . . 0.0 113.902 174.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.78 96.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.671 -1.893 . . . . 0.0 115.05 172.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.03 -56.39 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 123.594 0.757 . . . . 0.0 110.406 172.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -51.28 -46.49 62.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.06 1.344 . . . . 0.0 113.602 177.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 m -59.58 -30.39 68.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.384 1.874 . . . . 0.0 114.422 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.6 mt -89.34 -38.65 14.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.161 -1.587 . . . . 0.0 113.366 173.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.44 39.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.575 2.35 . . . . 0.0 114.863 -172.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 15.13 0.58 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.5 p -91.68 158.86 16.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.287 2.635 . . . . 0.0 111.013 -169.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.55 -61.67 3.08 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 121.414 -0.804 . . . . 0.0 114.286 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.52 -64.84 0.18 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.236 -1.155 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.09 129.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.153 1.454 . . . . 0.0 111.541 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -115.58 105.3 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.834 1.654 . . . . 0.0 107.749 172.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -78.74 106.17 10.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.572 -1.33 . . . . 0.0 109.284 169.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mt -87.41 110.37 20.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.067 1.747 . . . . 0.0 108.677 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.9 101.86 13.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 172.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.89 143.26 34.28 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 -175.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.16 143.16 45.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.888 2.075 . . . . 0.0 106.226 171.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -78.54 129.48 34.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 123.564 0.746 . . . . 0.0 110.892 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.96 -74.13 0.55 Allowed Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 123.628 0.633 . . . . 0.0 113.811 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -159.38 8.6 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.12 118.39 62.68 Favored Pre-proline 0 N--CA 1.431 -1.406 0 O-C-N 119.953 -1.717 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 C--N 1.3 -2.018 0 CA-C-N 124.784 2.744 . . . . 0.0 115.419 -176.982 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp 74.73 -175.68 0.14 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.648 2.379 . . . . 0.0 112.618 -178.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.419 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.412 5.7 m 45.23 92.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 162.925 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -128.34 125.05 37.93 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 -171.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.3 m -74.23 123.84 25.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.293 1.837 . . . . 0.0 108.575 177.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.657 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -163.15 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 121.209 0.528 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.09 160.94 29.18 Favored Pre-proline 0 N--CA 1.43 -1.454 0 O-C-N 120.92 -1.112 . . . . 0.0 110.39 -175.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -66.28 132.79 30.6 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 122.333 2.022 . . . . 0.0 113.607 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.46 -32.0 4.84 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 123.712 0.672 . . . . 0.0 113.638 174.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.42 132.13 41.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -104.13 143.84 32.38 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.1 1.36 . . . . 0.0 107.408 157.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -125.22 120.94 32.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.52 74.83 1.91 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.893 1.277 . . . . 0.0 107.734 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.99 151.23 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.302 2.241 . . . . 0.0 109.355 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -128.27 128.68 45.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.435 -2.041 . . . . 0.0 111.165 168.266 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -126.0 141.16 52.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 124.553 1.141 . . . . 0.0 109.058 -171.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.66 111.47 23.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.65 124.06 18.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.45 1.1 . . . . 0.0 111.7 -177.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -94.37 108.58 20.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.92 1.343 . . . . 0.0 108.982 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 60.23 34.86 20.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.823 2.049 . . . . 0.0 114.686 -179.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.46 60.57 2.47 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.742 -1.224 . . . . 0.0 114.367 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m 172.34 120.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.868 2.067 . . . . 0.0 105.574 -175.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.85 -41.44 78.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.217 1.484 . . . . 0.0 107.966 161.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.11 22.95 3.08 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.471 170.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.7 pt -111.39 130.24 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.213 -1.169 . . . . 0.0 111.224 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -79.67 112.53 17.03 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.201 1.0 . . . . 0.0 110.576 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 m -84.15 131.15 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -123.11 166.73 14.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.618 -1.927 . . . . 0.0 109.824 176.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.69 -150.83 31.61 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.787 1.185 . . . . 0.0 113.857 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.49 166.05 16.16 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 125.49 1.519 . . . . 0.0 110.556 -177.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -66.78 -6.55 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -72.49 -39.88 67.32 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.211 -1.555 . . . . 0.0 112.674 171.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.5 p -109.96 174.19 5.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.337 -1.477 . . . . 0.0 110.858 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.4 m -80.65 90.52 5.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.492 -2.005 . . . . 0.0 112.864 -175.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.68 -165.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.458 1.503 . . . . 0.0 109.803 172.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.76 -69.52 0.41 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.774 -1.829 . . . . 0.0 110.005 173.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 119.9 3.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.098 -1.002 . . . . 0.0 109.216 163.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 46.64 87.95 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 127.564 2.507 . . . . 0.0 118.797 166.067 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.72 -171.91 39.48 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 120.477 -1.602 . . . . 0.0 111.098 169.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.268 1.8 tp -115.3 162.04 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.776 0.798 . . . . 0.0 109.454 -172.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -142.69 154.07 43.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -169.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.6 t -90.1 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.965 -1.709 . . . . 0.0 111.988 179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -90.47 -48.37 7.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.519 -1.363 . . . . 0.0 111.169 176.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.05 128.72 18.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.003 0.906 . . . . 0.0 112.217 -172.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.7 mm -92.68 134.24 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.205 2.202 . . . . 0.0 109.175 178.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.06 143.87 74.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.132 1.373 . . . . 0.0 109.911 175.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -60.75 88.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.379 2.719 . . . . 0.0 115.053 161.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 mttt 66.6 63.06 0.52 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.46 -120.56 2.77 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 158.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.29 -44.64 7.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.532 -0.981 . . . . 0.0 112.307 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.55 -41.31 72.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.93 -31.36 71.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.152 -2.217 . . . . 0.0 110.862 170.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.04 5.79 6.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -72.52 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.296 -2.128 . . . . 0.0 105.9 149.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.0 1.0 Allowed Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.862 163.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -79.55 -17.48 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 117.172 0.486 . . . . 0.0 112.309 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.49 133.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.174 2.19 . . . . 0.0 111.67 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.93 -178.94 5.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.895 -1.128 . . . . 0.0 108.763 169.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -86.23 60.42 6.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.923 -2.361 . . . . 0.0 113.258 -174.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.91 -7.52 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 121.086 -1.009 . . . . 0.0 114.787 176.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -76.05 154.12 35.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.399 1.571 . . . . 0.0 114.92 -172.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -102.64 105.83 16.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.406 1.882 . . . . 0.0 108.79 -173.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.37 113.14 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.8 -1.813 . . . . 0.0 108.949 -179.391 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.42 -29.0 13.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.137 1.375 . . . . 0.0 113.41 -173.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 155.18 38.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 119.984 1.266 . . . . 0.0 112.745 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -132.98 119.0 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.595 -0.691 . . . . 0.0 111.175 -177.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 56.09 31.98 19.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 120.409 1.459 . . . . 0.0 114.027 -168.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.29 9.9 85.62 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.809 -1.182 . . . . 0.0 114.301 -173.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -100.26 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.4 p -60.42 138.1 58.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.83 31.77 0.84 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.76 -1.213 . . . . 0.0 112.15 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.72 76.13 1.55 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.201 2.201 . . . . 0.0 110.941 -177.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.99 5.79 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 125.047 1.308 . . . . 0.0 114.44 -170.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.59 139.08 31.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.021 1.911 . . . . 0.0 112.587 177.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t -112.13 -165.26 0.98 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.458 2.303 . . . . 0.0 105.95 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -53.9 -57.68 10.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.391 1.876 . . . . 0.0 113.641 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -69.62 -46.99 64.96 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 111.987 -174.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -48.64 66.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.918 1.687 . . . . 0.0 113.572 173.272 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.61 86.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.208 -1.558 . . . . 0.0 114.609 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.79 -47.97 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.35 1.06 . . . . 0.0 112.193 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -68.47 -29.23 67.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.251 -1.531 . . . . 0.0 114.158 177.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.6 m -68.55 -26.3 65.35 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.948 1.699 . . . . 0.0 113.194 174.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.51 -48.66 6.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.341 1.457 . . . . 0.0 113.58 172.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -82.61 -36.97 25.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -172.103 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.01 29.26 1.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.31 1.868 . . . . 0.0 112.594 -172.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.4 p -88.76 -168.35 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.373 3.069 . . . . 0.0 109.933 175.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.52 -110.85 3.02 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.211 -1.555 . . . . 0.0 111.547 175.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -102.12 -61.17 1.42 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.863 0.831 . . . . 0.0 112.567 -176.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.64 125.86 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.765 1.269 . . . . 0.0 110.45 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.1 t -109.92 111.51 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 125.395 1.478 . . . . 0.0 107.833 165.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 17' ' ' GLU . 78.5 m80 -79.87 112.26 16.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.773 -1.204 . . . . 0.0 108.643 166.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mt -94.28 112.96 24.79 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.054 1.342 . . . . 0.0 109.015 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.45 101.01 13.69 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.05 143.61 34.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.489 2.315 . . . . 0.0 110.182 -175.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -122.66 143.57 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.197 1.399 . . . . 0.0 109.95 173.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.52 113.87 0.56 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.807 3.262 . . . . 0.0 119.807 -175.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.87 64.31 3.41 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.952 -2.343 . . . . 0.0 113.144 172.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -141.59 169.13 18.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.443 1.097 . . . . 0.0 111.76 -178.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.63 129.18 32.13 Favored Pre-proline 0 N--CA 1.43 -1.436 0 C-N-CA 125.959 1.704 . . . . 0.0 110.577 -172.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 C--N 1.3 -2.009 0 C-N-CA 123.072 2.514 . . . . 0.0 117.177 174.951 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.6 tp -156.34 173.31 17.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.466 6.9 m 43.57 87.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 128.789 2.836 . . . . 0.0 117.439 170.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 77.1 m -129.37 120.82 26.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -176.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -78.86 121.98 25.51 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.314 1.446 . . . . 0.0 109.501 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 -171.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -119.79 140.29 29.36 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.506 -1.371 . . . . 0.0 108.026 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.21 138.08 19.83 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 123.574 2.312 . . . . 0.0 111.764 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.64 25.65 71.69 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.28 104.06 15.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.592 1.196 . . . . 0.0 111.916 -169.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 p -76.66 143.49 40.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.554 -1.341 . . . . 0.0 113.804 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.35 132.69 48.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.562 1.145 . . . . 0.0 108.489 174.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 84.86 2.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.207 1.003 . . . . 0.0 109.569 175.279 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.96 155.0 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.479 1.911 . . . . 0.0 109.644 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -130.54 118.82 21.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.287 -2.133 . . . . 0.0 110.097 165.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.3 mt -122.36 154.47 37.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.937 -1.102 . . . . 0.0 109.975 -174.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.95 119.64 39.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.1 0.952 . . . . 0.0 109.223 162.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 123.43 19.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.992 1.317 . . . . 0.0 113.025 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -90.1 115.12 27.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.777 -1.202 . . . . 0.0 109.501 -175.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 52.43 42.63 31.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.317 1.847 . . . . 0.0 114.915 -172.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.57 43.17 53.41 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.271 0.938 . . . . 0.0 115.342 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -166.74 113.49 0.82 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -170.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' H ' ' C ' ' B' ' 210' ' ' VAL . 6.0 mt -75.07 -28.79 60.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.118 -1.614 . . . . 0.0 107.443 169.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.35 13.09 11.02 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.988 168.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.0 pt -114.75 125.76 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 118.226 1.013 . . . . 0.0 110.454 -171.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -80.86 121.77 26.38 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.509 1.124 . . . . 0.0 113.536 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.19 132.47 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -127.96 170.57 12.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.509 1.524 . . . . 0.0 109.045 169.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.43 -123.08 6.31 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.291 1.424 . . . . 0.0 113.734 178.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.15 155.17 27.53 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 121.681 -0.893 . . . . 0.0 112.993 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -61.1 -24.88 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.881 -1.364 . . . . 0.0 112.794 -177.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -65.19 -32.41 74.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.173 2.189 . . . . 0.0 113.542 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.8 m -79.84 -48.87 12.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.591 1.156 . . . . 0.0 109.462 176.564 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.377 66.1 p 102.39 106.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.111 3.364 . . . . 0.0 109.582 -174.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.62 56.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.993 1.317 . . . . 0.0 109.064 -163.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.267 70.9 ttt180 71.02 -62.98 0.44 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.809 2.044 . . . . 0.0 114.972 -171.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -137.57 -50.95 0.62 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.643 -1.286 . . . . 0.0 110.365 178.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.08 -137.21 3.42 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 105.743 -2.943 . . . . 0.0 105.743 -178.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.93 173.23 27.76 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 121.714 -0.874 . . . . 0.0 112.492 -168.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -123.32 161.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 170.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -132.71 152.03 51.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.78 -1.825 . . . . 0.0 106.647 -171.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.27 119.43 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 120.04 -1.663 . . . . 0.0 108.973 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -82.91 -60.33 2.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.605 -1.309 . . . . 0.0 110.833 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.91 132.28 56.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.26 1.029 . . . . 0.0 110.838 -176.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -94.6 131.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 164.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt -101.52 157.74 33.1 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 111.685 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.48 109.37 2.03 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.56 2.173 . . . . 0.0 113.149 171.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt 68.89 61.05 0.34 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 167.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.41 -100.29 2.04 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 162.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.07 -38.74 0.77 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.51 1.124 . . . . 0.0 110.569 170.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.9 64.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.48 -41.43 80.68 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.306 -1.496 . . . . 0.0 111.468 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -73.6 6.27 3.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.348 2.259 . . . . 0.0 116.496 -177.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.55 -82.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.405 -2.06 . . . . 0.0 107.742 152.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.55 -32.64 1.11 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 170.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -83.92 -15.8 46.6 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.072 0.949 . . . . 0.0 113.162 -172.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.87 133.01 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.941 1.696 . . . . 0.0 110.989 173.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 61' ' ' LYS . 4.3 t-160 -131.55 -172.71 2.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.285 1.434 . . . . 0.0 109.936 173.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' H ' ' CD2' ' A' ' 60' ' ' HIS . 55.5 mtmt -85.95 113.06 21.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.876 -1.765 . . . . 0.0 109.898 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.23 10.8 12.98 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.354 0.978 . . . . 0.0 114.946 -175.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.25 164.09 20.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.465 1.506 . . . . 0.0 112.826 176.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -116.3 121.39 41.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.668 2.387 . . . . 0.0 111.647 -173.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.07 122.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.512 1.525 . . . . 0.0 107.895 174.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 -39.88 8.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 120.255 -1.528 . . . . 0.0 112.309 175.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.98 159.94 42.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.787 1.176 . . . . 0.0 113.783 -176.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.01 119.8 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 124.378 1.071 . . . . 0.0 110.126 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 56.82 25.11 9.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.258 -1.527 . . . . 0.0 115.034 -171.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.74 -2.98 84.88 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.12 1.343 . . . . 0.0 114.6 -171.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.6 t -93.86 100.46 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 0.0 108.361 -174.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t -70.29 137.37 50.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.315 1.446 . . . . 0.0 113.497 -178.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.92 52.16 1.45 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.099 2.16 . . . . 0.0 112.403 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -79.25 119.06 21.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.005 1.322 . . . . 0.0 109.925 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 14.03 75.31 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.886 -1.134 . . . . 0.0 114.959 -175.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.51 138.78 31.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.855 1.312 . . . . 0.0 112.299 -177.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.3 p -101.11 -162.55 0.95 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.682 1.993 . . . . 0.0 109.699 -174.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -59.84 -54.07 50.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.977 -1.702 . . . . 0.0 112.001 164.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -71.59 -41.13 69.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.498 -0.751 . . . . 0.0 112.869 -176.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -40.5 96.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 175.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.37 95.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.888 -1.758 . . . . 0.0 114.584 173.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -53.8 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 119.123 0.874 . . . . 0.0 111.189 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -64.58 -36.73 85.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.878 2.471 . . . . 0.0 113.643 176.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.94 -26.96 18.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.305 1.842 . . . . 0.0 115.269 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -83.97 -52.8 6.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.423 1.889 . . . . 0.0 112.489 -176.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -93.68 63.77 3.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 110.695 -175.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.447 ' HG1' HG22 ' A' ' 92' ' ' VAL . 73.2 p -96.14 -129.65 0.16 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.006 1.322 . . . . 0.0 111.815 177.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.29 57.36 0.43 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 64.08 -54.4 0.25 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.785 3.234 . . . . 0.0 114.47 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.35 124.99 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.572 1.177 . . . . 0.0 110.156 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.447 HG22 ' HG1' ' A' ' 88' ' ' THR . 85.0 t -110.92 106.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 168.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -77.97 102.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.942 -1.099 . . . . 0.0 108.952 166.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.43 118.31 24.88 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.577 -1.327 . . . . 0.0 110.475 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.96 100.92 13.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 148.86 25.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.481 1.512 . . . . 0.0 109.991 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -164.04 1.08 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.038 2.135 . . . . 0.0 107.562 173.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.05 106.54 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.259 -2.151 . . . . 0.0 112.282 159.142 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.09 66.63 3.82 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.331 -1.48 . . . . 0.0 112.265 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -144.76 168.74 19.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.52 1.528 . . . . 0.0 108.584 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.83 165.85 44.7 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 125.275 1.43 . . . . 0.0 112.791 -173.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 C--N 1.299 -2.043 0 C-N-CA 123.91 3.073 . . . . 0.0 110.656 153.598 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 122.662 1.22 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.656 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.3 tp -124.0 -147.13 0.37 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.656 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.38 2.4 t 25.52 101.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.188 4.195 . . . . 0.0 118.568 163.604 . . . . . . . . 4 3 . 1 . 024 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 2.6 p -144.92 116.02 7.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -172.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.4 p -75.25 130.2 38.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.382 1.073 . . . . 0.0 110.424 174.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 25' ' ' LEU . 2.8 p . . . . . 0 C--O 1.261 1.682 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -171.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.431 -1.405 0 CA-C-O 122.755 1.264 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -117.39 155.72 49.77 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 158.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -65.29 131.02 26.95 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.013 2.112 . . . . 0.0 113.308 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 50.67 20.12 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -77.9 123.12 26.38 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.844 -1.386 . . . . 0.0 110.923 176.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 p -82.59 144.04 30.61 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.085 -1.635 . . . . 0.0 112.321 177.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.26 1.6 m-30 -107.67 144.01 35.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -118.51 77.41 1.17 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 158.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.47 112.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.917 2.087 . . . . 0.0 107.098 -168.42 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.71 135.36 54.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.935 -1.728 . . . . 0.0 112.719 -175.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.15 178.3 9.42 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.344 -0.847 . . . . 0.0 108.9 -171.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.05 139.2 52.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.841 -1.162 . . . . 0.0 111.461 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 144.22 28.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.18 -1.575 . . . . 0.0 111.305 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -96.89 102.22 13.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.771 -1.206 . . . . 0.0 109.317 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.32 61.98 2.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -171.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.53 49.74 63.14 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.845 -1.159 . . . . 0.0 114.201 178.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.4 t -168.3 96.58 0.41 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.732 1.73 . . . . 0.0 107.319 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.02 -46.52 56.85 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.048 2.139 . . . . 0.0 106.514 166.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.66 39.93 0.96 Allowed Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.708 175.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.52 130.0 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.946 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -84.65 113.76 21.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.09 1.356 . . . . 0.0 112.072 170.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.81 125.65 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -175.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -122.71 164.04 19.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.656 1.982 . . . . 0.0 109.367 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.41 17.26 Favored Glycine 0 N--CA 1.431 -1.683 0 C-N-CA 124.71 1.148 . . . . 0.0 112.547 178.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.93 165.26 34.14 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.246 0.926 . . . . 0.0 111.565 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.64 -13.94 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.467 -1.607 . . . . 0.0 113.492 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -67.36 -39.81 85.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.316 1.846 . . . . 0.0 113.803 171.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 m -84.3 -33.37 23.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.88 -1.137 . . . . 0.0 109.931 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 t 81.29 86.24 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.862 2.065 . . . . 0.0 109.97 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.8 73.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 125.034 1.333 . . . . 0.0 108.867 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.5 mtp85 68.95 -49.65 0.59 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.996 2.118 . . . . 0.0 113.714 -168.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -145.77 -102.44 0.1 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.431 1.893 . . . . 0.0 105.926 164.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.3 -131.88 4.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 167.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.35 15.01 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.902 -1.351 . . . . 0.0 111.529 -166.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.274 4.0 tp -110.3 163.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.973 -1.31 . . . . 0.0 108.181 173.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -137.39 161.91 35.02 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.915 -1.74 . . . . 0.0 107.0 -174.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.91 125.86 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.296 -1.503 . . . . 0.0 111.841 173.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -82.13 -51.84 7.58 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.732 -1.23 . . . . 0.0 109.948 166.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.62 32.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.763 1.225 . . . . 0.0 110.443 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.51 121.57 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 pt -76.97 142.41 69.12 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 110.229 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.7 106.94 1.93 Allowed 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.578 2.186 . . . . 0.0 113.285 -164.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 64.89 64.11 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.465 1.506 . . . . 0.0 113.44 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.08 -146.29 20.05 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 167.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.6 -41.16 21.93 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.659 -1.495 . . . . 0.0 111.151 175.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -51.49 57.5 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.741 2.016 . . . . 0.0 115.119 -176.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.72 -41.87 82.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.276 1.036 . . . . 0.0 111.373 173.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -69.19 -5.52 23.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -178.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.89 -101.22 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.329 2.331 . . . . 0.0 110.457 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.31 -97.71 0.96 Allowed Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.211 -1.556 . . . . 0.0 112.805 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -133.99 26.08 3.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.999 -0.706 . . . . 0.0 112.744 -156.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 mt -87.11 127.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.86 -1.775 . . . . 0.0 113.427 -170.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -143.85 155.02 43.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 163.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -62.78 148.76 45.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -153.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.73 23.61 7.07 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -103.02 172.95 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.725 1.762 . . . . 0.0 112.693 174.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -98.34 136.5 38.41 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.368 1.067 . . . . 0.0 110.738 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.35 101.89 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.034 2.934 . . . . 0.0 105.01 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.253 0.9 OUTLIER -98.02 -38.18 9.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.235 -2.166 . . . . 0.0 114.827 -173.946 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 145.21 27.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.236 1.38 . . . . 0.0 113.49 -176.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.23 116.02 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 O-C-N 120.994 -1.066 . . . . 0.0 111.914 -171.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 55.59 33.99 22.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.222 1.409 . . . . 0.0 113.677 -170.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.42 25.71 62.82 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 113.495 -176.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.9 t -123.63 100.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.82 38.34 0.7 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.913 1.685 . . . . 0.0 114.189 -173.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -82.81 111.1 18.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.486 -2.009 . . . . 0.0 110.718 175.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 8.95 68.87 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.947 -1.095 . . . . 0.0 113.083 -175.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.12 155.02 17.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.985 1.374 . . . . 0.0 110.067 171.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.567 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 71.2 p -106.87 -170.34 1.7 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.426 1.89 . . . . 0.0 108.718 -172.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -57.29 -49.95 74.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.762 -1.211 . . . . 0.0 112.903 161.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -69.9 -43.8 71.0 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 112.215 -176.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.567 ' HB2' ' H ' ' A' ' 77' ' ' THR . 4.7 mp0 -67.19 -34.3 77.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.633 -1.292 . . . . 0.0 112.947 175.177 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.92 87.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.9 -1.75 . . . . 0.0 114.475 172.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -57.47 -49.19 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.379 -0.825 . . . . 0.0 111.923 172.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.9 -31.28 71.56 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.012 -1.68 . . . . 0.0 114.901 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.6 m -74.93 -27.75 60.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.558 1.943 . . . . 0.0 112.714 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.89 -43.69 10.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.297 1.839 . . . . 0.0 112.892 174.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -84.24 -34.38 23.88 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -172.612 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -86.1 35.31 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.512 -1.992 . . . . 0.0 112.309 -176.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.6 p -93.69 163.25 13.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.142 2.577 . . . . 0.0 113.483 -176.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.75 59.57 4.9 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 125.065 1.317 . . . . 0.0 114.268 -176.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.259 46.4 tt0 68.09 -53.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.617 2.767 . . . . 0.0 114.634 -174.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -76.37 136.33 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.169 1.388 . . . . 0.0 110.721 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.15 101.39 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.65 1.98 . . . . 0.0 107.165 171.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -82.29 97.61 8.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.815 2.446 . . . . 0.0 108.58 170.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.04 113.24 21.97 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.913 0.863 . . . . 0.0 111.462 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.47 102.73 13.03 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 163.347 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.16 152.8 24.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.991 1.316 . . . . 0.0 108.053 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.0 125.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.9 123.05 18.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.849 1.26 . . . . 0.0 112.148 -178.124 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.4 70.22 2.66 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.472 1.034 . . . . 0.0 112.64 -174.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.94 137.02 50.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.852 1.661 . . . . 0.0 109.674 -176.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.38 161.43 33.39 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 127.083 2.153 . . . . 0.0 107.482 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 C--N 1.3 -2.019 0 CA-C-N 123.102 2.143 . . . . 0.0 113.799 -175.576 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 19.9 tp -86.34 165.11 16.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.081 0.952 . . . . 0.0 109.206 163.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.397 2.7 t 72.58 115.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.768 2.223 . . . . 0.0 115.511 164.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 73.0 m -141.53 123.23 15.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -77.14 124.06 27.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.26 1.615 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -162.566 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 122.216 1.007 . . . . 0.0 108.644 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -97.18 148.1 33.9 Favored Pre-proline 0 N--CA 1.43 -1.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.707 176.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.78 129.21 14.16 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 122.826 2.045 . . . . 0.0 113.346 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.59 25.09 75.17 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 125.376 1.465 . . . . 0.0 115.321 176.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -79.59 129.98 34.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.002 -1.293 . . . . 0.0 113.137 -173.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 p -93.69 143.12 26.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.409 -1.432 . . . . 0.0 113.802 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -132.02 118.86 20.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.874 1.27 . . . . 0.0 108.921 173.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 86.45 5.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.268 1.427 . . . . 0.0 109.146 173.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.97 156.85 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.211 2.204 . . . . 0.0 109.982 178.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.85 132.77 50.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.616 -1.927 . . . . 0.0 107.159 166.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.6 mt -129.46 153.37 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.013 -1.054 . . . . 0.0 109.572 -177.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.52 110.01 17.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.434 1.094 . . . . 0.0 109.067 166.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HB2' ' H ' ' A' ' 24' ' ' SER . 15.5 ptpt -60.04 141.31 55.92 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 127.77 2.428 . . . . 0.0 114.746 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 t -101.57 113.76 27.17 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.698 -1.251 . . . . 0.0 109.344 -174.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 58.76 -18.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 129.189 2.995 . . . . 0.0 118.171 -169.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.19 59.32 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.847 1.689 . . . . 0.0 109.27 -178.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.539 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 95.4 p -178.2 120.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -173.783 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' H ' ' C ' ' B' ' 210' ' ' VAL . 9.8 mt -79.45 -40.02 30.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.436 1.894 . . . . 0.0 106.586 168.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.06 29.3 2.02 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.035 1.303 . . . . 0.0 111.988 171.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 pt -114.78 131.03 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.632 174.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 m -83.91 117.07 23.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.236 0.614 . . . . 0.0 111.04 162.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.67 132.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -128.28 163.55 24.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.102 2.161 . . . . 0.0 109.608 174.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.35 -137.36 13.26 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 125.279 1.419 . . . . 0.0 111.788 -177.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 155.63 28.07 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 -17.2 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.546 -1.561 . . . . 0.0 114.06 -178.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -55.91 -37.45 68.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.987 1.715 . . . . 0.0 114.292 169.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 m -128.13 71.71 1.39 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -28.27 116.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.496 3.517 . . . . 0.0 120.496 -162.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 95.41 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.181 1.392 . . . . 0.0 109.78 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 65.08 -96.79 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.584 1.954 . . . . 0.0 111.885 -174.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -124.65 10.28 8.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.652 -1.28 . . . . 0.0 112.645 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.53 86.36 1.9 Allowed Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.11 -0.994 . . . . 0.0 114.288 174.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.51 -172.75 20.67 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 175.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.255 2.2 tp -120.49 162.1 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 118.049 0.924 . . . . 0.0 109.078 -166.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -142.08 162.11 36.31 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 -171.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 t -88.36 132.31 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.679 -1.263 . . . . 0.0 111.769 172.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -88.52 -46.85 8.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.529 -1.357 . . . . 0.0 110.554 170.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.02 134.02 24.08 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.067 -1.021 . . . . 0.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.3 mm -93.84 128.92 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.433 1.493 . . . . 0.0 108.725 173.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.6 pt -83.26 133.44 47.63 Favored Pre-proline 0 N--CA 1.43 -1.454 0 O-C-N 121.184 -0.948 . . . . 0.0 110.836 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.08 64.75 7.08 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 121.558 1.592 . . . . 0.0 111.064 178.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt 173.04 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.456 1.502 . . . . 0.0 109.781 -175.268 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.46 4.92 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.728 -1.857 . . . . 0.0 111.061 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.87 -39.26 4.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.447 1.099 . . . . 0.0 111.603 -172.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.78 66.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.009 1.323 . . . . 0.0 113.84 -178.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -56.76 -34.17 67.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.968 1.307 . . . . 0.0 112.504 167.124 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -70.27 -5.46 27.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.97 -79.27 0.06 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 118.643 -2.536 . . . . 0.0 108.061 159.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.33 -20.14 3.36 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 169.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -85.31 -32.99 22.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.887 -0.772 . . . . 0.0 111.537 177.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.6 mt -65.86 125.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.735 1.614 . . . . 0.0 113.097 178.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.471 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 17.3 t60 -136.71 177.9 7.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.319 1.056 . . . . 0.0 109.954 171.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 30.1 pttt -79.74 58.9 2.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.852 -1.78 . . . . 0.0 115.347 -172.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.32 -10.32 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.188 1.375 . . . . 0.0 113.238 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -78.62 154.35 30.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 118.611 1.206 . . . . 0.0 113.427 -173.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 138.74 32.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.408 1.483 . . . . 0.0 107.465 175.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.42 115.68 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 161.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.76 -30.53 11.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 113.412 -172.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 153.52 38.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.02 0.827 . . . . 0.0 112.584 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 t -135.75 120.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.453 0.701 . . . . 0.0 112.173 -175.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 55.5 33.87 21.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.432 -1.417 . . . . 0.0 114.203 -168.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.67 11.72 85.06 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 120.68 -1.263 . . . . 0.0 113.538 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.64 100.3 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -60.75 135.2 57.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.078 1.751 . . . . 0.0 113.306 174.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.6 mt -68.96 -49.35 58.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.445 -0.785 . . . . 0.0 112.476 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 46.39 27.79 0.64 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.939 2.94 . . . . 0.0 118.939 166.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.61 27.91 0.93 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.268 -1.52 . . . . 0.0 112.885 -169.033 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.86 146.05 26.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.803 -1.41 . . . . 0.0 110.702 175.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.424 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 72.5 p -94.83 -167.7 1.69 Allowed 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.719 1.608 . . . . 0.0 109.148 -178.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -61.52 -50.2 73.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.029 -1.669 . . . . 0.0 112.151 165.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.19 -49.41 74.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.424 ' HB3' ' H ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -62.76 -38.11 89.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.1 -1.0 . . . . 0.0 113.286 179.833 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.23 96.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.034 -1.666 . . . . 0.0 114.983 172.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.55 -54.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.465 173.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -49.72 -43.11 47.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.245 1.384 . . . . 0.0 114.555 175.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.6 m -68.22 -27.45 66.38 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.272 2.229 . . . . 0.0 114.882 -178.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.3 -41.43 10.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.87 -1.769 . . . . 0.0 113.78 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -53.89 6.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.557 2.343 . . . . 0.0 114.214 -169.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.51 36.43 0.75 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.509 1.623 . . . . 0.0 111.96 -168.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.2 p -93.44 -172.48 2.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.588 2.755 . . . . 0.0 109.636 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.11 -90.48 0.48 Allowed Glycine 0 N--CA 1.429 -1.818 0 O-C-N 119.86 -1.775 . . . . 0.0 112.599 174.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -142.99 -50.15 0.34 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.747 1.219 . . . . 0.0 110.013 -175.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.64 131.52 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.173 -1.579 . . . . 0.0 110.129 172.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.3 112.54 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -76.52 113.28 13.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.647 -1.283 . . . . 0.0 108.806 163.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mt -94.83 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.978 -1.077 . . . . 0.0 108.766 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.43 102.77 15.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.07 150.67 23.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.049 2.139 . . . . 0.0 111.358 -177.458 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -127.38 136.35 51.74 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.261 1.024 . . . . 0.0 108.878 169.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -61.51 128.24 35.33 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.234 2.214 . . . . 0.0 114.445 -175.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.92 65.49 0.3 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.983 -1.073 . . . . 0.0 114.403 175.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -116.05 161.93 18.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.952 1.301 . . . . 0.0 109.602 174.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -82.91 129.78 60.35 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.755 -1.215 . . . . 0.0 112.901 -178.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--N 1.3 -2.002 0 C-N-CA 123.09 2.527 . . . . 0.0 114.125 167.573 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.3 tp 77.25 160.05 0.21 Allowed 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.879 2.871 . . . . 0.0 112.572 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.422 1.4 t 77.6 102.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 124.584 2.135 . . . . 0.0 113.311 171.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 89.4 m -136.72 119.68 16.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -171.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.5 p -75.1 129.23 37.21 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.984 1.313 . . . . 0.0 109.253 174.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 25' ' ' LEU . 8.5 p . . . . . 0 C--O 1.26 1.63 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 -162.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 121.709 0.766 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -135.21 133.42 20.67 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -67.41 115.99 3.98 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 122.861 2.057 . . . . 0.0 112.937 172.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.82 78.7 0.31 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 124.183 0.897 . . . . 0.0 114.412 -175.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.48 140.04 45.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 121.482 -1.011 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p -97.29 141.25 30.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.84 -1.162 . . . . 0.0 113.077 177.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.69 137.79 53.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.744 1.618 . . . . 0.0 107.823 176.046 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -114.44 82.9 1.79 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.216 1.484 . . . . 0.0 108.802 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.12 142.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.0 2.12 . . . . 0.0 109.083 -178.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.34 123.53 44.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.037 -2.289 . . . . 0.0 109.2 170.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.35 162.06 19.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.064 0.946 . . . . 0.0 108.778 -176.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 125.0 53.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 157.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HB2' ' H ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -61.48 136.69 58.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.038 1.335 . . . . 0.0 112.025 169.224 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -90.71 95.45 10.15 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.354 1.55 . . . . 0.0 108.682 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 62.54 -17.71 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.724 2.861 . . . . 0.0 118.724 -171.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.2 62.56 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.846 -1.784 . . . . 0.0 109.919 -178.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.502 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 45.7 t 167.8 104.46 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -162.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.8 mt -75.17 -41.59 57.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 161.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 41.44 1.09 Allowed Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.676 171.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.5 pt -119.45 129.04 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 121.653 0.74 . . . . 0.0 110.297 171.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -82.29 113.95 20.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.294 1.037 . . . . 0.0 110.481 167.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.38 129.78 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -128.82 166.37 19.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.004 1.722 . . . . 0.0 110.373 176.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.35 -157.35 46.21 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 125.118 1.342 . . . . 0.0 111.463 -170.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.35 151.68 8.95 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.869 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -3.58 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -170.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -72.06 -28.49 63.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.187 -1.57 . . . . 0.0 114.042 177.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.2 p -116.66 176.38 5.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 t -81.9 111.63 18.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.604 -1.935 . . . . 0.0 108.781 173.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.62 -65.49 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.213 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -179.88 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.96 2.104 . . . . 0.0 106.539 164.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -142.29 154.91 45.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.74 56.02 4.75 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.85 -168.93 26.27 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 163.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 tp -125.26 155.84 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -139.14 156.43 47.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -166.073 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.6 137.87 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 119.096 -2.252 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.08 -64.65 1.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.414 -1.429 . . . . 0.0 108.529 160.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.44 136.62 50.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.245 1.018 . . . . 0.0 110.785 -175.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.5 mm -89.81 118.99 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.667 1.587 . . . . 0.0 107.424 169.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 pt -79.23 157.78 75.14 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 117.728 -1.13 . . . . 0.0 111.776 -177.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -69.87 89.79 0.53 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.435 2.09 . . . . 0.0 114.974 -172.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 70.09 65.38 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.797 1.639 . . . . 0.0 114.967 166.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.75 -95.02 1.54 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 168.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.2 -39.16 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.291 -1.123 . . . . 0.0 111.698 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -48.86 36.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.463 1.905 . . . . 0.0 114.639 -174.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.22 -39.51 56.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.071 1.415 . . . . 0.0 111.789 169.07 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -67.83 -2.76 7.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -67.72 -90.99 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.2 2.273 . . . . 0.0 109.145 164.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.79 -35.34 0.5 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 111.615 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.61 -25.85 35.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.791 -0.829 . . . . 0.0 113.113 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.06 131.26 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.068 -1.645 . . . . 0.0 112.339 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -136.58 179.25 6.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.983 -1.073 . . . . 0.0 108.795 167.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -84.54 49.15 1.63 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.231 -1.543 . . . . 0.0 114.905 -167.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.41 19.64 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.899 -1.75 . . . . 0.0 114.057 176.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.33 179.99 4.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.028 -1.277 . . . . 0.0 112.425 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -113.01 142.54 45.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.768 2.027 . . . . 0.0 109.088 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.78 133.9 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.324 -1.485 . . . . 0.0 108.126 165.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.59 -30.48 5.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.556 -1.34 . . . . 0.0 113.93 -173.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 157.25 42.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.162 1.346 . . . . 0.0 113.452 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.8 t -137.99 123.27 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 123.821 0.848 . . . . 0.0 110.955 -177.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 52.67 33.89 14.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.61 1.564 . . . . 0.0 114.641 -173.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.89 23.46 69.29 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.065 -1.022 . . . . 0.0 113.512 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.12 100.07 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 124.333 1.053 . . . . 0.0 108.392 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.09 142.61 41.75 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.928 2.091 . . . . 0.0 115.468 173.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.45 -56.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.624 -1.297 . . . . 0.0 111.555 176.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 43.24 43.97 4.3 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 169.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 45.16 0.97 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 120.819 -1.176 . . . . 0.0 110.679 -168.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.57 144.69 28.37 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.443 -1.033 . . . . 0.0 108.918 171.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.6 p -97.01 -160.98 0.84 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.481 1.512 . . . . 0.0 109.946 -175.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.42 -49.9 65.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.951 -1.718 . . . . 0.0 110.802 167.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -66.5 -46.93 74.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 112.775 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.71 -33.01 71.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.48 91.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.465 -2.022 . . . . 0.0 113.533 170.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.59 -52.38 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 118.885 -0.579 . . . . 0.0 111.314 172.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -47.24 -45.16 23.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 171.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -73.64 -27.47 61.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.95 1.3 . . . . 0.0 112.368 -171.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.27 -48.12 7.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.077 1.751 . . . . 0.0 114.51 172.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -48.24 17.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.956 2.103 . . . . 0.0 113.402 -173.287 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.38 31.41 0.82 Allowed 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.859 -1.776 . . . . 0.0 112.426 -166.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.3 p -83.04 -168.06 1.92 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.283 3.433 . . . . 0.0 109.388 171.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.5 -108.08 0.53 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.383 -1.448 . . . . 0.0 110.723 170.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -120.18 -44.87 2.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.567 1.147 . . . . 0.0 110.436 174.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -72.72 129.89 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.449 1.119 . . . . 0.0 112.116 173.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.8 t -129.76 99.87 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 126.415 1.886 . . . . 0.0 108.116 179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -78.02 98.62 5.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.552 1.941 . . . . 0.0 110.312 168.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -84.79 113.16 21.14 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.455 1.902 . . . . 0.0 109.911 -175.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 98.36 11.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 168.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.06 147.97 25.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.364 1.865 . . . . 0.0 109.717 -177.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.97 132.97 56.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.702 1.239 . . . . 0.0 108.236 167.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -74.24 139.88 44.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.862 1.265 . . . . 0.0 109.79 176.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -80.93 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 112.475 165.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.83 -40.33 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 159.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . 0.346 11.6 p -4.72 82.11 0.03 OUTLIER Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 129.658 3.183 . . . . 0.0 118.819 -156.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 C--N 1.299 -2.036 0 C-N-CA 122.225 1.95 . . . . 0.0 116.829 -151.263 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 tp -146.13 179.17 7.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.951 -1.093 . . . . 0.0 108.068 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.398 2.2 t 67.86 104.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 124.924 2.297 . . . . 0.0 114.378 169.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 34.1 m -140.24 122.76 16.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.612 -3.107 . . . . 0.0 102.612 -171.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.3 p -80.55 121.29 25.62 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.984 0.914 . . . . 0.0 109.986 175.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.0 m . . . . . 0 C--O 1.259 1.579 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -169.488 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.8 mpt? . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -118.43 118.24 33.99 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.987 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -69.9 96.53 0.61 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 123.115 2.148 . . . . 0.0 116.317 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.85 55.82 0.57 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 126.155 1.836 . . . . 0.0 111.747 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -133.99 124.24 25.95 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 118.099 0.949 . . . . 0.0 110.04 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -95.54 147.07 23.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.521 1.153 . . . . 0.0 110.743 170.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.38 128.25 41.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.725 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -103.25 81.24 1.92 Allowed 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.609 1.195 . . . . 0.0 108.316 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.95 109.11 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 126.926 2.091 . . . . 0.0 112.543 -173.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 124.64 44.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.92 -1.738 . . . . 0.0 109.384 -177.061 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.1 mt -134.93 158.73 43.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 109.045 -171.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.28 43.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 162.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -63.18 146.51 53.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.885 -1.134 . . . . 0.0 113.37 -175.136 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -92.41 88.66 6.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.963 1.364 . . . . 0.0 107.381 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 t0 44.99 64.98 1.2 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.18 2.592 . . . . 0.0 117.108 -177.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 52.8 6.02 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.634 -1.291 . . . . 0.0 114.119 179.154 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.42 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 3.9 m 177.33 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.166 1.386 . . . . 0.0 108.618 -169.354 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.7 mt -74.39 -45.68 45.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.248 1.819 . . . . 0.0 107.426 163.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.88 47.06 0.85 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 125.444 1.497 . . . . 0.0 111.054 177.1 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 pt -128.8 131.65 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.39 0.614 . . . . 0.0 109.429 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.1 m -91.05 113.03 25.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.434 1.094 . . . . 0.0 111.95 171.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.6 m -80.85 140.13 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -172.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -130.67 168.18 17.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.098 1.759 . . . . 0.0 109.602 172.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.85 -150.23 34.02 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.977 1.275 . . . . 0.0 114.08 -177.1 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 161.44 21.76 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 125.439 1.495 . . . . 0.0 109.602 -179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.44 11.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.094 -1.827 . . . . 0.0 115.136 -171.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -58.71 -37.81 76.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.741 -2.474 . . . . 0.0 115.711 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.3 p -116.92 -172.68 2.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.76 1.224 . . . . 0.0 107.902 166.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -73.56 89.3 1.7 Allowed 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.61 -1.931 . . . . 0.0 112.478 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 174.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 176.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -69.78 78.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.545 -1.972 . . . . 0.0 112.653 176.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.9 t60 69.91 -38.45 0.41 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.59 3.556 . . . . 0.0 116.282 -178.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.59 -129.1 1.7 Allowed Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.35 -3.5 . . . . 0.0 104.35 -178.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.78 164.73 4.52 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 124.702 1.144 . . . . 0.0 113.584 -173.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.287 3.9 tp -124.33 156.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 120.103 -1.821 . . . . 0.0 106.826 170.659 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.09 151.63 52.01 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -170.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.0 t -85.87 130.91 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.403 -2.061 . . . . 0.0 110.524 176.252 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -90.23 -45.96 8.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.035 -1.666 . . . . 0.0 110.379 168.192 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 143.87 33.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.605 1.193 . . . . 0.0 112.784 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.8 mm -105.02 116.97 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.513 2.725 . . . . 0.0 108.001 -176.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -84.08 154.69 63.94 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.539 -1.351 . . . . 0.0 112.653 -177.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -67.92 106.55 1.34 Allowed 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.734 2.289 . . . . 0.0 115.36 -169.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 mttm 41.39 65.02 0.9 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.044 2.537 . . . . 0.0 117.701 175.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.62 -90.13 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 169.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.54 -41.58 2.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.728 -0.866 . . . . 0.0 111.093 169.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 -49.0 50.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.955 1.702 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.17 -29.98 70.74 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.454 -1.403 . . . . 0.0 111.929 173.023 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 m -69.72 -2.36 11.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 176.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.95 -80.9 0.05 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 120.872 1.669 . . . . 0.0 107.427 157.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.62 -33.94 0.82 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.25 -0.906 . . . . 0.0 111.413 165.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -72.25 -26.49 62.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -169.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.02 141.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.706 1.202 . . . . 0.0 114.125 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.421 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 3.6 t-80 -134.21 -166.93 1.87 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.607 -1.308 . . . . 0.0 110.783 165.046 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 53.1 mtpt -80.84 135.34 35.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.041 -1.662 . . . . 0.0 110.337 -176.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.65 2.34 72.8 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.076 -1.64 . . . . 0.0 114.642 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.21 151.52 39.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.437 1.119 . . . . 0.0 111.682 176.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -106.19 114.46 28.6 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.419 1.087 . . . . 0.0 109.357 -167.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -92.89 120.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.132 -1.605 . . . . 0.0 108.814 173.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.04 -39.84 9.95 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.651 -1.281 . . . . 0.0 111.544 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.63 149.23 34.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 t -129.59 117.73 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 O-C-N 120.804 -1.185 . . . . 0.0 113.061 -173.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 0.4 OUTLIER 46.62 37.54 4.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.277 2.231 . . . . 0.0 115.754 -169.863 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.24 5.88 57.93 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 114.201 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -121.87 105.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 118.346 1.073 . . . . 0.0 110.366 -168.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 t -60.74 139.24 57.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.759 172.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.84 60.33 2.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.911 2.084 . . . . 0.0 111.614 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.01 105.26 10.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.081 2.153 . . . . 0.0 111.796 -169.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.93 21.03 79.15 Favored Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.813 -1.179 . . . . 0.0 114.026 -175.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.27 141.07 29.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.161 -1.2 . . . . 0.0 113.165 -175.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -104.57 -156.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.591 2.356 . . . . 0.0 109.66 -174.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.97 -50.94 44.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.707 -1.871 . . . . 0.0 111.384 168.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.72 -51.76 68.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 112.337 174.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.83 -36.07 82.71 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.006 -1.059 . . . . 0.0 113.846 -175.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.15 92.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.156 -1.59 . . . . 0.0 114.953 171.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.05 -49.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 110.764 174.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.36 -26.12 67.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.891 -1.756 . . . . 0.0 114.902 178.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -75.97 -27.98 57.7 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.158 1.783 . . . . 0.0 113.172 176.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.6 mt -89.63 -47.72 7.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.227 -1.545 . . . . 0.0 113.963 173.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 -37.1 22.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.695 1.598 . . . . 0.0 114.072 -170.277 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.55 37.58 0.92 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.979 -1.701 . . . . 0.0 111.274 -172.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.5 p -100.17 179.41 4.49 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.132 3.373 . . . . 0.0 111.555 -179.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.94 -136.68 4.22 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.611 -1.306 . . . . 0.0 112.871 173.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -85.06 -62.42 1.54 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.802 -1.411 . . . . 0.0 111.869 -177.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -75.75 124.28 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.89 1.329 . . . . 0.0 111.787 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.5 t -114.99 114.94 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 167.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -87.35 110.66 20.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.12 111.14 20.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.585 -1.322 . . . . 0.0 110.253 174.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 98.36 10.97 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.4 mt -104.97 137.92 41.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.968 2.507 . . . . 0.0 110.759 -173.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.6 148.05 42.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.235 1.814 . . . . 0.0 108.545 170.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 133.56 55.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 176.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.72 19.7 53.64 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.422 -2.048 . . . . 0.0 113.465 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -96.71 130.95 43.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.085 1.754 . . . . 0.0 110.503 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.47 146.05 52.89 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 116.891 -1.528 . . . . 0.0 110.008 172.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 N--CA 1.433 -2.041 0 CA-C-N 124.966 2.809 . . . . 0.0 114.672 179.463 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.351 0.596 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.477 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 7.8 tp 66.82 168.48 0.24 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.215 2.206 . . . . 0.0 114.006 -161.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.477 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.452 5.7 m 46.06 76.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 128.058 2.543 . . . . 0.0 117.311 171.107 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.1 m -117.78 117.86 30.48 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 69.3 p -78.86 117.98 20.47 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.017 1.327 . . . . 0.0 111.323 178.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 25' ' ' LEU . 1.4 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -171.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -145.43 164.41 26.52 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -63.51 139.29 69.64 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.687 2.258 . . . . 0.0 112.621 160.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.77 35.45 50.78 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 174.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.7 103.99 6.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.41 1.605 . . . . 0.0 110.994 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 p -94.57 119.54 33.41 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.439 1.114 . . . . 0.0 110.907 170.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 117.46 33.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.218 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.53 89.05 7.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.985 1.85 . . . . 0.0 109.513 170.4 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.36 150.77 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.388 1.875 . . . . 0.0 108.358 176.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.79 130.7 34.45 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.799 -1.813 . . . . 0.0 109.164 168.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.08 165.42 36.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.223 1.011 . . . . 0.0 111.718 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.18 132.77 45.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.578 1.151 . . . . 0.0 110.355 170.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -70.49 164.27 25.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 0.0 112.374 177.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 t -114.64 96.94 5.99 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.532 -1.355 . . . . 0.0 109.36 -179.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 53.08 55.08 9.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.011 2.125 . . . . 0.0 115.399 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.74 48.75 16.06 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 114.001 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 p -178.58 119.32 0.08 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.66 -38.19 62.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.91 2.084 . . . . 0.0 106.449 164.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.52 18.25 4.11 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.253 1.406 . . . . 0.0 110.864 168.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 pt -107.93 129.19 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.715 1.245 . . . . 0.0 110.541 -176.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.0 m -85.96 113.61 22.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.513 1.125 . . . . 0.0 110.864 173.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.13 131.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -171.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -126.24 164.96 19.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.118 2.167 . . . . 0.0 110.83 177.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -136.18 13.69 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 125.877 1.703 . . . . 0.0 114.009 174.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.52 176.84 49.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 124.662 1.125 . . . . 0.0 114.457 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -60.42 -16.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.521 2.328 . . . . 0.0 115.343 -172.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.2 -39.88 80.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.542 -1.349 . . . . 0.0 113.627 171.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.1 t -113.18 167.68 10.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.452 1.501 . . . . 0.0 109.556 -178.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -80.85 88.08 5.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.781 -1.824 . . . . 0.0 111.441 176.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.79 77.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 123.266 1.507 . . . . 0.0 107.9 177.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.02 -95.91 0.06 Allowed 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 126.387 1.875 . . . . 0.0 112.605 -167.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -115.4 -57.84 2.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.568 1.147 . . . . 0.0 111.119 176.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.1 -115.73 0.35 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.08 -165.03 53.2 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 121.178 -1.189 . . . . 0.0 114.716 -178.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.264 3.1 tp -145.52 164.53 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 161.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -145.53 157.49 43.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -168.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.8 t -90.06 130.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.015 -1.678 . . . . 0.0 113.208 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -87.73 -53.56 4.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.896 -1.128 . . . . 0.0 111.375 170.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.76 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.035 0.921 . . . . 0.0 111.472 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.6 mm -98.39 137.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.522 2.329 . . . . 0.0 107.787 172.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 59.3 mt -85.5 141.04 36.24 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-O 116.827 -1.559 . . . . 0.0 108.426 176.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.31 92.65 0.34 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.367 2.711 . . . . 0.0 112.911 171.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt 59.13 60.62 2.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.797 2.039 . . . . 0.0 114.964 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.16 -68.72 1.32 Allowed Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.333 -1.479 . . . . 0.0 110.008 170.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.59 -52.74 0.44 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 123.653 0.781 . . . . 0.0 109.043 163.523 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.58 -33.68 75.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.459 2.762 . . . . 0.0 118.459 -171.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.0 -35.25 80.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.088 -2.882 . . . . 0.0 111.014 171.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -74.34 0.54 14.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -72.48 -51.72 18.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.672 -1.893 . . . . 0.0 109.941 168.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.09 -73.76 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.798 158.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.96 -19.24 63.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -166.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.5 133.06 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 121.748 2.067 . . . . 0.0 115.575 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -129.49 178.71 6.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.555 1.542 . . . . 0.0 111.718 172.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -83.03 124.75 30.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.213 -1.555 . . . . 0.0 109.523 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.15 52.98 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 121.118 -0.989 . . . . 0.0 113.933 -173.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -81.83 165.04 21.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.588 1.185 . . . . 0.0 111.896 176.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -107.69 131.15 54.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.678 -172.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.43 120.49 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.092 -1.63 . . . . 0.0 107.541 163.046 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.24 -37.59 9.61 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.618 -1.301 . . . . 0.0 112.308 -179.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.13 156.87 43.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 119.467 1.03 . . . . 0.0 113.217 -177.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.71 123.34 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 111.646 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 53.46 32.8 14.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.218 1.372 . . . . 0.0 114.566 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.4 20.65 76.72 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.899 -1.126 . . . . 0.0 114.49 -175.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -115.23 102.61 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.7 m -59.46 135.83 57.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.883 -1.136 . . . . 0.0 112.457 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.95 70.71 2.69 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.0 111.897 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.82 101.26 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.387 1.875 . . . . 0.0 112.349 -174.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.49 38.02 95.65 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.119 -0.988 . . . . 0.0 112.978 -175.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.05 140.52 35.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.417 -1.049 . . . . 0.0 109.706 176.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -114.48 -168.78 1.42 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 103.892 -2.632 . . . . 0.0 103.892 174.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -56.45 -52.88 63.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.91 -1.744 . . . . 0.0 114.168 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -74.14 -41.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.707 1.14 . . . . 0.0 112.315 -174.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -59.45 -47.1 86.77 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 119.957 -1.714 . . . . 0.0 114.449 172.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.41 -29.9 70.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.459 -1.401 . . . . 0.0 114.597 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.5 -56.86 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.43 166.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -51.56 -42.4 61.83 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -61.17 -29.81 70.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.933 2.093 . . . . 0.0 115.012 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -97.74 -33.43 11.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.104 2.162 . . . . 0.0 115.263 173.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -49.44 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.168 2.587 . . . . 0.0 114.147 -169.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -92.91 30.92 1.48 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.564 1.65 . . . . 0.0 111.548 -169.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -87.14 -174.57 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.628 2.771 . . . . 0.0 111.175 -176.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.37 173.44 51.22 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.337 158.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -61.53 -41.22 97.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.691 1.596 . . . . 0.0 113.07 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.23 126.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.939 1.352 . . . . 0.0 111.043 169.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -120.51 105.22 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.607 1.563 . . . . 0.0 107.394 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -77.83 103.55 7.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.605 -1.309 . . . . 0.0 109.542 165.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -89.17 118.4 28.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.744 -1.222 . . . . 0.0 110.429 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.38 95.34 10.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.12 145.61 26.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.885 2.074 . . . . 0.0 110.196 -177.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.62 139.23 52.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.772 1.273 . . . . 0.0 110.048 163.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.61 124.73 24.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.686 1.994 . . . . 0.0 113.267 177.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.05 73.21 2.67 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.316 -1.49 . . . . 0.0 113.09 172.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.05 160.41 14.35 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.319 2.247 . . . . 0.0 111.403 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.76 113.53 44.71 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.942 -1.504 . . . . 0.0 108.628 173.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 C--N 1.3 -2.014 0 CA-C-N 123.802 2.394 . . . . 0.0 116.53 -175.168 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.625 1.202 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp -107.78 158.47 17.27 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.333 1.453 . . . . 0.0 109.957 176.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.395 2.3 t 77.09 121.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 163.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 20.5 m -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 10.8 p -80.99 122.95 27.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.795 1.638 . . . . 0.0 110.661 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.261 1.664 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 -170.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.476 0.655 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.62 138.35 19.57 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 109.838 177.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.18 147.46 42.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.037 1.825 . . . . 0.0 110.516 172.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.58 19.19 74.5 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -78.86 123.68 27.48 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.903 -1.351 . . . . 0.0 111.452 -176.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -102.25 126.25 49.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.678 -1.264 . . . . 0.0 111.112 -178.055 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.01 121.8 44.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.449 1.5 . . . . 0.0 108.806 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -101.32 75.14 1.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.511 1.524 . . . . 0.0 111.375 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.58 121.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.193 -1.567 . . . . 0.0 114.817 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.72 122.24 39.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.774 -1.829 . . . . 0.0 111.328 175.22 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.23 170.64 16.33 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.439 1.096 . . . . 0.0 108.578 175.079 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.0 133.49 55.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.423 1.089 . . . . 0.0 109.501 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 155.03 34.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.992 -1.068 . . . . 0.0 111.42 -174.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 t -100.9 100.03 10.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.838 -1.164 . . . . 0.0 109.052 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.265 2.4 m-20 37.81 60.23 1.2 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.536 2.735 . . . . 0.0 117.141 -172.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.6 54.66 5.37 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.969 -1.082 . . . . 0.0 114.198 178.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 m 179.22 109.91 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.237 1.415 . . . . 0.0 107.354 -172.148 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.9 mt -76.84 -44.86 30.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.39 45.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.806 1.193 . . . . 0.0 110.768 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.16 136.94 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 121.553 0.692 . . . . 0.0 110.793 169.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.1 m -80.09 110.52 15.57 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.091 1.757 . . . . 0.0 112.442 167.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.8 123.47 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -172.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -121.72 171.08 9.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.574 2.349 . . . . 0.0 109.98 176.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.63 -131.01 10.29 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.238 1.399 . . . . 0.0 112.606 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.65 168.73 44.84 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.271 0.939 . . . . 0.0 111.895 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.5 -12.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.161 1.784 . . . . 0.0 115.006 -171.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -74.55 -24.55 58.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.84 -1.788 . . . . 0.0 111.18 173.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -97.08 -173.9 2.81 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.513 1.525 . . . . 0.0 109.396 174.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -96.85 91.12 5.5 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.405 -2.059 . . . . 0.0 112.372 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 m -112.82 -172.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.794 -175.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.48 45.43 0.39 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.529 2.332 . . . . 0.0 115.44 -173.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.282 1.5 t-160 62.06 40.34 12.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.373 1.869 . . . . 0.0 114.023 -169.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.93 116.92 4.28 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.126 1.346 . . . . 0.0 112.197 -175.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.53 153.12 9.98 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 173.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -110.15 157.71 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.133 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -137.01 153.1 50.75 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.016 -1.678 . . . . 0.0 108.056 -169.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.3 t -90.85 117.89 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.41 -1.431 . . . . 0.0 112.074 178.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -81.66 -33.98 31.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.844 -1.16 . . . . 0.0 112.102 177.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.93 146.15 18.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.803 0.811 . . . . 0.0 109.776 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.2 mm -100.76 121.67 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 pt -78.34 148.41 74.05 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 120.55 -1.344 . . . . 0.0 112.547 -176.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -85.92 66.54 5.36 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 C-N-CA 122.593 2.195 . . . . 0.0 112.221 167.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.276 23.7 pttm 170.86 65.94 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.592 2.357 . . . . 0.0 110.243 166.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.7 179.6 34.24 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.211 -2.18 . . . . 0.0 111.336 -178.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.19 17.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.336 2.654 . . . . 0.0 111.869 -172.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.72 72.74 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.946 1.698 . . . . 0.0 113.625 -176.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.91 -36.19 62.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.4 -1.437 . . . . 0.0 113.424 165.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 t -75.36 2.31 11.59 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.325 -2.11 . . . . 0.0 107.923 153.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.71 -28.12 1.46 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 170.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.8 mtt85 -81.77 -27.61 33.66 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mt -67.02 133.82 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 119.235 0.925 . . . . 0.0 113.436 178.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.23 -178.43 4.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.734 -1.229 . . . . 0.0 109.424 166.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -76.6 103.34 6.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.517 -1.989 . . . . 0.0 111.132 174.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.7 -17.72 1.82 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.783 -1.198 . . . . 0.0 115.505 -173.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.49 156.65 36.69 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 119.918 1.859 . . . . 0.0 115.226 -172.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.19 122.31 45.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.655 1.582 . . . . 0.0 109.513 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.48 114.39 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.94 -38.89 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.403 -1.435 . . . . 0.0 112.939 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.16 160.18 44.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.022 1.283 . . . . 0.0 114.147 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.0 t -134.3 113.32 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 111.49 -175.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 10.2 p30 43.44 33.98 0.7 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 -163.708 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.07 22.29 59.51 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.575 -1.328 . . . . 0.0 113.383 -177.032 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.99 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 172.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -70.38 144.26 51.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.475 1.131 . . . . 0.0 113.248 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.79 56.38 3.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.727 1.211 . . . . 0.0 110.037 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.27 24.56 0.18 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 128.588 2.755 . . . . 0.0 114.654 -163.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.1 40.21 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.085 1.802 . . . . 0.0 111.173 -176.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.47 148.39 25.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.287 -1.125 . . . . 0.0 111.81 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.608 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 46.6 p -95.91 -159.7 0.74 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.727 2.811 . . . . 0.0 109.872 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -63.96 -54.88 27.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.831 -1.793 . . . . 0.0 112.228 163.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -68.05 -38.7 82.78 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 114.446 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.608 ' HB2' ' H ' ' A' ' 77' ' ' THR . 35.2 mt-30 -68.52 -38.84 81.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.975 -1.703 . . . . 0.0 113.128 174.391 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.41 87.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.79 -1.819 . . . . 0.0 113.597 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.634 1.173 . . . . 0.0 110.751 175.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -51.93 -41.07 61.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 174.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -70.64 -24.66 62.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.705 1.602 . . . . 0.0 113.984 -175.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.85 -40.18 11.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.008 -1.683 . . . . 0.0 114.141 167.288 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -46.76 44.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.181 1.792 . . . . 0.0 114.786 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.88 34.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.935 -1.728 . . . . 0.0 113.496 -170.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.0 p -103.03 153.35 20.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.416 2.286 . . . . 0.0 114.158 -170.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.31 62.08 4.52 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.321 1.439 . . . . 0.0 115.888 -175.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.321 9.8 tt0 64.63 -50.68 0.31 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.354 3.462 . . . . 0.0 116.929 178.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.19 127.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.263 1.506 . . . . 0.0 109.8 173.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.11 104.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -79.09 102.78 8.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 165.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.59 113.85 23.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 110.39 -175.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.12 95.78 10.28 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.7 141.21 36.46 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.543 2.337 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.79 139.02 45.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.813 1.245 . . . . 0.0 109.287 167.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -65.17 110.13 2.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.467 2.307 . . . . 0.0 114.387 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.06 52.76 2.21 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 120.218 -1.552 . . . . 0.0 112.001 175.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -119.41 147.23 44.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.649 1.579 . . . . 0.0 107.962 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.4 m -82.21 152.75 68.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.673 -1.267 . . . . 0.0 110.25 176.131 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 N--CA 1.433 -2.056 0 CA-C-N 122.486 1.924 . . . . 0.0 111.503 175.756 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.8 tp -158.08 152.55 24.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.891 -1.131 . . . . 0.0 109.544 -176.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.374 15.6 t 67.59 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 124.352 2.025 . . . . 0.0 114.732 171.108 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 98.3 m -138.29 133.65 33.34 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 43.7 m -74.47 118.87 17.92 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.436 1.494 . . . . 0.0 109.509 171.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.572 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -176.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.429 -1.505 0 CA-C-O 121.741 0.781 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -132.14 150.0 74.81 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 120.633 -1.292 . . . . 0.0 107.881 179.457 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 148.35 40.76 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.496 2.131 . . . . 0.0 112.224 173.613 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.27 28.7 55.27 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 171.241 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -87.06 125.76 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.206 -1.173 . . . . 0.0 112.79 -163.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p -78.55 133.72 37.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.597 -1.314 . . . . 0.0 112.697 177.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.277 0.0 OUTLIER -131.2 132.61 44.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.749 1.22 . . . . 0.0 108.247 170.473 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -106.71 87.18 2.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.217 1.007 . . . . 0.0 109.102 175.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.4 t -90.68 122.84 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.205 2.202 . . . . 0.0 113.044 -174.73 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -105.73 118.36 36.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.005 -2.309 . . . . 0.0 113.22 -179.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 mt -120.12 160.85 22.04 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.943 -1.098 . . . . 0.0 111.161 -173.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.26 102.65 8.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.001 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.86 143.83 57.22 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -173.045 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 t -104.39 93.99 5.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.425 1.49 . . . . 0.0 109.627 -168.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.62 56.44 7.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.674 2.39 . . . . 0.0 114.156 -173.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.39 60.01 7.17 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.792 -1.193 . . . . 0.0 114.231 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -175.81 104.47 0.08 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.33 -49.98 30.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 164.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.03 37.63 0.3 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 113.307 -1.77 . . . . 0.0 111.605 165.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.05 130.69 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.324 1.059 . . . . 0.0 112.127 179.814 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -73.32 111.22 8.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.217 1.007 . . . . 0.0 111.954 160.575 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.8 m -84.12 124.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.44 169.7 9.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.459 1.904 . . . . 0.0 110.04 175.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.46 -121.51 5.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.481 1.515 . . . . 0.0 113.613 178.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.31 147.71 22.13 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -175.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 m -64.08 -11.23 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -171.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -48.57 -67.82 0.24 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.887 2.075 . . . . 0.0 115.574 -171.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -135.7 -82.67 0.4 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 111.469 -174.745 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -52.44 -24.38 7.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.02 2.97 . . . . 0.0 119.02 -166.159 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 m -85.28 -3.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.156 -1.59 . . . . 0.0 113.371 -178.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 21.3 mtp-105 71.38 23.95 3.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.15 2.18 . . . . 0.0 113.197 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.252 2.4 t-80 78.08 125.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.97 2.908 . . . . 0.0 112.554 -170.063 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.03 -111.18 0.24 Allowed Glycine 0 N--CA 1.431 -1.686 0 O-C-N 119.526 -1.983 . . . . 0.0 114.203 -160.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.42 -150.22 5.76 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 178.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -108.85 155.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 168.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.002 -1.686 . . . . 0.0 107.292 -171.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.7 t -79.9 130.68 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.375 -1.453 . . . . 0.0 110.432 173.384 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -90.3 -49.47 6.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.235 -1.541 . . . . 0.0 110.327 168.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.99 37.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.128 0.971 . . . . 0.0 109.824 -173.097 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mm -95.15 137.45 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 170.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.17 152.37 39.39 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 120.869 -1.145 . . . . 0.0 113.215 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -80.09 68.21 8.38 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.865 2.377 . . . . 0.0 112.397 168.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -121.51 -73.54 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.833 0.853 . . . . 0.0 111.254 171.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.42 -99.61 0.12 Allowed Glycine 0 N--CA 1.431 -1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 113.331 -169.034 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -49.04 -52.87 22.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 118.989 2.959 . . . . 0.0 118.989 -152.49 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 -28.89 61.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.184 -1.572 . . . . 0.0 114.991 179.07 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.14 -37.3 83.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.179 -1.576 . . . . 0.0 110.942 168.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -69.93 -1.7 10.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -178.373 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -71.56 -83.4 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.062 -2.274 . . . . 0.0 109.793 165.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.88 -41.08 0.93 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.957 -1.089 . . . . 0.0 111.561 174.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -84.94 -18.6 34.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.31 127.22 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.843 1.257 . . . . 0.0 110.836 176.303 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.8 -179.42 5.07 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.634 1.574 . . . . 0.0 110.359 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -76.52 70.55 3.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.326 1.45 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.68 -13.03 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.384 -1.447 . . . . 0.0 116.561 179.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -71.34 157.4 38.15 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -92.92 130.33 38.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.392 1.477 . . . . 0.0 110.216 -177.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.26 122.3 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.123 1.369 . . . . 0.0 107.754 167.809 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -32.84 8.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.993 -1.067 . . . . 0.0 113.155 175.101 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 159.72 44.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.763 -1.211 . . . . 0.0 112.811 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 t -141.08 123.66 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 111.863 -174.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.09 30.43 19.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.28 -1.512 . . . . 0.0 112.687 -178.26 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.84 78.06 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 125.73 1.633 . . . . 0.0 114.557 -174.245 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.92 109.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -177.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 m -60.57 146.21 45.98 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.124 1.44 . . . . 0.0 113.677 175.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -79.28 65.01 4.33 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.52 -1.362 . . . . 0.0 110.303 172.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.38 98.77 9.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.242 -1.536 . . . . 0.0 111.019 -176.307 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.93 66.43 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.361 -0.837 . . . . 0.0 112.896 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.82 129.15 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.955 1.836 . . . . 0.0 115.087 -170.178 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.491 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.5 p -93.4 -165.19 1.29 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.645 2.378 . . . . 0.0 107.741 -179.745 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.6 -49.99 75.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.085 -1.635 . . . . 0.0 112.737 164.735 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -69.83 -45.38 67.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' HB3' ' H ' ' A' ' 77' ' ' THR . 58.9 tt0 -69.22 -32.86 72.4 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.979 -1.076 . . . . 0.0 112.97 177.7 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.1 89.97 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.394 -1.441 . . . . 0.0 114.312 173.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.89 -52.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.398 -0.811 . . . . 0.0 110.146 171.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.24 -40.81 78.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.2 m -62.4 -28.78 70.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 175.054 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.27 -40.79 11.94 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.824 1.65 . . . . 0.0 115.057 172.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -75.69 -44.33 42.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.912 2.885 . . . . 0.0 113.483 -173.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -87.93 38.61 0.85 Allowed 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.336 -1.477 . . . . 0.0 111.471 -169.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.0 p -109.26 166.45 10.85 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.722 2.009 . . . . 0.0 112.125 -173.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.13 -89.09 0.19 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.199 -1.563 . . . . 0.0 115.564 -172.699 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.64 -62.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.602 -0.94 . . . . 0.0 110.177 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.2 t -75.09 125.79 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 122.961 1.362 . . . . 0.0 110.707 172.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.7 t -114.37 103.99 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -83.12 103.88 12.88 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 108.622 172.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.73 118.76 26.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.025 -1.047 . . . . 0.0 111.483 178.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 102.53 15.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.75 144.49 30.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.588 1.955 . . . . 0.0 110.427 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.98 132.15 54.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 163.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -74.33 121.86 22.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.961 0.905 . . . . 0.0 112.258 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.05 68.24 3.47 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -169.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -131.03 150.58 52.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.42 1.088 . . . . 0.0 110.892 174.388 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 p -98.5 131.93 25.08 Favored Pre-proline 0 N--CA 1.431 -1.39 0 C-N-CA 126.437 1.895 . . . . 0.0 110.14 -172.723 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo . . . . . 0 N--CA 1.433 -2.035 0 CA-C-N 123.326 2.223 . . . . 0.0 114.446 178.348 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 121.664 0.745 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.3 tp -144.04 166.13 25.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.831 -1.168 . . . . 0.0 110.041 -174.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.507 28.0 m 54.41 98.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 169.314 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 31.2 m -133.76 124.51 26.75 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 -174.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -69.83 128.78 37.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.488 1.115 . . . . 0.0 110.672 171.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.259 1.594 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -170.744 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 59.2 mtm . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -129.61 155.87 79.61 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 120.825 -1.172 . . . . 0.0 109.129 178.573 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -75.66 129.67 11.97 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.82 2.347 . . . . 0.0 111.517 167.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.52 40.41 96.14 Favored Glycine 0 N--CA 1.429 -1.811 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 170.687 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.84 118.49 22.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.207 -1.173 . . . . 0.0 109.48 177.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 p -90.83 135.42 33.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.728 -1.233 . . . . 0.0 111.202 174.033 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -131.11 137.55 49.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.558 1.143 . . . . 0.0 108.004 178.22 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.39 76.36 0.97 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.032 1.333 . . . . 0.0 109.364 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.74 121.71 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.044 1.738 . . . . 0.0 114.942 -169.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -99.54 116.56 31.95 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.512 -1.992 . . . . 0.0 110.46 174.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.29 170.68 15.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.51 141.06 49.53 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.967 -1.083 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -63.99 145.98 54.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.573 1.949 . . . . 0.0 112.593 174.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -101.73 101.65 12.18 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.392 1.091 . . . . 0.0 109.495 179.708 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.95 -20.77 0.06 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.704 2.802 . . . . 0.0 117.522 -173.226 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.16 43.81 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.799 -1.813 . . . . 0.0 111.97 179.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.9 p -174.12 129.07 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.3 mt -78.99 -40.55 31.31 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.716 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.56 43.19 0.59 Allowed Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.39 169.235 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 pt -120.21 134.73 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.695 0.76 . . . . 0.0 109.886 167.238 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.6 m -96.12 117.13 30.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.162 0.985 . . . . 0.0 111.042 169.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.67 142.09 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -167.339 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 159.51 40.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.855 1.662 . . . . 0.0 109.448 168.384 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.98 -141.79 16.3 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.839 1.209 . . . . 0.0 114.593 173.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -175.54 48.6 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.668 1.127 . . . . 0.0 115.252 -178.689 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.56 -15.74 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 127.634 2.374 . . . . 0.0 114.085 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.867 1.667 . . . . 0.0 112.942 174.707 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -126.98 -163.6 1.26 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.841 1.657 . . . . 0.0 107.547 174.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.9 p -107.78 105.67 15.62 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.899 -2.376 . . . . 0.0 110.669 174.085 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 m -106.08 -130.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 124.275 1.03 . . . . 0.0 110.598 -176.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -92.17 -67.0 0.88 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.071 -1.643 . . . . 0.0 108.755 168.151 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -156.81 62.64 0.52 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 178.545 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.11 8.24 87.96 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 117.619 1.808 . . . . 0.0 117.619 174.123 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 159.99 29.82 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 119.762 1.781 . . . . 0.0 112.779 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -107.64 162.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.338 -170.479 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.852 -1.78 . . . . 0.0 107.777 -173.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.2 t -96.68 125.16 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 120.558 -1.339 . . . . 0.0 111.469 176.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 -33.55 14.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.373 -1.454 . . . . 0.0 112.261 175.049 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.14 137.58 24.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 110.977 177.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.9 mm -96.23 140.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.581 1.952 . . . . 0.0 107.411 173.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.1 mt -82.76 131.95 53.05 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.853 -1.546 . . . . 0.0 109.521 169.249 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.64 101.41 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.106 2.537 . . . . 0.0 114.04 168.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt 68.88 50.2 0.63 Allowed 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.994 1.718 . . . . 0.0 114.669 170.573 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.48 -98.18 0.49 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 162.167 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.09 -38.79 2.13 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.689 1.195 . . . . 0.0 110.965 171.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.05 66.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.267 -1.521 . . . . 0.0 114.729 -175.16 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.56 -32.91 69.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.114 -1.616 . . . . 0.0 111.343 167.665 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -73.76 5.69 3.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 177.323 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.64 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.101 -2.249 . . . . 0.0 107.733 151.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.77 -42.14 0.6 Allowed Glycine 0 N--CA 1.431 -1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 112.712 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 2.5 mpt_? -79.7 -17.85 52.64 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.067 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -72.59 143.8 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.013 1.725 . . . . 0.0 112.457 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.13 -178.87 5.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.376 -1.452 . . . . 0.0 109.278 159.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.25 135.25 36.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.1 -1.625 . . . . 0.0 111.861 177.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.22 -21.53 17.39 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.619 1.104 . . . . 0.0 112.725 -170.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -71.55 159.65 34.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.217 1.407 . . . . 0.0 114.232 -172.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -101.53 134.88 43.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.753 1.263 . . . . 0.0 110.916 -177.47 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 t -112.6 111.75 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.063 2.545 . . . . 0.0 105.055 178.215 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.82 -33.66 9.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.422 -1.424 . . . . 0.0 113.64 -175.266 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.64 158.05 39.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.75 1.159 . . . . 0.0 113.361 -179.198 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.2 t -129.9 129.5 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.043 -1.036 . . . . 0.0 110.606 174.996 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.385 0.5 OUTLIER 39.25 43.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.927 2.491 . . . . 0.0 116.081 -171.879 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.87 12.26 81.54 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.452 1.501 . . . . 0.0 114.649 178.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.9 t -109.32 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.606 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 p -71.36 153.77 42.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.314 1.53 . . . . 0.0 113.301 174.038 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.56 74.15 7.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.452 1.12 . . . . 0.0 112.253 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -84.28 107.95 16.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.016 1.389 . . . . 0.0 110.052 176.242 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.84 11.18 84.8 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.339 -1.476 . . . . 0.0 116.373 -177.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.95 141.78 34.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 123.478 1.609 . . . . 0.0 114.909 -169.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.48 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 66.9 p -99.22 -156.74 0.56 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.067 2.147 . . . . 0.0 109.455 -175.555 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -53.48 19.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.129 -1.607 . . . . 0.0 110.563 164.458 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -69.8 -38.63 76.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.251 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.48 ' HB3' ' H ' ' A' ' 77' ' ' THR . 10.5 tt0 -65.42 -37.5 87.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.957 -1.714 . . . . 0.0 113.79 171.371 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.34 -36.22 83.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.678 -1.889 . . . . 0.0 114.397 172.747 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.11 -57.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.028 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -48.46 -38.89 21.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 175.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.4 m -65.3 -33.3 75.66 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.879 2.471 . . . . 0.0 113.759 177.077 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mt -90.87 -29.62 17.41 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.702 -1.874 . . . . 0.0 114.577 171.846 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.15 -48.62 7.91 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.676 2.39 . . . . 0.0 114.739 -168.738 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -87.2 37.92 0.79 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.034 -1.666 . . . . 0.0 111.531 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 35.7 p -95.59 159.47 14.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.435 2.694 . . . . 0.0 112.087 -175.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.03 63.32 3.77 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.796 -1.19 . . . . 0.0 114.251 -174.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.289 28.3 tt0 68.69 -51.51 0.57 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.377 2.671 . . . . 0.0 115.423 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.34 125.97 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.673 1.225 . . . . 0.0 110.513 170.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.67 107.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -89.53 96.63 10.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 124.26 34.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 111.825 -169.023 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.14 100.89 13.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.3 1.048 . . . . 0.0 108.286 165.372 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.9 147.54 26.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.221 2.208 . . . . 0.0 109.378 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.62 138.43 54.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.521 1.153 . . . . 0.0 108.481 166.206 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -74.59 118.78 17.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.968 -1.083 . . . . 0.0 112.2 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.82 4.07 Favored Glycine 0 N--CA 1.43 -1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 114.664 -164.568 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -129.66 140.06 51.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.762 1.225 . . . . 0.0 108.019 172.147 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.8 156.29 39.56 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 125.134 1.374 . . . . 0.0 110.054 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--N 1.299 -2.067 0 C-N-CA 122.529 2.153 . . . . 0.0 113.119 -179.026 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 123.092 1.425 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 17.5 tp -97.96 179.59 4.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.913 1.685 . . . . 0.0 109.745 -179.054 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.454 1.1 t 69.68 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 125.051 2.358 . . . . 0.0 115.69 154.313 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.0 m -130.5 122.3 27.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -170.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.8 p -74.27 130.03 38.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.609 1.563 . . . . 0.0 110.319 176.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 25' ' ' LEU . 11.7 p . . . . . 0 C--O 1.259 1.579 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -164.178 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.943 1.354 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.49 147.33 37.27 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 124.283 1.033 . . . . 0.0 109.204 178.208 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.96 149.77 37.38 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 123.198 2.178 . . . . 0.0 110.649 169.131 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.01 31.85 65.73 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 117.031 1.572 . . . . 0.0 117.031 173.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 120.48 38.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.836 -1.39 . . . . 0.0 111.068 -168.864 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -79.82 134.44 36.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.108 -1.62 . . . . 0.0 112.116 172.472 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.62 122.47 24.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.369 1.468 . . . . 0.0 109.088 176.734 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -88.35 86.41 7.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.384 1.564 . . . . 0.0 110.34 168.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.17 143.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.3 1.44 . . . . 0.0 108.876 176.177 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 117.92 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.894 -1.754 . . . . 0.0 109.65 174.668 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.1 mt -120.84 161.23 21.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.513 1.125 . . . . 0.0 109.916 -173.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.13 117.43 26.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 166.318 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -63.9 145.33 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.1 1.36 . . . . 0.0 114.303 -173.96 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.6 t -97.62 104.09 16.08 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 120.511 -1.368 . . . . 0.0 110.474 178.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 49.83 39.82 19.08 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.157 2.183 . . . . 0.0 115.28 -174.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 65.54 1.98 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 121.107 -0.996 . . . . 0.0 115.004 -173.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 46.6 t 177.98 114.01 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -175.305 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.8 mt -76.52 -38.25 55.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.5 27.65 2.32 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.122 169.067 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 pt -124.37 127.36 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.684 0.754 . . . . 0.0 109.96 -174.232 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -79.12 110.69 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.028 1.331 . . . . 0.0 114.003 173.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.46 129.39 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -176.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -124.27 167.88 13.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.727 . . . . 0.0 109.939 172.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.7 -152.03 42.06 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.975 1.274 . . . . 0.0 113.61 -177.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.0 165.7 19.65 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.288 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.07 -27.54 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.634 -1.509 . . . . 0.0 114.372 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -80.7 -11.68 59.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.848 -1.782 . . . . 0.0 113.402 179.338 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.9 m -88.52 -22.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 120.452 -1.405 . . . . 0.0 110.729 173.063 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m 77.74 87.85 0.07 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.324 2.25 . . . . 0.0 111.141 -177.195 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.19 -116.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -170.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.1 mmt-85 -82.7 -98.35 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.24 -1.538 . . . . 0.0 107.78 161.144 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -105.77 -35.06 7.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.978 2.111 . . . . 0.0 112.171 176.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.51 -127.48 1.11 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 104.121 -3.591 . . . . 0.0 104.121 178.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.61 -175.16 53.51 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 112.004 -167.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.4 tp -140.92 163.0 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -135.72 155.32 50.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.292 -1.505 . . . . 0.0 107.356 -173.177 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.96 121.39 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.758 -1.214 . . . . 0.0 111.611 -178.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.31 -34.48 18.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.246 -1.534 . . . . 0.0 113.21 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.21 132.68 18.64 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -177.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mm -93.48 126.3 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 166.561 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 pt -79.7 160.78 68.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 121.631 -0.668 . . . . 0.0 111.859 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.04 106.06 2.14 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.136 1.89 . . . . 0.0 112.178 168.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.524 0.1 OUTLIER 57.98 98.38 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.064 2.546 . . . . 0.0 117.521 179.385 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.15 -110.22 1.89 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 164.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.55 -42.06 2.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.302 1.441 . . . . 0.0 111.265 170.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.8 -41.1 79.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.668 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.77 -30.5 56.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.234 -1.541 . . . . 0.0 112.996 174.395 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -72.29 2.22 6.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 175.762 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.13 -99.86 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.874 -2.391 . . . . 0.0 109.045 162.519 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 -47.36 0.14 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.654 -1.904 . . . . 0.0 113.404 175.475 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 mtm-85 -69.2 -33.83 73.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.92 1.288 . . . . 0.0 113.143 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -52.13 129.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.062 2.945 . . . . 0.0 116.016 -175.386 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.87 177.79 8.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.57 -1.331 . . . . 0.0 110.93 167.38 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -72.16 121.26 19.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.475 -2.641 . . . . 0.0 112.445 175.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.06 0.95 11.55 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -176.264 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.95 158.69 29.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.528 2.164 . . . . 0.0 112.836 176.206 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -100.62 129.92 46.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.244 1.418 . . . . 0.0 108.971 178.453 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.52 117.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.03 -39.12 8.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.875 -1.765 . . . . 0.0 113.332 176.442 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.55 159.18 44.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 119.993 1.269 . . . . 0.0 113.721 -177.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG12 HG11 ' A' ' 92' ' ' VAL . 67.0 t -133.28 115.78 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 123.881 0.872 . . . . 0.0 111.271 179.905 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 52.49 27.11 4.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.066 -1.646 . . . . 0.0 115.305 -168.184 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 4.52 72.97 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 114.25 -173.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.39 93.5 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -177.636 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.5 p -71.42 135.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.34 1.067 . . . . 0.0 113.634 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.2 mt -80.12 56.67 2.48 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.081 2.152 . . . . 0.0 112.354 -174.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -73.35 82.04 1.4 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.289 2.236 . . . . 0.0 112.643 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.27 29.41 19.79 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 120.711 -1.243 . . . . 0.0 113.446 -178.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.29 149.85 35.32 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.687 1.232 . . . . 0.0 112.238 176.037 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -104.66 -163.27 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.503 1.921 . . . . 0.0 109.121 -176.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -66.72 -54.11 26.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 111.511 169.24 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -64.35 -46.54 82.98 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.499 1.12 . . . . 0.0 112.659 177.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -63.38 -41.76 98.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.417 -1.427 . . . . 0.0 113.654 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.21 -38.4 87.88 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.295 -1.503 . . . . 0.0 114.918 174.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.79 -56.34 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 118.7 0.682 . . . . 0.0 110.494 170.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 36.0 mt-10 -64.18 -25.45 68.08 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -65.13 -35.05 79.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.357 1.863 . . . . 0.0 111.186 173.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.95 -40.85 13.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.241 1.816 . . . . 0.0 114.507 174.123 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HG3' ' HA ' ' A' ' 83' ' ' GLU 0.356 0.0 OUTLIER -82.33 -35.59 27.75 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -174.457 . . . . . . . . 4 4 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -81.33 41.58 0.62 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.559 -1.963 . . . . 0.0 113.333 178.101 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -105.42 -169.02 1.53 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.087 2.155 . . . . 0.0 110.488 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.86 -117.02 3.99 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.194 1.378 . . . . 0.0 110.736 176.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -66.35 0.93 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.877 -1.367 . . . . 0.0 111.438 178.098 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.46 129.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.907 -174.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 68' ' ' VAL . 30.1 t -121.28 105.99 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 172.277 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -77.43 100.43 5.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.653 1.581 . . . . 0.0 108.844 165.368 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -84.6 111.83 19.89 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.462 1.505 . . . . 0.0 108.065 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 99.61 12.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 171.596 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.5 144.1 32.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.286 1.434 . . . . 0.0 109.802 -177.672 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.62 125.26 53.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 166.301 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -65.41 122.12 16.44 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.808 1.243 . . . . 0.0 113.567 -171.306 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.84 71.53 2.19 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.756 1.169 . . . . 0.0 112.622 -173.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -138.34 147.4 43.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -87.06 145.53 38.45 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 124.927 1.291 . . . . 0.0 110.001 -172.81 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo . . . . . 0 C--N 1.3 -2.025 0 CA-C-N 123.252 2.197 . . . . 0.0 114.25 173.321 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.54 -148.9 0.41 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.912 -1.117 . . . . 0.0 110.928 174.996 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER 85.8 112.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 123.981 1.848 . . . . 0.0 113.466 165.823 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.6 m -139.4 118.8 12.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 -172.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 85.8 p -73.14 129.1 37.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.383 0.992 . . . . 0.0 109.426 170.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.0 p . . . . . 0 C--O 1.261 1.697 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -161.306 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 120.782 0.325 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.55 148.3 38.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 174.439 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -72.93 161.9 42.42 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 122.902 2.401 . . . . 0.0 111.484 171.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.49 74.06 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 115.618 1.007 . . . . 0.0 115.618 -173.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -90.72 97.28 11.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.24 -1.741 . . . . 0.0 112.192 -172.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p -100.77 148.83 24.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.814 -1.179 . . . . 0.0 108.842 159.579 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 124.58 31.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.18 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.01 82.23 3.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.687 1.232 . . . . 0.0 108.567 176.27 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.54 153.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.301 1.44 . . . . 0.0 109.709 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -129.31 122.35 29.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.177 -1.577 . . . . 0.0 107.807 166.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -119.89 153.25 36.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.936 -1.103 . . . . 0.0 108.336 -173.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.07 8.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.63 123.9 15.61 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.85 1.66 . . . . 0.0 113.303 -168.873 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.259 11.1 t -85.7 104.45 15.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.303 -1.498 . . . . 0.0 110.978 -169.815 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.61 16.71 9.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 127.2 2.2 . . . . 0.0 116.019 -173.835 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.99 84.58 1.35 Allowed Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.262 -1.524 . . . . 0.0 111.041 -175.566 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.254 79.2 p 151.51 109.31 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.346 2.658 . . . . 0.0 107.447 -169.023 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.7 mt -68.13 -40.94 82.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.239 2.216 . . . . 0.0 107.369 161.047 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.74 32.23 2.73 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 124.953 1.263 . . . . 0.0 110.765 173.038 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 pt -121.37 130.7 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 121.86 -0.788 . . . . 0.0 109.484 174.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -87.04 119.33 27.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.026 0.917 . . . . 0.0 111.096 168.249 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 m -86.08 133.65 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -126.22 170.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.534 1.534 . . . . 0.0 110.83 176.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.91 -121.73 5.69 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 125.23 1.395 . . . . 0.0 113.461 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.39 155.05 30.78 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.624 1.107 . . . . 0.0 112.236 -177.884 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.58 -19.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 126.312 1.845 . . . . 0.0 114.154 -175.462 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.75 -42.39 90.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.189 2.596 . . . . 0.0 113.554 178.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.7 m -131.63 -97.7 0.32 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 123.166 0.587 . . . . 0.0 110.659 -171.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -100.85 78.03 1.91 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.025 -1.672 . . . . 0.0 114.102 -164.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.42 -176.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 165.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -80.78 -54.71 5.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.597 -1.314 . . . . 0.0 108.9 161.547 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.64 -2.09 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.384 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.86 126.96 0.92 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 119.018 -2.301 . . . . 0.0 110.898 -173.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.99 169.42 16.18 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 172.151 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.1 tp -116.13 155.87 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.488 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -132.66 152.3 51.72 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.236 -1.54 . . . . 0.0 107.904 -169.308 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.36 107.42 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.846 -1.158 . . . . 0.0 111.397 -170.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -86.93 -42.09 13.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.631 -1.918 . . . . 0.0 113.416 -177.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.55 133.13 47.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 113.576 176.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.9 128.93 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.884 2.474 . . . . 0.0 109.777 175.622 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.94 113.37 61.99 Favored Pre-proline 0 N--CA 1.429 -1.502 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.692 174.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.68 66.19 8.81 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.311 2.575 . . . . 0.0 113.45 171.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.59 15.3 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.576 2.35 . . . . 0.0 112.341 171.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.17 -108.67 2.07 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 119.528 -1.982 . . . . 0.0 111.667 174.267 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 -39.45 0.27 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.63 -0.924 . . . . 0.0 110.781 -175.108 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.57 -40.5 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.509 1.924 . . . . 0.0 113.652 -176.545 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -62.6 -33.57 75.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.286 -1.508 . . . . 0.0 111.227 170.122 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.35 1.66 7.45 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 174.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.25 -70.98 0.28 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.636 -1.915 . . . . 0.0 108.751 157.097 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -11.46 5.74 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 123.462 0.553 . . . . 0.0 112.984 164.278 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -94.78 -12.71 26.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.25 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -86.32 138.0 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.935 1.694 . . . . 0.0 112.746 -173.835 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -128.24 -171.95 2.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.858 1.263 . . . . 0.0 110.65 170.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -94.78 36.07 1.21 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.397 -2.064 . . . . 0.0 115.182 -163.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.9 16.85 1.07 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.372 -1.455 . . . . 0.0 111.749 175.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -92.62 151.5 20.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.894 0.854 . . . . 0.0 111.949 -162.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -96.64 124.67 40.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.073 0.949 . . . . 0.0 110.526 -176.242 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.2 108.67 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 167.488 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -39.69 11.51 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.949 -1.72 . . . . 0.0 112.09 178.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.63 38.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 119.509 1.049 . . . . 0.0 113.47 -176.355 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.36 118.21 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 123.58 0.752 . . . . 0.0 111.432 -175.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 61.72 29.6 18.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.049 1.295 . . . . 0.0 111.808 -173.549 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.18 4.35 89.78 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.509 -1.37 . . . . 0.0 115.278 -171.523 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.8 107.33 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 118.639 1.219 . . . . 0.0 108.081 -172.501 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 m -70.41 138.22 51.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.206 -0.934 . . . . 0.0 113.333 -178.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.46 37.95 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.298 1.839 . . . . 0.0 111.727 -178.055 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -84.53 74.29 10.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.669 1.988 . . . . 0.0 110.227 -169.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.63 9.6 6.94 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 124.175 0.893 . . . . 0.0 112.985 -170.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.49 140.46 32.3 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.147 1.473 . . . . 0.0 112.953 177.763 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.514 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.2 p -92.12 -160.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.706 2.002 . . . . 0.0 109.912 -178.735 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -66.5 -56.42 10.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.031 -1.668 . . . . 0.0 111.317 165.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -69.38 -38.4 77.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 121.355 -0.841 . . . . 0.0 112.673 -177.127 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.514 ' HB3' ' H ' ' A' ' 77' ' ' THR . 9.0 tt0 -65.96 -36.91 84.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 174.867 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.24 96.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.563 -1.96 . . . . 0.0 113.929 171.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 t -56.21 -49.8 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.74 1.216 . . . . 0.0 111.933 174.827 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.006 -1.684 . . . . 0.0 114.029 176.163 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.2 m -66.31 -24.72 66.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.303 1.841 . . . . 0.0 113.216 -179.313 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.44 -46.39 8.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.848 1.259 . . . . 0.0 114.138 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -85.47 -33.62 21.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.045 -1.66 . . . . 0.0 115.376 -169.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.53 34.23 0.98 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.901 -1.75 . . . . 0.0 111.032 -174.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.3 p -88.48 -166.15 1.52 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.368 2.667 . . . . 0.0 110.429 177.404 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.89 -123.92 3.79 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.019 -1.676 . . . . 0.0 110.138 170.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.8 -50.61 4.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.184 -1.186 . . . . 0.0 109.8 177.142 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.19 123.63 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 123.22 1.486 . . . . 0.0 110.776 176.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 t -114.58 112.48 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.833 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -78.51 116.11 18.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.72 110.08 22.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.027 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.72 99.91 12.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.532 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.55 142.89 36.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.37 1.868 . . . . 0.0 110.207 -173.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -121.81 151.61 40.41 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.004 1.722 . . . . 0.0 109.514 177.329 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 123.86 10.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 174.483 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.18 57.52 3.2 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.788 -1.82 . . . . 0.0 113.15 171.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -151.88 151.22 30.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 122.038 -0.683 . . . . 0.0 109.217 177.333 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.98 155.39 64.33 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 125.182 1.393 . . . . 0.0 111.612 -178.186 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.299 -2.048 0 C-N-CA 122.438 2.092 . . . . 0.0 115.657 -174.775 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.879 1.323 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 16.1 tp -141.21 -170.26 3.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.184 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.427 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.45 2.9 m 52.61 88.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.132 2.173 . . . . 0.0 115.077 170.302 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 61.7 m -126.77 118.21 24.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -168.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.3 p -79.59 120.45 23.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.4 1.08 . . . . 0.0 110.304 -179.37 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 2.8 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -169.155 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.474 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -130.73 142.83 46.95 Favored Pre-proline 0 N--CA 1.431 -1.412 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.576 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 142.49 30.59 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 123.139 2.157 . . . . 0.0 112.204 -179.408 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.82 17.22 73.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 124.398 0.999 . . . . 0.0 115.491 178.672 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -76.63 111.15 11.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.326 -1.103 . . . . 0.0 111.765 -174.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -81.81 146.47 29.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.461 1.124 . . . . 0.0 111.753 172.633 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.2 117.28 14.37 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.562 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.53 76.65 3.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.887 1.327 . . . . 0.0 109.601 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.03 116.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.706 2.402 . . . . 0.0 112.472 -169.211 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.332 0.2 OUTLIER -104.56 118.36 36.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.834 -1.791 . . . . 0.0 112.078 -173.999 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 mt -127.72 178.38 6.18 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.768 -1.207 . . . . 0.0 109.216 -171.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.28 119.33 22.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 162.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HB3' ' H ' ' A' ' 24' ' ' SER . 2.1 mtpt -62.31 128.6 36.83 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.576 -1.328 . . . . 0.0 113.09 -174.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -88.72 121.02 30.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.505 -1.372 . . . . 0.0 109.392 179.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.26 4.59 3.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.845 2.058 . . . . 0.0 114.743 178.182 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.93 86.24 0.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 125.527 1.537 . . . . 0.0 110.581 -164.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.55 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 37.3 m 163.57 119.81 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 128.192 2.597 . . . . 0.0 106.584 -169.697 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' CD2' HG21 ' A' ' 92' ' ' VAL . 23.6 mt -72.7 -37.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.785 1.755 . . . . 0.0 109.095 162.778 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.58 34.66 4.05 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.141 178.726 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.9 pt -119.99 136.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 122.031 -0.688 . . . . 0.0 109.683 173.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.2 m -84.46 122.35 28.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 123.307 0.643 . . . . 0.0 109.754 160.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 m -85.13 132.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.617 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -122.85 161.83 23.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.538 -1.976 . . . . 0.0 109.691 174.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.72 -148.62 30.69 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.764 1.174 . . . . 0.0 113.998 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.83 146.91 5.46 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 p -54.1 -21.36 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 126.525 1.93 . . . . 0.0 114.996 -178.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -51.01 -60.15 3.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.593 1.957 . . . . 0.0 114.618 -174.858 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.0 t -152.18 -57.96 0.15 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.356 -1.465 . . . . 0.0 112.694 -172.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.9 p -67.53 -13.78 62.36 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -162.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.2 7.07 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 120.685 -1.259 . . . . 0.0 113.106 -178.163 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 58.97 59.82 2.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.392 1.477 . . . . 0.0 113.022 -172.189 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 m170 52.11 82.65 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.15 -117.18 1.27 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.095 -1.628 . . . . 0.0 113.781 -177.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -137.35 2.98 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.931 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.27 2.1 tp -116.04 157.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 119.644 1.722 . . . . 0.0 110.7 -173.976 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -140.5 152.79 45.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -170.511 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 t -87.99 131.66 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.698 -1.877 . . . . 0.0 111.506 -178.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -96.98 -52.38 3.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.908 -1.12 . . . . 0.0 111.213 175.75 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.81 118.07 17.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.074 -1.016 . . . . 0.0 111.163 -171.671 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.92 129.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 126.28 1.832 . . . . 0.0 109.346 177.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.9 mt -78.16 121.19 83.59 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.449 174.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 54.9 Cg_endo -81.29 66.85 8.66 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.653 2.34 . . . . 0.0 113.062 -178.301 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt 170.47 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.43 1.892 . . . . 0.0 115.055 175.256 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.18 -74.33 0.57 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -159.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.32 -56.09 0.09 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.324 -1.104 . . . . 0.0 111.114 -178.165 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.05 80.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.352 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 18.7 tp10 -51.72 -35.83 44.61 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.107 1.363 . . . . 0.0 113.548 167.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 -16.18 46.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.97 -77.15 0.07 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.019 0.927 . . . . 0.0 110.281 164.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.36 -20.95 3.9 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 114.804 160.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.76 -13.62 60.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 118.778 1.289 . . . . 0.0 113.479 178.002 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 141.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 125.082 1.353 . . . . 0.0 113.542 -176.328 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.69 -174.24 3.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.697 -1.252 . . . . 0.0 110.372 169.055 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -81.69 56.25 2.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.388 -1.445 . . . . 0.0 112.914 -175.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -172.56 -8.91 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.248 -0.908 . . . . 0.0 114.58 -176.443 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.68 157.67 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.663 1.732 . . . . 0.0 114.855 -177.1 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -93.7 123.8 37.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.42 1.088 . . . . 0.0 110.412 -176.722 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.78 110.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.588 -1.32 . . . . 0.0 107.983 174.104 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.45 -26.59 12.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.64 172.0 17.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.62 2.009 . . . . 0.0 113.239 176.336 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.89 120.51 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 177.019 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.501 0.0 OUTLIER 30.22 43.77 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.0 2.963 . . . . 0.0 119.0 -151.501 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.48 10.31 86.03 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 126.452 1.977 . . . . 0.0 115.366 -175.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.16 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.472 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -63.72 130.43 44.21 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.063 1.745 . . . . 0.0 115.576 -170.318 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mt -89.42 -6.65 56.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.969 2.108 . . . . 0.0 110.366 171.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.94 108.74 9.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.988 -1.695 . . . . 0.0 109.202 172.047 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.62 28.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.181 -0.95 . . . . 0.0 113.421 -163.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 142.07 34.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.791 -1.417 . . . . 0.0 113.08 -179.506 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.568 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 60.4 p -91.1 -162.0 0.87 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.868 2.467 . . . . 0.0 109.746 -177.89 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -62.87 -51.62 66.3 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.647 -1.908 . . . . 0.0 111.47 167.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -65.26 -50.62 65.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.339 1.055 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' HB2' ' H ' ' A' ' 77' ' ' THR . 2.3 mp0 -63.03 -33.37 75.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.607 -1.308 . . . . 0.0 113.856 177.471 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.85 89.61 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 120.263 1.392 . . . . 0.0 114.185 174.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -59.12 -51.21 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 121.58 -0.7 . . . . 0.0 111.212 176.058 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -63.44 -32.58 74.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.346 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.4 m -60.72 -45.18 95.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.886 1.674 . . . . 0.0 112.332 172.27 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.6 -41.3 12.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 113.323 -174.476 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -44.12 56.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -88.47 42.32 1.06 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.654 -1.904 . . . . 0.0 112.421 -169.711 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 p -99.5 -171.0 1.99 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.407 3.483 . . . . 0.0 109.496 177.13 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.93 -132.95 4.53 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.533 -1.354 . . . . 0.0 111.681 175.106 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -93.37 -52.17 4.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.403 -1.645 . . . . 0.0 112.563 178.136 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.59 130.98 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 122.0 0.905 . . . . 0.0 111.308 176.596 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.422 HG21 ' CD2' ' A' ' 25' ' ' LEU . 3.9 m -122.23 113.45 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.405 1.082 . . . . 0.0 108.086 172.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -81.57 94.26 6.87 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.552 -1.343 . . . . 0.0 108.826 160.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mt -73.3 110.49 7.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.034 1.333 . . . . 0.0 110.053 178.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.38 100.43 11.84 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.455 -0.778 . . . . 0.0 110.358 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.71 149.07 28.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.986 1.714 . . . . 0.0 109.585 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -124.44 147.49 48.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.94 1.296 . . . . 0.0 108.36 167.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -58.37 115.35 2.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 176.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.92 61.93 0.94 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.639 1.114 . . . . 0.0 110.686 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -144.02 156.57 44.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.52 166.39 39.97 Favored Pre-proline 0 N--CA 1.429 -1.486 0 C-N-CA 124.344 1.057 . . . . 0.0 111.917 176.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo . . . . . 0 C--N 1.299 -2.049 0 C-N-CA 123.058 2.505 . . . . 0.0 112.759 168.514 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' B' B ' 206' ' ' LEU . . . . . 0.636 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp 65.92 -147.55 0.21 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.532 1.933 . . . . 0.0 113.076 -178.842 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.636 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.378 15.4 m 23.14 100.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.155 3.782 . . . . 0.0 119.663 161.87 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -130.55 123.05 28.71 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 -176.42 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.5 p -72.17 129.02 37.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.093 0.949 . . . . 0.0 110.068 169.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.26 1.619 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 -158.466 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.399 0 CA-C-O 121.678 0.752 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.18 118.1 33.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.963 1.305 . . . . 0.0 109.093 174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.23 92.06 7.05 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.051 1.405 . . . . 0.0 110.078 170.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.2 t -89.45 127.91 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 126.315 1.846 . . . . 0.0 112.454 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 0.0 OUTLIER -108.35 122.54 47.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.012 -2.305 . . . . 0.0 110.238 174.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.84 157.64 37.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.005 -173.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.05 113.22 22.89 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 163.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -56.41 132.45 51.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.262 1.425 . . . . 0.0 113.953 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.5 t -97.74 110.13 22.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.605 -1.31 . . . . 0.0 109.138 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 46.07 55.43 7.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.896 2.478 . . . . 0.0 115.457 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.98 51.22 19.72 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.714 -1.241 . . . . 0.0 114.828 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 p -178.24 111.57 0.07 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.3 mt -66.63 -53.51 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.408 2.283 . . . . 0.0 108.15 166.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.796 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 133.96 26.73 0.56 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.911 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 44' ' ' VAL . 11.2 pt -126.27 137.61 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.306 1.05 . . . . 0.0 111.171 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -87.27 119.82 27.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.982 1.713 . . . . 0.0 111.649 164.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 29' ' ' VAL . 21.8 m -84.63 140.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.02 178.25 7.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.463 1.905 . . . . 0.0 109.291 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 -118.2 4.73 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.27 1.414 . . . . 0.0 113.105 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.79 162.2 36.01 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 121.432 -1.04 . . . . 0.0 112.502 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.274 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.458 ' H ' HD13 ' A' ' 73' ' ' LEU . 6.3 tp -107.25 156.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.94 157.54 46.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.877 -1.764 . . . . 0.0 106.416 -170.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' ILE . 9.6 t -87.32 131.29 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.141 -1.599 . . . . 0.0 111.9 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -41.48 9.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.367 -1.458 . . . . 0.0 110.816 171.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.45 136.03 25.7 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.032 -1.042 . . . . 0.0 111.102 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.509 HD13 HG11 ' A' ' 44' ' ' VAL . 36.2 mm -97.43 137.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 127.017 2.127 . . . . 0.0 108.597 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.796 HD12 ' HA2' ' A' ' 26' ' ' GLY . 50.1 mt . . . . . 0 N--CA 1.43 -1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 110.151 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.73 54.19 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.181 2.192 . . . . 0.0 115.104 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.53 -26.93 68.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.923 -1.736 . . . . 0.0 112.292 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -70.11 -18.73 63.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.033 -1.667 . . . . 0.0 115.066 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.74 -71.57 0.24 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.036 -2.29 . . . . 0.0 107.368 157.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.0 5.63 62.4 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 161.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -80.75 -19.37 45.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 110.115 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.08 149.29 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.298 1.839 . . . . 0.0 114.253 162.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.44 -161.23 1.11 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.62 1.568 . . . . 0.0 107.464 157.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.3 45.45 1.28 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.959 -2.338 . . . . 0.0 112.549 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.73 -20.13 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 O-C-N 120.609 -1.307 . . . . 0.0 114.807 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -78.76 161.06 27.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -166.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -104.07 124.65 49.44 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.64 1.576 . . . . 0.0 110.411 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.26 117.24 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 107.248 166.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 -36.19 9.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.824 -1.797 . . . . 0.0 112.754 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.26 154.22 38.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.82 -1.175 . . . . 0.0 111.401 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.04 121.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.065 -1.022 . . . . 0.0 111.259 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.8 t30 63.77 21.33 12.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.643 -1.285 . . . . 0.0 113.389 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.94 20.38 63.34 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.665 -1.272 . . . . 0.0 113.492 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.9 110.67 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 121.079 -1.248 . . . . 0.0 107.99 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.7 m -58.13 141.18 51.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.383 1.873 . . . . 0.0 114.543 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 42' ' ' ILE . 4.3 mt -81.08 47.62 1.03 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.284 1.516 . . . . 0.0 111.889 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.76 117.03 21.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.196 1.799 . . . . 0.0 109.707 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.86 72.02 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 114.734 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.21 132.76 36.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.529 1.633 . . . . 0.0 112.639 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -110.46 -164.92 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.006 2.523 . . . . 0.0 105.517 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -58.18 -52.17 66.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.557 -1.965 . . . . 0.0 112.947 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -70.53 -44.63 67.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.121 0.968 . . . . 0.0 112.583 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -38.83 92.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.05 1.34 . . . . 0.0 113.807 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.32 97.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 0.0 114.312 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.37 -54.51 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 118.127 0.421 . . . . 0.0 110.247 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.77 -37.12 40.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 126.085 1.754 . . . . 0.0 115.351 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.7 m -72.22 -31.46 65.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.68 2.392 . . . . 0.0 113.898 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -89.02 -37.94 14.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.242 1.817 . . . . 0.0 114.102 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -82.97 -45.45 14.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.624 1.97 . . . . 0.0 113.378 -166.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -90.88 37.32 0.92 Allowed 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.038 1.399 . . . . 0.0 112.623 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.8 p -90.1 173.51 8.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.949 2.1 . . . . 0.0 114.058 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.71 51.39 4.45 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.673 -1.892 . . . . 0.0 113.972 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 68.27 -51.78 0.54 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.299 3.04 . . . . 0.0 115.673 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.6 t -76.86 128.46 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 123.144 1.449 . . . . 0.0 109.844 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.03 100.22 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -82.26 98.49 8.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.875 1.67 . . . . 0.0 107.987 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -87.51 112.75 22.55 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.322 1.449 . . . . 0.0 109.878 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.26 100.52 12.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.84 136.97 44.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.413 1.885 . . . . 0.0 110.881 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.28 158.23 17.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.134 1.774 . . . . 0.0 109.37 171.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.551 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.6 tp . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.551 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.419 16.0 m 33.12 89.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 129.934 3.294 . . . . 0.0 116.775 171.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 64.5 m -125.11 121.83 35.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.0 p -71.62 121.1 18.18 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.574 1.15 . . . . 0.0 109.779 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.636 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.911 0.862 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.58 121.54 37.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.517 1.127 . . . . 0.0 108.599 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -88.74 87.63 7.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.965 1.364 . . . . 0.0 111.021 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.9 t -85.82 110.77 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.941 1.696 . . . . 0.0 111.493 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.58 123.21 40.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.621 -1.924 . . . . 0.0 108.24 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.11 172.36 12.48 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.13 128.77 55.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 158.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.3 137.17 52.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.578 1.151 . . . . 0.0 110.565 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -89.35 92.2 9.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.015 -1.678 . . . . 0.0 110.67 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.5 -18.82 0.11 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.52 61.07 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 119.983 -1.698 . . . . 0.0 110.028 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -179.97 119.64 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.875 1.797 . . . . 0.0 107.266 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' CD2' HG21 ' A' ' 92' ' ' VAL . 16.9 mt -74.87 -47.54 29.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.001 1.857 . . . . 0.0 106.575 162.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 112.01 39.94 1.23 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.426 1.489 . . . . 0.0 111.4 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' A' ' 44' ' ' VAL . 42.9 pt -124.85 136.65 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.812 0.815 . . . . 0.0 109.713 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 m -88.31 121.57 30.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.342 1.457 . . . . 0.0 111.398 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.11 138.41 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -174.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.2 t -138.6 175.9 9.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.16 2.584 . . . . 0.0 108.581 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 -128.34 9.02 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 113.123 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.8 163.49 39.44 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.796 -1.414 . . . . 0.0 114.525 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.431 -1.401 0 C-N-CA 126.697 1.999 . . . . 0.0 114.615 -175.145 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -105.57 160.33 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.9 160.31 38.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.926 -1.734 . . . . 0.0 107.017 -171.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' ILE . 4.0 t -92.07 134.46 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.429 -1.42 . . . . 0.0 112.219 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -99.56 -36.64 9.46 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.72 -1.237 . . . . 0.0 111.441 171.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.05 129.95 16.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.216 -1.553 . . . . 0.0 111.654 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.509 HD13 HG11 ' A' ' 44' ' ' VAL . 38.6 mm -95.25 136.86 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 108.816 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.695 HD12 ' HA2' ' A' ' 26' ' ' GLY . 62.4 mt . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 119.919 -1.738 . . . . 0.0 110.176 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 121.687 0.756 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.87 63.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.081 1.753 . . . . 0.0 114.656 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.73 -28.37 67.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.44 -1.412 . . . . 0.0 112.956 171.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -14.54 63.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.69 -70.52 0.34 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.163 -1.586 . . . . 0.0 108.685 159.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.47 6.64 56.42 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 114.206 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -78.83 -27.62 44.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.301 -1.705 . . . . 0.0 109.102 164.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -69.27 143.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.873 1.669 . . . . 0.0 114.198 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -132.61 172.81 12.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.696 -1.252 . . . . 0.0 110.049 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -82.62 58.39 4.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.686 -1.884 . . . . 0.0 113.458 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.55 31.4 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -103.75 159.19 15.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -100.73 130.22 46.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.713 1.205 . . . . 0.0 109.772 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.21 114.35 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.98 -34.11 11.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.575 -1.328 . . . . 0.0 112.225 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.08 165.34 37.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.217 1.371 . . . . 0.0 113.327 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 HD23 ' A' ' 85' ' ' LEU . 14.9 t -134.27 119.17 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 110.552 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.89 27.1 8.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 121.101 1.773 . . . . 0.0 115.247 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.67 17.82 74.55 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 120.88 -1.137 . . . . 0.0 114.5 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.9 98.29 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 t -68.64 137.12 53.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.277 1.431 . . . . 0.0 114.642 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.93 30.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.855 2.062 . . . . 0.0 111.702 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 10.49 1.19 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -167.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.62 36.59 0.39 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.829 -1.17 . . . . 0.0 110.401 166.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.32 37.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.059 0.943 . . . . 0.0 113.31 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -108.73 -161.59 0.77 Allowed 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.415 2.286 . . . . 0.0 106.859 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -55.09 -55.97 25.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.637 1.975 . . . . 0.0 114.09 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -64.64 -54.45 31.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.082 0.944 . . . . 0.0 112.724 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -41.09 71.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.132 1.773 . . . . 0.0 114.256 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.51 89.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.208 -1.558 . . . . 0.0 114.844 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.1 t -57.52 -52.5 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 119.196 0.907 . . . . 0.0 110.333 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.03 -35.9 74.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.6 m -64.58 -34.65 78.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.966 1.706 . . . . 0.0 113.772 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 68' ' ' VAL . 16.5 mt -87.98 -39.48 14.66 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.258 -1.526 . . . . 0.0 113.481 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -50.81 10.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.409 2.284 . . . . 0.0 113.986 -173.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.59 43.03 0.94 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 124.023 1.868 . . . . 0.0 112.044 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.4 p -99.08 174.64 6.24 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.93 2.892 . . . . 0.0 108.35 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.24 -131.22 0.76 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.646 -1.284 . . . . 0.0 112.743 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -97.19 -49.78 4.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.023 -1.281 . . . . 0.0 110.45 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.6 129.88 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.184 1.468 . . . . 0.0 110.977 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.573 HG21 ' CD2' ' A' ' 25' ' ' LEU . 13.9 m -121.37 110.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.821 1.648 . . . . 0.0 107.062 170.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -82.84 96.15 8.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 161.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.38 122.42 24.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.748 -1.22 . . . . 0.0 110.817 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.8 103.58 15.48 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 108.664 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -112.83 144.54 42.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.155 1.382 . . . . 0.0 110.219 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -119.29 133.63 55.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.013 1.325 . . . . 0.0 109.519 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.403 0 C-N-CA 125.068 1.347 . . . . 0.0 114.386 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.517 17.4 m 61.92 98.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.001 2.521 . . . . 0.0 116.531 171.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.2 m -129.43 120.99 26.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.4 p -71.36 135.72 47.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.168 0.987 . . . . 0.0 109.796 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.259 1.604 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -166.062 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.375 0.607 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 134.42 54.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.77 1.228 . . . . 0.0 107.947 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.21 68.49 0.71 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.94 1.352 . . . . 0.0 108.819 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.4 t -75.97 112.77 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.522 2.329 . . . . 0.0 112.21 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.29 3.0 pm0 -100.74 120.84 40.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.879 -1.763 . . . . 0.0 111.708 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 94' ' ' LEU . 13.4 mt -133.73 174.34 10.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.56 1.144 . . . . 0.0 108.802 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.03 125.52 52.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 160.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.93 143.82 41.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 113.117 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -91.15 87.28 6.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.965 1.364 . . . . 0.0 110.69 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 67.58 6.88 5.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.947 2.099 . . . . 0.0 115.404 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.47 72.88 0.53 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.8 t 167.97 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.332 1.853 . . . . 0.0 108.447 -166.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.3 mt -70.14 -45.13 67.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 154.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.12 40.67 0.95 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 124.848 1.213 . . . . 0.0 110.68 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -127.84 134.22 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.962 0.887 . . . . 0.0 109.862 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.5 m -85.07 120.46 26.6 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 123.677 0.791 . . . . 0.0 111.553 163.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.54 142.35 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -142.8 170.72 15.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.316 1.446 . . . . 0.0 110.0 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 -130.96 10.55 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.053 1.311 . . . . 0.0 112.368 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.32 157.62 31.56 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.598 1.094 . . . . 0.0 111.421 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.43 -1.469 0 C-N-CA 126.391 1.877 . . . . 0.0 113.193 173.49 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.724 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.421 HG22 HG13 ' A' ' 65' ' ' VAL . 6.2 tp -143.31 160.93 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.289 -1.712 . . . . 0.0 106.79 160.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -125.56 166.74 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.092 -1.63 . . . . 0.0 107.291 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.4 t -83.89 141.35 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.085 -1.634 . . . . 0.0 110.216 170.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -97.09 -57.69 2.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.803 -1.185 . . . . 0.0 109.535 160.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.69 145.11 49.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.879 0.872 . . . . 0.0 111.135 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.1 mm -101.07 131.94 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.279 1.831 . . . . 0.0 106.706 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt . . . . . 0 N--CA 1.431 -1.381 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.339 179.115 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.517 0 CA-C-O 121.667 0.746 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.18 59.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 126.213 1.805 . . . . 0.0 114.443 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.7 -32.54 67.48 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.032 -1.668 . . . . 0.0 113.06 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -70.54 -0.62 8.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.69 -96.98 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.209 -2.182 . . . . 0.0 107.553 156.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.93 -14.42 0.77 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.75 -1.219 . . . . 0.0 113.067 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -84.63 -23.45 29.52 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.939 -1.33 . . . . 0.0 110.733 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.39 135.22 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.181 2.592 . . . . 0.0 113.965 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.58 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 4.1 t-80 -143.98 -173.72 4.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.419 1.58 . . . . 0.0 114.343 167.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.58 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 78.4 mttt -89.22 81.16 6.76 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.185 1.794 . . . . 0.0 111.348 -164.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.98 -14.28 0.77 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.17 -0.956 . . . . 0.0 113.029 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.84 170.26 8.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -106.3 143.83 33.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.232 1.413 . . . . 0.0 109.643 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.421 HG13 HG22 ' A' ' 42' ' ' ILE . 3.9 p -110.48 129.38 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 164.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.05 -32.84 8.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.878 -1.764 . . . . 0.0 112.211 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.03 156.89 42.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.729 -1.232 . . . . 0.0 112.441 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.539 HG21 HD23 ' A' ' 85' ' ' LEU . 3.6 t -136.15 120.77 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.083 -1.01 . . . . 0.0 110.784 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.3 t30 65.3 19.21 11.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.892 1.277 . . . . 0.0 112.736 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.17 46.25 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.601 -1.312 . . . . 0.0 113.284 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.95 104.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.3 p -65.56 138.51 58.1 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.323 1.449 . . . . 0.0 114.32 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -80.71 49.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.31 1.844 . . . . 0.0 111.247 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.44 107.96 6.91 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.584 1.554 . . . . 0.0 110.643 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 29.61 62.48 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 114.025 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.84 137.25 33.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.567 1.651 . . . . 0.0 113.555 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.6 p -93.66 -165.74 1.38 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.365 1.866 . . . . 0.0 108.341 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -64.71 -50.07 68.38 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 119.547 -1.971 . . . . 0.0 111.371 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -64.28 -49.04 73.38 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.393 1.077 . . . . 0.0 113.194 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -67.69 -30.95 70.6 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.603 -1.311 . . . . 0.0 114.332 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.14 93.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.126 -1.609 . . . . 0.0 114.48 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.4 t -53.68 -51.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.609 1.163 . . . . 0.0 111.574 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -58.4 -43.4 88.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.512 -1.368 . . . . 0.0 114.463 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.0 m -65.53 -30.79 71.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.551 1.54 . . . . 0.0 114.508 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.539 HD23 HG21 ' A' ' 68' ' ' VAL . 19.9 mt -88.62 -49.23 7.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.946 1.298 . . . . 0.0 112.096 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.22 44.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -91.63 37.75 0.97 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.071 -1.643 . . . . 0.0 110.898 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 p -94.06 170.09 9.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.053 2.141 . . . . 0.0 108.125 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.1 -79.24 1.04 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 119.83 -1.794 . . . . 0.0 112.693 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -137.75 -57.7 0.68 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.653 -0.91 . . . . 0.0 108.979 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.5 t -78.07 130.47 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 123.114 1.435 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.482 HG21 HD22 ' A' ' 25' ' ' LEU . 13.3 m -115.26 117.88 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.464 1.106 . . . . 0.0 108.157 167.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -85.72 97.54 10.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.258 -1.527 . . . . 0.0 107.349 161.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 18' ' ' LEU . 9.8 mt -85.19 112.57 20.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 110.762 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.07 105.19 17.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.168 0.987 . . . . 0.0 108.719 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mt -117.9 144.26 45.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.589 1.555 . . . . 0.0 111.352 -165.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.07 138.67 54.61 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.462 1.505 . . . . 0.0 109.637 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp . . . . . 0 N--CA 1.43 -1.443 0 C-N-CA 124.731 1.212 . . . . 0.0 113.735 -172.362 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 5.5 tp . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.619 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.411 1.9 t 38.22 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 129.81 3.244 . . . . 0.0 116.281 152.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 46.7 m -138.04 122.61 18.52 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 102.941 -2.985 . . . . 0.0 102.941 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -83.52 127.91 34.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.006 0.908 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.261 1.678 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -163.097 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 122.525 1.155 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.04 120.01 33.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.85 74.41 3.58 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.359 1.064 . . . . 0.0 108.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.94 153.12 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 127.187 2.195 . . . . 0.0 110.02 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -130.33 123.03 29.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.945 -1.722 . . . . 0.0 109.501 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -122.89 174.85 6.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.516 1.126 . . . . 0.0 109.29 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.51 136.87 54.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 153.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 24' ' ' SER . 7.7 ptpt -66.85 130.25 42.54 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.067 1.747 . . . . 0.0 113.365 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 101.52 13.3 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.527 -1.358 . . . . 0.0 109.649 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 51.37 64.95 1.64 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.733 2.013 . . . . 0.0 114.01 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.48 72.64 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.869 -1.144 . . . . 0.0 115.234 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.42 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 35.9 t -172.75 99.01 0.14 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.62 -41.99 95.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.363 2.265 . . . . 0.0 107.075 164.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 106.29 46.32 1.16 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.359 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -123.36 136.9 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 124.358 0.681 . . . . 0.0 110.108 165.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.3 m -84.72 120.0 25.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.3 1.04 . . . . 0.0 110.677 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -90.01 129.82 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -126.54 165.33 19.35 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.232 -2.167 . . . . 0.0 110.958 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 -130.58 10.37 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.333 1.444 . . . . 0.0 113.221 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.2 158.69 24.15 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.756 1.646 . . . . 0.0 110.897 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.429 -1.475 0 C-N-CA 125.098 1.359 . . . . 0.0 114.12 -177.245 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 65' ' ' VAL . 3.8 tp -115.99 151.03 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 167.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.14 153.69 46.59 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.282 -2.137 . . . . 0.0 105.512 -168.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.458 HG11 HD13 ' A' ' 47' ' ' ILE . 15.5 t -82.69 127.03 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.593 -1.942 . . . . 0.0 111.535 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -84.43 -54.49 4.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.497 -1.377 . . . . 0.0 109.977 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 137.82 34.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.292 0.637 . . . . 0.0 110.321 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.458 HD13 HG11 ' A' ' 44' ' ' VAL . 44.9 mm -90.62 144.98 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.271 1.828 . . . . 0.0 107.582 175.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 26' ' ' GLY . 59.8 mt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 119.725 -1.859 . . . . 0.0 108.326 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.43 0 CA-C-O 121.858 0.837 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -46.88 60.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.824 -1.798 . . . . 0.0 113.072 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.11 -32.87 56.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.803 1.287 . . . . 0.0 113.576 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 p -59.24 -20.98 58.72 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.18 -79.35 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.435 1.094 . . . . 0.0 110.939 167.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.88 -19.32 6.15 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 121.463 -0.773 . . . . 0.0 113.913 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -30.16 60.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.816 -1.402 . . . . 0.0 112.319 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.81 140.79 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -134.83 -164.08 1.47 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -73.42 150.73 41.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.479 -2.013 . . . . 0.0 110.725 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.38 74.75 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 120.57 -1.331 . . . . 0.0 115.445 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.09 148.86 41.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 118.896 1.348 . . . . 0.0 111.891 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.45 112.33 25.18 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.88 1.272 . . . . 0.0 110.036 -168.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 42' ' ' ILE 0.26 3.5 p -84.47 116.03 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 119.963 -1.71 . . . . 0.0 108.36 173.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 -37.18 12.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.181 -1.574 . . . . 0.0 111.436 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.14 28.31 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.166 0.984 . . . . 0.0 112.906 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.35 128.94 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.75 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 52.61 18.97 1.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.86 -2.4 . . . . 0.0 117.408 -170.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.1 6.15 63.4 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.425 -1.422 . . . . 0.0 114.945 -171.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -108.03 101.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 125.726 1.611 . . . . 0.0 109.786 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.8 m -68.72 145.02 54.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -82.16 43.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.033 2.533 . . . . 0.0 112.848 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.55 117.33 23.06 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.928 -1.733 . . . . 0.0 110.72 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.5 86.55 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 123.926 0.774 . . . . 0.0 113.436 -170.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.87 133.96 33.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.939 1.37 . . . . 0.0 113.434 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.6 p -97.14 -160.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.402 2.681 . . . . 0.0 108.228 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -63.77 -55.96 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.045 -1.659 . . . . 0.0 111.771 164.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -64.98 -38.76 92.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.86 -37.31 73.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.789 -1.819 . . . . 0.0 114.149 174.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.62 76.42 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.2 -1.563 . . . . 0.0 114.22 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.3 t -58.93 -56.37 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.729 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.97 -43.23 63.46 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 m -56.18 -45.55 79.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.188 2.195 . . . . 0.0 114.629 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.91 -32.38 15.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.746 -1.846 . . . . 0.0 115.26 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -79.34 -50.08 11.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.488 1.515 . . . . 0.0 113.145 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -92.19 52.23 1.92 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.126 -1.609 . . . . 0.0 111.922 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.1 p -95.04 -164.96 1.23 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.303 2.241 . . . . 0.0 110.656 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.25 -75.43 1.19 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.089 -1.632 . . . . 0.0 112.365 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -150.6 -60.21 0.19 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.822 -1.399 . . . . 0.0 110.225 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -72.35 125.04 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.219 1.485 . . . . 0.0 110.614 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.97 103.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -73.85 110.35 8.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.917 -1.114 . . . . 0.0 110.38 165.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.2 mt -91.79 110.67 22.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.367 0.985 . . . . 0.0 108.681 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.66 95.41 10.25 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.906 0.86 . . . . 0.0 108.769 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.14 138.91 40.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.102 1.761 . . . . 0.0 110.273 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.91 137.02 46.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.59 1.956 . . . . 0.0 108.088 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 tptt . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.785 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.416 2.3 t 67.79 104.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 124.395 2.045 . . . . 0.0 113.484 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 59.5 m -135.84 123.82 22.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -70.44 121.64 18.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.627 1.171 . . . . 0.0 108.549 167.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.259 1.589 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -166.567 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 121.183 0.516 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.94 116.97 24.48 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.615 1.166 . . . . 0.0 109.39 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.71 86.61 7.31 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.273 1.035 . . . . 0.0 110.279 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.12 121.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.874 2.069 . . . . 0.0 109.722 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.07 116.8 24.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.547 -1.971 . . . . 0.0 111.448 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.13 167.79 27.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.223 -1.548 . . . . 0.0 112.279 -167.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.22 138.8 40.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.378 1.071 . . . . 0.0 110.212 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -75.67 160.91 29.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.717 -1.24 . . . . 0.0 112.539 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 m -92.6 71.8 5.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.276 -1.515 . . . . 0.0 109.343 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 53.57 63.58 2.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.158 2.183 . . . . 0.0 114.959 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.45 38.57 14.25 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -177.54 108.59 0.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.201 1.4 . . . . 0.0 107.932 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 9.4 mt -66.0 -48.04 72.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.279 2.632 . . . . 0.0 108.2 169.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.07 34.41 0.78 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.094 1.33 . . . . 0.0 112.645 172.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 pt -121.76 129.66 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 121.454 0.645 . . . . 0.0 110.514 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.257 5.5 m -78.68 122.9 26.56 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 111.81 162.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.19 134.29 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -130.61 168.08 17.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.115 1.366 . . . . 0.0 109.069 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.59 -146.99 21.06 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.237 0.923 . . . . 0.0 113.28 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.69 169.65 43.98 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 121.314 -1.11 . . . . 0.0 112.02 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -171.93 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.289 2.7 tp -112.61 151.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.804 -1.41 . . . . 0.0 107.459 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.98 155.13 50.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -167.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.0 t -82.52 136.7 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 119.48 -2.012 . . . . 0.0 111.387 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -92.59 -51.71 4.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.025 0.93 . . . . 0.0 110.507 166.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.82 141.78 38.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.594 -0.691 . . . . 0.0 111.574 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.487 ' CD1' HG11 ' A' ' 44' ' ' VAL . 44.2 mm -103.66 128.63 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.259 1.823 . . . . 0.0 109.676 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 pt . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.498 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.86 88.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.5 -40.06 65.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.16 1.457 . . . . 0.0 112.889 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 t -79.58 -16.14 56.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.25 -54.05 14.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.753 2.524 . . . . 0.0 111.365 -164.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.58 -77.78 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 118.925 -1.607 . . . . 0.0 113.476 153.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -81.74 -7.8 59.63 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -164.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mt -73.29 126.47 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.039 -1.663 . . . . 0.0 114.196 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 74.9 t60 -128.81 -160.1 1.0 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 163.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 20.6 pttp -92.95 67.09 4.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.349 -2.72 . . . . 0.0 114.442 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.35 42.83 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.461 -2.649 . . . . 0.0 116.717 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -116.17 174.67 5.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.987 1.393 . . . . 0.0 111.213 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 129.7 56.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.868 1.667 . . . . 0.0 107.435 176.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.269 9.4 p -100.13 119.86 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.061 1.3 . . . . 0.0 107.892 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -39.01 10.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.524 -1.36 . . . . 0.0 111.547 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.23 150.36 42.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.03 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.0 t -133.14 116.94 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.19 31.1 20.39 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.974 1.31 . . . . 0.0 112.92 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.16 30.92 54.18 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.192 -0.943 . . . . 0.0 112.939 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -129.12 100.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 t -70.37 137.31 50.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 112.814 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.12 57.1 3.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.515 1.526 . . . . 0.0 112.562 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.23 94.69 9.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.538 -1.976 . . . . 0.0 110.729 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.04 45.58 4.12 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 121.349 -0.844 . . . . 0.0 111.521 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.18 147.56 37.17 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.592 1.187 . . . . 0.0 109.202 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -126.21 -165.35 1.43 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 82' ' ' VAL . 10.3 t-80 -52.58 -55.16 24.2 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.216 -1.553 . . . . 0.0 114.292 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -62.5 -50.55 70.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.672 1.225 . . . . 0.0 113.491 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -42.58 99.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.546 1.138 . . . . 0.0 113.426 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.98 89.36 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 120.442 -1.411 . . . . 0.0 114.431 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 78' ' ' HIS . 52.1 t -54.94 -56.59 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.328 0.967 . . . . 0.0 110.676 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.41 -27.38 65.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -65.78 -26.6 67.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.78 2.032 . . . . 0.0 112.623 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.93 -46.46 8.52 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.14 1.376 . . . . 0.0 112.587 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' B' ' 210' ' ' VAL 0.45 0.0 OUTLIER -71.74 -45.78 60.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.048 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -93.7 45.4 1.15 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.323 1.535 . . . . 0.0 110.344 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.4 p -98.13 157.23 16.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.512 2.325 . . . . 0.0 108.256 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -63.53 4.19 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.21 -0.931 . . . . 0.0 115.418 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -155.22 -59.93 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.687 -0.89 . . . . 0.0 109.03 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.83 124.72 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.212 1.482 . . . . 0.0 110.6 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.5 t -112.27 104.83 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.24 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -78.33 104.81 9.16 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mt -90.83 107.37 19.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.401 1.481 . . . . 0.0 107.783 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.35 95.92 10.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 173.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.22 142.9 32.73 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.068 2.147 . . . . 0.0 110.362 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -115.07 136.58 52.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.436 1.094 . . . . 0.0 109.029 167.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 125.918 1.687 . . . . 0.0 113.543 179.484 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.425 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.434 2.6 t 69.93 96.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 124.969 2.318 . . . . 0.0 113.393 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 79.6 m -149.1 121.8 8.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 -165.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -72.41 139.67 47.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.952 0.901 . . . . 0.0 111.169 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 86' ' ' ARG . 7.7 p . . . . . 0 C--O 1.26 1.639 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 122.419 1.104 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.275 0.1 OUTLIER -114.96 113.81 24.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.712 -1.243 . . . . 0.0 108.697 174.229 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.29 81.85 5.47 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.108 0.956 . . . . 0.0 109.342 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.68 143.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.769 2.028 . . . . 0.0 109.466 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.52 130.49 55.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.413 -2.054 . . . . 0.0 110.643 166.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.57 157.58 33.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.225 1.01 . . . . 0.0 108.314 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.77 105.78 13.43 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.957 0.884 . . . . 0.0 109.181 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.37 135.12 45.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.509 1.924 . . . . 0.0 112.992 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -101.88 108.62 20.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.791 -1.193 . . . . 0.0 108.869 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 42.76 49.12 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.619 2.368 . . . . 0.0 116.162 -166.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 45.84 26.81 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.808 -1.183 . . . . 0.0 115.248 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -161.06 117.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.899 1.809 . . . . 0.0 106.138 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.08 -36.05 66.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.292 1.837 . . . . 0.0 107.732 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.03 2.14 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.478 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 47' ' ' ILE . 8.4 pt -127.67 135.36 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.674 1.226 . . . . 0.0 109.566 171.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' HG22 ' B' ' 207' ' ' VAL . 75.6 m -78.94 112.02 15.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.937 1.695 . . . . 0.0 112.507 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.86 131.67 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -132.88 174.05 10.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.956 2.502 . . . . 0.0 108.325 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.87 45.18 76.05 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 118.608 2.203 . . . . 0.0 118.608 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.54 169.81 47.67 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 120.592 -1.534 . . . . 0.0 111.227 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.31 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.776 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.5 tp -145.79 162.15 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 159.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.9 165.62 27.02 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.41 -1.431 . . . . 0.0 108.642 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -80.31 138.19 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.574 1.95 . . . . 0.0 110.643 167.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -95.24 -57.47 2.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.395 -1.441 . . . . 0.0 109.542 159.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.78 134.74 52.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.879 1.272 . . . . 0.0 111.301 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 27' ' ' ILE . 48.7 mm -93.33 133.46 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 pt . . . . . 0 N--CA 1.431 -1.403 0 O-C-N 121.113 -0.992 . . . . 0.0 111.637 172.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.53 -42.0 65.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.41 -36.8 61.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.942 1.829 . . . . 0.0 112.535 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -74.56 6.49 3.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.12 -79.26 0.09 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.894 -2.379 . . . . 0.0 106.357 152.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.51 -31.6 1.66 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.271 -0.893 . . . . 0.0 111.179 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -89.07 -20.87 23.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.533 -0.98 . . . . 0.0 111.335 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mt -66.46 130.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 124.859 1.264 . . . . 0.0 110.106 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -155.34 169.79 23.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -161.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -80.03 77.04 6.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.74 -1.225 . . . . 0.0 111.864 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.78 60.05 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.376 0.989 . . . . 0.0 110.839 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.57 -151.52 0.34 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.895 2.078 . . . . 0.0 110.222 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -160.04 121.04 3.08 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 149.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.56 122.73 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.034 -1.667 . . . . 0.0 107.728 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -30.3 9.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.888 -1.133 . . . . 0.0 113.275 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.26 159.01 41.07 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 120.244 1.383 . . . . 0.0 113.64 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 t -137.19 119.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 123.997 0.919 . . . . 0.0 111.856 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.99 34.4 22.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.876 -1.765 . . . . 0.0 113.473 -167.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.17 -5.13 73.33 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.627 1.584 . . . . 0.0 113.834 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.61 106.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 121.008 -1.289 . . . . 0.0 108.297 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.8 p -60.71 137.21 58.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.244 1.018 . . . . 0.0 113.612 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.27 -48.8 55.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.4 1.08 . . . . 0.0 111.143 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 34.5 41.83 0.06 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.248 3.425 . . . . 0.0 120.248 160.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.37 -16.85 2.49 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.129 -1.607 . . . . 0.0 111.88 -165.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.29 132.35 44.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.042 1.877 . . . . 0.0 115.119 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -175.45 2.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -48.03 -52.77 18.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.585 -1.947 . . . . 0.0 115.455 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -74.16 -43.95 55.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.309 -0.869 . . . . 0.0 112.161 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -57.58 -43.6 84.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.11 1.364 . . . . 0.0 114.328 172.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -40.68 95.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.452 -1.405 . . . . 0.0 114.292 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.4 -42.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 121.076 -1.015 . . . . 0.0 111.593 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.91 -44.22 97.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.943 -1.723 . . . . 0.0 114.697 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.8 m -58.93 -26.51 64.44 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.688 1.995 . . . . 0.0 114.83 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -91.24 -46.52 8.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.634 1.574 . . . . 0.0 112.679 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -79.35 -34.9 41.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.999 -1.688 . . . . 0.0 114.569 -172.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.82 35.22 0.68 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.455 1.598 . . . . 0.0 111.888 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.4 p -99.67 -176.81 3.38 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.564 3.146 . . . . 0.0 108.203 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.42 -115.02 0.57 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.264 -1.522 . . . . 0.0 112.069 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.62 -44.88 4.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.246 1.018 . . . . 0.0 110.868 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.48 125.01 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.041 1.4 . . . . 0.0 110.462 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.8 t -114.0 106.49 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -83.36 101.66 11.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.575 1.55 . . . . 0.0 109.155 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.27 115.91 26.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 99.52 12.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.08 148.62 25.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.696 1.999 . . . . 0.0 111.776 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.32 1.448 . . . . 0.0 109.608 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? . . . . . 0 CA--C 1.489 -1.371 0 O-C-N 120.179 -1.575 . . . . 0.0 110.982 176.662 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 28' ' ' SER 0.46 3.5 t 64.26 106.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 162.098 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 88.4 m -143.92 120.82 11.31 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 103.039 -2.948 . . . . 0.0 103.039 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -76.39 119.91 20.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.604 1.093 . . . . 0.0 109.62 173.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.26 1.634 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -167.082 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.259 0.1 OUTLIER -132.56 115.14 15.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.88 91.41 8.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.591 1.186 . . . . 0.0 110.282 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.12 154.1 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.71 2.004 . . . . 0.0 108.494 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -130.99 113.24 13.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.212 -2.18 . . . . 0.0 110.322 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.5 mt -119.62 152.15 37.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.587 -1.32 . . . . 0.0 111.001 -170.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.96 117.87 35.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 165.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.54 138.01 54.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.952 -1.092 . . . . 0.0 112.581 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -89.83 103.34 16.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.648 1.213 . . . . 0.0 109.075 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 51.71 44.62 29.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.788 2.435 . . . . 0.0 115.248 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 48.72 26.9 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 119.888 -1.757 . . . . 0.0 114.398 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -161.81 111.55 1.56 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' CD1' HD22 ' A' ' 85' ' ' LEU . 7.2 mt -73.44 -45.19 55.83 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 167.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.52 31.65 0.76 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.089 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.43 124.98 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 122.278 1.037 . . . . 0.0 110.647 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 114.44 17.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.385 1.074 . . . . 0.0 111.481 166.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 127.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -128.16 -179.7 5.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.834 2.453 . . . . 0.0 108.702 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -125.22 7.05 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.346 -1.471 . . . . 0.0 111.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.51 162.64 35.05 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.477 -1.014 . . . . 0.0 114.164 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.431 -1.414 0 C-N-CA 125.399 1.48 . . . . 0.0 113.667 -177.516 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.56 161.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -133.94 162.08 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.299 -2.125 . . . . 0.0 106.646 -170.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.98 132.57 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.391 -1.443 . . . . 0.0 110.61 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -90.37 -53.44 4.44 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.44 -1.413 . . . . 0.0 109.161 163.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.96 135.68 31.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.897 0.879 . . . . 0.0 109.49 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.82 128.66 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 pt . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.749 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.44 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.25 86.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.674 1.589 . . . . 0.0 114.226 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -60.3 -38.19 82.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.906 -1.121 . . . . 0.0 111.253 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -70.95 0.52 7.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.45 -74.23 0.19 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.524 -2.61 . . . . 0.0 108.205 156.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.61 -26.22 3.5 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 121.638 -0.664 . . . . 0.0 111.518 167.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -80.52 -24.84 39.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.739 -0.859 . . . . 0.0 112.149 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 132.6 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.011 1.324 . . . . 0.0 112.392 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 41.5 t60 -138.28 -178.44 5.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 173.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 27.0 mttm -78.35 69.21 4.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.573 -1.329 . . . . 0.0 113.157 -168.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 3.31 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -80.37 171.76 14.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.197 1.999 . . . . 0.0 114.005 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.3 ttt-85 -108.24 139.11 43.39 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.843 1.257 . . . . 0.0 109.942 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.28 115.27 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.384 1.874 . . . . 0.0 107.662 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.45 -34.41 10.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.832 -1.792 . . . . 0.0 113.846 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.11 152.68 39.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.773 1.17 . . . . 0.0 113.696 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.63 HG13 HG13 ' A' ' 92' ' ' VAL . 70.0 t -135.72 122.75 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.43 0.692 . . . . 0.0 111.129 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 58.98 28.04 17.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.25 1.02 . . . . 0.0 113.409 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.35 46.06 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.737 1.636 . . . . 0.0 114.015 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.95 96.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 118.761 1.28 . . . . 0.0 110.275 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.3 p -67.49 142.49 56.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.78 68.39 10.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.28 128.01 33.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 109.247 162.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.99 -2.28 65.57 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.754 1.862 . . . . 0.0 117.754 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 135.96 33.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.422 2.111 . . . . 0.0 113.586 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.0 t -109.35 -169.61 1.51 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.5 2.72 . . . . 0.0 106.143 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -49.16 -58.89 4.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.933 2.093 . . . . 0.0 115.103 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -72.23 -42.09 66.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.165 1.46 . . . . 0.0 111.077 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -59.19 -47.34 85.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.954 1.702 . . . . 0.0 113.84 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.55 79.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.94 -51.85 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 121.134 -0.979 . . . . 0.0 111.221 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -56.8 -36.65 70.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 m -69.43 -24.24 63.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.309 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 68' ' ' VAL . 9.8 mt -89.82 -44.41 9.97 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.534 -1.978 . . . . 0.0 111.877 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -78.6 -44.17 24.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 127.743 2.417 . . . . 0.0 116.037 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -81.31 13.35 2.96 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 123.941 1.829 . . . . 0.0 114.503 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -84.15 -176.37 6.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.457 3.103 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.33 -123.88 2.1 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 120.131 -1.605 . . . . 0.0 112.762 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -95.33 -60.26 1.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 111.091 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.26 120.99 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 123.051 1.405 . . . . 0.0 112.109 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.63 HG13 HG13 ' A' ' 68' ' ' VAL . 2.4 t -111.13 110.68 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.054 1.742 . . . . 0.0 107.816 168.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.55 102.82 7.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.929 -1.107 . . . . 0.0 110.312 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 113.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.899 1.279 . . . . 0.0 109.132 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.92 105.36 17.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.359 -0.838 . . . . 0.0 109.197 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.78 145.78 29.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.457 1.503 . . . . 0.0 111.403 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.71 145.96 42.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.48 1.912 . . . . 0.0 106.694 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.632 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 121.201 0.524 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.412 2.3 t 79.8 112.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 124.221 1.962 . . . . 0.0 113.319 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 38.9 m -145.02 124.99 13.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.515 -3.143 . . . . 0.0 102.515 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -80.83 131.42 35.39 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.257 0.935 . . . . 0.0 110.865 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 -160.143 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.431 -1.413 0 CA-C-O 122.519 1.152 . . . . 0.0 113.636 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.14 119.6 12.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.432 1.493 . . . . 0.0 107.871 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.42 66.88 1.5 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.576 1.15 . . . . 0.0 111.265 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.32 111.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.113 2.165 . . . . 0.0 114.426 -168.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.31 0.2 OUTLIER -96.31 111.95 23.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.781 -1.824 . . . . 0.0 112.86 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.75 159.75 22.5 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.546 1.138 . . . . 0.0 107.984 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.38 24.08 10.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.398 1.094 . . . . 0.0 111.142 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HB3' ' H ' ' A' ' 24' ' ' SER . 30.3 mttt 52.29 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.984 2.914 . . . . 0.0 114.515 -171.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -122.42 81.3 1.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.35 -2.094 . . . . 0.0 106.506 159.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 55.73 64.05 1.86 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.938 2.095 . . . . 0.0 115.15 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.47 46.79 9.53 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.85 -1.156 . . . . 0.0 114.987 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.529 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 47.7 t 178.53 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 8.2 mt -75.54 -38.34 59.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.426 1.89 . . . . 0.0 107.368 169.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.22 14.83 4.38 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.941 168.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.22 125.32 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.263 1.03 . . . . 0.0 110.732 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.446 ' HB3' HG13 ' B' ' 207' ' ' VAL . 45.9 m -78.35 109.27 12.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.717 1.207 . . . . 0.0 110.504 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.35 127.19 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -125.31 167.9 14.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.424 1.49 . . . . 0.0 110.406 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 -125.6 7.07 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.564 1.554 . . . . 0.0 113.183 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.3 167.34 30.12 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 120.163 -1.787 . . . . 0.0 113.554 179.026 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.42 167.31 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -136.14 156.5 48.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.559 -1.963 . . . . 0.0 107.12 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 47' ' ' ILE . 3.4 t -80.57 130.46 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.262 -1.524 . . . . 0.0 112.015 165.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -91.89 -38.68 12.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.417 -1.427 . . . . 0.0 112.531 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.3 136.08 22.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.7 -1.25 . . . . 0.0 112.129 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 HD13 HG11 ' A' ' 44' ' ' VAL . 25.3 mm -96.75 143.32 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.026 2.131 . . . . 0.0 108.008 175.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 120.72 -1.238 . . . . 0.0 113.827 176.075 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.52 78.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.66 -35.6 81.07 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.6 -1.938 . . . . 0.0 111.741 170.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.27 2.58 24.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.15 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.859 -1.776 . . . . 0.0 108.476 160.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 -41.79 0.29 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.783 -1.198 . . . . 0.0 111.186 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.9 mtm-85 -87.42 -17.35 32.46 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.58 133.45 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.676 -1.265 . . . . 0.0 112.293 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.505 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 21.9 t-80 -129.24 -165.18 1.48 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.939 0.896 . . . . 0.0 108.604 170.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 43.2 pttt -102.71 44.79 0.99 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.852 -1.78 . . . . 0.0 112.229 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.68 33.97 0.16 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -97.74 178.19 5.23 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.358 1.063 . . . . 0.0 109.667 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -114.33 128.63 56.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.745 -1.847 . . . . 0.0 108.698 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.36 110.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.378 -1.452 . . . . 0.0 107.27 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -48.58 7.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.507 -1.996 . . . . 0.0 112.348 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -136.79 160.87 37.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.882 -1.136 . . . . 0.0 113.479 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.451 HG13 HG13 ' A' ' 92' ' ' VAL . 47.4 t -134.0 112.94 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 123.964 0.905 . . . . 0.0 111.285 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 58.74 26.82 15.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.138 -1.601 . . . . 0.0 113.536 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 12.98 83.66 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.702 -1.249 . . . . 0.0 113.705 -171.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.85 100.27 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -68.14 148.46 50.88 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 121.109 -0.995 . . . . 0.0 110.091 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.561 2.059 . . . . 0.0 116.561 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 61.29 51.63 4.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.334 1.54 . . . . 0.0 112.314 169.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.58 35.0 80.03 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.087 -1.633 . . . . 0.0 115.617 -173.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.65 151.99 23.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.541 1.639 . . . . 0.0 113.13 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.503 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 64.5 p -104.2 -158.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.161 2.585 . . . . 0.0 109.381 -169.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -60.21 -51.3 70.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.191 -1.568 . . . . 0.0 112.471 161.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -70.69 -46.14 63.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.126 0.971 . . . . 0.0 111.983 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HB2' ' H ' ' A' ' 77' ' ' THR . 65.9 mt-30 -66.57 -34.38 77.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.993 -1.067 . . . . 0.0 113.454 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.11 93.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.313 1.87 . . . . 0.0 114.288 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.8 -50.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.909 0.884 . . . . 0.0 111.596 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -59.26 -40.53 86.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.346 -1.471 . . . . 0.0 113.874 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -59.78 -30.36 68.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.623 1.969 . . . . 0.0 113.428 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -89.96 -42.05 11.4 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.342 1.857 . . . . 0.0 113.78 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -24.87 24.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -90.05 24.5 2.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.276 -2.14 . . . . 0.0 112.907 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 p -94.38 162.39 13.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.655 2.782 . . . . 0.0 112.409 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.37 65.02 3.44 Favored Glycine 0 N--CA 1.431 -1.695 0 O-C-N 120.528 -1.358 . . . . 0.0 113.718 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.271 28.1 tt0 68.33 -55.24 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.0 115.368 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.75 132.6 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.381 1.086 . . . . 0.0 110.625 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.451 HG13 HG13 ' A' ' 68' ' ' VAL . 23.1 t -126.3 108.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -77.35 108.04 10.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.906 -1.121 . . . . 0.0 108.445 163.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.0 105.29 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.538 -1.351 . . . . 0.0 109.486 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.07 93.96 8.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mt -98.59 139.71 33.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.877 2.071 . . . . 0.0 109.703 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -109.47 135.96 49.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 106.798 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.429 -1.502 0 C-N-CA 124.755 1.222 . . . . 0.0 112.021 -179.571 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' A' ' 28' ' ' SER 0.418 2.1 t 76.02 106.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.56 2.124 . . . . 0.0 113.358 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -141.31 122.26 14.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.795 -3.039 . . . . 0.0 102.795 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 41.5 m -78.0 129.26 35.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.261 1.684 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -163.213 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.429 -1.486 0 CA-C-O 123.091 1.424 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.82 116.51 18.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -89.57 83.99 6.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.911 1.339 . . . . 0.0 109.741 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -80.84 110.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 126.947 2.099 . . . . 0.0 112.99 -173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.64 121.67 41.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.101 -2.249 . . . . 0.0 109.531 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -122.04 172.81 7.96 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.089 0.956 . . . . 0.0 109.9 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.23 122.17 23.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 161.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 10.7 ptpt -67.02 160.46 26.48 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.442 1.897 . . . . 0.0 114.805 -177.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -115.75 106.94 14.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.163 1.385 . . . . 0.0 108.924 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.88 55.0 9.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.641 2.376 . . . . 0.0 114.503 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.62 48.55 61.63 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 119.974 -1.704 . . . . 0.0 114.982 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 m -172.01 111.05 0.28 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 -172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -72.73 -36.68 67.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.876 2.07 . . . . 0.0 108.101 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.04 38.15 1.73 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.425 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.45 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 121.838 0.828 . . . . 0.0 110.222 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.413 ' HB3' HG13 ' B' ' 207' ' ' VAL . 74.7 m -85.27 114.11 22.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.16 129.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 t -121.25 164.27 17.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.769 2.428 . . . . 0.0 111.023 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.51 -145.85 18.22 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 125.397 1.475 . . . . 0.0 111.854 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.64 153.87 23.71 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.062 1.315 . . . . 0.0 111.929 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.779 1.631 . . . . 0.0 115.315 -173.866 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.783 0 N-CA-C 104.577 -3.409 . . . . 0.0 104.577 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 65' ' ' VAL 0.256 4.4 tp -129.13 163.0 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -138.84 160.94 38.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 47' ' ' ILE . 88.5 t -80.69 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.302 -1.499 . . . . 0.0 110.393 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -88.13 -55.85 3.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.136 -1.602 . . . . 0.0 110.208 166.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.42 139.64 25.72 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.103 0.954 . . . . 0.0 110.782 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD11 HG11 ' A' ' 44' ' ' VAL . 36.4 mm -91.23 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.552 1.541 . . . . 0.0 107.042 173.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 121.435 -0.79 . . . . 0.0 112.505 -178.933 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.44 83.52 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -48.09 -36.85 13.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.716 1.606 . . . . 0.0 114.172 167.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 t -73.14 4.25 4.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.66 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.462 -2.024 . . . . 0.0 108.249 155.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.37 -23.69 2.04 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.323 -0.86 . . . . 0.0 112.562 164.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mtt85 -77.56 -31.78 53.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.806 1.242 . . . . 0.0 112.18 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -67.49 143.72 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.244 1.818 . . . . 0.0 113.966 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 44.6 t60 -142.44 -167.03 2.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.975 -1.078 . . . . 0.0 109.628 170.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.533 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 58.3 mttp -80.06 53.97 1.82 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.859 -1.776 . . . . 0.0 113.255 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.28 -35.08 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.823 -1.798 . . . . 0.0 114.998 -169.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.38 156.29 32.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -167.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 117.37 33.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.292 1.437 . . . . 0.0 110.19 -170.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 42' ' ' ILE . 2.7 p -93.46 125.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.255 1.503 . . . . 0.0 109.504 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -37.16 9.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.967 1.307 . . . . 0.0 112.214 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.12 157.11 44.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.68 115.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 124.36 1.064 . . . . 0.0 111.541 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.94 23.13 6.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -168.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.8 12.7 68.36 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.795 -1.19 . . . . 0.0 113.859 -171.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.33 99.27 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.6 p -61.95 139.12 58.42 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 125.832 1.653 . . . . 0.0 113.573 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.26 47.32 1.32 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.708 -1.245 . . . . 0.0 112.66 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -74.59 115.04 13.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.663 -1.898 . . . . 0.0 110.695 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.85 84.92 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.793 -1.192 . . . . 0.0 115.07 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.98 136.3 33.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.847 1.823 . . . . 0.0 112.95 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -95.44 -161.37 0.86 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.087 2.155 . . . . 0.0 109.836 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -64.3 -56.25 15.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.008 -1.682 . . . . 0.0 111.628 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -66.96 -38.73 86.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -67.12 -36.17 81.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.971 -1.706 . . . . 0.0 113.908 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.23 90.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.487 -2.008 . . . . 0.0 113.782 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -55.93 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 124.0 0.92 . . . . 0.0 110.461 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.06 -33.48 57.56 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.5 m -68.67 -36.47 78.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.827 2.051 . . . . 0.0 112.006 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.4 mt -89.29 -34.57 16.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.808 1.643 . . . . 0.0 114.934 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -45.29 17.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.965 1.706 . . . . 0.0 112.445 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -90.0 47.48 1.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.858 -1.777 . . . . 0.0 112.227 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.6 p -107.31 -166.62 1.17 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.988 2.115 . . . . 0.0 110.524 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.73 -93.92 1.25 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.078 -1.639 . . . . 0.0 114.647 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -132.91 -53.01 0.92 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.072 1.349 . . . . 0.0 109.519 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.06 139.84 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.472 -1.392 . . . . 0.0 110.89 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.21 121.82 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -86.46 105.82 17.04 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.66 1.184 . . . . 0.0 109.969 166.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mt -87.24 110.8 20.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.333 -1.48 . . . . 0.0 109.652 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 97.94 11.16 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.728 -1.232 . . . . 0.0 108.44 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -101.54 141.33 34.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.075 2.15 . . . . 0.0 110.901 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -108.27 141.09 40.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.461 1.904 . . . . 0.0 107.488 166.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tptp . . . . . 0 N--CA 1.429 -1.496 0 C-N-CA 126.236 1.814 . . . . 0.0 113.917 179.451 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 28' ' ' SER 0.417 2.1 t 70.82 104.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 124.553 2.12 . . . . 0.0 114.633 164.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.8 m -142.48 121.99 13.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.325 -2.842 . . . . 0.0 103.325 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 7.4 m -76.21 126.43 30.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.626 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.702 0.763 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 121.4 35.49 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.823 1.249 . . . . 0.0 108.353 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -98.7 79.36 2.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.317 1.532 . . . . 0.0 108.836 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.91 115.55 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.323 2.249 . . . . 0.0 111.581 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.266 3.1 pt-20 -105.87 115.45 30.25 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.221 -2.174 . . . . 0.0 110.276 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -117.28 160.66 20.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.885 1.274 . . . . 0.0 109.568 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.92 105.3 11.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -66.84 145.88 55.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -173.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 t -99.48 110.64 23.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.563 1.545 . . . . 0.0 109.068 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t70 58.11 20.41 6.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.57 1.948 . . . . 0.0 116.017 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 57.6 2.02 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.008 -1.682 . . . . 0.0 112.654 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -173.93 112.72 0.19 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 126.207 1.803 . . . . 0.0 106.823 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.6 mt -74.88 -40.15 61.09 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.413 1.885 . . . . 0.0 106.219 165.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 112.45 40.63 1.11 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.474 170.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 47' ' ' ILE . 21.8 pt -131.68 127.92 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.298 1.047 . . . . 0.0 110.585 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -80.41 123.28 27.9 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.644 1.177 . . . . 0.0 111.515 167.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.72 145.79 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.98 170.74 15.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.349 1.46 . . . . 0.0 109.074 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.12 -133.29 11.71 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.882 1.229 . . . . 0.0 113.615 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.47 161.57 34.82 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 124.753 1.168 . . . . 0.0 112.551 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.43 -1.469 0 O-C-N 120.45 -1.618 . . . . 0.0 115.03 -179.34 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.78 0 N-CA-C 105.153 -3.179 . . . . 0.0 105.153 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.49 HG22 HG13 ' A' ' 65' ' ' VAL 0.262 3.8 tp -118.73 158.09 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 166.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.94 158.05 45.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.7 t -86.76 138.6 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.227 -1.546 . . . . 0.0 110.732 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -101.51 -74.05 0.63 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.509 -1.369 . . . . 0.0 109.955 167.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.21 124.82 50.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.142 0.972 . . . . 0.0 111.534 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.0 mm -90.21 133.92 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.274 1.83 . . . . 0.0 108.562 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' HA2' ' A' ' 26' ' ' GLY . 73.4 mt . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 116.047 -1.93 . . . . 0.0 109.771 170.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.45 0 CA-C-O 121.782 0.801 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 -45.71 69.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -56.15 -36.08 67.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.132 -1.605 . . . . 0.0 111.933 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -71.31 3.04 4.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.67 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.982 1.719 . . . . 0.0 108.83 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.77 -41.49 0.19 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.562 -1.336 . . . . 0.0 111.903 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -84.92 -26.82 27.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.9 mt -65.69 129.09 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 125.174 1.39 . . . . 0.0 114.6 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -132.95 177.71 7.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.731 2.013 . . . . 0.0 110.683 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -71.01 77.03 0.66 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.376 -1.452 . . . . 0.0 113.463 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.81 19.18 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -85.58 165.0 17.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 119.175 1.488 . . . . 0.0 112.147 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 120.72 43.32 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.679 1.191 . . . . 0.0 110.598 -171.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 42' ' ' ILE . 5.8 p -95.84 122.63 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.178 -1.577 . . . . 0.0 110.658 171.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.0 -36.42 11.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.304 -1.497 . . . . 0.0 111.366 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 155.82 43.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.993 -1.067 . . . . 0.0 113.049 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -131.42 118.52 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.328 -0.857 . . . . 0.0 111.504 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.34 30.78 20.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.266 1.426 . . . . 0.0 112.77 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.51 79.82 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.444 -1.41 . . . . 0.0 114.251 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.35 104.91 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.462 1.505 . . . . 0.0 107.661 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.8 p -64.27 144.76 56.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.21 40.22 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.217 1.407 . . . . 0.0 112.793 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.54 118.48 16.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.117 -1.615 . . . . 0.0 111.305 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.24 88.64 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.063 -1.023 . . . . 0.0 114.846 -174.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.17 140.81 29.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.736 1.732 . . . . 0.0 113.262 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.04 -174.17 2.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -45.93 -50.9 14.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.086 2.154 . . . . 0.0 114.863 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -70.04 -44.31 69.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.787 0.835 . . . . 0.0 112.428 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.89 -37.75 76.11 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.005 -1.059 . . . . 0.0 112.459 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.4 97.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.702 -1.249 . . . . 0.0 113.71 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.3 t -57.0 -53.63 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 123.45 0.7 . . . . 0.0 111.388 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.37 -31.39 67.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.8 m -71.6 -26.21 62.5 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.774 2.029 . . . . 0.0 112.896 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.52 -46.65 8.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.007 1.723 . . . . 0.0 114.275 168.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -32.9 22.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.31 1.844 . . . . 0.0 115.064 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -91.4 41.66 1.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.999 -2.313 . . . . 0.0 111.589 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.9 p -102.84 160.86 14.23 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.681 1.992 . . . . 0.0 108.975 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.5 -70.36 1.11 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.31 -1.494 . . . . 0.0 113.906 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -153.57 -52.73 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.968 -0.724 . . . . 0.0 109.407 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.14 130.53 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.658 1.218 . . . . 0.0 112.049 171.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.24 109.8 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.425 1.09 . . . . 0.0 108.063 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -83.02 109.75 17.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.777 -1.202 . . . . 0.0 109.418 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -89.54 110.1 20.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.55 1.14 . . . . 0.0 108.506 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.15 93.49 9.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.96 144.13 28.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.335 1.854 . . . . 0.0 110.577 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -111.54 144.02 41.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.901 1.68 . . . . 0.0 107.075 164.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 pptt? . . . . . 0 N--CA 1.43 -1.444 0 C-N-CA 126.482 1.913 . . . . 0.0 115.089 172.978 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.525 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.8 tp . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.525 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.443 29.4 m 53.74 82.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.159 2.184 . . . . 0.0 116.667 166.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 94.6 m -118.7 114.31 22.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -170.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.3 m -83.09 124.52 30.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 122.907 0.483 . . . . 0.0 110.118 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.628 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 122.558 1.17 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.48 116.49 14.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.859 1.263 . . . . 0.0 109.107 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.52 81.61 5.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.311 1.529 . . . . 0.0 112.677 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.63 114.68 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 126.651 1.98 . . . . 0.0 112.219 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.55 113.05 26.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.762 -1.836 . . . . 0.0 110.744 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.24 161.49 25.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.78 -1.2 . . . . 0.0 110.28 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.89 117.04 29.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 163.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -49.27 130.76 19.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.33 1.852 . . . . 0.0 114.711 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -96.95 109.9 22.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.775 1.63 . . . . 0.0 107.955 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.57 26.84 11.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.21 2.204 . . . . 0.0 115.3 -171.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.71 64.74 2.09 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.115 -1.616 . . . . 0.0 112.437 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 174.58 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.72 -45.52 36.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.347 2.022 . . . . 0.0 106.472 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.0 32.02 0.89 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 113.672 -1.604 . . . . 0.0 111.568 169.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.0 pt -113.0 129.93 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.884 0.849 . . . . 0.0 109.74 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -83.07 112.45 19.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.286 1.035 . . . . 0.0 110.031 161.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.93 138.32 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.3 t -131.26 167.83 18.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.111 -1.618 . . . . 0.0 108.763 172.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.52 -140.49 18.96 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 124.641 1.115 . . . . 0.0 113.62 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.2 155.43 31.69 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 124.476 1.036 . . . . 0.0 110.56 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.43 -1.47 0 C-N-CA 126.853 2.061 . . . . 0.0 114.959 -178.046 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 CA-C-O 121.533 0.519 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.551 HG22 HG13 ' A' ' 65' ' ' VAL . 3.3 tp -124.95 160.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.55 153.89 43.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -168.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.456 HG11 HD13 ' A' ' 47' ' ' ILE . 8.5 t -84.37 138.28 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.159 -2.213 . . . . 0.0 111.789 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -94.47 -58.48 2.19 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.778 -1.201 . . . . 0.0 109.603 166.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.17 51.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.377 -0.827 . . . . 0.0 111.647 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.456 HD13 HG11 ' A' ' 44' ' ' VAL . 37.4 mm -96.17 125.43 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.074 1.35 . . . . 0.0 108.439 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 120.733 -1.23 . . . . 0.0 112.772 -179.355 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -45.73 75.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.062 -1.649 . . . . 0.0 113.451 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -19.63 65.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.524 -1.36 . . . . 0.0 112.977 172.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 t -69.11 -22.18 63.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.5 -89.94 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.199 -1.563 . . . . 0.0 110.32 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.84 -3.79 9.22 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.916 -1.115 . . . . 0.0 113.197 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -84.57 -27.94 26.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.013 -1.287 . . . . 0.0 108.399 161.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.13 128.6 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.619 1.567 . . . . 0.0 112.761 166.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -133.74 -155.82 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -90.36 81.73 6.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.201 -2.187 . . . . 0.0 112.894 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.06 39.97 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 118.854 2.301 . . . . 0.0 118.854 164.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -98.19 163.57 12.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.539 1.536 . . . . 0.0 110.943 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -89.26 125.48 35.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.569 -1.332 . . . . 0.0 108.395 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 42' ' ' ILE 0.26 2.9 p -102.48 120.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 -28.93 11.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.796 -1.19 . . . . 0.0 112.124 -173.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.46 161.69 42.26 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 121.635 -0.666 . . . . 0.0 112.459 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.6 122.82 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 121.269 -0.895 . . . . 0.0 110.54 -176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 60.61 26.8 16.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.439 1.927 . . . . 0.0 113.353 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.04 -0.57 89.39 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 125.713 1.625 . . . . 0.0 114.085 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.03 101.88 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.805 1.242 . . . . 0.0 108.132 -172.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -62.6 136.92 58.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.852 -1.155 . . . . 0.0 113.659 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.85 -43.81 91.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.065 0.946 . . . . 0.0 113.512 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 28.22 79.6 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.361 2.664 . . . . 0.0 117.939 158.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.66 -22.32 30.55 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.021 1.296 . . . . 0.0 114.69 -170.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.37 141.43 57.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -98.93 -153.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.814 2.046 . . . . 0.0 110.061 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -73.28 -50.68 20.88 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.8 -1.813 . . . . 0.0 110.918 167.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -64.32 -44.74 90.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.531 0.732 . . . . 0.0 112.757 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -31.87 72.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.641 -1.287 . . . . 0.0 114.25 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.09 94.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.319 -2.113 . . . . 0.0 114.756 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 86' ' ' ARG . 73.3 t -55.08 -56.24 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.197 0.999 . . . . 0.0 110.049 170.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 28.3 tt0 -48.04 -46.99 33.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 175.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.5 m -62.47 -31.92 72.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.821 2.448 . . . . 0.0 113.58 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.25 -40.78 13.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.53 -1.981 . . . . 0.0 113.668 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 82' ' ' VAL . 4.4 ppt_? -80.01 -38.74 31.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -166.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.64 29.7 1.12 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.87 -1.769 . . . . 0.0 111.705 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 60.7 p -96.43 151.47 19.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.748 2.819 . . . . 0.0 109.854 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.25 -58.12 4.44 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.687 -1.258 . . . . 0.0 114.643 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -150.93 -67.52 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.651 -0.911 . . . . 0.0 112.297 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.96 128.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.643 1.211 . . . . 0.0 111.086 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -124.11 103.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.92 1.688 . . . . 0.0 106.977 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -81.37 103.61 11.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.768 -1.207 . . . . 0.0 109.379 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.04 115.8 22.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.461 -1.4 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.25 95.1 9.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.09 151.31 19.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.825 2.05 . . . . 0.0 110.708 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.37 147.67 49.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.522 1.129 . . . . 0.0 108.402 164.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm . . . . . 0 N--CA 1.43 -1.458 0 C-N-CA 125.814 1.646 . . . . 0.0 114.511 170.87 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 15.2 tp . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.678 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.341 8.8 m 21.72 80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 130.948 3.699 . . . . 0.0 117.636 160.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 44.2 m -118.94 121.38 39.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.8 p -79.14 127.89 32.6 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.563 1.145 . . . . 0.0 110.508 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 86' ' ' ARG . 14.9 p . . . . . 0 C--O 1.26 1.655 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -160.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.119 0.962 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 121.48 16.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.398 1.079 . . . . 0.0 108.908 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -98.88 77.83 2.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.278 1.031 . . . . 0.0 109.729 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.4 t -84.4 132.24 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.871 2.868 . . . . 0.0 113.316 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -110.51 124.75 52.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.886 -2.384 . . . . 0.0 111.8 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.52 150.87 48.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.576 -1.327 . . . . 0.0 110.375 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.11 104.97 12.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 122.181 0.991 . . . . 0.0 108.74 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.709 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.72 140.51 49.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.257 1.576 . . . . 0.0 115.257 -172.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 t -99.38 95.19 6.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.412 1.577 . . . . 0.0 110.138 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t70 56.73 58.11 4.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.753 2.021 . . . . 0.0 113.936 -174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.94 52.21 49.75 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 114.392 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -167.73 98.08 0.47 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.491 1.615 . . . . 0.0 107.647 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.709 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.3 mt -73.53 -42.22 62.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.364 1.866 . . . . 0.0 106.753 168.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.7 43.65 0.95 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.295 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 47' ' ' ILE . 32.3 pt -125.4 136.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 121.754 0.788 . . . . 0.0 109.462 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.402 ' HB3' HG22 ' B' ' 207' ' ' VAL . 4.1 m -82.25 118.09 22.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.941 -1.1 . . . . 0.0 111.716 161.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.48 120.46 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -119.21 163.23 17.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.694 2.798 . . . . 0.0 109.796 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.1 -147.75 19.8 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 124.627 1.108 . . . . 0.0 112.412 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.27 158.48 19.67 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.104 1.335 . . . . 0.0 111.01 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 120.425 -1.633 . . . . 0.0 114.752 -177.68 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 42' ' ' ILE . 3.6 tp -118.3 162.41 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -141.81 165.1 28.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 47' ' ' ILE . 6.3 t -89.02 135.93 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.494 -1.379 . . . . 0.0 112.338 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -73.04 0.55 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.98 -1.075 . . . . 0.0 108.929 164.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.57 126.01 51.72 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.444 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.443 HD13 HG22 ' A' ' 27' ' ' ILE . 25.9 mm -82.69 125.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 161.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt . . . . . 0 N--CA 1.429 -1.511 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.248 175.269 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 121.135 0.493 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.6 57.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.469 1.908 . . . . 0.0 115.753 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -53.6 -43.28 68.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.864 1.316 . . . . 0.0 111.353 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -69.02 5.91 1.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 -78.15 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.385 -1.447 . . . . 0.0 108.944 156.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -39.51 0.45 Allowed Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -93.86 -19.6 20.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 mt -72.57 127.49 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.109 -1.619 . . . . 0.0 113.018 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -125.64 -178.32 4.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.949 1.3 . . . . 0.0 109.045 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -79.06 82.98 5.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 0.0 112.114 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.12 -8.71 0.33 Allowed Glycine 0 N--CA 1.431 -1.655 0 O-C-N 120.122 -1.611 . . . . 0.0 115.815 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.12 157.03 36.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 119.205 1.503 . . . . 0.0 114.266 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.65 132.51 36.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.911 1.284 . . . . 0.0 109.374 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 t -92.39 117.47 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 160.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -31.53 11.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.666 -1.896 . . . . 0.0 112.218 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.56 160.51 43.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.341 -0.849 . . . . 0.0 112.13 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.62 118.58 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 111.037 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.52 26.77 14.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.178 -1.577 . . . . 0.0 113.946 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.59 85.46 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.165 -0.959 . . . . 0.0 113.765 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.04 101.23 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 121.25 -1.147 . . . . 0.0 108.205 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 p -56.97 124.1 17.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.748 2.019 . . . . 0.0 112.759 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.12 -46.29 78.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.934 -1.104 . . . . 0.0 113.664 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 6.01 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.922 3.689 . . . . 0.0 117.68 167.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.8 -23.05 5.08 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.562 -1.336 . . . . 0.0 113.461 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.77 141.82 39.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.1 p -98.13 -161.6 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.789 1.635 . . . . 0.0 108.422 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -59.62 -48.0 83.37 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 119.874 -1.766 . . . . 0.0 112.511 164.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -71.04 -45.1 64.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.285 1.434 . . . . 0.0 111.68 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.52 -33.35 72.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.366 -1.459 . . . . 0.0 114.262 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.85 88.89 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.663 -1.898 . . . . 0.0 114.402 172.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.7 t -54.48 -54.3 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.919 0.888 . . . . 0.0 111.047 171.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 55.0 mt-10 -59.06 -37.56 77.34 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 m -61.97 -27.72 69.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.358 1.863 . . . . 0.0 112.204 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.25 -41.93 10.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.473 1.509 . . . . 0.0 114.525 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HB3' HG23 ' B' ' 210' ' ' VAL 0.293 0.0 OUTLIER -88.7 -32.25 18.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -165.52 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -88.6 39.54 0.92 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.666 1.222 . . . . 0.0 111.647 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.0 p -105.81 170.81 7.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.696 1.999 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.22 -92.17 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 114.101 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -133.44 -48.22 0.83 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.552 -1.558 . . . . 0.0 109.263 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.31 121.12 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.976 1.37 . . . . 0.0 111.242 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.61 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -87.16 99.97 12.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.769 2.027 . . . . 0.0 107.486 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.06 124.59 31.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.363 -1.461 . . . . 0.0 109.892 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.39 100.55 13.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 146.32 26.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.47 1.908 . . . . 0.0 111.431 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -124.02 144.1 50.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.244 1.417 . . . . 0.0 108.807 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.251 0.548 . . . . 0.0 112.394 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 28' ' ' SER 0.405 3.8 t 71.33 114.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 124.22 1.962 . . . . 0.0 113.567 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 54.2 m -153.3 129.18 10.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 81.1 p -74.54 129.08 37.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.864 1.266 . . . . 0.0 110.079 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 86' ' ' ARG . 11.6 p . . . . . 0 C--O 1.26 1.608 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -161.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.429 -1.483 0 CA-C-O 123.024 1.392 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.4 113.23 16.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 173.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -87.14 85.68 7.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 123.265 1.507 . . . . 0.0 109.949 170.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.16 152.91 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.133 2.173 . . . . 0.0 109.844 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -128.32 131.67 48.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.103 -1.623 . . . . 0.0 108.716 164.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 167.99 16.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.64 134.47 51.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 157.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.569 ' HB3' ' H ' ' A' ' 24' ' ' SER . 24.0 mttt -61.61 136.49 58.03 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.077 1.351 . . . . 0.0 113.848 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -84.68 84.37 7.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.417 -1.427 . . . . 0.0 110.047 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.16 60.09 2.18 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.358 2.263 . . . . 0.0 114.602 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.72 48.72 60.11 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.714 -1.241 . . . . 0.0 115.044 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.569 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 40.3 t 176.96 106.7 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -166.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 7.7 mt -66.02 -47.27 74.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.898 2.285 . . . . 0.0 106.283 164.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.34 38.02 0.7 Allowed Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.296 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.15 127.87 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.796 0.808 . . . . 0.0 110.52 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -78.36 104.91 9.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.632 1.973 . . . . 0.0 113.149 165.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.08 125.11 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t -118.57 161.43 20.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.757 2.423 . . . . 0.0 111.457 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.3 21.59 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.129 1.347 . . . . 0.0 113.453 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.68 169.5 20.18 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 124.602 1.096 . . . . 0.0 111.017 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -179.381 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 65' ' ' VAL . 4.7 tp -116.17 157.17 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -131.57 161.7 32.03 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.649 -1.907 . . . . 0.0 106.562 -170.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 47' ' ' ILE . 85.4 t -86.67 128.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.962 1.305 . . . . 0.0 111.512 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -99.17 -35.6 9.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.735 -1.853 . . . . 0.0 111.739 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.02 133.85 11.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.569 0.699 . . . . 0.0 110.446 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.436 HD11 HG11 ' A' ' 44' ' ' VAL . 46.9 mm -100.44 115.78 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.771 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.94 85.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.068 -1.645 . . . . 0.0 113.102 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.07 -33.85 76.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.702 -1.249 . . . . 0.0 112.516 168.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.75 -20.43 65.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.78 -76.16 0.1 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.552 -1.342 . . . . 0.0 109.429 162.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.15 7.91 56.96 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.317 -0.864 . . . . 0.0 113.788 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -88.55 -18.69 27.57 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.91 -1.347 . . . . 0.0 109.711 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 153.34 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.634 1.574 . . . . 0.0 112.632 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 65.7 t60 -147.89 176.59 10.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 166.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 24.6 pttm -81.16 57.06 3.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.48 0.94 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.552 -1.342 . . . . 0.0 114.841 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -80.11 166.47 21.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 118.982 1.391 . . . . 0.0 114.415 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -103.87 132.08 50.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.95 1.3 . . . . 0.0 109.234 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG13 HG22 ' A' ' 42' ' ' ILE . 2.8 p -105.37 125.0 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 107.809 167.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 -28.69 9.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.468 -1.395 . . . . 0.0 113.401 -175.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.22 161.0 42.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 120.007 1.276 . . . . 0.0 112.777 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 92' ' ' VAL . 65.7 t -133.63 116.76 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.264 1.026 . . . . 0.0 110.532 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 58.77 24.0 11.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.197 -1.564 . . . . 0.0 114.164 -173.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.71 4.93 84.78 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 124.573 1.083 . . . . 0.0 114.132 -171.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.29 102.21 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 p -55.35 135.27 50.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.761 2.024 . . . . 0.0 115.168 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -74.74 -54.51 7.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.837 -1.165 . . . . 0.0 110.8 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -5.07 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.262 3.825 . . . . 0.0 117.897 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.02 6.46 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -163.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.26 138.98 37.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 120.675 -1.486 . . . . 0.0 114.748 -176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -110.71 -161.0 0.73 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.279 2.231 . . . . 0.0 106.391 177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -61.57 -51.83 66.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.466 -2.021 . . . . 0.0 112.793 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -66.51 -49.97 64.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.015 -1.053 . . . . 0.0 112.239 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.22 93.67 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.291 -2.13 . . . . 0.0 114.4 173.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.45 -50.72 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.03 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -47.22 -47.58 24.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.594 1.543 . . . . 0.0 115.03 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 m -62.99 -36.45 83.57 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.456 2.702 . . . . 0.0 114.533 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -90.98 -44.36 9.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.817 1.247 . . . . 0.0 113.73 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.12 13.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.81 2.044 . . . . 0.0 112.599 -170.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -89.17 38.31 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.489 1.614 . . . . 0.0 112.531 -166.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.5 p -91.57 -168.91 2.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.097 2.959 . . . . 0.0 108.944 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -89.6 -116.89 1.63 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.122 -1.611 . . . . 0.0 110.542 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -105.65 -47.7 3.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.72 -0.871 . . . . 0.0 109.951 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.61 129.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.111 -0.993 . . . . 0.0 111.77 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 68' ' ' VAL . 79.6 t -122.64 108.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 56.4 m-70 -78.99 109.78 13.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.786 -1.196 . . . . 0.0 108.585 163.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -89.02 120.23 30.25 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.643 -1.286 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.33 97.26 11.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.23 142.14 35.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.544 1.938 . . . . 0.0 110.52 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -115.34 140.4 49.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.786 1.634 . . . . 0.0 108.912 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.45 0 C-N-CA 125.858 1.663 . . . . 0.0 113.853 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.356 4.9 t 74.46 120.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 123.936 1.826 . . . . 0.0 114.813 167.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.3 m -143.15 132.17 22.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.9 p -82.93 129.99 35.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.882 1.273 . . . . 0.0 109.244 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.642 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -164.653 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 96' ' ' LEU 0.299 0.1 OUTLIER -136.25 129.15 31.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.648 1.179 . . . . 0.0 108.681 171.384 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -105.97 79.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.626 1.203 . . . . 0.0 109.64 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.21 159.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.986 2.114 . . . . 0.0 110.796 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.74 129.91 50.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 119.949 -1.72 . . . . 0.0 108.386 164.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -125.88 164.95 19.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.102 1.761 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.15 112.92 14.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.274 1.03 . . . . 0.0 109.587 167.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -56.51 144.71 30.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.225 2.21 . . . . 0.0 115.849 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -113.08 117.94 33.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.992 1.317 . . . . 0.0 108.253 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 36.05 51.73 0.79 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.422 2.689 . . . . 0.0 117.522 -166.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.86 48.05 22.97 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.276 -1.515 . . . . 0.0 114.565 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -172.48 111.25 0.25 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.082 1.42 . . . . 0.0 107.298 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.32 -45.3 73.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.322 2.249 . . . . 0.0 108.057 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 123.68 41.0 0.44 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.176 167.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.64 135.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.983 0.896 . . . . 0.0 110.646 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -85.68 114.21 22.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.263 1.025 . . . . 0.0 109.666 163.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.02 137.2 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -127.98 165.77 19.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.652 1.981 . . . . 0.0 110.075 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.84 -149.11 39.2 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.888 1.233 . . . . 0.0 112.893 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.66 168.11 13.31 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 120.837 -1.39 . . . . 0.0 113.759 -178.55 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 N-CA-C 119.998 2.759 . . . . 0.0 119.998 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 tp -94.08 167.51 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 0.0 109.768 -170.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -136.4 158.79 43.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.228 -2.17 . . . . 0.0 107.722 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.624 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.2 t -89.5 128.82 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.813 -1.179 . . . . 0.0 111.12 175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -88.51 -63.08 1.35 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.21 133.83 54.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.206 1.402 . . . . 0.0 110.125 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.624 ' CD1' HG11 ' A' ' 44' ' ' VAL . 30.4 mm -97.83 135.89 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.281 1.832 . . . . 0.0 108.274 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.741 HD12 ' HA2' ' A' ' 26' ' ' GLY . 55.8 mt . . . . . 0 N--CA 1.429 -1.477 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.213 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.77 60.93 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.55 -34.4 70.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.057 1.408 . . . . 0.0 111.71 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -72.09 1.27 7.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.51 -74.15 0.17 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.615 -1.928 . . . . 0.0 107.541 156.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.79 -18.5 2.58 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 113.486 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -92.99 -15.73 25.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.474 0.71 . . . . 0.0 112.48 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -80.86 133.79 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.048 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.29 177.45 8.61 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.188 0.994 . . . . 0.0 111.031 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.91 104.15 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.932 1.693 . . . . 0.0 112.441 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.44 -31.31 2.34 Favored Glycine 0 N--CA 1.429 -1.818 0 O-C-N 120.696 -1.253 . . . . 0.0 115.191 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.73 161.18 31.06 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 118.507 1.154 . . . . 0.0 113.71 -170.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -98.69 134.44 41.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.48 1.112 . . . . 0.0 110.894 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.38 114.11 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.771 1.628 . . . . 0.0 107.072 171.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -27.86 12.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.699 -1.876 . . . . 0.0 113.973 -173.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.35 166.68 30.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 119.073 0.851 . . . . 0.0 112.501 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 HG22 ' A' ' 84' ' ' THR . 4.1 p -146.31 135.35 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 112.077 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.0 m120 56.41 20.22 4.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.382 -2.074 . . . . 0.0 115.93 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.1 79.35 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.255 -1.528 . . . . 0.0 115.383 -168.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 t -109.43 106.26 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.107 1.763 . . . . 0.0 109.485 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.8 p -62.16 141.51 58.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.41 34.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.227 -1.546 . . . . 0.0 113.214 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.74 103.19 3.56 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.5 -2.0 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.1 13.58 58.72 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.376 -0.827 . . . . 0.0 114.079 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 140.03 29.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.673 -1.486 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -95.05 -163.62 1.07 Allowed 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.131 1.772 . . . . 0.0 110.408 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -59.97 -54.42 46.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.973 -1.704 . . . . 0.0 112.749 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -67.35 -44.79 78.18 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 111.951 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -68.2 -33.89 75.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.32 93.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.695 -1.878 . . . . 0.0 113.727 170.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.4 -53.98 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 122.995 0.518 . . . . 0.0 111.135 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -69.45 -20.13 63.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.464 HG22 HG12 ' A' ' 68' ' ' VAL . 95.7 m -63.81 -36.08 82.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.686 1.595 . . . . 0.0 110.756 168.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.27 -40.0 12.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.312 1.445 . . . . 0.0 114.717 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.459 0.0 OUTLIER -72.83 -43.42 62.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.874 -2.391 . . . . 0.0 116.546 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -87.87 47.41 1.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.007 1.384 . . . . 0.0 111.102 -174.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.0 p -102.09 175.29 5.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.39 2.676 . . . . 0.0 111.417 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.34 75.51 0.21 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 124.802 1.191 . . . . 0.0 111.654 175.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 69.22 -50.61 0.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.068 2.547 . . . . 0.0 117.382 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.86 135.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 125.631 1.572 . . . . 0.0 109.772 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.457 HG13 ' CG2' ' A' ' 68' ' ' VAL . 2.1 t -119.32 107.31 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -79.02 103.03 8.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 109.329 162.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -85.39 117.36 24.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.386 1.474 . . . . 0.0 109.343 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.78 102.94 15.64 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.694 0.759 . . . . 0.0 109.39 167.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.445 HD13 ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -104.82 145.32 30.55 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.521 1.928 . . . . 0.0 110.862 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.76 120.79 43.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 163.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.6 tptt . . . . . 0 N--CA 1.431 -1.404 0 O-C-N 120.73 -1.231 . . . . 0.0 107.691 169.577 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 8.3 tp . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.445 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.461 19.5 m 46.68 91.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 128.12 2.568 . . . . 0.0 117.023 170.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.5 m -128.88 126.58 40.06 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 42.4 m -62.78 123.36 18.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.868 2.467 . . . . 0.0 109.239 170.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--O 1.26 1.651 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 -172.544 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 122.549 1.166 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 111.4 16.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.169 1.388 . . . . 0.0 108.94 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.96 75.0 8.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.344 1.458 . . . . 0.0 110.842 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.42 121.26 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.397 -1.439 . . . . 0.0 114.033 -171.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -100.89 132.41 46.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.758 -1.839 . . . . 0.0 112.192 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.61 178.57 8.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.56 43.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.53 -1.356 . . . . 0.0 109.845 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 146.29 24.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 113.021 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -96.63 85.2 3.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.911 1.338 . . . . 0.0 108.91 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 55.71 72.96 0.45 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.253 1.821 . . . . 0.0 115.015 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.0 50.54 60.96 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.267 1.413 . . . . 0.0 114.324 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 t -169.96 98.08 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -169.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.54 HD11 HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.16 -47.05 30.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.054 1.883 . . . . 0.0 105.956 164.66 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 116.11 46.39 0.55 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.114 171.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 pt -118.09 134.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.003 0.921 . . . . 0.0 109.429 166.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -88.99 112.66 23.63 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.574 1.15 . . . . 0.0 109.951 166.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 m -79.23 143.65 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -138.08 171.33 14.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.699 -1.876 . . . . 0.0 109.001 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.98 -133.4 11.78 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 125.011 1.291 . . . . 0.0 112.815 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.36 154.71 29.89 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 123.985 0.803 . . . . 0.0 112.566 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.431 -1.415 0 C-N-CA 125.402 1.481 . . . . 0.0 113.751 -176.581 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.818 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.281 2.4 tp -111.54 159.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.257 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -139.48 157.45 45.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 47' ' ' ILE . 53.9 t -82.33 137.9 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.552 -1.967 . . . . 0.0 110.592 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -100.31 -53.29 3.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.941 -1.1 . . . . 0.0 109.851 165.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.65 48.3 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.939 0.876 . . . . 0.0 111.231 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 44' ' ' VAL . 47.1 mm -110.79 133.63 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.465 1.906 . . . . 0.0 109.21 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.587 HD12 ' HA2' ' A' ' 26' ' ' GLY . 62.3 mt . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.762 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 120.574 0.226 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.62 -45.11 72.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.936 1.694 . . . . 0.0 115.513 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.62 -33.64 68.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.927 -1.733 . . . . 0.0 111.737 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t -72.7 6.33 2.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.84 -88.55 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.001 -1.687 . . . . 0.0 106.888 149.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.33 -21.78 0.95 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.893 -1.129 . . . . 0.0 112.122 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -85.82 -35.56 20.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 121.365 -1.079 . . . . 0.0 111.145 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 mt -60.4 125.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.524 1.53 . . . . 0.0 113.102 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -177.06 4.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.586 1.154 . . . . 0.0 109.412 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -76.62 89.89 3.35 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.086 -1.634 . . . . 0.0 111.434 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.95 -21.17 0.37 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.707 -1.246 . . . . 0.0 114.964 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -68.2 155.32 39.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 114.71 29.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.711 2.004 . . . . 0.0 109.43 -168.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.27 112.68 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.225 -1.547 . . . . 0.0 108.743 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.61 -31.75 11.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.451 -1.406 . . . . 0.0 112.962 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.76 160.25 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.637 1.108 . . . . 0.0 112.553 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 t -137.2 127.32 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.85 27.02 12.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.027 1.74 . . . . 0.0 114.608 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.1 18.73 79.78 Favored Glycine 0 N--CA 1.43 -1.766 0 O-C-N 120.598 -1.314 . . . . 0.0 113.644 -172.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.35 102.22 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 t -60.76 138.06 58.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -86.19 82.12 8.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -110.09 42.09 1.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.315 2.007 . . . . 0.0 110.308 -170.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.17 55.44 0.18 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.01 141.94 43.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.013 0.911 . . . . 0.0 108.581 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.8 p -96.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.572 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.04 -54.67 38.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.47 -1.394 . . . . 0.0 111.713 165.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -67.8 -42.9 80.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.6 tt0 -63.97 -46.49 84.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.8 77.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.91 -53.74 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 121.709 -0.619 . . . . 0.0 111.285 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.41 -30.87 71.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.4 m -60.3 -28.92 68.49 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.465 1.506 . . . . 0.0 112.303 171.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.54 HD22 HD11 ' A' ' 25' ' ' LEU . 14.0 mt -88.34 -47.0 8.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.02 -1.675 . . . . 0.0 113.355 168.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -88.07 -27.88 21.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -162.097 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -86.9 18.98 3.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.627 -1.296 . . . . 0.0 113.217 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.0 p -88.29 170.49 10.94 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.978 2.511 . . . . 0.0 111.396 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.15 -90.13 0.21 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.373 -1.455 . . . . 0.0 115.238 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -129.44 -57.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.531 . . . . 0.0 110.321 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.24 136.82 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 122.041 0.924 . . . . 0.0 111.028 173.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.69 109.66 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 168.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -85.54 102.67 13.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.644 1.178 . . . . 0.0 109.284 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.65 120.03 28.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.769 -1.832 . . . . 0.0 110.439 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.85 97.72 11.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.911 -1.118 . . . . 0.0 108.663 169.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.38 145.8 28.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.466 1.906 . . . . 0.0 110.41 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.62 144.18 46.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.769 1.228 . . . . 0.0 108.971 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 tptt . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -172.956 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.4 tp . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.576 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.359 13.5 m 29.27 101.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.781 3.232 . . . . 0.0 119.071 157.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -132.57 123.68 26.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.0 p -75.5 119.93 20.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.692 1.597 . . . . 0.0 110.793 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.566 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.06 126.12 51.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.385 2.674 . . . . 0.0 109.147 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.24 67.16 1.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.222 1.409 . . . . 0.0 110.83 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.38 112.64 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -165.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 5.5 tt0 -93.1 118.81 31.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.432 -2.043 . . . . 0.0 111.418 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.6 169.65 17.18 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.612 1.165 . . . . 0.0 109.351 175.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.31 150.13 32.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.783 1.633 . . . . 0.0 110.006 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.96 174.2 9.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.163 -0.961 . . . . 0.0 112.101 -170.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.8 t -110.89 103.87 12.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.124 -1.61 . . . . 0.0 107.361 168.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t70 34.42 67.48 0.22 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.523 2.729 . . . . 0.0 117.18 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.36 48.35 45.7 Favored Glycine 0 N--CA 1.429 -1.808 0 O-C-N 119.961 -1.712 . . . . 0.0 115.069 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 m -175.98 111.15 0.1 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.56 -45.56 68.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.153 1.781 . . . . 0.0 108.094 167.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.501 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 106.01 45.13 1.31 Allowed Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.774 1.178 . . . . 0.0 110.799 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -125.8 141.96 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 163.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 m -90.37 126.17 35.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 164.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.47 148.83 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -149.38 167.8 25.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.341 -1.475 . . . . 0.0 108.743 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.19 -138.21 14.21 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.854 -1.154 . . . . 0.0 112.704 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.86 167.57 28.3 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.43 -1.469 0 C-N-CA 126.609 1.964 . . . . 0.0 113.3 171.931 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.647 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 42' ' ' ILE . 3.9 tp -107.93 156.86 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -131.7 161.09 33.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.548 HG11 HD13 ' A' ' 47' ' ' ILE . 35.4 t -91.87 134.17 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.577 -1.327 . . . . 0.0 109.497 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -85.48 -57.26 3.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.586 172.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.85 129.23 25.76 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 123.919 0.888 . . . . 0.0 110.628 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.548 HD13 HG11 ' A' ' 44' ' ' VAL . 35.0 mm -91.7 122.86 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.698 1.599 . . . . 0.0 109.181 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.501 HD12 ' CA ' ' A' ' 26' ' ' GLY . 54.2 mt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.018 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 120.814 0.34 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.46 -48.19 67.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.503 1.921 . . . . 0.0 115.876 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.32 -30.47 66.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.126 -1.608 . . . . 0.0 112.344 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t -71.34 3.94 3.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.41 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.438 -1.414 . . . . 0.0 109.378 155.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.67 -45.81 0.26 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.174 -0.953 . . . . 0.0 111.551 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -86.54 -39.9 15.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -53.68 130.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -163.394 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 53.0 t60 -127.38 175.17 8.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.543 1.937 . . . . 0.0 110.833 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 51.0 mttp -86.11 40.96 0.9 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.058 1.743 . . . . 0.0 113.558 -169.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.26 38.58 0.09 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.258 -1.526 . . . . 0.0 110.864 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -103.45 158.1 16.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.07 1.348 . . . . 0.0 109.719 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.69 134.07 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 123.79 0.836 . . . . 0.0 109.229 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.12 110.54 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 163.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.75 -27.86 15.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.96 -1.713 . . . . 0.0 112.187 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.21 41.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 111.39 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -137.37 121.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.938 -1.101 . . . . 0.0 110.297 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.373 0.8 OUTLIER 43.02 34.29 0.61 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -173.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.34 60.64 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.284 0.945 . . . . 0.0 114.008 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.83 98.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.629 1.572 . . . . 0.0 107.225 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -62.36 142.52 57.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.854 -1.154 . . . . 0.0 113.352 173.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.9 mt -87.28 30.74 0.76 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.56 -1.337 . . . . 0.0 112.726 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.38 97.43 2.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.489 1.916 . . . . 0.0 109.061 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.16 -3.21 33.28 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.337 0.97 . . . . 0.0 114.986 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.73 140.95 29.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.943 1.872 . . . . 0.0 114.378 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 80.6 p -101.99 -163.0 0.97 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.503 2.321 . . . . 0.0 109.863 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.01 -53.21 53.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.214 -1.554 . . . . 0.0 111.343 166.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.1 -45.19 82.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.605 -0.684 . . . . 0.0 112.727 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.511 ' HB2' ' H ' ' A' ' 77' ' ' THR . 1.6 mm-40 -61.05 -43.07 99.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.79 -1.194 . . . . 0.0 113.253 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.22 94.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.956 -1.715 . . . . 0.0 115.411 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.43 -48.67 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 121.481 -0.762 . . . . 0.0 111.365 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.05 -36.69 84.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.643 -1.286 . . . . 0.0 114.104 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 m -63.59 -26.56 68.74 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.897 1.679 . . . . 0.0 113.351 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.33 -42.58 11.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.974 -1.704 . . . . 0.0 113.596 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -22.77 23.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.054 -1.654 . . . . 0.0 115.291 -169.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -102.71 37.51 1.92 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.61 -1.931 . . . . 0.0 111.28 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.5 p -87.76 -171.58 3.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.627 2.371 . . . . 0.0 111.207 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.42 62.54 0.3 Allowed Glycine 0 N--CA 1.431 -1.693 0 O-C-N 120.508 -1.37 . . . . 0.0 112.52 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 72.88 -54.05 0.7 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.301 2.641 . . . . 0.0 114.567 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 t -82.49 132.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 123.071 1.415 . . . . 0.0 109.98 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.76 109.72 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 8.4 m80 -84.62 102.01 12.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.902 -1.123 . . . . 0.0 108.434 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.5 110.89 21.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.424 -1.422 . . . . 0.0 111.56 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.9 89.31 7.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.398 1.094 . . . . 0.0 108.318 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.9 mt -103.79 148.61 25.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.88 2.472 . . . . 0.0 111.633 -173.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -135.37 140.69 45.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.824 -1.173 . . . . 0.0 109.528 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 120.358 -1.464 . . . . 0.0 113.134 -174.034 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.495 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.52 33.4 m 66.65 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 127.823 2.449 . . . . 0.0 117.543 174.477 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 99.6 m -152.55 118.45 5.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 91.1 p -78.65 128.62 33.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.403 1.097 . . . . 0.0 109.935 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.261 1.658 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 -156.386 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.429 -1.523 0 CA-C-O 122.128 0.966 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.05 129.38 56.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.5 1.52 . . . . 0.0 107.483 170.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.46 84.44 3.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.929 1.292 . . . . 0.0 108.815 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.8 107.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.215 2.206 . . . . 0.0 111.662 -171.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.27 112.75 24.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.826 -1.796 . . . . 0.0 109.643 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.8 mt -122.94 150.75 42.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.43 110.5 20.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 148.34 37.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.544 1.138 . . . . 0.0 113.709 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -102.33 97.18 7.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.427 -1.421 . . . . 0.0 109.96 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 60.49 50.12 6.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.787 2.035 . . . . 0.0 112.57 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.81 55.69 25.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 120.352 -1.467 . . . . 0.0 113.934 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -165.87 112.33 0.89 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.236 1.493 . . . . 0.0 107.005 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.697 HD21 HG21 ' A' ' 92' ' ' VAL . 6.9 mt -67.33 -49.61 63.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.482 1.913 . . . . 0.0 106.258 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.96 39.06 0.66 Allowed Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.562 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.446 ' HB ' HG13 ' A' ' 44' ' ' VAL . 44.8 pt -123.9 132.28 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.673 0.749 . . . . 0.0 109.817 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -77.22 117.4 18.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.443 -0.785 . . . . 0.0 111.742 159.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.36 128.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -130.19 169.69 15.04 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.379 1.471 . . . . 0.0 108.898 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.82 58.87 7.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.472 2.149 . . . . 0.0 118.472 169.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.52 -176.63 34.18 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.34 -1.683 . . . . 0.0 109.604 172.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.663 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.797 0 CA-C-O 121.911 0.728 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.5 tp -148.05 161.35 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 161.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -135.71 161.24 36.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.528 -1.982 . . . . 0.0 106.739 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 47' ' ' ILE . 10.9 t -92.44 129.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.031 -1.668 . . . . 0.0 111.643 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.67 -49.31 6.94 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.808 -1.182 . . . . 0.0 111.429 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.47 126.92 28.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.845 -1.159 . . . . 0.0 110.626 -170.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.61 HD13 HG11 ' A' ' 44' ' ' VAL . 34.3 mm -96.07 119.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt . . . . . 0 N--CA 1.431 -1.407 0 O-C-N 120.841 -1.162 . . . . 0.0 112.735 -177.188 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.57 -50.96 65.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.715 1.606 . . . . 0.0 114.454 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.96 -34.43 68.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.683 -1.26 . . . . 0.0 111.915 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 t -72.51 -6.33 43.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.54 -75.45 0.15 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.632 -1.918 . . . . 0.0 108.552 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.76 -10.19 12.43 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.399 -0.813 . . . . 0.0 114.238 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 -81.74 -23.74 36.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.78 -0.835 . . . . 0.0 111.395 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.99 139.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.165 1.786 . . . . 0.0 112.868 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -138.32 -167.91 2.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.248 1.023 . . . . 0.0 108.758 166.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -80.78 75.95 7.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.328 -1.483 . . . . 0.0 111.967 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.38 13.3 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.747 -1.221 . . . . 0.0 116.126 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -81.97 158.95 23.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.488 1.644 . . . . 0.0 113.18 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.65 114.17 27.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.236 1.415 . . . . 0.0 110.616 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.96 117.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.383 -1.448 . . . . 0.0 108.075 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -97.21 -39.46 9.26 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.003 -1.061 . . . . 0.0 112.163 173.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.524 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -156.2 166.21 34.12 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.118 1.326 . . . . 0.0 114.279 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG21 HD23 ' A' ' 85' ' ' LEU . 9.1 t -135.16 122.56 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 110.644 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 49.13 30.77 3.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -167.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.85 27.79 57.97 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 120.503 -1.373 . . . . 0.0 113.813 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.83 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.7 m -60.53 136.76 58.15 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.123 1.369 . . . . 0.0 114.59 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.97 53.11 1.9 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.169 1.788 . . . . 0.0 113.446 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.44 117.95 23.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.654 1.582 . . . . 0.0 108.198 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 9.53 86.51 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 120.87 -1.144 . . . . 0.0 115.727 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.76 140.29 29.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.865 1.317 . . . . 0.0 112.659 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 p -100.6 -164.89 1.15 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.968 1.707 . . . . 0.0 109.222 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -60.17 -57.33 13.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.446 -1.409 . . . . 0.0 112.651 163.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.61 -43.82 95.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 112.968 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -37.04 86.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.759 -1.213 . . . . 0.0 113.471 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.87 89.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.314 -1.491 . . . . 0.0 114.986 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.3 t -57.84 -53.21 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 121.69 -0.631 . . . . 0.0 112.108 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.3 m -64.23 -30.17 71.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.53 2.332 . . . . 0.0 113.294 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 68' ' ' VAL . 24.8 mt -88.47 -43.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.99 -1.694 . . . . 0.0 113.771 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -48.46 11.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.784 1.634 . . . . 0.0 114.976 -162.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -81.12 18.98 0.96 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.719 1.208 . . . . 0.0 113.723 -169.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.1 p -85.02 177.1 8.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.182 2.593 . . . . 0.0 112.08 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.87 -77.82 0.28 Allowed Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.167 -1.583 . . . . 0.0 115.217 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -154.29 -54.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.982 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.44 128.08 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.846 1.308 . . . . 0.0 111.006 170.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.697 HG21 HD21 ' A' ' 25' ' ' LEU . 2.7 m -118.42 112.2 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.977 1.711 . . . . 0.0 107.53 166.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -78.85 95.22 5.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.685 -1.259 . . . . 0.0 107.71 164.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 117.3 15.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.791 -1.193 . . . . 0.0 113.063 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.524 HD12 ' HB3' ' A' ' 67' ' ' ALA . 7.1 mt -86.04 95.64 9.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.8 mt -104.19 130.64 51.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.902 2.881 . . . . 0.0 111.688 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -105.94 140.24 39.25 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.778 -1.202 . . . . 0.0 110.24 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.1 tptt . . . . . 0 N--CA 1.43 -1.439 0 C-N-CA 125.111 1.364 . . . . 0.0 113.121 -175.316 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.451 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.521 30.1 m 66.46 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 127.571 2.348 . . . . 0.0 116.932 171.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 80.3 m -152.82 125.6 8.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 78.7 p -76.91 126.43 30.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.592 1.157 . . . . 0.0 108.404 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.613 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 -161.575 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 121.436 0.636 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.312 0.0 OUTLIER -106.62 136.88 45.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.591 1.556 . . . . 0.0 110.075 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -117.64 76.72 1.08 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.068 1.347 . . . . 0.0 108.423 -173.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.68 137.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 126.851 2.06 . . . . 0.0 111.233 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 127.64 53.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.354 2.343 . . . . 0.0 110.093 167.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.5 128.8 49.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.207 1.003 . . . . 0.0 110.156 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.1 90.88 6.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.219 1.009 . . . . 0.0 109.313 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.08 137.52 58.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -104.05 105.19 15.28 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.82 1.295 . . . . 0.0 109.413 -160.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 54.78 37.33 28.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.198 2.199 . . . . 0.0 114.958 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.62 88.62 0.25 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.794 -1.191 . . . . 0.0 112.371 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.284 51.9 p 149.32 112.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.727 2.411 . . . . 0.0 109.519 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 20' ' ' LYS . 8.0 mt -73.28 -43.16 61.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 156.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.94 17.81 3.31 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.545 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.3 pt -105.8 126.22 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 122.013 0.911 . . . . 0.0 111.09 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -79.31 109.68 13.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.06 1.344 . . . . 0.0 111.469 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.64 127.62 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -134.07 178.93 6.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.697 2.399 . . . . 0.0 108.699 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.11 39.94 35.96 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 119.881 -1.762 . . . . 0.0 117.26 168.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.48 -179.88 49.31 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.092 -1.828 . . . . 0.0 113.606 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.425 0 C-N-CA 126.288 1.835 . . . . 0.0 114.345 179.868 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.704 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.4 tp -136.32 156.18 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 155.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -137.12 154.56 50.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -171.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 47' ' ' ILE . 11.9 t -84.08 131.94 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 119.694 -1.879 . . . . 0.0 111.067 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.33 -52.66 5.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 109.956 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.43 140.43 41.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 111.696 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 44' ' ' VAL . 46.3 mm -97.61 127.57 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.503 1.921 . . . . 0.0 106.789 169.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 pt . . . . . 0 N--CA 1.429 -1.5 0 O-C-N 121.194 -0.941 . . . . 0.0 112.092 176.782 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.42 0 CA-C-O 121.583 0.706 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.73 72.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.121 -1.612 . . . . 0.0 113.228 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.68 -26.84 64.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.618 1.567 . . . . 0.0 112.424 165.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -80.93 -9.49 59.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.437 -2.039 . . . . 0.0 115.788 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -76.22 -62.45 1.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.748 2.067 . . . . 0.0 106.049 156.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.62 -9.68 62.45 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 121.499 -0.75 . . . . 0.0 112.935 162.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -74.23 -28.77 61.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 123.66 0.784 . . . . 0.0 109.174 166.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.7 mt -61.71 128.08 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 126.938 2.095 . . . . 0.0 110.716 165.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.598 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 24.7 t-80 -127.7 -161.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.109 0.963 . . . . 0.0 109.665 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.598 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 95.1 mttt -92.45 66.27 4.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.555 -2.59 . . . . 0.0 111.12 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.92 53.5 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.45 -0.781 . . . . 0.0 114.911 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -109.83 173.68 6.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.778 1.231 . . . . 0.0 108.898 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -103.89 136.43 43.56 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.034 0.934 . . . . 0.0 110.377 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.63 119.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.41 -34.21 8.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.864 -1.772 . . . . 0.0 113.161 177.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.58 153.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.119 1.327 . . . . 0.0 112.9 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -133.92 111.96 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 112.102 -174.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.74 31.19 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.437 -1.415 . . . . 0.0 113.744 -166.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.42 80.7 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.123 1.344 . . . . 0.0 113.921 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.75 102.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.992 -1.299 . . . . 0.0 107.584 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -65.75 137.1 57.04 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 126.136 1.774 . . . . 0.0 114.359 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.2 mt -86.99 26.39 1.16 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.561 1.544 . . . . 0.0 113.009 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -68.21 118.16 10.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.573 -1.955 . . . . 0.0 110.023 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.28 6.53 86.1 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 120.954 -1.091 . . . . 0.0 115.201 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.37 137.94 32.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 118.945 1.372 . . . . 0.0 111.744 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -113.64 -168.15 1.3 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -54.62 -52.0 63.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.603 -1.936 . . . . 0.0 114.647 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.31 -46.24 74.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.242 -0.912 . . . . 0.0 112.978 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.99 -46.44 90.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.497 1.519 . . . . 0.0 114.809 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.29 -34.63 78.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.371 -1.456 . . . . 0.0 114.404 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.12 -54.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.151 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -55.48 -47.71 75.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.2 m -52.56 -33.16 44.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 126.283 1.833 . . . . 0.0 115.182 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 mt -92.2 -46.7 7.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.176 1.79 . . . . 0.0 115.449 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -37.05 55.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.592 2.357 . . . . 0.0 114.586 -172.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.54 30.49 0.71 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.157 -1.59 . . . . 0.0 112.363 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.6 p -106.19 176.78 5.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.761 2.424 . . . . 0.0 109.361 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.42 -74.63 1.28 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 119.444 -2.035 . . . . 0.0 113.954 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -139.91 -66.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.966 -1.314 . . . . 0.0 110.068 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.59 115.35 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.17 1.462 . . . . 0.0 110.605 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.74 103.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.23 97.77 8.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.594 1.158 . . . . 0.0 109.133 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.29 114.01 22.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.829 1.652 . . . . 0.0 108.993 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 103.85 16.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mt -108.97 142.84 39.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.317 1.847 . . . . 0.0 110.408 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -114.04 129.45 56.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.564 1.146 . . . . 0.0 108.034 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tptm . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 126.539 1.936 . . . . 0.0 113.264 -171.408 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.41 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.389 2.7 t 66.86 91.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 124.943 2.306 . . . . 0.0 113.016 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 90.4 m -136.61 128.62 29.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.193 -2.891 . . . . 0.0 103.193 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.7 m -72.89 120.03 17.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.036 0.922 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.72 126.57 54.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.8 1.64 . . . . 0.0 107.739 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -99.69 85.39 3.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.979 1.371 . . . . 0.0 108.312 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -81.1 115.52 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.668 1.987 . . . . 0.0 111.594 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 118.53 36.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.289 -2.132 . . . . 0.0 110.761 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.4 mt -126.02 -178.86 4.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.557 1.143 . . . . 0.0 108.973 -170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.43 126.86 30.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 162.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.57 53.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.9 -1.125 . . . . 0.0 112.755 -174.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 t -97.23 92.8 6.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.439 1.59 . . . . 0.0 109.543 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.38 25.82 12.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.004 1.722 . . . . 0.0 114.31 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.3 65.46 1.32 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 124.677 1.132 . . . . 0.0 112.662 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.3 t 179.33 113.94 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.3 mt -78.58 -36.26 44.64 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.357 2.027 . . . . 0.0 106.466 162.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.545 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 101.82 43.93 2.02 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -128.3 133.64 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.5 m -89.34 108.03 19.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.683 1.593 . . . . 0.0 111.736 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 m -77.89 137.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -171.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 t -133.07 166.32 22.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.316 -1.49 . . . . 0.0 110.37 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.49 -130.86 10.27 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 125.106 1.336 . . . . 0.0 112.645 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.52 160.68 30.35 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.529 1.061 . . . . 0.0 112.049 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 119.808 -1.995 . . . . 0.0 115.729 -177.0 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.765 0 N-CA-C 105.936 -2.865 . . . . 0.0 105.936 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.34 154.94 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 119.489 1.645 . . . . 0.0 106.936 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -138.79 148.75 44.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.315 -2.116 . . . . 0.0 105.853 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 47' ' ' ILE . 69.9 t -73.39 127.56 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 120.622 -1.299 . . . . 0.0 111.505 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -88.23 -66.05 0.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.725 -1.235 . . . . 0.0 108.722 166.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 133.53 53.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.527 1.131 . . . . 0.0 111.711 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 44' ' ' VAL . 51.0 mm -93.44 137.1 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 169.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.545 HD12 ' CA ' ' A' ' 26' ' ' GLY . 54.5 mt . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 116.525 -1.703 . . . . 0.0 110.726 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 120.786 1.63 . . . . 0.0 113.314 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 p -55.18 -27.28 44.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.17 -73.8 0.06 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.872 1.269 . . . . 0.0 111.173 170.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.44 -9.92 14.8 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 121.667 -0.646 . . . . 0.0 112.95 164.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -79.17 -27.69 42.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.135 -1.215 . . . . 0.0 110.557 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -69.98 146.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.549 1.939 . . . . 0.0 114.434 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -148.58 -171.59 3.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.833 -1.167 . . . . 0.0 109.317 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -78.12 93.74 4.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.902 -2.373 . . . . 0.0 112.569 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.38 -19.24 0.26 Allowed Glycine 0 N--CA 1.429 -1.782 0 O-C-N 121.023 -1.048 . . . . 0.0 114.467 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -70.05 153.43 43.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -172.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -105.51 121.3 43.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.407 1.575 . . . . 0.0 111.325 -172.45 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.22 109.48 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.418 2.687 . . . . 0.0 106.232 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.09 -37.07 9.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.192 -0.943 . . . . 0.0 112.488 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.93 166.5 33.35 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.979 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' A' ' 92' ' ' VAL . 4.8 p -142.54 123.57 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 121.311 -0.868 . . . . 0.0 113.023 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.24 30.89 3.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.82 22.4 66.45 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.608 -1.308 . . . . 0.0 114.329 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.81 98.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -67.0 137.59 56.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 125.106 1.362 . . . . 0.0 112.554 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -75.63 61.16 1.32 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.069 1.748 . . . . 0.0 113.679 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.1 110.18 5.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.192 1.397 . . . . 0.0 111.56 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.65 30.53 78.18 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.717 1.151 . . . . 0.0 115.6 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.54 140.45 29.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.762 1.281 . . . . 0.0 112.821 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.5 p -97.96 -157.44 0.6 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.698 1.999 . . . . 0.0 109.934 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.421 -2.049 . . . . 0.0 109.754 168.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -53.21 55.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.327 1.051 . . . . 0.0 111.645 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.07 -26.9 64.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.07 78.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.481 -2.012 . . . . 0.0 113.644 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG12 ' HG2' ' A' ' 86' ' ' ARG . 24.0 t -57.88 -52.56 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.16 -0.963 . . . . 0.0 110.184 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.406 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 62.1 mt-10 -54.02 -41.19 67.73 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.5 m -57.25 -39.31 75.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.905 2.082 . . . . 0.0 114.452 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mt -92.21 -28.4 17.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.842 1.257 . . . . 0.0 113.252 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG2' HG12 ' A' ' 82' ' ' VAL . 4.4 ppt_? -86.6 -47.98 8.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.02 43.98 1.17 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.667 1.699 . . . . 0.0 110.473 -171.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.8 p -95.94 -152.8 0.38 Allowed 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.103 2.961 . . . . 0.0 109.609 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.14 -137.42 9.56 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.144 -1.598 . . . . 0.0 110.43 172.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -92.9 -51.48 5.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.522 1.129 . . . . 0.0 109.055 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.76 132.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.976 1.37 . . . . 0.0 110.139 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 68' ' ' VAL . 4.5 t -124.01 111.76 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.66 103.55 10.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.126 1.371 . . . . 0.0 107.772 160.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -83.27 108.77 16.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.716 2.007 . . . . 0.0 108.284 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.7 102.57 11.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 110.722 169.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -109.6 147.97 32.1 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.392 2.277 . . . . 0.0 110.228 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.88 152.21 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.172 1.789 . . . . 0.0 106.425 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -171.392 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.606 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.0 tp . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.606 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.394 10.9 m 31.71 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 130.308 3.443 . . . . 0.0 118.213 164.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 82.2 m -119.47 124.15 45.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 36.9 t -67.98 112.43 4.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.519 1.128 . . . . 0.0 108.562 164.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 25' ' ' LEU . 13.1 p . . . . . 0 C--O 1.26 1.624 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 -167.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 122.303 1.049 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -133.87 133.43 41.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.352 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -111.4 76.03 0.95 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.967 1.307 . . . . 0.0 108.939 -177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.72 118.91 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 125.712 1.605 . . . . 0.0 114.543 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.268 6.3 pm0 -99.68 126.39 45.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.466 -2.021 . . . . 0.0 111.977 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 169.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.62 148.17 33.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.697 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 146.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 111.005 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -94.45 93.07 7.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.528 -1.357 . . . . 0.0 108.244 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 45.81 67.72 0.7 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.257 2.623 . . . . 0.0 115.861 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.82 42.7 77.97 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 121.507 -0.746 . . . . 0.0 113.862 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 p -167.89 106.18 0.51 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.848 1.785 . . . . 0.0 108.49 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.13 -47.23 59.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 162.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 27.77 1.67 Allowed Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.186 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 pt -109.13 122.93 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 122.998 1.38 . . . . 0.0 109.541 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -84.51 110.54 18.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.176 1.39 . . . . 0.0 109.209 171.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -80.9 138.43 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.477 ' HA ' HD11 ' B' ' 206' ' ' LEU . 9.2 t -133.51 171.63 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.017 1.727 . . . . 0.0 108.281 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.42 -143.73 18.05 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 124.985 1.279 . . . . 0.0 113.163 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.6 159.39 28.82 Favored Glycine 0 N--CA 1.431 -1.661 0 O-C-N 121.562 -0.963 . . . . 0.0 111.808 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.43 -1.46 0 C-N-CA 126.052 1.741 . . . . 0.0 114.503 -174.739 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 tp -102.88 158.8 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 167.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -133.94 158.73 42.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.576 -1.952 . . . . 0.0 105.914 -171.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 47' ' ' ILE . 3.3 t -89.7 134.49 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.578 -1.951 . . . . 0.0 109.873 174.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -39.16 10.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.356 -1.465 . . . . 0.0 110.923 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.67 20.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.555 -0.716 . . . . 0.0 111.265 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.506 HD13 HG11 ' A' ' 44' ' ' VAL . 30.9 mm -99.01 135.02 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.6 1.96 . . . . 0.0 107.3 171.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.909 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.425 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.69 82.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.141 -1.599 . . . . 0.0 115.114 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.36 -29.77 70.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.496 -1.378 . . . . 0.0 111.583 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.35 -0.86 15.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 115.405 1.632 . . . . 0.0 115.405 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.73 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 108.447 158.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.57 -1.54 15.81 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 113.353 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -95.05 -31.9 13.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.023 -1.281 . . . . 0.0 110.237 169.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.36 139.54 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.131 -1.605 . . . . 0.0 114.594 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -127.54 177.47 6.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.982 0.896 . . . . 0.0 109.213 160.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.63 50.78 0.44 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.25 -1.53 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.154 -2.216 . . . . 0.0 115.666 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -76.01 161.73 28.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 118.567 1.183 . . . . 0.0 114.175 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -96.0 131.9 41.9 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.736 1.214 . . . . 0.0 109.869 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.48 115.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 168.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.35 -35.83 12.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.196 -1.565 . . . . 0.0 111.915 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.98 156.8 41.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.009 0.822 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.16 119.94 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 121.007 -1.058 . . . . 0.0 109.948 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.74 28.12 16.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.119 -1.613 . . . . 0.0 114.186 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.7 90.41 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 125.035 1.302 . . . . 0.0 113.486 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.6 t -97.33 104.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.155 -1.203 . . . . 0.0 109.163 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -53.4 137.17 36.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.357 2.263 . . . . 0.0 115.697 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.24 25.55 1.6 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.736 -1.227 . . . . 0.0 112.584 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.7 111.57 11.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.011 -1.68 . . . . 0.0 110.574 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.45 -1.67 72.92 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.777 -0.577 . . . . 0.0 113.039 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.22 138.66 31.4 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.552 1.644 . . . . 0.0 111.59 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.486 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 3.8 t -117.57 -171.7 2.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.677 2.391 . . . . 0.0 104.836 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -48.96 -52.65 23.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.844 1.658 . . . . 0.0 114.856 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.42 -47.74 59.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.755 1.161 . . . . 0.0 113.188 -175.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' HB2' ' H ' ' A' ' 77' ' ' THR . 5.1 mm100 -50.67 -49.35 57.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.554 1.542 . . . . 0.0 114.474 168.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.61 84.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.436 -1.415 . . . . 0.0 114.5 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.417 HG13 HG11 ' B' ' 210' ' ' VAL . 65.1 t -62.53 -48.19 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 111.512 175.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -58.14 -39.0 77.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.212 -1.555 . . . . 0.0 113.592 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.5 m -64.56 -26.81 68.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.518 2.327 . . . . 0.0 113.715 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.46 -47.02 7.67 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.349 1.459 . . . . 0.0 114.087 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.269 0.1 OUTLIER -79.62 -35.09 39.98 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.361 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.75 40.31 1.03 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.436 -2.04 . . . . 0.0 111.61 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.1 p -101.2 159.07 15.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.75 2.42 . . . . 0.0 111.663 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.09 65.09 4.17 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 121.165 -0.959 . . . . 0.0 112.103 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 67.46 -48.09 0.5 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 129.319 3.048 . . . . 0.0 116.133 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.2 t -80.5 131.66 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.775 1.274 . . . . 0.0 110.874 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.415 HG12 ' HG ' ' A' ' 94' ' ' LEU . 60.9 t -117.73 109.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -88.4 101.15 13.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.935 -1.103 . . . . 0.0 109.153 171.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.415 ' HG ' HG12 ' A' ' 92' ' ' VAL . 15.2 mt -90.37 122.62 33.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.864 -1.148 . . . . 0.0 111.627 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.07 102.95 14.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.7 mt -112.47 142.52 44.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.507 1.923 . . . . 0.0 110.583 -171.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.65 142.09 50.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.207 2.203 . . . . 0.0 108.512 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.764 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 30' ' ' THR . 10.5 tp . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.407 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.491 5.9 m 52.82 100.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.103 2.961 . . . . 0.0 117.827 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 53.5 m -130.62 118.93 21.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 76.2 p -77.67 122.83 25.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.575 1.15 . . . . 0.0 109.244 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.633 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -175.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.37 1.081 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 114.74 26.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 174.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -92.29 83.45 5.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.24 153.39 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 127.761 2.425 . . . . 0.0 110.339 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.52 50.96 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.513 -1.992 . . . . 0.0 108.321 167.285 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.8 mt -128.75 161.72 29.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 123.998 0.919 . . . . 0.0 109.689 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.74 117.13 26.67 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.032 0.92 . . . . 0.0 108.863 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 1.2 ptmm? -62.84 126.25 26.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.051 1.74 . . . . 0.0 113.087 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -96.48 118.27 32.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.989 -1.069 . . . . 0.0 108.709 -171.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.34 -19.93 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.29 2.236 . . . . 0.0 117.006 -171.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 53.26 0.11 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.971 1.748 . . . . 0.0 110.682 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 m -177.81 126.87 0.13 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 -173.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.2 mt -84.02 -39.4 19.68 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.393 2.277 . . . . 0.0 106.724 172.465 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA2' HD11 ' A' ' 48' ' ' ILE . . . 131.97 6.17 3.28 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 124.298 0.951 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 pt -102.0 127.55 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 122.428 1.108 . . . . 0.0 111.13 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -81.49 109.8 16.29 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.075 1.35 . . . . 0.0 112.102 168.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.91 125.95 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -172.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.5 t -120.22 160.84 22.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.938 2.095 . . . . 0.0 110.843 175.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.08 -125.14 8.24 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.668 1.604 . . . . 0.0 112.441 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.15 140.72 11.43 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 177.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 124.898 1.279 . . . . 0.0 114.28 -167.939 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.701 0 N-CA-C 107.354 -2.298 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.517 HG22 HG13 ' A' ' 65' ' ' VAL 0.287 2.3 tp -114.61 157.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.043 1.421 . . . . 0.0 108.701 175.432 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -140.6 157.25 45.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.892 -1.755 . . . . 0.0 106.614 -171.128 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 47' ' ' ILE . 6.2 t -88.73 127.37 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.305 -1.497 . . . . 0.0 112.2 174.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -83.27 -50.42 8.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.656 -1.277 . . . . 0.0 109.907 171.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.06 138.87 37.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -174.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.539 HD13 HG11 ' A' ' 44' ' ' VAL . 29.1 mm -97.03 145.58 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.121 1.768 . . . . 0.0 107.184 171.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.542 HD11 ' HA2' ' A' ' 26' ' ' GLY . 2.2 pt . . . . . 0 N--CA 1.43 -1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 110.776 169.066 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.498 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.13 72.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.322 -1.486 . . . . 0.0 113.916 -177.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.74 -32.99 72.26 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.274 1.43 . . . . 0.0 112.195 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -61.62 -28.54 69.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.32 -75.04 0.05 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.932 1.242 . . . . 0.0 111.797 176.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.16 -30.71 2.42 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 112.1 168.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -86.58 -20.97 27.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 113.644 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -71.75 133.89 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.159 1.784 . . . . 0.0 112.073 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -150.33 -159.75 1.08 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.638 -1.288 . . . . 0.0 110.557 165.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.76 129.03 36.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.215 -1.553 . . . . 0.0 112.1 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.75 23.24 56.42 Favored Glycine 0 N--CA 1.428 -1.839 0 O-C-N 120.151 -1.593 . . . . 0.0 114.965 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.85 148.14 22.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.289 -1.124 . . . . 0.0 109.821 168.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -90.99 129.8 36.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.04 -1.038 . . . . 0.0 109.976 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 42' ' ' ILE . 1.5 p -104.19 119.91 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 165.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.87 -31.57 11.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.754 -1.216 . . . . 0.0 112.852 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.2 43.48 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 119.04 0.836 . . . . 0.0 112.418 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 HG13 ' A' ' 92' ' ' VAL . 61.1 t -135.49 120.86 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 121.189 -0.945 . . . . 0.0 111.027 -177.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 54.94 29.79 12.82 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.412 1.485 . . . . 0.0 114.44 -170.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.77 22.36 77.15 Favored Glycine 0 N--CA 1.431 -1.659 0 O-C-N 121.037 -1.039 . . . . 0.0 114.117 -173.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.48 101.94 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.619 1.567 . . . . 0.0 107.86 177.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -66.19 143.49 57.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.843 -1.16 . . . . 0.0 113.915 177.035 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.39 62.0 3.61 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.902 1.681 . . . . 0.0 112.783 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.33 123.33 37.67 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.837 1.655 . . . . 0.0 108.539 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.5 -7.6 57.11 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.626 -1.296 . . . . 0.0 114.487 -171.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.93 129.26 34.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.128 1.918 . . . . 0.0 114.755 -169.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.1 p -96.17 -163.48 1.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.471 1.909 . . . . 0.0 108.415 -175.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.4 -51.66 66.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.986 -1.696 . . . . 0.0 112.374 163.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.61 -42.19 87.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.122 -0.986 . . . . 0.0 112.723 -177.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.9 tt0 -69.84 -34.32 73.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.43 75.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.217 -2.177 . . . . 0.0 114.097 171.291 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.59 -53.01 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.429 -0.794 . . . . 0.0 110.832 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.13 -41.36 62.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.418 1.463 . . . . 0.0 114.837 175.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.7 m -62.41 -29.95 70.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.65 2.38 . . . . 0.0 114.542 178.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.47 -40.95 9.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.263 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -50.55 15.06 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.534 2.334 . . . . 0.0 112.73 -171.262 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -91.44 42.55 1.11 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.977 1.37 . . . . 0.0 110.622 -168.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.1 p -102.44 164.7 11.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.51 2.324 . . . . 0.0 111.341 -174.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.04 58.23 4.77 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.759 -1.213 . . . . 0.0 113.125 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 71.16 -48.23 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.945 2.898 . . . . 0.0 116.858 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.49 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.596 1.188 . . . . 0.0 109.478 171.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.429 HG13 HG13 ' A' ' 68' ' ' VAL . 95.3 t -117.63 99.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -78.92 105.89 10.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.807 -1.183 . . . . 0.0 107.964 166.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -88.89 125.49 34.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.187 -1.571 . . . . 0.0 110.544 -177.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.42 102.09 14.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 108.567 166.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.32 148.29 24.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.2 1.8 . . . . 0.0 111.713 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -116.37 138.75 51.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 162.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.0 tptt . . . . . 0 N--CA 1.429 -1.515 0 C-N-CA 123.618 0.767 . . . . 0.0 112.982 176.432 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 20.2 tp . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 111.087 0.032 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.41 2.2 t 78.92 122.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.077 1.894 . . . . 0.0 114.565 166.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.1 m -147.21 125.11 11.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 176.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.7 p -75.52 128.99 36.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.013 0.925 . . . . 0.0 109.61 169.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.3 p . . . . . 0 C--O 1.259 1.588 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -162.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.429 -1.476 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -130.66 113.69 14.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.089 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.75 71.55 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.867 1.317 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.95 121.58 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.702 2.401 . . . . 0.0 111.721 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -105.24 115.34 30.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.423 -2.048 . . . . 0.0 109.398 -174.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -115.83 146.4 42.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.836 0.827 . . . . 0.0 110.003 -171.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.81 109.58 21.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 165.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -53.7 151.99 5.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.842 2.057 . . . . 0.0 112.77 175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -110.12 104.74 13.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 56.73 5.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.133 2.173 . . . . 0.0 116.086 -175.414 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.62 61.2 5.19 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 120.49 -1.381 . . . . 0.0 115.897 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 t 175.08 112.64 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.792 1.637 . . . . 0.0 106.77 -173.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.42 -41.93 45.93 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 126.233 1.813 . . . . 0.0 107.388 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.45 33.76 1.28 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.034 171.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.19 133.74 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 121.845 -0.797 . . . . 0.0 111.062 175.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -82.95 113.13 20.34 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.245 1.018 . . . . 0.0 111.088 164.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.555 HG23 ' CE1' ' A' ' 78' ' ' HIS . 21.0 m -85.26 128.98 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -124.11 167.15 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.448 1.899 . . . . 0.0 110.865 176.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 -137.65 15.6 Favored Glycine 0 N--CA 1.428 -1.846 0 C-N-CA 125.103 1.335 . . . . 0.0 112.915 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.11 161.88 21.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 124.433 1.015 . . . . 0.0 111.293 177.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.465 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 CA-C-O 121.041 0.245 . . . . 0.0 113.491 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.7 tp -116.59 164.39 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.189 0.995 . . . . 0.0 110.093 -166.099 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -140.72 156.75 46.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.028 -1.67 . . . . 0.0 106.786 -172.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.591 HG11 ' CD1' ' A' ' 47' ' ' ILE . 3.4 t -91.37 119.87 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.644 -1.285 . . . . 0.0 111.782 177.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -83.71 -40.49 18.81 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.732 -1.23 . . . . 0.0 111.065 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.42 131.8 17.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.964 0.905 . . . . 0.0 109.988 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.591 ' CD1' HG11 ' A' ' 44' ' ' VAL . 50.4 mm -97.33 120.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.113 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.9 pt . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 121.163 -0.961 . . . . 0.0 113.018 -175.517 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.24 -40.53 67.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.81 -28.7 69.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.469 -1.394 . . . . 0.0 111.796 168.225 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.7 t -73.33 -12.9 60.99 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.92 -85.03 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.923 2.147 . . . . 0.0 110.403 176.471 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.82 -30.22 0.82 Allowed Glycine 0 N--CA 1.431 -1.697 0 O-C-N 120.622 -1.299 . . . . 0.0 111.469 172.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -83.87 -43.08 15.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.55 -0.971 . . . . 0.0 111.287 -176.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 134.83 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 124.765 1.226 . . . . 0.0 114.046 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -133.5 -172.69 3.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 164.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -84.52 122.3 28.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.308 -2.12 . . . . 0.0 112.084 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.71 -30.71 2.73 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 112.395 -169.6 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -73.12 162.88 28.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.279 1.514 . . . . 0.0 113.768 -172.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -105.01 129.9 53.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.98 0.912 . . . . 0.0 109.884 -173.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.34 114.72 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.12 1.438 . . . . 0.0 107.984 167.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.41 -32.02 11.71 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 120.231 -1.543 . . . . 0.0 113.176 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.14 159.32 43.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.611 1.096 . . . . 0.0 111.867 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.0 126.2 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 110.415 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 m120 58.59 22.14 9.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.919 1.691 . . . . 0.0 114.828 -174.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.69 -2.72 80.61 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.629 1.109 . . . . 0.0 114.267 -172.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.81 103.01 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.115 1.366 . . . . 0.0 108.53 -172.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -62.77 141.39 58.62 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.599 1.56 . . . . 0.0 113.18 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.56 72.46 7.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.475 1.131 . . . . 0.0 111.098 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -91.65 111.18 22.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.769 1.228 . . . . 0.0 108.621 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.3 -3.86 85.15 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.988 -1.07 . . . . 0.0 115.349 -176.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.41 133.35 38.69 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 123.942 1.83 . . . . 0.0 114.745 -172.062 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 80.0 p -99.53 -155.82 0.52 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.558 2.343 . . . . 0.0 109.881 -169.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 29' ' ' VAL . 85.2 t60 -72.4 -50.47 26.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.612 -1.93 . . . . 0.0 111.19 168.218 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -42.82 80.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 77' ' ' THR . 17.8 tt0 -65.68 -35.87 82.01 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.12 -1.612 . . . . 0.0 113.902 174.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.78 96.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.671 -1.893 . . . . 0.0 115.05 172.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.03 -56.39 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 123.594 0.757 . . . . 0.0 110.406 172.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -51.28 -46.49 62.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.06 1.344 . . . . 0.0 113.602 177.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 m -59.58 -30.39 68.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.384 1.874 . . . . 0.0 114.422 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.6 mt -89.34 -38.65 14.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.161 -1.587 . . . . 0.0 113.366 173.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.44 39.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.575 2.35 . . . . 0.0 114.863 -172.51 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 15.13 0.58 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.5 p -91.68 158.86 16.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.287 2.635 . . . . 0.0 111.013 -169.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.55 -61.67 3.08 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 121.414 -0.804 . . . . 0.0 114.286 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.52 -64.84 0.18 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.236 -1.155 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.09 129.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.153 1.454 . . . . 0.0 111.541 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -115.58 105.3 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.834 1.654 . . . . 0.0 107.749 172.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -78.74 106.17 10.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.572 -1.33 . . . . 0.0 109.284 169.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mt -87.41 110.37 20.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.067 1.747 . . . . 0.0 108.677 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.9 101.86 13.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 172.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.89 143.26 34.28 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 -175.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.16 143.16 45.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.888 2.075 . . . . 0.0 106.226 171.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 N--CA 1.429 -1.511 0 C-N-CA 123.564 0.746 . . . . 0.0 110.892 178.943 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.404 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.412 5.7 m 45.23 92.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 162.925 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -128.34 125.05 37.93 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 -171.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.3 m -74.23 123.84 25.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.293 1.837 . . . . 0.0 108.575 177.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.657 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -163.15 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -125.22 120.94 32.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.52 74.83 1.91 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.893 1.277 . . . . 0.0 107.734 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.99 151.23 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.302 2.241 . . . . 0.0 109.355 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.27 128.68 45.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.435 -2.041 . . . . 0.0 111.165 168.266 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -126.0 141.16 52.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 124.553 1.141 . . . . 0.0 109.058 -171.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.66 111.47 23.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.65 124.06 18.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.45 1.1 . . . . 0.0 111.7 -177.525 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -94.37 108.58 20.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.92 1.343 . . . . 0.0 108.982 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 60.23 34.86 20.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.823 2.049 . . . . 0.0 114.686 -179.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.46 60.57 2.47 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.742 -1.224 . . . . 0.0 114.367 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m 172.34 120.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.868 2.067 . . . . 0.0 105.574 -175.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.85 -41.44 78.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.217 1.484 . . . . 0.0 107.966 161.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 120.11 22.95 3.08 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.471 170.186 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' A' ' 44' ' ' VAL . 36.7 pt -111.39 130.24 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.213 -1.169 . . . . 0.0 111.224 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -79.67 112.53 17.03 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.201 1.0 . . . . 0.0 110.576 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 m -84.15 131.15 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -123.11 166.73 14.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.618 -1.927 . . . . 0.0 109.824 176.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.69 -150.83 31.61 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.787 1.185 . . . . 0.0 113.857 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.49 166.05 16.16 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 125.49 1.519 . . . . 0.0 110.556 -177.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.551 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.268 1.8 tp -115.3 162.04 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.776 0.798 . . . . 0.0 109.454 -172.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -142.69 154.07 43.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -169.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG11 ' CD1' ' A' ' 47' ' ' ILE . 6.6 t -90.1 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.965 -1.709 . . . . 0.0 111.988 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -90.47 -48.37 7.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.519 -1.363 . . . . 0.0 111.169 176.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.05 128.72 18.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.003 0.906 . . . . 0.0 112.217 -172.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.535 ' CD1' HG11 ' A' ' 44' ' ' VAL . 43.7 mm -92.68 134.24 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.205 2.202 . . . . 0.0 109.175 178.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.553 HD12 ' CA ' ' A' ' 26' ' ' GLY . 29.6 mt . . . . . 0 N--CA 1.43 -1.429 0 C-N-CA 125.132 1.373 . . . . 0.0 109.911 175.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 121.132 0.491 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.55 -41.31 72.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.93 -31.36 71.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.152 -2.217 . . . . 0.0 110.862 170.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.04 5.79 6.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -72.52 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.296 -2.128 . . . . 0.0 105.9 149.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.0 1.0 Allowed Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.862 163.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -79.55 -17.48 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 117.172 0.486 . . . . 0.0 112.309 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.49 133.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.174 2.19 . . . . 0.0 111.67 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.93 -178.94 5.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.895 -1.128 . . . . 0.0 108.763 169.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -86.23 60.42 6.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.923 -2.361 . . . . 0.0 113.258 -174.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.91 -7.52 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 121.086 -1.009 . . . . 0.0 114.787 176.113 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -76.05 154.12 35.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.399 1.571 . . . . 0.0 114.92 -172.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -102.64 105.83 16.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.406 1.882 . . . . 0.0 108.79 -173.566 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.37 113.14 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.8 -1.813 . . . . 0.0 108.949 -179.391 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.42 -29.0 13.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.137 1.375 . . . . 0.0 113.41 -173.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 155.18 38.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 119.984 1.266 . . . . 0.0 112.745 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 92' ' ' VAL . 13.5 t -132.98 119.0 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.595 -0.691 . . . . 0.0 111.175 -177.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 56.09 31.98 19.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 120.409 1.459 . . . . 0.0 114.027 -168.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.29 9.9 85.62 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.809 -1.182 . . . . 0.0 114.301 -173.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -100.26 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.4 p -60.42 138.1 58.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.83 31.77 0.84 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.76 -1.213 . . . . 0.0 112.15 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.72 76.13 1.55 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.201 2.201 . . . . 0.0 110.941 -177.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.99 5.79 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 125.047 1.308 . . . . 0.0 114.44 -170.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.59 139.08 31.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.021 1.911 . . . . 0.0 112.587 177.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t -112.13 -165.26 0.98 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.458 2.303 . . . . 0.0 105.95 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -53.9 -57.68 10.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.391 1.876 . . . . 0.0 113.641 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -69.62 -46.99 64.96 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 111.987 -174.176 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -48.64 66.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.918 1.687 . . . . 0.0 113.572 173.272 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.61 86.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.208 -1.558 . . . . 0.0 114.609 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.79 -47.97 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.35 1.06 . . . . 0.0 112.193 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -68.47 -29.23 67.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.251 -1.531 . . . . 0.0 114.158 177.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.6 m -68.55 -26.3 65.35 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.948 1.699 . . . . 0.0 113.194 174.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.51 -48.66 6.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.341 1.457 . . . . 0.0 113.58 172.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -82.61 -36.97 25.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -172.103 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.01 29.26 1.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.31 1.868 . . . . 0.0 112.594 -172.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.4 p -88.76 -168.35 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.373 3.069 . . . . 0.0 109.933 175.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.52 -110.85 3.02 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.211 -1.555 . . . . 0.0 111.547 175.464 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -102.12 -61.17 1.42 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.863 0.831 . . . . 0.0 112.567 -176.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.64 125.86 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.765 1.269 . . . . 0.0 110.45 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 68' ' ' VAL . 8.1 t -109.92 111.51 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 125.395 1.478 . . . . 0.0 107.833 165.419 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -79.87 112.26 16.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.773 -1.204 . . . . 0.0 108.643 166.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mt -94.28 112.96 24.79 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.054 1.342 . . . . 0.0 109.015 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.45 101.01 13.69 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.05 143.61 34.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.489 2.315 . . . . 0.0 110.182 -175.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -122.66 143.57 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.197 1.399 . . . . 0.0 109.95 173.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 119.807 3.262 . . . . 0.0 119.807 -175.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.466 6.9 m 43.57 87.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 128.789 2.836 . . . . 0.0 117.439 170.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 77.1 m -129.37 120.82 26.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -176.353 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -78.86 121.98 25.51 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.314 1.446 . . . . 0.0 109.501 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 -171.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.35 132.69 48.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.562 1.145 . . . . 0.0 108.489 174.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 84.86 2.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.207 1.003 . . . . 0.0 109.569 175.279 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.96 155.0 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.479 1.911 . . . . 0.0 109.644 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -130.54 118.82 21.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.287 -2.133 . . . . 0.0 110.097 165.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.3 mt -122.36 154.47 37.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.937 -1.102 . . . . 0.0 109.975 -174.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.95 119.64 39.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.1 0.952 . . . . 0.0 109.223 162.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 123.43 19.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.992 1.317 . . . . 0.0 113.025 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -90.1 115.12 27.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.777 -1.202 . . . . 0.0 109.501 -175.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 52.43 42.63 31.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.317 1.847 . . . . 0.0 114.915 -172.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.57 43.17 53.41 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.271 0.938 . . . . 0.0 115.342 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -166.74 113.49 0.82 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -170.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' B' ' 210' ' ' VAL . 6.0 mt -75.07 -28.79 60.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.118 -1.614 . . . . 0.0 107.443 169.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.35 13.09 11.02 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.988 168.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.0 pt -114.75 125.76 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 118.226 1.013 . . . . 0.0 110.454 -171.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -80.86 121.77 26.38 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.509 1.124 . . . . 0.0 113.536 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.19 132.47 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -127.96 170.57 12.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.509 1.524 . . . . 0.0 109.045 169.025 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.43 -123.08 6.31 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.291 1.424 . . . . 0.0 113.734 178.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.15 155.17 27.53 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 121.681 -0.893 . . . . 0.0 112.993 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.43 -1.441 0 O-C-N 120.881 -1.364 . . . . 0.0 112.794 -177.968 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 CA-C-O 122.023 0.791 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -123.32 161.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 170.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -132.71 152.03 51.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.78 -1.825 . . . . 0.0 106.647 -171.141 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 47' ' ' ILE . 47.6 t -91.27 119.43 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 120.04 -1.663 . . . . 0.0 108.973 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -82.91 -60.33 2.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.605 -1.309 . . . . 0.0 110.833 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.91 132.28 56.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.26 1.029 . . . . 0.0 110.838 -176.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.492 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.3 mm -94.6 131.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 164.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 111.685 179.202 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 121.962 0.886 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.9 64.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.48 -41.43 80.68 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.306 -1.496 . . . . 0.0 111.468 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -73.6 6.27 3.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.348 2.259 . . . . 0.0 116.496 -177.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.55 -82.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.405 -2.06 . . . . 0.0 107.742 152.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.55 -32.64 1.11 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 170.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -83.92 -15.8 46.6 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.072 0.949 . . . . 0.0 113.162 -172.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.87 133.01 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.941 1.696 . . . . 0.0 110.989 173.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -131.55 -172.71 2.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.285 1.434 . . . . 0.0 109.936 173.067 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -85.95 113.06 21.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.876 -1.765 . . . . 0.0 109.898 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.23 10.8 12.98 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.354 0.978 . . . . 0.0 114.946 -175.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.25 164.09 20.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.465 1.506 . . . . 0.0 112.826 176.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -116.3 121.39 41.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.668 2.387 . . . . 0.0 111.647 -173.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.07 122.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.512 1.525 . . . . 0.0 107.895 174.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 -39.88 8.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 120.255 -1.528 . . . . 0.0 112.309 175.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.98 159.94 42.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.787 1.176 . . . . 0.0 113.783 -176.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 92' ' ' VAL . 79.7 t -132.01 119.8 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 124.378 1.071 . . . . 0.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 56.82 25.11 9.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.258 -1.527 . . . . 0.0 115.034 -171.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.74 -2.98 84.88 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.12 1.343 . . . . 0.0 114.6 -171.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.6 t -93.86 100.46 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 0.0 108.361 -174.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t -70.29 137.37 50.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.315 1.446 . . . . 0.0 113.497 -178.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.92 52.16 1.45 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.099 2.16 . . . . 0.0 112.403 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -79.25 119.06 21.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.005 1.322 . . . . 0.0 109.925 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 14.03 75.31 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.886 -1.134 . . . . 0.0 114.959 -175.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.51 138.78 31.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.855 1.312 . . . . 0.0 112.299 -177.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.3 p -101.11 -162.55 0.95 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.682 1.993 . . . . 0.0 109.699 -174.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -59.84 -54.07 50.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.977 -1.702 . . . . 0.0 112.001 164.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -71.59 -41.13 69.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.498 -0.751 . . . . 0.0 112.869 -176.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -40.5 96.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 175.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.37 95.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.888 -1.758 . . . . 0.0 114.584 173.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -53.8 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 119.123 0.874 . . . . 0.0 111.189 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -64.58 -36.73 85.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.878 2.471 . . . . 0.0 113.643 176.336 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.94 -26.96 18.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.305 1.842 . . . . 0.0 115.269 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HB2' HG21 ' B' ' 210' ' ' VAL . 3.7 tmt_? -83.97 -52.8 6.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.423 1.889 . . . . 0.0 112.489 -176.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -93.68 63.77 3.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 110.695 -175.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.2 p -96.14 -129.65 0.16 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.006 1.322 . . . . 0.0 111.815 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.29 57.36 0.43 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 64.08 -54.4 0.25 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.785 3.234 . . . . 0.0 114.47 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.35 124.99 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.572 1.177 . . . . 0.0 110.156 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 68' ' ' VAL . 85.0 t -110.92 106.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 168.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -77.97 102.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.942 -1.099 . . . . 0.0 108.952 166.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.43 118.31 24.88 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.577 -1.327 . . . . 0.0 110.475 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.96 100.92 13.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 148.86 25.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.481 1.512 . . . . 0.0 109.991 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -164.04 1.08 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.038 2.135 . . . . 0.0 107.562 173.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.429 -1.512 0 O-C-N 119.259 -2.151 . . . . 0.0 112.282 159.142 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.3 tp . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.673 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.38 2.4 t 25.52 101.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.188 4.195 . . . . 0.0 118.568 163.604 . . . . . . . . 4 3 . 1 . 024 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 2.6 p -144.92 116.02 7.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -172.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.4 p -75.25 130.2 38.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.382 1.073 . . . . 0.0 110.424 174.16 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 86' ' ' ARG . 2.8 p . . . . . 0 C--O 1.261 1.682 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -171.494 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 122.489 1.137 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.26 1.6 m-30 -107.67 144.01 35.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -118.51 77.41 1.17 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 158.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.47 112.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.917 2.087 . . . . 0.0 107.098 -168.42 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.71 135.36 54.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.935 -1.728 . . . . 0.0 112.719 -175.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.15 178.3 9.42 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.344 -0.847 . . . . 0.0 108.9 -171.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.05 139.2 52.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.841 -1.162 . . . . 0.0 111.461 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 144.22 28.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.18 -1.575 . . . . 0.0 111.305 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -96.89 102.22 13.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.771 -1.206 . . . . 0.0 109.317 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.32 61.98 2.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -171.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.53 49.74 63.14 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.845 -1.159 . . . . 0.0 114.201 178.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.4 t -168.3 96.58 0.41 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.732 1.73 . . . . 0.0 107.319 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.02 -46.52 56.85 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.048 2.139 . . . . 0.0 106.514 166.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.66 39.93 0.96 Allowed Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.708 175.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.52 130.0 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.946 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -84.65 113.76 21.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.09 1.356 . . . . 0.0 112.072 170.149 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.81 125.65 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -175.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -122.71 164.04 19.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.656 1.982 . . . . 0.0 109.367 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.41 17.26 Favored Glycine 0 N--CA 1.431 -1.683 0 C-N-CA 124.71 1.148 . . . . 0.0 112.547 178.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.93 165.26 34.14 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.246 0.926 . . . . 0.0 111.565 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.429 -1.476 0 O-C-N 120.467 -1.607 . . . . 0.0 113.492 -179.169 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.754 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 42' ' ' ILE 0.274 4.0 tp -110.3 163.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.973 -1.31 . . . . 0.0 108.181 173.423 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -137.39 161.91 35.02 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.915 -1.74 . . . . 0.0 107.0 -174.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.55 HG11 ' CD1' ' A' ' 47' ' ' ILE . 2.2 t -89.91 125.86 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.296 -1.503 . . . . 0.0 111.841 173.419 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -82.13 -51.84 7.58 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.732 -1.23 . . . . 0.0 109.948 166.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.62 32.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.763 1.225 . . . . 0.0 110.443 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.55 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.4 mm -91.51 121.57 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.431 -1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 110.229 179.216 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 121.388 0.614 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -51.49 57.5 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.741 2.016 . . . . 0.0 115.119 -176.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.72 -41.87 82.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.276 1.036 . . . . 0.0 111.373 173.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -69.19 -5.52 23.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -178.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.89 -101.22 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.329 2.331 . . . . 0.0 110.457 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.31 -97.71 0.96 Allowed Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.211 -1.556 . . . . 0.0 112.805 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -133.99 26.08 3.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.999 -0.706 . . . . 0.0 112.744 -156.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 mt -87.11 127.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.86 -1.775 . . . . 0.0 113.427 -170.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -143.85 155.02 43.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 163.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -62.78 148.76 45.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -153.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.73 23.61 7.07 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -103.02 172.95 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.725 1.762 . . . . 0.0 112.693 174.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -98.34 136.5 38.41 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.368 1.067 . . . . 0.0 110.738 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.35 101.89 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.034 2.934 . . . . 0.0 105.01 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.253 0.9 OUTLIER -98.02 -38.18 9.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.235 -2.166 . . . . 0.0 114.827 -173.946 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 145.21 27.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.236 1.38 . . . . 0.0 113.49 -176.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.23 116.02 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 O-C-N 120.994 -1.066 . . . . 0.0 111.914 -171.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 55.59 33.99 22.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.222 1.409 . . . . 0.0 113.677 -170.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.42 25.71 62.82 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 113.495 -176.172 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.9 t -123.63 100.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.82 38.34 0.7 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.913 1.685 . . . . 0.0 114.189 -173.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -82.81 111.1 18.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.486 -2.009 . . . . 0.0 110.718 175.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 8.95 68.87 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.947 -1.095 . . . . 0.0 113.083 -175.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.12 155.02 17.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.985 1.374 . . . . 0.0 110.067 171.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.567 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 71.2 p -106.87 -170.34 1.7 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.426 1.89 . . . . 0.0 108.718 -172.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -57.29 -49.95 74.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.762 -1.211 . . . . 0.0 112.903 161.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -69.9 -43.8 71.0 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 112.215 -176.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.567 ' HB2' ' H ' ' A' ' 77' ' ' THR . 4.7 mp0 -67.19 -34.3 77.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.633 -1.292 . . . . 0.0 112.947 175.177 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.92 87.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.9 -1.75 . . . . 0.0 114.475 172.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -57.47 -49.19 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.379 -0.825 . . . . 0.0 111.923 172.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.9 -31.28 71.56 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.012 -1.68 . . . . 0.0 114.901 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.6 m -74.93 -27.75 60.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.558 1.943 . . . . 0.0 112.714 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.89 -43.69 10.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.297 1.839 . . . . 0.0 112.892 174.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -84.24 -34.38 23.88 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -172.612 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -86.1 35.31 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.512 -1.992 . . . . 0.0 112.309 -176.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.6 p -93.69 163.25 13.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.142 2.577 . . . . 0.0 113.483 -176.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.75 59.57 4.9 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 125.065 1.317 . . . . 0.0 114.268 -176.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.259 46.4 tt0 68.09 -53.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.617 2.767 . . . . 0.0 114.634 -174.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -76.37 136.33 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.169 1.388 . . . . 0.0 110.721 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.15 101.39 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.65 1.98 . . . . 0.0 107.165 171.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -82.29 97.61 8.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.815 2.446 . . . . 0.0 108.58 170.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.04 113.24 21.97 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.913 0.863 . . . . 0.0 111.462 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -84.47 102.73 13.03 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 163.347 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.16 152.8 24.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.991 1.316 . . . . 0.0 108.053 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.0 125.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.036 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tptt . . . . . 0 N--CA 1.429 -1.486 0 C-N-CA 124.849 1.26 . . . . 0.0 112.148 -178.124 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.397 2.7 t 72.58 115.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.768 2.223 . . . . 0.0 115.511 164.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 73.0 m -141.53 123.23 15.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -77.14 124.06 27.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.26 1.615 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -162.566 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 122.488 1.137 . . . . 0.0 113.802 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -132.02 118.86 20.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.874 1.27 . . . . 0.0 108.921 173.889 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 86.45 5.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.268 1.427 . . . . 0.0 109.146 173.307 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.97 156.85 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.211 2.204 . . . . 0.0 109.982 178.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 93' ' ' HIS . 0.8 OUTLIER -126.85 132.77 50.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.616 -1.927 . . . . 0.0 107.159 166.728 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.6 mt -129.46 153.37 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.013 -1.054 . . . . 0.0 109.572 -177.884 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.52 110.01 17.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.434 1.094 . . . . 0.0 109.067 166.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 24' ' ' SER . 15.5 ptpt -60.04 141.31 55.92 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 127.77 2.428 . . . . 0.0 114.746 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 t -101.57 113.76 27.17 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.698 -1.251 . . . . 0.0 109.344 -174.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 58.76 -18.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 129.189 2.995 . . . . 0.0 118.171 -169.342 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.19 59.32 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.847 1.689 . . . . 0.0 109.27 -178.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.491 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 95.4 p -178.2 120.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -173.783 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' B' ' 210' ' ' VAL . 9.8 mt -79.45 -40.02 30.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.436 1.894 . . . . 0.0 106.586 168.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 48' ' ' ILE . . . 118.06 29.3 2.02 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.035 1.303 . . . . 0.0 111.988 171.304 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 pt -114.78 131.03 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.632 174.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 m -83.91 117.07 23.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.236 0.614 . . . . 0.0 111.04 162.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.67 132.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -128.28 163.55 24.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.102 2.161 . . . . 0.0 109.608 174.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.35 -137.36 13.26 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 125.279 1.419 . . . . 0.0 111.788 -177.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 155.63 28.07 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.429 -1.478 0 O-C-N 120.546 -1.561 . . . . 0.0 114.06 -178.148 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.464 HG22 HG13 ' A' ' 65' ' ' VAL 0.255 2.2 tp -120.49 162.1 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 118.049 0.924 . . . . 0.0 109.078 -166.621 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -142.08 162.11 36.31 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 -171.429 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 47' ' ' ILE . 3.3 t -88.36 132.31 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.679 -1.263 . . . . 0.0 111.769 172.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -88.52 -46.85 8.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.529 -1.357 . . . . 0.0 110.554 170.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.02 134.02 24.08 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.067 -1.021 . . . . 0.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.471 HD13 HG11 ' A' ' 44' ' ' VAL . 27.3 mm -93.84 128.92 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.433 1.493 . . . . 0.0 108.725 173.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.428 HD11 ' HA2' ' A' ' 26' ' ' GLY . 2.6 pt . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 121.184 -0.948 . . . . 0.0 110.836 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.78 66.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.009 1.323 . . . . 0.0 113.84 -178.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -56.76 -34.17 67.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.968 1.307 . . . . 0.0 112.504 167.124 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -70.27 -5.46 27.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.97 -79.27 0.06 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 118.643 -2.536 . . . . 0.0 108.061 159.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.33 -20.14 3.36 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 169.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -85.31 -32.99 22.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.887 -0.772 . . . . 0.0 111.537 177.313 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.6 mt -65.86 125.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.735 1.614 . . . . 0.0 113.097 178.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.465 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 17.3 t60 -136.71 177.9 7.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.319 1.056 . . . . 0.0 109.954 171.884 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 30.1 pttt -79.74 58.9 2.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.852 -1.78 . . . . 0.0 115.347 -172.691 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.32 -10.32 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.188 1.375 . . . . 0.0 113.238 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -78.62 154.35 30.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 118.611 1.206 . . . . 0.0 113.427 -173.251 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 138.74 32.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.408 1.483 . . . . 0.0 107.465 175.329 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -113.42 115.68 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 161.654 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.76 -30.53 11.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 113.412 -172.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 153.52 38.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.02 0.827 . . . . 0.0 112.584 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 92' ' ' VAL . 11.6 t -135.75 120.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.453 0.701 . . . . 0.0 112.173 -175.499 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 55.5 33.87 21.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.432 -1.417 . . . . 0.0 114.203 -168.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.67 11.72 85.06 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 120.68 -1.263 . . . . 0.0 113.538 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.64 100.3 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -60.75 135.2 57.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.078 1.751 . . . . 0.0 113.306 174.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.6 mt -68.96 -49.35 58.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.445 -0.785 . . . . 0.0 112.476 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 46.39 27.79 0.64 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.939 2.94 . . . . 0.0 118.939 166.344 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.61 27.91 0.93 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.268 -1.52 . . . . 0.0 112.885 -169.033 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.86 146.05 26.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.803 -1.41 . . . . 0.0 110.702 175.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -94.83 -167.7 1.69 Allowed 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.719 1.608 . . . . 0.0 109.148 -178.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -61.52 -50.2 73.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.029 -1.669 . . . . 0.0 112.151 165.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.19 -49.41 74.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -38.11 89.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.1 -1.0 . . . . 0.0 113.286 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.23 96.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.034 -1.666 . . . . 0.0 114.983 172.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.55 -54.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.465 173.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -49.72 -43.11 47.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.245 1.384 . . . . 0.0 114.555 175.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.6 m -68.22 -27.45 66.38 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.272 2.229 . . . . 0.0 114.882 -178.471 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.3 -41.43 10.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.87 -1.769 . . . . 0.0 113.78 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -53.89 6.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.557 2.343 . . . . 0.0 114.214 -169.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.51 36.43 0.75 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.509 1.623 . . . . 0.0 111.96 -168.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.2 p -93.44 -172.48 2.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.588 2.755 . . . . 0.0 109.636 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.11 -90.48 0.48 Allowed Glycine 0 N--CA 1.429 -1.818 0 O-C-N 119.86 -1.775 . . . . 0.0 112.599 174.334 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -142.99 -50.15 0.34 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.747 1.219 . . . . 0.0 110.013 -175.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.64 131.52 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.173 -1.579 . . . . 0.0 110.129 172.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 68' ' ' VAL . 2.4 t -122.3 112.54 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.082 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 71.1 m80 -76.52 113.28 13.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.647 -1.283 . . . . 0.0 108.806 163.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mt -94.83 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.978 -1.077 . . . . 0.0 108.766 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.43 102.77 15.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.749 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.07 150.67 23.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.049 2.139 . . . . 0.0 111.358 -177.458 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -127.38 136.35 51.74 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.261 1.024 . . . . 0.0 108.878 169.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 127.234 2.214 . . . . 0.0 114.445 -175.115 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 N--CA 1.429 -1.475 0 CA-C-O 121.588 0.708 . . . . 0.0 112.572 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.422 1.4 t 77.6 102.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 124.584 2.135 . . . . 0.0 113.311 171.241 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 89.4 m -136.72 119.68 16.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -171.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.5 p -75.1 129.23 37.21 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.984 1.313 . . . . 0.0 109.253 174.418 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 8.5 p . . . . . 0 C--O 1.26 1.63 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 -162.119 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 122.139 0.971 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.69 137.79 53.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.744 1.618 . . . . 0.0 107.823 176.046 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -114.44 82.9 1.79 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.216 1.484 . . . . 0.0 108.802 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.12 142.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.0 2.12 . . . . 0.0 109.083 -178.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.34 123.53 44.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.037 -2.289 . . . . 0.0 109.2 170.804 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.35 162.06 19.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.064 0.946 . . . . 0.0 108.778 -176.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 125.0 53.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 157.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' HB2' ' H ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -61.48 136.69 58.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.038 1.335 . . . . 0.0 112.025 169.224 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -90.71 95.45 10.15 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.354 1.55 . . . . 0.0 108.682 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 62.54 -17.71 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.724 2.861 . . . . 0.0 118.724 -171.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.2 62.56 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.846 -1.784 . . . . 0.0 109.919 -178.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 45.7 t 167.8 104.46 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -162.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.8 mt -75.17 -41.59 57.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 161.829 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 41.44 1.09 Allowed Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.676 171.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 47' ' ' ILE . 6.5 pt -119.45 129.04 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 121.653 0.74 . . . . 0.0 110.297 171.211 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' HG13 ' B' ' 207' ' ' VAL . 63.6 m -82.29 113.95 20.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.294 1.037 . . . . 0.0 110.481 167.251 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.38 129.78 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.142 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -128.82 166.37 19.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.004 1.722 . . . . 0.0 110.373 176.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.35 -157.35 46.21 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 125.118 1.342 . . . . 0.0 111.463 -170.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.35 151.68 8.95 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.869 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -170.042 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.714 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 tp -125.26 155.84 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -139.14 156.43 47.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -166.073 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.6 137.87 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 119.096 -2.252 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.08 -64.65 1.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.414 -1.429 . . . . 0.0 108.529 160.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.44 136.62 50.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.245 1.018 . . . . 0.0 110.785 -175.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 27' ' ' ILE . 36.5 mm -89.81 118.99 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.667 1.587 . . . . 0.0 107.424 169.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 N--CA 1.429 -1.49 0 CA-C-O 117.728 -1.13 . . . . 0.0 111.776 -177.673 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -48.86 36.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.463 1.905 . . . . 0.0 114.639 -174.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.22 -39.51 56.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.071 1.415 . . . . 0.0 111.789 169.07 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -67.83 -2.76 7.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -67.72 -90.99 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.2 2.273 . . . . 0.0 109.145 164.051 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.79 -35.34 0.5 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 111.615 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.61 -25.85 35.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.791 -0.829 . . . . 0.0 113.113 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.06 131.26 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.068 -1.645 . . . . 0.0 112.339 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -136.58 179.25 6.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.983 -1.073 . . . . 0.0 108.795 167.69 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -84.54 49.15 1.63 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.231 -1.543 . . . . 0.0 114.905 -167.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.41 19.64 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.899 -1.75 . . . . 0.0 114.057 176.081 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.33 179.99 4.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.028 -1.277 . . . . 0.0 112.425 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -113.01 142.54 45.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.768 2.027 . . . . 0.0 109.088 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.78 133.9 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.324 -1.485 . . . . 0.0 108.126 165.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.59 -30.48 5.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.556 -1.34 . . . . 0.0 113.93 -173.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 157.25 42.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.162 1.346 . . . . 0.0 113.452 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 92' ' ' VAL . 92.8 t -137.99 123.27 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 123.821 0.848 . . . . 0.0 110.955 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 52.67 33.89 14.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.61 1.564 . . . . 0.0 114.641 -173.166 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.89 23.46 69.29 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.065 -1.022 . . . . 0.0 113.512 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.12 100.07 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 124.333 1.053 . . . . 0.0 108.392 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.09 142.61 41.75 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.928 2.091 . . . . 0.0 115.468 173.268 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.45 -56.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.624 -1.297 . . . . 0.0 111.555 176.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 43.24 43.97 4.3 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 169.006 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 45.16 0.97 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 120.819 -1.176 . . . . 0.0 110.679 -168.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.57 144.69 28.37 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.443 -1.033 . . . . 0.0 108.918 171.223 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.6 p -97.01 -160.98 0.84 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.481 1.512 . . . . 0.0 109.946 -175.528 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.42 -49.9 65.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.951 -1.718 . . . . 0.0 110.802 167.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -66.5 -46.93 74.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 112.775 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.71 -33.01 71.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.48 91.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.465 -2.022 . . . . 0.0 113.533 170.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.59 -52.38 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 118.885 -0.579 . . . . 0.0 111.314 172.544 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -47.24 -45.16 23.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 171.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -73.64 -27.47 61.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.95 1.3 . . . . 0.0 112.368 -171.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.27 -48.12 7.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.077 1.751 . . . . 0.0 114.51 172.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -48.24 17.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.956 2.103 . . . . 0.0 113.402 -173.287 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.38 31.41 0.82 Allowed 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.859 -1.776 . . . . 0.0 112.426 -166.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.3 p -83.04 -168.06 1.92 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.283 3.433 . . . . 0.0 109.388 171.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.5 -108.08 0.53 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.383 -1.448 . . . . 0.0 110.723 170.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -120.18 -44.87 2.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.567 1.147 . . . . 0.0 110.436 174.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -72.72 129.89 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.449 1.119 . . . . 0.0 112.116 173.333 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 68' ' ' VAL . 45.8 t -129.76 99.87 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 126.415 1.886 . . . . 0.0 108.116 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -78.02 98.62 5.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.552 1.941 . . . . 0.0 110.312 168.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -84.79 113.16 21.14 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.455 1.902 . . . . 0.0 109.911 -175.312 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 98.36 11.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 168.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.06 147.97 25.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.364 1.865 . . . . 0.0 109.717 -177.63 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.97 132.97 56.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.702 1.239 . . . . 0.0 108.236 167.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? . . . . . 0 N--CA 1.43 -1.429 0 C-N-CA 124.862 1.265 . . . . 0.0 109.79 176.56 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 tp . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 28' ' ' SER 0.398 2.2 t 67.86 104.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 124.924 2.297 . . . . 0.0 114.378 169.819 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 34.1 m -140.24 122.76 16.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.612 -3.107 . . . . 0.0 102.612 -171.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.3 p -80.55 121.29 25.62 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.984 0.914 . . . . 0.0 109.986 175.46 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.0 m . . . . . 0 C--O 1.259 1.579 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -169.488 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 122.521 1.153 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.38 128.25 41.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.725 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -103.25 81.24 1.92 Allowed 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.609 1.195 . . . . 0.0 108.316 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.95 109.11 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 126.926 2.091 . . . . 0.0 112.543 -173.184 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 124.64 44.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.92 -1.738 . . . . 0.0 109.384 -177.061 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.1 mt -134.93 158.73 43.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 109.045 -171.422 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.28 43.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 162.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -63.18 146.51 53.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.885 -1.134 . . . . 0.0 113.37 -175.136 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -92.41 88.66 6.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.963 1.364 . . . . 0.0 107.381 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 t0 44.99 64.98 1.2 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.18 2.592 . . . . 0.0 117.108 -177.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 52.8 6.02 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.634 -1.291 . . . . 0.0 114.119 179.154 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 3.9 m 177.33 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.166 1.386 . . . . 0.0 108.618 -169.354 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.39 -45.68 45.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.248 1.819 . . . . 0.0 107.426 163.346 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.88 47.06 0.85 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 125.444 1.497 . . . . 0.0 111.054 177.1 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 pt -128.8 131.65 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.39 0.614 . . . . 0.0 109.429 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.1 m -91.05 113.03 25.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.434 1.094 . . . . 0.0 111.95 171.589 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.6 m -80.85 140.13 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -172.037 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -130.67 168.18 17.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.098 1.759 . . . . 0.0 109.602 172.417 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.85 -150.23 34.02 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.977 1.275 . . . . 0.0 114.08 -177.1 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 161.44 21.76 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 125.439 1.495 . . . . 0.0 109.602 -179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 120.094 -1.827 . . . . 0.0 115.136 -171.562 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 CA-C-O 121.415 0.453 . . . . 0.0 113.584 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 65' ' ' VAL 0.287 3.9 tp -124.33 156.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 120.103 -1.821 . . . . 0.0 106.826 170.659 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.09 151.63 52.01 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -170.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 47' ' ' ILE . 16.0 t -85.87 130.91 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.403 -2.061 . . . . 0.0 110.524 176.252 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -90.23 -45.96 8.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.035 -1.666 . . . . 0.0 110.379 168.192 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 143.87 33.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.605 1.193 . . . . 0.0 112.784 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.601 ' CD1' HG11 ' A' ' 44' ' ' VAL . 47.8 mm -105.02 116.97 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.513 2.725 . . . . 0.0 108.001 -176.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 120.539 -1.351 . . . . 0.0 112.653 -177.007 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 -49.0 50.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.955 1.702 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.17 -29.98 70.74 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.454 -1.403 . . . . 0.0 111.929 173.023 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 m -69.72 -2.36 11.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 176.005 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.95 -80.9 0.05 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 120.872 1.669 . . . . 0.0 107.427 157.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.62 -33.94 0.82 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.25 -0.906 . . . . 0.0 111.413 165.078 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -72.25 -26.49 62.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -169.378 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.02 141.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.706 1.202 . . . . 0.0 114.125 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -134.21 -166.93 1.87 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.607 -1.308 . . . . 0.0 110.783 165.046 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -80.84 135.34 35.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.041 -1.662 . . . . 0.0 110.337 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.65 2.34 72.8 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.076 -1.64 . . . . 0.0 114.642 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.21 151.52 39.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.437 1.119 . . . . 0.0 111.682 176.561 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -106.19 114.46 28.6 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.419 1.087 . . . . 0.0 109.357 -167.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 42' ' ' ILE . 3.3 p -92.89 120.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.132 -1.605 . . . . 0.0 108.814 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.04 -39.84 9.95 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.651 -1.281 . . . . 0.0 111.544 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.63 149.23 34.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 92' ' ' VAL . 10.7 t -129.59 117.73 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 O-C-N 120.804 -1.185 . . . . 0.0 113.061 -173.079 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 0.4 OUTLIER 46.62 37.54 4.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.277 2.231 . . . . 0.0 115.754 -169.863 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.24 5.88 57.93 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 114.201 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -121.87 105.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 118.346 1.073 . . . . 0.0 110.366 -168.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 t -60.74 139.24 57.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.759 172.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.84 60.33 2.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.911 2.084 . . . . 0.0 111.614 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.01 105.26 10.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.081 2.153 . . . . 0.0 111.796 -169.755 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.93 21.03 79.15 Favored Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.813 -1.179 . . . . 0.0 114.026 -175.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.27 141.07 29.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.161 -1.2 . . . . 0.0 113.165 -175.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -104.57 -156.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.591 2.356 . . . . 0.0 109.66 -174.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.97 -50.94 44.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.707 -1.871 . . . . 0.0 111.384 168.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.72 -51.76 68.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 112.337 174.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.83 -36.07 82.71 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.006 -1.059 . . . . 0.0 113.846 -175.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.15 92.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.156 -1.59 . . . . 0.0 114.953 171.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.05 -49.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 110.764 174.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.36 -26.12 67.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.891 -1.756 . . . . 0.0 114.902 178.05 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -75.97 -27.98 57.7 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.158 1.783 . . . . 0.0 113.172 176.257 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.6 mt -89.63 -47.72 7.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.227 -1.545 . . . . 0.0 113.963 173.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 -37.1 22.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.695 1.598 . . . . 0.0 114.072 -170.277 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.55 37.58 0.92 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.979 -1.701 . . . . 0.0 111.274 -172.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.5 p -100.17 179.41 4.49 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.132 3.373 . . . . 0.0 111.555 -179.275 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.94 -136.68 4.22 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.611 -1.306 . . . . 0.0 112.871 173.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -85.06 -62.42 1.54 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.802 -1.411 . . . . 0.0 111.869 -177.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -75.75 124.28 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.89 1.329 . . . . 0.0 111.787 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 68' ' ' VAL . 13.5 t -114.99 114.94 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 167.411 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -87.35 110.66 20.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.386 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.12 111.14 20.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.585 -1.322 . . . . 0.0 110.253 174.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 98.36 10.97 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.4 mt -104.97 137.92 41.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.968 2.507 . . . . 0.0 110.759 -173.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.6 148.05 42.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.235 1.814 . . . . 0.0 108.545 170.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 176.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 7.8 tp . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.462 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.452 5.7 m 46.06 76.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 128.058 2.543 . . . . 0.0 117.311 171.107 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.1 m -117.78 117.86 30.48 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 69.3 p -78.86 117.98 20.47 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.017 1.327 . . . . 0.0 111.323 178.296 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -171.567 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 122.439 1.114 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 117.46 33.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.218 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.53 89.05 7.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.985 1.85 . . . . 0.0 109.513 170.4 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.36 150.77 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.388 1.875 . . . . 0.0 108.358 176.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.79 130.7 34.45 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.799 -1.813 . . . . 0.0 109.164 168.251 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.08 165.42 36.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.223 1.011 . . . . 0.0 111.718 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.18 132.77 45.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.578 1.151 . . . . 0.0 110.355 170.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HB3' HD23 ' A' ' 25' ' ' LEU . 5.5 ptpt -70.49 164.27 25.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 0.0 112.374 177.189 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 t -114.64 96.94 5.99 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.532 -1.355 . . . . 0.0 109.36 -179.017 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 53.08 55.08 9.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.011 2.125 . . . . 0.0 115.399 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.74 48.75 16.06 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 114.001 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 p -178.58 119.32 0.08 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 20' ' ' LYS . 10.8 mt -74.66 -38.19 62.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.91 2.084 . . . . 0.0 106.449 164.076 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.473 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 120.52 18.25 4.11 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.253 1.406 . . . . 0.0 110.864 168.837 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 pt -107.93 129.19 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.715 1.245 . . . . 0.0 110.541 -176.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.421 ' HB3' HG22 ' B' ' 207' ' ' VAL . 28.0 m -85.96 113.61 22.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.513 1.125 . . . . 0.0 110.864 173.552 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.13 131.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -171.122 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -126.24 164.96 19.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.118 2.167 . . . . 0.0 110.83 177.064 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -136.18 13.69 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 125.877 1.703 . . . . 0.0 114.009 174.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.52 176.84 49.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 124.662 1.125 . . . . 0.0 114.457 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.429 -1.49 0 C-N-CA 127.521 2.328 . . . . 0.0 115.343 -172.263 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.765 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.42 HG22 HG13 ' A' ' 65' ' ' VAL 0.264 3.1 tp -145.52 164.53 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 161.121 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -145.53 157.49 43.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -168.268 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.498 HG11 HD13 ' A' ' 47' ' ' ILE . 7.8 t -90.06 130.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.015 -1.678 . . . . 0.0 113.208 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -87.73 -53.56 4.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.896 -1.128 . . . . 0.0 111.375 170.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.76 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.035 0.921 . . . . 0.0 111.472 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.498 HD13 HG11 ' A' ' 44' ' ' VAL . 39.6 mm -98.39 137.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.522 2.329 . . . . 0.0 107.787 172.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.473 HD12 ' CA ' ' A' ' 26' ' ' GLY . 59.3 mt . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 116.827 -1.559 . . . . 0.0 108.426 176.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.58 -33.68 75.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.459 2.762 . . . . 0.0 118.459 -171.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.0 -35.25 80.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.088 -2.882 . . . . 0.0 111.014 171.389 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -74.34 0.54 14.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -72.48 -51.72 18.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.672 -1.893 . . . . 0.0 109.941 168.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.09 -73.76 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.798 158.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.96 -19.24 63.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -166.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.5 133.06 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 121.748 2.067 . . . . 0.0 115.575 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -129.49 178.71 6.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.555 1.542 . . . . 0.0 111.718 172.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -83.03 124.75 30.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.213 -1.555 . . . . 0.0 109.523 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.15 52.98 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 121.118 -0.989 . . . . 0.0 113.933 -173.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -81.83 165.04 21.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.588 1.185 . . . . 0.0 111.896 176.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -107.69 131.15 54.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.678 -172.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 42' ' ' ILE . 2.3 p -106.43 120.49 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.092 -1.63 . . . . 0.0 107.541 163.046 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.24 -37.59 9.61 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.618 -1.301 . . . . 0.0 112.308 -179.264 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.13 156.87 43.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 119.467 1.03 . . . . 0.0 113.217 -177.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.71 123.34 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 111.646 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 53.46 32.8 14.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.218 1.372 . . . . 0.0 114.566 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.4 20.65 76.72 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.899 -1.126 . . . . 0.0 114.49 -175.138 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -115.23 102.61 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.7 m -59.46 135.83 57.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.883 -1.136 . . . . 0.0 112.457 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.95 70.71 2.69 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.0 111.897 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.82 101.26 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.387 1.875 . . . . 0.0 112.349 -174.511 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.49 38.02 95.65 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.119 -0.988 . . . . 0.0 112.978 -175.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.05 140.52 35.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.417 -1.049 . . . . 0.0 109.706 176.288 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -114.48 -168.78 1.42 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 103.892 -2.632 . . . . 0.0 103.892 174.462 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -56.45 -52.88 63.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.91 -1.744 . . . . 0.0 114.168 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -74.14 -41.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.707 1.14 . . . . 0.0 112.315 -174.06 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -59.45 -47.1 86.77 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 119.957 -1.714 . . . . 0.0 114.449 172.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.41 -29.9 70.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.459 -1.401 . . . . 0.0 114.597 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.5 -56.86 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.43 166.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -51.56 -42.4 61.83 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -61.17 -29.81 70.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.933 2.093 . . . . 0.0 115.012 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -97.74 -33.43 11.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.104 2.162 . . . . 0.0 115.263 173.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -49.44 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.168 2.587 . . . . 0.0 114.147 -169.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -92.91 30.92 1.48 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.564 1.65 . . . . 0.0 111.548 -169.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -87.14 -174.57 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.628 2.771 . . . . 0.0 111.175 -176.065 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.37 173.44 51.22 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.337 158.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -61.53 -41.22 97.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.691 1.596 . . . . 0.0 113.07 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.23 126.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.939 1.352 . . . . 0.0 111.043 169.12 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -120.51 105.22 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.607 1.563 . . . . 0.0 107.394 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -77.83 103.55 7.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.605 -1.309 . . . . 0.0 109.542 165.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -89.17 118.4 28.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.744 -1.222 . . . . 0.0 110.429 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.38 95.34 10.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.12 145.61 26.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.885 2.074 . . . . 0.0 110.196 -177.333 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.62 139.23 52.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.772 1.273 . . . . 0.0 110.048 163.573 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? . . . . . 0 N--CA 1.429 -1.497 0 C-N-CA 126.686 1.994 . . . . 0.0 113.267 177.195 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 28' ' ' SER 0.395 2.3 t 77.09 121.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 163.093 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 20.5 m -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 10.8 p -80.99 122.95 27.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.795 1.638 . . . . 0.0 110.661 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.261 1.664 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 -170.416 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 121.764 0.792 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -114.01 121.8 44.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.449 1.5 . . . . 0.0 108.806 179.041 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -101.32 75.14 1.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.511 1.524 . . . . 0.0 111.375 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.58 121.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.193 -1.567 . . . . 0.0 114.817 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.72 122.24 39.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.774 -1.829 . . . . 0.0 111.328 175.22 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.23 170.64 16.33 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.439 1.096 . . . . 0.0 108.578 175.079 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.0 133.49 55.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.423 1.089 . . . . 0.0 109.501 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 155.03 34.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.992 -1.068 . . . . 0.0 111.42 -174.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 t -100.9 100.03 10.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.838 -1.164 . . . . 0.0 109.052 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.265 2.4 m-20 37.81 60.23 1.2 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.536 2.735 . . . . 0.0 117.141 -172.643 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.6 54.66 5.37 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.969 -1.082 . . . . 0.0 114.198 178.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 m 179.22 109.91 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.237 1.415 . . . . 0.0 107.354 -172.148 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.9 mt -76.84 -44.86 30.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.39 45.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.806 1.193 . . . . 0.0 110.768 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.16 136.94 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 121.553 0.692 . . . . 0.0 110.793 169.077 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB3' HG13 ' B' ' 207' ' ' VAL . 71.1 m -80.09 110.52 15.57 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.091 1.757 . . . . 0.0 112.442 167.603 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.8 123.47 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -172.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -121.72 171.08 9.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.574 2.349 . . . . 0.0 109.98 176.294 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.63 -131.01 10.29 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.238 1.399 . . . . 0.0 112.606 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.65 168.73 44.84 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.271 0.939 . . . . 0.0 111.895 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.468 0 C-N-CA 126.161 1.784 . . . . 0.0 115.006 -171.824 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.706 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -110.15 157.71 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.133 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -137.01 153.1 50.75 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.016 -1.678 . . . . 0.0 108.056 -169.225 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.55 HG11 HD13 ' A' ' 47' ' ' ILE . 14.3 t -90.85 117.89 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.41 -1.431 . . . . 0.0 112.074 178.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -81.66 -33.98 31.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.844 -1.16 . . . . 0.0 112.102 177.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.93 146.15 18.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.803 0.811 . . . . 0.0 109.776 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.55 HD13 HG11 ' A' ' 44' ' ' VAL . 44.2 mm -100.76 121.67 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 120.55 -1.344 . . . . 0.0 112.547 -176.069 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.502 0.668 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.72 72.74 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.946 1.698 . . . . 0.0 113.625 -176.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.91 -36.19 62.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.4 -1.437 . . . . 0.0 113.424 165.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 t -75.36 2.31 11.59 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.325 -2.11 . . . . 0.0 107.923 153.825 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.71 -28.12 1.46 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 170.308 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 36.8 mtt85 -81.77 -27.61 33.66 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mt -67.02 133.82 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 119.235 0.925 . . . . 0.0 113.436 178.162 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.23 -178.43 4.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.734 -1.229 . . . . 0.0 109.424 166.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -76.6 103.34 6.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.517 -1.989 . . . . 0.0 111.132 174.151 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.7 -17.72 1.82 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.783 -1.198 . . . . 0.0 115.505 -173.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.49 156.65 36.69 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 119.918 1.859 . . . . 0.0 115.226 -172.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.19 122.31 45.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.655 1.582 . . . . 0.0 109.513 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.48 114.39 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.94 -38.89 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.403 -1.435 . . . . 0.0 112.939 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.16 160.18 44.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.022 1.283 . . . . 0.0 114.147 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 92' ' ' VAL . 47.0 t -134.3 113.32 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 111.49 -175.454 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 10.2 p30 43.44 33.98 0.7 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 -163.708 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.07 22.29 59.51 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.575 -1.328 . . . . 0.0 113.383 -177.032 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.99 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 172.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -70.38 144.26 51.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.475 1.131 . . . . 0.0 113.248 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.79 56.38 3.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.727 1.211 . . . . 0.0 110.037 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.27 24.56 0.18 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 128.588 2.755 . . . . 0.0 114.654 -163.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.1 40.21 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.085 1.802 . . . . 0.0 111.173 -176.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.47 148.39 25.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.287 -1.125 . . . . 0.0 111.81 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.609 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 46.6 p -95.91 -159.7 0.74 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.727 2.811 . . . . 0.0 109.872 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -63.96 -54.88 27.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.831 -1.793 . . . . 0.0 112.228 163.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -68.05 -38.7 82.78 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 114.446 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB2' ' H ' ' A' ' 77' ' ' THR . 35.2 mt-30 -68.52 -38.84 81.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.975 -1.703 . . . . 0.0 113.128 174.391 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.41 87.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.79 -1.819 . . . . 0.0 113.597 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.634 1.173 . . . . 0.0 110.751 175.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -51.93 -41.07 61.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 174.163 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -70.64 -24.66 62.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.705 1.602 . . . . 0.0 113.984 -175.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.85 -40.18 11.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.008 -1.683 . . . . 0.0 114.141 167.288 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -46.76 44.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.181 1.792 . . . . 0.0 114.786 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.88 34.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.935 -1.728 . . . . 0.0 113.496 -170.524 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.0 p -103.03 153.35 20.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.416 2.286 . . . . 0.0 114.158 -170.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.31 62.08 4.52 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.321 1.439 . . . . 0.0 115.888 -175.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.321 9.8 tt0 64.63 -50.68 0.31 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.354 3.462 . . . . 0.0 116.929 178.369 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.19 127.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.263 1.506 . . . . 0.0 109.8 173.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 68' ' ' VAL . 47.9 t -120.11 104.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.744 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -79.09 102.78 8.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 165.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.526 ' HG ' HG12 ' A' ' 92' ' ' VAL . 14.9 mt -87.59 113.85 23.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 110.39 -175.267 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.12 95.78 10.28 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.7 141.21 36.46 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.543 2.337 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.79 139.02 45.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.813 1.245 . . . . 0.0 109.287 167.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? . . . . . 0 N--CA 1.43 -1.455 0 C-N-CA 127.467 2.307 . . . . 0.0 114.387 178.393 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 28' ' ' SER 0.374 15.6 t 67.59 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 124.352 2.025 . . . . 0.0 114.732 171.108 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 98.3 m -138.29 133.65 33.34 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 43.7 m -74.47 118.87 17.92 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.436 1.494 . . . . 0.0 109.509 171.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.572 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -176.573 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.277 0.0 OUTLIER -131.2 132.61 44.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.749 1.22 . . . . 0.0 108.247 170.473 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -106.71 87.18 2.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.217 1.007 . . . . 0.0 109.102 175.874 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.4 t -90.68 122.84 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.205 2.202 . . . . 0.0 113.044 -174.73 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -105.73 118.36 36.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.005 -2.309 . . . . 0.0 113.22 -179.762 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 mt -120.12 160.85 22.04 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.943 -1.098 . . . . 0.0 111.161 -173.201 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.26 102.65 8.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.001 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.604 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.86 143.83 57.22 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -173.045 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 t -104.39 93.99 5.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.425 1.49 . . . . 0.0 109.627 -168.184 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.62 56.44 7.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.674 2.39 . . . . 0.0 114.156 -173.573 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.39 60.01 7.17 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.792 -1.193 . . . . 0.0 114.231 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -175.81 104.47 0.08 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 20' ' ' LYS . 9.2 mt -72.33 -49.98 30.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 164.884 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.03 37.63 0.3 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 113.307 -1.77 . . . . 0.0 111.605 165.787 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.05 130.69 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.324 1.059 . . . . 0.0 112.127 179.814 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -73.32 111.22 8.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.217 1.007 . . . . 0.0 111.954 160.575 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.8 m -84.12 124.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.895 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.44 169.7 9.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.459 1.904 . . . . 0.0 110.04 175.133 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.46 -121.51 5.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.481 1.515 . . . . 0.0 113.613 178.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.31 147.71 22.13 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -175.813 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -171.363 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.776 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -108.85 155.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 168.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.002 -1.686 . . . . 0.0 107.292 -171.134 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 47' ' ' ILE . 8.7 t -79.9 130.68 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.375 -1.453 . . . . 0.0 110.432 173.384 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -90.3 -49.47 6.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.235 -1.541 . . . . 0.0 110.327 168.886 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.99 37.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.128 0.971 . . . . 0.0 109.824 -173.097 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.461 HD13 HG11 ' A' ' 44' ' ' VAL . 45.3 mm -95.15 137.45 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 170.766 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 N--CA 1.43 -1.431 0 O-C-N 120.869 -1.145 . . . . 0.0 113.215 -179.118 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 118.989 2.959 . . . . 0.0 118.989 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 -28.89 61.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.184 -1.572 . . . . 0.0 114.991 179.07 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.14 -37.3 83.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.179 -1.576 . . . . 0.0 110.942 168.047 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -69.93 -1.7 10.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -178.373 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -71.56 -83.4 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.062 -2.274 . . . . 0.0 109.793 165.568 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.88 -41.08 0.93 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.957 -1.089 . . . . 0.0 111.561 174.979 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -84.94 -18.6 34.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.14 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.31 127.22 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.843 1.257 . . . . 0.0 110.836 176.303 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.8 -179.42 5.07 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.634 1.574 . . . . 0.0 110.359 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -76.52 70.55 3.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.326 1.45 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.68 -13.03 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.384 -1.447 . . . . 0.0 116.561 179.523 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -71.34 157.4 38.15 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -92.92 130.33 38.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.392 1.477 . . . . 0.0 110.216 -177.171 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.26 122.3 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.123 1.369 . . . . 0.0 107.754 167.809 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -32.84 8.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.993 -1.067 . . . . 0.0 113.155 175.101 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 159.72 44.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.763 -1.211 . . . . 0.0 112.811 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 t -141.08 123.66 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 111.863 -174.812 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.09 30.43 19.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.28 -1.512 . . . . 0.0 112.687 -178.26 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.84 78.06 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 125.73 1.633 . . . . 0.0 114.557 -174.245 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.92 109.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -177.281 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 m -60.57 146.21 45.98 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.124 1.44 . . . . 0.0 113.677 175.087 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -79.28 65.01 4.33 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.52 -1.362 . . . . 0.0 110.303 172.875 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.38 98.77 9.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.242 -1.536 . . . . 0.0 111.019 -176.307 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.93 66.43 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.361 -0.837 . . . . 0.0 112.896 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.82 129.15 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.955 1.836 . . . . 0.0 115.087 -170.178 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.5 p -93.4 -165.19 1.29 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.645 2.378 . . . . 0.0 107.741 -179.745 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.6 -49.99 75.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.085 -1.635 . . . . 0.0 112.737 164.735 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -69.83 -45.38 67.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.328 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 77' ' ' THR . 58.9 tt0 -69.22 -32.86 72.4 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.979 -1.076 . . . . 0.0 112.97 177.7 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.1 89.97 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.394 -1.441 . . . . 0.0 114.312 173.047 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.89 -52.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.398 -0.811 . . . . 0.0 110.146 171.706 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.24 -40.81 78.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.8 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.2 m -62.4 -28.78 70.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 175.054 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.27 -40.79 11.94 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.824 1.65 . . . . 0.0 115.057 172.234 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -75.69 -44.33 42.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.912 2.885 . . . . 0.0 113.483 -173.87 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -87.93 38.61 0.85 Allowed 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.336 -1.477 . . . . 0.0 111.471 -169.579 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.0 p -109.26 166.45 10.85 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.722 2.009 . . . . 0.0 112.125 -173.617 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.13 -89.09 0.19 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.199 -1.563 . . . . 0.0 115.564 -172.699 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.64 -62.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.602 -0.94 . . . . 0.0 110.177 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.2 t -75.09 125.79 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 122.961 1.362 . . . . 0.0 110.707 172.346 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.7 t -114.37 103.99 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -83.12 103.88 12.88 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 108.622 172.856 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.73 118.76 26.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.025 -1.047 . . . . 0.0 111.483 178.817 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 102.53 15.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.858 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.75 144.49 30.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.588 1.955 . . . . 0.0 110.427 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.98 132.15 54.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 163.093 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 tptt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 123.961 0.905 . . . . 0.0 112.258 179.738 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.507 28.0 m 54.41 98.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 169.314 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 31.2 m -133.76 124.51 26.75 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 -174.842 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -69.83 128.78 37.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.488 1.115 . . . . 0.0 110.672 171.925 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.259 1.594 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -170.744 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.431 -1.396 0 CA-C-O 122.055 0.931 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -131.11 137.55 49.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.558 1.143 . . . . 0.0 108.004 178.22 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.39 76.36 0.97 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.032 1.333 . . . . 0.0 109.364 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.74 121.71 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.044 1.738 . . . . 0.0 114.942 -169.212 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -99.54 116.56 31.95 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.512 -1.992 . . . . 0.0 110.46 174.777 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.29 170.68 15.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.51 141.06 49.53 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.967 -1.083 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -63.99 145.98 54.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.573 1.949 . . . . 0.0 112.593 174.648 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -101.73 101.65 12.18 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.392 1.091 . . . . 0.0 109.495 179.708 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.95 -20.77 0.06 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.704 2.802 . . . . 0.0 117.522 -173.226 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.16 43.81 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.799 -1.813 . . . . 0.0 111.97 179.572 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.9 p -174.12 129.07 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.3 mt -78.99 -40.55 31.31 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.716 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 117.56 43.19 0.59 Allowed Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.39 169.235 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 pt -120.21 134.73 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.695 0.76 . . . . 0.0 109.886 167.238 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.6 m -96.12 117.13 30.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.162 0.985 . . . . 0.0 111.042 169.947 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.67 142.09 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -167.339 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 159.51 40.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.855 1.662 . . . . 0.0 109.448 168.384 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.98 -141.79 16.3 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.839 1.209 . . . . 0.0 114.593 173.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -175.54 48.6 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.668 1.127 . . . . 0.0 115.252 -178.689 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 N--CA 1.429 -1.478 0 C-N-CA 127.634 2.374 . . . . 0.0 114.085 178.126 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 N-CA-C 112.779 -0.128 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -107.64 162.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.338 -170.479 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.852 -1.78 . . . . 0.0 107.777 -173.995 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.586 HG11 HD13 ' A' ' 47' ' ' ILE . 6.2 t -96.68 125.16 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 120.558 -1.339 . . . . 0.0 111.469 176.505 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 -33.55 14.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.373 -1.454 . . . . 0.0 112.261 175.049 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.14 137.58 24.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 110.977 177.237 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.586 HD13 HG11 ' A' ' 44' ' ' VAL . 43.9 mm -96.23 140.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.581 1.952 . . . . 0.0 107.411 173.951 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.671 HD12 ' HA2' ' A' ' 26' ' ' GLY . 68.1 mt . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 116.853 -1.546 . . . . 0.0 109.521 169.249 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 121.524 0.678 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.05 66.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.267 -1.521 . . . . 0.0 114.729 -175.16 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.56 -32.91 69.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.114 -1.616 . . . . 0.0 111.343 167.665 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -73.76 5.69 3.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 177.323 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.64 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.101 -2.249 . . . . 0.0 107.733 151.607 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.77 -42.14 0.6 Allowed Glycine 0 N--CA 1.431 -1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 112.712 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.512 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 2.5 mpt_? -79.7 -17.85 52.64 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.067 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -72.59 143.8 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.013 1.725 . . . . 0.0 112.457 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.13 -178.87 5.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.376 -1.452 . . . . 0.0 109.278 159.931 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.25 135.25 36.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.1 -1.625 . . . . 0.0 111.861 177.773 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.22 -21.53 17.39 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.619 1.104 . . . . 0.0 112.725 -170.297 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -71.55 159.65 34.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.217 1.407 . . . . 0.0 114.232 -172.884 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -101.53 134.88 43.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.753 1.263 . . . . 0.0 110.916 -177.47 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 t -112.6 111.75 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.063 2.545 . . . . 0.0 105.055 178.215 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.82 -33.66 9.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.422 -1.424 . . . . 0.0 113.64 -175.266 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.64 158.05 39.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.75 1.159 . . . . 0.0 113.361 -179.198 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.2 t -129.9 129.5 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.043 -1.036 . . . . 0.0 110.606 174.996 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.385 0.5 OUTLIER 39.25 43.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.927 2.491 . . . . 0.0 116.081 -171.879 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.87 12.26 81.54 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.452 1.501 . . . . 0.0 114.649 178.866 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.9 t -109.32 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.606 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 p -71.36 153.77 42.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.314 1.53 . . . . 0.0 113.301 174.038 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.56 74.15 7.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.452 1.12 . . . . 0.0 112.253 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -84.28 107.95 16.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.016 1.389 . . . . 0.0 110.052 176.242 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.84 11.18 84.8 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.339 -1.476 . . . . 0.0 116.373 -177.777 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.95 141.78 34.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 123.478 1.609 . . . . 0.0 114.909 -169.254 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 66.9 p -99.22 -156.74 0.56 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.067 2.147 . . . . 0.0 109.455 -175.555 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -53.48 19.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.129 -1.607 . . . . 0.0 110.563 164.458 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -69.8 -38.63 76.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.251 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 77' ' ' THR . 10.5 tt0 -65.42 -37.5 87.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.957 -1.714 . . . . 0.0 113.79 171.371 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.34 -36.22 83.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.678 -1.889 . . . . 0.0 114.397 172.747 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.11 -57.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.028 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -48.46 -38.89 21.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 175.578 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.4 m -65.3 -33.3 75.66 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.879 2.471 . . . . 0.0 113.759 177.077 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mt -90.87 -29.62 17.41 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.702 -1.874 . . . . 0.0 114.577 171.846 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.15 -48.62 7.91 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.676 2.39 . . . . 0.0 114.739 -168.738 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -87.2 37.92 0.79 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.034 -1.666 . . . . 0.0 111.531 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 35.7 p -95.59 159.47 14.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.435 2.694 . . . . 0.0 112.087 -175.678 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.03 63.32 3.77 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.796 -1.19 . . . . 0.0 114.251 -174.711 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.289 28.3 tt0 68.69 -51.51 0.57 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.377 2.671 . . . . 0.0 115.423 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.34 125.97 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.673 1.225 . . . . 0.0 110.513 170.581 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.67 107.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -89.53 96.63 10.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.462 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 124.26 34.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 111.825 -169.023 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.14 100.89 13.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.3 1.048 . . . . 0.0 108.286 165.372 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.9 147.54 26.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.221 2.208 . . . . 0.0 109.378 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.62 138.43 54.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.521 1.153 . . . . 0.0 108.481 166.206 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 tptt . . . . . 0 N--CA 1.431 -1.397 0 O-C-N 120.968 -1.083 . . . . 0.0 112.2 -178.281 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.454 1.1 t 69.68 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 125.051 2.358 . . . . 0.0 115.69 154.313 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.0 m -130.5 122.3 27.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -170.098 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.8 p -74.27 130.03 38.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.609 1.563 . . . . 0.0 110.319 176.95 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' LEU . 11.7 p . . . . . 0 C--O 1.259 1.579 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -164.178 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 122.148 0.975 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.62 122.47 24.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.369 1.468 . . . . 0.0 109.088 176.734 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -88.35 86.41 7.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.384 1.564 . . . . 0.0 110.34 168.981 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.17 143.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.3 1.44 . . . . 0.0 108.876 176.177 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 117.92 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.894 -1.754 . . . . 0.0 109.65 174.668 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.1 mt -120.84 161.23 21.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.513 1.125 . . . . 0.0 109.916 -173.705 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.13 117.43 26.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 166.318 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -63.9 145.33 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.1 1.36 . . . . 0.0 114.303 -173.96 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.6 t -97.62 104.09 16.08 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 120.511 -1.368 . . . . 0.0 110.474 178.807 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 49.83 39.82 19.08 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.157 2.183 . . . . 0.0 115.28 -174.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 65.54 1.98 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 121.107 -0.996 . . . . 0.0 115.004 -173.525 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.487 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 46.6 t 177.98 114.01 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -175.305 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.8 mt -76.52 -38.25 55.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.528 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.5 27.65 2.32 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.122 169.067 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HB ' HG13 ' A' ' 44' ' ' VAL . 40.1 pt -124.37 127.36 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.684 0.754 . . . . 0.0 109.96 -174.232 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -79.12 110.69 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.028 1.331 . . . . 0.0 114.003 173.61 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.46 129.39 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -176.598 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -124.27 167.88 13.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.727 . . . . 0.0 109.939 172.961 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.7 -152.03 42.06 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.975 1.274 . . . . 0.0 113.61 -177.837 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.0 165.7 19.65 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.288 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.43 -1.447 0 O-C-N 120.634 -1.509 . . . . 0.0 114.372 -171.332 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 CA-C-O 121.554 0.53 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 5.4 tp -140.92 163.0 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.809 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -135.72 155.32 50.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.292 -1.505 . . . . 0.0 107.356 -173.177 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 47' ' ' ILE . 21.9 t -96.96 121.39 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.758 -1.214 . . . . 0.0 111.611 -178.497 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.31 -34.48 18.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.246 -1.534 . . . . 0.0 113.21 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.21 132.68 18.64 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -177.743 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.476 ' CD1' HG11 ' A' ' 44' ' ' VAL . 38.6 mm -93.48 126.3 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 166.561 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 121.631 -0.668 . . . . 0.0 111.859 179.442 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.439 0 CA-C-O 121.07 0.462 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.8 -41.1 79.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.668 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.77 -30.5 56.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.234 -1.541 . . . . 0.0 112.996 174.395 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -72.29 2.22 6.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 175.762 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.13 -99.86 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.874 -2.391 . . . . 0.0 109.045 162.519 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 -47.36 0.14 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.654 -1.904 . . . . 0.0 113.404 175.475 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 mtm-85 -69.2 -33.83 73.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.92 1.288 . . . . 0.0 113.143 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -52.13 129.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.062 2.945 . . . . 0.0 116.016 -175.386 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.87 177.79 8.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.57 -1.331 . . . . 0.0 110.93 167.38 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -72.16 121.26 19.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.475 -2.641 . . . . 0.0 112.445 175.623 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.06 0.95 11.55 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -176.264 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.95 158.69 29.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.528 2.164 . . . . 0.0 112.836 176.206 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -100.62 129.92 46.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.244 1.418 . . . . 0.0 108.971 178.453 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.52 117.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.225 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.03 -39.12 8.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.875 -1.765 . . . . 0.0 113.332 176.442 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.55 159.18 44.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 119.993 1.269 . . . . 0.0 113.721 -177.871 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 92' ' ' VAL . 67.0 t -133.28 115.78 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 123.881 0.872 . . . . 0.0 111.271 179.905 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 52.49 27.11 4.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.066 -1.646 . . . . 0.0 115.305 -168.184 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 4.52 72.97 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 114.25 -173.65 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.39 93.5 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -177.636 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.5 p -71.42 135.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.34 1.067 . . . . 0.0 113.634 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.2 mt -80.12 56.67 2.48 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.081 2.152 . . . . 0.0 112.354 -174.915 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -73.35 82.04 1.4 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.289 2.236 . . . . 0.0 112.643 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.27 29.41 19.79 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 120.711 -1.243 . . . . 0.0 113.446 -178.408 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.29 149.85 35.32 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.687 1.232 . . . . 0.0 112.238 176.037 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -104.66 -163.27 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.503 1.921 . . . . 0.0 109.121 -176.013 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -66.72 -54.11 26.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 111.511 169.24 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -64.35 -46.54 82.98 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.499 1.12 . . . . 0.0 112.659 177.889 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -63.38 -41.76 98.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.417 -1.427 . . . . 0.0 113.654 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.21 -38.4 87.88 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.295 -1.503 . . . . 0.0 114.918 174.238 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.79 -56.34 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 118.7 0.682 . . . . 0.0 110.494 170.298 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 36.0 mt-10 -64.18 -25.45 68.08 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -65.13 -35.05 79.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.357 1.863 . . . . 0.0 111.186 173.419 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.95 -40.85 13.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.241 1.816 . . . . 0.0 114.507 174.123 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 83' ' ' GLU 0.356 0.0 OUTLIER -82.33 -35.59 27.75 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -174.457 . . . . . . . . 4 4 . 1 . 033 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -81.33 41.58 0.62 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.559 -1.963 . . . . 0.0 113.333 178.101 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -105.42 -169.02 1.53 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.087 2.155 . . . . 0.0 110.488 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.86 -117.02 3.99 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.194 1.378 . . . . 0.0 110.736 176.616 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -66.35 0.93 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.877 -1.367 . . . . 0.0 111.438 178.098 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.46 129.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.907 -174.802 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 68' ' ' VAL . 30.1 t -121.28 105.99 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 172.277 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -77.43 100.43 5.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.653 1.581 . . . . 0.0 108.844 165.368 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -84.6 111.83 19.89 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.462 1.505 . . . . 0.0 108.065 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 99.61 12.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 171.596 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.5 144.1 32.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.286 1.434 . . . . 0.0 109.802 -177.672 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.62 125.26 53.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 166.301 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptm . . . . . 0 N--CA 1.429 -1.491 0 C-N-CA 124.808 1.243 . . . . 0.0 113.567 -171.306 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 120.351 0.119 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER 85.8 112.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 123.981 1.848 . . . . 0.0 113.466 165.823 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.6 m -139.4 118.8 12.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 -172.547 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 85.8 p -73.14 129.1 37.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.383 0.992 . . . . 0.0 109.426 170.084 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.0 p . . . . . 0 C--O 1.261 1.697 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -161.306 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.244 1.021 . . . . 0.0 108.842 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 124.58 31.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.18 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.01 82.23 3.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.687 1.232 . . . . 0.0 108.567 176.27 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.54 153.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.301 1.44 . . . . 0.0 109.709 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -129.31 122.35 29.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.177 -1.577 . . . . 0.0 107.807 166.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -119.89 153.25 36.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.936 -1.103 . . . . 0.0 108.336 -173.93 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.07 8.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.904 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.63 123.9 15.61 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.85 1.66 . . . . 0.0 113.303 -168.873 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.259 11.1 t -85.7 104.45 15.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.303 -1.498 . . . . 0.0 110.978 -169.815 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.61 16.71 9.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 127.2 2.2 . . . . 0.0 116.019 -173.835 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.99 84.58 1.35 Allowed Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.262 -1.524 . . . . 0.0 111.041 -175.566 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.254 79.2 p 151.51 109.31 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.346 2.658 . . . . 0.0 107.447 -169.023 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.13 -40.94 82.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.239 2.216 . . . . 0.0 107.369 161.047 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 110.74 32.23 2.73 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 124.953 1.263 . . . . 0.0 110.765 173.038 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 pt -121.37 130.7 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 121.86 -0.788 . . . . 0.0 109.484 174.893 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -87.04 119.33 27.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.026 0.917 . . . . 0.0 111.096 168.249 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 29' ' ' VAL . 15.9 m -86.08 133.65 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.905 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -126.22 170.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.534 1.534 . . . . 0.0 110.83 176.779 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.91 -121.73 5.69 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 125.23 1.395 . . . . 0.0 113.461 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.39 155.05 30.78 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.624 1.107 . . . . 0.0 112.236 -177.884 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.488 -1.418 0 C-N-CA 126.312 1.845 . . . . 0.0 114.154 -175.462 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.693 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 42' ' ' ILE . 4.1 tp -116.13 155.87 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.488 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -132.66 152.3 51.72 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.236 -1.54 . . . . 0.0 107.904 -169.308 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.36 107.42 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.846 -1.158 . . . . 0.0 111.397 -170.722 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -86.93 -42.09 13.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.631 -1.918 . . . . 0.0 113.416 -177.226 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.55 133.13 47.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 113.576 176.985 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.9 128.93 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.884 2.474 . . . . 0.0 109.777 175.622 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.601 HD12 ' HA2' ' A' ' 26' ' ' GLY . 72.9 mt . . . . . 0 N--CA 1.429 -1.502 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.692 174.779 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.57 -40.5 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.509 1.924 . . . . 0.0 113.652 -176.545 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -62.6 -33.57 75.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.286 -1.508 . . . . 0.0 111.227 170.122 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.35 1.66 7.45 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 174.731 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.25 -70.98 0.28 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.636 -1.915 . . . . 0.0 108.751 157.097 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -11.46 5.74 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 123.462 0.553 . . . . 0.0 112.984 164.278 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -94.78 -12.71 26.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.25 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -86.32 138.0 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.935 1.694 . . . . 0.0 112.746 -173.835 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -128.24 -171.95 2.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.858 1.263 . . . . 0.0 110.65 170.957 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -94.78 36.07 1.21 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.397 -2.064 . . . . 0.0 115.182 -163.667 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.9 16.85 1.07 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.372 -1.455 . . . . 0.0 111.749 175.717 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -92.62 151.5 20.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.894 0.854 . . . . 0.0 111.949 -162.659 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -96.64 124.67 40.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.073 0.949 . . . . 0.0 110.526 -176.242 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.2 108.67 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 167.488 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -39.69 11.51 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.949 -1.72 . . . . 0.0 112.09 178.406 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.63 38.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 119.509 1.049 . . . . 0.0 113.47 -176.355 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 92' ' ' VAL . 11.2 t -133.36 118.21 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 123.58 0.752 . . . . 0.0 111.432 -175.861 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 61.72 29.6 18.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.049 1.295 . . . . 0.0 111.808 -173.549 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.18 4.35 89.78 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.509 -1.37 . . . . 0.0 115.278 -171.523 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.8 107.33 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 118.639 1.219 . . . . 0.0 108.081 -172.501 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 m -70.41 138.22 51.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.206 -0.934 . . . . 0.0 113.333 -178.042 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.46 37.95 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.298 1.839 . . . . 0.0 111.727 -178.055 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -84.53 74.29 10.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.669 1.988 . . . . 0.0 110.227 -169.794 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.63 9.6 6.94 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 124.175 0.893 . . . . 0.0 112.985 -170.101 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.49 140.46 32.3 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.147 1.473 . . . . 0.0 112.953 177.763 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.473 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.2 p -92.12 -160.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.706 2.002 . . . . 0.0 109.912 -178.735 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -66.5 -56.42 10.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.031 -1.668 . . . . 0.0 111.317 165.69 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -69.38 -38.4 77.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 121.355 -0.841 . . . . 0.0 112.673 -177.127 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' A' ' 77' ' ' THR . 9.0 tt0 -65.96 -36.91 84.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 174.867 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.24 96.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.563 -1.96 . . . . 0.0 113.929 171.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 t -56.21 -49.8 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.74 1.216 . . . . 0.0 111.933 174.827 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.006 -1.684 . . . . 0.0 114.029 176.163 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.2 m -66.31 -24.72 66.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.303 1.841 . . . . 0.0 113.216 -179.313 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.44 -46.39 8.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.848 1.259 . . . . 0.0 114.138 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -85.47 -33.62 21.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.045 -1.66 . . . . 0.0 115.376 -169.969 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.53 34.23 0.98 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.901 -1.75 . . . . 0.0 111.032 -174.655 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.3 p -88.48 -166.15 1.52 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.368 2.667 . . . . 0.0 110.429 177.404 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.89 -123.92 3.79 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.019 -1.676 . . . . 0.0 110.138 170.945 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.8 -50.61 4.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.184 -1.186 . . . . 0.0 109.8 177.142 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.19 123.63 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 123.22 1.486 . . . . 0.0 110.776 176.898 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 68' ' ' VAL . 6.4 t -114.58 112.48 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.833 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -78.51 116.11 18.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.67 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.72 110.08 22.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.027 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.72 99.91 12.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.532 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.55 142.89 36.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.37 1.868 . . . . 0.0 110.207 -173.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -121.81 151.61 40.41 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.004 1.722 . . . . 0.0 109.514 177.329 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 174.483 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 16.1 tp . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.448 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.45 2.9 m 52.61 88.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.132 2.173 . . . . 0.0 115.077 170.302 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 61.7 m -126.77 118.21 24.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -168.88 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.3 p -79.59 120.45 23.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.4 1.08 . . . . 0.0 110.304 -179.37 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -169.155 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.43 -1.454 0 CA-C-O 122.461 1.124 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.2 117.28 14.37 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.562 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.53 76.65 3.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.887 1.327 . . . . 0.0 109.601 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.03 116.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.706 2.402 . . . . 0.0 112.472 -169.211 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.332 0.2 OUTLIER -104.56 118.36 36.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.834 -1.791 . . . . 0.0 112.078 -173.999 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 mt -127.72 178.38 6.18 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.768 -1.207 . . . . 0.0 109.216 -171.635 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.28 119.33 22.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 162.59 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HB3' ' H ' ' A' ' 24' ' ' SER . 2.1 mtpt -62.31 128.6 36.83 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.576 -1.328 . . . . 0.0 113.09 -174.979 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -88.72 121.02 30.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.505 -1.372 . . . . 0.0 109.392 179.105 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.26 4.59 3.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.845 2.058 . . . . 0.0 114.743 178.182 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.93 86.24 0.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 125.527 1.537 . . . . 0.0 110.581 -164.794 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.55 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 37.3 m 163.57 119.81 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 128.192 2.597 . . . . 0.0 106.584 -169.697 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 92' ' ' VAL . 23.6 mt -72.7 -37.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.785 1.755 . . . . 0.0 109.095 162.778 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 102.58 34.66 4.05 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.141 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HB ' HG13 ' A' ' 44' ' ' VAL . 41.9 pt -119.99 136.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 122.031 -0.688 . . . . 0.0 109.683 173.287 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.2 m -84.46 122.35 28.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 123.307 0.643 . . . . 0.0 109.754 160.972 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 m -85.13 132.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.617 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -122.85 161.83 23.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.538 -1.976 . . . . 0.0 109.691 174.93 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.72 -148.62 30.69 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.764 1.174 . . . . 0.0 113.998 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.83 146.91 5.46 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.431 -1.419 0 C-N-CA 126.525 1.93 . . . . 0.0 114.996 -178.242 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.683 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.27 2.1 tp -116.04 157.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 119.644 1.722 . . . . 0.0 110.7 -173.976 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -140.5 152.79 45.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -170.511 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' A' ' 47' ' ' ILE . 14.7 t -87.99 131.66 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.698 -1.877 . . . . 0.0 111.506 -178.609 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -96.98 -52.38 3.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.908 -1.12 . . . . 0.0 111.213 175.75 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.81 118.07 17.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.074 -1.016 . . . . 0.0 111.163 -171.671 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 44' ' ' VAL . 32.2 mm -88.92 129.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 126.28 1.832 . . . . 0.0 109.346 177.222 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' HA2' ' A' ' 26' ' ' GLY . 79.9 mt . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.449 174.51 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.515 0 CA-C-O 120.643 0.259 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.05 80.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.352 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -51.72 -35.83 44.61 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.107 1.363 . . . . 0.0 113.548 167.984 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 -16.18 46.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.97 -77.15 0.07 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.019 0.927 . . . . 0.0 110.281 164.791 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.36 -20.95 3.9 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 114.804 160.946 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.76 -13.62 60.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 118.778 1.289 . . . . 0.0 113.479 178.002 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 141.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 125.082 1.353 . . . . 0.0 113.542 -176.328 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.69 -174.24 3.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.697 -1.252 . . . . 0.0 110.372 169.055 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -81.69 56.25 2.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.388 -1.445 . . . . 0.0 112.914 -175.971 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -172.56 -8.91 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.248 -0.908 . . . . 0.0 114.58 -176.443 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.68 157.67 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.663 1.732 . . . . 0.0 114.855 -177.1 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -93.7 123.8 37.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.42 1.088 . . . . 0.0 110.412 -176.722 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.78 110.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.588 -1.32 . . . . 0.0 107.983 174.104 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.45 -26.59 12.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.84 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.64 172.0 17.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.62 2.009 . . . . 0.0 113.239 176.336 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 HD23 ' A' ' 94' ' ' LEU . 9.7 p -142.89 120.51 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 177.019 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.501 0.0 OUTLIER 30.22 43.77 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.0 2.963 . . . . 0.0 119.0 -151.501 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.48 10.31 86.03 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 126.452 1.977 . . . . 0.0 115.366 -175.798 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.16 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.472 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -63.72 130.43 44.21 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.063 1.745 . . . . 0.0 115.576 -170.318 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mt -89.42 -6.65 56.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.969 2.108 . . . . 0.0 110.366 171.694 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.94 108.74 9.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.988 -1.695 . . . . 0.0 109.202 172.047 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.62 28.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.181 -0.95 . . . . 0.0 113.421 -163.951 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 142.07 34.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.791 -1.417 . . . . 0.0 113.08 -179.506 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.57 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 60.4 p -91.1 -162.0 0.87 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.868 2.467 . . . . 0.0 109.746 -177.89 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -62.87 -51.62 66.3 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.647 -1.908 . . . . 0.0 111.47 167.147 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -65.26 -50.62 65.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.339 1.055 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.57 ' HB2' ' H ' ' A' ' 77' ' ' THR . 2.3 mp0 -63.03 -33.37 75.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.607 -1.308 . . . . 0.0 113.856 177.471 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.85 89.61 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 120.263 1.392 . . . . 0.0 114.185 174.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -59.12 -51.21 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 121.58 -0.7 . . . . 0.0 111.212 176.058 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -63.44 -32.58 74.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.346 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.4 m -60.72 -45.18 95.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.886 1.674 . . . . 0.0 112.332 172.27 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.6 -41.3 12.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 113.323 -174.476 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -44.12 56.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -88.47 42.32 1.06 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.654 -1.904 . . . . 0.0 112.421 -169.711 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 p -99.5 -171.0 1.99 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.407 3.483 . . . . 0.0 109.496 177.13 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.93 -132.95 4.53 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.533 -1.354 . . . . 0.0 111.681 175.106 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -93.37 -52.17 4.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.403 -1.645 . . . . 0.0 112.563 178.136 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.59 130.98 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 122.0 0.905 . . . . 0.0 111.308 176.596 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 25' ' ' LEU . 3.9 m -122.23 113.45 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.405 1.082 . . . . 0.0 108.086 172.56 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -81.57 94.26 6.87 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.552 -1.343 . . . . 0.0 108.826 160.909 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 68' ' ' VAL . 4.8 mt -73.3 110.49 7.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.034 1.333 . . . . 0.0 110.053 178.985 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.38 100.43 11.84 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.455 -0.778 . . . . 0.0 110.358 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.71 149.07 28.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.986 1.714 . . . . 0.0 109.585 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -124.44 147.49 48.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.94 1.296 . . . . 0.0 108.36 167.965 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 176.093 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' B' B ' 206' ' ' LEU . . . . . 0.674 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.674 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.378 15.4 m 23.14 100.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.155 3.782 . . . . 0.0 119.663 161.87 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -130.55 123.05 28.71 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 -176.42 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.5 p -72.17 129.02 37.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.093 0.949 . . . . 0.0 110.068 169.735 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.26 1.619 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 -158.466 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.949 0.881 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -139.77 146.97 49.63 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.553 -1.342 . . . . 0.0 108.891 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.72 163.37 35.91 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.657 1.985 . . . . 0.0 111.618 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.47 30.67 76.93 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.786 1.184 . . . . 0.0 115.353 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.18 131.19 54.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.955 -1.32 . . . . 0.0 110.786 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.78 133.86 52.99 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.177 1.791 . . . . 0.0 110.143 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.18 118.1 33.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.963 1.305 . . . . 0.0 109.093 174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.23 92.06 7.05 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.051 1.405 . . . . 0.0 110.078 170.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.2 t -89.45 127.91 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 126.315 1.846 . . . . 0.0 112.454 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 0.0 OUTLIER -108.35 122.54 47.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.012 -2.305 . . . . 0.0 110.238 174.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.84 157.64 37.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.005 -173.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.05 113.22 22.89 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 163.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -56.41 132.45 51.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.262 1.425 . . . . 0.0 113.953 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.5 t -97.74 110.13 22.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.605 -1.31 . . . . 0.0 109.138 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 46.07 55.43 7.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.896 2.478 . . . . 0.0 115.457 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.98 51.22 19.72 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.714 -1.241 . . . . 0.0 114.828 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 p -178.24 111.57 0.07 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.3 mt -66.63 -53.51 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.408 2.283 . . . . 0.0 108.15 166.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.796 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 133.96 26.73 0.56 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.911 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 44' ' ' VAL . 11.2 pt -126.27 137.61 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.306 1.05 . . . . 0.0 111.171 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -87.27 119.82 27.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.982 1.713 . . . . 0.0 111.649 164.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 29' ' ' VAL . 21.8 m -84.63 140.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.02 178.25 7.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.463 1.905 . . . . 0.0 109.291 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 -118.2 4.73 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.27 1.414 . . . . 0.0 113.105 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.79 162.2 36.01 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 121.432 -1.04 . . . . 0.0 112.502 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -61.6 -20.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.66 -22.4 60.93 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.467 1.507 . . . . 0.0 112.346 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 m -100.28 158.29 15.98 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.25 2.22 . . . . 0.0 106.114 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 p -78.35 67.53 4.17 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.691 -2.505 . . . . 0.0 114.958 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.75 -160.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.049 2.14 . . . . 0.0 110.397 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -81.03 43.85 0.73 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.236 -2.165 . . . . 0.0 113.588 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 m170 53.56 33.13 15.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.45 115.97 1.15 Allowed Glycine 0 N--CA 1.43 -1.739 0 O-C-N 119.883 -1.76 . . . . 0.0 110.939 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.51 140.7 3.02 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.458 ' H ' HD13 ' A' ' 73' ' ' LEU . 6.3 tp -107.25 156.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.94 157.54 46.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.877 -1.764 . . . . 0.0 106.416 -170.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' ILE . 9.6 t -87.32 131.29 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.141 -1.599 . . . . 0.0 111.9 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -41.48 9.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.367 -1.458 . . . . 0.0 110.816 171.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.45 136.03 25.7 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.032 -1.042 . . . . 0.0 111.102 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.509 HD13 HG11 ' A' ' 44' ' ' VAL . 36.2 mm -97.43 137.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 127.017 2.127 . . . . 0.0 108.597 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.796 HD12 ' HA2' ' A' ' 26' ' ' GLY . 50.1 mt -77.22 132.67 69.69 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 110.151 171.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.04 93.88 0.46 Allowed 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.968 2.445 . . . . 0.0 112.192 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.256 30.4 mmtp 82.57 53.32 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.938 2.495 . . . . 0.0 113.725 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.92 -179.08 30.53 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 151.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.9 -39.11 68.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.056 1.742 . . . . 0.0 115.348 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.73 54.19 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.181 2.192 . . . . 0.0 115.104 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.53 -26.93 68.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.923 -1.736 . . . . 0.0 112.292 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -70.11 -18.73 63.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.033 -1.667 . . . . 0.0 115.066 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.74 -71.57 0.24 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.036 -2.29 . . . . 0.0 107.368 157.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.0 5.63 62.4 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 161.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -80.75 -19.37 45.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 110.115 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.08 149.29 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.298 1.839 . . . . 0.0 114.253 162.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.44 -161.23 1.11 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.62 1.568 . . . . 0.0 107.464 157.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.3 45.45 1.28 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.959 -2.338 . . . . 0.0 112.549 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.73 -20.13 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 O-C-N 120.609 -1.307 . . . . 0.0 114.807 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -78.76 161.06 27.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -166.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -104.07 124.65 49.44 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.64 1.576 . . . . 0.0 110.411 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.26 117.24 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 107.248 166.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 -36.19 9.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.824 -1.797 . . . . 0.0 112.754 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.26 154.22 38.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.82 -1.175 . . . . 0.0 111.401 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.04 121.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.065 -1.022 . . . . 0.0 111.259 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.8 t30 63.77 21.33 12.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.643 -1.285 . . . . 0.0 113.389 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.94 20.38 63.34 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.665 -1.272 . . . . 0.0 113.492 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.9 110.67 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 121.079 -1.248 . . . . 0.0 107.99 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.7 m -58.13 141.18 51.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.383 1.873 . . . . 0.0 114.543 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 42' ' ' ILE . 4.3 mt -81.08 47.62 1.03 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.284 1.516 . . . . 0.0 111.889 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.76 117.03 21.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.196 1.799 . . . . 0.0 109.707 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.86 72.02 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 114.734 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.21 132.76 36.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.529 1.633 . . . . 0.0 112.639 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -110.46 -164.92 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.006 2.523 . . . . 0.0 105.517 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -58.18 -52.17 66.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.557 -1.965 . . . . 0.0 112.947 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -70.53 -44.63 67.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.121 0.968 . . . . 0.0 112.583 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -38.83 92.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.05 1.34 . . . . 0.0 113.807 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.32 97.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 0.0 114.312 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.37 -54.51 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 118.127 0.421 . . . . 0.0 110.247 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.77 -37.12 40.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 126.085 1.754 . . . . 0.0 115.351 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.7 m -72.22 -31.46 65.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.68 2.392 . . . . 0.0 113.898 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -89.02 -37.94 14.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.242 1.817 . . . . 0.0 114.102 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -82.97 -45.45 14.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.624 1.97 . . . . 0.0 113.378 -166.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -90.88 37.32 0.92 Allowed 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.038 1.399 . . . . 0.0 112.623 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.8 p -90.1 173.51 8.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.949 2.1 . . . . 0.0 114.058 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.71 51.39 4.45 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.673 -1.892 . . . . 0.0 113.972 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 68.27 -51.78 0.54 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.299 3.04 . . . . 0.0 115.673 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.6 t -76.86 128.46 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 123.144 1.449 . . . . 0.0 109.844 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.03 100.22 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -82.26 98.49 8.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.875 1.67 . . . . 0.0 107.987 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -87.51 112.75 22.55 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.322 1.449 . . . . 0.0 109.878 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.26 100.52 12.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.84 136.97 44.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.413 1.885 . . . . 0.0 110.881 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.28 158.23 17.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.134 1.774 . . . . 0.0 109.37 171.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 131.71 31.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.98 14.3 64.7 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.624 -1.923 . . . . 0.0 113.961 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -111.73 121.66 45.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.392 1.877 . . . . 0.0 109.997 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 m -75.04 154.94 86.64 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.327 -1.483 . . . . 0.0 113.531 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.3 -1.983 0 C-N-CA 122.546 2.164 . . . . 0.0 113.369 169.78 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 N--CA 1.431 -1.416 0 CA-C-O 121.328 0.585 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.551 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.6 tp 61.37 179.8 0.11 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.634 2.374 . . . . 0.0 114.819 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.551 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.419 16.0 m 33.12 89.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 129.934 3.294 . . . . 0.0 116.775 171.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 64.5 m -125.11 121.83 35.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.0 p -71.62 121.1 18.18 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.574 1.15 . . . . 0.0 109.779 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.636 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 33.5 ttm . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -119.69 140.26 29.2 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 120.119 -1.613 . . . . 0.0 107.156 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -68.96 115.26 3.89 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 123.888 2.424 . . . . 0.0 113.057 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.69 50.44 42.5 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 115.185 0.834 . . . . 0.0 115.185 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.52 128.14 33.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.354 -1.086 . . . . 0.0 109.238 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 p -91.68 130.63 37.44 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.911 0.862 . . . . 0.0 110.566 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.58 121.54 37.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.517 1.127 . . . . 0.0 108.599 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -88.74 87.63 7.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.965 1.364 . . . . 0.0 111.021 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.9 t -85.82 110.77 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.941 1.696 . . . . 0.0 111.493 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.58 123.21 40.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.621 -1.924 . . . . 0.0 108.24 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.11 172.36 12.48 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.13 128.77 55.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 158.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.3 137.17 52.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.578 1.151 . . . . 0.0 110.565 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -89.35 92.2 9.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.015 -1.678 . . . . 0.0 110.67 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.5 -18.82 0.11 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.52 61.07 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 119.983 -1.698 . . . . 0.0 110.028 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -179.97 119.64 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.875 1.797 . . . . 0.0 107.266 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' CD2' HG21 ' A' ' 92' ' ' VAL . 16.9 mt -74.87 -47.54 29.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.001 1.857 . . . . 0.0 106.575 162.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 112.01 39.94 1.23 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.426 1.489 . . . . 0.0 111.4 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' A' ' 44' ' ' VAL . 42.9 pt -124.85 136.65 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.812 0.815 . . . . 0.0 109.713 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 m -88.31 121.57 30.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.342 1.457 . . . . 0.0 111.398 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.11 138.41 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -174.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.2 t -138.6 175.9 9.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.16 2.584 . . . . 0.0 108.581 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 -128.34 9.02 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 113.123 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.8 163.49 39.44 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.796 -1.414 . . . . 0.0 114.525 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -59.94 -24.08 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 126.697 1.999 . . . . 0.0 114.615 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.36 6.8 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.133 -1.604 . . . . 0.0 114.297 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 p -123.16 174.66 7.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.231 -1.543 . . . . 0.0 107.907 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.4 m -87.98 60.08 5.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.581 -1.95 . . . . 0.0 114.257 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.1 -164.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.213 1.805 . . . . 0.0 110.937 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -77.26 63.61 2.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.127 -2.233 . . . . 0.0 111.841 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.31 30.7 p80 30.64 31.0 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 132.316 4.246 . . . . 0.0 120.647 -179.694 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.92 111.98 0.45 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 119.801 -1.812 . . . . 0.0 110.29 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.01 147.08 4.45 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -105.57 160.33 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.9 160.31 38.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.926 -1.734 . . . . 0.0 107.017 -171.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' ILE . 4.0 t -92.07 134.46 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.429 -1.42 . . . . 0.0 112.219 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -99.56 -36.64 9.46 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.72 -1.237 . . . . 0.0 111.441 171.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.05 129.95 16.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.216 -1.553 . . . . 0.0 111.654 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.509 HD13 HG11 ' A' ' 44' ' ' VAL . 38.6 mm -95.25 136.86 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 108.816 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.695 HD12 ' HA2' ' A' ' 26' ' ' GLY . 62.4 mt -80.46 134.55 54.59 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 119.919 -1.738 . . . . 0.0 110.176 172.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -59.18 96.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 123.683 2.922 . . . . 0.0 114.667 168.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 37.5 mmtm 65.0 57.88 0.95 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.152 2.181 . . . . 0.0 114.429 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.19 -113.13 0.53 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 158.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.45 -44.99 3.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.16 -1.2 . . . . 0.0 110.71 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.87 63.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.081 1.753 . . . . 0.0 114.656 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 50' ' ' LYS . 5.9 tp10 -59.73 -28.37 67.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.44 -1.412 . . . . 0.0 112.956 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -14.54 63.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.69 -70.52 0.34 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.163 -1.586 . . . . 0.0 108.685 159.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.47 6.64 56.42 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 114.206 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -78.83 -27.62 44.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.301 -1.705 . . . . 0.0 109.102 164.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -69.27 143.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.873 1.669 . . . . 0.0 114.198 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -132.61 172.81 12.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.696 -1.252 . . . . 0.0 110.049 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -82.62 58.39 4.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.686 -1.884 . . . . 0.0 113.458 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.55 31.4 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -103.75 159.19 15.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -100.73 130.22 46.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.713 1.205 . . . . 0.0 109.772 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.21 114.35 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.98 -34.11 11.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.575 -1.328 . . . . 0.0 112.225 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.08 165.34 37.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.217 1.371 . . . . 0.0 113.327 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 HD23 ' A' ' 85' ' ' LEU . 14.9 t -134.27 119.17 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 110.552 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.89 27.1 8.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 121.101 1.773 . . . . 0.0 115.247 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.67 17.82 74.55 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 120.88 -1.137 . . . . 0.0 114.5 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.9 98.29 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 t -68.64 137.12 53.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.277 1.431 . . . . 0.0 114.642 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.93 30.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.855 2.062 . . . . 0.0 111.702 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 10.49 1.19 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -167.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.62 36.59 0.39 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.829 -1.17 . . . . 0.0 110.401 166.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.32 37.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.059 0.943 . . . . 0.0 113.31 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -108.73 -161.59 0.77 Allowed 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.415 2.286 . . . . 0.0 106.859 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -55.09 -55.97 25.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.637 1.975 . . . . 0.0 114.09 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -64.64 -54.45 31.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.082 0.944 . . . . 0.0 112.724 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -41.09 71.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.132 1.773 . . . . 0.0 114.256 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.51 89.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.208 -1.558 . . . . 0.0 114.844 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.1 t -57.52 -52.5 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 119.196 0.907 . . . . 0.0 110.333 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.03 -35.9 74.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.6 m -64.58 -34.65 78.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.966 1.706 . . . . 0.0 113.772 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 68' ' ' VAL . 16.5 mt -87.98 -39.48 14.66 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.258 -1.526 . . . . 0.0 113.481 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -50.81 10.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.409 2.284 . . . . 0.0 113.986 -173.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.59 43.03 0.94 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 124.023 1.868 . . . . 0.0 112.044 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.4 p -99.08 174.64 6.24 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.93 2.892 . . . . 0.0 108.35 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.24 -131.22 0.76 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.646 -1.284 . . . . 0.0 112.743 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -97.19 -49.78 4.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.023 -1.281 . . . . 0.0 110.45 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.6 129.88 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.184 1.468 . . . . 0.0 110.977 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.573 HG21 ' CD2' ' A' ' 25' ' ' LEU . 13.9 m -121.37 110.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.821 1.648 . . . . 0.0 107.062 170.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -82.84 96.15 8.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 161.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.38 122.42 24.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.748 -1.22 . . . . 0.0 110.817 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.8 103.58 15.48 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 108.664 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -112.83 144.54 42.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.155 1.382 . . . . 0.0 110.219 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -119.29 133.63 55.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.013 1.325 . . . . 0.0 109.519 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.21 119.58 11.74 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.068 1.347 . . . . 0.0 114.386 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.99 73.54 0.7 Allowed Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 125.731 1.634 . . . . 0.0 111.282 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -135.64 160.28 39.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.473 -1.016 . . . . 0.0 109.828 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.52 139.69 26.64 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.819 -1.563 . . . . 0.0 110.222 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo . . . . . 0 N--CA 1.434 -2.029 0 C-N-CA 123.027 2.485 . . . . 0.0 116.845 178.32 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 120.94 0.4 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.19 172.65 12.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.885 1.274 . . . . 0.0 114.371 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.517 17.4 m 61.92 98.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.001 2.521 . . . . 0.0 116.531 171.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.2 m -129.43 120.99 26.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.4 p -71.36 135.72 47.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.168 0.987 . . . . 0.0 109.796 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.259 1.604 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -166.062 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.525 ' N ' ' HZ3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.387 1.089 . . . . 0.0 109.963 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -121.83 153.12 60.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 C-N-CA 125.326 1.45 . . . . 0.0 107.773 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.9 126.57 12.69 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.527 2.151 . . . . 0.0 112.148 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.15 77.92 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 123.778 0.704 . . . . 0.0 113.619 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.1 88.96 5.96 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.996 -1.297 . . . . 0.0 109.526 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -75.84 132.47 40.38 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 125.328 1.451 . . . . 0.0 112.15 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 134.42 54.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.77 1.228 . . . . 0.0 107.947 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.21 68.49 0.71 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.94 1.352 . . . . 0.0 108.819 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.4 t -75.97 112.77 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.522 2.329 . . . . 0.0 112.21 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.29 3.0 pm0 -100.74 120.84 40.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.879 -1.763 . . . . 0.0 111.708 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 94' ' ' LEU . 13.4 mt -133.73 174.34 10.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.56 1.144 . . . . 0.0 108.802 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.03 125.52 52.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 160.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.93 143.82 41.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 113.117 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -91.15 87.28 6.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.965 1.364 . . . . 0.0 110.69 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 67.58 6.88 5.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.947 2.099 . . . . 0.0 115.404 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.47 72.88 0.53 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.8 t 167.97 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.332 1.853 . . . . 0.0 108.447 -166.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.3 mt -70.14 -45.13 67.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 154.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.12 40.67 0.95 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 124.848 1.213 . . . . 0.0 110.68 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -127.84 134.22 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.962 0.887 . . . . 0.0 109.862 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.5 m -85.07 120.46 26.6 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 123.677 0.791 . . . . 0.0 111.553 163.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.54 142.35 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -142.8 170.72 15.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.316 1.446 . . . . 0.0 110.0 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 -130.96 10.55 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.053 1.311 . . . . 0.0 112.368 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.32 157.62 31.56 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.598 1.094 . . . . 0.0 111.421 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.2 t -45.19 -40.72 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.391 1.877 . . . . 0.0 113.193 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -68.28 -26.23 65.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.596 1.958 . . . . 0.0 115.006 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.9 m -80.88 -33.31 34.44 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.656 -1.278 . . . . 0.0 111.481 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.268 3.8 t 96.04 87.62 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.959 2.904 . . . . 0.0 110.208 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 m -119.75 -156.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.729 2.012 . . . . 0.0 109.334 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -83.36 79.38 9.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.401 -2.062 . . . . 0.0 110.77 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 71.8 -80.05 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.311 1.844 . . . . 0.0 112.047 -169.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -151.65 -121.3 0.94 Allowed Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 126.378 1.942 . . . . 0.0 108.677 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.35 -170.18 53.67 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.013 -1.287 . . . . 0.0 111.946 -168.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.421 HG22 HG13 ' A' ' 65' ' ' VAL . 6.2 tp -143.31 160.93 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.289 -1.712 . . . . 0.0 106.79 160.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -125.56 166.74 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.092 -1.63 . . . . 0.0 107.291 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.4 t -83.89 141.35 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.085 -1.634 . . . . 0.0 110.216 170.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -97.09 -57.69 2.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.803 -1.185 . . . . 0.0 109.535 160.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.69 145.11 49.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.879 0.872 . . . . 0.0 111.135 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.1 mm -101.07 131.94 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.279 1.831 . . . . 0.0 106.706 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -88.92 163.86 33.37 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.339 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.38 103.5 0.66 Allowed 'Trans proline' 0 C--N 1.298 -2.082 0 C-N-CA 122.923 2.416 . . . . 0.0 114.279 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 50.5 70.72 0.48 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 170.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.65 -92.4 0.76 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 164.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.06 -36.82 1.74 Allowed 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 124.811 1.244 . . . . 0.0 109.981 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.18 59.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 126.213 1.805 . . . . 0.0 114.443 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.7 -32.54 67.48 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.032 -1.668 . . . . 0.0 113.06 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -70.54 -0.62 8.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.69 -96.98 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.209 -2.182 . . . . 0.0 107.553 156.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.93 -14.42 0.77 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.75 -1.219 . . . . 0.0 113.067 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -84.63 -23.45 29.52 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.939 -1.33 . . . . 0.0 110.733 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.39 135.22 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.181 2.592 . . . . 0.0 113.965 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.58 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 4.1 t-80 -143.98 -173.72 4.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.419 1.58 . . . . 0.0 114.343 167.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.58 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 78.4 mttt -89.22 81.16 6.76 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.185 1.794 . . . . 0.0 111.348 -164.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.98 -14.28 0.77 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.17 -0.956 . . . . 0.0 113.029 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.84 170.26 8.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -106.3 143.83 33.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.232 1.413 . . . . 0.0 109.643 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.421 HG13 HG22 ' A' ' 42' ' ' ILE . 3.9 p -110.48 129.38 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 164.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.05 -32.84 8.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.878 -1.764 . . . . 0.0 112.211 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.03 156.89 42.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.729 -1.232 . . . . 0.0 112.441 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.539 HG21 HD23 ' A' ' 85' ' ' LEU . 3.6 t -136.15 120.77 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.083 -1.01 . . . . 0.0 110.784 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.3 t30 65.3 19.21 11.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.892 1.277 . . . . 0.0 112.736 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.17 46.25 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.601 -1.312 . . . . 0.0 113.284 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.95 104.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.3 p -65.56 138.51 58.1 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.323 1.449 . . . . 0.0 114.32 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -80.71 49.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.31 1.844 . . . . 0.0 111.247 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.44 107.96 6.91 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.584 1.554 . . . . 0.0 110.643 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 29.61 62.48 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 114.025 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.84 137.25 33.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.567 1.651 . . . . 0.0 113.555 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.6 p -93.66 -165.74 1.38 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.365 1.866 . . . . 0.0 108.341 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -64.71 -50.07 68.38 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 119.547 -1.971 . . . . 0.0 111.371 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -64.28 -49.04 73.38 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.393 1.077 . . . . 0.0 113.194 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -67.69 -30.95 70.6 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.603 -1.311 . . . . 0.0 114.332 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.14 93.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.126 -1.609 . . . . 0.0 114.48 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.4 t -53.68 -51.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.609 1.163 . . . . 0.0 111.574 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -58.4 -43.4 88.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.512 -1.368 . . . . 0.0 114.463 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.0 m -65.53 -30.79 71.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.551 1.54 . . . . 0.0 114.508 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.539 HD23 HG21 ' A' ' 68' ' ' VAL . 19.9 mt -88.62 -49.23 7.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.946 1.298 . . . . 0.0 112.096 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.22 44.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -91.63 37.75 0.97 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.071 -1.643 . . . . 0.0 110.898 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 p -94.06 170.09 9.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.053 2.141 . . . . 0.0 108.125 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.1 -79.24 1.04 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 119.83 -1.794 . . . . 0.0 112.693 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -137.75 -57.7 0.68 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.653 -0.91 . . . . 0.0 108.979 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.5 t -78.07 130.47 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 123.114 1.435 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.482 HG21 HD22 ' A' ' 25' ' ' LEU . 13.3 m -115.26 117.88 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.464 1.106 . . . . 0.0 108.157 167.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -85.72 97.54 10.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.258 -1.527 . . . . 0.0 107.349 161.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 18' ' ' LEU . 9.8 mt -85.19 112.57 20.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 110.762 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.07 105.19 17.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.168 0.987 . . . . 0.0 108.719 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mt -117.9 144.26 45.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.589 1.555 . . . . 0.0 111.352 -165.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.07 138.67 54.61 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.462 1.505 . . . . 0.0 109.637 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 27.1 mmtp -75.0 136.02 41.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.731 1.212 . . . . 0.0 113.735 -172.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.96 61.34 3.39 Favored Glycine 0 N--CA 1.431 -1.651 0 O-C-N 120.772 -1.205 . . . . 0.0 111.555 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -126.01 -172.65 2.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.103 1.761 . . . . 0.0 110.687 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.41 156.62 79.28 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.89 1.676 . . . . 0.0 108.953 -168.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo . . . . . 0 N--CA 1.433 -2.045 0 C-N-CA 122.822 2.348 . . . . 0.0 114.887 167.258 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 N--CA 1.429 -1.496 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 5.5 tp 54.73 -148.69 0.47 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.76 2.024 . . . . 0.0 113.35 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.619 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.411 1.9 t 38.22 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 129.81 3.244 . . . . 0.0 116.281 152.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 46.7 m -138.04 122.61 18.52 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 102.941 -2.985 . . . . 0.0 102.941 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -83.52 127.91 34.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.006 0.908 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.261 1.678 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -163.097 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 121.418 0.628 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.1 151.07 41.45 Favored Pre-proline 0 N--CA 1.429 -1.478 0 C-N-CA 125.109 1.364 . . . . 0.0 111.388 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.06 114.35 3.95 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.922 2.415 . . . . 0.0 114.332 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.37 28.65 61.37 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 121.481 -0.762 . . . . 0.0 114.702 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.66 133.67 34.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.502 -0.999 . . . . 0.0 110.485 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.3 p -91.0 138.19 31.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.724 -1.235 . . . . 0.0 112.559 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.04 120.01 33.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.85 74.41 3.58 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.359 1.064 . . . . 0.0 108.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.94 153.12 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 127.187 2.195 . . . . 0.0 110.02 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -130.33 123.03 29.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.945 -1.722 . . . . 0.0 109.501 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -122.89 174.85 6.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.516 1.126 . . . . 0.0 109.29 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.51 136.87 54.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 153.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 24' ' ' SER . 7.7 ptpt -66.85 130.25 42.54 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.067 1.747 . . . . 0.0 113.365 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 101.52 13.3 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.527 -1.358 . . . . 0.0 109.649 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 51.37 64.95 1.64 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.733 2.013 . . . . 0.0 114.01 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.48 72.64 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.869 -1.144 . . . . 0.0 115.234 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.42 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 35.9 t -172.75 99.01 0.14 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.62 -41.99 95.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.363 2.265 . . . . 0.0 107.075 164.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 106.29 46.32 1.16 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.359 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -123.36 136.9 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 124.358 0.681 . . . . 0.0 110.108 165.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.3 m -84.72 120.0 25.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.3 1.04 . . . . 0.0 110.677 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -90.01 129.82 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -126.54 165.33 19.35 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.232 -2.167 . . . . 0.0 110.958 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 -130.58 10.37 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.333 1.444 . . . . 0.0 113.221 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.2 158.69 24.15 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.756 1.646 . . . . 0.0 110.897 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.3 p -60.42 -20.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.098 1.359 . . . . 0.0 114.12 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -55.35 -49.63 71.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.654 1.982 . . . . 0.0 114.379 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -166.1 164.21 18.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.318 10.5 p 85.74 -21.02 0.23 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.5 -170.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.024 -1.672 . . . . 0.0 110.238 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -76.49 -62.54 1.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.444 -1.41 . . . . 0.0 110.22 171.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.83 5.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.98 107.14 0.2 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.527 -2.608 . . . . 0.0 113.657 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.79 171.35 26.63 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 65' ' ' VAL . 3.8 tp -115.99 151.03 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 167.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.14 153.69 46.59 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.282 -2.137 . . . . 0.0 105.512 -168.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.458 HG11 HD13 ' A' ' 47' ' ' ILE . 15.5 t -82.69 127.03 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.593 -1.942 . . . . 0.0 111.535 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -84.43 -54.49 4.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.497 -1.377 . . . . 0.0 109.977 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 137.82 34.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.292 0.637 . . . . 0.0 110.321 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.458 HD13 HG11 ' A' ' 44' ' ' VAL . 44.9 mm -90.62 144.98 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.271 1.828 . . . . 0.0 107.582 175.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 26' ' ' GLY . 59.8 mt -87.2 117.15 68.2 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 119.725 -1.859 . . . . 0.0 108.326 164.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.3 65.93 8.86 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 CA-C-N 124.161 2.522 . . . . 0.0 111.938 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 0.7 OUTLIER 152.29 45.76 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 131.45 3.9 . . . . 0.0 111.342 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -108.15 -121.38 4.58 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.777 -2.452 . . . . 0.0 110.383 167.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.61 -31.1 2.5 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.972 1.709 . . . . 0.0 110.362 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -46.88 60.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.824 -1.798 . . . . 0.0 113.072 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.11 -32.87 56.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.803 1.287 . . . . 0.0 113.576 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 p -59.24 -20.98 58.72 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.18 -79.35 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.435 1.094 . . . . 0.0 110.939 167.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.88 -19.32 6.15 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 121.463 -0.773 . . . . 0.0 113.913 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -30.16 60.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.816 -1.402 . . . . 0.0 112.319 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.81 140.79 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -134.83 -164.08 1.47 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -73.42 150.73 41.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.479 -2.013 . . . . 0.0 110.725 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.38 74.75 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 120.57 -1.331 . . . . 0.0 115.445 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.09 148.86 41.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 118.896 1.348 . . . . 0.0 111.891 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.45 112.33 25.18 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.88 1.272 . . . . 0.0 110.036 -168.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 42' ' ' ILE 0.26 3.5 p -84.47 116.03 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 119.963 -1.71 . . . . 0.0 108.36 173.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 -37.18 12.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.181 -1.574 . . . . 0.0 111.436 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.14 28.31 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.166 0.984 . . . . 0.0 112.906 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.35 128.94 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.75 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 52.61 18.97 1.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.86 -2.4 . . . . 0.0 117.408 -170.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.1 6.15 63.4 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.425 -1.422 . . . . 0.0 114.945 -171.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -108.03 101.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 125.726 1.611 . . . . 0.0 109.786 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.8 m -68.72 145.02 54.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -82.16 43.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.033 2.533 . . . . 0.0 112.848 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.55 117.33 23.06 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.928 -1.733 . . . . 0.0 110.72 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.5 86.55 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 123.926 0.774 . . . . 0.0 113.436 -170.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.87 133.96 33.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.939 1.37 . . . . 0.0 113.434 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.6 p -97.14 -160.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.402 2.681 . . . . 0.0 108.228 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -63.77 -55.96 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.045 -1.659 . . . . 0.0 111.771 164.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -64.98 -38.76 92.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.86 -37.31 73.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.789 -1.819 . . . . 0.0 114.149 174.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.62 76.42 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.2 -1.563 . . . . 0.0 114.22 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.3 t -58.93 -56.37 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.729 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.97 -43.23 63.46 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 m -56.18 -45.55 79.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.188 2.195 . . . . 0.0 114.629 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.91 -32.38 15.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.746 -1.846 . . . . 0.0 115.26 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -79.34 -50.08 11.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.488 1.515 . . . . 0.0 113.145 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -92.19 52.23 1.92 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.126 -1.609 . . . . 0.0 111.922 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.1 p -95.04 -164.96 1.23 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.303 2.241 . . . . 0.0 110.656 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.25 -75.43 1.19 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.089 -1.632 . . . . 0.0 112.365 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -150.6 -60.21 0.19 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.822 -1.399 . . . . 0.0 110.225 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -72.35 125.04 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.219 1.485 . . . . 0.0 110.614 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.97 103.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -73.85 110.35 8.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.917 -1.114 . . . . 0.0 110.38 165.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.2 mt -91.79 110.67 22.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.367 0.985 . . . . 0.0 108.681 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.66 95.41 10.25 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.906 0.86 . . . . 0.0 108.769 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.14 138.91 40.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.102 1.761 . . . . 0.0 110.273 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.91 137.02 46.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.59 1.956 . . . . 0.0 108.088 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -79.75 126.2 30.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 56.58 5.01 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 113.859 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.0 151.15 28.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.983 1.713 . . . . 0.0 110.902 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.94 145.05 31.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 116.125 -1.893 . . . . 0.0 107.432 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--N 1.3 -2.018 0 CA-C-N 124.381 2.6 . . . . 0.0 115.285 -176.53 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 121.918 0.866 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.53 -149.57 0.31 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.337 -1.477 . . . . 0.0 109.355 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.416 2.3 t 67.79 104.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 124.395 2.045 . . . . 0.0 113.484 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 59.5 m -135.84 123.82 22.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -70.44 121.64 18.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.627 1.171 . . . . 0.0 108.549 167.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.259 1.589 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -166.567 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 121.31 0.576 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -147.86 147.75 28.01 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.1 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.79 137.9 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 123.484 2.28 . . . . 0.0 112.442 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.54 76.67 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 116.285 1.274 . . . . 0.0 116.285 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -82.72 130.83 35.19 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.777 -1.425 . . . . 0.0 110.773 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 129.68 45.12 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.754 -1.217 . . . . 0.0 110.748 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.94 116.97 24.48 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.615 1.166 . . . . 0.0 109.39 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.71 86.61 7.31 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.273 1.035 . . . . 0.0 110.279 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.12 121.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.874 2.069 . . . . 0.0 109.722 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.07 116.8 24.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.547 -1.971 . . . . 0.0 111.448 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.13 167.79 27.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.223 -1.548 . . . . 0.0 112.279 -167.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.22 138.8 40.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.378 1.071 . . . . 0.0 110.212 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -75.67 160.91 29.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.717 -1.24 . . . . 0.0 112.539 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 m -92.6 71.8 5.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.276 -1.515 . . . . 0.0 109.343 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 53.57 63.58 2.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.158 2.183 . . . . 0.0 114.959 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.45 38.57 14.25 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -177.54 108.59 0.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.201 1.4 . . . . 0.0 107.932 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 9.4 mt -66.0 -48.04 72.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.279 2.632 . . . . 0.0 108.2 169.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.07 34.41 0.78 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.094 1.33 . . . . 0.0 112.645 172.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 pt -121.76 129.66 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 121.454 0.645 . . . . 0.0 110.514 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.257 5.5 m -78.68 122.9 26.56 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 111.81 162.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.19 134.29 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -130.61 168.08 17.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.115 1.366 . . . . 0.0 109.069 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.59 -146.99 21.06 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.237 0.923 . . . . 0.0 113.28 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.69 169.65 43.98 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 121.314 -1.11 . . . . 0.0 112.02 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.73 -21.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -71.76 -20.78 61.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -111.39 166.51 11.06 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.509 -1.369 . . . . 0.0 109.976 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.8 m -84.51 99.17 10.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.991 -1.068 . . . . 0.0 108.716 172.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 p -146.21 54.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 123.987 1.851 . . . . 0.0 107.586 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 70.73 -72.41 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.119 2.168 . . . . 0.0 112.655 -168.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -138.23 -85.25 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.569 1.147 . . . . 0.0 109.657 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.95 16.6 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -168.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.69 176.2 54.76 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 119.056 1.428 . . . . 0.0 110.296 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.289 2.7 tp -112.61 151.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.804 -1.41 . . . . 0.0 107.459 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.98 155.13 50.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -167.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.0 t -82.52 136.7 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 119.48 -2.012 . . . . 0.0 111.387 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -92.59 -51.71 4.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.025 0.93 . . . . 0.0 110.507 166.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.82 141.78 38.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.594 -0.691 . . . . 0.0 111.574 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.487 ' CD1' HG11 ' A' ' 44' ' ' VAL . 44.2 mm -103.66 128.63 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.259 1.823 . . . . 0.0 109.676 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.6 139.74 41.07 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.35 68.84 7.64 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.523 2.149 . . . . 0.0 112.233 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -117.28 -87.12 0.62 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.158 0.983 . . . . 0.0 109.11 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.04 45.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . -109.46 -77.07 0.6 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.006 1.903 . . . . 0.0 109.112 157.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.86 88.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.5 -40.06 65.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.16 1.457 . . . . 0.0 112.889 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 t -79.58 -16.14 56.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.25 -54.05 14.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.753 2.524 . . . . 0.0 111.365 -164.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.58 -77.78 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 118.925 -1.607 . . . . 0.0 113.476 153.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -81.74 -7.8 59.63 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -164.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mt -73.29 126.47 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.039 -1.663 . . . . 0.0 114.196 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 74.9 t60 -128.81 -160.1 1.0 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 163.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 20.6 pttp -92.95 67.09 4.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.349 -2.72 . . . . 0.0 114.442 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.35 42.83 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.461 -2.649 . . . . 0.0 116.717 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -116.17 174.67 5.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.987 1.393 . . . . 0.0 111.213 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 129.7 56.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.868 1.667 . . . . 0.0 107.435 176.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.269 9.4 p -100.13 119.86 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.061 1.3 . . . . 0.0 107.892 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -39.01 10.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.524 -1.36 . . . . 0.0 111.547 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.23 150.36 42.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.03 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.0 t -133.14 116.94 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.19 31.1 20.39 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.974 1.31 . . . . 0.0 112.92 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.16 30.92 54.18 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.192 -0.943 . . . . 0.0 112.939 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -129.12 100.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 t -70.37 137.31 50.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 112.814 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.12 57.1 3.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.515 1.526 . . . . 0.0 112.562 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.23 94.69 9.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.538 -1.976 . . . . 0.0 110.729 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.04 45.58 4.12 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 121.349 -0.844 . . . . 0.0 111.521 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.18 147.56 37.17 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.592 1.187 . . . . 0.0 109.202 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -126.21 -165.35 1.43 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 82' ' ' VAL . 10.3 t-80 -52.58 -55.16 24.2 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.216 -1.553 . . . . 0.0 114.292 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -62.5 -50.55 70.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.672 1.225 . . . . 0.0 113.491 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -42.58 99.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.546 1.138 . . . . 0.0 113.426 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.98 89.36 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 120.442 -1.411 . . . . 0.0 114.431 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 78' ' ' HIS . 52.1 t -54.94 -56.59 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.328 0.967 . . . . 0.0 110.676 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.41 -27.38 65.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -65.78 -26.6 67.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.78 2.032 . . . . 0.0 112.623 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.93 -46.46 8.52 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.14 1.376 . . . . 0.0 112.587 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' B' ' 210' ' ' VAL 0.45 0.0 OUTLIER -71.74 -45.78 60.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.048 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -93.7 45.4 1.15 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.323 1.535 . . . . 0.0 110.344 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.4 p -98.13 157.23 16.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.512 2.325 . . . . 0.0 108.256 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -63.53 4.19 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.21 -0.931 . . . . 0.0 115.418 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -155.22 -59.93 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.687 -0.89 . . . . 0.0 109.03 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.83 124.72 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.212 1.482 . . . . 0.0 110.6 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.5 t -112.27 104.83 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.24 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -78.33 104.81 9.16 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mt -90.83 107.37 19.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.401 1.481 . . . . 0.0 107.783 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.35 95.92 10.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 173.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.22 142.9 32.73 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.068 2.147 . . . . 0.0 110.362 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -115.07 136.58 52.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.436 1.094 . . . . 0.0 109.029 167.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -62.56 117.88 6.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.918 1.687 . . . . 0.0 113.543 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.42 61.56 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.789 -1.194 . . . . 0.0 114.095 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -117.4 152.31 35.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.697 1.599 . . . . 0.0 109.64 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.1 m -86.76 149.91 49.38 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 121.305 -0.872 . . . . 0.0 112.367 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 C--N 1.299 -2.073 0 C-N-CA 122.729 2.286 . . . . 0.0 116.226 179.033 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.3 -156.28 0.69 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.398 -0.813 . . . . 0.0 109.807 174.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.434 2.6 t 69.93 96.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 124.969 2.318 . . . . 0.0 113.393 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 79.6 m -149.1 121.8 8.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 -165.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -72.41 139.67 47.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.952 0.901 . . . . 0.0 111.169 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 86' ' ' ARG . 7.7 p . . . . . 0 C--O 1.26 1.639 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 122.415 1.103 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -106.71 111.28 63.95 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 164.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -72.04 119.45 6.19 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 123.272 2.204 . . . . 0.0 111.977 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 16.41 61.27 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.91 126.57 31.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.216 1.008 . . . . 0.0 111.841 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -94.64 130.41 41.12 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.419 1.104 . . . . 0.0 110.627 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.275 0.1 OUTLIER -114.96 113.81 24.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.712 -1.243 . . . . 0.0 108.697 174.229 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.29 81.85 5.47 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.108 0.956 . . . . 0.0 109.342 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.68 143.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.769 2.028 . . . . 0.0 109.466 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.52 130.49 55.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.413 -2.054 . . . . 0.0 110.643 166.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.57 157.58 33.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.225 1.01 . . . . 0.0 108.314 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.77 105.78 13.43 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.957 0.884 . . . . 0.0 109.181 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.37 135.12 45.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.509 1.924 . . . . 0.0 112.992 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -101.88 108.62 20.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.791 -1.193 . . . . 0.0 108.869 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 42.76 49.12 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.619 2.368 . . . . 0.0 116.162 -166.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 45.84 26.81 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.808 -1.183 . . . . 0.0 115.248 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -161.06 117.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.899 1.809 . . . . 0.0 106.138 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.08 -36.05 66.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.292 1.837 . . . . 0.0 107.732 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.03 2.14 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.478 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 47' ' ' ILE . 8.4 pt -127.67 135.36 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.674 1.226 . . . . 0.0 109.566 171.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' HG22 ' B' ' 207' ' ' VAL . 75.6 m -78.94 112.02 15.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.937 1.695 . . . . 0.0 112.507 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.86 131.67 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -132.88 174.05 10.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.956 2.502 . . . . 0.0 108.325 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.87 45.18 76.05 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 118.608 2.203 . . . . 0.0 118.608 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.54 169.81 47.67 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 120.592 -1.534 . . . . 0.0 111.227 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 m -55.74 -19.42 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -48.89 -64.76 0.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -170.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -143.97 -70.19 0.31 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m -42.22 -49.19 4.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.89 2.876 . . . . 0.0 117.67 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -92.34 -1.22 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.943 -1.098 . . . . 0.0 113.769 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 64.65 49.93 2.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.317 1.447 . . . . 0.0 111.745 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 72.12 164.99 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.495 2.318 . . . . 0.0 113.07 -164.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.92 -96.7 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.206 -2.808 . . . . 0.0 118.965 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.59 -117.5 0.68 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.5 tp -145.79 162.15 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 159.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.9 165.62 27.02 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.41 -1.431 . . . . 0.0 108.642 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -80.31 138.19 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.574 1.95 . . . . 0.0 110.643 167.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -95.24 -57.47 2.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.395 -1.441 . . . . 0.0 109.542 159.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.78 134.74 52.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.879 1.272 . . . . 0.0 111.301 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 27' ' ' ILE . 48.7 mm -93.33 133.46 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.25 147.22 33.36 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 121.113 -0.992 . . . . 0.0 111.637 172.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 111.79 3.2 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.952 2.434 . . . . 0.0 112.156 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 67.98 64.2 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.43 -96.92 2.21 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 166.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.61 -38.34 0.66 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 110.342 171.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.53 -42.0 65.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.41 -36.8 61.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.942 1.829 . . . . 0.0 112.535 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -74.56 6.49 3.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.12 -79.26 0.09 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.894 -2.379 . . . . 0.0 106.357 152.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.51 -31.6 1.66 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.271 -0.893 . . . . 0.0 111.179 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -89.07 -20.87 23.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.533 -0.98 . . . . 0.0 111.335 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mt -66.46 130.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 124.859 1.264 . . . . 0.0 110.106 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -155.34 169.79 23.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -161.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -80.03 77.04 6.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.74 -1.225 . . . . 0.0 111.864 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.78 60.05 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.376 0.989 . . . . 0.0 110.839 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.57 -151.52 0.34 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.895 2.078 . . . . 0.0 110.222 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -160.04 121.04 3.08 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 149.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.56 122.73 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.034 -1.667 . . . . 0.0 107.728 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -30.3 9.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.888 -1.133 . . . . 0.0 113.275 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.26 159.01 41.07 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 120.244 1.383 . . . . 0.0 113.64 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 t -137.19 119.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 123.997 0.919 . . . . 0.0 111.856 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.99 34.4 22.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.876 -1.765 . . . . 0.0 113.473 -167.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.17 -5.13 73.33 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.627 1.584 . . . . 0.0 113.834 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.61 106.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 121.008 -1.289 . . . . 0.0 108.297 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.8 p -60.71 137.21 58.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.244 1.018 . . . . 0.0 113.612 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.27 -48.8 55.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.4 1.08 . . . . 0.0 111.143 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 34.5 41.83 0.06 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.248 3.425 . . . . 0.0 120.248 160.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.37 -16.85 2.49 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.129 -1.607 . . . . 0.0 111.88 -165.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.29 132.35 44.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.042 1.877 . . . . 0.0 115.119 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -175.45 2.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -48.03 -52.77 18.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.585 -1.947 . . . . 0.0 115.455 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -74.16 -43.95 55.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.309 -0.869 . . . . 0.0 112.161 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -57.58 -43.6 84.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.11 1.364 . . . . 0.0 114.328 172.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -40.68 95.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.452 -1.405 . . . . 0.0 114.292 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.4 -42.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 121.076 -1.015 . . . . 0.0 111.593 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.91 -44.22 97.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.943 -1.723 . . . . 0.0 114.697 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.8 m -58.93 -26.51 64.44 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.688 1.995 . . . . 0.0 114.83 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -91.24 -46.52 8.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.634 1.574 . . . . 0.0 112.679 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -79.35 -34.9 41.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.999 -1.688 . . . . 0.0 114.569 -172.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.82 35.22 0.68 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.455 1.598 . . . . 0.0 111.888 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.4 p -99.67 -176.81 3.38 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.564 3.146 . . . . 0.0 108.203 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.42 -115.02 0.57 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.264 -1.522 . . . . 0.0 112.069 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.62 -44.88 4.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.246 1.018 . . . . 0.0 110.868 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.48 125.01 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.041 1.4 . . . . 0.0 110.462 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.8 t -114.0 106.49 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -83.36 101.66 11.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.575 1.55 . . . . 0.0 109.155 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.27 115.91 26.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 99.52 12.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.08 148.62 25.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.696 1.999 . . . . 0.0 111.776 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.32 1.448 . . . . 0.0 109.608 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -78.26 99.42 6.27 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.179 -1.575 . . . . 0.0 110.982 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.18 64.57 4.29 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.781 1.182 . . . . 0.0 114.134 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -135.99 137.39 41.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.967 1.307 . . . . 0.0 108.2 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.77 158.61 82.58 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 120.832 -1.168 . . . . 0.0 112.024 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo . . . . . 0 N--CA 1.434 -1.994 0 C-N-CA 122.801 2.334 . . . . 0.0 115.433 -179.5 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 49.9 p90 . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.88 0.847 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 9.3 tp -145.58 159.5 43.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 28' ' ' SER 0.46 3.5 t 64.26 106.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 162.098 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 88.4 m -143.92 120.82 11.31 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 103.039 -2.948 . . . . 0.0 103.039 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -76.39 119.91 20.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.604 1.093 . . . . 0.0 109.62 173.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.26 1.634 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -167.082 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 122.999 1.38 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 9' ' ' LYS . 2.9 mptt -63.65 138.71 97.45 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.533 1.933 . . . . 0.0 115.184 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 9' ' ' LYS . 82.8 Cg_exo -71.27 112.47 3.34 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 123.693 2.355 . . . . 0.0 116.629 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 33.32 9.84 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 123.679 0.657 . . . . 0.0 113.363 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.72 14.81 0.07 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -142.15 128.63 20.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.774 -1.204 . . . . 0.0 108.171 155.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.259 0.1 OUTLIER -132.56 115.14 15.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.88 91.41 8.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.591 1.186 . . . . 0.0 110.282 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.12 154.1 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.71 2.004 . . . . 0.0 108.494 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -130.99 113.24 13.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.212 -2.18 . . . . 0.0 110.322 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.5 mt -119.62 152.15 37.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.587 -1.32 . . . . 0.0 111.001 -170.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.96 117.87 35.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 165.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.54 138.01 54.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.952 -1.092 . . . . 0.0 112.581 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -89.83 103.34 16.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.648 1.213 . . . . 0.0 109.075 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 51.71 44.62 29.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.788 2.435 . . . . 0.0 115.248 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 48.72 26.9 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 119.888 -1.757 . . . . 0.0 114.398 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -161.81 111.55 1.56 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' CD1' HD22 ' A' ' 85' ' ' LEU . 7.2 mt -73.44 -45.19 55.83 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 167.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.52 31.65 0.76 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.089 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.43 124.98 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 122.278 1.037 . . . . 0.0 110.647 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 114.44 17.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.385 1.074 . . . . 0.0 111.481 166.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 127.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -128.16 -179.7 5.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.834 2.453 . . . . 0.0 108.702 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -125.22 7.05 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.346 -1.471 . . . . 0.0 111.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.51 162.64 35.05 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.477 -1.014 . . . . 0.0 114.164 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.03 -32.25 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.399 1.48 . . . . 0.0 113.667 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -72.92 -19.75 61.2 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.53 -1.356 . . . . 0.0 114.569 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.4 p -100.21 -6.09 26.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.763 -1.211 . . . . 0.0 111.803 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t 67.24 83.8 0.16 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.695 2.398 . . . . 0.0 113.817 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.22 27.32 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.671 -1.268 . . . . 0.0 112.708 -167.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.274 32.5 ttp180 73.92 71.43 0.11 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.933 1.693 . . . . 0.0 110.874 -168.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 79.75 -61.35 0.3 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.931 2.093 . . . . 0.0 113.299 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.75 -149.28 6.52 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.18 155.84 22.7 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -157.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.56 161.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -133.94 162.08 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.299 -2.125 . . . . 0.0 106.646 -170.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.98 132.57 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.391 -1.443 . . . . 0.0 110.61 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -90.37 -53.44 4.44 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.44 -1.413 . . . . 0.0 109.161 163.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.96 135.68 31.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.897 0.879 . . . . 0.0 109.49 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.82 128.66 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 pt -76.32 156.87 83.4 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.749 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.38 95.41 0.86 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 122.237 1.958 . . . . 0.0 113.346 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.252 46.9 mtmt 83.88 77.89 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.612 2.365 . . . . 0.0 114.287 166.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.5 -157.68 8.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 168.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.32 1.048 . . . . 0.0 113.719 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.25 86.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.674 1.589 . . . . 0.0 114.226 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -60.3 -38.19 82.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.906 -1.121 . . . . 0.0 111.253 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -70.95 0.52 7.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.45 -74.23 0.19 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.524 -2.61 . . . . 0.0 108.205 156.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.61 -26.22 3.5 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 121.638 -0.664 . . . . 0.0 111.518 167.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -80.52 -24.84 39.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.739 -0.859 . . . . 0.0 112.149 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 132.6 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.011 1.324 . . . . 0.0 112.392 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 41.5 t60 -138.28 -178.44 5.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 173.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 27.0 mttm -78.35 69.21 4.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.573 -1.329 . . . . 0.0 113.157 -168.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 3.31 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -80.37 171.76 14.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.197 1.999 . . . . 0.0 114.005 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.3 ttt-85 -108.24 139.11 43.39 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.843 1.257 . . . . 0.0 109.942 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.28 115.27 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.384 1.874 . . . . 0.0 107.662 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.45 -34.41 10.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.832 -1.792 . . . . 0.0 113.846 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.11 152.68 39.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.773 1.17 . . . . 0.0 113.696 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.63 HG13 HG13 ' A' ' 92' ' ' VAL . 70.0 t -135.72 122.75 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.43 0.692 . . . . 0.0 111.129 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 58.98 28.04 17.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.25 1.02 . . . . 0.0 113.409 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.35 46.06 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.737 1.636 . . . . 0.0 114.015 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.95 96.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 118.761 1.28 . . . . 0.0 110.275 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.3 p -67.49 142.49 56.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.78 68.39 10.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.28 128.01 33.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 109.247 162.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.99 -2.28 65.57 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.754 1.862 . . . . 0.0 117.754 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 135.96 33.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.422 2.111 . . . . 0.0 113.586 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.0 t -109.35 -169.61 1.51 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.5 2.72 . . . . 0.0 106.143 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -49.16 -58.89 4.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.933 2.093 . . . . 0.0 115.103 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -72.23 -42.09 66.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.165 1.46 . . . . 0.0 111.077 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -59.19 -47.34 85.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.954 1.702 . . . . 0.0 113.84 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.55 79.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.94 -51.85 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 121.134 -0.979 . . . . 0.0 111.221 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -56.8 -36.65 70.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 m -69.43 -24.24 63.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.309 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 68' ' ' VAL . 9.8 mt -89.82 -44.41 9.97 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.534 -1.978 . . . . 0.0 111.877 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -78.6 -44.17 24.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 127.743 2.417 . . . . 0.0 116.037 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -81.31 13.35 2.96 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 123.941 1.829 . . . . 0.0 114.503 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -84.15 -176.37 6.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.457 3.103 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.33 -123.88 2.1 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 120.131 -1.605 . . . . 0.0 112.762 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -95.33 -60.26 1.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 111.091 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.26 120.99 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 123.051 1.405 . . . . 0.0 112.109 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.63 HG13 HG13 ' A' ' 68' ' ' VAL . 2.4 t -111.13 110.68 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.054 1.742 . . . . 0.0 107.816 168.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.55 102.82 7.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.929 -1.107 . . . . 0.0 110.312 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 113.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.899 1.279 . . . . 0.0 109.132 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.92 105.36 17.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.359 -0.838 . . . . 0.0 109.197 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.78 145.78 29.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.457 1.503 . . . . 0.0 111.403 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.71 145.96 42.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.48 1.912 . . . . 0.0 106.694 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -72.64 143.48 48.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -71.62 0.74 Allowed Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 126.126 1.822 . . . . 0.0 113.428 167.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -163.91 -35.41 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 169.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.6 m -78.81 152.57 77.57 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 120.648 -1.283 . . . . 0.0 114.171 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 C--N 1.299 -2.033 0 C-N-CA 122.757 2.305 . . . . 0.0 113.121 178.369 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.92 -161.32 0.83 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.663 1.585 . . . . 0.0 112.372 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.412 2.3 t 79.8 112.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 124.221 1.962 . . . . 0.0 113.319 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 38.9 m -145.02 124.99 13.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.515 -3.143 . . . . 0.0 102.515 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -80.83 131.42 35.39 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.257 0.935 . . . . 0.0 110.865 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 -160.143 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 122.42 1.105 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.89 131.9 22.9 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.681 -1.262 . . . . 0.0 107.739 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 135.4 22.76 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 123.461 2.272 . . . . 0.0 111.947 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.77 16.63 80.53 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.58 123.31 27.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.865 1.266 . . . . 0.0 111.942 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -90.04 141.92 28.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.519 1.152 . . . . 0.0 113.636 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.14 119.6 12.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.432 1.493 . . . . 0.0 107.871 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.42 66.88 1.5 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.576 1.15 . . . . 0.0 111.265 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.32 111.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.113 2.165 . . . . 0.0 114.426 -168.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.31 0.2 OUTLIER -96.31 111.95 23.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.781 -1.824 . . . . 0.0 112.86 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.75 159.75 22.5 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.546 1.138 . . . . 0.0 107.984 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.38 24.08 10.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.398 1.094 . . . . 0.0 111.142 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HB3' ' H ' ' A' ' 24' ' ' SER . 30.3 mttt 52.29 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.984 2.914 . . . . 0.0 114.515 -171.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -122.42 81.3 1.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.35 -2.094 . . . . 0.0 106.506 159.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 55.73 64.05 1.86 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.938 2.095 . . . . 0.0 115.15 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.47 46.79 9.53 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.85 -1.156 . . . . 0.0 114.987 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.529 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 47.7 t 178.53 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 8.2 mt -75.54 -38.34 59.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.426 1.89 . . . . 0.0 107.368 169.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.22 14.83 4.38 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.941 168.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.22 125.32 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.263 1.03 . . . . 0.0 110.732 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.446 ' HB3' HG13 ' B' ' 207' ' ' VAL . 45.9 m -78.35 109.27 12.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.717 1.207 . . . . 0.0 110.504 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.35 127.19 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -125.31 167.9 14.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.424 1.49 . . . . 0.0 110.406 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 -125.6 7.07 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.564 1.554 . . . . 0.0 113.183 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.3 167.34 30.12 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.71 -12.87 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.163 -1.787 . . . . 0.0 113.554 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -60.27 -31.54 70.33 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.83 2.052 . . . . 0.0 113.969 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 m -100.2 -33.14 10.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.217 -1.552 . . . . 0.0 109.633 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.288 8.1 t 97.47 119.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.408 2.683 . . . . 0.0 109.474 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG13 ' CZ ' ' A' ' 43' ' ' TYR . 14.6 t -126.41 70.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -168.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.4 ttt-85 69.85 -68.78 0.19 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.491 1.916 . . . . 0.0 113.32 -172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -136.92 -11.79 1.73 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.351 1.461 . . . . 0.0 111.202 172.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.59 130.13 1.99 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 -162.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.82 170.49 33.52 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.42 167.31 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.406 ' CZ ' HG13 ' A' ' 37' ' ' VAL . 13.9 m-85 -136.14 156.5 48.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.559 -1.963 . . . . 0.0 107.12 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 47' ' ' ILE . 3.4 t -80.57 130.46 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.262 -1.524 . . . . 0.0 112.015 165.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -91.89 -38.68 12.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.417 -1.427 . . . . 0.0 112.531 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.3 136.08 22.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.7 -1.25 . . . . 0.0 112.129 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 HD13 HG11 ' A' ' 44' ' ' VAL . 25.3 mm -96.75 143.32 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.026 2.131 . . . . 0.0 108.008 175.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 pt -107.59 146.5 33.47 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 120.72 -1.238 . . . . 0.0 113.827 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.64 69.22 8.05 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -103.76 -68.77 0.83 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 110.753 170.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.6 23.19 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.741 0 O-C-N 120.845 -1.159 . . . . 0.0 115.422 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . -118.38 -82.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.29 -1.123 . . . . 0.0 109.047 174.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.52 78.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.66 -35.6 81.07 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.6 -1.938 . . . . 0.0 111.741 170.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.27 2.58 24.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.15 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.859 -1.776 . . . . 0.0 108.476 160.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 -41.79 0.29 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.783 -1.198 . . . . 0.0 111.186 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.9 mtm-85 -87.42 -17.35 32.46 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.58 133.45 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.676 -1.265 . . . . 0.0 112.293 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.505 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 21.9 t-80 -129.24 -165.18 1.48 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.939 0.896 . . . . 0.0 108.604 170.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 43.2 pttt -102.71 44.79 0.99 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.852 -1.78 . . . . 0.0 112.229 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.68 33.97 0.16 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -97.74 178.19 5.23 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.358 1.063 . . . . 0.0 109.667 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -114.33 128.63 56.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.745 -1.847 . . . . 0.0 108.698 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.36 110.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.378 -1.452 . . . . 0.0 107.27 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -48.58 7.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.507 -1.996 . . . . 0.0 112.348 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -136.79 160.87 37.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.882 -1.136 . . . . 0.0 113.479 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.451 HG13 HG13 ' A' ' 92' ' ' VAL . 47.4 t -134.0 112.94 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 123.964 0.905 . . . . 0.0 111.285 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 58.74 26.82 15.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.138 -1.601 . . . . 0.0 113.536 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 12.98 83.66 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.702 -1.249 . . . . 0.0 113.705 -171.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.85 100.27 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -68.14 148.46 50.88 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 121.109 -0.995 . . . . 0.0 110.091 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.561 2.059 . . . . 0.0 116.561 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 61.29 51.63 4.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.334 1.54 . . . . 0.0 112.314 169.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.58 35.0 80.03 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.087 -1.633 . . . . 0.0 115.617 -173.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.65 151.99 23.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.541 1.639 . . . . 0.0 113.13 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.503 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 64.5 p -104.2 -158.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.161 2.585 . . . . 0.0 109.381 -169.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -60.21 -51.3 70.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.191 -1.568 . . . . 0.0 112.471 161.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -70.69 -46.14 63.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.126 0.971 . . . . 0.0 111.983 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HB2' ' H ' ' A' ' 77' ' ' THR . 65.9 mt-30 -66.57 -34.38 77.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.993 -1.067 . . . . 0.0 113.454 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.11 93.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.313 1.87 . . . . 0.0 114.288 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.8 -50.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.909 0.884 . . . . 0.0 111.596 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -59.26 -40.53 86.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.346 -1.471 . . . . 0.0 113.874 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -59.78 -30.36 68.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.623 1.969 . . . . 0.0 113.428 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -89.96 -42.05 11.4 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.342 1.857 . . . . 0.0 113.78 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -24.87 24.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -90.05 24.5 2.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.276 -2.14 . . . . 0.0 112.907 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 p -94.38 162.39 13.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.655 2.782 . . . . 0.0 112.409 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.37 65.02 3.44 Favored Glycine 0 N--CA 1.431 -1.695 0 O-C-N 120.528 -1.358 . . . . 0.0 113.718 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.271 28.1 tt0 68.33 -55.24 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.0 115.368 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.75 132.6 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.381 1.086 . . . . 0.0 110.625 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.451 HG13 HG13 ' A' ' 68' ' ' VAL . 23.1 t -126.3 108.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -77.35 108.04 10.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.906 -1.121 . . . . 0.0 108.445 163.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.0 105.29 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.538 -1.351 . . . . 0.0 109.486 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.07 93.96 8.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mt -98.59 139.71 33.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.877 2.071 . . . . 0.0 109.703 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -109.47 135.96 49.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 106.798 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -69.1 115.27 8.2 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.755 1.222 . . . . 0.0 112.021 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.89 37.23 3.43 Favored Glycine 0 N--CA 1.432 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 115.041 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -115.03 151.93 33.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.801 1.24 . . . . 0.0 111.221 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.72 140.11 33.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 125.561 1.544 . . . . 0.0 110.501 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo . . . . . 0 N--CA 1.434 -2.024 0 C-N-CA 122.919 2.413 . . . . 0.0 115.273 -179.191 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 122.896 1.331 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.441 ' CD2' ' H ' ' B' ' 206' ' ' LEU . 0.3 OUTLIER -83.94 -143.18 0.08 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.093 1.757 . . . . 0.0 112.721 178.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' A' ' 28' ' ' SER 0.418 2.1 t 76.02 106.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.56 2.124 . . . . 0.0 113.358 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -141.31 122.26 14.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.795 -3.039 . . . . 0.0 102.795 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 41.5 m -78.0 129.26 35.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.261 1.684 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -163.213 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 122.465 1.126 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -106.86 119.41 51.48 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.378 -1.451 . . . . 0.0 109.765 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -64.79 124.17 12.77 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.462 2.108 . . . . 0.0 113.568 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.21 19.97 50.92 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.394 1.473 . . . . 0.0 115.082 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.78 116.77 17.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 119.444 1.622 . . . . 0.0 111.89 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 p -90.42 142.08 28.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.091 1.424 . . . . 0.0 112.715 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.82 116.51 18.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -89.57 83.99 6.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.911 1.339 . . . . 0.0 109.741 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -80.84 110.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 126.947 2.099 . . . . 0.0 112.99 -173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.64 121.67 41.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.101 -2.249 . . . . 0.0 109.531 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -122.04 172.81 7.96 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.089 0.956 . . . . 0.0 109.9 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.23 122.17 23.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 161.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 10.7 ptpt -67.02 160.46 26.48 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.442 1.897 . . . . 0.0 114.805 -177.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -115.75 106.94 14.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.163 1.385 . . . . 0.0 108.924 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.88 55.0 9.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.641 2.376 . . . . 0.0 114.503 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.62 48.55 61.63 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 119.974 -1.704 . . . . 0.0 114.982 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 m -172.01 111.05 0.28 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 -172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -72.73 -36.68 67.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.876 2.07 . . . . 0.0 108.101 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.04 38.15 1.73 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.425 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.45 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 121.838 0.828 . . . . 0.0 110.222 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.413 ' HB3' HG13 ' B' ' 207' ' ' VAL . 74.7 m -85.27 114.11 22.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.16 129.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 t -121.25 164.27 17.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.769 2.428 . . . . 0.0 111.023 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.51 -145.85 18.22 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 125.397 1.475 . . . . 0.0 111.854 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.64 153.87 23.71 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.062 1.315 . . . . 0.0 111.929 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.05 -2.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.779 1.631 . . . . 0.0 115.315 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.42 -20.97 63.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.766 -1.834 . . . . 0.0 111.869 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -123.07 172.48 8.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 p -86.72 68.47 10.14 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.919 -1.738 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.46 -39.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 124.821 1.248 . . . . 0.0 109.339 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -162.34 -101.58 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -128.32 -12.31 5.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.637 -1.289 . . . . 0.0 112.914 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.17 115.58 0.6 Allowed Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.82 168.4 34.76 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 104.577 -3.409 . . . . 0.0 104.577 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 65' ' ' VAL 0.256 4.4 tp -129.13 163.0 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -138.84 160.94 38.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 47' ' ' ILE . 88.5 t -80.69 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.302 -1.499 . . . . 0.0 110.393 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -88.13 -55.85 3.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.136 -1.602 . . . . 0.0 110.208 166.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.42 139.64 25.72 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.103 0.954 . . . . 0.0 110.782 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD11 HG11 ' A' ' 44' ' ' VAL . 36.4 mm -91.23 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.552 1.541 . . . . 0.0 107.042 173.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 pt -85.75 166.83 27.64 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 121.435 -0.79 . . . . 0.0 112.505 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.12 93.71 1.08 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.58 2.187 . . . . 0.0 113.457 166.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.334 48.6 mtmt 74.12 84.33 0.11 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.354 2.262 . . . . 0.0 116.59 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -110.01 -107.35 3.05 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 158.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.36 -40.44 0.73 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.746 1.219 . . . . 0.0 112.606 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.44 83.52 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -48.09 -36.85 13.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.716 1.606 . . . . 0.0 114.172 167.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 t -73.14 4.25 4.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.66 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.462 -2.024 . . . . 0.0 108.249 155.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.37 -23.69 2.04 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.323 -0.86 . . . . 0.0 112.562 164.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mtt85 -77.56 -31.78 53.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.806 1.242 . . . . 0.0 112.18 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -67.49 143.72 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.244 1.818 . . . . 0.0 113.966 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 44.6 t60 -142.44 -167.03 2.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.975 -1.078 . . . . 0.0 109.628 170.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 58.3 mttp -80.06 53.97 1.82 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.859 -1.776 . . . . 0.0 113.255 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.28 -35.08 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.823 -1.798 . . . . 0.0 114.998 -169.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.38 156.29 32.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -167.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 117.37 33.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.292 1.437 . . . . 0.0 110.19 -170.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 42' ' ' ILE . 2.7 p -93.46 125.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.255 1.503 . . . . 0.0 109.504 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -37.16 9.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.967 1.307 . . . . 0.0 112.214 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.12 157.11 44.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.68 115.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 124.36 1.064 . . . . 0.0 111.541 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.94 23.13 6.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -168.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.8 12.7 68.36 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.795 -1.19 . . . . 0.0 113.859 -171.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.33 99.27 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.6 p -61.95 139.12 58.42 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 125.832 1.653 . . . . 0.0 113.573 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.26 47.32 1.32 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.708 -1.245 . . . . 0.0 112.66 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -74.59 115.04 13.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.663 -1.898 . . . . 0.0 110.695 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.85 84.92 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.793 -1.192 . . . . 0.0 115.07 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.98 136.3 33.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.847 1.823 . . . . 0.0 112.95 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -95.44 -161.37 0.86 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.087 2.155 . . . . 0.0 109.836 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' B' ' 205' ' ' TYR . 79.3 t60 -64.3 -56.25 15.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.008 -1.682 . . . . 0.0 111.628 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -66.96 -38.73 86.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -67.12 -36.17 81.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.971 -1.706 . . . . 0.0 113.908 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.23 90.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.487 -2.008 . . . . 0.0 113.782 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -55.93 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 124.0 0.92 . . . . 0.0 110.461 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.06 -33.48 57.56 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.5 m -68.67 -36.47 78.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.827 2.051 . . . . 0.0 112.006 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.4 mt -89.29 -34.57 16.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.808 1.643 . . . . 0.0 114.934 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -45.29 17.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.965 1.706 . . . . 0.0 112.445 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -90.0 47.48 1.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.858 -1.777 . . . . 0.0 112.227 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.6 p -107.31 -166.62 1.17 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.988 2.115 . . . . 0.0 110.524 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.73 -93.92 1.25 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.078 -1.639 . . . . 0.0 114.647 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -132.91 -53.01 0.92 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.072 1.349 . . . . 0.0 109.519 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.06 139.84 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.472 -1.392 . . . . 0.0 110.89 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.21 121.82 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -86.46 105.82 17.04 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.66 1.184 . . . . 0.0 109.969 166.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mt -87.24 110.8 20.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.333 -1.48 . . . . 0.0 109.652 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 97.94 11.16 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.728 -1.232 . . . . 0.0 108.44 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -101.54 141.33 34.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.075 2.15 . . . . 0.0 110.901 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -108.27 141.09 40.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.461 1.904 . . . . 0.0 107.488 166.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -59.42 119.58 7.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.236 1.814 . . . . 0.0 113.917 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 65.5 4.12 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 120.671 -1.268 . . . . 0.0 114.457 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.34 151.44 44.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.199 1.399 . . . . 0.0 111.83 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.6 m -92.39 157.4 40.44 Favored Pre-proline 0 N--CA 1.431 -1.419 0 C-N-CA 124.734 1.214 . . . . 0.0 109.323 164.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.3 -2.008 0 C-N-CA 122.624 2.216 . . . . 0.0 114.022 -179.429 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 205' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 41.5 p90 . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 122.251 1.024 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp -99.34 155.8 17.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.907 -1.121 . . . . 0.0 109.145 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 28' ' ' SER 0.417 2.1 t 70.82 104.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 124.553 2.12 . . . . 0.0 114.633 164.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.8 m -142.48 121.99 13.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.325 -2.842 . . . . 0.0 103.325 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 7.4 m -76.21 126.43 30.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.626 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.431 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -122.74 151.71 60.99 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 121.069 -1.019 . . . . 0.0 111.991 -171.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.61 154.73 27.36 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 122.913 2.076 . . . . 0.0 113.109 171.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.72 53.02 41.83 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 125.654 1.597 . . . . 0.0 114.544 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.91 98.5 6.52 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 121.569 -0.959 . . . . 0.0 108.433 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -94.81 131.5 40.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.222 -0.923 . . . . 0.0 109.762 168.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 121.4 35.49 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.823 1.249 . . . . 0.0 108.353 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -98.7 79.36 2.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.317 1.532 . . . . 0.0 108.836 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.91 115.55 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.323 2.249 . . . . 0.0 111.581 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.266 3.1 pt-20 -105.87 115.45 30.25 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.221 -2.174 . . . . 0.0 110.276 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -117.28 160.66 20.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.885 1.274 . . . . 0.0 109.568 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.92 105.3 11.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -66.84 145.88 55.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -173.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 t -99.48 110.64 23.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.563 1.545 . . . . 0.0 109.068 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t70 58.11 20.41 6.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.57 1.948 . . . . 0.0 116.017 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 57.6 2.02 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.008 -1.682 . . . . 0.0 112.654 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -173.93 112.72 0.19 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 126.207 1.803 . . . . 0.0 106.823 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.6 mt -74.88 -40.15 61.09 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.413 1.885 . . . . 0.0 106.219 165.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 112.45 40.63 1.11 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.474 170.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 47' ' ' ILE . 21.8 pt -131.68 127.92 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.298 1.047 . . . . 0.0 110.585 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -80.41 123.28 27.9 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.644 1.177 . . . . 0.0 111.515 167.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.72 145.79 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.98 170.74 15.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.349 1.46 . . . . 0.0 109.074 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.12 -133.29 11.71 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.882 1.229 . . . . 0.0 113.615 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.47 161.57 34.82 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 124.753 1.168 . . . . 0.0 112.551 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.15 -14.36 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.45 -1.618 . . . . 0.0 115.03 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -63.69 -47.48 81.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.724 1.609 . . . . 0.0 114.447 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 m -161.73 120.15 2.33 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.375 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t 69.08 77.25 0.23 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 164.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 m -137.11 -165.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.285 1.834 . . . . 0.0 108.386 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -76.64 -63.26 1.38 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.969 -1.707 . . . . 0.0 109.298 162.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -157.35 -15.0 0.09 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.43 94.66 0.1 Allowed Glycine 0 N--CA 1.431 -1.639 0 O-C-N 119.273 -2.142 . . . . 0.0 112.69 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.64 41.92 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 105.153 -3.179 . . . . 0.0 105.153 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.49 HG22 HG13 ' A' ' 65' ' ' VAL 0.262 3.8 tp -118.73 158.09 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 166.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.94 158.05 45.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.7 t -86.76 138.6 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.227 -1.546 . . . . 0.0 110.732 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -101.51 -74.05 0.63 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.509 -1.369 . . . . 0.0 109.955 167.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.21 124.82 50.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.142 0.972 . . . . 0.0 111.534 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.0 mm -90.21 133.92 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.274 1.83 . . . . 0.0 108.562 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' HA2' ' A' ' 26' ' ' GLY . 73.4 mt -79.88 136.47 54.6 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 116.047 -1.93 . . . . 0.0 109.771 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -59.98 107.41 0.4 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.181 2.587 . . . . 0.0 112.853 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.256 83.0 mttt 31.52 73.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.97 -76.96 1.02 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.56 -45.33 0.49 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.435 1.094 . . . . 0.0 109.649 166.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 -45.71 69.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -56.15 -36.08 67.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.132 -1.605 . . . . 0.0 111.933 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -71.31 3.04 4.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.67 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.982 1.719 . . . . 0.0 108.83 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.77 -41.49 0.19 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.562 -1.336 . . . . 0.0 111.903 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -84.92 -26.82 27.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.9 mt -65.69 129.09 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 125.174 1.39 . . . . 0.0 114.6 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -132.95 177.71 7.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.731 2.013 . . . . 0.0 110.683 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -71.01 77.03 0.66 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.376 -1.452 . . . . 0.0 113.463 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.81 19.18 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -85.58 165.0 17.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 119.175 1.488 . . . . 0.0 112.147 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 120.72 43.32 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.679 1.191 . . . . 0.0 110.598 -171.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 42' ' ' ILE . 5.8 p -95.84 122.63 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.178 -1.577 . . . . 0.0 110.658 171.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.0 -36.42 11.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.304 -1.497 . . . . 0.0 111.366 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 155.82 43.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.993 -1.067 . . . . 0.0 113.049 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -131.42 118.52 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.328 -0.857 . . . . 0.0 111.504 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.34 30.78 20.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.266 1.426 . . . . 0.0 112.77 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.51 79.82 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.444 -1.41 . . . . 0.0 114.251 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.35 104.91 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.462 1.505 . . . . 0.0 107.661 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.8 p -64.27 144.76 56.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.21 40.22 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.217 1.407 . . . . 0.0 112.793 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.54 118.48 16.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.117 -1.615 . . . . 0.0 111.305 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.24 88.64 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.063 -1.023 . . . . 0.0 114.846 -174.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.17 140.81 29.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.736 1.732 . . . . 0.0 113.262 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.04 -174.17 2.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -45.93 -50.9 14.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.086 2.154 . . . . 0.0 114.863 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -70.04 -44.31 69.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.787 0.835 . . . . 0.0 112.428 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.89 -37.75 76.11 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.005 -1.059 . . . . 0.0 112.459 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.4 97.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.702 -1.249 . . . . 0.0 113.71 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.3 t -57.0 -53.63 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 123.45 0.7 . . . . 0.0 111.388 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.37 -31.39 67.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.8 m -71.6 -26.21 62.5 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.774 2.029 . . . . 0.0 112.896 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.52 -46.65 8.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.007 1.723 . . . . 0.0 114.275 168.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -32.9 22.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.31 1.844 . . . . 0.0 115.064 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -91.4 41.66 1.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.999 -2.313 . . . . 0.0 111.589 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.9 p -102.84 160.86 14.23 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.681 1.992 . . . . 0.0 108.975 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.5 -70.36 1.11 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.31 -1.494 . . . . 0.0 113.906 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -153.57 -52.73 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.968 -0.724 . . . . 0.0 109.407 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.14 130.53 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.658 1.218 . . . . 0.0 112.049 171.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.24 109.8 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.425 1.09 . . . . 0.0 108.063 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -83.02 109.75 17.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.777 -1.202 . . . . 0.0 109.418 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -89.54 110.1 20.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.55 1.14 . . . . 0.0 108.506 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.15 93.49 9.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.96 144.13 28.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.335 1.854 . . . . 0.0 110.577 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -111.54 144.02 41.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.901 1.68 . . . . 0.0 107.075 164.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 100' ' ' GLN . 1.1 pptt? -53.64 130.39 36.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.482 1.913 . . . . 0.0 115.089 172.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.64 43.76 3.2 Favored Glycine 0 N--CA 1.428 -1.842 0 O-C-N 118.807 -2.433 . . . . 0.0 112.003 171.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.429 ' H ' ' HD2' ' A' ' 98' ' ' LYS . 4.2 tp-100 -118.11 143.33 46.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.995 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -82.9 126.88 71.71 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 125.233 1.413 . . . . 0.0 110.727 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.3 -2.003 0 C-N-CA 122.467 2.111 . . . . 0.0 114.795 171.158 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 123.068 1.413 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.525 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.8 tp -161.59 -154.39 0.34 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 176.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.525 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.443 29.4 m 53.74 82.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.159 2.184 . . . . 0.0 116.667 166.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 94.6 m -118.7 114.31 22.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -170.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.3 m -83.09 124.52 30.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 122.907 0.483 . . . . 0.0 110.118 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.628 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -136.76 161.84 59.4 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 149.43 64.7 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 CA-C-N 121.913 1.719 . . . . 0.0 111.534 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.06 9.29 60.88 Favored Glycine 0 N--CA 1.429 -1.785 0 O-C-N 121.523 -0.735 . . . . 0.0 114.831 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -86.76 104.75 16.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.62 -1.518 . . . . 0.0 110.252 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p -96.1 147.09 24.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.56 1.544 . . . . 0.0 112.785 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.48 116.49 14.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.859 1.263 . . . . 0.0 109.107 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.52 81.61 5.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.311 1.529 . . . . 0.0 112.677 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.63 114.68 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 126.651 1.98 . . . . 0.0 112.219 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.55 113.05 26.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.762 -1.836 . . . . 0.0 110.744 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.24 161.49 25.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.78 -1.2 . . . . 0.0 110.28 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.89 117.04 29.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 163.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -49.27 130.76 19.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.33 1.852 . . . . 0.0 114.711 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -96.95 109.9 22.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.775 1.63 . . . . 0.0 107.955 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.57 26.84 11.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.21 2.204 . . . . 0.0 115.3 -171.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.71 64.74 2.09 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.115 -1.616 . . . . 0.0 112.437 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 174.58 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.72 -45.52 36.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.347 2.022 . . . . 0.0 106.472 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.0 32.02 0.89 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 113.672 -1.604 . . . . 0.0 111.568 169.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.0 pt -113.0 129.93 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.884 0.849 . . . . 0.0 109.74 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -83.07 112.45 19.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.286 1.035 . . . . 0.0 110.031 161.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.93 138.32 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.3 t -131.26 167.83 18.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.111 -1.618 . . . . 0.0 108.763 172.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.52 -140.49 18.96 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 124.641 1.115 . . . . 0.0 113.62 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.2 155.43 31.69 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 124.476 1.036 . . . . 0.0 110.56 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 t -43.19 -38.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 126.853 2.061 . . . . 0.0 114.959 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.59 -41.19 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.811 2.044 . . . . 0.0 114.697 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -87.62 -13.64 42.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.404 1.882 . . . . 0.0 112.335 -165.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.305 22.4 m 84.65 80.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.581 1.952 . . . . 0.0 112.762 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.89 57.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.814 1.246 . . . . 0.0 110.393 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.44 -67.09 0.23 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.747 1.619 . . . . 0.0 112.532 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -131.41 -79.23 0.52 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.351 1.86 . . . . 0.0 106.784 171.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.38 -126.86 1.41 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 173.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.31 168.75 24.15 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.574 -0.956 . . . . 0.0 112.014 -164.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.551 HG22 HG13 ' A' ' 65' ' ' VAL . 3.3 tp -124.95 160.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.55 153.89 43.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -168.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.456 HG11 HD13 ' A' ' 47' ' ' ILE . 8.5 t -84.37 138.28 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.159 -2.213 . . . . 0.0 111.789 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -94.47 -58.48 2.19 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.778 -1.201 . . . . 0.0 109.603 166.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.17 51.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.377 -0.827 . . . . 0.0 111.647 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.456 HD13 HG11 ' A' ' 44' ' ' VAL . 37.4 mm -96.17 125.43 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.074 1.35 . . . . 0.0 108.439 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.0 pt -85.37 154.58 59.78 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 120.733 -1.23 . . . . 0.0 112.772 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 70.69 7.26 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 C-N-CA 122.479 2.119 . . . . 0.0 112.641 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -115.82 -86.76 0.61 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.469 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.29 48.79 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.86 -63.41 1.27 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 118.946 1.373 . . . . 0.0 108.554 153.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -45.73 75.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.062 -1.649 . . . . 0.0 113.451 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -19.63 65.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.524 -1.36 . . . . 0.0 112.977 172.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 t -69.11 -22.18 63.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.5 -89.94 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.199 -1.563 . . . . 0.0 110.32 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.84 -3.79 9.22 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.916 -1.115 . . . . 0.0 113.197 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -84.57 -27.94 26.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.013 -1.287 . . . . 0.0 108.399 161.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.13 128.6 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.619 1.567 . . . . 0.0 112.761 166.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -133.74 -155.82 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -90.36 81.73 6.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.201 -2.187 . . . . 0.0 112.894 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.06 39.97 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 118.854 2.301 . . . . 0.0 118.854 164.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -98.19 163.57 12.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.539 1.536 . . . . 0.0 110.943 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -89.26 125.48 35.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.569 -1.332 . . . . 0.0 108.395 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 42' ' ' ILE 0.26 2.9 p -102.48 120.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 -28.93 11.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.796 -1.19 . . . . 0.0 112.124 -173.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.46 161.69 42.26 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 121.635 -0.666 . . . . 0.0 112.459 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.6 122.82 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 121.269 -0.895 . . . . 0.0 110.54 -176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 60.61 26.8 16.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.439 1.927 . . . . 0.0 113.353 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.04 -0.57 89.39 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 125.713 1.625 . . . . 0.0 114.085 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.03 101.88 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.805 1.242 . . . . 0.0 108.132 -172.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -62.6 136.92 58.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.852 -1.155 . . . . 0.0 113.659 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.85 -43.81 91.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.065 0.946 . . . . 0.0 113.512 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 28.22 79.6 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.361 2.664 . . . . 0.0 117.939 158.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.66 -22.32 30.55 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.021 1.296 . . . . 0.0 114.69 -170.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.37 141.43 57.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -98.93 -153.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.814 2.046 . . . . 0.0 110.061 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -73.28 -50.68 20.88 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.8 -1.813 . . . . 0.0 110.918 167.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -64.32 -44.74 90.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.531 0.732 . . . . 0.0 112.757 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -31.87 72.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.641 -1.287 . . . . 0.0 114.25 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.09 94.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.319 -2.113 . . . . 0.0 114.756 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 86' ' ' ARG . 73.3 t -55.08 -56.24 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.197 0.999 . . . . 0.0 110.049 170.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 28.3 tt0 -48.04 -46.99 33.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 175.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.5 m -62.47 -31.92 72.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.821 2.448 . . . . 0.0 113.58 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.25 -40.78 13.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.53 -1.981 . . . . 0.0 113.668 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 82' ' ' VAL . 4.4 ppt_? -80.01 -38.74 31.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -166.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.64 29.7 1.12 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.87 -1.769 . . . . 0.0 111.705 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 60.7 p -96.43 151.47 19.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.748 2.819 . . . . 0.0 109.854 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.25 -58.12 4.44 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.687 -1.258 . . . . 0.0 114.643 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -150.93 -67.52 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.651 -0.911 . . . . 0.0 112.297 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.96 128.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.643 1.211 . . . . 0.0 111.086 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -124.11 103.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.92 1.688 . . . . 0.0 106.977 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -81.37 103.61 11.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.768 -1.207 . . . . 0.0 109.379 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.04 115.8 22.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.461 -1.4 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.25 95.1 9.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.09 151.31 19.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.825 2.05 . . . . 0.0 110.708 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.37 147.67 49.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.522 1.129 . . . . 0.0 108.402 164.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -50.02 117.78 2.52 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.814 1.646 . . . . 0.0 114.511 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.36 70.46 3.15 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.803 -1.186 . . . . 0.0 113.073 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -124.75 158.85 32.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.646 1.178 . . . . 0.0 110.382 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.06 143.62 43.01 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 117.718 -1.134 . . . . 0.0 109.749 168.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo . . . . . 0 N--CA 1.433 -2.057 0 CA-C-N 123.293 2.212 . . . . 0.0 114.913 176.23 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 15.2 tp 78.74 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.238 2.615 . . . . 0.0 109.343 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.678 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.341 8.8 m 21.72 80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 130.948 3.699 . . . . 0.0 117.636 160.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 44.2 m -118.94 121.38 39.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.8 p -79.14 127.89 32.6 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.563 1.145 . . . . 0.0 110.508 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 86' ' ' ARG . 14.9 p . . . . . 0 C--O 1.26 1.655 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -160.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 121.532 0.682 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -129.06 163.06 48.34 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 126.778 2.031 . . . . 0.0 109.055 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.05 159.36 47.92 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.047 2.124 . . . . 0.0 113.175 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.71 0.16 87.87 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.06 98.83 9.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.038 1.419 . . . . 0.0 113.618 -164.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p -91.51 155.58 18.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.474 -1.392 . . . . 0.0 110.948 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 121.48 16.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.398 1.079 . . . . 0.0 108.908 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -98.88 77.83 2.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.278 1.031 . . . . 0.0 109.729 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.4 t -84.4 132.24 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.871 2.868 . . . . 0.0 113.316 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -110.51 124.75 52.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.886 -2.384 . . . . 0.0 111.8 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.52 150.87 48.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.576 -1.327 . . . . 0.0 110.375 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.11 104.97 12.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 122.181 0.991 . . . . 0.0 108.74 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.709 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.72 140.51 49.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.257 1.576 . . . . 0.0 115.257 -172.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 t -99.38 95.19 6.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.412 1.577 . . . . 0.0 110.138 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t70 56.73 58.11 4.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.753 2.021 . . . . 0.0 113.936 -174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.94 52.21 49.75 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 114.392 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -167.73 98.08 0.47 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.491 1.615 . . . . 0.0 107.647 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.709 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.3 mt -73.53 -42.22 62.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.364 1.866 . . . . 0.0 106.753 168.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.7 43.65 0.95 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.295 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 47' ' ' ILE . 32.3 pt -125.4 136.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 121.754 0.788 . . . . 0.0 109.462 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.402 ' HB3' HG22 ' B' ' 207' ' ' VAL . 4.1 m -82.25 118.09 22.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.941 -1.1 . . . . 0.0 111.716 161.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.48 120.46 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -119.21 163.23 17.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.694 2.798 . . . . 0.0 109.796 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.1 -147.75 19.8 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 124.627 1.108 . . . . 0.0 112.412 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.27 158.48 19.67 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.104 1.335 . . . . 0.0 111.01 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.6 -18.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.425 -1.633 . . . . 0.0 114.752 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -70.77 -26.87 63.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.365 -0.835 . . . . 0.0 112.298 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.15 12.45 30.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.242 1.017 . . . . 0.0 110.792 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.279 99.2 p 47.08 79.55 0.06 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 117.784 2.512 . . . . 0.0 117.784 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -110.23 116.43 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 120.643 -1.286 . . . . 0.0 108.206 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 36.97 -103.36 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.875 2.07 . . . . 0.0 115.167 -163.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -132.16 38.74 3.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.786 -1.196 . . . . 0.0 112.145 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.78 107.51 3.06 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-O 122.926 1.292 . . . . 0.0 116.263 166.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -175.83 179.77 46.78 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 42' ' ' ILE . 3.6 tp -118.3 162.41 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -141.81 165.1 28.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 47' ' ' ILE . 6.3 t -89.02 135.93 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.494 -1.379 . . . . 0.0 112.338 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -73.04 0.55 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.98 -1.075 . . . . 0.0 108.929 164.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.57 126.01 51.72 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.444 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.443 HD13 HG22 ' A' ' 27' ' ' ILE . 25.9 mm -82.69 125.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 161.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -88.91 153.74 49.62 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.248 175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.34 106.6 1.05 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.592 2.195 . . . . 0.0 113.754 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.322 30.4 pttt 45.5 62.8 2.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.241 3.016 . . . . 0.0 117.893 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.06 -81.9 0.82 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 120.822 -1.174 . . . . 0.0 111.064 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 -38.58 0.4 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.347 1.059 . . . . 0.0 110.365 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.6 57.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.469 1.908 . . . . 0.0 115.753 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -53.6 -43.28 68.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.864 1.316 . . . . 0.0 111.353 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -69.02 5.91 1.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 -78.15 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.385 -1.447 . . . . 0.0 108.944 156.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -39.51 0.45 Allowed Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -93.86 -19.6 20.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 mt -72.57 127.49 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.109 -1.619 . . . . 0.0 113.018 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -125.64 -178.32 4.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.949 1.3 . . . . 0.0 109.045 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -79.06 82.98 5.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 0.0 112.114 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.12 -8.71 0.33 Allowed Glycine 0 N--CA 1.431 -1.655 0 O-C-N 120.122 -1.611 . . . . 0.0 115.815 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.12 157.03 36.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 119.205 1.503 . . . . 0.0 114.266 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.65 132.51 36.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.911 1.284 . . . . 0.0 109.374 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 t -92.39 117.47 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 160.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -31.53 11.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.666 -1.896 . . . . 0.0 112.218 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.56 160.51 43.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.341 -0.849 . . . . 0.0 112.13 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.62 118.58 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 111.037 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.52 26.77 14.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.178 -1.577 . . . . 0.0 113.946 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.59 85.46 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.165 -0.959 . . . . 0.0 113.765 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.04 101.23 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 121.25 -1.147 . . . . 0.0 108.205 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 p -56.97 124.1 17.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.748 2.019 . . . . 0.0 112.759 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.12 -46.29 78.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.934 -1.104 . . . . 0.0 113.664 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 6.01 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.922 3.689 . . . . 0.0 117.68 167.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.8 -23.05 5.08 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.562 -1.336 . . . . 0.0 113.461 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.77 141.82 39.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.1 p -98.13 -161.6 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.789 1.635 . . . . 0.0 108.422 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -59.62 -48.0 83.37 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 119.874 -1.766 . . . . 0.0 112.511 164.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -71.04 -45.1 64.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.285 1.434 . . . . 0.0 111.68 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.52 -33.35 72.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.366 -1.459 . . . . 0.0 114.262 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.85 88.89 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.663 -1.898 . . . . 0.0 114.402 172.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.7 t -54.48 -54.3 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.919 0.888 . . . . 0.0 111.047 171.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 55.0 mt-10 -59.06 -37.56 77.34 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 m -61.97 -27.72 69.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.358 1.863 . . . . 0.0 112.204 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.25 -41.93 10.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.473 1.509 . . . . 0.0 114.525 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HB3' HG23 ' B' ' 210' ' ' VAL 0.293 0.0 OUTLIER -88.7 -32.25 18.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -165.52 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -88.6 39.54 0.92 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.666 1.222 . . . . 0.0 111.647 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.0 p -105.81 170.81 7.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.696 1.999 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.22 -92.17 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 114.101 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -133.44 -48.22 0.83 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.552 -1.558 . . . . 0.0 109.263 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.31 121.12 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.976 1.37 . . . . 0.0 111.242 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.61 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -87.16 99.97 12.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.769 2.027 . . . . 0.0 107.486 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.06 124.59 31.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.363 -1.461 . . . . 0.0 109.892 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.39 100.55 13.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 146.32 26.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.47 1.908 . . . . 0.0 111.431 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -124.02 144.1 50.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.244 1.417 . . . . 0.0 108.807 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 130.52 15.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 72.05 2.46 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 119.767 -1.833 . . . . 0.0 113.538 168.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -162.14 157.76 23.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.75 152.46 37.81 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.176 -1.578 . . . . 0.0 110.418 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.3 -2.016 0 CA-C-N 123.527 2.295 . . . . 0.0 113.973 166.407 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 50.0 t80 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.57 -173.41 3.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.224 -0.923 . . . . 0.0 112.394 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 28' ' ' SER 0.405 3.8 t 71.33 114.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 124.22 1.962 . . . . 0.0 113.567 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 54.2 m -153.3 129.18 10.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 81.1 p -74.54 129.08 37.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.864 1.266 . . . . 0.0 110.079 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 86' ' ' ARG . 11.6 p . . . . . 0 C--O 1.26 1.608 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -161.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.431 -1.419 0 CA-C-O 121.296 0.57 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -148.54 158.36 40.44 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.61 135.9 22.66 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 C-N-CA 122.721 2.281 . . . . 0.0 112.867 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.2 73.01 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 125.133 1.349 . . . . 0.0 114.516 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.69 114.13 20.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.962 1.305 . . . . 0.0 111.268 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.8 p -88.33 145.67 25.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.024 1.392 . . . . 0.0 112.41 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.4 113.23 16.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 173.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -87.14 85.68 7.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 123.265 1.507 . . . . 0.0 109.949 170.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.16 152.91 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.133 2.173 . . . . 0.0 109.844 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -128.32 131.67 48.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.103 -1.623 . . . . 0.0 108.716 164.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 167.99 16.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.64 134.47 51.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 157.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.569 ' HB3' ' H ' ' A' ' 24' ' ' SER . 24.0 mttt -61.61 136.49 58.03 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.077 1.351 . . . . 0.0 113.848 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -84.68 84.37 7.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.417 -1.427 . . . . 0.0 110.047 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.16 60.09 2.18 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.358 2.263 . . . . 0.0 114.602 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.72 48.72 60.11 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.714 -1.241 . . . . 0.0 115.044 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.569 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 40.3 t 176.96 106.7 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -166.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 7.7 mt -66.02 -47.27 74.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.898 2.285 . . . . 0.0 106.283 164.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.34 38.02 0.7 Allowed Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.296 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.15 127.87 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.796 0.808 . . . . 0.0 110.52 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -78.36 104.91 9.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.632 1.973 . . . . 0.0 113.149 165.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.08 125.11 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t -118.57 161.43 20.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.757 2.423 . . . . 0.0 111.457 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.3 21.59 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.129 1.347 . . . . 0.0 113.453 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.68 169.5 20.18 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 124.602 1.096 . . . . 0.0 111.017 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.95 -7.81 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -61.8 -27.2 68.59 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -138.76 -163.28 1.44 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 110.474 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 m -85.16 92.31 8.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.942 1.697 . . . . 0.0 111.673 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.48 -129.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -88.54 -99.71 0.09 Allowed 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.774 -1.829 . . . . 0.0 107.19 162.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -134.19 22.8 3.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.891 -1.755 . . . . 0.0 112.148 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.77 129.25 3.2 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.438 -1.414 . . . . 0.0 110.934 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.7 176.79 31.15 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 65' ' ' VAL . 4.7 tp -116.17 157.17 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -131.57 161.7 32.03 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.649 -1.907 . . . . 0.0 106.562 -170.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 47' ' ' ILE . 85.4 t -86.67 128.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.962 1.305 . . . . 0.0 111.512 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -99.17 -35.6 9.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.735 -1.853 . . . . 0.0 111.739 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.02 133.85 11.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.569 0.699 . . . . 0.0 110.446 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.436 HD11 HG11 ' A' ' 44' ' ' VAL . 46.9 mm -100.44 115.78 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.7 pt -81.45 144.22 52.9 Favored Pre-proline 0 N--CA 1.43 -1.45 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.4 71.4 6.81 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.95 2.433 . . . . 0.0 112.189 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -111.86 -89.06 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 123.58 0.752 . . . . 0.0 108.973 164.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 50.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.724 -0.61 . . . . 0.0 113.855 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . -127.03 -72.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.895 -1.356 . . . . 0.0 108.479 164.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.94 85.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.068 -1.645 . . . . 0.0 113.102 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.07 -33.85 76.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.702 -1.249 . . . . 0.0 112.516 168.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.75 -20.43 65.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.78 -76.16 0.1 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.552 -1.342 . . . . 0.0 109.429 162.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.15 7.91 56.96 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.317 -0.864 . . . . 0.0 113.788 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -88.55 -18.69 27.57 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.91 -1.347 . . . . 0.0 109.711 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 153.34 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.634 1.574 . . . . 0.0 112.632 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 65.7 t60 -147.89 176.59 10.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 166.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 24.6 pttm -81.16 57.06 3.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.48 0.94 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.552 -1.342 . . . . 0.0 114.841 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -80.11 166.47 21.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 118.982 1.391 . . . . 0.0 114.415 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -103.87 132.08 50.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.95 1.3 . . . . 0.0 109.234 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG13 HG22 ' A' ' 42' ' ' ILE . 2.8 p -105.37 125.0 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 107.809 167.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 -28.69 9.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.468 -1.395 . . . . 0.0 113.401 -175.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.22 161.0 42.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 120.007 1.276 . . . . 0.0 112.777 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 92' ' ' VAL . 65.7 t -133.63 116.76 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.264 1.026 . . . . 0.0 110.532 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 58.77 24.0 11.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.197 -1.564 . . . . 0.0 114.164 -173.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.71 4.93 84.78 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 124.573 1.083 . . . . 0.0 114.132 -171.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.29 102.21 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 p -55.35 135.27 50.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.761 2.024 . . . . 0.0 115.168 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -74.74 -54.51 7.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.837 -1.165 . . . . 0.0 110.8 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -5.07 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.262 3.825 . . . . 0.0 117.897 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.02 6.46 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -163.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.26 138.98 37.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 120.675 -1.486 . . . . 0.0 114.748 -176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -110.71 -161.0 0.73 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.279 2.231 . . . . 0.0 106.391 177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -61.57 -51.83 66.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.466 -2.021 . . . . 0.0 112.793 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -66.51 -49.97 64.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.015 -1.053 . . . . 0.0 112.239 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.22 93.67 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.291 -2.13 . . . . 0.0 114.4 173.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.45 -50.72 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.03 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -47.22 -47.58 24.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.594 1.543 . . . . 0.0 115.03 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 m -62.99 -36.45 83.57 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.456 2.702 . . . . 0.0 114.533 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -90.98 -44.36 9.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.817 1.247 . . . . 0.0 113.73 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.12 13.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.81 2.044 . . . . 0.0 112.599 -170.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -89.17 38.31 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.489 1.614 . . . . 0.0 112.531 -166.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.5 p -91.57 -168.91 2.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.097 2.959 . . . . 0.0 108.944 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -89.6 -116.89 1.63 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.122 -1.611 . . . . 0.0 110.542 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -105.65 -47.7 3.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.72 -0.871 . . . . 0.0 109.951 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.61 129.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.111 -0.993 . . . . 0.0 111.77 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 68' ' ' VAL . 79.6 t -122.64 108.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 56.4 m-70 -78.99 109.78 13.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.786 -1.196 . . . . 0.0 108.585 163.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -89.02 120.23 30.25 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.643 -1.286 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.33 97.26 11.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.23 142.14 35.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.544 1.938 . . . . 0.0 110.52 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -115.34 140.4 49.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.786 1.634 . . . . 0.0 108.912 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.07 115.44 4.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.858 1.663 . . . . 0.0 113.853 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.44 48.32 3.56 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.321 -1.487 . . . . 0.0 112.428 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -120.02 137.71 53.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.079 1.351 . . . . 0.0 109.179 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -84.35 156.91 62.57 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 124.965 1.306 . . . . 0.0 111.765 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 N--CA 1.434 -2.021 0 C-N-CA 123.065 2.51 . . . . 0.0 114.458 178.766 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.0 tp 75.98 155.3 0.16 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.831 2.453 . . . . 0.0 115.026 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.356 4.9 t 74.46 120.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 123.936 1.826 . . . . 0.0 114.813 167.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.3 m -143.15 132.17 22.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.9 p -82.93 129.99 35.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.882 1.273 . . . . 0.0 109.244 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.642 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -164.653 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.431 -1.412 0 CA-C-O 121.1 0.476 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -127.32 -159.1 0.03 OUTLIER Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -63.71 112.47 1.81 Allowed 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 124.359 2.592 . . . . 0.0 111.536 155.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 137.34 57.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.0 163.06 36.77 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -68.82 152.65 45.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.951 -1.718 . . . . 0.0 113.824 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 96' ' ' LEU 0.299 0.1 OUTLIER -136.25 129.15 31.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.648 1.179 . . . . 0.0 108.681 171.384 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -105.97 79.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.626 1.203 . . . . 0.0 109.64 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.21 159.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.986 2.114 . . . . 0.0 110.796 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.74 129.91 50.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 119.949 -1.72 . . . . 0.0 108.386 164.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -125.88 164.95 19.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.102 1.761 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.15 112.92 14.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.274 1.03 . . . . 0.0 109.587 167.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -56.51 144.71 30.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.225 2.21 . . . . 0.0 115.849 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -113.08 117.94 33.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.992 1.317 . . . . 0.0 108.253 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 36.05 51.73 0.79 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.422 2.689 . . . . 0.0 117.522 -166.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.86 48.05 22.97 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.276 -1.515 . . . . 0.0 114.565 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -172.48 111.25 0.25 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.082 1.42 . . . . 0.0 107.298 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.32 -45.3 73.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.322 2.249 . . . . 0.0 108.057 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 123.68 41.0 0.44 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.176 167.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.64 135.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.983 0.896 . . . . 0.0 110.646 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -85.68 114.21 22.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.263 1.025 . . . . 0.0 109.666 163.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.02 137.2 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -127.98 165.77 19.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.652 1.981 . . . . 0.0 110.075 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.84 -149.11 39.2 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.888 1.233 . . . . 0.0 112.893 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' H ' HG11 ' A' ' 37' ' ' VAL . . . 121.66 168.11 13.31 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 177.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.77 -21.71 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.837 -1.39 . . . . 0.0 113.759 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -71.34 -29.22 64.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.577 -1.327 . . . . 0.0 113.64 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 m -117.51 74.6 0.94 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.5 m -25.09 106.81 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.072 2.949 . . . . 0.0 118.366 -167.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.466 HG11 ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -92.91 -98.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.975 1.71 . . . . 0.0 111.34 -166.233 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -123.08 -79.55 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 163.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -125.9 144.05 50.83 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 158.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 24.8 -69.44 0.0 OUTLIER Glycine 0 N--CA 1.43 -1.712 1 C-N-CA 132.742 4.973 . . . . 0.0 121.267 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -30.24 141.28 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 130.038 3.685 . . . . 0.0 119.998 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 tp -94.08 167.51 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 0.0 109.768 -170.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -136.4 158.79 43.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.228 -2.17 . . . . 0.0 107.722 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.624 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.2 t -89.5 128.82 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.813 -1.179 . . . . 0.0 111.12 175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -88.51 -63.08 1.35 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.21 133.83 54.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.206 1.402 . . . . 0.0 110.125 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.624 ' CD1' HG11 ' A' ' 44' ' ' VAL . 30.4 mm -97.83 135.89 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.281 1.832 . . . . 0.0 108.274 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.741 HD12 ' HA2' ' A' ' 26' ' ' GLY . 55.8 mt -75.34 132.36 76.24 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.213 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -61.66 94.4 0.12 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.409 2.739 . . . . 0.0 114.575 168.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 74.4 51.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.871 2.069 . . . . 0.0 113.983 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.82 -119.33 0.74 Allowed Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 161.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.44 -40.73 4.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.228 -1.16 . . . . 0.0 111.221 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.77 60.93 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.55 -34.4 70.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.057 1.408 . . . . 0.0 111.71 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -72.09 1.27 7.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.51 -74.15 0.17 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.615 -1.928 . . . . 0.0 107.541 156.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.79 -18.5 2.58 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 113.486 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -92.99 -15.73 25.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.474 0.71 . . . . 0.0 112.48 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -80.86 133.79 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.048 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.29 177.45 8.61 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.188 0.994 . . . . 0.0 111.031 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.91 104.15 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.932 1.693 . . . . 0.0 112.441 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.44 -31.31 2.34 Favored Glycine 0 N--CA 1.429 -1.818 0 O-C-N 120.696 -1.253 . . . . 0.0 115.191 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.73 161.18 31.06 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 118.507 1.154 . . . . 0.0 113.71 -170.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -98.69 134.44 41.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.48 1.112 . . . . 0.0 110.894 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.38 114.11 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.771 1.628 . . . . 0.0 107.072 171.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -27.86 12.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.699 -1.876 . . . . 0.0 113.973 -173.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.35 166.68 30.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 119.073 0.851 . . . . 0.0 112.501 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 HG22 ' A' ' 84' ' ' THR . 4.1 p -146.31 135.35 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 112.077 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.0 m120 56.41 20.22 4.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.382 -2.074 . . . . 0.0 115.93 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.1 79.35 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.255 -1.528 . . . . 0.0 115.383 -168.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 t -109.43 106.26 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.107 1.763 . . . . 0.0 109.485 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.8 p -62.16 141.51 58.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.41 34.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.227 -1.546 . . . . 0.0 113.214 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.74 103.19 3.56 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.5 -2.0 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.1 13.58 58.72 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.376 -0.827 . . . . 0.0 114.079 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 140.03 29.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.673 -1.486 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -95.05 -163.62 1.07 Allowed 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.131 1.772 . . . . 0.0 110.408 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -59.97 -54.42 46.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.973 -1.704 . . . . 0.0 112.749 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -67.35 -44.79 78.18 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 111.951 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -68.2 -33.89 75.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.32 93.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.695 -1.878 . . . . 0.0 113.727 170.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.4 -53.98 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 122.995 0.518 . . . . 0.0 111.135 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -69.45 -20.13 63.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.464 HG22 HG12 ' A' ' 68' ' ' VAL . 95.7 m -63.81 -36.08 82.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.686 1.595 . . . . 0.0 110.756 168.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.27 -40.0 12.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.312 1.445 . . . . 0.0 114.717 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.459 0.0 OUTLIER -72.83 -43.42 62.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.874 -2.391 . . . . 0.0 116.546 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -87.87 47.41 1.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.007 1.384 . . . . 0.0 111.102 -174.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.0 p -102.09 175.29 5.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.39 2.676 . . . . 0.0 111.417 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.34 75.51 0.21 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 124.802 1.191 . . . . 0.0 111.654 175.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 69.22 -50.61 0.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.068 2.547 . . . . 0.0 117.382 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.86 135.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 125.631 1.572 . . . . 0.0 109.772 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.457 HG13 ' CG2' ' A' ' 68' ' ' VAL . 2.1 t -119.32 107.31 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -79.02 103.03 8.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 109.329 162.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -85.39 117.36 24.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.386 1.474 . . . . 0.0 109.343 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.78 102.94 15.64 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.694 0.759 . . . . 0.0 109.39 167.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.445 HD13 ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -104.82 145.32 30.55 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.521 1.928 . . . . 0.0 110.862 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.76 120.79 43.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 163.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -76.65 126.18 30.53 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.73 -1.231 . . . . 0.0 107.691 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -46.58 -76.25 0.14 Allowed Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.291 13.5 pt20 178.34 45.21 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.844 1.657 . . . . 0.0 111.837 149.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -95.31 118.95 66.21 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 120.202 -1.561 . . . . 0.0 110.844 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo . . . . . 0 N--CA 1.434 -2.011 0 C-N-CA 123.141 2.561 . . . . 0.0 111.613 160.699 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 8.3 tp 70.38 172.03 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.625 1.97 . . . . 0.0 113.831 -176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.445 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.461 19.5 m 46.68 91.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 128.12 2.568 . . . . 0.0 117.023 170.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.5 m -128.88 126.58 40.06 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 42.4 m -62.78 123.36 18.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.868 2.467 . . . . 0.0 109.239 170.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--O 1.26 1.651 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 -172.544 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.43 -1.468 0 CA-C-O 122.39 1.091 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -124.78 150.46 65.75 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 126.632 1.973 . . . . 0.0 106.729 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -67.56 112.02 2.5 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-N 123.829 2.403 . . . . 0.0 116.082 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.08 18.99 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.231 0.919 . . . . 0.0 114.162 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.4 123.19 22.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.207 1.403 . . . . 0.0 111.799 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -96.67 132.97 41.79 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.508 -1.37 . . . . 0.0 111.299 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 111.4 16.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.169 1.388 . . . . 0.0 108.94 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.96 75.0 8.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.344 1.458 . . . . 0.0 110.842 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.42 121.26 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.397 -1.439 . . . . 0.0 114.033 -171.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -100.89 132.41 46.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.758 -1.839 . . . . 0.0 112.192 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.61 178.57 8.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.56 43.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.53 -1.356 . . . . 0.0 109.845 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 146.29 24.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 113.021 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -96.63 85.2 3.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.911 1.338 . . . . 0.0 108.91 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 55.71 72.96 0.45 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.253 1.821 . . . . 0.0 115.015 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.0 50.54 60.96 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.267 1.413 . . . . 0.0 114.324 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 t -169.96 98.08 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -169.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.54 HD11 HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.16 -47.05 30.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.054 1.883 . . . . 0.0 105.956 164.66 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 116.11 46.39 0.55 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.114 171.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 pt -118.09 134.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.003 0.921 . . . . 0.0 109.429 166.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -88.99 112.66 23.63 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.574 1.15 . . . . 0.0 109.951 166.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 m -79.23 143.65 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -138.08 171.33 14.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.699 -1.876 . . . . 0.0 109.001 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.98 -133.4 11.78 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 125.011 1.291 . . . . 0.0 112.815 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.36 154.71 29.89 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 123.985 0.803 . . . . 0.0 112.566 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -58.81 -28.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.402 1.481 . . . . 0.0 113.751 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -79.5 -15.36 57.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.814 -1.179 . . . . 0.0 112.276 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 m -91.14 -23.58 20.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.716 -1.24 . . . . 0.0 109.379 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.0 m 74.01 93.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.228 2.611 . . . . 0.0 111.402 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.01 49.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.123 0.969 . . . . 0.0 110.542 -168.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 72.02 -52.24 0.7 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.531 2.333 . . . . 0.0 113.396 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 38.4 t-80 -114.07 -140.92 0.38 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.241 1.416 . . . . 0.0 107.328 160.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' H ' ' CG ' ' A' ' 39' ' ' HIS . . . -140.5 43.18 1.14 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.086 -1.634 . . . . 0.0 113.378 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 -175.69 31.11 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 124.0 0.81 . . . . 0.0 111.972 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.281 2.4 tp -111.54 159.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.257 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -139.48 157.45 45.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 47' ' ' ILE . 53.9 t -82.33 137.9 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.552 -1.967 . . . . 0.0 110.592 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -100.31 -53.29 3.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.941 -1.1 . . . . 0.0 109.851 165.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.65 48.3 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.939 0.876 . . . . 0.0 111.231 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 44' ' ' VAL . 47.1 mm -110.79 133.63 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.465 1.906 . . . . 0.0 109.21 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.587 HD12 ' HA2' ' A' ' 26' ' ' GLY . 62.3 mt -74.71 133.65 76.39 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.762 174.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.75 95.67 0.24 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 123.543 2.829 . . . . 0.0 114.047 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp 63.23 47.33 4.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 127.743 2.417 . . . . 0.0 116.008 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.24 -70.25 1.33 Allowed Glycine 0 N--CA 1.431 -1.657 0 O-C-N 120.932 -1.105 . . . . 0.0 112.34 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.31 -48.43 0.27 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.659 -0.906 . . . . 0.0 110.86 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.62 -45.11 72.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.936 1.694 . . . . 0.0 115.513 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.62 -33.64 68.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.927 -1.733 . . . . 0.0 111.737 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t -72.7 6.33 2.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.84 -88.55 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.001 -1.687 . . . . 0.0 106.888 149.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.33 -21.78 0.95 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.893 -1.129 . . . . 0.0 112.122 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -85.82 -35.56 20.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 121.365 -1.079 . . . . 0.0 111.145 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 mt -60.4 125.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.524 1.53 . . . . 0.0 113.102 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -177.06 4.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.586 1.154 . . . . 0.0 109.412 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -76.62 89.89 3.35 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.086 -1.634 . . . . 0.0 111.434 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.95 -21.17 0.37 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.707 -1.246 . . . . 0.0 114.964 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -68.2 155.32 39.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 114.71 29.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.711 2.004 . . . . 0.0 109.43 -168.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.27 112.68 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.225 -1.547 . . . . 0.0 108.743 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.61 -31.75 11.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.451 -1.406 . . . . 0.0 112.962 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.76 160.25 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.637 1.108 . . . . 0.0 112.553 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 t -137.2 127.32 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.85 27.02 12.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.027 1.74 . . . . 0.0 114.608 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.1 18.73 79.78 Favored Glycine 0 N--CA 1.43 -1.766 0 O-C-N 120.598 -1.314 . . . . 0.0 113.644 -172.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.35 102.22 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 t -60.76 138.06 58.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -86.19 82.12 8.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -110.09 42.09 1.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.315 2.007 . . . . 0.0 110.308 -170.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.17 55.44 0.18 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.01 141.94 43.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.013 0.911 . . . . 0.0 108.581 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.8 p -96.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.572 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.04 -54.67 38.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.47 -1.394 . . . . 0.0 111.713 165.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -67.8 -42.9 80.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.6 tt0 -63.97 -46.49 84.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.8 77.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.91 -53.74 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 121.709 -0.619 . . . . 0.0 111.285 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.41 -30.87 71.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.4 m -60.3 -28.92 68.49 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.465 1.506 . . . . 0.0 112.303 171.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.54 HD22 HD11 ' A' ' 25' ' ' LEU . 14.0 mt -88.34 -47.0 8.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.02 -1.675 . . . . 0.0 113.355 168.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -88.07 -27.88 21.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -162.097 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -86.9 18.98 3.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.627 -1.296 . . . . 0.0 113.217 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.0 p -88.29 170.49 10.94 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.978 2.511 . . . . 0.0 111.396 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.15 -90.13 0.21 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.373 -1.455 . . . . 0.0 115.238 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -129.44 -57.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.531 . . . . 0.0 110.321 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.24 136.82 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 122.041 0.924 . . . . 0.0 111.028 173.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.69 109.66 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 168.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -85.54 102.67 13.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.644 1.178 . . . . 0.0 109.284 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.65 120.03 28.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.769 -1.832 . . . . 0.0 110.439 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.85 97.72 11.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.911 -1.118 . . . . 0.0 108.663 169.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.38 145.8 28.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.466 1.906 . . . . 0.0 110.41 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.62 144.18 46.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.769 1.228 . . . . 0.0 108.971 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.97 120.0 11.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.94 56.72 5.07 Favored Glycine 0 N--CA 1.429 -1.798 0 O-C-N 120.77 -1.206 . . . . 0.0 113.643 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -139.74 158.39 44.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.356 1.862 . . . . 0.0 108.299 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.67 171.39 4.84 Favored Pre-proline 0 N--CA 1.429 -1.475 0 C-N-CA 125.517 1.527 . . . . 0.0 110.433 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 C--N 1.299 -2.034 0 C-N-CA 123.122 2.548 . . . . 0.0 113.645 164.237 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.4 tp 64.78 -157.17 0.3 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.897 2.079 . . . . 0.0 111.871 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.576 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.359 13.5 m 29.27 101.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.781 3.232 . . . . 0.0 119.071 157.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -132.57 123.68 26.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.0 p -75.5 119.93 20.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.692 1.597 . . . . 0.0 110.793 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.566 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.431 -1.399 0 CA-C-O 121.737 0.78 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -119.91 177.53 1.37 Allowed Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 163.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -68.02 94.21 0.4 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 CA-C-N 124.799 2.75 . . . . 0.0 112.186 168.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.87 50.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.607 1.563 . . . . 0.0 108.821 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p -78.33 125.94 30.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -173.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.06 126.12 51.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.385 2.674 . . . . 0.0 109.147 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.24 67.16 1.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.222 1.409 . . . . 0.0 110.83 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.38 112.64 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -165.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 5.5 tt0 -93.1 118.81 31.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.432 -2.043 . . . . 0.0 111.418 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.6 169.65 17.18 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.612 1.165 . . . . 0.0 109.351 175.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.31 150.13 32.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.783 1.633 . . . . 0.0 110.006 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.96 174.2 9.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.163 -0.961 . . . . 0.0 112.101 -170.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.8 t -110.89 103.87 12.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.124 -1.61 . . . . 0.0 107.361 168.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t70 34.42 67.48 0.22 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.523 2.729 . . . . 0.0 117.18 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.36 48.35 45.7 Favored Glycine 0 N--CA 1.429 -1.808 0 O-C-N 119.961 -1.712 . . . . 0.0 115.069 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 m -175.98 111.15 0.1 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.56 -45.56 68.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.153 1.781 . . . . 0.0 108.094 167.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.501 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 106.01 45.13 1.31 Allowed Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.774 1.178 . . . . 0.0 110.799 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -125.8 141.96 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 163.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 m -90.37 126.17 35.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 164.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.47 148.83 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -149.38 167.8 25.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.341 -1.475 . . . . 0.0 108.743 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.19 -138.21 14.21 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.854 -1.154 . . . . 0.0 112.704 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.86 167.57 28.3 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -49.85 -37.45 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.609 1.964 . . . . 0.0 113.3 171.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -55.02 -40.99 70.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.819 2.448 . . . . 0.0 116.289 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -93.71 -6.31 46.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.545 -1.347 . . . . 0.0 110.923 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m 64.62 90.8 0.08 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.288 1.835 . . . . 0.0 112.862 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -93.25 -142.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.029 1.331 . . . . 0.0 107.791 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 ttm-85 -88.77 91.38 8.79 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.627 -1.921 . . . . 0.0 108.46 166.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 66.58 -65.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.188 2.595 . . . . 0.0 115.524 -171.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.34 118.49 0.62 Allowed Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 106.529 -2.628 . . . . 0.0 106.529 -162.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.7 150.24 8.69 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 42' ' ' ILE . 3.9 tp -107.93 156.86 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -131.7 161.09 33.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.548 HG11 HD13 ' A' ' 47' ' ' ILE . 35.4 t -91.87 134.17 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.577 -1.327 . . . . 0.0 109.497 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -85.48 -57.26 3.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.586 172.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.85 129.23 25.76 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 123.919 0.888 . . . . 0.0 110.628 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.548 HD13 HG11 ' A' ' 44' ' ' VAL . 35.0 mm -91.7 122.86 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.698 1.599 . . . . 0.0 109.181 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.501 HD12 ' CA ' ' A' ' 26' ' ' GLY . 54.2 mt -67.49 133.98 92.9 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.018 176.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.31 91.45 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 123.314 2.676 . . . . 0.0 112.166 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.268 10.8 mmmm 68.48 78.85 0.22 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.13 2.572 . . . . 0.0 115.203 -173.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.15 -134.16 8.25 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 148.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.655 -1.497 . . . . 0.0 111.468 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.46 -48.19 67.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.503 1.921 . . . . 0.0 115.876 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.32 -30.47 66.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.126 -1.608 . . . . 0.0 112.344 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t -71.34 3.94 3.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.41 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.438 -1.414 . . . . 0.0 109.378 155.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.67 -45.81 0.26 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.174 -0.953 . . . . 0.0 111.551 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -86.54 -39.9 15.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -53.68 130.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -163.394 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 53.0 t60 -127.38 175.17 8.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.543 1.937 . . . . 0.0 110.833 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 51.0 mttp -86.11 40.96 0.9 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.058 1.743 . . . . 0.0 113.558 -169.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.26 38.58 0.09 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.258 -1.526 . . . . 0.0 110.864 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -103.45 158.1 16.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.07 1.348 . . . . 0.0 109.719 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.69 134.07 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 123.79 0.836 . . . . 0.0 109.229 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.12 110.54 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 163.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.75 -27.86 15.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.96 -1.713 . . . . 0.0 112.187 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.21 41.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 111.39 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -137.37 121.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.938 -1.101 . . . . 0.0 110.297 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.373 0.8 OUTLIER 43.02 34.29 0.61 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -173.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.34 60.64 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.284 0.945 . . . . 0.0 114.008 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.83 98.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.629 1.572 . . . . 0.0 107.225 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -62.36 142.52 57.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.854 -1.154 . . . . 0.0 113.352 173.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.9 mt -87.28 30.74 0.76 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.56 -1.337 . . . . 0.0 112.726 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.38 97.43 2.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.489 1.916 . . . . 0.0 109.061 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.16 -3.21 33.28 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.337 0.97 . . . . 0.0 114.986 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.73 140.95 29.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.943 1.872 . . . . 0.0 114.378 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 80.6 p -101.99 -163.0 0.97 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.503 2.321 . . . . 0.0 109.863 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.01 -53.21 53.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.214 -1.554 . . . . 0.0 111.343 166.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.1 -45.19 82.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.605 -0.684 . . . . 0.0 112.727 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.511 ' HB2' ' H ' ' A' ' 77' ' ' THR . 1.6 mm-40 -61.05 -43.07 99.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.79 -1.194 . . . . 0.0 113.253 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.22 94.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.956 -1.715 . . . . 0.0 115.411 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.43 -48.67 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 121.481 -0.762 . . . . 0.0 111.365 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.05 -36.69 84.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.643 -1.286 . . . . 0.0 114.104 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 m -63.59 -26.56 68.74 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.897 1.679 . . . . 0.0 113.351 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.33 -42.58 11.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.974 -1.704 . . . . 0.0 113.596 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -22.77 23.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.054 -1.654 . . . . 0.0 115.291 -169.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -102.71 37.51 1.92 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.61 -1.931 . . . . 0.0 111.28 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.5 p -87.76 -171.58 3.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.627 2.371 . . . . 0.0 111.207 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.42 62.54 0.3 Allowed Glycine 0 N--CA 1.431 -1.693 0 O-C-N 120.508 -1.37 . . . . 0.0 112.52 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 72.88 -54.05 0.7 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.301 2.641 . . . . 0.0 114.567 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 t -82.49 132.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 123.071 1.415 . . . . 0.0 109.98 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.76 109.72 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 8.4 m80 -84.62 102.01 12.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.902 -1.123 . . . . 0.0 108.434 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.5 110.89 21.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.424 -1.422 . . . . 0.0 111.56 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.9 89.31 7.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.398 1.094 . . . . 0.0 108.318 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.9 mt -103.79 148.61 25.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.88 2.472 . . . . 0.0 111.633 -173.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -135.37 140.69 45.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.824 -1.173 . . . . 0.0 109.528 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -82.7 61.8 5.98 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.358 -1.464 . . . . 0.0 113.134 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.2 -88.34 0.15 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.069 -1.644 . . . . 0.0 113.135 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 179.2 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.457 2.303 . . . . 0.0 110.393 163.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.5 m -93.06 165.45 18.5 Favored Pre-proline 0 N--CA 1.43 -1.473 0 C-N-CA 124.696 1.198 . . . . 0.0 111.656 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 N--CA 1.434 -1.998 0 C-N-CA 122.502 2.135 . . . . 0.0 115.762 -179.466 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 47.5 p90 . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 121.705 0.764 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 3.3 tp -88.4 -156.96 0.4 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.353 1.461 . . . . 0.0 110.161 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.495 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.52 33.4 m 66.65 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 127.823 2.449 . . . . 0.0 117.543 174.477 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 99.6 m -152.55 118.45 5.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 91.1 p -78.65 128.62 33.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.403 1.097 . . . . 0.0 109.935 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.261 1.658 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 -156.386 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.1 mmt . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 138.94 33.27 Favored Pre-proline 0 N--CA 1.429 -1.484 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.55 121.01 5.78 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.552 2.168 . . . . 0.0 112.204 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.1 79.55 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 121.438 -0.789 . . . . 0.0 114.3 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.51 129.88 34.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.849 1.26 . . . . 0.0 111.138 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -82.97 124.31 30.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 120.943 -1.098 . . . . 0.0 112.654 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.05 129.38 56.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.5 1.52 . . . . 0.0 107.483 170.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.46 84.44 3.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.929 1.292 . . . . 0.0 108.815 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.8 107.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.215 2.206 . . . . 0.0 111.662 -171.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.27 112.75 24.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.826 -1.796 . . . . 0.0 109.643 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.8 mt -122.94 150.75 42.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.43 110.5 20.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 148.34 37.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.544 1.138 . . . . 0.0 113.709 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -102.33 97.18 7.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.427 -1.421 . . . . 0.0 109.96 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 60.49 50.12 6.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.787 2.035 . . . . 0.0 112.57 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.81 55.69 25.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 120.352 -1.467 . . . . 0.0 113.934 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -165.87 112.33 0.89 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.236 1.493 . . . . 0.0 107.005 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.697 HD21 HG21 ' A' ' 92' ' ' VAL . 6.9 mt -67.33 -49.61 63.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.482 1.913 . . . . 0.0 106.258 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.96 39.06 0.66 Allowed Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.562 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.446 ' HB ' HG13 ' A' ' 44' ' ' VAL . 44.8 pt -123.9 132.28 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.673 0.749 . . . . 0.0 109.817 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -77.22 117.4 18.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.443 -0.785 . . . . 0.0 111.742 159.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.36 128.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -130.19 169.69 15.04 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.379 1.471 . . . . 0.0 108.898 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.82 58.87 7.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.472 2.149 . . . . 0.0 118.472 169.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.52 -176.63 34.18 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.34 -1.683 . . . . 0.0 109.604 172.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.43 -29.95 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -68.6 -34.57 76.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.4 p -94.68 14.76 20.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.478 -1.389 . . . . 0.0 113.58 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m 67.82 63.27 0.4 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.216 1.806 . . . . 0.0 114.244 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.8 m -87.52 -133.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 124.339 1.056 . . . . 0.0 111.343 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -82.92 -57.15 3.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.577 -1.952 . . . . 0.0 110.258 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -136.3 -89.66 0.29 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 156.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.54 -131.71 6.88 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 164.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.71 -172.27 34.01 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-O 121.911 0.728 . . . . 0.0 111.904 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.5 tp -148.05 161.35 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 161.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -135.71 161.24 36.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.528 -1.982 . . . . 0.0 106.739 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 47' ' ' ILE . 10.9 t -92.44 129.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.031 -1.668 . . . . 0.0 111.643 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.67 -49.31 6.94 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.808 -1.182 . . . . 0.0 111.429 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.47 126.92 28.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.845 -1.159 . . . . 0.0 110.626 -170.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.61 HD13 HG11 ' A' ' 44' ' ' VAL . 34.3 mm -96.07 119.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -84.37 145.66 45.84 Favored Pre-proline 0 N--CA 1.431 -1.407 0 O-C-N 120.841 -1.162 . . . . 0.0 112.735 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.94 77.83 3.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.877 2.385 . . . . 0.0 113.254 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -125.34 -89.43 0.57 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.25 58.54 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.72 0 O-C-N 120.306 -1.496 . . . . 0.0 116.262 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.64 -62.45 1.02 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 153.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.57 -50.96 65.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.715 1.606 . . . . 0.0 114.454 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.96 -34.43 68.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.683 -1.26 . . . . 0.0 111.915 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 t -72.51 -6.33 43.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.54 -75.45 0.15 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.632 -1.918 . . . . 0.0 108.552 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.76 -10.19 12.43 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.399 -0.813 . . . . 0.0 114.238 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 -81.74 -23.74 36.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.78 -0.835 . . . . 0.0 111.395 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.99 139.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.165 1.786 . . . . 0.0 112.868 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -138.32 -167.91 2.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.248 1.023 . . . . 0.0 108.758 166.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -80.78 75.95 7.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.328 -1.483 . . . . 0.0 111.967 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.38 13.3 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.747 -1.221 . . . . 0.0 116.126 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -81.97 158.95 23.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.488 1.644 . . . . 0.0 113.18 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.65 114.17 27.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.236 1.415 . . . . 0.0 110.616 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.96 117.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.383 -1.448 . . . . 0.0 108.075 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -97.21 -39.46 9.26 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.003 -1.061 . . . . 0.0 112.163 173.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.524 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -156.2 166.21 34.12 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.118 1.326 . . . . 0.0 114.279 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG21 HD23 ' A' ' 85' ' ' LEU . 9.1 t -135.16 122.56 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 110.644 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 49.13 30.77 3.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -167.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.85 27.79 57.97 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 120.503 -1.373 . . . . 0.0 113.813 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.83 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.7 m -60.53 136.76 58.15 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.123 1.369 . . . . 0.0 114.59 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.97 53.11 1.9 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.169 1.788 . . . . 0.0 113.446 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.44 117.95 23.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.654 1.582 . . . . 0.0 108.198 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 9.53 86.51 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 120.87 -1.144 . . . . 0.0 115.727 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.76 140.29 29.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.865 1.317 . . . . 0.0 112.659 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 p -100.6 -164.89 1.15 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.968 1.707 . . . . 0.0 109.222 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -60.17 -57.33 13.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.446 -1.409 . . . . 0.0 112.651 163.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.61 -43.82 95.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 112.968 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -37.04 86.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.759 -1.213 . . . . 0.0 113.471 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.87 89.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.314 -1.491 . . . . 0.0 114.986 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.3 t -57.84 -53.21 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 121.69 -0.631 . . . . 0.0 112.108 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.3 m -64.23 -30.17 71.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.53 2.332 . . . . 0.0 113.294 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 68' ' ' VAL . 24.8 mt -88.47 -43.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.99 -1.694 . . . . 0.0 113.771 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -48.46 11.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.784 1.634 . . . . 0.0 114.976 -162.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -81.12 18.98 0.96 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.719 1.208 . . . . 0.0 113.723 -169.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.1 p -85.02 177.1 8.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.182 2.593 . . . . 0.0 112.08 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.87 -77.82 0.28 Allowed Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.167 -1.583 . . . . 0.0 115.217 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -154.29 -54.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.982 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.44 128.08 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.846 1.308 . . . . 0.0 111.006 170.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.697 HG21 HD21 ' A' ' 25' ' ' LEU . 2.7 m -118.42 112.2 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.977 1.711 . . . . 0.0 107.53 166.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -78.85 95.22 5.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.685 -1.259 . . . . 0.0 107.71 164.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 117.3 15.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.791 -1.193 . . . . 0.0 113.063 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.524 HD12 ' HB3' ' A' ' 67' ' ' ALA . 7.1 mt -86.04 95.64 9.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.8 mt -104.19 130.64 51.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.902 2.881 . . . . 0.0 111.688 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -105.94 140.24 39.25 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.778 -1.202 . . . . 0.0 110.24 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -70.89 111.35 6.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.111 1.364 . . . . 0.0 113.121 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.82 70.43 2.55 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 120.708 -1.245 . . . . 0.0 113.394 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.97 164.47 28.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.286 -1.126 . . . . 0.0 110.766 -177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.3 t -79.27 140.25 56.59 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 126.737 2.015 . . . . 0.0 112.328 -175.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 N--CA 1.433 -2.078 0 C-N-CA 123.934 3.089 . . . . 0.0 115.116 169.408 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 0.7 OUTLIER -125.01 -121.6 0.26 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.266 1.027 . . . . 0.0 110.831 -176.05 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.451 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.521 30.1 m 66.46 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 127.571 2.348 . . . . 0.0 116.932 171.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 80.3 m -152.82 125.6 8.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 78.7 p -76.91 126.43 30.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.592 1.157 . . . . 0.0 108.404 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.613 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 -161.575 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.598 ' N ' ' HZ3' ' A' ' 98' ' ' LYS . 63.5 ttp . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -99.03 144.21 27.79 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 124.88 1.272 . . . . 0.0 108.412 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.5 116.52 3.81 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 123.389 2.246 . . . . 0.0 115.494 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.1 36.48 40.52 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 124.062 0.839 . . . . 0.0 114.671 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -76.17 130.52 38.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.892 -1.358 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.48 117.14 31.07 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 120.139 -1.6 . . . . 0.0 112.019 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.312 0.0 OUTLIER -106.62 136.88 45.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.591 1.556 . . . . 0.0 110.075 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -117.64 76.72 1.08 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.068 1.347 . . . . 0.0 108.423 -173.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.68 137.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 126.851 2.06 . . . . 0.0 111.233 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 127.64 53.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.354 2.343 . . . . 0.0 110.093 167.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.5 128.8 49.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.207 1.003 . . . . 0.0 110.156 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.1 90.88 6.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.219 1.009 . . . . 0.0 109.313 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.08 137.52 58.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -104.05 105.19 15.28 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.82 1.295 . . . . 0.0 109.413 -160.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 54.78 37.33 28.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.198 2.199 . . . . 0.0 114.958 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.62 88.62 0.25 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.794 -1.191 . . . . 0.0 112.371 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.284 51.9 p 149.32 112.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.727 2.411 . . . . 0.0 109.519 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 20' ' ' LYS . 8.0 mt -73.28 -43.16 61.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 156.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.94 17.81 3.31 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.545 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.3 pt -105.8 126.22 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 122.013 0.911 . . . . 0.0 111.09 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -79.31 109.68 13.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.06 1.344 . . . . 0.0 111.469 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.64 127.62 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -134.07 178.93 6.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.697 2.399 . . . . 0.0 108.699 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.11 39.94 35.96 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 119.881 -1.762 . . . . 0.0 117.26 168.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.48 -179.88 49.31 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.092 -1.828 . . . . 0.0 113.606 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.81 -8.69 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.288 1.835 . . . . 0.0 114.345 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -65.51 -33.18 75.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.764 -1.835 . . . . 0.0 114.314 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -99.23 -166.7 1.38 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.931 -1.106 . . . . 0.0 108.685 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.8 m -103.25 92.32 4.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.871 -1.768 . . . . 0.0 109.354 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -104.9 179.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -53.97 -64.34 0.86 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -161.28 59.89 0.28 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.684 -1.26 . . . . 0.0 110.009 167.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.16 130.44 4.3 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-O 123.295 1.497 . . . . 0.0 110.728 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 179.04 -169.98 41.54 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 169.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.4 tp -136.32 156.18 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 155.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -137.12 154.56 50.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -171.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 47' ' ' ILE . 11.9 t -84.08 131.94 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 119.694 -1.879 . . . . 0.0 111.067 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.33 -52.66 5.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 109.956 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.43 140.43 41.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 111.696 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 44' ' ' VAL . 46.3 mm -97.61 127.57 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.503 1.921 . . . . 0.0 106.789 169.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 pt -78.74 157.15 77.17 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 121.194 -0.941 . . . . 0.0 112.092 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.61 84.59 0.62 Allowed 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 121.922 1.748 . . . . 0.0 115.575 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 86.29 82.71 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.506 2.322 . . . . 0.0 112.978 165.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.96 -116.12 3.09 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.57 -37.55 4.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.462 1.105 . . . . 0.0 112.282 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.73 72.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.121 -1.612 . . . . 0.0 113.228 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.68 -26.84 64.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.618 1.567 . . . . 0.0 112.424 165.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -80.93 -9.49 59.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.437 -2.039 . . . . 0.0 115.788 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -76.22 -62.45 1.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.748 2.067 . . . . 0.0 106.049 156.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.62 -9.68 62.45 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 121.499 -0.75 . . . . 0.0 112.935 162.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -74.23 -28.77 61.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 123.66 0.784 . . . . 0.0 109.174 166.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.7 mt -61.71 128.08 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 126.938 2.095 . . . . 0.0 110.716 165.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.598 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 24.7 t-80 -127.7 -161.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.109 0.963 . . . . 0.0 109.665 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.598 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 95.1 mttt -92.45 66.27 4.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.555 -2.59 . . . . 0.0 111.12 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.92 53.5 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.45 -0.781 . . . . 0.0 114.911 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -109.83 173.68 6.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.778 1.231 . . . . 0.0 108.898 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -103.89 136.43 43.56 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.034 0.934 . . . . 0.0 110.377 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.63 119.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.41 -34.21 8.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.864 -1.772 . . . . 0.0 113.161 177.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.58 153.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.119 1.327 . . . . 0.0 112.9 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -133.92 111.96 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 112.102 -174.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.74 31.19 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.437 -1.415 . . . . 0.0 113.744 -166.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.42 80.7 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.123 1.344 . . . . 0.0 113.921 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.75 102.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.992 -1.299 . . . . 0.0 107.584 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -65.75 137.1 57.04 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 126.136 1.774 . . . . 0.0 114.359 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.2 mt -86.99 26.39 1.16 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.561 1.544 . . . . 0.0 113.009 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -68.21 118.16 10.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.573 -1.955 . . . . 0.0 110.023 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.28 6.53 86.1 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 120.954 -1.091 . . . . 0.0 115.201 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.37 137.94 32.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 118.945 1.372 . . . . 0.0 111.744 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -113.64 -168.15 1.3 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -54.62 -52.0 63.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.603 -1.936 . . . . 0.0 114.647 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.31 -46.24 74.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.242 -0.912 . . . . 0.0 112.978 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.99 -46.44 90.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.497 1.519 . . . . 0.0 114.809 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.29 -34.63 78.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.371 -1.456 . . . . 0.0 114.404 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.12 -54.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.151 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -55.48 -47.71 75.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.2 m -52.56 -33.16 44.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 126.283 1.833 . . . . 0.0 115.182 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 mt -92.2 -46.7 7.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.176 1.79 . . . . 0.0 115.449 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -37.05 55.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.592 2.357 . . . . 0.0 114.586 -172.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.54 30.49 0.71 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.157 -1.59 . . . . 0.0 112.363 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.6 p -106.19 176.78 5.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.761 2.424 . . . . 0.0 109.361 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.42 -74.63 1.28 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 119.444 -2.035 . . . . 0.0 113.954 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -139.91 -66.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.966 -1.314 . . . . 0.0 110.068 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.59 115.35 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.17 1.462 . . . . 0.0 110.605 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.74 103.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.23 97.77 8.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.594 1.158 . . . . 0.0 109.133 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.29 114.01 22.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.829 1.652 . . . . 0.0 108.993 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 103.85 16.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mt -108.97 142.84 39.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.317 1.847 . . . . 0.0 110.408 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -114.04 129.45 56.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.564 1.146 . . . . 0.0 108.034 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.598 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 17.3 tptm -71.76 122.81 21.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.539 1.936 . . . . 0.0 113.264 -171.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.94 66.88 3.04 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 117.196 1.638 . . . . 0.0 117.196 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -127.88 154.3 45.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.261 1.424 . . . . 0.0 109.278 166.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.12 144.4 28.56 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.117 1.367 . . . . 0.0 110.28 -172.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo . . . . . 0 N--CA 1.434 -1.992 0 C-N-CA 122.346 2.031 . . . . 0.0 114.903 171.854 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 123.081 1.42 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.72 -156.06 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.389 2.7 t 66.86 91.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 124.943 2.306 . . . . 0.0 113.016 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 90.4 m -136.61 128.62 29.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.193 -2.891 . . . . 0.0 103.193 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.7 m -72.89 120.03 17.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 17.0 ptm . . . . . 0 N--CA 1.431 -1.384 0 CA-C-O 122.307 1.051 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.59 159.01 72.93 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.271 -1.518 . . . . 0.0 109.845 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 147.12 25.65 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.478 2.118 . . . . 0.0 111.694 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.31 61.53 2.78 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 124.566 1.079 . . . . 0.0 113.496 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -142.42 99.28 3.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.881 1.273 . . . . 0.0 108.198 -169.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -84.01 132.32 34.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.558 -1.339 . . . . 0.0 111.93 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.72 126.57 54.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.8 1.64 . . . . 0.0 107.739 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -99.69 85.39 3.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.979 1.371 . . . . 0.0 108.312 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -81.1 115.52 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.668 1.987 . . . . 0.0 111.594 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 118.53 36.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.289 -2.132 . . . . 0.0 110.761 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.4 mt -126.02 -178.86 4.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.557 1.143 . . . . 0.0 108.973 -170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.43 126.86 30.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 162.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.57 53.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.9 -1.125 . . . . 0.0 112.755 -174.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 t -97.23 92.8 6.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.439 1.59 . . . . 0.0 109.543 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.38 25.82 12.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.004 1.722 . . . . 0.0 114.31 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.3 65.46 1.32 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 124.677 1.132 . . . . 0.0 112.662 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.3 t 179.33 113.94 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.3 mt -78.58 -36.26 44.64 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.357 2.027 . . . . 0.0 106.466 162.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.545 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 101.82 43.93 2.02 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -128.3 133.64 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.5 m -89.34 108.03 19.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.683 1.593 . . . . 0.0 111.736 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 m -77.89 137.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -171.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 t -133.07 166.32 22.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.316 -1.49 . . . . 0.0 110.37 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.49 -130.86 10.27 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 125.106 1.336 . . . . 0.0 112.645 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.52 160.68 30.35 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.529 1.061 . . . . 0.0 112.049 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.87 11.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.808 -1.995 . . . . 0.0 115.729 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.08 -39.37 75.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.312 -1.492 . . . . 0.0 111.367 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.2 p -99.55 -155.53 0.51 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.883 1.273 . . . . 0.0 110.101 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -119.06 81.99 1.79 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.008 -1.683 . . . . 0.0 108.069 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.03 81.61 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 123.757 1.741 . . . . 0.0 110.305 -167.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 67.41 -109.4 0.12 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.788 1.635 . . . . 0.0 109.267 -168.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -146.83 52.24 1.1 Allowed 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.58 -1.325 . . . . 0.0 111.264 160.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.37 122.82 4.45 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-O 122.845 1.247 . . . . 0.0 114.921 166.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.11 177.24 36.69 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 105.936 -2.865 . . . . 0.0 105.936 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.34 154.94 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 119.489 1.645 . . . . 0.0 106.936 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -138.79 148.75 44.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.315 -2.116 . . . . 0.0 105.853 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 47' ' ' ILE . 69.9 t -73.39 127.56 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 120.622 -1.299 . . . . 0.0 111.505 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -88.23 -66.05 0.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.725 -1.235 . . . . 0.0 108.722 166.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 133.53 53.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.527 1.131 . . . . 0.0 111.711 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 44' ' ' VAL . 51.0 mm -93.44 137.1 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 169.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.545 HD12 ' CA ' ' A' ' 26' ' ' GLY . 54.5 mt -78.59 143.09 62.74 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.525 -1.703 . . . . 0.0 110.726 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.4 94.66 0.17 Allowed 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.486 2.79 . . . . 0.0 112.946 166.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.325 48.9 mtmt 43.84 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.446 2.698 . . . . 0.0 117.346 -169.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.22 -136.18 9.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 151.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.52 -44.69 18.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.255 -1.733 . . . . 0.0 113.732 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 120.786 1.63 . . . . 0.0 113.314 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 p -55.18 -27.28 44.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.17 -73.8 0.06 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.872 1.269 . . . . 0.0 111.173 170.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.44 -9.92 14.8 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 121.667 -0.646 . . . . 0.0 112.95 164.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -79.17 -27.69 42.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.135 -1.215 . . . . 0.0 110.557 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -69.98 146.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.549 1.939 . . . . 0.0 114.434 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -148.58 -171.59 3.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.833 -1.167 . . . . 0.0 109.317 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -78.12 93.74 4.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.902 -2.373 . . . . 0.0 112.569 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.38 -19.24 0.26 Allowed Glycine 0 N--CA 1.429 -1.782 0 O-C-N 121.023 -1.048 . . . . 0.0 114.467 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -70.05 153.43 43.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -172.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -105.51 121.3 43.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.407 1.575 . . . . 0.0 111.325 -172.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.22 109.48 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.418 2.687 . . . . 0.0 106.232 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.09 -37.07 9.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.192 -0.943 . . . . 0.0 112.488 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.93 166.5 33.35 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.979 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' A' ' 92' ' ' VAL . 4.8 p -142.54 123.57 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 121.311 -0.868 . . . . 0.0 113.023 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.24 30.89 3.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.82 22.4 66.45 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.608 -1.308 . . . . 0.0 114.329 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.81 98.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -67.0 137.59 56.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 125.106 1.362 . . . . 0.0 112.554 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -75.63 61.16 1.32 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.069 1.748 . . . . 0.0 113.679 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.1 110.18 5.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.192 1.397 . . . . 0.0 111.56 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.65 30.53 78.18 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.717 1.151 . . . . 0.0 115.6 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.54 140.45 29.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.762 1.281 . . . . 0.0 112.821 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.5 p -97.96 -157.44 0.6 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.698 1.999 . . . . 0.0 109.934 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.421 -2.049 . . . . 0.0 109.754 168.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -53.21 55.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.327 1.051 . . . . 0.0 111.645 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.07 -26.9 64.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.07 78.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.481 -2.012 . . . . 0.0 113.644 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG12 ' HG2' ' A' ' 86' ' ' ARG . 24.0 t -57.88 -52.56 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.16 -0.963 . . . . 0.0 110.184 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.406 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 62.1 mt-10 -54.02 -41.19 67.73 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.5 m -57.25 -39.31 75.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.905 2.082 . . . . 0.0 114.452 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mt -92.21 -28.4 17.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.842 1.257 . . . . 0.0 113.252 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG2' HG12 ' A' ' 82' ' ' VAL . 4.4 ppt_? -86.6 -47.98 8.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.02 43.98 1.17 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.667 1.699 . . . . 0.0 110.473 -171.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.8 p -95.94 -152.8 0.38 Allowed 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.103 2.961 . . . . 0.0 109.609 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.14 -137.42 9.56 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.144 -1.598 . . . . 0.0 110.43 172.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -92.9 -51.48 5.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.522 1.129 . . . . 0.0 109.055 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.76 132.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.976 1.37 . . . . 0.0 110.139 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 68' ' ' VAL . 4.5 t -124.01 111.76 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.66 103.55 10.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.126 1.371 . . . . 0.0 107.772 160.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -83.27 108.77 16.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.716 2.007 . . . . 0.0 108.284 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.7 102.57 11.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 110.722 169.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -109.6 147.97 32.1 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.392 2.277 . . . . 0.0 110.228 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.88 152.21 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.172 1.789 . . . . 0.0 106.425 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.64 141.53 46.51 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.87 -6.36 85.29 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 125.975 1.75 . . . . 0.0 113.243 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -80.14 65.52 5.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.805 1.642 . . . . 0.0 110.381 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.91 164.12 49.87 Favored Pre-proline 0 N--CA 1.431 -1.422 0 C-N-CA 126.678 1.991 . . . . 0.0 113.001 -172.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo . . . . . 0 C--N 1.3 -1.984 0 CA-C-N 121.782 1.672 . . . . 0.0 115.586 -173.342 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 43.1 t80 . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.442 0.639 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.606 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.0 tp -138.89 -162.13 1.28 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.104 0.962 . . . . 0.0 109.331 -172.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.606 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.394 10.9 m 31.71 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 130.308 3.443 . . . . 0.0 118.213 164.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 82.2 m -119.47 124.15 45.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 36.9 t -67.98 112.43 4.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.519 1.128 . . . . 0.0 108.562 164.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 25' ' ' LEU . 13.1 p . . . . . 0 C--O 1.26 1.624 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 -167.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 121.074 0.464 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -101.92 139.02 19.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 CA-C-O 116.968 -1.491 . . . . 0.0 107.479 166.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -58.57 115.55 2.62 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 123.472 2.276 . . . . 0.0 116.835 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.36 2.49 6.39 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.214 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -89.63 109.72 20.66 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 120.079 1.94 . . . . 0.0 110.121 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -96.69 155.81 16.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 111.575 172.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -133.87 133.43 41.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.352 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -111.4 76.03 0.95 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.967 1.307 . . . . 0.0 108.939 -177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.72 118.91 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 125.712 1.605 . . . . 0.0 114.543 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.268 6.3 pm0 -99.68 126.39 45.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.466 -2.021 . . . . 0.0 111.977 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 169.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.62 148.17 33.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.697 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 146.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 111.005 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -94.45 93.07 7.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.528 -1.357 . . . . 0.0 108.244 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 45.81 67.72 0.7 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.257 2.623 . . . . 0.0 115.861 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.82 42.7 77.97 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 121.507 -0.746 . . . . 0.0 113.862 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 p -167.89 106.18 0.51 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.848 1.785 . . . . 0.0 108.49 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.13 -47.23 59.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 162.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 27.77 1.67 Allowed Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.186 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 pt -109.13 122.93 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 122.998 1.38 . . . . 0.0 109.541 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -84.51 110.54 18.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.176 1.39 . . . . 0.0 109.209 171.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -80.9 138.43 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.477 ' HA ' HD11 ' B' ' 206' ' ' LEU . 9.2 t -133.51 171.63 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.017 1.727 . . . . 0.0 108.281 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.42 -143.73 18.05 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 124.985 1.279 . . . . 0.0 113.163 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.6 159.39 28.82 Favored Glycine 0 N--CA 1.431 -1.661 0 O-C-N 121.562 -0.963 . . . . 0.0 111.808 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.33 -32.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.052 1.741 . . . . 0.0 114.503 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.59 -11.43 42.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.492 -1.38 . . . . 0.0 113.253 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 m -88.82 -96.24 0.1 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.93 -1.106 . . . . 0.0 110.01 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 t -159.82 80.81 0.72 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.74 -1.85 . . . . 0.0 109.528 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.38 -167.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.807 -1.183 . . . . 0.0 108.834 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -72.92 -69.06 0.44 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.005 1.322 . . . . 0.0 110.875 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.03 -1.64 0.24 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.276 -1.515 . . . . 0.0 114.289 165.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.51 117.52 0.48 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.555 -1.966 . . . . 0.0 109.667 -175.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.05 145.44 4.3 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 tp -102.88 158.8 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 167.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -133.94 158.73 42.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.576 -1.952 . . . . 0.0 105.914 -171.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 47' ' ' ILE . 3.3 t -89.7 134.49 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.578 -1.951 . . . . 0.0 109.873 174.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -39.16 10.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.356 -1.465 . . . . 0.0 110.923 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.67 20.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.555 -0.716 . . . . 0.0 111.265 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.506 HD13 HG11 ' A' ' 44' ' ' VAL . 30.9 mm -99.01 135.02 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.6 1.96 . . . . 0.0 107.3 171.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt -100.71 147.47 33.69 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.6 73.08 6.19 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 123.101 2.534 . . . . 0.0 113.189 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -110.17 -85.91 0.54 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.065 -1.022 . . . . 0.0 111.732 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.53 38.66 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.311 -1.493 . . . . 0.0 114.236 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.23 -75.66 0.52 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.69 82.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.141 -1.599 . . . . 0.0 115.114 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.36 -29.77 70.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.496 -1.378 . . . . 0.0 111.583 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.35 -0.86 15.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 115.405 1.632 . . . . 0.0 115.405 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.73 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 108.447 158.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.57 -1.54 15.81 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 113.353 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -95.05 -31.9 13.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.023 -1.281 . . . . 0.0 110.237 169.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.36 139.54 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.131 -1.605 . . . . 0.0 114.594 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -127.54 177.47 6.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.982 0.896 . . . . 0.0 109.213 160.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.63 50.78 0.44 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.25 -1.53 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.154 -2.216 . . . . 0.0 115.666 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -76.01 161.73 28.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 118.567 1.183 . . . . 0.0 114.175 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -96.0 131.9 41.9 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.736 1.214 . . . . 0.0 109.869 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.48 115.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 168.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.35 -35.83 12.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.196 -1.565 . . . . 0.0 111.915 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.98 156.8 41.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.009 0.822 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.16 119.94 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 121.007 -1.058 . . . . 0.0 109.948 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.74 28.12 16.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.119 -1.613 . . . . 0.0 114.186 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.7 90.41 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 125.035 1.302 . . . . 0.0 113.486 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.6 t -97.33 104.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.155 -1.203 . . . . 0.0 109.163 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -53.4 137.17 36.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.357 2.263 . . . . 0.0 115.697 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.24 25.55 1.6 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.736 -1.227 . . . . 0.0 112.584 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.7 111.57 11.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.011 -1.68 . . . . 0.0 110.574 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.45 -1.67 72.92 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.777 -0.577 . . . . 0.0 113.039 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.22 138.66 31.4 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.552 1.644 . . . . 0.0 111.59 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.486 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 3.8 t -117.57 -171.7 2.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.677 2.391 . . . . 0.0 104.836 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -48.96 -52.65 23.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.844 1.658 . . . . 0.0 114.856 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.42 -47.74 59.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.755 1.161 . . . . 0.0 113.188 -175.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' HB2' ' H ' ' A' ' 77' ' ' THR . 5.1 mm100 -50.67 -49.35 57.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.554 1.542 . . . . 0.0 114.474 168.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.61 84.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.436 -1.415 . . . . 0.0 114.5 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.417 HG13 HG11 ' B' ' 210' ' ' VAL . 65.1 t -62.53 -48.19 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 111.512 175.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -58.14 -39.0 77.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.212 -1.555 . . . . 0.0 113.592 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.5 m -64.56 -26.81 68.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.518 2.327 . . . . 0.0 113.715 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.46 -47.02 7.67 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.349 1.459 . . . . 0.0 114.087 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.269 0.1 OUTLIER -79.62 -35.09 39.98 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.361 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.75 40.31 1.03 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.436 -2.04 . . . . 0.0 111.61 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.1 p -101.2 159.07 15.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.75 2.42 . . . . 0.0 111.663 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.09 65.09 4.17 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 121.165 -0.959 . . . . 0.0 112.103 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 67.46 -48.09 0.5 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 129.319 3.048 . . . . 0.0 116.133 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.2 t -80.5 131.66 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.775 1.274 . . . . 0.0 110.874 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.415 HG12 ' HG ' ' A' ' 94' ' ' LEU . 60.9 t -117.73 109.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -88.4 101.15 13.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.935 -1.103 . . . . 0.0 109.153 171.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.415 ' HG ' HG12 ' A' ' 92' ' ' VAL . 15.2 mt -90.37 122.62 33.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.864 -1.148 . . . . 0.0 111.627 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.07 102.95 14.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.7 mt -112.47 142.52 44.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.507 1.923 . . . . 0.0 110.583 -171.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.65 142.09 50.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.207 2.203 . . . . 0.0 108.512 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -67.79 127.12 31.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.4 69.69 1.5 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.154 1.359 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -130.42 166.21 20.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.944 1.298 . . . . 0.0 110.164 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.24 160.41 42.77 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.362 1.465 . . . . 0.0 110.479 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 N--CA 1.434 -2.006 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 176.798 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 30' ' ' THR . 10.5 tp 77.15 173.43 0.21 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.288 2.635 . . . . 0.0 114.2 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.407 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.491 5.9 m 52.82 100.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.103 2.961 . . . . 0.0 117.827 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 53.5 m -130.62 118.93 21.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 76.2 p -77.67 122.83 25.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.575 1.15 . . . . 0.0 109.244 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.633 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -175.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 121.764 0.793 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -138.2 147.45 55.9 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 175.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.71 105.23 1.27 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.66 2.343 . . . . 0.0 116.19 -168.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.47 39.81 97.82 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 124.762 1.172 . . . . 0.0 113.739 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.01 135.75 44.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.146 0.978 . . . . 0.0 111.727 -172.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -89.52 120.68 31.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.37 1.081 . . . . 0.0 111.23 174.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 114.74 26.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 174.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -92.29 83.45 5.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.24 153.39 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 127.761 2.425 . . . . 0.0 110.339 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.52 50.96 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.513 -1.992 . . . . 0.0 108.321 167.285 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.8 mt -128.75 161.72 29.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 123.998 0.919 . . . . 0.0 109.689 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.74 117.13 26.67 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.032 0.92 . . . . 0.0 108.863 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 1.2 ptmm? -62.84 126.25 26.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.051 1.74 . . . . 0.0 113.087 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -96.48 118.27 32.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.989 -1.069 . . . . 0.0 108.709 -171.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.34 -19.93 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.29 2.236 . . . . 0.0 117.006 -171.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 53.26 0.11 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.971 1.748 . . . . 0.0 110.682 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 m -177.81 126.87 0.13 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 -173.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.2 mt -84.02 -39.4 19.68 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.393 2.277 . . . . 0.0 106.724 172.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA2' HD11 ' A' ' 48' ' ' ILE . . . 131.97 6.17 3.28 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 124.298 0.951 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 pt -102.0 127.55 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 122.428 1.108 . . . . 0.0 111.13 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -81.49 109.8 16.29 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.075 1.35 . . . . 0.0 112.102 168.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.91 125.95 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -172.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.5 t -120.22 160.84 22.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.938 2.095 . . . . 0.0 110.843 175.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.08 -125.14 8.24 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.668 1.604 . . . . 0.0 112.441 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.15 140.72 11.43 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 177.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 40' ' ' GLY . 9.1 m -56.5 -27.56 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.898 1.279 . . . . 0.0 114.28 -167.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' HB2' HG22 ' A' ' 77' ' ' THR . 63.1 t30 -47.22 -55.34 8.76 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 128.064 2.545 . . . . 0.0 116.275 -167.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 p -140.96 -77.75 0.29 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -41.82 -46.75 4.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.575 3.15 . . . . 0.0 117.648 -171.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.31 -6.9 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 O-C-N 119.934 -1.729 . . . . 0.0 112.854 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 61.34 52.75 3.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.031 2.132 . . . . 0.0 112.751 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.367 17.9 m-70 59.51 132.46 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.395 2.278 . . . . 0.0 116.174 -164.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 33' ' ' VAL . . . -178.23 -107.09 0.21 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.976 -2.328 . . . . 0.0 113.776 -162.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.92 -157.03 13.65 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 107.354 -2.298 . . . . 0.0 107.354 -177.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.517 HG22 HG13 ' A' ' 65' ' ' VAL 0.287 2.3 tp -114.61 157.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.043 1.421 . . . . 0.0 108.701 175.432 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -140.6 157.25 45.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.892 -1.755 . . . . 0.0 106.614 -171.128 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 47' ' ' ILE . 6.2 t -88.73 127.37 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.305 -1.497 . . . . 0.0 112.2 174.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -83.27 -50.42 8.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.656 -1.277 . . . . 0.0 109.907 171.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.06 138.87 37.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -174.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.539 HD13 HG11 ' A' ' 44' ' ' VAL . 29.1 mm -97.03 145.58 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.121 1.768 . . . . 0.0 107.184 171.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.542 HD11 ' HA2' ' A' ' 26' ' ' GLY . 2.2 pt -99.05 138.97 20.69 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 110.776 169.066 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.3 67.31 8.63 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.491 2.127 . . . . 0.0 110.895 171.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.16 73.63 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.866 2.066 . . . . 0.0 110.098 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 177.04 164.98 31.7 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 118.628 -2.545 . . . . 0.0 109.453 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.14 84.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.746 2.019 . . . . 0.0 114.475 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.13 72.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.322 -1.486 . . . . 0.0 113.916 -177.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.74 -32.99 72.26 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.274 1.43 . . . . 0.0 112.195 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -61.62 -28.54 69.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.32 -75.04 0.05 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.932 1.242 . . . . 0.0 111.797 176.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.16 -30.71 2.42 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 112.1 168.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -86.58 -20.97 27.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 113.644 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -71.75 133.89 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.159 1.784 . . . . 0.0 112.073 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -150.33 -159.75 1.08 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.638 -1.288 . . . . 0.0 110.557 165.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.76 129.03 36.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.215 -1.553 . . . . 0.0 112.1 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.75 23.24 56.42 Favored Glycine 0 N--CA 1.428 -1.839 0 O-C-N 120.151 -1.593 . . . . 0.0 114.965 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.85 148.14 22.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.289 -1.124 . . . . 0.0 109.821 168.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -90.99 129.8 36.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.04 -1.038 . . . . 0.0 109.976 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 42' ' ' ILE . 1.5 p -104.19 119.91 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 165.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.87 -31.57 11.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.754 -1.216 . . . . 0.0 112.852 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.2 43.48 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 119.04 0.836 . . . . 0.0 112.418 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 HG13 ' A' ' 92' ' ' VAL . 61.1 t -135.49 120.86 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 121.189 -0.945 . . . . 0.0 111.027 -177.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 54.94 29.79 12.82 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.412 1.485 . . . . 0.0 114.44 -170.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.77 22.36 77.15 Favored Glycine 0 N--CA 1.431 -1.659 0 O-C-N 121.037 -1.039 . . . . 0.0 114.117 -173.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.48 101.94 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.619 1.567 . . . . 0.0 107.86 177.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -66.19 143.49 57.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.843 -1.16 . . . . 0.0 113.915 177.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.39 62.0 3.61 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.902 1.681 . . . . 0.0 112.783 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.33 123.33 37.67 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.837 1.655 . . . . 0.0 108.539 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.5 -7.6 57.11 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.626 -1.296 . . . . 0.0 114.487 -171.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.93 129.26 34.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.128 1.918 . . . . 0.0 114.755 -169.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 34' ' ' ASN . 73.1 p -96.17 -163.48 1.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.471 1.909 . . . . 0.0 108.415 -175.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.4 -51.66 66.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.986 -1.696 . . . . 0.0 112.374 163.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.61 -42.19 87.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.122 -0.986 . . . . 0.0 112.723 -177.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.9 tt0 -69.84 -34.32 73.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.43 75.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.217 -2.177 . . . . 0.0 114.097 171.291 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.59 -53.01 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.429 -0.794 . . . . 0.0 110.832 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.13 -41.36 62.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.418 1.463 . . . . 0.0 114.837 175.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.7 m -62.41 -29.95 70.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.65 2.38 . . . . 0.0 114.542 178.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.47 -40.95 9.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -50.55 15.06 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.534 2.334 . . . . 0.0 112.73 -171.262 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -91.44 42.55 1.11 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.977 1.37 . . . . 0.0 110.622 -168.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.1 p -102.44 164.7 11.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.51 2.324 . . . . 0.0 111.341 -174.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.04 58.23 4.77 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.759 -1.213 . . . . 0.0 113.125 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 71.16 -48.23 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.945 2.898 . . . . 0.0 116.858 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.49 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.596 1.188 . . . . 0.0 109.478 171.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.429 HG13 HG13 ' A' ' 68' ' ' VAL . 95.3 t -117.63 99.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -78.92 105.89 10.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.807 -1.183 . . . . 0.0 107.964 166.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -88.89 125.49 34.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.187 -1.571 . . . . 0.0 110.544 -177.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.42 102.09 14.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 108.567 166.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.32 148.29 24.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.2 1.8 . . . . 0.0 111.713 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -116.37 138.75 51.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 162.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -67.86 126.1 28.38 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.618 0.767 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -21.57 76.0 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 124.883 1.23 . . . . 0.0 114.497 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -84.32 104.89 14.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.149 1.78 . . . . 0.0 109.641 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.2 105.12 49.45 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 121.258 -0.901 . . . . 0.0 111.637 -173.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--N 1.299 -2.042 0 N-CA-C 118.04 2.284 . . . . 0.0 118.04 162.98 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 20.2 tp -86.82 157.55 19.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.301 -1.499 . . . . 0.0 111.087 172.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.41 2.2 t 78.92 122.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.077 1.894 . . . . 0.0 114.565 166.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.1 m -147.21 125.11 11.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 176.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.7 p -75.52 128.99 36.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.013 0.925 . . . . 0.0 109.61 169.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.3 p . . . . . 0 C--O 1.259 1.588 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -162.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -87.09 156.43 54.72 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 120.042 -1.661 . . . . 0.0 110.692 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -58.3 129.73 34.25 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 120.045 3.056 . . . . 0.0 120.045 -155.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.73 12.65 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 125.733 1.635 . . . . 0.0 112.727 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.55 16.39 0.65 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.493 3.516 . . . . 0.0 120.493 -160.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.17 114.59 7.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 156.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -130.66 113.69 14.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.089 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.75 71.55 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.867 1.317 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.95 121.58 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.702 2.401 . . . . 0.0 111.721 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -105.24 115.34 30.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.423 -2.048 . . . . 0.0 109.398 -174.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -115.83 146.4 42.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.836 0.827 . . . . 0.0 110.003 -171.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.81 109.58 21.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 165.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -53.7 151.99 5.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.842 2.057 . . . . 0.0 112.77 175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -110.12 104.74 13.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 56.73 5.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.133 2.173 . . . . 0.0 116.086 -175.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.62 61.2 5.19 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 120.49 -1.381 . . . . 0.0 115.897 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 t 175.08 112.64 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.792 1.637 . . . . 0.0 106.77 -173.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.42 -41.93 45.93 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 126.233 1.813 . . . . 0.0 107.388 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.45 33.76 1.28 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.034 171.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.19 133.74 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 121.845 -0.797 . . . . 0.0 111.062 175.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -82.95 113.13 20.34 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.245 1.018 . . . . 0.0 111.088 164.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.555 HG23 ' CE1' ' A' ' 78' ' ' HIS . 21.0 m -85.26 128.98 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -124.11 167.15 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.448 1.899 . . . . 0.0 110.865 176.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 -137.65 15.6 Favored Glycine 0 N--CA 1.428 -1.846 0 C-N-CA 125.103 1.335 . . . . 0.0 112.915 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.11 161.88 21.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 124.433 1.015 . . . . 0.0 111.293 177.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 t -56.05 -32.7 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -70.48 -27.84 64.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -171.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 p -103.95 3.37 33.49 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.454 -1.404 . . . . 0.0 112.433 -175.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t 68.11 84.68 0.15 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.011 1.725 . . . . 0.0 113.094 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.04 -159.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.848 1.659 . . . . 0.0 110.014 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -56.29 -66.93 0.35 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.1 -1.625 . . . . 0.0 112.852 175.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -167.07 116.75 0.86 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 156.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.36 105.59 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.415 2.126 . . . . 0.0 118.415 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -167.96 21.34 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.513 -0.993 . . . . 0.0 113.491 162.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.7 tp -116.59 164.39 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.189 0.995 . . . . 0.0 110.093 -166.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -140.72 156.75 46.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.028 -1.67 . . . . 0.0 106.786 -172.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.591 HG11 ' CD1' ' A' ' 47' ' ' ILE . 3.4 t -91.37 119.87 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.644 -1.285 . . . . 0.0 111.782 177.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -83.71 -40.49 18.81 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.732 -1.23 . . . . 0.0 111.065 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.42 131.8 17.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.964 0.905 . . . . 0.0 109.988 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.591 ' CD1' HG11 ' A' ' 44' ' ' VAL . 50.4 mm -97.33 120.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.113 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.9 pt -77.56 152.46 80.88 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 121.163 -0.961 . . . . 0.0 113.018 -175.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.77 92.54 0.96 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 122.159 1.906 . . . . 0.0 113.243 -177.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.308 46.7 mtpt 92.64 88.33 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 127.129 2.172 . . . . 0.0 110.641 169.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.41 -172.96 20.8 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 103.284 -3.926 . . . . 0.0 103.284 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.72 82.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.24 -40.53 67.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.81 -28.7 69.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.469 -1.394 . . . . 0.0 111.796 168.225 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.7 t -73.33 -12.9 60.99 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.92 -85.03 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.923 2.147 . . . . 0.0 110.403 176.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.82 -30.22 0.82 Allowed Glycine 0 N--CA 1.431 -1.697 0 O-C-N 120.622 -1.299 . . . . 0.0 111.469 172.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -83.87 -43.08 15.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.55 -0.971 . . . . 0.0 111.287 -176.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 134.83 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 124.765 1.226 . . . . 0.0 114.046 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -133.5 -172.69 3.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 164.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -84.52 122.3 28.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.308 -2.12 . . . . 0.0 112.084 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.71 -30.71 2.73 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 112.395 -169.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -73.12 162.88 28.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.279 1.514 . . . . 0.0 113.768 -172.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -105.01 129.9 53.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.98 0.912 . . . . 0.0 109.884 -173.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.34 114.72 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.12 1.438 . . . . 0.0 107.984 167.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.41 -32.02 11.71 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 120.231 -1.543 . . . . 0.0 113.176 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.14 159.32 43.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.611 1.096 . . . . 0.0 111.867 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.0 126.2 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 110.415 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 m120 58.59 22.14 9.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.919 1.691 . . . . 0.0 114.828 -174.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.69 -2.72 80.61 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.629 1.109 . . . . 0.0 114.267 -172.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.81 103.01 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.115 1.366 . . . . 0.0 108.53 -172.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -62.77 141.39 58.62 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.599 1.56 . . . . 0.0 113.18 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.56 72.46 7.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.475 1.131 . . . . 0.0 111.098 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -91.65 111.18 22.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.769 1.228 . . . . 0.0 108.621 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.3 -3.86 85.15 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.988 -1.07 . . . . 0.0 115.349 -176.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.41 133.35 38.69 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 123.942 1.83 . . . . 0.0 114.745 -172.062 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 80.0 p -99.53 -155.82 0.52 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.558 2.343 . . . . 0.0 109.881 -169.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 29' ' ' VAL . 85.2 t60 -72.4 -50.47 26.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.612 -1.93 . . . . 0.0 111.19 168.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -42.82 80.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 77' ' ' THR . 17.8 tt0 -65.68 -35.87 82.01 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.12 -1.612 . . . . 0.0 113.902 174.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.78 96.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.671 -1.893 . . . . 0.0 115.05 172.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.03 -56.39 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 123.594 0.757 . . . . 0.0 110.406 172.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -51.28 -46.49 62.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.06 1.344 . . . . 0.0 113.602 177.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 m -59.58 -30.39 68.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.384 1.874 . . . . 0.0 114.422 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.6 mt -89.34 -38.65 14.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.161 -1.587 . . . . 0.0 113.366 173.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.44 39.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.575 2.35 . . . . 0.0 114.863 -172.51 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 15.13 0.58 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.5 p -91.68 158.86 16.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.287 2.635 . . . . 0.0 111.013 -169.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.55 -61.67 3.08 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 121.414 -0.804 . . . . 0.0 114.286 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.52 -64.84 0.18 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.236 -1.155 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.09 129.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.153 1.454 . . . . 0.0 111.541 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -115.58 105.3 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.834 1.654 . . . . 0.0 107.749 172.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -78.74 106.17 10.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.572 -1.33 . . . . 0.0 109.284 169.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mt -87.41 110.37 20.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.067 1.747 . . . . 0.0 108.677 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.9 101.86 13.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 172.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.89 143.26 34.28 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 -175.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.16 143.16 45.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.888 2.075 . . . . 0.0 106.226 171.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -78.54 129.48 34.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 123.564 0.746 . . . . 0.0 110.892 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.96 -74.13 0.55 Allowed Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 123.628 0.633 . . . . 0.0 113.811 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -159.38 8.6 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.12 118.39 62.68 Favored Pre-proline 0 N--CA 1.431 -1.406 0 O-C-N 119.953 -1.717 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 C--N 1.3 -2.018 0 CA-C-N 124.784 2.744 . . . . 0.0 115.419 -176.982 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp 74.73 -175.68 0.14 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.648 2.379 . . . . 0.0 112.618 -178.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.404 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.412 5.7 m 45.23 92.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 162.925 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -128.34 125.05 37.93 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 -171.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.3 m -74.23 123.84 25.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.293 1.837 . . . . 0.0 108.575 177.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.657 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -163.15 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 121.209 0.528 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.09 160.94 29.18 Favored Pre-proline 0 N--CA 1.43 -1.454 0 O-C-N 120.92 -1.112 . . . . 0.0 110.39 -175.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -66.28 132.79 30.6 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 122.333 2.022 . . . . 0.0 113.607 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.46 -32.0 4.84 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 123.712 0.672 . . . . 0.0 113.638 174.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.42 132.13 41.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -104.13 143.84 32.38 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.1 1.36 . . . . 0.0 107.408 157.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -125.22 120.94 32.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.52 74.83 1.91 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.893 1.277 . . . . 0.0 107.734 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.99 151.23 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.302 2.241 . . . . 0.0 109.355 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.27 128.68 45.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.435 -2.041 . . . . 0.0 111.165 168.266 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -126.0 141.16 52.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 124.553 1.141 . . . . 0.0 109.058 -171.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.66 111.47 23.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.65 124.06 18.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.45 1.1 . . . . 0.0 111.7 -177.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -94.37 108.58 20.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.92 1.343 . . . . 0.0 108.982 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 60.23 34.86 20.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.823 2.049 . . . . 0.0 114.686 -179.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.46 60.57 2.47 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.742 -1.224 . . . . 0.0 114.367 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m 172.34 120.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.868 2.067 . . . . 0.0 105.574 -175.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.85 -41.44 78.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.217 1.484 . . . . 0.0 107.966 161.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 120.11 22.95 3.08 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.471 170.186 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' A' ' 44' ' ' VAL . 36.7 pt -111.39 130.24 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.213 -1.169 . . . . 0.0 111.224 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -79.67 112.53 17.03 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.201 1.0 . . . . 0.0 110.576 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 m -84.15 131.15 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -123.11 166.73 14.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.618 -1.927 . . . . 0.0 109.824 176.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.69 -150.83 31.61 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.787 1.185 . . . . 0.0 113.857 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.458 ' H ' HG11 ' A' ' 37' ' ' VAL . . . 113.49 166.05 16.16 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 125.49 1.519 . . . . 0.0 110.556 -177.539 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -66.78 -6.55 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -72.49 -39.88 67.32 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.211 -1.555 . . . . 0.0 112.674 171.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.5 p -109.96 174.19 5.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.337 -1.477 . . . . 0.0 110.858 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.4 m -80.65 90.52 5.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.492 -2.005 . . . . 0.0 112.864 -175.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG11 ' H ' ' A' ' 32' ' ' GLY . 19.7 m -94.68 -165.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.458 1.503 . . . . 0.0 109.803 172.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.76 -69.52 0.41 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.774 -1.829 . . . . 0.0 110.005 173.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 119.9 3.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.098 -1.002 . . . . 0.0 109.216 163.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 46.64 87.95 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 127.564 2.507 . . . . 0.0 118.797 166.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.72 -171.91 39.48 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 120.477 -1.602 . . . . 0.0 111.098 169.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.268 1.8 tp -115.3 162.04 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.776 0.798 . . . . 0.0 109.454 -172.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -142.69 154.07 43.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -169.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG11 ' CD1' ' A' ' 47' ' ' ILE . 6.6 t -90.1 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.965 -1.709 . . . . 0.0 111.988 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -90.47 -48.37 7.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.519 -1.363 . . . . 0.0 111.169 176.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.05 128.72 18.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.003 0.906 . . . . 0.0 112.217 -172.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.535 ' CD1' HG11 ' A' ' 44' ' ' VAL . 43.7 mm -92.68 134.24 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.205 2.202 . . . . 0.0 109.175 178.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.553 HD12 ' CA ' ' A' ' 26' ' ' GLY . 29.6 mt -76.06 143.87 74.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.132 1.373 . . . . 0.0 109.911 175.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -60.75 88.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.379 2.719 . . . . 0.0 115.053 161.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 mttt 66.6 63.06 0.52 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.46 -120.56 2.77 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 158.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.29 -44.64 7.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.532 -0.981 . . . . 0.0 112.307 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.55 -41.31 72.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.93 -31.36 71.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.152 -2.217 . . . . 0.0 110.862 170.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.04 5.79 6.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -72.52 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.296 -2.128 . . . . 0.0 105.9 149.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.0 1.0 Allowed Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.862 163.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -79.55 -17.48 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 117.172 0.486 . . . . 0.0 112.309 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.49 133.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.174 2.19 . . . . 0.0 111.67 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.93 -178.94 5.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.895 -1.128 . . . . 0.0 108.763 169.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -86.23 60.42 6.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.923 -2.361 . . . . 0.0 113.258 -174.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.91 -7.52 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 121.086 -1.009 . . . . 0.0 114.787 176.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -76.05 154.12 35.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.399 1.571 . . . . 0.0 114.92 -172.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -102.64 105.83 16.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.406 1.882 . . . . 0.0 108.79 -173.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.37 113.14 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.8 -1.813 . . . . 0.0 108.949 -179.391 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.42 -29.0 13.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.137 1.375 . . . . 0.0 113.41 -173.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 155.18 38.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 119.984 1.266 . . . . 0.0 112.745 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 92' ' ' VAL . 13.5 t -132.98 119.0 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.595 -0.691 . . . . 0.0 111.175 -177.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 56.09 31.98 19.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 120.409 1.459 . . . . 0.0 114.027 -168.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.29 9.9 85.62 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.809 -1.182 . . . . 0.0 114.301 -173.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -100.26 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.4 p -60.42 138.1 58.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.83 31.77 0.84 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.76 -1.213 . . . . 0.0 112.15 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.72 76.13 1.55 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.201 2.201 . . . . 0.0 110.941 -177.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.99 5.79 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 125.047 1.308 . . . . 0.0 114.44 -170.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.59 139.08 31.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.021 1.911 . . . . 0.0 112.587 177.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t -112.13 -165.26 0.98 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.458 2.303 . . . . 0.0 105.95 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -53.9 -57.68 10.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.391 1.876 . . . . 0.0 113.641 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -69.62 -46.99 64.96 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 111.987 -174.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -48.64 66.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.918 1.687 . . . . 0.0 113.572 173.272 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.61 86.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.208 -1.558 . . . . 0.0 114.609 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.79 -47.97 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.35 1.06 . . . . 0.0 112.193 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -68.47 -29.23 67.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.251 -1.531 . . . . 0.0 114.158 177.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.6 m -68.55 -26.3 65.35 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.948 1.699 . . . . 0.0 113.194 174.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.51 -48.66 6.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.341 1.457 . . . . 0.0 113.58 172.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -82.61 -36.97 25.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -172.103 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.01 29.26 1.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.31 1.868 . . . . 0.0 112.594 -172.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.4 p -88.76 -168.35 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.373 3.069 . . . . 0.0 109.933 175.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.52 -110.85 3.02 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.211 -1.555 . . . . 0.0 111.547 175.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -102.12 -61.17 1.42 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.863 0.831 . . . . 0.0 112.567 -176.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.64 125.86 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.765 1.269 . . . . 0.0 110.45 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 68' ' ' VAL . 8.1 t -109.92 111.51 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 125.395 1.478 . . . . 0.0 107.833 165.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -79.87 112.26 16.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.773 -1.204 . . . . 0.0 108.643 166.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mt -94.28 112.96 24.79 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.054 1.342 . . . . 0.0 109.015 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.45 101.01 13.69 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.05 143.61 34.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.489 2.315 . . . . 0.0 110.182 -175.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -122.66 143.57 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.197 1.399 . . . . 0.0 109.95 173.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.52 113.87 0.56 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.807 3.262 . . . . 0.0 119.807 -175.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.87 64.31 3.41 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.952 -2.343 . . . . 0.0 113.144 172.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -141.59 169.13 18.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.443 1.097 . . . . 0.0 111.76 -178.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.63 129.18 32.13 Favored Pre-proline 0 N--CA 1.43 -1.436 0 C-N-CA 125.959 1.704 . . . . 0.0 110.577 -172.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 C--N 1.3 -2.009 0 C-N-CA 123.072 2.514 . . . . 0.0 117.177 174.951 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.6 tp -156.34 173.31 17.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.466 6.9 m 43.57 87.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 128.789 2.836 . . . . 0.0 117.439 170.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 77.1 m -129.37 120.82 26.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -176.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -78.86 121.98 25.51 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.314 1.446 . . . . 0.0 109.501 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 -171.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -119.79 140.29 29.36 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.506 -1.371 . . . . 0.0 108.026 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.21 138.08 19.83 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 123.574 2.312 . . . . 0.0 111.764 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.64 25.65 71.69 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.146 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.28 104.06 15.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.592 1.196 . . . . 0.0 111.916 -169.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 p -76.66 143.49 40.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.554 -1.341 . . . . 0.0 113.804 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.35 132.69 48.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.562 1.145 . . . . 0.0 108.489 174.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 84.86 2.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.207 1.003 . . . . 0.0 109.569 175.279 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.96 155.0 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.479 1.911 . . . . 0.0 109.644 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -130.54 118.82 21.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.287 -2.133 . . . . 0.0 110.097 165.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.3 mt -122.36 154.47 37.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.937 -1.102 . . . . 0.0 109.975 -174.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.95 119.64 39.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.1 0.952 . . . . 0.0 109.223 162.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 123.43 19.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.992 1.317 . . . . 0.0 113.025 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -90.1 115.12 27.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.777 -1.202 . . . . 0.0 109.501 -175.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 52.43 42.63 31.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.317 1.847 . . . . 0.0 114.915 -172.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.57 43.17 53.41 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.271 0.938 . . . . 0.0 115.342 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -166.74 113.49 0.82 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -170.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' B' ' 210' ' ' VAL . 6.0 mt -75.07 -28.79 60.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.118 -1.614 . . . . 0.0 107.443 169.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.35 13.09 11.02 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.988 168.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.0 pt -114.75 125.76 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 118.226 1.013 . . . . 0.0 110.454 -171.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -80.86 121.77 26.38 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.509 1.124 . . . . 0.0 113.536 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.19 132.47 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -127.96 170.57 12.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.509 1.524 . . . . 0.0 109.045 169.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.43 -123.08 6.31 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.291 1.424 . . . . 0.0 113.734 178.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.15 155.17 27.53 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 121.681 -0.893 . . . . 0.0 112.993 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -61.1 -24.88 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.881 -1.364 . . . . 0.0 112.794 -177.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -65.19 -32.41 74.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.173 2.189 . . . . 0.0 113.542 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.8 m -79.84 -48.87 12.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.591 1.156 . . . . 0.0 109.462 176.564 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.377 66.1 p 102.39 106.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.111 3.364 . . . . 0.0 109.582 -174.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.62 56.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.993 1.317 . . . . 0.0 109.064 -163.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.267 70.9 ttt180 71.02 -62.98 0.44 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.809 2.044 . . . . 0.0 114.972 -171.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -137.57 -50.95 0.62 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.643 -1.286 . . . . 0.0 110.365 178.048 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.08 -137.21 3.42 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 105.743 -2.943 . . . . 0.0 105.743 -178.358 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.93 173.23 27.76 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 121.714 -0.874 . . . . 0.0 112.492 -168.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -123.32 161.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 170.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -132.71 152.03 51.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.78 -1.825 . . . . 0.0 106.647 -171.141 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 47' ' ' ILE . 47.6 t -91.27 119.43 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 120.04 -1.663 . . . . 0.0 108.973 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -82.91 -60.33 2.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.605 -1.309 . . . . 0.0 110.833 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.91 132.28 56.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.26 1.029 . . . . 0.0 110.838 -176.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.492 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.3 mm -94.6 131.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 164.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt -101.52 157.74 33.1 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 111.685 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.48 109.37 2.03 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.56 2.173 . . . . 0.0 113.149 171.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt 68.89 61.05 0.34 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 167.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.41 -100.29 2.04 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 162.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.07 -38.74 0.77 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.51 1.124 . . . . 0.0 110.569 170.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.9 64.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.48 -41.43 80.68 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.306 -1.496 . . . . 0.0 111.468 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -73.6 6.27 3.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.348 2.259 . . . . 0.0 116.496 -177.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.55 -82.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.405 -2.06 . . . . 0.0 107.742 152.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.55 -32.64 1.11 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 170.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -83.92 -15.8 46.6 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.072 0.949 . . . . 0.0 113.162 -172.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.87 133.01 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.941 1.696 . . . . 0.0 110.989 173.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -131.55 -172.71 2.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.285 1.434 . . . . 0.0 109.936 173.067 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -85.95 113.06 21.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.876 -1.765 . . . . 0.0 109.898 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.23 10.8 12.98 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.354 0.978 . . . . 0.0 114.946 -175.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.25 164.09 20.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.465 1.506 . . . . 0.0 112.826 176.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -116.3 121.39 41.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.668 2.387 . . . . 0.0 111.647 -173.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.07 122.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.512 1.525 . . . . 0.0 107.895 174.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 -39.88 8.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 120.255 -1.528 . . . . 0.0 112.309 175.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.98 159.94 42.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.787 1.176 . . . . 0.0 113.783 -176.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 92' ' ' VAL . 79.7 t -132.01 119.8 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 124.378 1.071 . . . . 0.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 56.82 25.11 9.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.258 -1.527 . . . . 0.0 115.034 -171.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.74 -2.98 84.88 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.12 1.343 . . . . 0.0 114.6 -171.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.6 t -93.86 100.46 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 0.0 108.361 -174.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t -70.29 137.37 50.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.315 1.446 . . . . 0.0 113.497 -178.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.92 52.16 1.45 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.099 2.16 . . . . 0.0 112.403 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -79.25 119.06 21.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.005 1.322 . . . . 0.0 109.925 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 14.03 75.31 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.886 -1.134 . . . . 0.0 114.959 -175.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.51 138.78 31.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.855 1.312 . . . . 0.0 112.299 -177.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.3 p -101.11 -162.55 0.95 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.682 1.993 . . . . 0.0 109.699 -174.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -59.84 -54.07 50.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.977 -1.702 . . . . 0.0 112.001 164.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -71.59 -41.13 69.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.498 -0.751 . . . . 0.0 112.869 -176.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -40.5 96.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 175.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.37 95.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.888 -1.758 . . . . 0.0 114.584 173.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -53.8 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 119.123 0.874 . . . . 0.0 111.189 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -64.58 -36.73 85.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.878 2.471 . . . . 0.0 113.643 176.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.94 -26.96 18.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.305 1.842 . . . . 0.0 115.269 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HB2' HG21 ' B' ' 210' ' ' VAL . 3.7 tmt_? -83.97 -52.8 6.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.423 1.889 . . . . 0.0 112.489 -176.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -93.68 63.77 3.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 110.695 -175.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.2 p -96.14 -129.65 0.16 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.006 1.322 . . . . 0.0 111.815 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.29 57.36 0.43 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 64.08 -54.4 0.25 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.785 3.234 . . . . 0.0 114.47 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.35 124.99 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.572 1.177 . . . . 0.0 110.156 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 68' ' ' VAL . 85.0 t -110.92 106.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 168.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -77.97 102.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.942 -1.099 . . . . 0.0 108.952 166.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.43 118.31 24.88 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.577 -1.327 . . . . 0.0 110.475 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.96 100.92 13.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 148.86 25.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.481 1.512 . . . . 0.0 109.991 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -164.04 1.08 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.038 2.135 . . . . 0.0 107.562 173.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.05 106.54 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.259 -2.151 . . . . 0.0 112.282 159.142 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.09 66.63 3.82 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.331 -1.48 . . . . 0.0 112.265 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -144.76 168.74 19.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.52 1.528 . . . . 0.0 108.584 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.83 165.85 44.7 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 125.275 1.43 . . . . 0.0 112.791 -173.303 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 C--N 1.299 -2.043 0 C-N-CA 123.91 3.073 . . . . 0.0 110.656 153.598 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 122.662 1.22 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.3 tp -124.0 -147.13 0.37 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.673 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.38 2.4 t 25.52 101.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.188 4.195 . . . . 0.0 118.568 163.604 . . . . . . . . 4 3 . 1 . 024 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 2.6 p -144.92 116.02 7.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -172.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.4 p -75.25 130.2 38.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.382 1.073 . . . . 0.0 110.424 174.16 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 86' ' ' ARG . 2.8 p . . . . . 0 C--O 1.261 1.682 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -171.494 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.431 -1.405 0 CA-C-O 122.755 1.264 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -117.39 155.72 49.77 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 158.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -65.29 131.02 26.95 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.013 2.112 . . . . 0.0 113.308 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 50.67 20.12 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 178.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -77.9 123.12 26.38 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.844 -1.386 . . . . 0.0 110.923 176.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 p -82.59 144.04 30.61 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.085 -1.635 . . . . 0.0 112.321 177.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.26 1.6 m-30 -107.67 144.01 35.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -118.51 77.41 1.17 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 158.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.47 112.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.917 2.087 . . . . 0.0 107.098 -168.42 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.71 135.36 54.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.935 -1.728 . . . . 0.0 112.719 -175.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.15 178.3 9.42 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.344 -0.847 . . . . 0.0 108.9 -171.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.05 139.2 52.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.841 -1.162 . . . . 0.0 111.461 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 144.22 28.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.18 -1.575 . . . . 0.0 111.305 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -96.89 102.22 13.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.771 -1.206 . . . . 0.0 109.317 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.32 61.98 2.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -171.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.53 49.74 63.14 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.845 -1.159 . . . . 0.0 114.201 178.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.4 t -168.3 96.58 0.41 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.732 1.73 . . . . 0.0 107.319 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.02 -46.52 56.85 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.048 2.139 . . . . 0.0 106.514 166.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.66 39.93 0.96 Allowed Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.708 175.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.52 130.0 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.946 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -84.65 113.76 21.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.09 1.356 . . . . 0.0 112.072 170.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.81 125.65 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -175.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -122.71 164.04 19.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.656 1.982 . . . . 0.0 109.367 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.41 17.26 Favored Glycine 0 N--CA 1.431 -1.683 0 C-N-CA 124.71 1.148 . . . . 0.0 112.547 178.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.93 165.26 34.14 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.246 0.926 . . . . 0.0 111.565 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.64 -13.94 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.467 -1.607 . . . . 0.0 113.492 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -67.36 -39.81 85.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.316 1.846 . . . . 0.0 113.803 171.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 m -84.3 -33.37 23.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.88 -1.137 . . . . 0.0 109.931 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 t 81.29 86.24 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.862 2.065 . . . . 0.0 109.97 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.8 73.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 125.034 1.333 . . . . 0.0 108.867 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.5 mtp85 68.95 -49.65 0.59 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.996 2.118 . . . . 0.0 113.714 -168.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -145.77 -102.44 0.1 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.431 1.893 . . . . 0.0 105.926 164.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.3 -131.88 4.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 167.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.35 15.01 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.902 -1.351 . . . . 0.0 111.529 -166.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 42' ' ' ILE 0.274 4.0 tp -110.3 163.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.973 -1.31 . . . . 0.0 108.181 173.423 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -137.39 161.91 35.02 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.915 -1.74 . . . . 0.0 107.0 -174.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.55 HG11 ' CD1' ' A' ' 47' ' ' ILE . 2.2 t -89.91 125.86 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.296 -1.503 . . . . 0.0 111.841 173.419 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -82.13 -51.84 7.58 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.732 -1.23 . . . . 0.0 109.948 166.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.62 32.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.763 1.225 . . . . 0.0 110.443 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.55 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.4 mm -91.51 121.57 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 pt -76.97 142.41 69.12 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 110.229 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.7 106.94 1.93 Allowed 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.578 2.186 . . . . 0.0 113.285 -164.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 64.89 64.11 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.465 1.506 . . . . 0.0 113.44 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.08 -146.29 20.05 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 167.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.6 -41.16 21.93 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.659 -1.495 . . . . 0.0 111.151 175.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -51.49 57.5 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.741 2.016 . . . . 0.0 115.119 -176.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.72 -41.87 82.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.276 1.036 . . . . 0.0 111.373 173.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -69.19 -5.52 23.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -178.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.89 -101.22 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.329 2.331 . . . . 0.0 110.457 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.31 -97.71 0.96 Allowed Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.211 -1.556 . . . . 0.0 112.805 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -133.99 26.08 3.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.999 -0.706 . . . . 0.0 112.744 -156.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 mt -87.11 127.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.86 -1.775 . . . . 0.0 113.427 -170.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -143.85 155.02 43.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 163.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -62.78 148.76 45.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -153.031 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.73 23.61 7.07 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -103.02 172.95 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.725 1.762 . . . . 0.0 112.693 174.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -98.34 136.5 38.41 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.368 1.067 . . . . 0.0 110.738 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.35 101.89 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.034 2.934 . . . . 0.0 105.01 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.253 0.9 OUTLIER -98.02 -38.18 9.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.235 -2.166 . . . . 0.0 114.827 -173.946 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 145.21 27.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.236 1.38 . . . . 0.0 113.49 -176.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.23 116.02 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 O-C-N 120.994 -1.066 . . . . 0.0 111.914 -171.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 55.59 33.99 22.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.222 1.409 . . . . 0.0 113.677 -170.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.42 25.71 62.82 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 113.495 -176.172 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.9 t -123.63 100.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.82 38.34 0.7 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.913 1.685 . . . . 0.0 114.189 -173.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -82.81 111.1 18.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.486 -2.009 . . . . 0.0 110.718 175.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 8.95 68.87 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.947 -1.095 . . . . 0.0 113.083 -175.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.12 155.02 17.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.985 1.374 . . . . 0.0 110.067 171.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.567 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 71.2 p -106.87 -170.34 1.7 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.426 1.89 . . . . 0.0 108.718 -172.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -57.29 -49.95 74.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.762 -1.211 . . . . 0.0 112.903 161.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -69.9 -43.8 71.0 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 112.215 -176.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.567 ' HB2' ' H ' ' A' ' 77' ' ' THR . 4.7 mp0 -67.19 -34.3 77.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.633 -1.292 . . . . 0.0 112.947 175.177 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.92 87.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.9 -1.75 . . . . 0.0 114.475 172.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -57.47 -49.19 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.379 -0.825 . . . . 0.0 111.923 172.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.9 -31.28 71.56 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.012 -1.68 . . . . 0.0 114.901 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.6 m -74.93 -27.75 60.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.558 1.943 . . . . 0.0 112.714 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.89 -43.69 10.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.297 1.839 . . . . 0.0 112.892 174.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -84.24 -34.38 23.88 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -172.612 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -86.1 35.31 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.512 -1.992 . . . . 0.0 112.309 -176.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.6 p -93.69 163.25 13.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.142 2.577 . . . . 0.0 113.483 -176.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.75 59.57 4.9 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 125.065 1.317 . . . . 0.0 114.268 -176.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.259 46.4 tt0 68.09 -53.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.617 2.767 . . . . 0.0 114.634 -174.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -76.37 136.33 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.169 1.388 . . . . 0.0 110.721 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.15 101.39 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.65 1.98 . . . . 0.0 107.165 171.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -82.29 97.61 8.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.815 2.446 . . . . 0.0 108.58 170.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.04 113.24 21.97 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.913 0.863 . . . . 0.0 111.462 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -84.47 102.73 13.03 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 163.347 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.16 152.8 24.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.991 1.316 . . . . 0.0 108.053 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.0 125.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.036 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.9 123.05 18.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.849 1.26 . . . . 0.0 112.148 -178.124 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.4 70.22 2.66 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.472 1.034 . . . . 0.0 112.64 -174.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.94 137.02 50.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.852 1.661 . . . . 0.0 109.674 -176.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.38 161.43 33.39 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 127.083 2.153 . . . . 0.0 107.482 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 C--N 1.3 -2.019 0 CA-C-N 123.102 2.143 . . . . 0.0 113.799 -175.576 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 19.9 tp -86.34 165.11 16.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.081 0.952 . . . . 0.0 109.206 163.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.397 2.7 t 72.58 115.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.768 2.223 . . . . 0.0 115.511 164.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 73.0 m -141.53 123.23 15.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -77.14 124.06 27.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.26 1.615 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -162.566 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 122.216 1.007 . . . . 0.0 108.644 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -97.18 148.1 33.9 Favored Pre-proline 0 N--CA 1.43 -1.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.707 176.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.78 129.21 14.16 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 122.826 2.045 . . . . 0.0 113.346 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.59 25.09 75.17 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 125.376 1.465 . . . . 0.0 115.321 176.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -79.59 129.98 34.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.002 -1.293 . . . . 0.0 113.137 -173.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 p -93.69 143.12 26.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.409 -1.432 . . . . 0.0 113.802 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -132.02 118.86 20.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.874 1.27 . . . . 0.0 108.921 173.889 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 86.45 5.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.268 1.427 . . . . 0.0 109.146 173.307 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.97 156.85 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.211 2.204 . . . . 0.0 109.982 178.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 93' ' ' HIS . 0.8 OUTLIER -126.85 132.77 50.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.616 -1.927 . . . . 0.0 107.159 166.728 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.6 mt -129.46 153.37 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.013 -1.054 . . . . 0.0 109.572 -177.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.52 110.01 17.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.434 1.094 . . . . 0.0 109.067 166.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 24' ' ' SER . 15.5 ptpt -60.04 141.31 55.92 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 127.77 2.428 . . . . 0.0 114.746 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 t -101.57 113.76 27.17 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.698 -1.251 . . . . 0.0 109.344 -174.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 58.76 -18.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 129.189 2.995 . . . . 0.0 118.171 -169.342 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.19 59.32 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.847 1.689 . . . . 0.0 109.27 -178.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.491 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 95.4 p -178.2 120.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -173.783 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' B' ' 210' ' ' VAL . 9.8 mt -79.45 -40.02 30.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.436 1.894 . . . . 0.0 106.586 168.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 48' ' ' ILE . . . 118.06 29.3 2.02 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.035 1.303 . . . . 0.0 111.988 171.304 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 pt -114.78 131.03 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.632 174.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 m -83.91 117.07 23.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.236 0.614 . . . . 0.0 111.04 162.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.67 132.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -128.28 163.55 24.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.102 2.161 . . . . 0.0 109.608 174.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.35 -137.36 13.26 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 125.279 1.419 . . . . 0.0 111.788 -177.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 155.63 28.07 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 -17.2 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.546 -1.561 . . . . 0.0 114.06 -178.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -55.91 -37.45 68.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.987 1.715 . . . . 0.0 114.292 169.053 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 m -128.13 71.71 1.39 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -28.27 116.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.496 3.517 . . . . 0.0 120.496 -162.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 95.41 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.181 1.392 . . . . 0.0 109.78 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 65.08 -96.79 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.584 1.954 . . . . 0.0 111.885 -174.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -124.65 10.28 8.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.652 -1.28 . . . . 0.0 112.645 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.53 86.36 1.9 Allowed Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.11 -0.994 . . . . 0.0 114.288 174.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.51 -172.75 20.67 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 175.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.464 HG22 HG13 ' A' ' 65' ' ' VAL 0.255 2.2 tp -120.49 162.1 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 118.049 0.924 . . . . 0.0 109.078 -166.621 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -142.08 162.11 36.31 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 -171.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 47' ' ' ILE . 3.3 t -88.36 132.31 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.679 -1.263 . . . . 0.0 111.769 172.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -88.52 -46.85 8.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.529 -1.357 . . . . 0.0 110.554 170.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.02 134.02 24.08 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.067 -1.021 . . . . 0.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.471 HD13 HG11 ' A' ' 44' ' ' VAL . 27.3 mm -93.84 128.92 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.433 1.493 . . . . 0.0 108.725 173.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.428 HD11 ' HA2' ' A' ' 26' ' ' GLY . 2.6 pt -83.26 133.44 47.63 Favored Pre-proline 0 N--CA 1.43 -1.454 0 O-C-N 121.184 -0.948 . . . . 0.0 110.836 172.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.08 64.75 7.08 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 121.558 1.592 . . . . 0.0 111.064 178.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt 173.04 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.456 1.502 . . . . 0.0 109.781 -175.268 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.46 4.92 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.728 -1.857 . . . . 0.0 111.061 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.87 -39.26 4.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.447 1.099 . . . . 0.0 111.603 -172.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.78 66.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.009 1.323 . . . . 0.0 113.84 -178.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -56.76 -34.17 67.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.968 1.307 . . . . 0.0 112.504 167.124 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -70.27 -5.46 27.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.97 -79.27 0.06 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 118.643 -2.536 . . . . 0.0 108.061 159.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.33 -20.14 3.36 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 169.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -85.31 -32.99 22.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.887 -0.772 . . . . 0.0 111.537 177.313 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.6 mt -65.86 125.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.735 1.614 . . . . 0.0 113.097 178.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.465 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 17.3 t60 -136.71 177.9 7.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.319 1.056 . . . . 0.0 109.954 171.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 30.1 pttt -79.74 58.9 2.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.852 -1.78 . . . . 0.0 115.347 -172.691 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.32 -10.32 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.188 1.375 . . . . 0.0 113.238 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -78.62 154.35 30.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 118.611 1.206 . . . . 0.0 113.427 -173.251 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 138.74 32.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.408 1.483 . . . . 0.0 107.465 175.329 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -113.42 115.68 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 161.654 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.76 -30.53 11.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 113.412 -172.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 153.52 38.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.02 0.827 . . . . 0.0 112.584 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 92' ' ' VAL . 11.6 t -135.75 120.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.453 0.701 . . . . 0.0 112.173 -175.499 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 55.5 33.87 21.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.432 -1.417 . . . . 0.0 114.203 -168.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.67 11.72 85.06 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 120.68 -1.263 . . . . 0.0 113.538 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.64 100.3 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -60.75 135.2 57.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.078 1.751 . . . . 0.0 113.306 174.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.6 mt -68.96 -49.35 58.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.445 -0.785 . . . . 0.0 112.476 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 46.39 27.79 0.64 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.939 2.94 . . . . 0.0 118.939 166.344 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.61 27.91 0.93 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.268 -1.52 . . . . 0.0 112.885 -169.033 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.86 146.05 26.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.803 -1.41 . . . . 0.0 110.702 175.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -94.83 -167.7 1.69 Allowed 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.719 1.608 . . . . 0.0 109.148 -178.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -61.52 -50.2 73.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.029 -1.669 . . . . 0.0 112.151 165.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.19 -49.41 74.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -38.11 89.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.1 -1.0 . . . . 0.0 113.286 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.23 96.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.034 -1.666 . . . . 0.0 114.983 172.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.55 -54.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.465 173.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -49.72 -43.11 47.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.245 1.384 . . . . 0.0 114.555 175.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.6 m -68.22 -27.45 66.38 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.272 2.229 . . . . 0.0 114.882 -178.471 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.3 -41.43 10.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.87 -1.769 . . . . 0.0 113.78 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -53.89 6.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.557 2.343 . . . . 0.0 114.214 -169.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.51 36.43 0.75 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.509 1.623 . . . . 0.0 111.96 -168.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.2 p -93.44 -172.48 2.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.588 2.755 . . . . 0.0 109.636 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.11 -90.48 0.48 Allowed Glycine 0 N--CA 1.429 -1.818 0 O-C-N 119.86 -1.775 . . . . 0.0 112.599 174.334 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -142.99 -50.15 0.34 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.747 1.219 . . . . 0.0 110.013 -175.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.64 131.52 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.173 -1.579 . . . . 0.0 110.129 172.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 68' ' ' VAL . 2.4 t -122.3 112.54 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.082 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 71.1 m80 -76.52 113.28 13.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.647 -1.283 . . . . 0.0 108.806 163.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mt -94.83 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.978 -1.077 . . . . 0.0 108.766 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.43 102.77 15.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.07 150.67 23.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.049 2.139 . . . . 0.0 111.358 -177.458 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -127.38 136.35 51.74 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.261 1.024 . . . . 0.0 108.878 169.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -61.51 128.24 35.33 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.234 2.214 . . . . 0.0 114.445 -175.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.92 65.49 0.3 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.983 -1.073 . . . . 0.0 114.403 175.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -116.05 161.93 18.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.952 1.301 . . . . 0.0 109.602 174.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -82.91 129.78 60.35 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.755 -1.215 . . . . 0.0 112.901 -178.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--N 1.3 -2.002 0 C-N-CA 123.09 2.527 . . . . 0.0 114.125 167.573 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.3 tp 77.25 160.05 0.21 Allowed 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.879 2.871 . . . . 0.0 112.572 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.422 1.4 t 77.6 102.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 124.584 2.135 . . . . 0.0 113.311 171.241 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 89.4 m -136.72 119.68 16.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -171.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.5 p -75.1 129.23 37.21 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.984 1.313 . . . . 0.0 109.253 174.418 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 8.5 p . . . . . 0 C--O 1.26 1.63 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 -162.119 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 121.709 0.766 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -135.21 133.42 20.67 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -67.41 115.99 3.98 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 122.861 2.057 . . . . 0.0 112.937 172.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.82 78.7 0.31 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 124.183 0.897 . . . . 0.0 114.412 -175.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.48 140.04 45.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 121.482 -1.011 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p -97.29 141.25 30.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.84 -1.162 . . . . 0.0 113.077 177.486 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.69 137.79 53.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.744 1.618 . . . . 0.0 107.823 176.046 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -114.44 82.9 1.79 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.216 1.484 . . . . 0.0 108.802 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.12 142.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.0 2.12 . . . . 0.0 109.083 -178.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.34 123.53 44.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.037 -2.289 . . . . 0.0 109.2 170.804 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.35 162.06 19.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.064 0.946 . . . . 0.0 108.778 -176.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 125.0 53.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 157.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' HB2' ' H ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -61.48 136.69 58.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.038 1.335 . . . . 0.0 112.025 169.224 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -90.71 95.45 10.15 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.354 1.55 . . . . 0.0 108.682 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 62.54 -17.71 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.724 2.861 . . . . 0.0 118.724 -171.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.2 62.56 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.846 -1.784 . . . . 0.0 109.919 -178.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 45.7 t 167.8 104.46 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -162.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.8 mt -75.17 -41.59 57.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 161.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 41.44 1.09 Allowed Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.676 171.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 47' ' ' ILE . 6.5 pt -119.45 129.04 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 121.653 0.74 . . . . 0.0 110.297 171.211 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' HG13 ' B' ' 207' ' ' VAL . 63.6 m -82.29 113.95 20.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.294 1.037 . . . . 0.0 110.481 167.251 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.38 129.78 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.142 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -128.82 166.37 19.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.004 1.722 . . . . 0.0 110.373 176.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.35 -157.35 46.21 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 125.118 1.342 . . . . 0.0 111.463 -170.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.35 151.68 8.95 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.869 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -3.58 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -170.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -72.06 -28.49 63.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.187 -1.57 . . . . 0.0 114.042 177.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.2 p -116.66 176.38 5.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 t -81.9 111.63 18.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.604 -1.935 . . . . 0.0 108.781 173.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.62 -65.49 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.213 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -179.88 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.96 2.104 . . . . 0.0 106.539 164.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -142.29 154.91 45.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.74 56.02 4.75 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.85 -168.93 26.27 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 163.162 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 tp -125.26 155.84 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -139.14 156.43 47.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -166.073 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.6 137.87 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 119.096 -2.252 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.08 -64.65 1.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.414 -1.429 . . . . 0.0 108.529 160.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.44 136.62 50.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.245 1.018 . . . . 0.0 110.785 -175.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 27' ' ' ILE . 36.5 mm -89.81 118.99 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.667 1.587 . . . . 0.0 107.424 169.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 pt -79.23 157.78 75.14 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 117.728 -1.13 . . . . 0.0 111.776 -177.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -69.87 89.79 0.53 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.435 2.09 . . . . 0.0 114.974 -172.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 70.09 65.38 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.797 1.639 . . . . 0.0 114.967 166.062 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.75 -95.02 1.54 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 168.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.2 -39.16 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.291 -1.123 . . . . 0.0 111.698 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -48.86 36.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.463 1.905 . . . . 0.0 114.639 -174.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.22 -39.51 56.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.071 1.415 . . . . 0.0 111.789 169.07 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -67.83 -2.76 7.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -67.72 -90.99 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.2 2.273 . . . . 0.0 109.145 164.051 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.79 -35.34 0.5 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 111.615 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.61 -25.85 35.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.791 -0.829 . . . . 0.0 113.113 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.06 131.26 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.068 -1.645 . . . . 0.0 112.339 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -136.58 179.25 6.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.983 -1.073 . . . . 0.0 108.795 167.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -84.54 49.15 1.63 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.231 -1.543 . . . . 0.0 114.905 -167.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.41 19.64 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.899 -1.75 . . . . 0.0 114.057 176.081 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.33 179.99 4.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.028 -1.277 . . . . 0.0 112.425 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -113.01 142.54 45.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.768 2.027 . . . . 0.0 109.088 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.78 133.9 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.324 -1.485 . . . . 0.0 108.126 165.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.59 -30.48 5.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.556 -1.34 . . . . 0.0 113.93 -173.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 157.25 42.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.162 1.346 . . . . 0.0 113.452 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 92' ' ' VAL . 92.8 t -137.99 123.27 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 123.821 0.848 . . . . 0.0 110.955 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 52.67 33.89 14.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.61 1.564 . . . . 0.0 114.641 -173.166 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.89 23.46 69.29 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.065 -1.022 . . . . 0.0 113.512 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.12 100.07 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 124.333 1.053 . . . . 0.0 108.392 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.09 142.61 41.75 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.928 2.091 . . . . 0.0 115.468 173.268 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.45 -56.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.624 -1.297 . . . . 0.0 111.555 176.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 43.24 43.97 4.3 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 169.006 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 45.16 0.97 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 120.819 -1.176 . . . . 0.0 110.679 -168.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.57 144.69 28.37 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.443 -1.033 . . . . 0.0 108.918 171.223 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.6 p -97.01 -160.98 0.84 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.481 1.512 . . . . 0.0 109.946 -175.528 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.42 -49.9 65.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.951 -1.718 . . . . 0.0 110.802 167.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -66.5 -46.93 74.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 112.775 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.71 -33.01 71.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.48 91.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.465 -2.022 . . . . 0.0 113.533 170.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.59 -52.38 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 118.885 -0.579 . . . . 0.0 111.314 172.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -47.24 -45.16 23.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 171.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -73.64 -27.47 61.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.95 1.3 . . . . 0.0 112.368 -171.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.27 -48.12 7.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.077 1.751 . . . . 0.0 114.51 172.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -48.24 17.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.956 2.103 . . . . 0.0 113.402 -173.287 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.38 31.41 0.82 Allowed 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.859 -1.776 . . . . 0.0 112.426 -166.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.3 p -83.04 -168.06 1.92 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.283 3.433 . . . . 0.0 109.388 171.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.5 -108.08 0.53 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.383 -1.448 . . . . 0.0 110.723 170.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -120.18 -44.87 2.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.567 1.147 . . . . 0.0 110.436 174.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -72.72 129.89 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.449 1.119 . . . . 0.0 112.116 173.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 68' ' ' VAL . 45.8 t -129.76 99.87 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 126.415 1.886 . . . . 0.0 108.116 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -78.02 98.62 5.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.552 1.941 . . . . 0.0 110.312 168.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -84.79 113.16 21.14 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.455 1.902 . . . . 0.0 109.911 -175.312 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 98.36 11.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 168.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.06 147.97 25.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.364 1.865 . . . . 0.0 109.717 -177.63 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.97 132.97 56.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.702 1.239 . . . . 0.0 108.236 167.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -74.24 139.88 44.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.862 1.265 . . . . 0.0 109.79 176.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -80.93 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 112.475 165.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.83 -40.33 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 159.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . 0.346 11.6 p -4.72 82.11 0.03 OUTLIER Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 129.658 3.183 . . . . 0.0 118.819 -156.443 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 C--N 1.299 -2.036 0 C-N-CA 122.225 1.95 . . . . 0.0 116.829 -151.263 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 tp -146.13 179.17 7.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.951 -1.093 . . . . 0.0 108.068 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 28' ' ' SER 0.398 2.2 t 67.86 104.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 124.924 2.297 . . . . 0.0 114.378 169.819 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 34.1 m -140.24 122.76 16.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.612 -3.107 . . . . 0.0 102.612 -171.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.3 p -80.55 121.29 25.62 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.984 0.914 . . . . 0.0 109.986 175.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.0 m . . . . . 0 C--O 1.259 1.579 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -169.488 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.8 mpt? . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -118.43 118.24 33.99 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.987 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -69.9 96.53 0.61 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 123.115 2.148 . . . . 0.0 116.317 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.85 55.82 0.57 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 126.155 1.836 . . . . 0.0 111.747 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -133.99 124.24 25.95 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 118.099 0.949 . . . . 0.0 110.04 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -95.54 147.07 23.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.521 1.153 . . . . 0.0 110.743 170.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.38 128.25 41.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.725 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -103.25 81.24 1.92 Allowed 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.609 1.195 . . . . 0.0 108.316 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.95 109.11 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 126.926 2.091 . . . . 0.0 112.543 -173.184 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 124.64 44.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.92 -1.738 . . . . 0.0 109.384 -177.061 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.1 mt -134.93 158.73 43.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 109.045 -171.422 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.28 43.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 162.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -63.18 146.51 53.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.885 -1.134 . . . . 0.0 113.37 -175.136 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -92.41 88.66 6.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.963 1.364 . . . . 0.0 107.381 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 t0 44.99 64.98 1.2 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.18 2.592 . . . . 0.0 117.108 -177.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 52.8 6.02 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.634 -1.291 . . . . 0.0 114.119 179.154 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 3.9 m 177.33 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.166 1.386 . . . . 0.0 108.618 -169.354 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.39 -45.68 45.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.248 1.819 . . . . 0.0 107.426 163.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.88 47.06 0.85 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 125.444 1.497 . . . . 0.0 111.054 177.1 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 pt -128.8 131.65 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.39 0.614 . . . . 0.0 109.429 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.1 m -91.05 113.03 25.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.434 1.094 . . . . 0.0 111.95 171.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.6 m -80.85 140.13 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -172.037 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -130.67 168.18 17.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.098 1.759 . . . . 0.0 109.602 172.417 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.85 -150.23 34.02 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.977 1.275 . . . . 0.0 114.08 -177.1 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 161.44 21.76 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 125.439 1.495 . . . . 0.0 109.602 -179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.44 11.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.094 -1.827 . . . . 0.0 115.136 -171.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -58.71 -37.81 76.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.741 -2.474 . . . . 0.0 115.711 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.3 p -116.92 -172.68 2.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.76 1.224 . . . . 0.0 107.902 166.291 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -73.56 89.3 1.7 Allowed 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.61 -1.931 . . . . 0.0 112.478 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 174.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 176.217 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -69.78 78.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.545 -1.972 . . . . 0.0 112.653 176.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.9 t60 69.91 -38.45 0.41 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.59 3.556 . . . . 0.0 116.282 -178.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.59 -129.1 1.7 Allowed Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.35 -3.5 . . . . 0.0 104.35 -178.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.78 164.73 4.52 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 124.702 1.144 . . . . 0.0 113.584 -173.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 65' ' ' VAL 0.287 3.9 tp -124.33 156.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 120.103 -1.821 . . . . 0.0 106.826 170.659 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.09 151.63 52.01 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -170.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 47' ' ' ILE . 16.0 t -85.87 130.91 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.403 -2.061 . . . . 0.0 110.524 176.252 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -90.23 -45.96 8.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.035 -1.666 . . . . 0.0 110.379 168.192 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 143.87 33.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.605 1.193 . . . . 0.0 112.784 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.601 ' CD1' HG11 ' A' ' 44' ' ' VAL . 47.8 mm -105.02 116.97 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.513 2.725 . . . . 0.0 108.001 -176.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -84.08 154.69 63.94 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.539 -1.351 . . . . 0.0 112.653 -177.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -67.92 106.55 1.34 Allowed 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.734 2.289 . . . . 0.0 115.36 -169.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 mttm 41.39 65.02 0.9 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.044 2.537 . . . . 0.0 117.701 175.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.62 -90.13 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 169.406 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.54 -41.58 2.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.728 -0.866 . . . . 0.0 111.093 169.212 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 -49.0 50.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.955 1.702 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.17 -29.98 70.74 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.454 -1.403 . . . . 0.0 111.929 173.023 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 m -69.72 -2.36 11.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 176.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.95 -80.9 0.05 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 120.872 1.669 . . . . 0.0 107.427 157.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.62 -33.94 0.82 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.25 -0.906 . . . . 0.0 111.413 165.078 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -72.25 -26.49 62.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -169.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.02 141.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.706 1.202 . . . . 0.0 114.125 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -134.21 -166.93 1.87 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.607 -1.308 . . . . 0.0 110.783 165.046 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -80.84 135.34 35.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.041 -1.662 . . . . 0.0 110.337 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.65 2.34 72.8 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.076 -1.64 . . . . 0.0 114.642 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.21 151.52 39.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.437 1.119 . . . . 0.0 111.682 176.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -106.19 114.46 28.6 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.419 1.087 . . . . 0.0 109.357 -167.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 42' ' ' ILE . 3.3 p -92.89 120.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.132 -1.605 . . . . 0.0 108.814 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.04 -39.84 9.95 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.651 -1.281 . . . . 0.0 111.544 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.63 149.23 34.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 92' ' ' VAL . 10.7 t -129.59 117.73 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 O-C-N 120.804 -1.185 . . . . 0.0 113.061 -173.079 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 0.4 OUTLIER 46.62 37.54 4.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.277 2.231 . . . . 0.0 115.754 -169.863 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.24 5.88 57.93 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 114.201 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -121.87 105.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 118.346 1.073 . . . . 0.0 110.366 -168.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 t -60.74 139.24 57.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.759 172.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.84 60.33 2.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.911 2.084 . . . . 0.0 111.614 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.01 105.26 10.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.081 2.153 . . . . 0.0 111.796 -169.755 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.93 21.03 79.15 Favored Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.813 -1.179 . . . . 0.0 114.026 -175.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.27 141.07 29.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.161 -1.2 . . . . 0.0 113.165 -175.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -104.57 -156.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.591 2.356 . . . . 0.0 109.66 -174.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.97 -50.94 44.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.707 -1.871 . . . . 0.0 111.384 168.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.72 -51.76 68.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 112.337 174.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.83 -36.07 82.71 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.006 -1.059 . . . . 0.0 113.846 -175.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.15 92.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.156 -1.59 . . . . 0.0 114.953 171.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.05 -49.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 110.764 174.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.36 -26.12 67.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.891 -1.756 . . . . 0.0 114.902 178.05 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -75.97 -27.98 57.7 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.158 1.783 . . . . 0.0 113.172 176.257 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.6 mt -89.63 -47.72 7.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.227 -1.545 . . . . 0.0 113.963 173.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 -37.1 22.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.695 1.598 . . . . 0.0 114.072 -170.277 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.55 37.58 0.92 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.979 -1.701 . . . . 0.0 111.274 -172.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.5 p -100.17 179.41 4.49 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.132 3.373 . . . . 0.0 111.555 -179.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.94 -136.68 4.22 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.611 -1.306 . . . . 0.0 112.871 173.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -85.06 -62.42 1.54 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.802 -1.411 . . . . 0.0 111.869 -177.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -75.75 124.28 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.89 1.329 . . . . 0.0 111.787 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 68' ' ' VAL . 13.5 t -114.99 114.94 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 167.411 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -87.35 110.66 20.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.386 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.12 111.14 20.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.585 -1.322 . . . . 0.0 110.253 174.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 98.36 10.97 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.4 mt -104.97 137.92 41.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.968 2.507 . . . . 0.0 110.759 -173.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.6 148.05 42.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.235 1.814 . . . . 0.0 108.545 170.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 133.56 55.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 176.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.72 19.7 53.64 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.422 -2.048 . . . . 0.0 113.465 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -96.71 130.95 43.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.085 1.754 . . . . 0.0 110.503 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.47 146.05 52.89 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 116.891 -1.528 . . . . 0.0 110.008 172.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 N--CA 1.433 -2.041 0 CA-C-N 124.966 2.809 . . . . 0.0 114.672 179.463 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.351 0.596 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 7.8 tp 66.82 168.48 0.24 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.215 2.206 . . . . 0.0 114.006 -161.486 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.462 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.452 5.7 m 46.06 76.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 128.058 2.543 . . . . 0.0 117.311 171.107 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.1 m -117.78 117.86 30.48 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 69.3 p -78.86 117.98 20.47 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.017 1.327 . . . . 0.0 111.323 178.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -171.567 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -145.43 164.41 26.52 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -63.51 139.29 69.64 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.687 2.258 . . . . 0.0 112.621 160.229 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.77 35.45 50.78 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 174.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.7 103.99 6.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.41 1.605 . . . . 0.0 110.994 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 p -94.57 119.54 33.41 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.439 1.114 . . . . 0.0 110.907 170.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 117.46 33.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.218 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.53 89.05 7.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.985 1.85 . . . . 0.0 109.513 170.4 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.36 150.77 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.388 1.875 . . . . 0.0 108.358 176.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.79 130.7 34.45 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.799 -1.813 . . . . 0.0 109.164 168.251 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.08 165.42 36.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.223 1.011 . . . . 0.0 111.718 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.18 132.77 45.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.578 1.151 . . . . 0.0 110.355 170.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HB3' HD23 ' A' ' 25' ' ' LEU . 5.5 ptpt -70.49 164.27 25.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 0.0 112.374 177.189 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 t -114.64 96.94 5.99 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.532 -1.355 . . . . 0.0 109.36 -179.017 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 53.08 55.08 9.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.011 2.125 . . . . 0.0 115.399 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.74 48.75 16.06 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 114.001 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 p -178.58 119.32 0.08 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 20' ' ' LYS . 10.8 mt -74.66 -38.19 62.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.91 2.084 . . . . 0.0 106.449 164.076 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.473 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 120.52 18.25 4.11 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.253 1.406 . . . . 0.0 110.864 168.837 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 pt -107.93 129.19 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.715 1.245 . . . . 0.0 110.541 -176.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.421 ' HB3' HG22 ' B' ' 207' ' ' VAL . 28.0 m -85.96 113.61 22.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.513 1.125 . . . . 0.0 110.864 173.552 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.13 131.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -171.122 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -126.24 164.96 19.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.118 2.167 . . . . 0.0 110.83 177.064 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -136.18 13.69 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 125.877 1.703 . . . . 0.0 114.009 174.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.52 176.84 49.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 124.662 1.125 . . . . 0.0 114.457 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -60.42 -16.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.521 2.328 . . . . 0.0 115.343 -172.263 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.2 -39.88 80.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.542 -1.349 . . . . 0.0 113.627 171.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.1 t -113.18 167.68 10.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.452 1.501 . . . . 0.0 109.556 -178.311 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -80.85 88.08 5.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.781 -1.824 . . . . 0.0 111.441 176.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.79 77.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 123.266 1.507 . . . . 0.0 107.9 177.165 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.02 -95.91 0.06 Allowed 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 126.387 1.875 . . . . 0.0 112.605 -167.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -115.4 -57.84 2.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.568 1.147 . . . . 0.0 111.119 176.045 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.1 -115.73 0.35 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.358 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.08 -165.03 53.2 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 121.178 -1.189 . . . . 0.0 114.716 -178.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.42 HG22 HG13 ' A' ' 65' ' ' VAL 0.264 3.1 tp -145.52 164.53 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 161.121 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -145.53 157.49 43.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -168.268 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.498 HG11 HD13 ' A' ' 47' ' ' ILE . 7.8 t -90.06 130.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.015 -1.678 . . . . 0.0 113.208 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -87.73 -53.56 4.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.896 -1.128 . . . . 0.0 111.375 170.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.76 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.035 0.921 . . . . 0.0 111.472 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.498 HD13 HG11 ' A' ' 44' ' ' VAL . 39.6 mm -98.39 137.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.522 2.329 . . . . 0.0 107.787 172.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.473 HD12 ' CA ' ' A' ' 26' ' ' GLY . 59.3 mt -85.5 141.04 36.24 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-O 116.827 -1.559 . . . . 0.0 108.426 176.31 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.31 92.65 0.34 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.367 2.711 . . . . 0.0 112.911 171.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt 59.13 60.62 2.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.797 2.039 . . . . 0.0 114.964 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.16 -68.72 1.32 Allowed Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.333 -1.479 . . . . 0.0 110.008 170.763 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.59 -52.74 0.44 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 123.653 0.781 . . . . 0.0 109.043 163.523 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.58 -33.68 75.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.459 2.762 . . . . 0.0 118.459 -171.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.0 -35.25 80.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.088 -2.882 . . . . 0.0 111.014 171.389 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -74.34 0.54 14.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -72.48 -51.72 18.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.672 -1.893 . . . . 0.0 109.941 168.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.09 -73.76 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.798 158.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.96 -19.24 63.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -166.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.5 133.06 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 121.748 2.067 . . . . 0.0 115.575 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -129.49 178.71 6.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.555 1.542 . . . . 0.0 111.718 172.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -83.03 124.75 30.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.213 -1.555 . . . . 0.0 109.523 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.15 52.98 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 121.118 -0.989 . . . . 0.0 113.933 -173.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -81.83 165.04 21.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.588 1.185 . . . . 0.0 111.896 176.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -107.69 131.15 54.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.678 -172.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 42' ' ' ILE . 2.3 p -106.43 120.49 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.092 -1.63 . . . . 0.0 107.541 163.046 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.24 -37.59 9.61 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.618 -1.301 . . . . 0.0 112.308 -179.264 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.13 156.87 43.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 119.467 1.03 . . . . 0.0 113.217 -177.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.71 123.34 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 111.646 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 53.46 32.8 14.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.218 1.372 . . . . 0.0 114.566 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.4 20.65 76.72 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.899 -1.126 . . . . 0.0 114.49 -175.138 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -115.23 102.61 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.7 m -59.46 135.83 57.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.883 -1.136 . . . . 0.0 112.457 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.95 70.71 2.69 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.0 111.897 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.82 101.26 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.387 1.875 . . . . 0.0 112.349 -174.511 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.49 38.02 95.65 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.119 -0.988 . . . . 0.0 112.978 -175.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.05 140.52 35.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.417 -1.049 . . . . 0.0 109.706 176.288 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -114.48 -168.78 1.42 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 103.892 -2.632 . . . . 0.0 103.892 174.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -56.45 -52.88 63.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.91 -1.744 . . . . 0.0 114.168 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -74.14 -41.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.707 1.14 . . . . 0.0 112.315 -174.06 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -59.45 -47.1 86.77 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 119.957 -1.714 . . . . 0.0 114.449 172.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.41 -29.9 70.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.459 -1.401 . . . . 0.0 114.597 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.5 -56.86 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.43 166.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -51.56 -42.4 61.83 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -61.17 -29.81 70.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.933 2.093 . . . . 0.0 115.012 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -97.74 -33.43 11.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.104 2.162 . . . . 0.0 115.263 173.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -49.44 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.168 2.587 . . . . 0.0 114.147 -169.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -92.91 30.92 1.48 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.564 1.65 . . . . 0.0 111.548 -169.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -87.14 -174.57 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.628 2.771 . . . . 0.0 111.175 -176.065 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.37 173.44 51.22 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.337 158.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -61.53 -41.22 97.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.691 1.596 . . . . 0.0 113.07 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.23 126.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.939 1.352 . . . . 0.0 111.043 169.12 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -120.51 105.22 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.607 1.563 . . . . 0.0 107.394 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -77.83 103.55 7.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.605 -1.309 . . . . 0.0 109.542 165.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -89.17 118.4 28.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.744 -1.222 . . . . 0.0 110.429 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.38 95.34 10.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.12 145.61 26.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.885 2.074 . . . . 0.0 110.196 -177.333 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.62 139.23 52.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.772 1.273 . . . . 0.0 110.048 163.573 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.61 124.73 24.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.686 1.994 . . . . 0.0 113.267 177.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.05 73.21 2.67 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.316 -1.49 . . . . 0.0 113.09 172.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.05 160.41 14.35 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.319 2.247 . . . . 0.0 111.403 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.76 113.53 44.71 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.942 -1.504 . . . . 0.0 108.628 173.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 C--N 1.3 -2.014 0 CA-C-N 123.802 2.394 . . . . 0.0 116.53 -175.168 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.625 1.202 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp -107.78 158.47 17.27 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.333 1.453 . . . . 0.0 109.957 176.377 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 28' ' ' SER 0.395 2.3 t 77.09 121.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 163.093 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 20.5 m -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 10.8 p -80.99 122.95 27.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.795 1.638 . . . . 0.0 110.661 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.261 1.664 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 -170.416 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.476 0.655 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.62 138.35 19.57 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 109.838 177.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.18 147.46 42.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.037 1.825 . . . . 0.0 110.516 172.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.58 19.19 74.5 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -78.86 123.68 27.48 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.903 -1.351 . . . . 0.0 111.452 -176.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -102.25 126.25 49.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.678 -1.264 . . . . 0.0 111.112 -178.055 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -114.01 121.8 44.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.449 1.5 . . . . 0.0 108.806 179.041 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -101.32 75.14 1.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.511 1.524 . . . . 0.0 111.375 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.58 121.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.193 -1.567 . . . . 0.0 114.817 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.72 122.24 39.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.774 -1.829 . . . . 0.0 111.328 175.22 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.23 170.64 16.33 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.439 1.096 . . . . 0.0 108.578 175.079 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.0 133.49 55.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.423 1.089 . . . . 0.0 109.501 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 155.03 34.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.992 -1.068 . . . . 0.0 111.42 -174.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 t -100.9 100.03 10.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.838 -1.164 . . . . 0.0 109.052 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.265 2.4 m-20 37.81 60.23 1.2 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.536 2.735 . . . . 0.0 117.141 -172.643 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.6 54.66 5.37 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.969 -1.082 . . . . 0.0 114.198 178.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 m 179.22 109.91 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.237 1.415 . . . . 0.0 107.354 -172.148 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.9 mt -76.84 -44.86 30.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.39 45.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.806 1.193 . . . . 0.0 110.768 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.16 136.94 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 121.553 0.692 . . . . 0.0 110.793 169.077 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB3' HG13 ' B' ' 207' ' ' VAL . 71.1 m -80.09 110.52 15.57 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.091 1.757 . . . . 0.0 112.442 167.603 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.8 123.47 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -172.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -121.72 171.08 9.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.574 2.349 . . . . 0.0 109.98 176.294 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.63 -131.01 10.29 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.238 1.399 . . . . 0.0 112.606 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.65 168.73 44.84 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.271 0.939 . . . . 0.0 111.895 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.5 -12.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.161 1.784 . . . . 0.0 115.006 -171.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -74.55 -24.55 58.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.84 -1.788 . . . . 0.0 111.18 173.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -97.08 -173.9 2.81 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.513 1.525 . . . . 0.0 109.396 174.503 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -96.85 91.12 5.5 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.405 -2.059 . . . . 0.0 112.372 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 40' ' ' GLY . 15.1 m -112.82 -172.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.794 -175.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.48 45.43 0.39 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.529 2.332 . . . . 0.0 115.44 -173.556 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.282 1.5 t-160 62.06 40.34 12.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.373 1.869 . . . . 0.0 114.023 -169.029 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' H ' HG23 ' A' ' 37' ' ' VAL . . . 104.93 116.92 4.28 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.126 1.346 . . . . 0.0 112.197 -175.722 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.53 153.12 9.98 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 173.205 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -110.15 157.71 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.133 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -137.01 153.1 50.75 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.016 -1.678 . . . . 0.0 108.056 -169.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.55 HG11 HD13 ' A' ' 47' ' ' ILE . 14.3 t -90.85 117.89 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.41 -1.431 . . . . 0.0 112.074 178.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -81.66 -33.98 31.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.844 -1.16 . . . . 0.0 112.102 177.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.93 146.15 18.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.803 0.811 . . . . 0.0 109.776 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.55 HD13 HG11 ' A' ' 44' ' ' VAL . 44.2 mm -100.76 121.67 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 pt -78.34 148.41 74.05 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 120.55 -1.344 . . . . 0.0 112.547 -176.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -85.92 66.54 5.36 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 C-N-CA 122.593 2.195 . . . . 0.0 112.221 167.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.276 23.7 pttm 170.86 65.94 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.592 2.357 . . . . 0.0 110.243 166.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.7 179.6 34.24 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.211 -2.18 . . . . 0.0 111.336 -178.696 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.19 17.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.336 2.654 . . . . 0.0 111.869 -172.186 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.72 72.74 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.946 1.698 . . . . 0.0 113.625 -176.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.91 -36.19 62.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.4 -1.437 . . . . 0.0 113.424 165.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 t -75.36 2.31 11.59 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.325 -2.11 . . . . 0.0 107.923 153.825 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.71 -28.12 1.46 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 170.308 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 36.8 mtt85 -81.77 -27.61 33.66 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mt -67.02 133.82 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 119.235 0.925 . . . . 0.0 113.436 178.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.23 -178.43 4.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.734 -1.229 . . . . 0.0 109.424 166.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -76.6 103.34 6.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.517 -1.989 . . . . 0.0 111.132 174.151 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.7 -17.72 1.82 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.783 -1.198 . . . . 0.0 115.505 -173.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.49 156.65 36.69 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 119.918 1.859 . . . . 0.0 115.226 -172.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.19 122.31 45.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.655 1.582 . . . . 0.0 109.513 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.48 114.39 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.94 -38.89 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.403 -1.435 . . . . 0.0 112.939 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.16 160.18 44.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.022 1.283 . . . . 0.0 114.147 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 92' ' ' VAL . 47.0 t -134.3 113.32 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 111.49 -175.454 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 10.2 p30 43.44 33.98 0.7 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 -163.708 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.07 22.29 59.51 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.575 -1.328 . . . . 0.0 113.383 -177.032 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.99 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 172.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -70.38 144.26 51.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.475 1.131 . . . . 0.0 113.248 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.79 56.38 3.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.727 1.211 . . . . 0.0 110.037 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.27 24.56 0.18 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 128.588 2.755 . . . . 0.0 114.654 -163.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.1 40.21 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.085 1.802 . . . . 0.0 111.173 -176.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.47 148.39 25.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.287 -1.125 . . . . 0.0 111.81 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.609 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 46.6 p -95.91 -159.7 0.74 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.727 2.811 . . . . 0.0 109.872 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -63.96 -54.88 27.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.831 -1.793 . . . . 0.0 112.228 163.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -68.05 -38.7 82.78 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 114.446 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB2' ' H ' ' A' ' 77' ' ' THR . 35.2 mt-30 -68.52 -38.84 81.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.975 -1.703 . . . . 0.0 113.128 174.391 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.41 87.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.79 -1.819 . . . . 0.0 113.597 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.634 1.173 . . . . 0.0 110.751 175.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -51.93 -41.07 61.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 174.163 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -70.64 -24.66 62.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.705 1.602 . . . . 0.0 113.984 -175.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.85 -40.18 11.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.008 -1.683 . . . . 0.0 114.141 167.288 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -46.76 44.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.181 1.792 . . . . 0.0 114.786 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.88 34.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.935 -1.728 . . . . 0.0 113.496 -170.524 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.0 p -103.03 153.35 20.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.416 2.286 . . . . 0.0 114.158 -170.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.31 62.08 4.52 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.321 1.439 . . . . 0.0 115.888 -175.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.321 9.8 tt0 64.63 -50.68 0.31 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.354 3.462 . . . . 0.0 116.929 178.369 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.19 127.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.263 1.506 . . . . 0.0 109.8 173.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 68' ' ' VAL . 47.9 t -120.11 104.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.744 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -79.09 102.78 8.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 165.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.526 ' HG ' HG12 ' A' ' 92' ' ' VAL . 14.9 mt -87.59 113.85 23.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 110.39 -175.267 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.12 95.78 10.28 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.7 141.21 36.46 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.543 2.337 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.79 139.02 45.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.813 1.245 . . . . 0.0 109.287 167.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -65.17 110.13 2.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.467 2.307 . . . . 0.0 114.387 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.06 52.76 2.21 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 120.218 -1.552 . . . . 0.0 112.001 175.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -119.41 147.23 44.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.649 1.579 . . . . 0.0 107.962 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.4 m -82.21 152.75 68.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.673 -1.267 . . . . 0.0 110.25 176.131 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 N--CA 1.433 -2.056 0 CA-C-N 122.486 1.924 . . . . 0.0 111.503 175.756 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.8 tp -158.08 152.55 24.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.891 -1.131 . . . . 0.0 109.544 -176.317 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 28' ' ' SER 0.374 15.6 t 67.59 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 124.352 2.025 . . . . 0.0 114.732 171.108 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 98.3 m -138.29 133.65 33.34 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 43.7 m -74.47 118.87 17.92 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.436 1.494 . . . . 0.0 109.509 171.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.572 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -176.573 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.429 -1.505 0 CA-C-O 121.741 0.781 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -132.14 150.0 74.81 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 120.633 -1.292 . . . . 0.0 107.881 179.457 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 148.35 40.76 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.496 2.131 . . . . 0.0 112.224 173.613 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.27 28.7 55.27 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 171.241 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -87.06 125.76 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.206 -1.173 . . . . 0.0 112.79 -163.225 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p -78.55 133.72 37.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.597 -1.314 . . . . 0.0 112.697 177.664 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.277 0.0 OUTLIER -131.2 132.61 44.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.749 1.22 . . . . 0.0 108.247 170.473 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -106.71 87.18 2.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.217 1.007 . . . . 0.0 109.102 175.874 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.4 t -90.68 122.84 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.205 2.202 . . . . 0.0 113.044 -174.73 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -105.73 118.36 36.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.005 -2.309 . . . . 0.0 113.22 -179.762 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 mt -120.12 160.85 22.04 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.943 -1.098 . . . . 0.0 111.161 -173.201 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.26 102.65 8.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.001 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.604 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.86 143.83 57.22 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -173.045 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 t -104.39 93.99 5.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.425 1.49 . . . . 0.0 109.627 -168.184 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.62 56.44 7.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.674 2.39 . . . . 0.0 114.156 -173.573 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.39 60.01 7.17 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.792 -1.193 . . . . 0.0 114.231 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -175.81 104.47 0.08 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 20' ' ' LYS . 9.2 mt -72.33 -49.98 30.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 164.884 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.03 37.63 0.3 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 113.307 -1.77 . . . . 0.0 111.605 165.787 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.05 130.69 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.324 1.059 . . . . 0.0 112.127 179.814 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -73.32 111.22 8.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.217 1.007 . . . . 0.0 111.954 160.575 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.8 m -84.12 124.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.895 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.44 169.7 9.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.459 1.904 . . . . 0.0 110.04 175.133 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.46 -121.51 5.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.481 1.515 . . . . 0.0 113.613 178.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.31 147.71 22.13 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -175.813 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 m -64.08 -11.23 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -171.363 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -48.57 -67.82 0.24 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.887 2.075 . . . . 0.0 115.574 -171.519 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -135.7 -82.67 0.4 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 111.469 -174.745 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -52.44 -24.38 7.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.02 2.97 . . . . 0.0 119.02 -166.159 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 m -85.28 -3.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.156 -1.59 . . . . 0.0 113.371 -178.248 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 21.3 mtp-105 71.38 23.95 3.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.15 2.18 . . . . 0.0 113.197 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.252 2.4 t-80 78.08 125.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.97 2.908 . . . . 0.0 112.554 -170.063 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.03 -111.18 0.24 Allowed Glycine 0 N--CA 1.431 -1.686 0 O-C-N 119.526 -1.983 . . . . 0.0 114.203 -160.363 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.42 -150.22 5.76 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 178.762 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -108.85 155.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 168.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.002 -1.686 . . . . 0.0 107.292 -171.134 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 47' ' ' ILE . 8.7 t -79.9 130.68 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.375 -1.453 . . . . 0.0 110.432 173.384 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -90.3 -49.47 6.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.235 -1.541 . . . . 0.0 110.327 168.886 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.99 37.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.128 0.971 . . . . 0.0 109.824 -173.097 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.461 HD13 HG11 ' A' ' 44' ' ' VAL . 45.3 mm -95.15 137.45 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 170.766 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.17 152.37 39.39 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 120.869 -1.145 . . . . 0.0 113.215 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -80.09 68.21 8.38 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.865 2.377 . . . . 0.0 112.397 168.253 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -121.51 -73.54 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.833 0.853 . . . . 0.0 111.254 171.838 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.42 -99.61 0.12 Allowed Glycine 0 N--CA 1.431 -1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 113.331 -169.034 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -49.04 -52.87 22.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 118.989 2.959 . . . . 0.0 118.989 -152.49 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 -28.89 61.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.184 -1.572 . . . . 0.0 114.991 179.07 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.14 -37.3 83.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.179 -1.576 . . . . 0.0 110.942 168.047 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -69.93 -1.7 10.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -178.373 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -71.56 -83.4 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.062 -2.274 . . . . 0.0 109.793 165.568 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.88 -41.08 0.93 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.957 -1.089 . . . . 0.0 111.561 174.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -84.94 -18.6 34.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.14 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.31 127.22 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.843 1.257 . . . . 0.0 110.836 176.303 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.8 -179.42 5.07 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.634 1.574 . . . . 0.0 110.359 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -76.52 70.55 3.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.326 1.45 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.68 -13.03 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.384 -1.447 . . . . 0.0 116.561 179.523 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -71.34 157.4 38.15 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -92.92 130.33 38.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.392 1.477 . . . . 0.0 110.216 -177.171 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.26 122.3 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.123 1.369 . . . . 0.0 107.754 167.809 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -32.84 8.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.993 -1.067 . . . . 0.0 113.155 175.101 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 159.72 44.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.763 -1.211 . . . . 0.0 112.811 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 t -141.08 123.66 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 111.863 -174.812 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.09 30.43 19.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.28 -1.512 . . . . 0.0 112.687 -178.26 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.84 78.06 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 125.73 1.633 . . . . 0.0 114.557 -174.245 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.92 109.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -177.281 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 m -60.57 146.21 45.98 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.124 1.44 . . . . 0.0 113.677 175.087 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -79.28 65.01 4.33 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.52 -1.362 . . . . 0.0 110.303 172.875 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.38 98.77 9.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.242 -1.536 . . . . 0.0 111.019 -176.307 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.93 66.43 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.361 -0.837 . . . . 0.0 112.896 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.82 129.15 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.955 1.836 . . . . 0.0 115.087 -170.178 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.5 p -93.4 -165.19 1.29 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.645 2.378 . . . . 0.0 107.741 -179.745 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.6 -49.99 75.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.085 -1.635 . . . . 0.0 112.737 164.735 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -69.83 -45.38 67.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.328 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 77' ' ' THR . 58.9 tt0 -69.22 -32.86 72.4 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.979 -1.076 . . . . 0.0 112.97 177.7 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.1 89.97 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.394 -1.441 . . . . 0.0 114.312 173.047 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.89 -52.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.398 -0.811 . . . . 0.0 110.146 171.706 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.24 -40.81 78.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.8 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.2 m -62.4 -28.78 70.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 175.054 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.27 -40.79 11.94 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.824 1.65 . . . . 0.0 115.057 172.234 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -75.69 -44.33 42.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.912 2.885 . . . . 0.0 113.483 -173.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -87.93 38.61 0.85 Allowed 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.336 -1.477 . . . . 0.0 111.471 -169.579 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.0 p -109.26 166.45 10.85 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.722 2.009 . . . . 0.0 112.125 -173.617 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.13 -89.09 0.19 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.199 -1.563 . . . . 0.0 115.564 -172.699 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.64 -62.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.602 -0.94 . . . . 0.0 110.177 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.2 t -75.09 125.79 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 122.961 1.362 . . . . 0.0 110.707 172.346 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.7 t -114.37 103.99 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -83.12 103.88 12.88 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 108.622 172.856 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.73 118.76 26.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.025 -1.047 . . . . 0.0 111.483 178.817 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 102.53 15.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.858 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.75 144.49 30.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.588 1.955 . . . . 0.0 110.427 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.98 132.15 54.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 163.093 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -74.33 121.86 22.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.961 0.905 . . . . 0.0 112.258 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.05 68.24 3.47 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -169.714 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -131.03 150.58 52.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.42 1.088 . . . . 0.0 110.892 174.388 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 p -98.5 131.93 25.08 Favored Pre-proline 0 N--CA 1.431 -1.39 0 C-N-CA 126.437 1.895 . . . . 0.0 110.14 -172.723 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo . . . . . 0 N--CA 1.433 -2.035 0 CA-C-N 123.326 2.223 . . . . 0.0 114.446 178.348 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 121.664 0.745 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.3 tp -144.04 166.13 25.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.831 -1.168 . . . . 0.0 110.041 -174.9 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.507 28.0 m 54.41 98.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 169.314 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 31.2 m -133.76 124.51 26.75 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 -174.842 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -69.83 128.78 37.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.488 1.115 . . . . 0.0 110.672 171.925 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.259 1.594 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -170.744 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 59.2 mtm . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -129.61 155.87 79.61 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 120.825 -1.172 . . . . 0.0 109.129 178.573 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -75.66 129.67 11.97 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.82 2.347 . . . . 0.0 111.517 167.894 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.52 40.41 96.14 Favored Glycine 0 N--CA 1.429 -1.811 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 170.687 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.84 118.49 22.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.207 -1.173 . . . . 0.0 109.48 177.474 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 p -90.83 135.42 33.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.728 -1.233 . . . . 0.0 111.202 174.033 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -131.11 137.55 49.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.558 1.143 . . . . 0.0 108.004 178.22 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.39 76.36 0.97 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.032 1.333 . . . . 0.0 109.364 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.74 121.71 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.044 1.738 . . . . 0.0 114.942 -169.212 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -99.54 116.56 31.95 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.512 -1.992 . . . . 0.0 110.46 174.777 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.29 170.68 15.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.51 141.06 49.53 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.967 -1.083 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -63.99 145.98 54.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.573 1.949 . . . . 0.0 112.593 174.648 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -101.73 101.65 12.18 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.392 1.091 . . . . 0.0 109.495 179.708 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.95 -20.77 0.06 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.704 2.802 . . . . 0.0 117.522 -173.226 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.16 43.81 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.799 -1.813 . . . . 0.0 111.97 179.572 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.9 p -174.12 129.07 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.3 mt -78.99 -40.55 31.31 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.716 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 117.56 43.19 0.59 Allowed Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.39 169.235 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 pt -120.21 134.73 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.695 0.76 . . . . 0.0 109.886 167.238 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.6 m -96.12 117.13 30.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.162 0.985 . . . . 0.0 111.042 169.947 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.67 142.09 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -167.339 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 159.51 40.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.855 1.662 . . . . 0.0 109.448 168.384 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.98 -141.79 16.3 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.839 1.209 . . . . 0.0 114.593 173.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -175.54 48.6 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.668 1.127 . . . . 0.0 115.252 -178.689 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.56 -15.74 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 127.634 2.374 . . . . 0.0 114.085 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.867 1.667 . . . . 0.0 112.942 174.707 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -126.98 -163.6 1.26 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.841 1.657 . . . . 0.0 107.547 174.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.9 p -107.78 105.67 15.62 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.899 -2.376 . . . . 0.0 110.669 174.085 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 m -106.08 -130.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 124.275 1.03 . . . . 0.0 110.598 -176.681 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -92.17 -67.0 0.88 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.071 -1.643 . . . . 0.0 108.755 168.151 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -156.81 62.64 0.52 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 178.545 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.11 8.24 87.96 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 117.619 1.808 . . . . 0.0 117.619 174.123 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 159.99 29.82 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 119.762 1.781 . . . . 0.0 112.779 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -107.64 162.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.338 -170.479 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.852 -1.78 . . . . 0.0 107.777 -173.995 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.586 HG11 HD13 ' A' ' 47' ' ' ILE . 6.2 t -96.68 125.16 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 120.558 -1.339 . . . . 0.0 111.469 176.505 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 -33.55 14.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.373 -1.454 . . . . 0.0 112.261 175.049 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.14 137.58 24.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 110.977 177.237 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.586 HD13 HG11 ' A' ' 44' ' ' VAL . 43.9 mm -96.23 140.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.581 1.952 . . . . 0.0 107.411 173.951 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.671 HD12 ' HA2' ' A' ' 26' ' ' GLY . 68.1 mt -82.76 131.95 53.05 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.853 -1.546 . . . . 0.0 109.521 169.249 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.64 101.41 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.106 2.537 . . . . 0.0 114.04 168.607 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt 68.88 50.2 0.63 Allowed 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.994 1.718 . . . . 0.0 114.669 170.573 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.48 -98.18 0.49 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 162.167 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.09 -38.79 2.13 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.689 1.195 . . . . 0.0 110.965 171.856 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.05 66.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.267 -1.521 . . . . 0.0 114.729 -175.16 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.56 -32.91 69.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.114 -1.616 . . . . 0.0 111.343 167.665 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -73.76 5.69 3.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 177.323 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.64 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.101 -2.249 . . . . 0.0 107.733 151.607 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.77 -42.14 0.6 Allowed Glycine 0 N--CA 1.431 -1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 112.712 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.512 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 2.5 mpt_? -79.7 -17.85 52.64 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.067 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -72.59 143.8 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.013 1.725 . . . . 0.0 112.457 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.13 -178.87 5.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.376 -1.452 . . . . 0.0 109.278 159.931 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.25 135.25 36.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.1 -1.625 . . . . 0.0 111.861 177.773 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.22 -21.53 17.39 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.619 1.104 . . . . 0.0 112.725 -170.297 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -71.55 159.65 34.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.217 1.407 . . . . 0.0 114.232 -172.884 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -101.53 134.88 43.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.753 1.263 . . . . 0.0 110.916 -177.47 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 t -112.6 111.75 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.063 2.545 . . . . 0.0 105.055 178.215 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.82 -33.66 9.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.422 -1.424 . . . . 0.0 113.64 -175.266 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.64 158.05 39.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.75 1.159 . . . . 0.0 113.361 -179.198 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.2 t -129.9 129.5 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.043 -1.036 . . . . 0.0 110.606 174.996 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.385 0.5 OUTLIER 39.25 43.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.927 2.491 . . . . 0.0 116.081 -171.879 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.87 12.26 81.54 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.452 1.501 . . . . 0.0 114.649 178.866 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.9 t -109.32 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.606 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 p -71.36 153.77 42.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.314 1.53 . . . . 0.0 113.301 174.038 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.56 74.15 7.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.452 1.12 . . . . 0.0 112.253 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -84.28 107.95 16.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.016 1.389 . . . . 0.0 110.052 176.242 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.84 11.18 84.8 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.339 -1.476 . . . . 0.0 116.373 -177.777 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.95 141.78 34.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 123.478 1.609 . . . . 0.0 114.909 -169.254 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 66.9 p -99.22 -156.74 0.56 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.067 2.147 . . . . 0.0 109.455 -175.555 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -53.48 19.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.129 -1.607 . . . . 0.0 110.563 164.458 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -69.8 -38.63 76.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.251 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 77' ' ' THR . 10.5 tt0 -65.42 -37.5 87.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.957 -1.714 . . . . 0.0 113.79 171.371 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.34 -36.22 83.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.678 -1.889 . . . . 0.0 114.397 172.747 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.11 -57.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.028 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -48.46 -38.89 21.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 175.578 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.4 m -65.3 -33.3 75.66 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.879 2.471 . . . . 0.0 113.759 177.077 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mt -90.87 -29.62 17.41 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.702 -1.874 . . . . 0.0 114.577 171.846 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.15 -48.62 7.91 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.676 2.39 . . . . 0.0 114.739 -168.738 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -87.2 37.92 0.79 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.034 -1.666 . . . . 0.0 111.531 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 35.7 p -95.59 159.47 14.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.435 2.694 . . . . 0.0 112.087 -175.678 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.03 63.32 3.77 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.796 -1.19 . . . . 0.0 114.251 -174.711 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.289 28.3 tt0 68.69 -51.51 0.57 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.377 2.671 . . . . 0.0 115.423 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.34 125.97 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.673 1.225 . . . . 0.0 110.513 170.581 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.67 107.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -89.53 96.63 10.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.462 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 124.26 34.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 111.825 -169.023 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.14 100.89 13.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.3 1.048 . . . . 0.0 108.286 165.372 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.9 147.54 26.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.221 2.208 . . . . 0.0 109.378 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.62 138.43 54.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.521 1.153 . . . . 0.0 108.481 166.206 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -74.59 118.78 17.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.968 -1.083 . . . . 0.0 112.2 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.82 4.07 Favored Glycine 0 N--CA 1.43 -1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 114.664 -164.568 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -129.66 140.06 51.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.762 1.225 . . . . 0.0 108.019 172.147 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.8 156.29 39.56 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 125.134 1.374 . . . . 0.0 110.054 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--N 1.299 -2.067 0 C-N-CA 122.529 2.153 . . . . 0.0 113.119 -179.026 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 123.092 1.425 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 17.5 tp -97.96 179.59 4.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.913 1.685 . . . . 0.0 109.745 -179.054 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.454 1.1 t 69.68 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 125.051 2.358 . . . . 0.0 115.69 154.313 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.0 m -130.5 122.3 27.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -170.098 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.8 p -74.27 130.03 38.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.609 1.563 . . . . 0.0 110.319 176.95 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' LEU . 11.7 p . . . . . 0 C--O 1.259 1.579 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -164.178 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.943 1.354 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.49 147.33 37.27 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 124.283 1.033 . . . . 0.0 109.204 178.208 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.96 149.77 37.38 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 123.198 2.178 . . . . 0.0 110.649 169.131 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.01 31.85 65.73 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 117.031 1.572 . . . . 0.0 117.031 173.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 120.48 38.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.836 -1.39 . . . . 0.0 111.068 -168.864 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -79.82 134.44 36.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.108 -1.62 . . . . 0.0 112.116 172.472 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.62 122.47 24.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.369 1.468 . . . . 0.0 109.088 176.734 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -88.35 86.41 7.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.384 1.564 . . . . 0.0 110.34 168.981 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.17 143.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.3 1.44 . . . . 0.0 108.876 176.177 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 117.92 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.894 -1.754 . . . . 0.0 109.65 174.668 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.1 mt -120.84 161.23 21.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.513 1.125 . . . . 0.0 109.916 -173.705 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.13 117.43 26.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 166.318 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -63.9 145.33 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.1 1.36 . . . . 0.0 114.303 -173.96 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.6 t -97.62 104.09 16.08 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 120.511 -1.368 . . . . 0.0 110.474 178.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 49.83 39.82 19.08 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.157 2.183 . . . . 0.0 115.28 -174.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 65.54 1.98 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 121.107 -0.996 . . . . 0.0 115.004 -173.525 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.487 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 46.6 t 177.98 114.01 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -175.305 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.8 mt -76.52 -38.25 55.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.528 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.5 27.65 2.32 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.122 169.067 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HB ' HG13 ' A' ' 44' ' ' VAL . 40.1 pt -124.37 127.36 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.684 0.754 . . . . 0.0 109.96 -174.232 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -79.12 110.69 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.028 1.331 . . . . 0.0 114.003 173.61 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.46 129.39 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -176.598 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -124.27 167.88 13.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.727 . . . . 0.0 109.939 172.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.7 -152.03 42.06 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.975 1.274 . . . . 0.0 113.61 -177.837 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.0 165.7 19.65 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.288 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.07 -27.54 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.634 -1.509 . . . . 0.0 114.372 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -80.7 -11.68 59.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.848 -1.782 . . . . 0.0 113.402 179.338 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.9 m -88.52 -22.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 120.452 -1.405 . . . . 0.0 110.729 173.063 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m 77.74 87.85 0.07 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.324 2.25 . . . . 0.0 111.141 -177.195 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.19 -116.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -170.605 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.1 mmt-85 -82.7 -98.35 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.24 -1.538 . . . . 0.0 107.78 161.144 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -105.77 -35.06 7.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.978 2.111 . . . . 0.0 112.171 176.853 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.51 -127.48 1.11 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 104.121 -3.591 . . . . 0.0 104.121 178.652 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.61 -175.16 53.51 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 112.004 -167.738 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 5.4 tp -140.92 163.0 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -135.72 155.32 50.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.292 -1.505 . . . . 0.0 107.356 -173.177 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 47' ' ' ILE . 21.9 t -96.96 121.39 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.758 -1.214 . . . . 0.0 111.611 -178.497 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.31 -34.48 18.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.246 -1.534 . . . . 0.0 113.21 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.21 132.68 18.64 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -177.743 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.476 ' CD1' HG11 ' A' ' 44' ' ' VAL . 38.6 mm -93.48 126.3 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 166.561 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 pt -79.7 160.78 68.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 121.631 -0.668 . . . . 0.0 111.859 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.04 106.06 2.14 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.136 1.89 . . . . 0.0 112.178 168.153 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.524 0.1 OUTLIER 57.98 98.38 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.064 2.546 . . . . 0.0 117.521 179.385 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.15 -110.22 1.89 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 164.034 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.55 -42.06 2.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.302 1.441 . . . . 0.0 111.265 170.92 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.8 -41.1 79.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.668 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.77 -30.5 56.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.234 -1.541 . . . . 0.0 112.996 174.395 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -72.29 2.22 6.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 175.762 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.13 -99.86 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.874 -2.391 . . . . 0.0 109.045 162.519 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 -47.36 0.14 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.654 -1.904 . . . . 0.0 113.404 175.475 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 mtm-85 -69.2 -33.83 73.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.92 1.288 . . . . 0.0 113.143 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -52.13 129.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.062 2.945 . . . . 0.0 116.016 -175.386 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.87 177.79 8.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.57 -1.331 . . . . 0.0 110.93 167.38 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -72.16 121.26 19.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.475 -2.641 . . . . 0.0 112.445 175.623 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.06 0.95 11.55 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -176.264 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.95 158.69 29.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.528 2.164 . . . . 0.0 112.836 176.206 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -100.62 129.92 46.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.244 1.418 . . . . 0.0 108.971 178.453 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.52 117.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.225 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.03 -39.12 8.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.875 -1.765 . . . . 0.0 113.332 176.442 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.55 159.18 44.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 119.993 1.269 . . . . 0.0 113.721 -177.871 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 92' ' ' VAL . 67.0 t -133.28 115.78 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 123.881 0.872 . . . . 0.0 111.271 179.905 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 52.49 27.11 4.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.066 -1.646 . . . . 0.0 115.305 -168.184 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 4.52 72.97 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 114.25 -173.65 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.39 93.5 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -177.636 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.5 p -71.42 135.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.34 1.067 . . . . 0.0 113.634 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.2 mt -80.12 56.67 2.48 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.081 2.152 . . . . 0.0 112.354 -174.915 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -73.35 82.04 1.4 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.289 2.236 . . . . 0.0 112.643 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.27 29.41 19.79 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 120.711 -1.243 . . . . 0.0 113.446 -178.408 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.29 149.85 35.32 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.687 1.232 . . . . 0.0 112.238 176.037 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -104.66 -163.27 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.503 1.921 . . . . 0.0 109.121 -176.013 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -66.72 -54.11 26.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 111.511 169.24 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -64.35 -46.54 82.98 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.499 1.12 . . . . 0.0 112.659 177.889 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -63.38 -41.76 98.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.417 -1.427 . . . . 0.0 113.654 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.21 -38.4 87.88 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.295 -1.503 . . . . 0.0 114.918 174.238 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.79 -56.34 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 118.7 0.682 . . . . 0.0 110.494 170.298 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 36.0 mt-10 -64.18 -25.45 68.08 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -65.13 -35.05 79.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.357 1.863 . . . . 0.0 111.186 173.419 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.95 -40.85 13.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.241 1.816 . . . . 0.0 114.507 174.123 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 83' ' ' GLU 0.356 0.0 OUTLIER -82.33 -35.59 27.75 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -174.457 . . . . . . . . 4 4 . 1 . 033 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -81.33 41.58 0.62 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.559 -1.963 . . . . 0.0 113.333 178.101 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -105.42 -169.02 1.53 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.087 2.155 . . . . 0.0 110.488 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.86 -117.02 3.99 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.194 1.378 . . . . 0.0 110.736 176.616 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -66.35 0.93 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.877 -1.367 . . . . 0.0 111.438 178.098 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.46 129.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.907 -174.802 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 68' ' ' VAL . 30.1 t -121.28 105.99 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 172.277 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -77.43 100.43 5.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.653 1.581 . . . . 0.0 108.844 165.368 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -84.6 111.83 19.89 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.462 1.505 . . . . 0.0 108.065 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 99.61 12.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 171.596 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.5 144.1 32.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.286 1.434 . . . . 0.0 109.802 -177.672 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.62 125.26 53.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 166.301 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -65.41 122.12 16.44 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.808 1.243 . . . . 0.0 113.567 -171.306 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.84 71.53 2.19 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.756 1.169 . . . . 0.0 112.622 -173.048 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -138.34 147.4 43.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.889 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -87.06 145.53 38.45 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 124.927 1.291 . . . . 0.0 110.001 -172.81 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo . . . . . 0 C--N 1.3 -2.025 0 CA-C-N 123.252 2.197 . . . . 0.0 114.25 173.321 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.54 -148.9 0.41 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.912 -1.117 . . . . 0.0 110.928 174.996 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER 85.8 112.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 123.981 1.848 . . . . 0.0 113.466 165.823 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.6 m -139.4 118.8 12.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 -172.547 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 85.8 p -73.14 129.1 37.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.383 0.992 . . . . 0.0 109.426 170.084 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.0 p . . . . . 0 C--O 1.261 1.697 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -161.306 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 120.782 0.325 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.55 148.3 38.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 174.439 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -72.93 161.9 42.42 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 122.902 2.401 . . . . 0.0 111.484 171.748 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.49 74.06 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 115.618 1.007 . . . . 0.0 115.618 -173.291 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -90.72 97.28 11.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.24 -1.741 . . . . 0.0 112.192 -172.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p -100.77 148.83 24.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.814 -1.179 . . . . 0.0 108.842 159.579 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 124.58 31.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.18 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.01 82.23 3.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.687 1.232 . . . . 0.0 108.567 176.27 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.54 153.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.301 1.44 . . . . 0.0 109.709 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -129.31 122.35 29.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.177 -1.577 . . . . 0.0 107.807 166.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -119.89 153.25 36.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.936 -1.103 . . . . 0.0 108.336 -173.93 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.07 8.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.904 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.63 123.9 15.61 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.85 1.66 . . . . 0.0 113.303 -168.873 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.259 11.1 t -85.7 104.45 15.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.303 -1.498 . . . . 0.0 110.978 -169.815 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.61 16.71 9.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 127.2 2.2 . . . . 0.0 116.019 -173.835 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.99 84.58 1.35 Allowed Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.262 -1.524 . . . . 0.0 111.041 -175.566 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.254 79.2 p 151.51 109.31 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.346 2.658 . . . . 0.0 107.447 -169.023 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.13 -40.94 82.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.239 2.216 . . . . 0.0 107.369 161.047 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 110.74 32.23 2.73 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 124.953 1.263 . . . . 0.0 110.765 173.038 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 pt -121.37 130.7 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 121.86 -0.788 . . . . 0.0 109.484 174.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -87.04 119.33 27.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.026 0.917 . . . . 0.0 111.096 168.249 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 29' ' ' VAL . 15.9 m -86.08 133.65 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.905 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -126.22 170.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.534 1.534 . . . . 0.0 110.83 176.779 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.91 -121.73 5.69 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 125.23 1.395 . . . . 0.0 113.461 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.39 155.05 30.78 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.624 1.107 . . . . 0.0 112.236 -177.884 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.58 -19.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 126.312 1.845 . . . . 0.0 114.154 -175.462 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.75 -42.39 90.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.189 2.596 . . . . 0.0 113.554 178.386 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.7 m -131.63 -97.7 0.32 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 123.166 0.587 . . . . 0.0 110.659 -171.435 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -100.85 78.03 1.91 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.025 -1.672 . . . . 0.0 114.102 -164.966 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.42 -176.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 165.881 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -80.78 -54.71 5.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.597 -1.314 . . . . 0.0 108.9 161.547 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.64 -2.09 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.384 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.86 126.96 0.92 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 119.018 -2.301 . . . . 0.0 110.898 -173.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.99 169.42 16.18 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 172.151 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 42' ' ' ILE . 4.1 tp -116.13 155.87 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.488 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -132.66 152.3 51.72 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.236 -1.54 . . . . 0.0 107.904 -169.308 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.36 107.42 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.846 -1.158 . . . . 0.0 111.397 -170.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -86.93 -42.09 13.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.631 -1.918 . . . . 0.0 113.416 -177.226 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.55 133.13 47.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 113.576 176.985 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.9 128.93 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.884 2.474 . . . . 0.0 109.777 175.622 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.601 HD12 ' HA2' ' A' ' 26' ' ' GLY . 72.9 mt -95.94 113.37 61.99 Favored Pre-proline 0 N--CA 1.429 -1.502 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.692 174.779 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.68 66.19 8.81 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.311 2.575 . . . . 0.0 113.45 171.886 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' H ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 175.59 15.3 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.576 2.35 . . . . 0.0 112.341 171.959 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 50' ' ' LYS . . . -94.17 -108.67 2.07 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 119.528 -1.982 . . . . 0.0 111.667 174.267 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 -39.45 0.27 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.63 -0.924 . . . . 0.0 110.781 -175.108 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.57 -40.5 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.509 1.924 . . . . 0.0 113.652 -176.545 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -62.6 -33.57 75.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.286 -1.508 . . . . 0.0 111.227 170.122 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.35 1.66 7.45 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 174.731 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.25 -70.98 0.28 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.636 -1.915 . . . . 0.0 108.751 157.097 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -11.46 5.74 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 123.462 0.553 . . . . 0.0 112.984 164.278 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -94.78 -12.71 26.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.25 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -86.32 138.0 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.935 1.694 . . . . 0.0 112.746 -173.835 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -128.24 -171.95 2.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.858 1.263 . . . . 0.0 110.65 170.957 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -94.78 36.07 1.21 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.397 -2.064 . . . . 0.0 115.182 -163.667 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.9 16.85 1.07 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.372 -1.455 . . . . 0.0 111.749 175.717 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -92.62 151.5 20.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.894 0.854 . . . . 0.0 111.949 -162.659 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -96.64 124.67 40.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.073 0.949 . . . . 0.0 110.526 -176.242 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.2 108.67 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 167.488 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -39.69 11.51 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.949 -1.72 . . . . 0.0 112.09 178.406 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.63 38.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 119.509 1.049 . . . . 0.0 113.47 -176.355 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 92' ' ' VAL . 11.2 t -133.36 118.21 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 123.58 0.752 . . . . 0.0 111.432 -175.861 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 61.72 29.6 18.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.049 1.295 . . . . 0.0 111.808 -173.549 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.18 4.35 89.78 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.509 -1.37 . . . . 0.0 115.278 -171.523 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.8 107.33 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 118.639 1.219 . . . . 0.0 108.081 -172.501 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 m -70.41 138.22 51.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.206 -0.934 . . . . 0.0 113.333 -178.042 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.46 37.95 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.298 1.839 . . . . 0.0 111.727 -178.055 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -84.53 74.29 10.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.669 1.988 . . . . 0.0 110.227 -169.794 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.63 9.6 6.94 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 124.175 0.893 . . . . 0.0 112.985 -170.101 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.49 140.46 32.3 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.147 1.473 . . . . 0.0 112.953 177.763 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.473 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.2 p -92.12 -160.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.706 2.002 . . . . 0.0 109.912 -178.735 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -66.5 -56.42 10.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.031 -1.668 . . . . 0.0 111.317 165.69 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -69.38 -38.4 77.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 121.355 -0.841 . . . . 0.0 112.673 -177.127 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' A' ' 77' ' ' THR . 9.0 tt0 -65.96 -36.91 84.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 174.867 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.24 96.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.563 -1.96 . . . . 0.0 113.929 171.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 t -56.21 -49.8 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.74 1.216 . . . . 0.0 111.933 174.827 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.006 -1.684 . . . . 0.0 114.029 176.163 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.2 m -66.31 -24.72 66.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.303 1.841 . . . . 0.0 113.216 -179.313 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.44 -46.39 8.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.848 1.259 . . . . 0.0 114.138 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -85.47 -33.62 21.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.045 -1.66 . . . . 0.0 115.376 -169.969 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.53 34.23 0.98 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.901 -1.75 . . . . 0.0 111.032 -174.655 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.3 p -88.48 -166.15 1.52 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.368 2.667 . . . . 0.0 110.429 177.404 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.89 -123.92 3.79 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.019 -1.676 . . . . 0.0 110.138 170.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.8 -50.61 4.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.184 -1.186 . . . . 0.0 109.8 177.142 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.19 123.63 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 123.22 1.486 . . . . 0.0 110.776 176.898 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 68' ' ' VAL . 6.4 t -114.58 112.48 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.833 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -78.51 116.11 18.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.67 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.72 110.08 22.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.027 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.72 99.91 12.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.532 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.55 142.89 36.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.37 1.868 . . . . 0.0 110.207 -173.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -121.81 151.61 40.41 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.004 1.722 . . . . 0.0 109.514 177.329 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 123.86 10.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 174.483 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.18 57.52 3.2 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.788 -1.82 . . . . 0.0 113.15 171.383 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -151.88 151.22 30.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 122.038 -0.683 . . . . 0.0 109.217 177.333 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.98 155.39 64.33 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 125.182 1.393 . . . . 0.0 111.612 -178.186 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.299 -2.048 0 C-N-CA 122.438 2.092 . . . . 0.0 115.657 -174.775 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.879 1.323 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 16.1 tp -141.21 -170.26 3.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.184 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.448 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.45 2.9 m 52.61 88.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.132 2.173 . . . . 0.0 115.077 170.302 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 61.7 m -126.77 118.21 24.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -168.88 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.3 p -79.59 120.45 23.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.4 1.08 . . . . 0.0 110.304 -179.37 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -169.155 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.474 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -130.73 142.83 46.95 Favored Pre-proline 0 N--CA 1.431 -1.412 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.576 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 142.49 30.59 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 123.139 2.157 . . . . 0.0 112.204 -179.408 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.82 17.22 73.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 124.398 0.999 . . . . 0.0 115.491 178.672 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -76.63 111.15 11.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.326 -1.103 . . . . 0.0 111.765 -174.847 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -81.81 146.47 29.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.461 1.124 . . . . 0.0 111.753 172.633 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.2 117.28 14.37 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.562 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.53 76.65 3.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.887 1.327 . . . . 0.0 109.601 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.03 116.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.706 2.402 . . . . 0.0 112.472 -169.211 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.332 0.2 OUTLIER -104.56 118.36 36.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.834 -1.791 . . . . 0.0 112.078 -173.999 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 mt -127.72 178.38 6.18 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.768 -1.207 . . . . 0.0 109.216 -171.635 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.28 119.33 22.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 162.59 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HB3' ' H ' ' A' ' 24' ' ' SER . 2.1 mtpt -62.31 128.6 36.83 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.576 -1.328 . . . . 0.0 113.09 -174.979 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -88.72 121.02 30.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.505 -1.372 . . . . 0.0 109.392 179.105 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.26 4.59 3.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.845 2.058 . . . . 0.0 114.743 178.182 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.93 86.24 0.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 125.527 1.537 . . . . 0.0 110.581 -164.794 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.55 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 37.3 m 163.57 119.81 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 128.192 2.597 . . . . 0.0 106.584 -169.697 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 92' ' ' VAL . 23.6 mt -72.7 -37.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.785 1.755 . . . . 0.0 109.095 162.778 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 102.58 34.66 4.05 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.141 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HB ' HG13 ' A' ' 44' ' ' VAL . 41.9 pt -119.99 136.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 122.031 -0.688 . . . . 0.0 109.683 173.287 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.2 m -84.46 122.35 28.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 123.307 0.643 . . . . 0.0 109.754 160.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 m -85.13 132.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.617 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -122.85 161.83 23.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.538 -1.976 . . . . 0.0 109.691 174.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.72 -148.62 30.69 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.764 1.174 . . . . 0.0 113.998 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.83 146.91 5.46 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.415 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 4.9 p -54.1 -21.36 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 126.525 1.93 . . . . 0.0 114.996 -178.242 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -51.01 -60.15 3.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.593 1.957 . . . . 0.0 114.618 -174.858 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.0 t -152.18 -57.96 0.15 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.356 -1.465 . . . . 0.0 112.694 -172.407 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.9 p -67.53 -13.78 62.36 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -162.373 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.2 7.07 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 120.685 -1.259 . . . . 0.0 113.106 -178.163 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 58.97 59.82 2.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.392 1.477 . . . . 0.0 113.022 -172.189 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 m170 52.11 82.65 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 33' ' ' VAL . . . -142.15 -117.18 1.27 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.095 -1.628 . . . . 0.0 113.781 -177.613 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -137.35 2.98 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.931 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.27 2.1 tp -116.04 157.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 119.644 1.722 . . . . 0.0 110.7 -173.976 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -140.5 152.79 45.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -170.511 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' A' ' 47' ' ' ILE . 14.7 t -87.99 131.66 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.698 -1.877 . . . . 0.0 111.506 -178.609 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -96.98 -52.38 3.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.908 -1.12 . . . . 0.0 111.213 175.75 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.81 118.07 17.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.074 -1.016 . . . . 0.0 111.163 -171.671 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 44' ' ' VAL . 32.2 mm -88.92 129.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 126.28 1.832 . . . . 0.0 109.346 177.222 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' HA2' ' A' ' 26' ' ' GLY . 79.9 mt -78.16 121.19 83.59 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.449 174.51 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 54.9 Cg_endo -81.29 66.85 8.66 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.653 2.34 . . . . 0.0 113.062 -178.301 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt 170.47 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.43 1.892 . . . . 0.0 115.055 175.256 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.18 -74.33 0.57 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -159.183 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.32 -56.09 0.09 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.324 -1.104 . . . . 0.0 111.114 -178.165 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.05 80.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.352 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 18.7 tp10 -51.72 -35.83 44.61 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.107 1.363 . . . . 0.0 113.548 167.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 -16.18 46.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.97 -77.15 0.07 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.019 0.927 . . . . 0.0 110.281 164.791 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.36 -20.95 3.9 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 114.804 160.946 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.76 -13.62 60.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 118.778 1.289 . . . . 0.0 113.479 178.002 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 141.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 125.082 1.353 . . . . 0.0 113.542 -176.328 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.69 -174.24 3.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.697 -1.252 . . . . 0.0 110.372 169.055 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -81.69 56.25 2.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.388 -1.445 . . . . 0.0 112.914 -175.971 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -172.56 -8.91 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.248 -0.908 . . . . 0.0 114.58 -176.443 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.68 157.67 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.663 1.732 . . . . 0.0 114.855 -177.1 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -93.7 123.8 37.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.42 1.088 . . . . 0.0 110.412 -176.722 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.78 110.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.588 -1.32 . . . . 0.0 107.983 174.104 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.45 -26.59 12.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.84 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.64 172.0 17.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.62 2.009 . . . . 0.0 113.239 176.336 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 HD23 ' A' ' 94' ' ' LEU . 9.7 p -142.89 120.51 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 177.019 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.501 0.0 OUTLIER 30.22 43.77 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.0 2.963 . . . . 0.0 119.0 -151.501 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.48 10.31 86.03 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 126.452 1.977 . . . . 0.0 115.366 -175.798 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.16 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.472 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -63.72 130.43 44.21 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.063 1.745 . . . . 0.0 115.576 -170.318 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mt -89.42 -6.65 56.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.969 2.108 . . . . 0.0 110.366 171.694 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.94 108.74 9.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.988 -1.695 . . . . 0.0 109.202 172.047 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.62 28.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.181 -0.95 . . . . 0.0 113.421 -163.951 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 142.07 34.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.791 -1.417 . . . . 0.0 113.08 -179.506 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.57 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 60.4 p -91.1 -162.0 0.87 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.868 2.467 . . . . 0.0 109.746 -177.89 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -62.87 -51.62 66.3 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.647 -1.908 . . . . 0.0 111.47 167.147 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -65.26 -50.62 65.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.339 1.055 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' HB2' ' H ' ' A' ' 77' ' ' THR . 2.3 mp0 -63.03 -33.37 75.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.607 -1.308 . . . . 0.0 113.856 177.471 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.85 89.61 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 120.263 1.392 . . . . 0.0 114.185 174.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -59.12 -51.21 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 121.58 -0.7 . . . . 0.0 111.212 176.058 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -63.44 -32.58 74.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.346 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.4 m -60.72 -45.18 95.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.886 1.674 . . . . 0.0 112.332 172.27 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.6 -41.3 12.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 113.323 -174.476 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -44.12 56.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -88.47 42.32 1.06 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.654 -1.904 . . . . 0.0 112.421 -169.711 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 p -99.5 -171.0 1.99 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.407 3.483 . . . . 0.0 109.496 177.13 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.93 -132.95 4.53 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.533 -1.354 . . . . 0.0 111.681 175.106 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -93.37 -52.17 4.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.403 -1.645 . . . . 0.0 112.563 178.136 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.59 130.98 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 122.0 0.905 . . . . 0.0 111.308 176.596 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 25' ' ' LEU . 3.9 m -122.23 113.45 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.405 1.082 . . . . 0.0 108.086 172.56 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -81.57 94.26 6.87 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.552 -1.343 . . . . 0.0 108.826 160.909 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 68' ' ' VAL . 4.8 mt -73.3 110.49 7.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.034 1.333 . . . . 0.0 110.053 178.985 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.38 100.43 11.84 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.455 -0.778 . . . . 0.0 110.358 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.71 149.07 28.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.986 1.714 . . . . 0.0 109.585 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -124.44 147.49 48.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.94 1.296 . . . . 0.0 108.36 167.965 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -58.37 115.35 2.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 176.093 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.92 61.93 0.94 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.639 1.114 . . . . 0.0 110.686 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -144.02 156.57 44.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.52 166.39 39.97 Favored Pre-proline 0 N--CA 1.429 -1.486 0 C-N-CA 124.344 1.057 . . . . 0.0 111.917 176.898 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo . . . . . 0 C--N 1.299 -2.049 0 C-N-CA 123.058 2.505 . . . . 0.0 112.759 168.514 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' B' B ' 206' ' ' LEU . . . . . 0.674 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp 65.92 -147.55 0.21 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.532 1.933 . . . . 0.0 113.076 -178.842 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.674 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.378 15.4 m 23.14 100.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.155 3.782 . . . . 0.0 119.663 161.87 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -130.55 123.05 28.71 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 -176.42 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.5 p -72.17 129.02 37.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.093 0.949 . . . . 0.0 110.068 169.735 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.26 1.619 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 -158.466 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.399 0 CA-C-O 121.678 0.752 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.18 118.1 33.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.963 1.305 . . . . 0.0 109.093 174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.23 92.06 7.05 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.051 1.405 . . . . 0.0 110.078 170.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.2 t -89.45 127.91 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 126.315 1.846 . . . . 0.0 112.454 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 0.0 OUTLIER -108.35 122.54 47.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.012 -2.305 . . . . 0.0 110.238 174.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.84 157.64 37.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.005 -173.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.05 113.22 22.89 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 163.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -56.41 132.45 51.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.262 1.425 . . . . 0.0 113.953 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.5 t -97.74 110.13 22.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.605 -1.31 . . . . 0.0 109.138 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 46.07 55.43 7.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.896 2.478 . . . . 0.0 115.457 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.98 51.22 19.72 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.714 -1.241 . . . . 0.0 114.828 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 p -178.24 111.57 0.07 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.3 mt -66.63 -53.51 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.408 2.283 . . . . 0.0 108.15 166.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.796 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 133.96 26.73 0.56 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.911 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 44' ' ' VAL . 11.2 pt -126.27 137.61 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.306 1.05 . . . . 0.0 111.171 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -87.27 119.82 27.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.982 1.713 . . . . 0.0 111.649 164.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 29' ' ' VAL . 21.8 m -84.63 140.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.02 178.25 7.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.463 1.905 . . . . 0.0 109.291 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 -118.2 4.73 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.27 1.414 . . . . 0.0 113.105 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.79 162.2 36.01 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 121.432 -1.04 . . . . 0.0 112.502 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.274 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.458 ' H ' HD13 ' A' ' 73' ' ' LEU . 6.3 tp -107.25 156.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.94 157.54 46.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.877 -1.764 . . . . 0.0 106.416 -170.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' ILE . 9.6 t -87.32 131.29 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.141 -1.599 . . . . 0.0 111.9 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -41.48 9.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.367 -1.458 . . . . 0.0 110.816 171.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.45 136.03 25.7 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.032 -1.042 . . . . 0.0 111.102 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.509 HD13 HG11 ' A' ' 44' ' ' VAL . 36.2 mm -97.43 137.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 127.017 2.127 . . . . 0.0 108.597 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.796 HD12 ' HA2' ' A' ' 26' ' ' GLY . 50.1 mt . . . . . 0 N--CA 1.43 -1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 110.151 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.73 54.19 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.181 2.192 . . . . 0.0 115.104 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.53 -26.93 68.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.923 -1.736 . . . . 0.0 112.292 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -70.11 -18.73 63.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.033 -1.667 . . . . 0.0 115.066 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.74 -71.57 0.24 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.036 -2.29 . . . . 0.0 107.368 157.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.0 5.63 62.4 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 161.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -80.75 -19.37 45.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 110.115 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.08 149.29 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.298 1.839 . . . . 0.0 114.253 162.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.44 -161.23 1.11 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.62 1.568 . . . . 0.0 107.464 157.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.3 45.45 1.28 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.959 -2.338 . . . . 0.0 112.549 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.73 -20.13 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 O-C-N 120.609 -1.307 . . . . 0.0 114.807 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -78.76 161.06 27.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -166.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -104.07 124.65 49.44 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.64 1.576 . . . . 0.0 110.411 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.26 117.24 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 107.248 166.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 -36.19 9.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.824 -1.797 . . . . 0.0 112.754 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.26 154.22 38.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.82 -1.175 . . . . 0.0 111.401 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.04 121.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.065 -1.022 . . . . 0.0 111.259 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.8 t30 63.77 21.33 12.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.643 -1.285 . . . . 0.0 113.389 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.94 20.38 63.34 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.665 -1.272 . . . . 0.0 113.492 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.9 110.67 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 121.079 -1.248 . . . . 0.0 107.99 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.7 m -58.13 141.18 51.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.383 1.873 . . . . 0.0 114.543 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 42' ' ' ILE . 4.3 mt -81.08 47.62 1.03 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.284 1.516 . . . . 0.0 111.889 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.76 117.03 21.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.196 1.799 . . . . 0.0 109.707 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.86 72.02 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 114.734 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.21 132.76 36.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.529 1.633 . . . . 0.0 112.639 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -110.46 -164.92 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.006 2.523 . . . . 0.0 105.517 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -58.18 -52.17 66.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.557 -1.965 . . . . 0.0 112.947 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -70.53 -44.63 67.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.121 0.968 . . . . 0.0 112.583 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -38.83 92.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.05 1.34 . . . . 0.0 113.807 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.32 97.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 0.0 114.312 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.37 -54.51 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 118.127 0.421 . . . . 0.0 110.247 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.77 -37.12 40.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 126.085 1.754 . . . . 0.0 115.351 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.7 m -72.22 -31.46 65.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.68 2.392 . . . . 0.0 113.898 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -89.02 -37.94 14.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.242 1.817 . . . . 0.0 114.102 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -82.97 -45.45 14.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.624 1.97 . . . . 0.0 113.378 -166.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -90.88 37.32 0.92 Allowed 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.038 1.399 . . . . 0.0 112.623 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.8 p -90.1 173.51 8.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.949 2.1 . . . . 0.0 114.058 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.71 51.39 4.45 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.673 -1.892 . . . . 0.0 113.972 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 68.27 -51.78 0.54 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.299 3.04 . . . . 0.0 115.673 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.6 t -76.86 128.46 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 123.144 1.449 . . . . 0.0 109.844 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.03 100.22 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -82.26 98.49 8.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.875 1.67 . . . . 0.0 107.987 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -87.51 112.75 22.55 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.322 1.449 . . . . 0.0 109.878 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.26 100.52 12.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.84 136.97 44.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.413 1.885 . . . . 0.0 110.881 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.28 158.23 17.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.134 1.774 . . . . 0.0 109.37 171.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.551 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.6 tp . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.551 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.419 16.0 m 33.12 89.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 129.934 3.294 . . . . 0.0 116.775 171.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 64.5 m -125.11 121.83 35.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.0 p -71.62 121.1 18.18 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.574 1.15 . . . . 0.0 109.779 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.636 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.911 0.862 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.58 121.54 37.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.517 1.127 . . . . 0.0 108.599 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -88.74 87.63 7.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.965 1.364 . . . . 0.0 111.021 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.9 t -85.82 110.77 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.941 1.696 . . . . 0.0 111.493 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.58 123.21 40.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.621 -1.924 . . . . 0.0 108.24 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.11 172.36 12.48 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.13 128.77 55.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 158.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.3 137.17 52.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.578 1.151 . . . . 0.0 110.565 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -89.35 92.2 9.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.015 -1.678 . . . . 0.0 110.67 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.5 -18.82 0.11 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.52 61.07 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 119.983 -1.698 . . . . 0.0 110.028 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -179.97 119.64 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.875 1.797 . . . . 0.0 107.266 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' CD2' HG21 ' A' ' 92' ' ' VAL . 16.9 mt -74.87 -47.54 29.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.001 1.857 . . . . 0.0 106.575 162.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 112.01 39.94 1.23 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.426 1.489 . . . . 0.0 111.4 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' A' ' 44' ' ' VAL . 42.9 pt -124.85 136.65 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.812 0.815 . . . . 0.0 109.713 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 m -88.31 121.57 30.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.342 1.457 . . . . 0.0 111.398 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.11 138.41 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -174.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.2 t -138.6 175.9 9.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.16 2.584 . . . . 0.0 108.581 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 -128.34 9.02 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 113.123 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.8 163.49 39.44 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.796 -1.414 . . . . 0.0 114.525 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.431 -1.401 0 C-N-CA 126.697 1.999 . . . . 0.0 114.615 -175.145 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -105.57 160.33 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.9 160.31 38.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.926 -1.734 . . . . 0.0 107.017 -171.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' ILE . 4.0 t -92.07 134.46 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.429 -1.42 . . . . 0.0 112.219 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -99.56 -36.64 9.46 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.72 -1.237 . . . . 0.0 111.441 171.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.05 129.95 16.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.216 -1.553 . . . . 0.0 111.654 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.509 HD13 HG11 ' A' ' 44' ' ' VAL . 38.6 mm -95.25 136.86 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 108.816 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.695 HD12 ' HA2' ' A' ' 26' ' ' GLY . 62.4 mt . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 119.919 -1.738 . . . . 0.0 110.176 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 121.687 0.756 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.87 63.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.081 1.753 . . . . 0.0 114.656 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.73 -28.37 67.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.44 -1.412 . . . . 0.0 112.956 171.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -14.54 63.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.69 -70.52 0.34 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.163 -1.586 . . . . 0.0 108.685 159.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.47 6.64 56.42 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 114.206 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -78.83 -27.62 44.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.301 -1.705 . . . . 0.0 109.102 164.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -69.27 143.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.873 1.669 . . . . 0.0 114.198 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -132.61 172.81 12.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.696 -1.252 . . . . 0.0 110.049 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -82.62 58.39 4.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.686 -1.884 . . . . 0.0 113.458 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.55 31.4 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -103.75 159.19 15.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -100.73 130.22 46.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.713 1.205 . . . . 0.0 109.772 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.21 114.35 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.98 -34.11 11.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.575 -1.328 . . . . 0.0 112.225 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.08 165.34 37.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.217 1.371 . . . . 0.0 113.327 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 HD23 ' A' ' 85' ' ' LEU . 14.9 t -134.27 119.17 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 110.552 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.89 27.1 8.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 121.101 1.773 . . . . 0.0 115.247 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.67 17.82 74.55 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 120.88 -1.137 . . . . 0.0 114.5 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.9 98.29 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 t -68.64 137.12 53.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.277 1.431 . . . . 0.0 114.642 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.93 30.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.855 2.062 . . . . 0.0 111.702 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 10.49 1.19 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -167.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.62 36.59 0.39 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.829 -1.17 . . . . 0.0 110.401 166.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.32 37.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.059 0.943 . . . . 0.0 113.31 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -108.73 -161.59 0.77 Allowed 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.415 2.286 . . . . 0.0 106.859 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -55.09 -55.97 25.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.637 1.975 . . . . 0.0 114.09 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -64.64 -54.45 31.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.082 0.944 . . . . 0.0 112.724 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -41.09 71.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.132 1.773 . . . . 0.0 114.256 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.51 89.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.208 -1.558 . . . . 0.0 114.844 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.1 t -57.52 -52.5 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 119.196 0.907 . . . . 0.0 110.333 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.03 -35.9 74.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.6 m -64.58 -34.65 78.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.966 1.706 . . . . 0.0 113.772 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 68' ' ' VAL . 16.5 mt -87.98 -39.48 14.66 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.258 -1.526 . . . . 0.0 113.481 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -50.81 10.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.409 2.284 . . . . 0.0 113.986 -173.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.59 43.03 0.94 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 124.023 1.868 . . . . 0.0 112.044 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.4 p -99.08 174.64 6.24 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.93 2.892 . . . . 0.0 108.35 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.24 -131.22 0.76 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.646 -1.284 . . . . 0.0 112.743 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -97.19 -49.78 4.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.023 -1.281 . . . . 0.0 110.45 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.6 129.88 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.184 1.468 . . . . 0.0 110.977 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.573 HG21 ' CD2' ' A' ' 25' ' ' LEU . 13.9 m -121.37 110.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.821 1.648 . . . . 0.0 107.062 170.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -82.84 96.15 8.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 161.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.38 122.42 24.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.748 -1.22 . . . . 0.0 110.817 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.8 103.58 15.48 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 108.664 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -112.83 144.54 42.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.155 1.382 . . . . 0.0 110.219 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -119.29 133.63 55.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.013 1.325 . . . . 0.0 109.519 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.403 0 C-N-CA 125.068 1.347 . . . . 0.0 114.386 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.517 17.4 m 61.92 98.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.001 2.521 . . . . 0.0 116.531 171.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.2 m -129.43 120.99 26.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.4 p -71.36 135.72 47.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.168 0.987 . . . . 0.0 109.796 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.259 1.604 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -166.062 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.375 0.607 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 134.42 54.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.77 1.228 . . . . 0.0 107.947 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.21 68.49 0.71 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.94 1.352 . . . . 0.0 108.819 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.4 t -75.97 112.77 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.522 2.329 . . . . 0.0 112.21 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.29 3.0 pm0 -100.74 120.84 40.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.879 -1.763 . . . . 0.0 111.708 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 94' ' ' LEU . 13.4 mt -133.73 174.34 10.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.56 1.144 . . . . 0.0 108.802 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.03 125.52 52.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 160.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.93 143.82 41.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 113.117 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -91.15 87.28 6.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.965 1.364 . . . . 0.0 110.69 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 67.58 6.88 5.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.947 2.099 . . . . 0.0 115.404 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.47 72.88 0.53 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.8 t 167.97 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.332 1.853 . . . . 0.0 108.447 -166.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.3 mt -70.14 -45.13 67.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 154.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.12 40.67 0.95 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 124.848 1.213 . . . . 0.0 110.68 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -127.84 134.22 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.962 0.887 . . . . 0.0 109.862 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.5 m -85.07 120.46 26.6 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 123.677 0.791 . . . . 0.0 111.553 163.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.54 142.35 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -142.8 170.72 15.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.316 1.446 . . . . 0.0 110.0 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 -130.96 10.55 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.053 1.311 . . . . 0.0 112.368 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.32 157.62 31.56 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.598 1.094 . . . . 0.0 111.421 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.43 -1.469 0 C-N-CA 126.391 1.877 . . . . 0.0 113.193 173.49 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.724 0 N-CA-C 111.946 -0.462 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.421 HG22 HG13 ' A' ' 65' ' ' VAL . 6.2 tp -143.31 160.93 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.289 -1.712 . . . . 0.0 106.79 160.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -125.56 166.74 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.092 -1.63 . . . . 0.0 107.291 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.4 t -83.89 141.35 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.085 -1.634 . . . . 0.0 110.216 170.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -97.09 -57.69 2.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.803 -1.185 . . . . 0.0 109.535 160.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.69 145.11 49.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.879 0.872 . . . . 0.0 111.135 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.1 mm -101.07 131.94 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.279 1.831 . . . . 0.0 106.706 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt . . . . . 0 N--CA 1.431 -1.381 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.339 179.115 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.517 0 CA-C-O 121.667 0.746 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.18 59.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 126.213 1.805 . . . . 0.0 114.443 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.7 -32.54 67.48 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.032 -1.668 . . . . 0.0 113.06 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -70.54 -0.62 8.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.69 -96.98 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.209 -2.182 . . . . 0.0 107.553 156.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.93 -14.42 0.77 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.75 -1.219 . . . . 0.0 113.067 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -84.63 -23.45 29.52 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.939 -1.33 . . . . 0.0 110.733 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.39 135.22 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.181 2.592 . . . . 0.0 113.965 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.58 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 4.1 t-80 -143.98 -173.72 4.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.419 1.58 . . . . 0.0 114.343 167.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.58 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 78.4 mttt -89.22 81.16 6.76 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.185 1.794 . . . . 0.0 111.348 -164.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.98 -14.28 0.77 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.17 -0.956 . . . . 0.0 113.029 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.84 170.26 8.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -106.3 143.83 33.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.232 1.413 . . . . 0.0 109.643 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.421 HG13 HG22 ' A' ' 42' ' ' ILE . 3.9 p -110.48 129.38 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 164.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.05 -32.84 8.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.878 -1.764 . . . . 0.0 112.211 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.03 156.89 42.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.729 -1.232 . . . . 0.0 112.441 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.539 HG21 HD23 ' A' ' 85' ' ' LEU . 3.6 t -136.15 120.77 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.083 -1.01 . . . . 0.0 110.784 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.3 t30 65.3 19.21 11.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.892 1.277 . . . . 0.0 112.736 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.17 46.25 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.601 -1.312 . . . . 0.0 113.284 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.95 104.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.3 p -65.56 138.51 58.1 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.323 1.449 . . . . 0.0 114.32 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -80.71 49.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.31 1.844 . . . . 0.0 111.247 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.44 107.96 6.91 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.584 1.554 . . . . 0.0 110.643 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 29.61 62.48 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 114.025 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.84 137.25 33.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.567 1.651 . . . . 0.0 113.555 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.6 p -93.66 -165.74 1.38 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.365 1.866 . . . . 0.0 108.341 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -64.71 -50.07 68.38 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 119.547 -1.971 . . . . 0.0 111.371 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -64.28 -49.04 73.38 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.393 1.077 . . . . 0.0 113.194 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -67.69 -30.95 70.6 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.603 -1.311 . . . . 0.0 114.332 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.14 93.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.126 -1.609 . . . . 0.0 114.48 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.4 t -53.68 -51.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.609 1.163 . . . . 0.0 111.574 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -58.4 -43.4 88.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.512 -1.368 . . . . 0.0 114.463 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.0 m -65.53 -30.79 71.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.551 1.54 . . . . 0.0 114.508 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.539 HD23 HG21 ' A' ' 68' ' ' VAL . 19.9 mt -88.62 -49.23 7.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.946 1.298 . . . . 0.0 112.096 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.22 44.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -91.63 37.75 0.97 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.071 -1.643 . . . . 0.0 110.898 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 p -94.06 170.09 9.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.053 2.141 . . . . 0.0 108.125 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.1 -79.24 1.04 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 119.83 -1.794 . . . . 0.0 112.693 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -137.75 -57.7 0.68 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.653 -0.91 . . . . 0.0 108.979 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.5 t -78.07 130.47 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 123.114 1.435 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.482 HG21 HD22 ' A' ' 25' ' ' LEU . 13.3 m -115.26 117.88 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.464 1.106 . . . . 0.0 108.157 167.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -85.72 97.54 10.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.258 -1.527 . . . . 0.0 107.349 161.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 18' ' ' LEU . 9.8 mt -85.19 112.57 20.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 110.762 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.07 105.19 17.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.168 0.987 . . . . 0.0 108.719 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mt -117.9 144.26 45.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.589 1.555 . . . . 0.0 111.352 -165.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.07 138.67 54.61 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.462 1.505 . . . . 0.0 109.637 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp . . . . . 0 N--CA 1.43 -1.443 0 C-N-CA 124.731 1.212 . . . . 0.0 113.735 -172.362 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 5.5 tp . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.619 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.411 1.9 t 38.22 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 129.81 3.244 . . . . 0.0 116.281 152.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 46.7 m -138.04 122.61 18.52 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 102.941 -2.985 . . . . 0.0 102.941 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -83.52 127.91 34.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.006 0.908 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.261 1.678 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -163.097 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 122.525 1.155 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.04 120.01 33.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.85 74.41 3.58 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.359 1.064 . . . . 0.0 108.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.94 153.12 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 127.187 2.195 . . . . 0.0 110.02 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -130.33 123.03 29.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.945 -1.722 . . . . 0.0 109.501 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -122.89 174.85 6.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.516 1.126 . . . . 0.0 109.29 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.51 136.87 54.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 153.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 24' ' ' SER . 7.7 ptpt -66.85 130.25 42.54 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.067 1.747 . . . . 0.0 113.365 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 101.52 13.3 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.527 -1.358 . . . . 0.0 109.649 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 51.37 64.95 1.64 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.733 2.013 . . . . 0.0 114.01 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.48 72.64 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.869 -1.144 . . . . 0.0 115.234 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.42 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 35.9 t -172.75 99.01 0.14 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.62 -41.99 95.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.363 2.265 . . . . 0.0 107.075 164.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 106.29 46.32 1.16 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.359 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -123.36 136.9 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 124.358 0.681 . . . . 0.0 110.108 165.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.3 m -84.72 120.0 25.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.3 1.04 . . . . 0.0 110.677 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -90.01 129.82 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -126.54 165.33 19.35 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.232 -2.167 . . . . 0.0 110.958 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 -130.58 10.37 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.333 1.444 . . . . 0.0 113.221 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.2 158.69 24.15 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.756 1.646 . . . . 0.0 110.897 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.429 -1.475 0 C-N-CA 125.098 1.359 . . . . 0.0 114.12 -177.245 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 65' ' ' VAL . 3.8 tp -115.99 151.03 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 167.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.14 153.69 46.59 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.282 -2.137 . . . . 0.0 105.512 -168.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.458 HG11 HD13 ' A' ' 47' ' ' ILE . 15.5 t -82.69 127.03 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.593 -1.942 . . . . 0.0 111.535 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -84.43 -54.49 4.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.497 -1.377 . . . . 0.0 109.977 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 137.82 34.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.292 0.637 . . . . 0.0 110.321 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.458 HD13 HG11 ' A' ' 44' ' ' VAL . 44.9 mm -90.62 144.98 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.271 1.828 . . . . 0.0 107.582 175.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 26' ' ' GLY . 59.8 mt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 119.725 -1.859 . . . . 0.0 108.326 164.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.43 0 CA-C-O 121.858 0.837 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -46.88 60.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.824 -1.798 . . . . 0.0 113.072 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.11 -32.87 56.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.803 1.287 . . . . 0.0 113.576 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 p -59.24 -20.98 58.72 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.18 -79.35 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.435 1.094 . . . . 0.0 110.939 167.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.88 -19.32 6.15 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 121.463 -0.773 . . . . 0.0 113.913 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -30.16 60.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.816 -1.402 . . . . 0.0 112.319 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.81 140.79 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -134.83 -164.08 1.47 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -73.42 150.73 41.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.479 -2.013 . . . . 0.0 110.725 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.38 74.75 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 120.57 -1.331 . . . . 0.0 115.445 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.09 148.86 41.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 118.896 1.348 . . . . 0.0 111.891 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.45 112.33 25.18 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.88 1.272 . . . . 0.0 110.036 -168.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 42' ' ' ILE 0.26 3.5 p -84.47 116.03 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 119.963 -1.71 . . . . 0.0 108.36 173.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 -37.18 12.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.181 -1.574 . . . . 0.0 111.436 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.14 28.31 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.166 0.984 . . . . 0.0 112.906 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.35 128.94 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.75 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 52.61 18.97 1.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.86 -2.4 . . . . 0.0 117.408 -170.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.1 6.15 63.4 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.425 -1.422 . . . . 0.0 114.945 -171.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -108.03 101.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 125.726 1.611 . . . . 0.0 109.786 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.8 m -68.72 145.02 54.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -82.16 43.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.033 2.533 . . . . 0.0 112.848 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.55 117.33 23.06 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.928 -1.733 . . . . 0.0 110.72 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.5 86.55 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 123.926 0.774 . . . . 0.0 113.436 -170.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.87 133.96 33.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.939 1.37 . . . . 0.0 113.434 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.6 p -97.14 -160.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.402 2.681 . . . . 0.0 108.228 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -63.77 -55.96 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.045 -1.659 . . . . 0.0 111.771 164.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -64.98 -38.76 92.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.86 -37.31 73.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.789 -1.819 . . . . 0.0 114.149 174.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.62 76.42 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.2 -1.563 . . . . 0.0 114.22 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.3 t -58.93 -56.37 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.729 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.97 -43.23 63.46 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 m -56.18 -45.55 79.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.188 2.195 . . . . 0.0 114.629 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.91 -32.38 15.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.746 -1.846 . . . . 0.0 115.26 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -79.34 -50.08 11.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.488 1.515 . . . . 0.0 113.145 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -92.19 52.23 1.92 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.126 -1.609 . . . . 0.0 111.922 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.1 p -95.04 -164.96 1.23 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.303 2.241 . . . . 0.0 110.656 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.25 -75.43 1.19 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.089 -1.632 . . . . 0.0 112.365 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -150.6 -60.21 0.19 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.822 -1.399 . . . . 0.0 110.225 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -72.35 125.04 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.219 1.485 . . . . 0.0 110.614 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.97 103.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -73.85 110.35 8.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.917 -1.114 . . . . 0.0 110.38 165.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.2 mt -91.79 110.67 22.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.367 0.985 . . . . 0.0 108.681 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.66 95.41 10.25 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.906 0.86 . . . . 0.0 108.769 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.14 138.91 40.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.102 1.761 . . . . 0.0 110.273 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.91 137.02 46.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.59 1.956 . . . . 0.0 108.088 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 tptt . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.416 2.3 t 67.79 104.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 124.395 2.045 . . . . 0.0 113.484 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 59.5 m -135.84 123.82 22.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -70.44 121.64 18.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.627 1.171 . . . . 0.0 108.549 167.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.259 1.589 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -166.567 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 121.183 0.516 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.94 116.97 24.48 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.615 1.166 . . . . 0.0 109.39 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.71 86.61 7.31 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.273 1.035 . . . . 0.0 110.279 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.12 121.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.874 2.069 . . . . 0.0 109.722 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.07 116.8 24.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.547 -1.971 . . . . 0.0 111.448 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.13 167.79 27.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.223 -1.548 . . . . 0.0 112.279 -167.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.22 138.8 40.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.378 1.071 . . . . 0.0 110.212 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -75.67 160.91 29.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.717 -1.24 . . . . 0.0 112.539 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 m -92.6 71.8 5.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.276 -1.515 . . . . 0.0 109.343 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 53.57 63.58 2.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.158 2.183 . . . . 0.0 114.959 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.45 38.57 14.25 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -177.54 108.59 0.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.201 1.4 . . . . 0.0 107.932 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 9.4 mt -66.0 -48.04 72.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.279 2.632 . . . . 0.0 108.2 169.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.07 34.41 0.78 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.094 1.33 . . . . 0.0 112.645 172.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 pt -121.76 129.66 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 121.454 0.645 . . . . 0.0 110.514 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.257 5.5 m -78.68 122.9 26.56 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 111.81 162.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.19 134.29 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -130.61 168.08 17.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.115 1.366 . . . . 0.0 109.069 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.59 -146.99 21.06 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.237 0.923 . . . . 0.0 113.28 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.69 169.65 43.98 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 121.314 -1.11 . . . . 0.0 112.02 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -171.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.289 2.7 tp -112.61 151.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.804 -1.41 . . . . 0.0 107.459 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.98 155.13 50.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -167.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.0 t -82.52 136.7 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 119.48 -2.012 . . . . 0.0 111.387 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -92.59 -51.71 4.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.025 0.93 . . . . 0.0 110.507 166.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.82 141.78 38.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.594 -0.691 . . . . 0.0 111.574 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.487 ' CD1' HG11 ' A' ' 44' ' ' VAL . 44.2 mm -103.66 128.63 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.259 1.823 . . . . 0.0 109.676 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 pt . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.498 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.86 88.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.5 -40.06 65.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.16 1.457 . . . . 0.0 112.889 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 t -79.58 -16.14 56.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.25 -54.05 14.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.753 2.524 . . . . 0.0 111.365 -164.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.58 -77.78 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 118.925 -1.607 . . . . 0.0 113.476 153.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -81.74 -7.8 59.63 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -164.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mt -73.29 126.47 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.039 -1.663 . . . . 0.0 114.196 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 74.9 t60 -128.81 -160.1 1.0 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 163.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 20.6 pttp -92.95 67.09 4.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.349 -2.72 . . . . 0.0 114.442 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.35 42.83 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.461 -2.649 . . . . 0.0 116.717 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -116.17 174.67 5.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.987 1.393 . . . . 0.0 111.213 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 129.7 56.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.868 1.667 . . . . 0.0 107.435 176.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.269 9.4 p -100.13 119.86 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.061 1.3 . . . . 0.0 107.892 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -39.01 10.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.524 -1.36 . . . . 0.0 111.547 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.23 150.36 42.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.03 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.0 t -133.14 116.94 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.19 31.1 20.39 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.974 1.31 . . . . 0.0 112.92 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.16 30.92 54.18 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.192 -0.943 . . . . 0.0 112.939 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -129.12 100.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 t -70.37 137.31 50.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 112.814 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.12 57.1 3.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.515 1.526 . . . . 0.0 112.562 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.23 94.69 9.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.538 -1.976 . . . . 0.0 110.729 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.04 45.58 4.12 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 121.349 -0.844 . . . . 0.0 111.521 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.18 147.56 37.17 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.592 1.187 . . . . 0.0 109.202 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -126.21 -165.35 1.43 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 82' ' ' VAL . 10.3 t-80 -52.58 -55.16 24.2 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.216 -1.553 . . . . 0.0 114.292 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -62.5 -50.55 70.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.672 1.225 . . . . 0.0 113.491 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -42.58 99.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.546 1.138 . . . . 0.0 113.426 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.98 89.36 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 120.442 -1.411 . . . . 0.0 114.431 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 78' ' ' HIS . 52.1 t -54.94 -56.59 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.328 0.967 . . . . 0.0 110.676 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.41 -27.38 65.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -65.78 -26.6 67.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.78 2.032 . . . . 0.0 112.623 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.93 -46.46 8.52 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.14 1.376 . . . . 0.0 112.587 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' B' ' 210' ' ' VAL 0.45 0.0 OUTLIER -71.74 -45.78 60.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.048 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -93.7 45.4 1.15 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.323 1.535 . . . . 0.0 110.344 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.4 p -98.13 157.23 16.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.512 2.325 . . . . 0.0 108.256 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -63.53 4.19 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.21 -0.931 . . . . 0.0 115.418 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -155.22 -59.93 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.687 -0.89 . . . . 0.0 109.03 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.83 124.72 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.212 1.482 . . . . 0.0 110.6 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.5 t -112.27 104.83 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.24 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -78.33 104.81 9.16 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mt -90.83 107.37 19.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.401 1.481 . . . . 0.0 107.783 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.35 95.92 10.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 173.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.22 142.9 32.73 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.068 2.147 . . . . 0.0 110.362 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -115.07 136.58 52.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.436 1.094 . . . . 0.0 109.029 167.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 125.918 1.687 . . . . 0.0 113.543 179.484 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.425 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.434 2.6 t 69.93 96.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 124.969 2.318 . . . . 0.0 113.393 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 79.6 m -149.1 121.8 8.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 -165.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -72.41 139.67 47.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.952 0.901 . . . . 0.0 111.169 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 86' ' ' ARG . 7.7 p . . . . . 0 C--O 1.26 1.639 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 122.419 1.104 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.275 0.1 OUTLIER -114.96 113.81 24.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.712 -1.243 . . . . 0.0 108.697 174.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.29 81.85 5.47 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.108 0.956 . . . . 0.0 109.342 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.68 143.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.769 2.028 . . . . 0.0 109.466 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.52 130.49 55.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.413 -2.054 . . . . 0.0 110.643 166.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.57 157.58 33.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.225 1.01 . . . . 0.0 108.314 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.77 105.78 13.43 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.957 0.884 . . . . 0.0 109.181 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.37 135.12 45.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.509 1.924 . . . . 0.0 112.992 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -101.88 108.62 20.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.791 -1.193 . . . . 0.0 108.869 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 42.76 49.12 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.619 2.368 . . . . 0.0 116.162 -166.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 45.84 26.81 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.808 -1.183 . . . . 0.0 115.248 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -161.06 117.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.899 1.809 . . . . 0.0 106.138 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.08 -36.05 66.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.292 1.837 . . . . 0.0 107.732 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.03 2.14 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.478 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 47' ' ' ILE . 8.4 pt -127.67 135.36 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.674 1.226 . . . . 0.0 109.566 171.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' HG22 ' B' ' 207' ' ' VAL . 75.6 m -78.94 112.02 15.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.937 1.695 . . . . 0.0 112.507 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.86 131.67 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -132.88 174.05 10.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.956 2.502 . . . . 0.0 108.325 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.87 45.18 76.05 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 118.608 2.203 . . . . 0.0 118.608 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.54 169.81 47.67 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 120.592 -1.534 . . . . 0.0 111.227 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.31 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.776 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.5 tp -145.79 162.15 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 159.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.9 165.62 27.02 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.41 -1.431 . . . . 0.0 108.642 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -80.31 138.19 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.574 1.95 . . . . 0.0 110.643 167.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -95.24 -57.47 2.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.395 -1.441 . . . . 0.0 109.542 159.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.78 134.74 52.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.879 1.272 . . . . 0.0 111.301 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 27' ' ' ILE . 48.7 mm -93.33 133.46 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 pt . . . . . 0 N--CA 1.431 -1.403 0 O-C-N 121.113 -0.992 . . . . 0.0 111.637 172.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.498 0 CA-C-O 121.43 0.633 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.53 -42.0 65.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.41 -36.8 61.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.942 1.829 . . . . 0.0 112.535 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -74.56 6.49 3.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.12 -79.26 0.09 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.894 -2.379 . . . . 0.0 106.357 152.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.51 -31.6 1.66 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.271 -0.893 . . . . 0.0 111.179 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -89.07 -20.87 23.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.533 -0.98 . . . . 0.0 111.335 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mt -66.46 130.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 124.859 1.264 . . . . 0.0 110.106 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -155.34 169.79 23.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -161.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -80.03 77.04 6.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.74 -1.225 . . . . 0.0 111.864 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.78 60.05 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.376 0.989 . . . . 0.0 110.839 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.57 -151.52 0.34 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.895 2.078 . . . . 0.0 110.222 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -160.04 121.04 3.08 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 149.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.56 122.73 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.034 -1.667 . . . . 0.0 107.728 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -30.3 9.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.888 -1.133 . . . . 0.0 113.275 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.26 159.01 41.07 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 120.244 1.383 . . . . 0.0 113.64 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 t -137.19 119.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 123.997 0.919 . . . . 0.0 111.856 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.99 34.4 22.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.876 -1.765 . . . . 0.0 113.473 -167.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.17 -5.13 73.33 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.627 1.584 . . . . 0.0 113.834 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.61 106.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 121.008 -1.289 . . . . 0.0 108.297 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.8 p -60.71 137.21 58.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.244 1.018 . . . . 0.0 113.612 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.27 -48.8 55.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.4 1.08 . . . . 0.0 111.143 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 34.5 41.83 0.06 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.248 3.425 . . . . 0.0 120.248 160.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.37 -16.85 2.49 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.129 -1.607 . . . . 0.0 111.88 -165.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.29 132.35 44.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.042 1.877 . . . . 0.0 115.119 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -175.45 2.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -48.03 -52.77 18.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.585 -1.947 . . . . 0.0 115.455 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -74.16 -43.95 55.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.309 -0.869 . . . . 0.0 112.161 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -57.58 -43.6 84.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.11 1.364 . . . . 0.0 114.328 172.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -40.68 95.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.452 -1.405 . . . . 0.0 114.292 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.4 -42.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 121.076 -1.015 . . . . 0.0 111.593 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.91 -44.22 97.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.943 -1.723 . . . . 0.0 114.697 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.8 m -58.93 -26.51 64.44 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.688 1.995 . . . . 0.0 114.83 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -91.24 -46.52 8.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.634 1.574 . . . . 0.0 112.679 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -79.35 -34.9 41.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.999 -1.688 . . . . 0.0 114.569 -172.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.82 35.22 0.68 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.455 1.598 . . . . 0.0 111.888 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.4 p -99.67 -176.81 3.38 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.564 3.146 . . . . 0.0 108.203 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.42 -115.02 0.57 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.264 -1.522 . . . . 0.0 112.069 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.62 -44.88 4.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.246 1.018 . . . . 0.0 110.868 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.48 125.01 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.041 1.4 . . . . 0.0 110.462 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.8 t -114.0 106.49 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -83.36 101.66 11.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.575 1.55 . . . . 0.0 109.155 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.27 115.91 26.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 99.52 12.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.08 148.62 25.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.696 1.999 . . . . 0.0 111.776 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.32 1.448 . . . . 0.0 109.608 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? . . . . . 0 CA--C 1.489 -1.371 0 O-C-N 120.179 -1.575 . . . . 0.0 110.982 176.662 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 9.3 tp . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 28' ' ' SER 0.46 3.5 t 64.26 106.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 162.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 88.4 m -143.92 120.82 11.31 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 103.039 -2.948 . . . . 0.0 103.039 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -76.39 119.91 20.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.604 1.093 . . . . 0.0 109.62 173.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.26 1.634 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -167.082 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.259 0.1 OUTLIER -132.56 115.14 15.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.88 91.41 8.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.591 1.186 . . . . 0.0 110.282 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.12 154.1 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.71 2.004 . . . . 0.0 108.494 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -130.99 113.24 13.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.212 -2.18 . . . . 0.0 110.322 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.5 mt -119.62 152.15 37.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.587 -1.32 . . . . 0.0 111.001 -170.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.96 117.87 35.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 165.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.54 138.01 54.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.952 -1.092 . . . . 0.0 112.581 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -89.83 103.34 16.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.648 1.213 . . . . 0.0 109.075 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 51.71 44.62 29.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.788 2.435 . . . . 0.0 115.248 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 48.72 26.9 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 119.888 -1.757 . . . . 0.0 114.398 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -161.81 111.55 1.56 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' CD1' HD22 ' A' ' 85' ' ' LEU . 7.2 mt -73.44 -45.19 55.83 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 167.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.52 31.65 0.76 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.089 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.43 124.98 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 122.278 1.037 . . . . 0.0 110.647 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 114.44 17.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.385 1.074 . . . . 0.0 111.481 166.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 127.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -128.16 -179.7 5.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.834 2.453 . . . . 0.0 108.702 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -125.22 7.05 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.346 -1.471 . . . . 0.0 111.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.51 162.64 35.05 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.477 -1.014 . . . . 0.0 114.164 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.431 -1.414 0 C-N-CA 125.399 1.48 . . . . 0.0 113.667 -177.516 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.56 161.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -133.94 162.08 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.299 -2.125 . . . . 0.0 106.646 -170.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.98 132.57 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.391 -1.443 . . . . 0.0 110.61 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -90.37 -53.44 4.44 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.44 -1.413 . . . . 0.0 109.161 163.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.96 135.68 31.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.897 0.879 . . . . 0.0 109.49 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.82 128.66 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 pt . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.749 -179.682 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.44 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.25 86.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.674 1.589 . . . . 0.0 114.226 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -60.3 -38.19 82.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.906 -1.121 . . . . 0.0 111.253 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -70.95 0.52 7.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.45 -74.23 0.19 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.524 -2.61 . . . . 0.0 108.205 156.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.61 -26.22 3.5 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 121.638 -0.664 . . . . 0.0 111.518 167.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -80.52 -24.84 39.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.739 -0.859 . . . . 0.0 112.149 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 132.6 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.011 1.324 . . . . 0.0 112.392 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 41.5 t60 -138.28 -178.44 5.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 173.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 27.0 mttm -78.35 69.21 4.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.573 -1.329 . . . . 0.0 113.157 -168.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 3.31 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -80.37 171.76 14.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.197 1.999 . . . . 0.0 114.005 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.3 ttt-85 -108.24 139.11 43.39 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.843 1.257 . . . . 0.0 109.942 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.28 115.27 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.384 1.874 . . . . 0.0 107.662 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.45 -34.41 10.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.832 -1.792 . . . . 0.0 113.846 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.11 152.68 39.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.773 1.17 . . . . 0.0 113.696 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.63 HG13 HG13 ' A' ' 92' ' ' VAL . 70.0 t -135.72 122.75 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.43 0.692 . . . . 0.0 111.129 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 58.98 28.04 17.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.25 1.02 . . . . 0.0 113.409 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.35 46.06 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.737 1.636 . . . . 0.0 114.015 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.95 96.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 118.761 1.28 . . . . 0.0 110.275 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.3 p -67.49 142.49 56.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.78 68.39 10.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.28 128.01 33.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 109.247 162.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.99 -2.28 65.57 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.754 1.862 . . . . 0.0 117.754 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 135.96 33.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.422 2.111 . . . . 0.0 113.586 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.0 t -109.35 -169.61 1.51 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.5 2.72 . . . . 0.0 106.143 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -49.16 -58.89 4.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.933 2.093 . . . . 0.0 115.103 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -72.23 -42.09 66.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.165 1.46 . . . . 0.0 111.077 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -59.19 -47.34 85.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.954 1.702 . . . . 0.0 113.84 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.55 79.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.94 -51.85 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 121.134 -0.979 . . . . 0.0 111.221 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -56.8 -36.65 70.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 m -69.43 -24.24 63.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.309 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 68' ' ' VAL . 9.8 mt -89.82 -44.41 9.97 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.534 -1.978 . . . . 0.0 111.877 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -78.6 -44.17 24.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 127.743 2.417 . . . . 0.0 116.037 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -81.31 13.35 2.96 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 123.941 1.829 . . . . 0.0 114.503 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -84.15 -176.37 6.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.457 3.103 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.33 -123.88 2.1 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 120.131 -1.605 . . . . 0.0 112.762 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -95.33 -60.26 1.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 111.091 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.26 120.99 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 123.051 1.405 . . . . 0.0 112.109 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.63 HG13 HG13 ' A' ' 68' ' ' VAL . 2.4 t -111.13 110.68 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.054 1.742 . . . . 0.0 107.816 168.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.55 102.82 7.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.929 -1.107 . . . . 0.0 110.312 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 113.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.899 1.279 . . . . 0.0 109.132 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.92 105.36 17.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.359 -0.838 . . . . 0.0 109.197 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.78 145.78 29.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.457 1.503 . . . . 0.0 111.403 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.71 145.96 42.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.48 1.912 . . . . 0.0 106.694 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.632 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 121.201 0.524 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.412 2.3 t 79.8 112.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 124.221 1.962 . . . . 0.0 113.319 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 38.9 m -145.02 124.99 13.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.515 -3.143 . . . . 0.0 102.515 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -80.83 131.42 35.39 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.257 0.935 . . . . 0.0 110.865 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 -160.143 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.431 -1.413 0 CA-C-O 122.519 1.152 . . . . 0.0 113.636 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.14 119.6 12.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.432 1.493 . . . . 0.0 107.871 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.42 66.88 1.5 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.576 1.15 . . . . 0.0 111.265 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.32 111.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.113 2.165 . . . . 0.0 114.426 -168.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.31 0.2 OUTLIER -96.31 111.95 23.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.781 -1.824 . . . . 0.0 112.86 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.75 159.75 22.5 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.546 1.138 . . . . 0.0 107.984 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.38 24.08 10.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.398 1.094 . . . . 0.0 111.142 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HB3' ' H ' ' A' ' 24' ' ' SER . 30.3 mttt 52.29 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.984 2.914 . . . . 0.0 114.515 -171.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -122.42 81.3 1.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.35 -2.094 . . . . 0.0 106.506 159.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 55.73 64.05 1.86 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.938 2.095 . . . . 0.0 115.15 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.47 46.79 9.53 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.85 -1.156 . . . . 0.0 114.987 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.529 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 47.7 t 178.53 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 8.2 mt -75.54 -38.34 59.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.426 1.89 . . . . 0.0 107.368 169.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.22 14.83 4.38 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.941 168.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.22 125.32 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.263 1.03 . . . . 0.0 110.732 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.446 ' HB3' HG13 ' B' ' 207' ' ' VAL . 45.9 m -78.35 109.27 12.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.717 1.207 . . . . 0.0 110.504 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.35 127.19 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -125.31 167.9 14.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.424 1.49 . . . . 0.0 110.406 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 -125.6 7.07 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.564 1.554 . . . . 0.0 113.183 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.3 167.34 30.12 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 120.163 -1.787 . . . . 0.0 113.554 179.026 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.42 167.31 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -136.14 156.5 48.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.559 -1.963 . . . . 0.0 107.12 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 47' ' ' ILE . 3.4 t -80.57 130.46 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.262 -1.524 . . . . 0.0 112.015 165.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -91.89 -38.68 12.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.417 -1.427 . . . . 0.0 112.531 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.3 136.08 22.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.7 -1.25 . . . . 0.0 112.129 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 HD13 HG11 ' A' ' 44' ' ' VAL . 25.3 mm -96.75 143.32 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.026 2.131 . . . . 0.0 108.008 175.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 120.72 -1.238 . . . . 0.0 113.827 176.075 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.431 -1.419 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.52 78.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.66 -35.6 81.07 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.6 -1.938 . . . . 0.0 111.741 170.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.27 2.58 24.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.15 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.859 -1.776 . . . . 0.0 108.476 160.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 -41.79 0.29 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.783 -1.198 . . . . 0.0 111.186 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.9 mtm-85 -87.42 -17.35 32.46 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.58 133.45 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.676 -1.265 . . . . 0.0 112.293 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.505 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 21.9 t-80 -129.24 -165.18 1.48 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.939 0.896 . . . . 0.0 108.604 170.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 43.2 pttt -102.71 44.79 0.99 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.852 -1.78 . . . . 0.0 112.229 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.68 33.97 0.16 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -97.74 178.19 5.23 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.358 1.063 . . . . 0.0 109.667 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -114.33 128.63 56.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.745 -1.847 . . . . 0.0 108.698 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.36 110.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.378 -1.452 . . . . 0.0 107.27 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -48.58 7.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.507 -1.996 . . . . 0.0 112.348 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -136.79 160.87 37.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.882 -1.136 . . . . 0.0 113.479 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.451 HG13 HG13 ' A' ' 92' ' ' VAL . 47.4 t -134.0 112.94 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 123.964 0.905 . . . . 0.0 111.285 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 58.74 26.82 15.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.138 -1.601 . . . . 0.0 113.536 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 12.98 83.66 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.702 -1.249 . . . . 0.0 113.705 -171.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.85 100.27 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -68.14 148.46 50.88 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 121.109 -0.995 . . . . 0.0 110.091 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.561 2.059 . . . . 0.0 116.561 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 61.29 51.63 4.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.334 1.54 . . . . 0.0 112.314 169.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.58 35.0 80.03 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.087 -1.633 . . . . 0.0 115.617 -173.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.65 151.99 23.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.541 1.639 . . . . 0.0 113.13 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.503 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 64.5 p -104.2 -158.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.161 2.585 . . . . 0.0 109.381 -169.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -60.21 -51.3 70.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.191 -1.568 . . . . 0.0 112.471 161.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -70.69 -46.14 63.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.126 0.971 . . . . 0.0 111.983 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HB2' ' H ' ' A' ' 77' ' ' THR . 65.9 mt-30 -66.57 -34.38 77.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.993 -1.067 . . . . 0.0 113.454 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.11 93.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.313 1.87 . . . . 0.0 114.288 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.8 -50.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.909 0.884 . . . . 0.0 111.596 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -59.26 -40.53 86.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.346 -1.471 . . . . 0.0 113.874 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -59.78 -30.36 68.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.623 1.969 . . . . 0.0 113.428 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -89.96 -42.05 11.4 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.342 1.857 . . . . 0.0 113.78 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -24.87 24.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -90.05 24.5 2.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.276 -2.14 . . . . 0.0 112.907 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 p -94.38 162.39 13.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.655 2.782 . . . . 0.0 112.409 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.37 65.02 3.44 Favored Glycine 0 N--CA 1.431 -1.695 0 O-C-N 120.528 -1.358 . . . . 0.0 113.718 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.271 28.1 tt0 68.33 -55.24 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.0 115.368 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.75 132.6 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.381 1.086 . . . . 0.0 110.625 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.451 HG13 HG13 ' A' ' 68' ' ' VAL . 23.1 t -126.3 108.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -77.35 108.04 10.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.906 -1.121 . . . . 0.0 108.445 163.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.0 105.29 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.538 -1.351 . . . . 0.0 109.486 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.07 93.96 8.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mt -98.59 139.71 33.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.877 2.071 . . . . 0.0 109.703 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -109.47 135.96 49.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 106.798 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 N--CA 1.429 -1.502 0 C-N-CA 124.755 1.222 . . . . 0.0 112.021 -179.571 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' A' ' 28' ' ' SER 0.418 2.1 t 76.02 106.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.56 2.124 . . . . 0.0 113.358 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -141.31 122.26 14.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.795 -3.039 . . . . 0.0 102.795 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 41.5 m -78.0 129.26 35.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.261 1.684 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -163.213 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.429 -1.486 0 CA-C-O 123.091 1.424 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.82 116.51 18.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -89.57 83.99 6.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.911 1.339 . . . . 0.0 109.741 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -80.84 110.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 126.947 2.099 . . . . 0.0 112.99 -173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.64 121.67 41.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.101 -2.249 . . . . 0.0 109.531 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -122.04 172.81 7.96 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.089 0.956 . . . . 0.0 109.9 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.23 122.17 23.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 161.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 10.7 ptpt -67.02 160.46 26.48 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.442 1.897 . . . . 0.0 114.805 -177.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -115.75 106.94 14.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.163 1.385 . . . . 0.0 108.924 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.88 55.0 9.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.641 2.376 . . . . 0.0 114.503 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.62 48.55 61.63 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 119.974 -1.704 . . . . 0.0 114.982 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 m -172.01 111.05 0.28 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 -172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -72.73 -36.68 67.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.876 2.07 . . . . 0.0 108.101 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.04 38.15 1.73 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.425 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.45 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 121.838 0.828 . . . . 0.0 110.222 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.413 ' HB3' HG13 ' B' ' 207' ' ' VAL . 74.7 m -85.27 114.11 22.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.16 129.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 t -121.25 164.27 17.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.769 2.428 . . . . 0.0 111.023 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.51 -145.85 18.22 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 125.397 1.475 . . . . 0.0 111.854 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.64 153.87 23.71 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.062 1.315 . . . . 0.0 111.929 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.43 -1.435 0 C-N-CA 125.779 1.631 . . . . 0.0 115.315 -173.866 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.783 0 N-CA-C 104.577 -3.409 . . . . 0.0 104.577 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 65' ' ' VAL 0.256 4.4 tp -129.13 163.0 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -138.84 160.94 38.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 47' ' ' ILE . 88.5 t -80.69 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.302 -1.499 . . . . 0.0 110.393 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -88.13 -55.85 3.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.136 -1.602 . . . . 0.0 110.208 166.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.42 139.64 25.72 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.103 0.954 . . . . 0.0 110.782 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD11 HG11 ' A' ' 44' ' ' VAL . 36.4 mm -91.23 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.552 1.541 . . . . 0.0 107.042 173.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 121.435 -0.79 . . . . 0.0 112.505 -178.933 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.44 83.52 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -48.09 -36.85 13.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.716 1.606 . . . . 0.0 114.172 167.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 t -73.14 4.25 4.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.66 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.462 -2.024 . . . . 0.0 108.249 155.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.37 -23.69 2.04 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.323 -0.86 . . . . 0.0 112.562 164.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mtt85 -77.56 -31.78 53.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.806 1.242 . . . . 0.0 112.18 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -67.49 143.72 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.244 1.818 . . . . 0.0 113.966 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 44.6 t60 -142.44 -167.03 2.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.975 -1.078 . . . . 0.0 109.628 170.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.533 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 58.3 mttp -80.06 53.97 1.82 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.859 -1.776 . . . . 0.0 113.255 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.28 -35.08 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.823 -1.798 . . . . 0.0 114.998 -169.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.38 156.29 32.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -167.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 117.37 33.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.292 1.437 . . . . 0.0 110.19 -170.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 42' ' ' ILE . 2.7 p -93.46 125.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.255 1.503 . . . . 0.0 109.504 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -37.16 9.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.967 1.307 . . . . 0.0 112.214 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.12 157.11 44.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.68 115.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 124.36 1.064 . . . . 0.0 111.541 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.94 23.13 6.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -168.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.8 12.7 68.36 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.795 -1.19 . . . . 0.0 113.859 -171.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.33 99.27 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.6 p -61.95 139.12 58.42 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 125.832 1.653 . . . . 0.0 113.573 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.26 47.32 1.32 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.708 -1.245 . . . . 0.0 112.66 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -74.59 115.04 13.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.663 -1.898 . . . . 0.0 110.695 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.85 84.92 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.793 -1.192 . . . . 0.0 115.07 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.98 136.3 33.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.847 1.823 . . . . 0.0 112.95 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -95.44 -161.37 0.86 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.087 2.155 . . . . 0.0 109.836 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -64.3 -56.25 15.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.008 -1.682 . . . . 0.0 111.628 165.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -66.96 -38.73 86.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -67.12 -36.17 81.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.971 -1.706 . . . . 0.0 113.908 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.23 90.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.487 -2.008 . . . . 0.0 113.782 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -55.93 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 124.0 0.92 . . . . 0.0 110.461 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.06 -33.48 57.56 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.5 m -68.67 -36.47 78.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.827 2.051 . . . . 0.0 112.006 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.4 mt -89.29 -34.57 16.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.808 1.643 . . . . 0.0 114.934 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -45.29 17.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.965 1.706 . . . . 0.0 112.445 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -90.0 47.48 1.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.858 -1.777 . . . . 0.0 112.227 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.6 p -107.31 -166.62 1.17 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.988 2.115 . . . . 0.0 110.524 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.73 -93.92 1.25 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.078 -1.639 . . . . 0.0 114.647 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -132.91 -53.01 0.92 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.072 1.349 . . . . 0.0 109.519 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.06 139.84 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.472 -1.392 . . . . 0.0 110.89 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.21 121.82 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -86.46 105.82 17.04 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.66 1.184 . . . . 0.0 109.969 166.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mt -87.24 110.8 20.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.333 -1.48 . . . . 0.0 109.652 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 97.94 11.16 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.728 -1.232 . . . . 0.0 108.44 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -101.54 141.33 34.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.075 2.15 . . . . 0.0 110.901 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -108.27 141.09 40.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.461 1.904 . . . . 0.0 107.488 166.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tptp . . . . . 0 N--CA 1.429 -1.496 0 C-N-CA 126.236 1.814 . . . . 0.0 113.917 179.451 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 28' ' ' SER 0.417 2.1 t 70.82 104.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 124.553 2.12 . . . . 0.0 114.633 164.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.8 m -142.48 121.99 13.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.325 -2.842 . . . . 0.0 103.325 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 7.4 m -76.21 126.43 30.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.626 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.702 0.763 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 121.4 35.49 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.823 1.249 . . . . 0.0 108.353 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -98.7 79.36 2.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.317 1.532 . . . . 0.0 108.836 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.91 115.55 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.323 2.249 . . . . 0.0 111.581 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.266 3.1 pt-20 -105.87 115.45 30.25 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.221 -2.174 . . . . 0.0 110.276 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -117.28 160.66 20.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.885 1.274 . . . . 0.0 109.568 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.92 105.3 11.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -66.84 145.88 55.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -173.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 t -99.48 110.64 23.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.563 1.545 . . . . 0.0 109.068 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t70 58.11 20.41 6.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.57 1.948 . . . . 0.0 116.017 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 57.6 2.02 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.008 -1.682 . . . . 0.0 112.654 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -173.93 112.72 0.19 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 126.207 1.803 . . . . 0.0 106.823 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.6 mt -74.88 -40.15 61.09 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.413 1.885 . . . . 0.0 106.219 165.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 112.45 40.63 1.11 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.474 170.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 47' ' ' ILE . 21.8 pt -131.68 127.92 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.298 1.047 . . . . 0.0 110.585 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -80.41 123.28 27.9 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.644 1.177 . . . . 0.0 111.515 167.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.72 145.79 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.98 170.74 15.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.349 1.46 . . . . 0.0 109.074 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.12 -133.29 11.71 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.882 1.229 . . . . 0.0 113.615 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.47 161.57 34.82 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 124.753 1.168 . . . . 0.0 112.551 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.43 -1.469 0 O-C-N 120.45 -1.618 . . . . 0.0 115.03 -179.34 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.78 0 N-CA-C 105.153 -3.179 . . . . 0.0 105.153 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.49 HG22 HG13 ' A' ' 65' ' ' VAL 0.262 3.8 tp -118.73 158.09 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 166.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.94 158.05 45.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.7 t -86.76 138.6 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.227 -1.546 . . . . 0.0 110.732 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -101.51 -74.05 0.63 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.509 -1.369 . . . . 0.0 109.955 167.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.21 124.82 50.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.142 0.972 . . . . 0.0 111.534 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.0 mm -90.21 133.92 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.274 1.83 . . . . 0.0 108.562 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' HA2' ' A' ' 26' ' ' GLY . 73.4 mt . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 116.047 -1.93 . . . . 0.0 109.771 170.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.45 0 CA-C-O 121.782 0.801 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 -45.71 69.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -56.15 -36.08 67.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.132 -1.605 . . . . 0.0 111.933 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -71.31 3.04 4.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.67 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.982 1.719 . . . . 0.0 108.83 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.77 -41.49 0.19 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.562 -1.336 . . . . 0.0 111.903 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -84.92 -26.82 27.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.9 mt -65.69 129.09 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 125.174 1.39 . . . . 0.0 114.6 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -132.95 177.71 7.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.731 2.013 . . . . 0.0 110.683 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -71.01 77.03 0.66 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.376 -1.452 . . . . 0.0 113.463 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.81 19.18 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -85.58 165.0 17.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 119.175 1.488 . . . . 0.0 112.147 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 120.72 43.32 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.679 1.191 . . . . 0.0 110.598 -171.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 42' ' ' ILE . 5.8 p -95.84 122.63 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.178 -1.577 . . . . 0.0 110.658 171.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.0 -36.42 11.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.304 -1.497 . . . . 0.0 111.366 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 155.82 43.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.993 -1.067 . . . . 0.0 113.049 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -131.42 118.52 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.328 -0.857 . . . . 0.0 111.504 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.34 30.78 20.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.266 1.426 . . . . 0.0 112.77 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.51 79.82 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.444 -1.41 . . . . 0.0 114.251 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.35 104.91 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.462 1.505 . . . . 0.0 107.661 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.8 p -64.27 144.76 56.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.21 40.22 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.217 1.407 . . . . 0.0 112.793 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.54 118.48 16.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.117 -1.615 . . . . 0.0 111.305 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.24 88.64 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.063 -1.023 . . . . 0.0 114.846 -174.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.17 140.81 29.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.736 1.732 . . . . 0.0 113.262 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.04 -174.17 2.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -45.93 -50.9 14.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.086 2.154 . . . . 0.0 114.863 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -70.04 -44.31 69.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.787 0.835 . . . . 0.0 112.428 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.89 -37.75 76.11 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.005 -1.059 . . . . 0.0 112.459 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.4 97.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.702 -1.249 . . . . 0.0 113.71 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.3 t -57.0 -53.63 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 123.45 0.7 . . . . 0.0 111.388 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.37 -31.39 67.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.8 m -71.6 -26.21 62.5 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.774 2.029 . . . . 0.0 112.896 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.52 -46.65 8.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.007 1.723 . . . . 0.0 114.275 168.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -32.9 22.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.31 1.844 . . . . 0.0 115.064 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -91.4 41.66 1.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.999 -2.313 . . . . 0.0 111.589 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.9 p -102.84 160.86 14.23 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.681 1.992 . . . . 0.0 108.975 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.5 -70.36 1.11 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.31 -1.494 . . . . 0.0 113.906 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -153.57 -52.73 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.968 -0.724 . . . . 0.0 109.407 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.14 130.53 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.658 1.218 . . . . 0.0 112.049 171.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.24 109.8 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.425 1.09 . . . . 0.0 108.063 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -83.02 109.75 17.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.777 -1.202 . . . . 0.0 109.418 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -89.54 110.1 20.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.55 1.14 . . . . 0.0 108.506 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.15 93.49 9.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.96 144.13 28.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.335 1.854 . . . . 0.0 110.577 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -111.54 144.02 41.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.901 1.68 . . . . 0.0 107.075 164.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 pptt? . . . . . 0 N--CA 1.43 -1.444 0 C-N-CA 126.482 1.913 . . . . 0.0 115.089 172.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.525 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.8 tp . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.525 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.443 29.4 m 53.74 82.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.159 2.184 . . . . 0.0 116.667 166.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 94.6 m -118.7 114.31 22.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -170.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.3 m -83.09 124.52 30.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 122.907 0.483 . . . . 0.0 110.118 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.628 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 122.558 1.17 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.48 116.49 14.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.859 1.263 . . . . 0.0 109.107 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.52 81.61 5.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.311 1.529 . . . . 0.0 112.677 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.63 114.68 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 126.651 1.98 . . . . 0.0 112.219 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.55 113.05 26.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.762 -1.836 . . . . 0.0 110.744 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.24 161.49 25.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.78 -1.2 . . . . 0.0 110.28 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.89 117.04 29.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 163.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -49.27 130.76 19.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.33 1.852 . . . . 0.0 114.711 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -96.95 109.9 22.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.775 1.63 . . . . 0.0 107.955 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.57 26.84 11.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.21 2.204 . . . . 0.0 115.3 -171.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.71 64.74 2.09 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.115 -1.616 . . . . 0.0 112.437 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 174.58 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.72 -45.52 36.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.347 2.022 . . . . 0.0 106.472 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.0 32.02 0.89 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 113.672 -1.604 . . . . 0.0 111.568 169.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.0 pt -113.0 129.93 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.884 0.849 . . . . 0.0 109.74 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -83.07 112.45 19.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.286 1.035 . . . . 0.0 110.031 161.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.93 138.32 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.3 t -131.26 167.83 18.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.111 -1.618 . . . . 0.0 108.763 172.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.52 -140.49 18.96 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 124.641 1.115 . . . . 0.0 113.62 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.2 155.43 31.69 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 124.476 1.036 . . . . 0.0 110.56 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 t . . . . . 0 N--CA 1.43 -1.47 0 C-N-CA 126.853 2.061 . . . . 0.0 114.959 -178.046 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 CA-C-O 121.533 0.519 . . . . 0.0 112.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.551 HG22 HG13 ' A' ' 65' ' ' VAL . 3.3 tp -124.95 160.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.55 153.89 43.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -168.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.456 HG11 HD13 ' A' ' 47' ' ' ILE . 8.5 t -84.37 138.28 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.159 -2.213 . . . . 0.0 111.789 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -94.47 -58.48 2.19 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.778 -1.201 . . . . 0.0 109.603 166.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.17 51.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.377 -0.827 . . . . 0.0 111.647 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.456 HD13 HG11 ' A' ' 44' ' ' VAL . 37.4 mm -96.17 125.43 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.074 1.35 . . . . 0.0 108.439 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 120.733 -1.23 . . . . 0.0 112.772 -179.355 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -45.73 75.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.062 -1.649 . . . . 0.0 113.451 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -19.63 65.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.524 -1.36 . . . . 0.0 112.977 172.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 t -69.11 -22.18 63.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.5 -89.94 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.199 -1.563 . . . . 0.0 110.32 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.84 -3.79 9.22 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.916 -1.115 . . . . 0.0 113.197 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -84.57 -27.94 26.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.013 -1.287 . . . . 0.0 108.399 161.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.13 128.6 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.619 1.567 . . . . 0.0 112.761 166.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -133.74 -155.82 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -90.36 81.73 6.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.201 -2.187 . . . . 0.0 112.894 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.06 39.97 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 118.854 2.301 . . . . 0.0 118.854 164.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -98.19 163.57 12.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.539 1.536 . . . . 0.0 110.943 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -89.26 125.48 35.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.569 -1.332 . . . . 0.0 108.395 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 42' ' ' ILE 0.26 2.9 p -102.48 120.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 -28.93 11.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.796 -1.19 . . . . 0.0 112.124 -173.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.46 161.69 42.26 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 121.635 -0.666 . . . . 0.0 112.459 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.6 122.82 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 121.269 -0.895 . . . . 0.0 110.54 -176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 60.61 26.8 16.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.439 1.927 . . . . 0.0 113.353 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.04 -0.57 89.39 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 125.713 1.625 . . . . 0.0 114.085 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.03 101.88 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.805 1.242 . . . . 0.0 108.132 -172.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -62.6 136.92 58.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.852 -1.155 . . . . 0.0 113.659 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.85 -43.81 91.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.065 0.946 . . . . 0.0 113.512 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 28.22 79.6 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.361 2.664 . . . . 0.0 117.939 158.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.66 -22.32 30.55 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.021 1.296 . . . . 0.0 114.69 -170.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.37 141.43 57.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -98.93 -153.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.814 2.046 . . . . 0.0 110.061 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -73.28 -50.68 20.88 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.8 -1.813 . . . . 0.0 110.918 167.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -64.32 -44.74 90.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.531 0.732 . . . . 0.0 112.757 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -31.87 72.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.641 -1.287 . . . . 0.0 114.25 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.09 94.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.319 -2.113 . . . . 0.0 114.756 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 86' ' ' ARG . 73.3 t -55.08 -56.24 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.197 0.999 . . . . 0.0 110.049 170.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 28.3 tt0 -48.04 -46.99 33.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 175.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.5 m -62.47 -31.92 72.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.821 2.448 . . . . 0.0 113.58 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.25 -40.78 13.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.53 -1.981 . . . . 0.0 113.668 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 82' ' ' VAL . 4.4 ppt_? -80.01 -38.74 31.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -166.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.64 29.7 1.12 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.87 -1.769 . . . . 0.0 111.705 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 60.7 p -96.43 151.47 19.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.748 2.819 . . . . 0.0 109.854 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.25 -58.12 4.44 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.687 -1.258 . . . . 0.0 114.643 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -150.93 -67.52 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.651 -0.911 . . . . 0.0 112.297 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.96 128.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.643 1.211 . . . . 0.0 111.086 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -124.11 103.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.92 1.688 . . . . 0.0 106.977 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -81.37 103.61 11.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.768 -1.207 . . . . 0.0 109.379 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.04 115.8 22.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.461 -1.4 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.25 95.1 9.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.09 151.31 19.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.825 2.05 . . . . 0.0 110.708 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.37 147.67 49.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.522 1.129 . . . . 0.0 108.402 164.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm . . . . . 0 N--CA 1.43 -1.458 0 C-N-CA 125.814 1.646 . . . . 0.0 114.511 170.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 15.2 tp . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.678 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.341 8.8 m 21.72 80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 130.948 3.699 . . . . 0.0 117.636 160.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 44.2 m -118.94 121.38 39.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.8 p -79.14 127.89 32.6 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.563 1.145 . . . . 0.0 110.508 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 86' ' ' ARG . 14.9 p . . . . . 0 C--O 1.26 1.655 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -160.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.119 0.962 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 121.48 16.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.398 1.079 . . . . 0.0 108.908 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -98.88 77.83 2.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.278 1.031 . . . . 0.0 109.729 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.4 t -84.4 132.24 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.871 2.868 . . . . 0.0 113.316 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -110.51 124.75 52.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.886 -2.384 . . . . 0.0 111.8 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.52 150.87 48.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.576 -1.327 . . . . 0.0 110.375 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.11 104.97 12.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 122.181 0.991 . . . . 0.0 108.74 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.709 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.72 140.51 49.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.257 1.576 . . . . 0.0 115.257 -172.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 t -99.38 95.19 6.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.412 1.577 . . . . 0.0 110.138 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t70 56.73 58.11 4.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.753 2.021 . . . . 0.0 113.936 -174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.94 52.21 49.75 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 114.392 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -167.73 98.08 0.47 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.491 1.615 . . . . 0.0 107.647 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.709 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.3 mt -73.53 -42.22 62.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.364 1.866 . . . . 0.0 106.753 168.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.7 43.65 0.95 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.295 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 47' ' ' ILE . 32.3 pt -125.4 136.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 121.754 0.788 . . . . 0.0 109.462 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.402 ' HB3' HG22 ' B' ' 207' ' ' VAL . 4.1 m -82.25 118.09 22.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.941 -1.1 . . . . 0.0 111.716 161.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.48 120.46 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -119.21 163.23 17.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.694 2.798 . . . . 0.0 109.796 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.1 -147.75 19.8 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 124.627 1.108 . . . . 0.0 112.412 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.27 158.48 19.67 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.104 1.335 . . . . 0.0 111.01 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 120.425 -1.633 . . . . 0.0 114.752 -177.68 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.691 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 42' ' ' ILE . 3.6 tp -118.3 162.41 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -141.81 165.1 28.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 47' ' ' ILE . 6.3 t -89.02 135.93 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.494 -1.379 . . . . 0.0 112.338 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -73.04 0.55 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.98 -1.075 . . . . 0.0 108.929 164.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.57 126.01 51.72 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.444 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.443 HD13 HG22 ' A' ' 27' ' ' ILE . 25.9 mm -82.69 125.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 161.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt . . . . . 0 N--CA 1.429 -1.511 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.248 175.269 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 121.135 0.493 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.6 57.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.469 1.908 . . . . 0.0 115.753 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -53.6 -43.28 68.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.864 1.316 . . . . 0.0 111.353 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -69.02 5.91 1.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 -78.15 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.385 -1.447 . . . . 0.0 108.944 156.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -39.51 0.45 Allowed Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -93.86 -19.6 20.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 mt -72.57 127.49 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.109 -1.619 . . . . 0.0 113.018 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -125.64 -178.32 4.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.949 1.3 . . . . 0.0 109.045 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -79.06 82.98 5.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 0.0 112.114 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.12 -8.71 0.33 Allowed Glycine 0 N--CA 1.431 -1.655 0 O-C-N 120.122 -1.611 . . . . 0.0 115.815 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.12 157.03 36.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 119.205 1.503 . . . . 0.0 114.266 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.65 132.51 36.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.911 1.284 . . . . 0.0 109.374 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 t -92.39 117.47 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 160.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -31.53 11.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.666 -1.896 . . . . 0.0 112.218 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.56 160.51 43.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.341 -0.849 . . . . 0.0 112.13 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.62 118.58 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 111.037 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.52 26.77 14.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.178 -1.577 . . . . 0.0 113.946 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.59 85.46 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.165 -0.959 . . . . 0.0 113.765 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.04 101.23 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 121.25 -1.147 . . . . 0.0 108.205 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 p -56.97 124.1 17.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.748 2.019 . . . . 0.0 112.759 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.12 -46.29 78.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.934 -1.104 . . . . 0.0 113.664 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 6.01 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.922 3.689 . . . . 0.0 117.68 167.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.8 -23.05 5.08 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.562 -1.336 . . . . 0.0 113.461 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.77 141.82 39.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.1 p -98.13 -161.6 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.789 1.635 . . . . 0.0 108.422 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -59.62 -48.0 83.37 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 119.874 -1.766 . . . . 0.0 112.511 164.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -71.04 -45.1 64.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.285 1.434 . . . . 0.0 111.68 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.52 -33.35 72.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.366 -1.459 . . . . 0.0 114.262 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.85 88.89 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.663 -1.898 . . . . 0.0 114.402 172.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.7 t -54.48 -54.3 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.919 0.888 . . . . 0.0 111.047 171.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 55.0 mt-10 -59.06 -37.56 77.34 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 m -61.97 -27.72 69.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.358 1.863 . . . . 0.0 112.204 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.25 -41.93 10.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.473 1.509 . . . . 0.0 114.525 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HG3' ' HA ' ' A' ' 83' ' ' GLU 0.293 0.0 OUTLIER -88.7 -32.25 18.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -165.52 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -88.6 39.54 0.92 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.666 1.222 . . . . 0.0 111.647 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.0 p -105.81 170.81 7.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.696 1.999 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.22 -92.17 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 114.101 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -133.44 -48.22 0.83 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.552 -1.558 . . . . 0.0 109.263 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.31 121.12 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.976 1.37 . . . . 0.0 111.242 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.61 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -87.16 99.97 12.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.769 2.027 . . . . 0.0 107.486 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.06 124.59 31.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.363 -1.461 . . . . 0.0 109.892 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.39 100.55 13.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 146.32 26.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.47 1.908 . . . . 0.0 111.431 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -124.02 144.1 50.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.244 1.417 . . . . 0.0 108.807 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.251 0.548 . . . . 0.0 112.394 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 28' ' ' SER 0.405 3.8 t 71.33 114.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 124.22 1.962 . . . . 0.0 113.567 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 54.2 m -153.3 129.18 10.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 81.1 p -74.54 129.08 37.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.864 1.266 . . . . 0.0 110.079 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 86' ' ' ARG . 11.6 p . . . . . 0 C--O 1.26 1.608 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -161.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.8 p . . . . . 0 N--CA 1.429 -1.483 0 CA-C-O 123.024 1.392 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.4 113.23 16.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 173.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -87.14 85.68 7.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 123.265 1.507 . . . . 0.0 109.949 170.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.16 152.91 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.133 2.173 . . . . 0.0 109.844 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -128.32 131.67 48.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.103 -1.623 . . . . 0.0 108.716 164.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 167.99 16.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.64 134.47 51.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 157.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.569 ' HB3' ' H ' ' A' ' 24' ' ' SER . 24.0 mttt -61.61 136.49 58.03 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.077 1.351 . . . . 0.0 113.848 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -84.68 84.37 7.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.417 -1.427 . . . . 0.0 110.047 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.16 60.09 2.18 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.358 2.263 . . . . 0.0 114.602 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.72 48.72 60.11 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.714 -1.241 . . . . 0.0 115.044 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.569 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 40.3 t 176.96 106.7 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -166.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 7.7 mt -66.02 -47.27 74.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.898 2.285 . . . . 0.0 106.283 164.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.34 38.02 0.7 Allowed Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.296 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.15 127.87 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.796 0.808 . . . . 0.0 110.52 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -78.36 104.91 9.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.632 1.973 . . . . 0.0 113.149 165.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.08 125.11 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t -118.57 161.43 20.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.757 2.423 . . . . 0.0 111.457 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.3 21.59 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.129 1.347 . . . . 0.0 113.453 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.68 169.5 20.18 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 124.602 1.096 . . . . 0.0 111.017 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -179.381 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 65' ' ' VAL . 4.7 tp -116.17 157.17 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -131.57 161.7 32.03 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.649 -1.907 . . . . 0.0 106.562 -170.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 47' ' ' ILE . 85.4 t -86.67 128.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.962 1.305 . . . . 0.0 111.512 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -99.17 -35.6 9.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.735 -1.853 . . . . 0.0 111.739 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.02 133.85 11.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.569 0.699 . . . . 0.0 110.446 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.436 HD11 HG11 ' A' ' 44' ' ' VAL . 46.9 mm -100.44 115.78 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.771 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.94 85.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.068 -1.645 . . . . 0.0 113.102 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.07 -33.85 76.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.702 -1.249 . . . . 0.0 112.516 168.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.75 -20.43 65.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.78 -76.16 0.1 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.552 -1.342 . . . . 0.0 109.429 162.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.15 7.91 56.96 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.317 -0.864 . . . . 0.0 113.788 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -88.55 -18.69 27.57 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.91 -1.347 . . . . 0.0 109.711 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 153.34 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.634 1.574 . . . . 0.0 112.632 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 65.7 t60 -147.89 176.59 10.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 166.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 24.6 pttm -81.16 57.06 3.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.48 0.94 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.552 -1.342 . . . . 0.0 114.841 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -80.11 166.47 21.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 118.982 1.391 . . . . 0.0 114.415 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -103.87 132.08 50.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.95 1.3 . . . . 0.0 109.234 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.483 HG13 HG22 ' A' ' 42' ' ' ILE . 2.8 p -105.37 125.0 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 107.809 167.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 -28.69 9.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.468 -1.395 . . . . 0.0 113.401 -175.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.22 161.0 42.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 120.007 1.276 . . . . 0.0 112.777 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 92' ' ' VAL . 65.7 t -133.63 116.76 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.264 1.026 . . . . 0.0 110.532 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 58.77 24.0 11.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.197 -1.564 . . . . 0.0 114.164 -173.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.71 4.93 84.78 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 124.573 1.083 . . . . 0.0 114.132 -171.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.29 102.21 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 p -55.35 135.27 50.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.761 2.024 . . . . 0.0 115.168 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -74.74 -54.51 7.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.837 -1.165 . . . . 0.0 110.8 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -5.07 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.262 3.825 . . . . 0.0 117.897 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.02 6.46 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -163.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.26 138.98 37.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 120.675 -1.486 . . . . 0.0 114.748 -176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -110.71 -161.0 0.73 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.279 2.231 . . . . 0.0 106.391 177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -61.57 -51.83 66.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.466 -2.021 . . . . 0.0 112.793 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -66.51 -49.97 64.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.015 -1.053 . . . . 0.0 112.239 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.22 93.67 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.291 -2.13 . . . . 0.0 114.4 173.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.45 -50.72 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.03 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -47.22 -47.58 24.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.594 1.543 . . . . 0.0 115.03 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 m -62.99 -36.45 83.57 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.456 2.702 . . . . 0.0 114.533 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -90.98 -44.36 9.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.817 1.247 . . . . 0.0 113.73 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.12 13.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.81 2.044 . . . . 0.0 112.599 -170.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -89.17 38.31 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.489 1.614 . . . . 0.0 112.531 -166.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.5 p -91.57 -168.91 2.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.097 2.959 . . . . 0.0 108.944 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -89.6 -116.89 1.63 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.122 -1.611 . . . . 0.0 110.542 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -105.65 -47.7 3.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.72 -0.871 . . . . 0.0 109.951 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.61 129.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.111 -0.993 . . . . 0.0 111.77 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 68' ' ' VAL . 79.6 t -122.64 108.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 40.8 m80 -78.99 109.78 13.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.786 -1.196 . . . . 0.0 108.585 163.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -89.02 120.23 30.25 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.643 -1.286 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.33 97.26 11.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.23 142.14 35.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.544 1.938 . . . . 0.0 110.52 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -115.34 140.4 49.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.786 1.634 . . . . 0.0 108.912 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.45 0 C-N-CA 125.858 1.663 . . . . 0.0 113.853 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.356 4.9 t 74.46 120.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 123.936 1.826 . . . . 0.0 114.813 167.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.3 m -143.15 132.17 22.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.9 p -82.93 129.99 35.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.882 1.273 . . . . 0.0 109.244 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.642 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -164.653 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.43 -1.433 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 96' ' ' LEU 0.299 0.1 OUTLIER -136.25 129.15 31.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.648 1.179 . . . . 0.0 108.681 171.384 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -105.97 79.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.626 1.203 . . . . 0.0 109.64 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.21 159.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.986 2.114 . . . . 0.0 110.796 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 0.1 OUTLIER -125.74 129.91 50.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 119.949 -1.72 . . . . 0.0 108.386 164.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -125.88 164.95 19.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.102 1.761 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.15 112.92 14.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.274 1.03 . . . . 0.0 109.587 167.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -56.51 144.71 30.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.225 2.21 . . . . 0.0 115.849 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -113.08 117.94 33.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.992 1.317 . . . . 0.0 108.253 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 36.05 51.73 0.79 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.422 2.689 . . . . 0.0 117.522 -166.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.86 48.05 22.97 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.276 -1.515 . . . . 0.0 114.565 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -172.48 111.25 0.25 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.082 1.42 . . . . 0.0 107.298 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.32 -45.3 73.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.322 2.249 . . . . 0.0 108.057 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 123.68 41.0 0.44 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.176 167.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.64 135.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.983 0.896 . . . . 0.0 110.646 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -85.68 114.21 22.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.263 1.025 . . . . 0.0 109.666 163.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.02 137.2 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -127.98 165.77 19.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.652 1.981 . . . . 0.0 110.075 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.84 -149.11 39.2 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.888 1.233 . . . . 0.0 112.893 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.66 168.11 13.31 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 120.837 -1.39 . . . . 0.0 113.759 -178.55 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 N-CA-C 119.998 2.759 . . . . 0.0 119.998 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 tp -94.08 167.51 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 0.0 109.768 -170.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -136.4 158.79 43.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.228 -2.17 . . . . 0.0 107.722 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.624 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.2 t -89.5 128.82 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.813 -1.179 . . . . 0.0 111.12 175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -88.51 -63.08 1.35 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.21 133.83 54.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.206 1.402 . . . . 0.0 110.125 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.624 ' CD1' HG11 ' A' ' 44' ' ' VAL . 30.4 mm -97.83 135.89 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.281 1.832 . . . . 0.0 108.274 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.741 HD12 ' HA2' ' A' ' 26' ' ' GLY . 55.8 mt . . . . . 0 N--CA 1.429 -1.477 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.213 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 120.98 0.419 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.77 60.93 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.55 -34.4 70.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.057 1.408 . . . . 0.0 111.71 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -72.09 1.27 7.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.51 -74.15 0.17 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.615 -1.928 . . . . 0.0 107.541 156.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.79 -18.5 2.58 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 113.486 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -92.99 -15.73 25.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.474 0.71 . . . . 0.0 112.48 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -80.86 133.79 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.048 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.29 177.45 8.61 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.188 0.994 . . . . 0.0 111.031 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.91 104.15 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.932 1.693 . . . . 0.0 112.441 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.44 -31.31 2.34 Favored Glycine 0 N--CA 1.429 -1.818 0 O-C-N 120.696 -1.253 . . . . 0.0 115.191 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.73 161.18 31.06 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 118.507 1.154 . . . . 0.0 113.71 -170.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -98.69 134.44 41.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.48 1.112 . . . . 0.0 110.894 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.38 114.11 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.771 1.628 . . . . 0.0 107.072 171.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -27.86 12.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.699 -1.876 . . . . 0.0 113.973 -173.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.35 166.68 30.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 119.073 0.851 . . . . 0.0 112.501 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 HG22 ' A' ' 84' ' ' THR . 4.1 p -146.31 135.35 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 112.077 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.0 m120 56.41 20.22 4.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.382 -2.074 . . . . 0.0 115.93 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.1 79.35 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.255 -1.528 . . . . 0.0 115.383 -168.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 t -109.43 106.26 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.107 1.763 . . . . 0.0 109.485 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.8 p -62.16 141.51 58.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.41 34.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.227 -1.546 . . . . 0.0 113.214 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.74 103.19 3.56 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.5 -2.0 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.1 13.58 58.72 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.376 -0.827 . . . . 0.0 114.079 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 140.03 29.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.673 -1.486 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -95.05 -163.62 1.07 Allowed 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.131 1.772 . . . . 0.0 110.408 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -59.97 -54.42 46.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.973 -1.704 . . . . 0.0 112.749 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -67.35 -44.79 78.18 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 111.951 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -68.2 -33.89 75.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.32 93.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.695 -1.878 . . . . 0.0 113.727 170.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.4 -53.98 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 122.995 0.518 . . . . 0.0 111.135 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -69.45 -20.13 63.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.464 HG22 HG12 ' A' ' 68' ' ' VAL . 95.7 m -63.81 -36.08 82.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.686 1.595 . . . . 0.0 110.756 168.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.27 -40.0 12.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.312 1.445 . . . . 0.0 114.717 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.459 0.0 OUTLIER -72.83 -43.42 62.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.874 -2.391 . . . . 0.0 116.546 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -87.87 47.41 1.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.007 1.384 . . . . 0.0 111.102 -174.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.0 p -102.09 175.29 5.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.39 2.676 . . . . 0.0 111.417 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.34 75.51 0.21 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 124.802 1.191 . . . . 0.0 111.654 175.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 69.22 -50.61 0.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.068 2.547 . . . . 0.0 117.382 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.86 135.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 125.631 1.572 . . . . 0.0 109.772 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.457 HG13 ' CG2' ' A' ' 68' ' ' VAL . 2.1 t -119.32 107.31 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.594 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 75.5 m80 -79.02 103.03 8.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 109.329 162.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -85.39 117.36 24.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.386 1.474 . . . . 0.0 109.343 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.78 102.94 15.64 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.694 0.759 . . . . 0.0 109.39 167.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.445 HD13 ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -104.82 145.32 30.55 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.521 1.928 . . . . 0.0 110.862 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.76 120.79 43.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 163.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.6 tptt . . . . . 0 N--CA 1.431 -1.404 0 O-C-N 120.73 -1.231 . . . . 0.0 107.691 169.577 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 8.3 tp . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.445 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.461 19.5 m 46.68 91.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 128.12 2.568 . . . . 0.0 117.023 170.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.5 m -128.88 126.58 40.06 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 42.4 m -62.78 123.36 18.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.868 2.467 . . . . 0.0 109.239 170.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--O 1.26 1.651 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 -172.544 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 122.549 1.166 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 111.4 16.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.169 1.388 . . . . 0.0 108.94 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.96 75.0 8.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.344 1.458 . . . . 0.0 110.842 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.42 121.26 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.397 -1.439 . . . . 0.0 114.033 -171.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -100.89 132.41 46.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.758 -1.839 . . . . 0.0 112.192 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.61 178.57 8.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.56 43.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.53 -1.356 . . . . 0.0 109.845 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 146.29 24.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 113.021 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -96.63 85.2 3.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.911 1.338 . . . . 0.0 108.91 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 55.71 72.96 0.45 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.253 1.821 . . . . 0.0 115.015 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.0 50.54 60.96 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.267 1.413 . . . . 0.0 114.324 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 t -169.96 98.08 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -169.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.54 HD11 HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.16 -47.05 30.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.054 1.883 . . . . 0.0 105.956 164.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 116.11 46.39 0.55 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.114 171.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 pt -118.09 134.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.003 0.921 . . . . 0.0 109.429 166.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -88.99 112.66 23.63 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.574 1.15 . . . . 0.0 109.951 166.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 m -79.23 143.65 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -138.08 171.33 14.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.699 -1.876 . . . . 0.0 109.001 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.98 -133.4 11.78 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 125.011 1.291 . . . . 0.0 112.815 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.36 154.71 29.89 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 123.985 0.803 . . . . 0.0 112.566 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.431 -1.415 0 C-N-CA 125.402 1.481 . . . . 0.0 113.751 -176.581 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.818 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.281 2.4 tp -111.54 159.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.257 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -139.48 157.45 45.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 47' ' ' ILE . 53.9 t -82.33 137.9 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.552 -1.967 . . . . 0.0 110.592 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -100.31 -53.29 3.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.941 -1.1 . . . . 0.0 109.851 165.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.65 48.3 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.939 0.876 . . . . 0.0 111.231 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 44' ' ' VAL . 47.1 mm -110.79 133.63 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.465 1.906 . . . . 0.0 109.21 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.587 HD12 ' HA2' ' A' ' 26' ' ' GLY . 62.3 mt . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.762 174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 120.574 0.226 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.62 -45.11 72.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.936 1.694 . . . . 0.0 115.513 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.62 -33.64 68.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.927 -1.733 . . . . 0.0 111.737 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t -72.7 6.33 2.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.84 -88.55 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.001 -1.687 . . . . 0.0 106.888 149.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.33 -21.78 0.95 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.893 -1.129 . . . . 0.0 112.122 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -85.82 -35.56 20.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 121.365 -1.079 . . . . 0.0 111.145 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 mt -60.4 125.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.524 1.53 . . . . 0.0 113.102 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -177.06 4.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.586 1.154 . . . . 0.0 109.412 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -76.62 89.89 3.35 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.086 -1.634 . . . . 0.0 111.434 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.95 -21.17 0.37 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.707 -1.246 . . . . 0.0 114.964 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -68.2 155.32 39.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 114.71 29.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.711 2.004 . . . . 0.0 109.43 -168.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.27 112.68 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.225 -1.547 . . . . 0.0 108.743 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.61 -31.75 11.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.451 -1.406 . . . . 0.0 112.962 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.76 160.25 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.637 1.108 . . . . 0.0 112.553 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 t -137.2 127.32 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.85 27.02 12.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.027 1.74 . . . . 0.0 114.608 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.1 18.73 79.78 Favored Glycine 0 N--CA 1.43 -1.766 0 O-C-N 120.598 -1.314 . . . . 0.0 113.644 -172.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.35 102.22 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 t -60.76 138.06 58.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -86.19 82.12 8.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -110.09 42.09 1.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.315 2.007 . . . . 0.0 110.308 -170.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.17 55.44 0.18 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.01 141.94 43.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.013 0.911 . . . . 0.0 108.581 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.8 p -96.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.572 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.04 -54.67 38.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.47 -1.394 . . . . 0.0 111.713 165.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -67.8 -42.9 80.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.6 tt0 -63.97 -46.49 84.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.8 77.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.91 -53.74 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 121.709 -0.619 . . . . 0.0 111.285 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.41 -30.87 71.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.4 m -60.3 -28.92 68.49 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.465 1.506 . . . . 0.0 112.303 171.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.54 HD22 HD11 ' A' ' 25' ' ' LEU . 14.0 mt -88.34 -47.0 8.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.02 -1.675 . . . . 0.0 113.355 168.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -88.07 -27.88 21.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -162.097 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -86.9 18.98 3.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.627 -1.296 . . . . 0.0 113.217 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.0 p -88.29 170.49 10.94 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.978 2.511 . . . . 0.0 111.396 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.15 -90.13 0.21 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.373 -1.455 . . . . 0.0 115.238 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -129.44 -57.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.531 . . . . 0.0 110.321 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.24 136.82 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 122.041 0.924 . . . . 0.0 111.028 173.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.69 109.66 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 168.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -85.54 102.67 13.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.644 1.178 . . . . 0.0 109.284 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.65 120.03 28.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.769 -1.832 . . . . 0.0 110.439 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.85 97.72 11.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.911 -1.118 . . . . 0.0 108.663 169.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.38 145.8 28.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.466 1.906 . . . . 0.0 110.41 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.62 144.18 46.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.769 1.228 . . . . 0.0 108.971 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 tptt . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -172.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.4 tp . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.576 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.359 13.5 m 29.27 101.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.781 3.232 . . . . 0.0 119.071 157.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -132.57 123.68 26.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.0 p -75.5 119.93 20.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.692 1.597 . . . . 0.0 110.793 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.566 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.06 126.12 51.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.385 2.674 . . . . 0.0 109.147 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.24 67.16 1.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.222 1.409 . . . . 0.0 110.83 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.38 112.64 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -165.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 5.5 tt0 -93.1 118.81 31.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.432 -2.043 . . . . 0.0 111.418 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.6 169.65 17.18 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.612 1.165 . . . . 0.0 109.351 175.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.31 150.13 32.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.783 1.633 . . . . 0.0 110.006 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.96 174.2 9.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.163 -0.961 . . . . 0.0 112.101 -170.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.8 t -110.89 103.87 12.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.124 -1.61 . . . . 0.0 107.361 168.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t70 34.42 67.48 0.22 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.523 2.729 . . . . 0.0 117.18 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.36 48.35 45.7 Favored Glycine 0 N--CA 1.429 -1.808 0 O-C-N 119.961 -1.712 . . . . 0.0 115.069 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 m -175.98 111.15 0.1 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.56 -45.56 68.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.153 1.781 . . . . 0.0 108.094 167.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.501 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 106.01 45.13 1.31 Allowed Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.774 1.178 . . . . 0.0 110.799 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -125.8 141.96 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 163.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 m -90.37 126.17 35.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 164.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.47 148.83 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -149.38 167.8 25.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.341 -1.475 . . . . 0.0 108.743 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.19 -138.21 14.21 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.854 -1.154 . . . . 0.0 112.704 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.86 167.57 28.3 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.43 -1.469 0 C-N-CA 126.609 1.964 . . . . 0.0 113.3 171.931 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.647 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 42' ' ' ILE . 3.9 tp -107.93 156.86 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -131.7 161.09 33.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.548 HG11 HD13 ' A' ' 47' ' ' ILE . 35.4 t -91.87 134.17 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.577 -1.327 . . . . 0.0 109.497 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -85.48 -57.26 3.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.586 172.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.85 129.23 25.76 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 123.919 0.888 . . . . 0.0 110.628 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.548 HD13 HG11 ' A' ' 44' ' ' VAL . 35.0 mm -91.7 122.86 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.698 1.599 . . . . 0.0 109.181 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.501 HD12 ' CA ' ' A' ' 26' ' ' GLY . 54.2 mt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.018 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 120.814 0.34 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.46 -48.19 67.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.503 1.921 . . . . 0.0 115.876 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.32 -30.47 66.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.126 -1.608 . . . . 0.0 112.344 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t -71.34 3.94 3.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.41 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.438 -1.414 . . . . 0.0 109.378 155.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.67 -45.81 0.26 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.174 -0.953 . . . . 0.0 111.551 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -86.54 -39.9 15.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -53.68 130.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -163.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 53.0 t60 -127.38 175.17 8.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.543 1.937 . . . . 0.0 110.833 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 51.0 mttp -86.11 40.96 0.9 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.058 1.743 . . . . 0.0 113.558 -169.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.26 38.58 0.09 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.258 -1.526 . . . . 0.0 110.864 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -103.45 158.1 16.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.07 1.348 . . . . 0.0 109.719 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.69 134.07 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 123.79 0.836 . . . . 0.0 109.229 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.12 110.54 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 163.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.75 -27.86 15.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.96 -1.713 . . . . 0.0 112.187 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.21 41.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 111.39 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -137.37 121.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.938 -1.101 . . . . 0.0 110.297 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.373 0.8 OUTLIER 43.02 34.29 0.61 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -173.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.34 60.64 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.284 0.945 . . . . 0.0 114.008 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.83 98.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.629 1.572 . . . . 0.0 107.225 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -62.36 142.52 57.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.854 -1.154 . . . . 0.0 113.352 173.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.9 mt -87.28 30.74 0.76 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.56 -1.337 . . . . 0.0 112.726 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.38 97.43 2.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.489 1.916 . . . . 0.0 109.061 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.16 -3.21 33.28 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.337 0.97 . . . . 0.0 114.986 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.73 140.95 29.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.943 1.872 . . . . 0.0 114.378 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 80.6 p -101.99 -163.0 0.97 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.503 2.321 . . . . 0.0 109.863 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.01 -53.21 53.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.214 -1.554 . . . . 0.0 111.343 166.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.1 -45.19 82.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.605 -0.684 . . . . 0.0 112.727 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.511 ' HB2' ' H ' ' A' ' 77' ' ' THR . 1.6 mm-40 -61.05 -43.07 99.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.79 -1.194 . . . . 0.0 113.253 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.22 94.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.956 -1.715 . . . . 0.0 115.411 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.43 -48.67 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 121.481 -0.762 . . . . 0.0 111.365 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.05 -36.69 84.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.643 -1.286 . . . . 0.0 114.104 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 m -63.59 -26.56 68.74 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.897 1.679 . . . . 0.0 113.351 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.33 -42.58 11.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.974 -1.704 . . . . 0.0 113.596 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -22.77 23.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.054 -1.654 . . . . 0.0 115.291 -169.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.71 37.51 1.92 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.61 -1.931 . . . . 0.0 111.28 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.5 p -87.76 -171.58 3.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.627 2.371 . . . . 0.0 111.207 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.42 62.54 0.3 Allowed Glycine 0 N--CA 1.431 -1.693 0 O-C-N 120.508 -1.37 . . . . 0.0 112.52 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 72.88 -54.05 0.7 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.301 2.641 . . . . 0.0 114.567 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 t -82.49 132.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 123.071 1.415 . . . . 0.0 109.98 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.76 109.72 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 8.4 m80 -84.62 102.01 12.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.902 -1.123 . . . . 0.0 108.434 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.5 110.89 21.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.424 -1.422 . . . . 0.0 111.56 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.9 89.31 7.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.398 1.094 . . . . 0.0 108.318 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.9 mt -103.79 148.61 25.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.88 2.472 . . . . 0.0 111.633 -173.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -135.37 140.69 45.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.824 -1.173 . . . . 0.0 109.528 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 120.358 -1.464 . . . . 0.0 113.134 -174.034 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.495 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.52 33.4 m 66.65 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 127.823 2.449 . . . . 0.0 117.543 174.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 99.6 m -152.55 118.45 5.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 91.1 p -78.65 128.62 33.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.403 1.097 . . . . 0.0 109.935 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.261 1.658 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 -156.386 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.429 -1.523 0 CA-C-O 122.128 0.966 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.05 129.38 56.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.5 1.52 . . . . 0.0 107.483 170.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.46 84.44 3.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.929 1.292 . . . . 0.0 108.815 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.8 107.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.215 2.206 . . . . 0.0 111.662 -171.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.27 112.75 24.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.826 -1.796 . . . . 0.0 109.643 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.8 mt -122.94 150.75 42.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.43 110.5 20.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 148.34 37.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.544 1.138 . . . . 0.0 113.709 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -102.33 97.18 7.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.427 -1.421 . . . . 0.0 109.96 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 60.49 50.12 6.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.787 2.035 . . . . 0.0 112.57 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.81 55.69 25.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 120.352 -1.467 . . . . 0.0 113.934 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -165.87 112.33 0.89 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.236 1.493 . . . . 0.0 107.005 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.697 HD21 HG21 ' A' ' 92' ' ' VAL . 6.9 mt -67.33 -49.61 63.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.482 1.913 . . . . 0.0 106.258 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.96 39.06 0.66 Allowed Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.562 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.446 ' HB ' HG13 ' A' ' 44' ' ' VAL . 44.8 pt -123.9 132.28 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.673 0.749 . . . . 0.0 109.817 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -77.22 117.4 18.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.443 -0.785 . . . . 0.0 111.742 159.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.36 128.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -130.19 169.69 15.04 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.379 1.471 . . . . 0.0 108.898 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.82 58.87 7.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.472 2.149 . . . . 0.0 118.472 169.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.52 -176.63 34.18 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.34 -1.683 . . . . 0.0 109.604 172.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.663 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.797 0 CA-C-O 121.911 0.728 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.5 tp -148.05 161.35 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 161.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -135.71 161.24 36.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.528 -1.982 . . . . 0.0 106.739 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 47' ' ' ILE . 10.9 t -92.44 129.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.031 -1.668 . . . . 0.0 111.643 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.67 -49.31 6.94 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.808 -1.182 . . . . 0.0 111.429 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.47 126.92 28.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.845 -1.159 . . . . 0.0 110.626 -170.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.61 HD13 HG11 ' A' ' 44' ' ' VAL . 34.3 mm -96.07 119.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt . . . . . 0 N--CA 1.431 -1.407 0 O-C-N 120.841 -1.162 . . . . 0.0 112.735 -177.188 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.57 -50.96 65.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.715 1.606 . . . . 0.0 114.454 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.96 -34.43 68.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.683 -1.26 . . . . 0.0 111.915 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 t -72.51 -6.33 43.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.54 -75.45 0.15 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.632 -1.918 . . . . 0.0 108.552 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.76 -10.19 12.43 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.399 -0.813 . . . . 0.0 114.238 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 -81.74 -23.74 36.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.78 -0.835 . . . . 0.0 111.395 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.99 139.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.165 1.786 . . . . 0.0 112.868 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -138.32 -167.91 2.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.248 1.023 . . . . 0.0 108.758 166.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -80.78 75.95 7.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.328 -1.483 . . . . 0.0 111.967 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.38 13.3 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.747 -1.221 . . . . 0.0 116.126 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -81.97 158.95 23.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.488 1.644 . . . . 0.0 113.18 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.65 114.17 27.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.236 1.415 . . . . 0.0 110.616 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.96 117.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.383 -1.448 . . . . 0.0 108.075 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -97.21 -39.46 9.26 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.003 -1.061 . . . . 0.0 112.163 173.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.524 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -156.2 166.21 34.12 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.118 1.326 . . . . 0.0 114.279 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG21 HD23 ' A' ' 85' ' ' LEU . 9.1 t -135.16 122.56 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 110.644 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 49.13 30.77 3.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -167.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.85 27.79 57.97 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 120.503 -1.373 . . . . 0.0 113.813 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.83 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.7 m -60.53 136.76 58.15 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.123 1.369 . . . . 0.0 114.59 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.97 53.11 1.9 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.169 1.788 . . . . 0.0 113.446 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.44 117.95 23.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.654 1.582 . . . . 0.0 108.198 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 9.53 86.51 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 120.87 -1.144 . . . . 0.0 115.727 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.76 140.29 29.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.865 1.317 . . . . 0.0 112.659 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 p -100.6 -164.89 1.15 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.968 1.707 . . . . 0.0 109.222 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -60.17 -57.33 13.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.446 -1.409 . . . . 0.0 112.651 163.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.61 -43.82 95.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 112.968 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -37.04 86.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.759 -1.213 . . . . 0.0 113.471 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.87 89.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.314 -1.491 . . . . 0.0 114.986 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.3 t -57.84 -53.21 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 121.69 -0.631 . . . . 0.0 112.108 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.3 m -64.23 -30.17 71.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.53 2.332 . . . . 0.0 113.294 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 68' ' ' VAL . 24.8 mt -88.47 -43.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.99 -1.694 . . . . 0.0 113.771 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -48.46 11.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.784 1.634 . . . . 0.0 114.976 -162.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -81.12 18.98 0.96 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.719 1.208 . . . . 0.0 113.723 -169.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.1 p -85.02 177.1 8.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.182 2.593 . . . . 0.0 112.08 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.87 -77.82 0.28 Allowed Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.167 -1.583 . . . . 0.0 115.217 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -154.29 -54.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.982 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.44 128.08 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.846 1.308 . . . . 0.0 111.006 170.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.697 HG21 HD21 ' A' ' 25' ' ' LEU . 2.7 m -118.42 112.2 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.977 1.711 . . . . 0.0 107.53 166.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -78.85 95.22 5.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.685 -1.259 . . . . 0.0 107.71 164.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 117.3 15.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.791 -1.193 . . . . 0.0 113.063 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.524 HD12 ' HB3' ' A' ' 67' ' ' ALA . 7.1 mt -86.04 95.64 9.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.8 mt -104.19 130.64 51.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.902 2.881 . . . . 0.0 111.688 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -105.94 140.24 39.25 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.778 -1.202 . . . . 0.0 110.24 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.1 tptt . . . . . 0 N--CA 1.43 -1.439 0 C-N-CA 125.111 1.364 . . . . 0.0 113.121 -175.316 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.451 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.521 30.1 m 66.46 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 127.571 2.348 . . . . 0.0 116.932 171.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 80.3 m -152.82 125.6 8.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 78.7 p -76.91 126.43 30.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.592 1.157 . . . . 0.0 108.404 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.613 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 -161.575 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 121.436 0.636 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.312 0.0 OUTLIER -106.62 136.88 45.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.591 1.556 . . . . 0.0 110.075 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -117.64 76.72 1.08 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.068 1.347 . . . . 0.0 108.423 -173.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.68 137.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 126.851 2.06 . . . . 0.0 111.233 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 127.64 53.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.354 2.343 . . . . 0.0 110.093 167.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.5 128.8 49.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.207 1.003 . . . . 0.0 110.156 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.1 90.88 6.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.219 1.009 . . . . 0.0 109.313 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.08 137.52 58.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -104.05 105.19 15.28 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.82 1.295 . . . . 0.0 109.413 -160.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 54.78 37.33 28.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.198 2.199 . . . . 0.0 114.958 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.62 88.62 0.25 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.794 -1.191 . . . . 0.0 112.371 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.284 51.9 p 149.32 112.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.727 2.411 . . . . 0.0 109.519 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 20' ' ' LYS . 8.0 mt -73.28 -43.16 61.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 156.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.94 17.81 3.31 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.545 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.3 pt -105.8 126.22 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 122.013 0.911 . . . . 0.0 111.09 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -79.31 109.68 13.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.06 1.344 . . . . 0.0 111.469 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.64 127.62 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -134.07 178.93 6.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.697 2.399 . . . . 0.0 108.699 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.11 39.94 35.96 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 119.881 -1.762 . . . . 0.0 117.26 168.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.48 -179.88 49.31 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.092 -1.828 . . . . 0.0 113.606 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.425 0 C-N-CA 126.288 1.835 . . . . 0.0 114.345 179.868 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.704 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.4 tp -136.32 156.18 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 155.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -137.12 154.56 50.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -171.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 47' ' ' ILE . 11.9 t -84.08 131.94 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 119.694 -1.879 . . . . 0.0 111.067 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.33 -52.66 5.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 109.956 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.43 140.43 41.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 111.696 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 44' ' ' VAL . 46.3 mm -97.61 127.57 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.503 1.921 . . . . 0.0 106.789 169.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 pt . . . . . 0 N--CA 1.429 -1.5 0 O-C-N 121.194 -0.941 . . . . 0.0 112.092 176.782 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.42 0 CA-C-O 121.583 0.706 . . . . 0.0 112.282 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.73 72.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.121 -1.612 . . . . 0.0 113.228 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.68 -26.84 64.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.618 1.567 . . . . 0.0 112.424 165.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -80.93 -9.49 59.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.437 -2.039 . . . . 0.0 115.788 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -76.22 -62.45 1.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.748 2.067 . . . . 0.0 106.049 156.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.62 -9.68 62.45 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 121.499 -0.75 . . . . 0.0 112.935 162.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -74.23 -28.77 61.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 123.66 0.784 . . . . 0.0 109.174 166.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.7 mt -61.71 128.08 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 126.938 2.095 . . . . 0.0 110.716 165.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.598 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 70.9 t60 -127.7 -161.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.109 0.963 . . . . 0.0 109.665 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.598 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 95.1 mttt -92.45 66.27 4.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.555 -2.59 . . . . 0.0 111.12 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.92 53.5 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.45 -0.781 . . . . 0.0 114.911 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -109.83 173.68 6.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.778 1.231 . . . . 0.0 108.898 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -103.89 136.43 43.56 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.034 0.934 . . . . 0.0 110.377 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.63 119.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.41 -34.21 8.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.864 -1.772 . . . . 0.0 113.161 177.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.58 153.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.119 1.327 . . . . 0.0 112.9 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -133.92 111.96 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 112.102 -174.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.74 31.19 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.437 -1.415 . . . . 0.0 113.744 -166.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.42 80.7 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.123 1.344 . . . . 0.0 113.921 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.75 102.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.992 -1.299 . . . . 0.0 107.584 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -65.75 137.1 57.04 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 126.136 1.774 . . . . 0.0 114.359 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.2 mt -86.99 26.39 1.16 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.561 1.544 . . . . 0.0 113.009 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -68.21 118.16 10.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.573 -1.955 . . . . 0.0 110.023 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.28 6.53 86.1 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 120.954 -1.091 . . . . 0.0 115.201 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.37 137.94 32.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 118.945 1.372 . . . . 0.0 111.744 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -113.64 -168.15 1.3 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -54.62 -52.0 63.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.603 -1.936 . . . . 0.0 114.647 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.31 -46.24 74.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.242 -0.912 . . . . 0.0 112.978 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.99 -46.44 90.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.497 1.519 . . . . 0.0 114.809 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.29 -34.63 78.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.371 -1.456 . . . . 0.0 114.404 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.12 -54.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.151 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -55.48 -47.71 75.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.2 m -52.56 -33.16 44.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 126.283 1.833 . . . . 0.0 115.182 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 mt -92.2 -46.7 7.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.176 1.79 . . . . 0.0 115.449 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -37.05 55.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.592 2.357 . . . . 0.0 114.586 -172.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.54 30.49 0.71 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.157 -1.59 . . . . 0.0 112.363 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.6 p -106.19 176.78 5.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.761 2.424 . . . . 0.0 109.361 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.42 -74.63 1.28 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 119.444 -2.035 . . . . 0.0 113.954 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -139.91 -66.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.966 -1.314 . . . . 0.0 110.068 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.59 115.35 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.17 1.462 . . . . 0.0 110.605 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.74 103.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.23 97.77 8.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.594 1.158 . . . . 0.0 109.133 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.29 114.01 22.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.829 1.652 . . . . 0.0 108.993 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 103.85 16.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mt -108.97 142.84 39.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.317 1.847 . . . . 0.0 110.408 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -114.04 129.45 56.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.564 1.146 . . . . 0.0 108.034 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tptm . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 126.539 1.936 . . . . 0.0 113.264 -171.408 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.41 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.389 2.7 t 66.86 91.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 124.943 2.306 . . . . 0.0 113.016 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 90.4 m -136.61 128.62 29.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.193 -2.891 . . . . 0.0 103.193 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.7 m -72.89 120.03 17.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.036 0.922 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.72 126.57 54.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.8 1.64 . . . . 0.0 107.739 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -99.69 85.39 3.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.979 1.371 . . . . 0.0 108.312 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -81.1 115.52 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.668 1.987 . . . . 0.0 111.594 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 118.53 36.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.289 -2.132 . . . . 0.0 110.761 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.4 mt -126.02 -178.86 4.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.557 1.143 . . . . 0.0 108.973 -170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.43 126.86 30.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 162.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.57 53.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.9 -1.125 . . . . 0.0 112.755 -174.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 t -97.23 92.8 6.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.439 1.59 . . . . 0.0 109.543 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.38 25.82 12.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.004 1.722 . . . . 0.0 114.31 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.3 65.46 1.32 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 124.677 1.132 . . . . 0.0 112.662 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.3 t 179.33 113.94 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.3 mt -78.58 -36.26 44.64 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.357 2.027 . . . . 0.0 106.466 162.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.545 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 101.82 43.93 2.02 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -128.3 133.64 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.5 m -89.34 108.03 19.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.683 1.593 . . . . 0.0 111.736 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 m -77.89 137.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -171.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 t -133.07 166.32 22.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.316 -1.49 . . . . 0.0 110.37 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.49 -130.86 10.27 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 125.106 1.336 . . . . 0.0 112.645 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.52 160.68 30.35 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.529 1.061 . . . . 0.0 112.049 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 119.808 -1.995 . . . . 0.0 115.729 -177.0 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.765 0 N-CA-C 105.936 -2.865 . . . . 0.0 105.936 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.34 154.94 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 119.489 1.645 . . . . 0.0 106.936 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -138.79 148.75 44.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.315 -2.116 . . . . 0.0 105.853 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 47' ' ' ILE . 69.9 t -73.39 127.56 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 120.622 -1.299 . . . . 0.0 111.505 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -88.23 -66.05 0.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.725 -1.235 . . . . 0.0 108.722 166.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 133.53 53.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.527 1.131 . . . . 0.0 111.711 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 44' ' ' VAL . 51.0 mm -93.44 137.1 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 169.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.545 HD12 ' CA ' ' A' ' 26' ' ' GLY . 54.5 mt . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 116.525 -1.703 . . . . 0.0 110.726 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 120.786 1.63 . . . . 0.0 113.314 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 p -55.18 -27.28 44.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.17 -73.8 0.06 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.872 1.269 . . . . 0.0 111.173 170.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.44 -9.92 14.8 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 121.667 -0.646 . . . . 0.0 112.95 164.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -79.17 -27.69 42.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.135 -1.215 . . . . 0.0 110.557 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -69.98 146.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.549 1.939 . . . . 0.0 114.434 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -148.58 -171.59 3.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.833 -1.167 . . . . 0.0 109.317 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -78.12 93.74 4.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.902 -2.373 . . . . 0.0 112.569 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.38 -19.24 0.26 Allowed Glycine 0 N--CA 1.429 -1.782 0 O-C-N 121.023 -1.048 . . . . 0.0 114.467 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -70.05 153.43 43.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -172.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -105.51 121.3 43.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.407 1.575 . . . . 0.0 111.325 -172.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.22 109.48 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.418 2.687 . . . . 0.0 106.232 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.09 -37.07 9.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.192 -0.943 . . . . 0.0 112.488 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.93 166.5 33.35 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.979 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' A' ' 92' ' ' VAL . 4.8 p -142.54 123.57 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 121.311 -0.868 . . . . 0.0 113.023 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.24 30.89 3.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.82 22.4 66.45 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.608 -1.308 . . . . 0.0 114.329 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.81 98.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -67.0 137.59 56.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 125.106 1.362 . . . . 0.0 112.554 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -75.63 61.16 1.32 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.069 1.748 . . . . 0.0 113.679 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.1 110.18 5.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.192 1.397 . . . . 0.0 111.56 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.65 30.53 78.18 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.717 1.151 . . . . 0.0 115.6 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.54 140.45 29.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.762 1.281 . . . . 0.0 112.821 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.5 p -97.96 -157.44 0.6 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.698 1.999 . . . . 0.0 109.934 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.421 -2.049 . . . . 0.0 109.754 168.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -53.21 55.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.327 1.051 . . . . 0.0 111.645 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.07 -26.9 64.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.07 78.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.481 -2.012 . . . . 0.0 113.644 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG12 ' HG2' ' A' ' 86' ' ' ARG . 24.0 t -57.88 -52.56 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.16 -0.963 . . . . 0.0 110.184 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.406 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 62.1 mt-10 -54.02 -41.19 67.73 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.5 m -57.25 -39.31 75.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.905 2.082 . . . . 0.0 114.452 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mt -92.21 -28.4 17.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.842 1.257 . . . . 0.0 113.252 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG2' HG12 ' A' ' 82' ' ' VAL . 4.4 ppt_? -86.6 -47.98 8.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.02 43.98 1.17 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.667 1.699 . . . . 0.0 110.473 -171.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.8 p -95.94 -152.8 0.38 Allowed 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.103 2.961 . . . . 0.0 109.609 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.14 -137.42 9.56 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.144 -1.598 . . . . 0.0 110.43 172.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -92.9 -51.48 5.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.522 1.129 . . . . 0.0 109.055 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.76 132.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.976 1.37 . . . . 0.0 110.139 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 68' ' ' VAL . 4.5 t -124.01 111.76 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.66 103.55 10.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.126 1.371 . . . . 0.0 107.772 160.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -83.27 108.77 16.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.716 2.007 . . . . 0.0 108.284 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.7 102.57 11.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 110.722 169.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -109.6 147.97 32.1 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.392 2.277 . . . . 0.0 110.228 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.88 152.21 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.172 1.789 . . . . 0.0 106.425 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -171.392 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.606 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.0 tp . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.606 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.394 10.9 m 31.71 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 130.308 3.443 . . . . 0.0 118.213 164.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 82.2 m -119.47 124.15 45.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 36.9 t -67.98 112.43 4.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.519 1.128 . . . . 0.0 108.562 164.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 25' ' ' LEU . 13.1 p . . . . . 0 C--O 1.26 1.624 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 -167.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 122.303 1.049 . . . . 0.0 111.575 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -133.87 133.43 41.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -111.4 76.03 0.95 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.967 1.307 . . . . 0.0 108.939 -177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.72 118.91 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 125.712 1.605 . . . . 0.0 114.543 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.268 6.3 pm0 -99.68 126.39 45.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.466 -2.021 . . . . 0.0 111.977 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 169.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.62 148.17 33.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.697 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 146.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 111.005 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -94.45 93.07 7.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.528 -1.357 . . . . 0.0 108.244 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 45.81 67.72 0.7 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.257 2.623 . . . . 0.0 115.861 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.82 42.7 77.97 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 121.507 -0.746 . . . . 0.0 113.862 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 p -167.89 106.18 0.51 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.848 1.785 . . . . 0.0 108.49 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.13 -47.23 59.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 162.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 27.77 1.67 Allowed Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.186 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 pt -109.13 122.93 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 122.998 1.38 . . . . 0.0 109.541 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -84.51 110.54 18.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.176 1.39 . . . . 0.0 109.209 171.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -80.9 138.43 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.477 ' HA ' HD11 ' B' ' 206' ' ' LEU . 9.2 t -133.51 171.63 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.017 1.727 . . . . 0.0 108.281 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.42 -143.73 18.05 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 124.985 1.279 . . . . 0.0 113.163 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.6 159.39 28.82 Favored Glycine 0 N--CA 1.431 -1.661 0 O-C-N 121.562 -0.963 . . . . 0.0 111.808 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.43 -1.46 0 C-N-CA 126.052 1.741 . . . . 0.0 114.503 -174.739 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 tp -102.88 158.8 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 167.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -133.94 158.73 42.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.576 -1.952 . . . . 0.0 105.914 -171.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 47' ' ' ILE . 3.3 t -89.7 134.49 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.578 -1.951 . . . . 0.0 109.873 174.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -39.16 10.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.356 -1.465 . . . . 0.0 110.923 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.67 20.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.555 -0.716 . . . . 0.0 111.265 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.506 HD13 HG11 ' A' ' 44' ' ' VAL . 30.9 mm -99.01 135.02 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.6 1.96 . . . . 0.0 107.3 171.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.425 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.69 82.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.141 -1.599 . . . . 0.0 115.114 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.36 -29.77 70.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.496 -1.378 . . . . 0.0 111.583 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.35 -0.86 15.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 115.405 1.632 . . . . 0.0 115.405 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.73 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 108.447 158.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.57 -1.54 15.81 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 113.353 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -95.05 -31.9 13.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.023 -1.281 . . . . 0.0 110.237 169.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.36 139.54 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.131 -1.605 . . . . 0.0 114.594 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -127.54 177.47 6.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.982 0.896 . . . . 0.0 109.213 160.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.63 50.78 0.44 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.25 -1.53 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.154 -2.216 . . . . 0.0 115.666 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -76.01 161.73 28.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 118.567 1.183 . . . . 0.0 114.175 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -96.0 131.9 41.9 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.736 1.214 . . . . 0.0 109.869 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.48 115.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 168.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.35 -35.83 12.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.196 -1.565 . . . . 0.0 111.915 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.98 156.8 41.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.009 0.822 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.16 119.94 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 121.007 -1.058 . . . . 0.0 109.948 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.74 28.12 16.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.119 -1.613 . . . . 0.0 114.186 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.7 90.41 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 125.035 1.302 . . . . 0.0 113.486 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.6 t -97.33 104.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.155 -1.203 . . . . 0.0 109.163 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -53.4 137.17 36.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.357 2.263 . . . . 0.0 115.697 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.24 25.55 1.6 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.736 -1.227 . . . . 0.0 112.584 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.7 111.57 11.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.011 -1.68 . . . . 0.0 110.574 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.45 -1.67 72.92 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.777 -0.577 . . . . 0.0 113.039 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.22 138.66 31.4 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.552 1.644 . . . . 0.0 111.59 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.486 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 3.8 t -117.57 -171.7 2.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.677 2.391 . . . . 0.0 104.836 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -48.96 -52.65 23.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.844 1.658 . . . . 0.0 114.856 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.42 -47.74 59.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.755 1.161 . . . . 0.0 113.188 -175.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' HB2' ' H ' ' A' ' 77' ' ' THR . 5.1 mm100 -50.67 -49.35 57.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.554 1.542 . . . . 0.0 114.474 168.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.61 84.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.436 -1.415 . . . . 0.0 114.5 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.417 HG13 HG11 ' B' ' 210' ' ' VAL . 65.1 t -62.53 -48.19 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 111.512 175.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -58.14 -39.0 77.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.212 -1.555 . . . . 0.0 113.592 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.5 m -64.56 -26.81 68.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.518 2.327 . . . . 0.0 113.715 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.46 -47.02 7.67 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.349 1.459 . . . . 0.0 114.087 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.269 0.1 OUTLIER -79.62 -35.09 39.98 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.361 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.75 40.31 1.03 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.436 -2.04 . . . . 0.0 111.61 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.1 p -101.2 159.07 15.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.75 2.42 . . . . 0.0 111.663 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.09 65.09 4.17 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 121.165 -0.959 . . . . 0.0 112.103 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 67.46 -48.09 0.5 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 129.319 3.048 . . . . 0.0 116.133 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.2 t -80.5 131.66 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.775 1.274 . . . . 0.0 110.874 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.415 HG12 ' HG ' ' A' ' 94' ' ' LEU . 60.9 t -117.73 109.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -88.4 101.15 13.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.935 -1.103 . . . . 0.0 109.153 171.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.415 ' HG ' HG12 ' A' ' 92' ' ' VAL . 15.2 mt -90.37 122.62 33.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.864 -1.148 . . . . 0.0 111.627 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.07 102.95 14.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.7 mt -112.47 142.52 44.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.507 1.923 . . . . 0.0 110.583 -171.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.65 142.09 50.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.207 2.203 . . . . 0.0 108.512 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? . . . . . 0 N--CA 1.43 -1.459 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.764 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 30' ' ' THR . 10.5 tp . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.407 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.491 5.9 m 52.82 100.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.103 2.961 . . . . 0.0 117.827 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 53.5 m -130.62 118.93 21.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 76.2 p -77.67 122.83 25.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.575 1.15 . . . . 0.0 109.244 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.633 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -175.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.37 1.081 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 114.74 26.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 174.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -92.29 83.45 5.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.24 153.39 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 127.761 2.425 . . . . 0.0 110.339 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.52 50.96 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.513 -1.992 . . . . 0.0 108.321 167.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.8 mt -128.75 161.72 29.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 123.998 0.919 . . . . 0.0 109.689 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.74 117.13 26.67 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.032 0.92 . . . . 0.0 108.863 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 1.2 ptmm? -62.84 126.25 26.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.051 1.74 . . . . 0.0 113.087 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -96.48 118.27 32.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.989 -1.069 . . . . 0.0 108.709 -171.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.34 -19.93 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.29 2.236 . . . . 0.0 117.006 -171.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 53.26 0.11 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.971 1.748 . . . . 0.0 110.682 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 m -177.81 126.87 0.13 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 -173.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.2 mt -84.02 -39.4 19.68 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.393 2.277 . . . . 0.0 106.724 172.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA2' HD11 ' A' ' 48' ' ' ILE . . . 131.97 6.17 3.28 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 124.298 0.951 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 pt -102.0 127.55 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 122.428 1.108 . . . . 0.0 111.13 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -81.49 109.8 16.29 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.075 1.35 . . . . 0.0 112.102 168.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.91 125.95 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -172.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.5 t -120.22 160.84 22.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.938 2.095 . . . . 0.0 110.843 175.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.08 -125.14 8.24 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.668 1.604 . . . . 0.0 112.441 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.15 140.72 11.43 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 177.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 124.898 1.279 . . . . 0.0 114.28 -167.939 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.701 0 N-CA-C 107.354 -2.298 . . . . 0.0 107.354 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.517 HG22 HG13 ' A' ' 65' ' ' VAL 0.287 2.3 tp -114.61 157.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.043 1.421 . . . . 0.0 108.701 175.432 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -140.6 157.25 45.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.892 -1.755 . . . . 0.0 106.614 -171.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 47' ' ' ILE . 6.2 t -88.73 127.37 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.305 -1.497 . . . . 0.0 112.2 174.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -83.27 -50.42 8.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.656 -1.277 . . . . 0.0 109.907 171.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.06 138.87 37.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -174.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.539 HD13 HG11 ' A' ' 44' ' ' VAL . 29.1 mm -97.03 145.58 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.121 1.768 . . . . 0.0 107.184 171.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.542 HD11 ' HA2' ' A' ' 26' ' ' GLY . 2.2 pt . . . . . 0 N--CA 1.43 -1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 110.776 169.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.498 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.13 72.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.322 -1.486 . . . . 0.0 113.916 -177.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.74 -32.99 72.26 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.274 1.43 . . . . 0.0 112.195 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -61.62 -28.54 69.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.32 -75.04 0.05 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.932 1.242 . . . . 0.0 111.797 176.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.16 -30.71 2.42 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 112.1 168.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -86.58 -20.97 27.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 113.644 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -71.75 133.89 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.159 1.784 . . . . 0.0 112.073 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -150.33 -159.75 1.08 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.638 -1.288 . . . . 0.0 110.557 165.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.76 129.03 36.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.215 -1.553 . . . . 0.0 112.1 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.75 23.24 56.42 Favored Glycine 0 N--CA 1.428 -1.839 0 O-C-N 120.151 -1.593 . . . . 0.0 114.965 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.85 148.14 22.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.289 -1.124 . . . . 0.0 109.821 168.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -90.99 129.8 36.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.04 -1.038 . . . . 0.0 109.976 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 42' ' ' ILE . 1.5 p -104.19 119.91 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 165.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.87 -31.57 11.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.754 -1.216 . . . . 0.0 112.852 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.2 43.48 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 119.04 0.836 . . . . 0.0 112.418 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 HG13 ' A' ' 92' ' ' VAL . 61.1 t -135.49 120.86 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 121.189 -0.945 . . . . 0.0 111.027 -177.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 54.94 29.79 12.82 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.412 1.485 . . . . 0.0 114.44 -170.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.77 22.36 77.15 Favored Glycine 0 N--CA 1.431 -1.659 0 O-C-N 121.037 -1.039 . . . . 0.0 114.117 -173.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.48 101.94 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.619 1.567 . . . . 0.0 107.86 177.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -66.19 143.49 57.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.843 -1.16 . . . . 0.0 113.915 177.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.39 62.0 3.61 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.902 1.681 . . . . 0.0 112.783 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.33 123.33 37.67 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.837 1.655 . . . . 0.0 108.539 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.5 -7.6 57.11 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.626 -1.296 . . . . 0.0 114.487 -171.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.93 129.26 34.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.128 1.918 . . . . 0.0 114.755 -169.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.1 p -96.17 -163.48 1.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.471 1.909 . . . . 0.0 108.415 -175.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.4 -51.66 66.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.986 -1.696 . . . . 0.0 112.374 163.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.61 -42.19 87.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.122 -0.986 . . . . 0.0 112.723 -177.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.9 tt0 -69.84 -34.32 73.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.43 75.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.217 -2.177 . . . . 0.0 114.097 171.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.59 -53.01 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.429 -0.794 . . . . 0.0 110.832 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.13 -41.36 62.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.418 1.463 . . . . 0.0 114.837 175.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.7 m -62.41 -29.95 70.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.65 2.38 . . . . 0.0 114.542 178.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.47 -40.95 9.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -50.55 15.06 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.534 2.334 . . . . 0.0 112.73 -171.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -91.44 42.55 1.11 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.977 1.37 . . . . 0.0 110.622 -168.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.1 p -102.44 164.7 11.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.51 2.324 . . . . 0.0 111.341 -174.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.04 58.23 4.77 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.759 -1.213 . . . . 0.0 113.125 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 71.16 -48.23 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.945 2.898 . . . . 0.0 116.858 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.49 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.596 1.188 . . . . 0.0 109.478 171.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.429 HG13 HG13 ' A' ' 68' ' ' VAL . 95.3 t -117.63 99.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -78.92 105.89 10.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.807 -1.183 . . . . 0.0 107.964 166.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -88.89 125.49 34.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.187 -1.571 . . . . 0.0 110.544 -177.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.42 102.09 14.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 108.567 166.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.32 148.29 24.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.2 1.8 . . . . 0.0 111.713 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -116.37 138.75 51.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 162.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.0 tptt . . . . . 0 N--CA 1.429 -1.515 0 C-N-CA 123.618 0.767 . . . . 0.0 112.982 176.432 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 20.2 tp . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 111.087 0.032 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.41 2.2 t 78.92 122.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.077 1.894 . . . . 0.0 114.565 166.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.1 m -147.21 125.11 11.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 176.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.7 p -75.52 128.99 36.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.013 0.925 . . . . 0.0 109.61 169.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.3 p . . . . . 0 C--O 1.259 1.588 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -162.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.429 -1.476 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -130.66 113.69 14.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.089 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.75 71.55 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.867 1.317 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.95 121.58 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.702 2.401 . . . . 0.0 111.721 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -105.24 115.34 30.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.423 -2.048 . . . . 0.0 109.398 -174.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -115.83 146.4 42.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.836 0.827 . . . . 0.0 110.003 -171.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.81 109.58 21.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 165.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -53.7 151.99 5.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.842 2.057 . . . . 0.0 112.77 175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -110.12 104.74 13.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 56.73 5.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.133 2.173 . . . . 0.0 116.086 -175.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.62 61.2 5.19 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 120.49 -1.381 . . . . 0.0 115.897 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 t 175.08 112.64 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.792 1.637 . . . . 0.0 106.77 -173.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.42 -41.93 45.93 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 126.233 1.813 . . . . 0.0 107.388 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.45 33.76 1.28 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.034 171.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.19 133.74 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 121.845 -0.797 . . . . 0.0 111.062 175.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -82.95 113.13 20.34 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.245 1.018 . . . . 0.0 111.088 164.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.555 HG23 ' CE1' ' A' ' 78' ' ' HIS . 21.0 m -85.26 128.98 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -124.11 167.15 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.448 1.899 . . . . 0.0 110.865 176.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 -137.65 15.6 Favored Glycine 0 N--CA 1.428 -1.846 0 C-N-CA 125.103 1.335 . . . . 0.0 112.915 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.11 161.88 21.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 124.433 1.015 . . . . 0.0 111.293 177.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.465 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 CA-C-O 121.041 0.245 . . . . 0.0 113.491 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.7 tp -116.59 164.39 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.189 0.995 . . . . 0.0 110.093 -166.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -140.72 156.75 46.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.028 -1.67 . . . . 0.0 106.786 -172.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.591 HG11 ' CD1' ' A' ' 47' ' ' ILE . 3.4 t -91.37 119.87 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.644 -1.285 . . . . 0.0 111.782 177.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -83.71 -40.49 18.81 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.732 -1.23 . . . . 0.0 111.065 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.42 131.8 17.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.964 0.905 . . . . 0.0 109.988 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.591 ' CD1' HG11 ' A' ' 44' ' ' VAL . 50.4 mm -97.33 120.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.9 pt . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 121.163 -0.961 . . . . 0.0 113.018 -175.517 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.24 -40.53 67.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.81 -28.7 69.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.469 -1.394 . . . . 0.0 111.796 168.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.7 t -73.33 -12.9 60.99 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.92 -85.03 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.923 2.147 . . . . 0.0 110.403 176.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.82 -30.22 0.82 Allowed Glycine 0 N--CA 1.431 -1.697 0 O-C-N 120.622 -1.299 . . . . 0.0 111.469 172.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -83.87 -43.08 15.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.55 -0.971 . . . . 0.0 111.287 -176.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 134.83 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 124.765 1.226 . . . . 0.0 114.046 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -133.5 -172.69 3.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 164.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -84.52 122.3 28.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.308 -2.12 . . . . 0.0 112.084 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.71 -30.71 2.73 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 112.395 -169.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -73.12 162.88 28.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.279 1.514 . . . . 0.0 113.768 -172.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -105.01 129.9 53.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.98 0.912 . . . . 0.0 109.884 -173.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.34 114.72 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.12 1.438 . . . . 0.0 107.984 167.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.41 -32.02 11.71 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 120.231 -1.543 . . . . 0.0 113.176 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.14 159.32 43.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.611 1.096 . . . . 0.0 111.867 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.0 126.2 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 110.415 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 m120 58.59 22.14 9.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.919 1.691 . . . . 0.0 114.828 -174.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.69 -2.72 80.61 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.629 1.109 . . . . 0.0 114.267 -172.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.81 103.01 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.115 1.366 . . . . 0.0 108.53 -172.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -62.77 141.39 58.62 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.599 1.56 . . . . 0.0 113.18 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.56 72.46 7.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.475 1.131 . . . . 0.0 111.098 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -91.65 111.18 22.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.769 1.228 . . . . 0.0 108.621 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.3 -3.86 85.15 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.988 -1.07 . . . . 0.0 115.349 -176.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.41 133.35 38.69 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 123.942 1.83 . . . . 0.0 114.745 -172.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 80.0 p -99.53 -155.82 0.52 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.558 2.343 . . . . 0.0 109.881 -169.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 29' ' ' VAL . 85.2 t60 -72.4 -50.47 26.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.612 -1.93 . . . . 0.0 111.19 168.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -42.82 80.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 77' ' ' THR . 17.8 tt0 -65.68 -35.87 82.01 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.12 -1.612 . . . . 0.0 113.902 174.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.78 96.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.671 -1.893 . . . . 0.0 115.05 172.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.03 -56.39 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 123.594 0.757 . . . . 0.0 110.406 172.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -51.28 -46.49 62.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.06 1.344 . . . . 0.0 113.602 177.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 m -59.58 -30.39 68.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.384 1.874 . . . . 0.0 114.422 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.6 mt -89.34 -38.65 14.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.161 -1.587 . . . . 0.0 113.366 173.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.44 39.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.575 2.35 . . . . 0.0 114.863 -172.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 15.13 0.58 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.5 p -91.68 158.86 16.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.287 2.635 . . . . 0.0 111.013 -169.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.55 -61.67 3.08 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 121.414 -0.804 . . . . 0.0 114.286 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.52 -64.84 0.18 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.236 -1.155 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.09 129.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.153 1.454 . . . . 0.0 111.541 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -115.58 105.3 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.834 1.654 . . . . 0.0 107.749 172.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -78.74 106.17 10.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.572 -1.33 . . . . 0.0 109.284 169.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mt -87.41 110.37 20.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.067 1.747 . . . . 0.0 108.677 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.9 101.86 13.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 172.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.89 143.26 34.28 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 -175.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.16 143.16 45.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.888 2.075 . . . . 0.0 106.226 171.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 N--CA 1.429 -1.511 0 C-N-CA 123.564 0.746 . . . . 0.0 110.892 178.943 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.404 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.412 5.7 m 45.23 92.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 162.925 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -128.34 125.05 37.93 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 -171.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.3 m -74.23 123.84 25.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.293 1.837 . . . . 0.0 108.575 177.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.657 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -163.15 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -125.22 120.94 32.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.52 74.83 1.91 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.893 1.277 . . . . 0.0 107.734 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.99 151.23 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.302 2.241 . . . . 0.0 109.355 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.522 ' HB3' ' CD2' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -128.27 128.68 45.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.435 -2.041 . . . . 0.0 111.165 168.266 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -126.0 141.16 52.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 124.553 1.141 . . . . 0.0 109.058 -171.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.66 111.47 23.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.65 124.06 18.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.45 1.1 . . . . 0.0 111.7 -177.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -94.37 108.58 20.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.92 1.343 . . . . 0.0 108.982 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 60.23 34.86 20.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.823 2.049 . . . . 0.0 114.686 -179.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.46 60.57 2.47 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.742 -1.224 . . . . 0.0 114.367 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m 172.34 120.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.868 2.067 . . . . 0.0 105.574 -175.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.85 -41.44 78.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.217 1.484 . . . . 0.0 107.966 161.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 120.11 22.95 3.08 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.471 170.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' A' ' 44' ' ' VAL . 36.7 pt -111.39 130.24 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.213 -1.169 . . . . 0.0 111.224 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -79.67 112.53 17.03 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.201 1.0 . . . . 0.0 110.576 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 m -84.15 131.15 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -123.11 166.73 14.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.618 -1.927 . . . . 0.0 109.824 176.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.69 -150.83 31.61 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.787 1.185 . . . . 0.0 113.857 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.49 166.05 16.16 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 125.49 1.519 . . . . 0.0 110.556 -177.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.551 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.268 1.8 tp -115.3 162.04 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.776 0.798 . . . . 0.0 109.454 -172.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -142.69 154.07 43.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -169.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG11 ' CD1' ' A' ' 47' ' ' ILE . 6.6 t -90.1 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.965 -1.709 . . . . 0.0 111.988 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -90.47 -48.37 7.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.519 -1.363 . . . . 0.0 111.169 176.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.05 128.72 18.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.003 0.906 . . . . 0.0 112.217 -172.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.535 ' CD1' HG11 ' A' ' 44' ' ' VAL . 43.7 mm -92.68 134.24 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.205 2.202 . . . . 0.0 109.175 178.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.553 HD12 ' CA ' ' A' ' 26' ' ' GLY . 29.6 mt . . . . . 0 N--CA 1.43 -1.429 0 C-N-CA 125.132 1.373 . . . . 0.0 109.911 175.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 121.132 0.491 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.55 -41.31 72.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.93 -31.36 71.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.152 -2.217 . . . . 0.0 110.862 170.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.04 5.79 6.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -72.52 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.296 -2.128 . . . . 0.0 105.9 149.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.0 1.0 Allowed Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.862 163.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -79.55 -17.48 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 117.172 0.486 . . . . 0.0 112.309 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.49 133.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.174 2.19 . . . . 0.0 111.67 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.93 -178.94 5.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.895 -1.128 . . . . 0.0 108.763 169.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -86.23 60.42 6.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.923 -2.361 . . . . 0.0 113.258 -174.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.91 -7.52 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 121.086 -1.009 . . . . 0.0 114.787 176.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -76.05 154.12 35.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.399 1.571 . . . . 0.0 114.92 -172.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -102.64 105.83 16.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.406 1.882 . . . . 0.0 108.79 -173.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.37 113.14 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.8 -1.813 . . . . 0.0 108.949 -179.391 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.42 -29.0 13.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.137 1.375 . . . . 0.0 113.41 -173.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 155.18 38.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 119.984 1.266 . . . . 0.0 112.745 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 92' ' ' VAL . 13.5 t -132.98 119.0 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.595 -0.691 . . . . 0.0 111.175 -177.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 56.09 31.98 19.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 120.409 1.459 . . . . 0.0 114.027 -168.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.29 9.9 85.62 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.809 -1.182 . . . . 0.0 114.301 -173.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -100.26 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.4 p -60.42 138.1 58.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.83 31.77 0.84 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.76 -1.213 . . . . 0.0 112.15 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.72 76.13 1.55 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.201 2.201 . . . . 0.0 110.941 -177.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.99 5.79 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 125.047 1.308 . . . . 0.0 114.44 -170.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.59 139.08 31.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.021 1.911 . . . . 0.0 112.587 177.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t -112.13 -165.26 0.98 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.458 2.303 . . . . 0.0 105.95 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -53.9 -57.68 10.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.391 1.876 . . . . 0.0 113.641 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -69.62 -46.99 64.96 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 111.987 -174.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -48.64 66.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.918 1.687 . . . . 0.0 113.572 173.272 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.61 86.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.208 -1.558 . . . . 0.0 114.609 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.79 -47.97 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.35 1.06 . . . . 0.0 112.193 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -68.47 -29.23 67.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.251 -1.531 . . . . 0.0 114.158 177.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.6 m -68.55 -26.3 65.35 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.948 1.699 . . . . 0.0 113.194 174.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.51 -48.66 6.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.341 1.457 . . . . 0.0 113.58 172.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -82.61 -36.97 25.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -172.103 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.01 29.26 1.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.31 1.868 . . . . 0.0 112.594 -172.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.4 p -88.76 -168.35 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.373 3.069 . . . . 0.0 109.933 175.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.52 -110.85 3.02 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.211 -1.555 . . . . 0.0 111.547 175.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -102.12 -61.17 1.42 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.863 0.831 . . . . 0.0 112.567 -176.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.64 125.86 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.765 1.269 . . . . 0.0 110.45 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 68' ' ' VAL . 8.1 t -109.92 111.51 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 125.395 1.478 . . . . 0.0 107.833 165.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 17' ' ' GLU . 78.5 m80 -79.87 112.26 16.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.773 -1.204 . . . . 0.0 108.643 166.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mt -94.28 112.96 24.79 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.054 1.342 . . . . 0.0 109.015 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.45 101.01 13.69 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.05 143.61 34.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.489 2.315 . . . . 0.0 110.182 -175.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -122.66 143.57 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.197 1.399 . . . . 0.0 109.95 173.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 119.807 3.262 . . . . 0.0 119.807 -175.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.6 tp . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.466 6.9 m 43.57 87.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 128.789 2.836 . . . . 0.0 117.439 170.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 77.1 m -129.37 120.82 26.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -176.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -78.86 121.98 25.51 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.314 1.446 . . . . 0.0 109.501 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 -171.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.35 132.69 48.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.562 1.145 . . . . 0.0 108.489 174.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 84.86 2.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.207 1.003 . . . . 0.0 109.569 175.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.96 155.0 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.479 1.911 . . . . 0.0 109.644 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -130.54 118.82 21.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.287 -2.133 . . . . 0.0 110.097 165.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.3 mt -122.36 154.47 37.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.937 -1.102 . . . . 0.0 109.975 -174.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.95 119.64 39.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.1 0.952 . . . . 0.0 109.223 162.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 123.43 19.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.992 1.317 . . . . 0.0 113.025 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -90.1 115.12 27.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.777 -1.202 . . . . 0.0 109.501 -175.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 52.43 42.63 31.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.317 1.847 . . . . 0.0 114.915 -172.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.57 43.17 53.41 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.271 0.938 . . . . 0.0 115.342 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -166.74 113.49 0.82 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -170.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' B' ' 210' ' ' VAL . 6.0 mt -75.07 -28.79 60.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.118 -1.614 . . . . 0.0 107.443 169.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.35 13.09 11.02 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.988 168.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.0 pt -114.75 125.76 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 118.226 1.013 . . . . 0.0 110.454 -171.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -80.86 121.77 26.38 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.509 1.124 . . . . 0.0 113.536 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.19 132.47 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -127.96 170.57 12.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.509 1.524 . . . . 0.0 109.045 169.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.43 -123.08 6.31 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.291 1.424 . . . . 0.0 113.734 178.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.15 155.17 27.53 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 121.681 -0.893 . . . . 0.0 112.993 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.43 -1.441 0 O-C-N 120.881 -1.364 . . . . 0.0 112.794 -177.968 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.7 0 CA-C-O 122.023 0.791 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -123.32 161.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 170.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -132.71 152.03 51.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.78 -1.825 . . . . 0.0 106.647 -171.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 47' ' ' ILE . 47.6 t -91.27 119.43 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 120.04 -1.663 . . . . 0.0 108.973 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -82.91 -60.33 2.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.605 -1.309 . . . . 0.0 110.833 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.91 132.28 56.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.26 1.029 . . . . 0.0 110.838 -176.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.492 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.3 mm -94.6 131.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 164.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 111.685 179.202 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 121.962 0.886 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.9 64.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.48 -41.43 80.68 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.306 -1.496 . . . . 0.0 111.468 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -73.6 6.27 3.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.348 2.259 . . . . 0.0 116.496 -177.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.55 -82.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.405 -2.06 . . . . 0.0 107.742 152.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.55 -32.64 1.11 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 170.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -83.92 -15.8 46.6 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.072 0.949 . . . . 0.0 113.162 -172.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.87 133.01 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.941 1.696 . . . . 0.0 110.989 173.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 61' ' ' LYS . 4.3 t-160 -131.55 -172.71 2.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.285 1.434 . . . . 0.0 109.936 173.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.404 ' H ' ' CD2' ' A' ' 60' ' ' HIS . 55.5 mtmt -85.95 113.06 21.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.876 -1.765 . . . . 0.0 109.898 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.23 10.8 12.98 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.354 0.978 . . . . 0.0 114.946 -175.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.25 164.09 20.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.465 1.506 . . . . 0.0 112.826 176.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -116.3 121.39 41.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.668 2.387 . . . . 0.0 111.647 -173.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.07 122.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.512 1.525 . . . . 0.0 107.895 174.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 -39.88 8.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 120.255 -1.528 . . . . 0.0 112.309 175.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.98 159.94 42.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.787 1.176 . . . . 0.0 113.783 -176.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 92' ' ' VAL . 79.7 t -132.01 119.8 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 124.378 1.071 . . . . 0.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 56.82 25.11 9.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.258 -1.527 . . . . 0.0 115.034 -171.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.74 -2.98 84.88 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.12 1.343 . . . . 0.0 114.6 -171.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.6 t -93.86 100.46 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 0.0 108.361 -174.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t -70.29 137.37 50.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.315 1.446 . . . . 0.0 113.497 -178.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.92 52.16 1.45 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.099 2.16 . . . . 0.0 112.403 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -79.25 119.06 21.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.005 1.322 . . . . 0.0 109.925 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 14.03 75.31 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.886 -1.134 . . . . 0.0 114.959 -175.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.51 138.78 31.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.855 1.312 . . . . 0.0 112.299 -177.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.3 p -101.11 -162.55 0.95 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.682 1.993 . . . . 0.0 109.699 -174.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -59.84 -54.07 50.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.977 -1.702 . . . . 0.0 112.001 164.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -71.59 -41.13 69.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.498 -0.751 . . . . 0.0 112.869 -176.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -40.5 96.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 175.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.37 95.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.888 -1.758 . . . . 0.0 114.584 173.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -53.8 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 119.123 0.874 . . . . 0.0 111.189 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -64.58 -36.73 85.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.878 2.471 . . . . 0.0 113.643 176.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.94 -26.96 18.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.305 1.842 . . . . 0.0 115.269 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HB2' HG21 ' B' ' 210' ' ' VAL . 3.7 tmt_? -83.97 -52.8 6.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.423 1.889 . . . . 0.0 112.489 -176.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -93.68 63.77 3.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 110.695 -175.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.2 p -96.14 -129.65 0.16 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.006 1.322 . . . . 0.0 111.815 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.29 57.36 0.43 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 64.08 -54.4 0.25 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.785 3.234 . . . . 0.0 114.47 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.35 124.99 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.572 1.177 . . . . 0.0 110.156 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 68' ' ' VAL . 85.0 t -110.92 106.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 168.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -77.97 102.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.942 -1.099 . . . . 0.0 108.952 166.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.43 118.31 24.88 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.577 -1.327 . . . . 0.0 110.475 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.96 100.92 13.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 148.86 25.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.481 1.512 . . . . 0.0 109.991 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -164.04 1.08 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.038 2.135 . . . . 0.0 107.562 173.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.429 -1.512 0 O-C-N 119.259 -2.151 . . . . 0.0 112.282 159.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.3 tp . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.673 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.38 2.4 t 25.52 101.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.188 4.195 . . . . 0.0 118.568 163.604 . . . . . . . . 4 3 . 1 . 024 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 2.6 p -144.92 116.02 7.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -172.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.4 p -75.25 130.2 38.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.382 1.073 . . . . 0.0 110.424 174.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 86' ' ' ARG . 2.8 p . . . . . 0 C--O 1.261 1.682 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -171.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 122.489 1.137 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.26 1.6 m-30 -107.67 144.01 35.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -118.51 77.41 1.17 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 158.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.47 112.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.917 2.087 . . . . 0.0 107.098 -168.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.71 135.36 54.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.935 -1.728 . . . . 0.0 112.719 -175.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.15 178.3 9.42 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.344 -0.847 . . . . 0.0 108.9 -171.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.05 139.2 52.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.841 -1.162 . . . . 0.0 111.461 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 144.22 28.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.18 -1.575 . . . . 0.0 111.305 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -96.89 102.22 13.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.771 -1.206 . . . . 0.0 109.317 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.32 61.98 2.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -171.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.53 49.74 63.14 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.845 -1.159 . . . . 0.0 114.201 178.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.4 t -168.3 96.58 0.41 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.732 1.73 . . . . 0.0 107.319 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.02 -46.52 56.85 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.048 2.139 . . . . 0.0 106.514 166.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.66 39.93 0.96 Allowed Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.708 175.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.52 130.0 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.946 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -84.65 113.76 21.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.09 1.356 . . . . 0.0 112.072 170.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.81 125.65 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -175.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -122.71 164.04 19.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.656 1.982 . . . . 0.0 109.367 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.41 17.26 Favored Glycine 0 N--CA 1.431 -1.683 0 C-N-CA 124.71 1.148 . . . . 0.0 112.547 178.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.93 165.26 34.14 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.246 0.926 . . . . 0.0 111.565 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.429 -1.476 0 O-C-N 120.467 -1.607 . . . . 0.0 113.492 -179.169 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.754 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 42' ' ' ILE 0.274 4.0 tp -110.3 163.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.973 -1.31 . . . . 0.0 108.181 173.423 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -137.39 161.91 35.02 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.915 -1.74 . . . . 0.0 107.0 -174.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.55 HG11 ' CD1' ' A' ' 47' ' ' ILE . 2.2 t -89.91 125.86 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.296 -1.503 . . . . 0.0 111.841 173.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -82.13 -51.84 7.58 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.732 -1.23 . . . . 0.0 109.948 166.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.62 32.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.763 1.225 . . . . 0.0 110.443 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.55 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.4 mm -91.51 121.57 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.431 -1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 110.229 179.216 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 121.388 0.614 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -51.49 57.5 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.741 2.016 . . . . 0.0 115.119 -176.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.72 -41.87 82.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.276 1.036 . . . . 0.0 111.373 173.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -69.19 -5.52 23.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -178.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.89 -101.22 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.329 2.331 . . . . 0.0 110.457 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.31 -97.71 0.96 Allowed Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.211 -1.556 . . . . 0.0 112.805 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -133.99 26.08 3.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.999 -0.706 . . . . 0.0 112.744 -156.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 mt -87.11 127.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.86 -1.775 . . . . 0.0 113.427 -170.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -143.85 155.02 43.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 163.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -62.78 148.76 45.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -153.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.73 23.61 7.07 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -103.02 172.95 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.725 1.762 . . . . 0.0 112.693 174.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -98.34 136.5 38.41 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.368 1.067 . . . . 0.0 110.738 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.35 101.89 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.034 2.934 . . . . 0.0 105.01 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.253 0.9 OUTLIER -98.02 -38.18 9.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.235 -2.166 . . . . 0.0 114.827 -173.946 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 145.21 27.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.236 1.38 . . . . 0.0 113.49 -176.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.23 116.02 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 O-C-N 120.994 -1.066 . . . . 0.0 111.914 -171.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 55.59 33.99 22.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.222 1.409 . . . . 0.0 113.677 -170.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.42 25.71 62.82 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 113.495 -176.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.9 t -123.63 100.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.82 38.34 0.7 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.913 1.685 . . . . 0.0 114.189 -173.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -82.81 111.1 18.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.486 -2.009 . . . . 0.0 110.718 175.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 8.95 68.87 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.947 -1.095 . . . . 0.0 113.083 -175.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.12 155.02 17.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.985 1.374 . . . . 0.0 110.067 171.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.567 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 71.2 p -106.87 -170.34 1.7 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.426 1.89 . . . . 0.0 108.718 -172.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -57.29 -49.95 74.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.762 -1.211 . . . . 0.0 112.903 161.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -69.9 -43.8 71.0 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 112.215 -176.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.567 ' HB2' ' H ' ' A' ' 77' ' ' THR . 4.7 mp0 -67.19 -34.3 77.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.633 -1.292 . . . . 0.0 112.947 175.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.92 87.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.9 -1.75 . . . . 0.0 114.475 172.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -57.47 -49.19 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.379 -0.825 . . . . 0.0 111.923 172.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.9 -31.28 71.56 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.012 -1.68 . . . . 0.0 114.901 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.6 m -74.93 -27.75 60.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.558 1.943 . . . . 0.0 112.714 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.89 -43.69 10.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.297 1.839 . . . . 0.0 112.892 174.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -84.24 -34.38 23.88 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -172.612 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -86.1 35.31 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.512 -1.992 . . . . 0.0 112.309 -176.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.6 p -93.69 163.25 13.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.142 2.577 . . . . 0.0 113.483 -176.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.75 59.57 4.9 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 125.065 1.317 . . . . 0.0 114.268 -176.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.259 46.4 tt0 68.09 -53.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.617 2.767 . . . . 0.0 114.634 -174.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -76.37 136.33 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.169 1.388 . . . . 0.0 110.721 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.15 101.39 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.65 1.98 . . . . 0.0 107.165 171.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -82.29 97.61 8.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.815 2.446 . . . . 0.0 108.58 170.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.04 113.24 21.97 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.913 0.863 . . . . 0.0 111.462 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -84.47 102.73 13.03 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 163.347 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.16 152.8 24.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.991 1.316 . . . . 0.0 108.053 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.0 125.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.036 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tptt . . . . . 0 N--CA 1.429 -1.486 0 C-N-CA 124.849 1.26 . . . . 0.0 112.148 -178.124 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.397 2.7 t 72.58 115.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.768 2.223 . . . . 0.0 115.511 164.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 73.0 m -141.53 123.23 15.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -77.14 124.06 27.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.26 1.615 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -162.566 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 122.488 1.137 . . . . 0.0 113.802 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -132.02 118.86 20.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.874 1.27 . . . . 0.0 108.921 173.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 86.45 5.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.268 1.427 . . . . 0.0 109.146 173.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.97 156.85 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.211 2.204 . . . . 0.0 109.982 178.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 93' ' ' HIS . 0.8 OUTLIER -126.85 132.77 50.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.616 -1.927 . . . . 0.0 107.159 166.728 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.6 mt -129.46 153.37 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.013 -1.054 . . . . 0.0 109.572 -177.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.52 110.01 17.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.434 1.094 . . . . 0.0 109.067 166.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 24' ' ' SER . 15.5 ptpt -60.04 141.31 55.92 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 127.77 2.428 . . . . 0.0 114.746 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 t -101.57 113.76 27.17 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.698 -1.251 . . . . 0.0 109.344 -174.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 58.76 -18.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 129.189 2.995 . . . . 0.0 118.171 -169.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.19 59.32 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.847 1.689 . . . . 0.0 109.27 -178.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.491 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 95.4 p -178.2 120.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -173.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' B' ' 210' ' ' VAL . 9.8 mt -79.45 -40.02 30.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.436 1.894 . . . . 0.0 106.586 168.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 48' ' ' ILE . . . 118.06 29.3 2.02 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.035 1.303 . . . . 0.0 111.988 171.304 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 pt -114.78 131.03 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.632 174.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 m -83.91 117.07 23.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.236 0.614 . . . . 0.0 111.04 162.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.67 132.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -128.28 163.55 24.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.102 2.161 . . . . 0.0 109.608 174.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.35 -137.36 13.26 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 125.279 1.419 . . . . 0.0 111.788 -177.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 155.63 28.07 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.429 -1.478 0 O-C-N 120.546 -1.561 . . . . 0.0 114.06 -178.148 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.464 HG22 HG13 ' A' ' 65' ' ' VAL 0.255 2.2 tp -120.49 162.1 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 118.049 0.924 . . . . 0.0 109.078 -166.621 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -142.08 162.11 36.31 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 -171.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 47' ' ' ILE . 3.3 t -88.36 132.31 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.679 -1.263 . . . . 0.0 111.769 172.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -88.52 -46.85 8.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.529 -1.357 . . . . 0.0 110.554 170.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.02 134.02 24.08 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.067 -1.021 . . . . 0.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.471 HD13 HG11 ' A' ' 44' ' ' VAL . 27.3 mm -93.84 128.92 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.433 1.493 . . . . 0.0 108.725 173.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.428 HD11 ' HA2' ' A' ' 26' ' ' GLY . 2.6 pt . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 121.184 -0.948 . . . . 0.0 110.836 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.426 0.631 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.78 66.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.009 1.323 . . . . 0.0 113.84 -178.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -56.76 -34.17 67.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.968 1.307 . . . . 0.0 112.504 167.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -70.27 -5.46 27.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.97 -79.27 0.06 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 118.643 -2.536 . . . . 0.0 108.061 159.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.33 -20.14 3.36 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 169.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -85.31 -32.99 22.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.887 -0.772 . . . . 0.0 111.537 177.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.6 mt -65.86 125.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.735 1.614 . . . . 0.0 113.097 178.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.465 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 17.3 t60 -136.71 177.9 7.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.319 1.056 . . . . 0.0 109.954 171.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 30.1 pttt -79.74 58.9 2.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.852 -1.78 . . . . 0.0 115.347 -172.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.32 -10.32 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.188 1.375 . . . . 0.0 113.238 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -78.62 154.35 30.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 118.611 1.206 . . . . 0.0 113.427 -173.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 138.74 32.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.408 1.483 . . . . 0.0 107.465 175.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -113.42 115.68 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 161.654 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.76 -30.53 11.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 113.412 -172.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 153.52 38.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.02 0.827 . . . . 0.0 112.584 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 92' ' ' VAL . 11.6 t -135.75 120.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.453 0.701 . . . . 0.0 112.173 -175.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 55.5 33.87 21.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.432 -1.417 . . . . 0.0 114.203 -168.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.67 11.72 85.06 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 120.68 -1.263 . . . . 0.0 113.538 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.64 100.3 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -60.75 135.2 57.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.078 1.751 . . . . 0.0 113.306 174.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.6 mt -68.96 -49.35 58.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.445 -0.785 . . . . 0.0 112.476 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 46.39 27.79 0.64 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.939 2.94 . . . . 0.0 118.939 166.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.61 27.91 0.93 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.268 -1.52 . . . . 0.0 112.885 -169.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.86 146.05 26.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.803 -1.41 . . . . 0.0 110.702 175.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -94.83 -167.7 1.69 Allowed 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.719 1.608 . . . . 0.0 109.148 -178.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -61.52 -50.2 73.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.029 -1.669 . . . . 0.0 112.151 165.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.19 -49.41 74.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -38.11 89.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.1 -1.0 . . . . 0.0 113.286 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.23 96.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.034 -1.666 . . . . 0.0 114.983 172.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.55 -54.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.465 173.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -49.72 -43.11 47.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.245 1.384 . . . . 0.0 114.555 175.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.6 m -68.22 -27.45 66.38 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.272 2.229 . . . . 0.0 114.882 -178.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.3 -41.43 10.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.87 -1.769 . . . . 0.0 113.78 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -53.89 6.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.557 2.343 . . . . 0.0 114.214 -169.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.51 36.43 0.75 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.509 1.623 . . . . 0.0 111.96 -168.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.2 p -93.44 -172.48 2.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.588 2.755 . . . . 0.0 109.636 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.11 -90.48 0.48 Allowed Glycine 0 N--CA 1.429 -1.818 0 O-C-N 119.86 -1.775 . . . . 0.0 112.599 174.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -142.99 -50.15 0.34 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.747 1.219 . . . . 0.0 110.013 -175.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.64 131.52 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.173 -1.579 . . . . 0.0 110.129 172.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 68' ' ' VAL . 2.4 t -122.3 112.54 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 71.1 m80 -76.52 113.28 13.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.647 -1.283 . . . . 0.0 108.806 163.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mt -94.83 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.978 -1.077 . . . . 0.0 108.766 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.43 102.77 15.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.07 150.67 23.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.049 2.139 . . . . 0.0 111.358 -177.458 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -127.38 136.35 51.74 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.261 1.024 . . . . 0.0 108.878 169.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 127.234 2.214 . . . . 0.0 114.445 -175.115 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 N--CA 1.429 -1.475 0 CA-C-O 121.588 0.708 . . . . 0.0 112.572 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.422 1.4 t 77.6 102.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 124.584 2.135 . . . . 0.0 113.311 171.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 89.4 m -136.72 119.68 16.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -171.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.5 p -75.1 129.23 37.21 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.984 1.313 . . . . 0.0 109.253 174.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 8.5 p . . . . . 0 C--O 1.26 1.63 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 -162.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 122.139 0.971 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.69 137.79 53.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.744 1.618 . . . . 0.0 107.823 176.046 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -114.44 82.9 1.79 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.216 1.484 . . . . 0.0 108.802 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.12 142.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.0 2.12 . . . . 0.0 109.083 -178.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.34 123.53 44.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.037 -2.289 . . . . 0.0 109.2 170.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.35 162.06 19.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.064 0.946 . . . . 0.0 108.778 -176.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 125.0 53.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 157.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' HB2' ' H ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -61.48 136.69 58.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.038 1.335 . . . . 0.0 112.025 169.224 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -90.71 95.45 10.15 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.354 1.55 . . . . 0.0 108.682 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 62.54 -17.71 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.724 2.861 . . . . 0.0 118.724 -171.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.2 62.56 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.846 -1.784 . . . . 0.0 109.919 -178.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 45.7 t 167.8 104.46 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -162.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.8 mt -75.17 -41.59 57.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 161.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 41.44 1.09 Allowed Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.676 171.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 47' ' ' ILE . 6.5 pt -119.45 129.04 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 121.653 0.74 . . . . 0.0 110.297 171.211 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' HG13 ' B' ' 207' ' ' VAL . 63.6 m -82.29 113.95 20.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.294 1.037 . . . . 0.0 110.481 167.251 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.38 129.78 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -128.82 166.37 19.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.004 1.722 . . . . 0.0 110.373 176.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.35 -157.35 46.21 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 125.118 1.342 . . . . 0.0 111.463 -170.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.35 151.68 8.95 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.869 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -170.042 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.714 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 tp -125.26 155.84 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -139.14 156.43 47.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -166.073 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.6 137.87 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 119.096 -2.252 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.08 -64.65 1.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.414 -1.429 . . . . 0.0 108.529 160.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.44 136.62 50.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.245 1.018 . . . . 0.0 110.785 -175.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 27' ' ' ILE . 36.5 mm -89.81 118.99 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.667 1.587 . . . . 0.0 107.424 169.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 pt . . . . . 0 N--CA 1.429 -1.49 0 CA-C-O 117.728 -1.13 . . . . 0.0 111.776 -177.673 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 120.89 0.376 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -48.86 36.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.463 1.905 . . . . 0.0 114.639 -174.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.22 -39.51 56.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.071 1.415 . . . . 0.0 111.789 169.07 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -67.83 -2.76 7.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -67.72 -90.99 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.2 2.273 . . . . 0.0 109.145 164.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.79 -35.34 0.5 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 111.615 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.61 -25.85 35.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.791 -0.829 . . . . 0.0 113.113 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.06 131.26 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.068 -1.645 . . . . 0.0 112.339 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -136.58 179.25 6.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.983 -1.073 . . . . 0.0 108.795 167.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -84.54 49.15 1.63 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.231 -1.543 . . . . 0.0 114.905 -167.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.41 19.64 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.899 -1.75 . . . . 0.0 114.057 176.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.33 179.99 4.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.028 -1.277 . . . . 0.0 112.425 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -113.01 142.54 45.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.768 2.027 . . . . 0.0 109.088 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.78 133.9 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.324 -1.485 . . . . 0.0 108.126 165.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.59 -30.48 5.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.556 -1.34 . . . . 0.0 113.93 -173.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 157.25 42.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.162 1.346 . . . . 0.0 113.452 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 92' ' ' VAL . 92.8 t -137.99 123.27 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 123.821 0.848 . . . . 0.0 110.955 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 52.67 33.89 14.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.61 1.564 . . . . 0.0 114.641 -173.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.89 23.46 69.29 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.065 -1.022 . . . . 0.0 113.512 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.12 100.07 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 124.333 1.053 . . . . 0.0 108.392 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.09 142.61 41.75 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.928 2.091 . . . . 0.0 115.468 173.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.45 -56.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.624 -1.297 . . . . 0.0 111.555 176.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 43.24 43.97 4.3 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 169.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 45.16 0.97 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 120.819 -1.176 . . . . 0.0 110.679 -168.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.57 144.69 28.37 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.443 -1.033 . . . . 0.0 108.918 171.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.6 p -97.01 -160.98 0.84 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.481 1.512 . . . . 0.0 109.946 -175.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.42 -49.9 65.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.951 -1.718 . . . . 0.0 110.802 167.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -66.5 -46.93 74.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 112.775 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.71 -33.01 71.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.48 91.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.465 -2.022 . . . . 0.0 113.533 170.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.59 -52.38 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 118.885 -0.579 . . . . 0.0 111.314 172.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -47.24 -45.16 23.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 171.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -73.64 -27.47 61.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.95 1.3 . . . . 0.0 112.368 -171.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.27 -48.12 7.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.077 1.751 . . . . 0.0 114.51 172.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -48.24 17.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.956 2.103 . . . . 0.0 113.402 -173.287 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.38 31.41 0.82 Allowed 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.859 -1.776 . . . . 0.0 112.426 -166.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.3 p -83.04 -168.06 1.92 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.283 3.433 . . . . 0.0 109.388 171.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.5 -108.08 0.53 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.383 -1.448 . . . . 0.0 110.723 170.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -120.18 -44.87 2.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.567 1.147 . . . . 0.0 110.436 174.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -72.72 129.89 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.449 1.119 . . . . 0.0 112.116 173.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 68' ' ' VAL . 45.8 t -129.76 99.87 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 126.415 1.886 . . . . 0.0 108.116 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -78.02 98.62 5.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.552 1.941 . . . . 0.0 110.312 168.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -84.79 113.16 21.14 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.455 1.902 . . . . 0.0 109.911 -175.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 98.36 11.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 168.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.06 147.97 25.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.364 1.865 . . . . 0.0 109.717 -177.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.97 132.97 56.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.702 1.239 . . . . 0.0 108.236 167.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? . . . . . 0 N--CA 1.43 -1.429 0 C-N-CA 124.862 1.265 . . . . 0.0 109.79 176.56 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 tp . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 28' ' ' SER 0.398 2.2 t 67.86 104.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 124.924 2.297 . . . . 0.0 114.378 169.819 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 34.1 m -140.24 122.76 16.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.612 -3.107 . . . . 0.0 102.612 -171.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.3 p -80.55 121.29 25.62 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.984 0.914 . . . . 0.0 109.986 175.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.0 m . . . . . 0 C--O 1.259 1.579 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -169.488 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 122.521 1.153 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.38 128.25 41.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -103.25 81.24 1.92 Allowed 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.609 1.195 . . . . 0.0 108.316 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.95 109.11 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 126.926 2.091 . . . . 0.0 112.543 -173.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 124.64 44.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.92 -1.738 . . . . 0.0 109.384 -177.061 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.1 mt -134.93 158.73 43.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 109.045 -171.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.28 43.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 162.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -63.18 146.51 53.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.885 -1.134 . . . . 0.0 113.37 -175.136 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -92.41 88.66 6.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.963 1.364 . . . . 0.0 107.381 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 t0 44.99 64.98 1.2 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.18 2.592 . . . . 0.0 117.108 -177.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 52.8 6.02 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.634 -1.291 . . . . 0.0 114.119 179.154 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 3.9 m 177.33 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.166 1.386 . . . . 0.0 108.618 -169.354 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.39 -45.68 45.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.248 1.819 . . . . 0.0 107.426 163.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.88 47.06 0.85 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 125.444 1.497 . . . . 0.0 111.054 177.1 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 pt -128.8 131.65 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.39 0.614 . . . . 0.0 109.429 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.1 m -91.05 113.03 25.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.434 1.094 . . . . 0.0 111.95 171.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.6 m -80.85 140.13 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -172.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -130.67 168.18 17.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.098 1.759 . . . . 0.0 109.602 172.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.85 -150.23 34.02 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.977 1.275 . . . . 0.0 114.08 -177.1 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 161.44 21.76 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 125.439 1.495 . . . . 0.0 109.602 -179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 120.094 -1.827 . . . . 0.0 115.136 -171.562 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 CA-C-O 121.415 0.453 . . . . 0.0 113.584 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 65' ' ' VAL 0.287 3.9 tp -124.33 156.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 120.103 -1.821 . . . . 0.0 106.826 170.659 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.09 151.63 52.01 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -170.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 47' ' ' ILE . 16.0 t -85.87 130.91 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.403 -2.061 . . . . 0.0 110.524 176.252 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -90.23 -45.96 8.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.035 -1.666 . . . . 0.0 110.379 168.192 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 143.87 33.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.605 1.193 . . . . 0.0 112.784 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.601 ' CD1' HG11 ' A' ' 44' ' ' VAL . 47.8 mm -105.02 116.97 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.513 2.725 . . . . 0.0 108.001 -176.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 120.539 -1.351 . . . . 0.0 112.653 -177.007 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 -49.0 50.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.955 1.702 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.17 -29.98 70.74 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.454 -1.403 . . . . 0.0 111.929 173.023 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 m -69.72 -2.36 11.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 176.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.95 -80.9 0.05 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 120.872 1.669 . . . . 0.0 107.427 157.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.62 -33.94 0.82 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.25 -0.906 . . . . 0.0 111.413 165.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -72.25 -26.49 62.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -169.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.02 141.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.706 1.202 . . . . 0.0 114.125 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -134.21 -166.93 1.87 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.607 -1.308 . . . . 0.0 110.783 165.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -80.84 135.34 35.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.041 -1.662 . . . . 0.0 110.337 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.65 2.34 72.8 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.076 -1.64 . . . . 0.0 114.642 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.21 151.52 39.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.437 1.119 . . . . 0.0 111.682 176.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -106.19 114.46 28.6 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.419 1.087 . . . . 0.0 109.357 -167.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 42' ' ' ILE . 3.3 p -92.89 120.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.132 -1.605 . . . . 0.0 108.814 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.04 -39.84 9.95 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.651 -1.281 . . . . 0.0 111.544 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.63 149.23 34.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 92' ' ' VAL . 10.7 t -129.59 117.73 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 O-C-N 120.804 -1.185 . . . . 0.0 113.061 -173.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 0.4 OUTLIER 46.62 37.54 4.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.277 2.231 . . . . 0.0 115.754 -169.863 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.24 5.88 57.93 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 114.201 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -121.87 105.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 118.346 1.073 . . . . 0.0 110.366 -168.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 t -60.74 139.24 57.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.759 172.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.84 60.33 2.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.911 2.084 . . . . 0.0 111.614 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.01 105.26 10.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.081 2.153 . . . . 0.0 111.796 -169.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.93 21.03 79.15 Favored Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.813 -1.179 . . . . 0.0 114.026 -175.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.27 141.07 29.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.161 -1.2 . . . . 0.0 113.165 -175.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -104.57 -156.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.591 2.356 . . . . 0.0 109.66 -174.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.97 -50.94 44.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.707 -1.871 . . . . 0.0 111.384 168.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.72 -51.76 68.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 112.337 174.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.83 -36.07 82.71 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.006 -1.059 . . . . 0.0 113.846 -175.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.15 92.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.156 -1.59 . . . . 0.0 114.953 171.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.05 -49.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 110.764 174.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.36 -26.12 67.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.891 -1.756 . . . . 0.0 114.902 178.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -75.97 -27.98 57.7 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.158 1.783 . . . . 0.0 113.172 176.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.6 mt -89.63 -47.72 7.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.227 -1.545 . . . . 0.0 113.963 173.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 -37.1 22.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.695 1.598 . . . . 0.0 114.072 -170.277 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.55 37.58 0.92 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.979 -1.701 . . . . 0.0 111.274 -172.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.5 p -100.17 179.41 4.49 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.132 3.373 . . . . 0.0 111.555 -179.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.94 -136.68 4.22 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.611 -1.306 . . . . 0.0 112.871 173.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -85.06 -62.42 1.54 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.802 -1.411 . . . . 0.0 111.869 -177.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -75.75 124.28 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.89 1.329 . . . . 0.0 111.787 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 68' ' ' VAL . 13.5 t -114.99 114.94 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 167.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -87.35 110.66 20.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.12 111.14 20.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.585 -1.322 . . . . 0.0 110.253 174.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 98.36 10.97 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.4 mt -104.97 137.92 41.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.968 2.507 . . . . 0.0 110.759 -173.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.6 148.05 42.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.235 1.814 . . . . 0.0 108.545 170.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 176.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 7.8 tp . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.462 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.452 5.7 m 46.06 76.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 128.058 2.543 . . . . 0.0 117.311 171.107 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.1 m -117.78 117.86 30.48 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 69.3 p -78.86 117.98 20.47 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.017 1.327 . . . . 0.0 111.323 178.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -171.567 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.43 -1.427 0 CA-C-O 122.439 1.114 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 117.46 33.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.218 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.53 89.05 7.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.985 1.85 . . . . 0.0 109.513 170.4 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.36 150.77 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.388 1.875 . . . . 0.0 108.358 176.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.79 130.7 34.45 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.799 -1.813 . . . . 0.0 109.164 168.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.08 165.42 36.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.223 1.011 . . . . 0.0 111.718 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.18 132.77 45.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.578 1.151 . . . . 0.0 110.355 170.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HB3' HD23 ' A' ' 25' ' ' LEU . 5.5 ptpt -70.49 164.27 25.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 0.0 112.374 177.189 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 t -114.64 96.94 5.99 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.532 -1.355 . . . . 0.0 109.36 -179.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 53.08 55.08 9.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.011 2.125 . . . . 0.0 115.399 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.74 48.75 16.06 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 114.001 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 p -178.58 119.32 0.08 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 20' ' ' LYS . 10.8 mt -74.66 -38.19 62.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.91 2.084 . . . . 0.0 106.449 164.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.473 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 120.52 18.25 4.11 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.253 1.406 . . . . 0.0 110.864 168.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 pt -107.93 129.19 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.715 1.245 . . . . 0.0 110.541 -176.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.421 ' HB3' HG22 ' B' ' 207' ' ' VAL . 28.0 m -85.96 113.61 22.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.513 1.125 . . . . 0.0 110.864 173.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.13 131.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -171.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -126.24 164.96 19.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.118 2.167 . . . . 0.0 110.83 177.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -136.18 13.69 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 125.877 1.703 . . . . 0.0 114.009 174.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.52 176.84 49.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 124.662 1.125 . . . . 0.0 114.457 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.429 -1.49 0 C-N-CA 127.521 2.328 . . . . 0.0 115.343 -172.263 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.765 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.42 HG22 HG13 ' A' ' 65' ' ' VAL 0.264 3.1 tp -145.52 164.53 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 161.121 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -145.53 157.49 43.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -168.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.498 HG11 HD13 ' A' ' 47' ' ' ILE . 7.8 t -90.06 130.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.015 -1.678 . . . . 0.0 113.208 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -87.73 -53.56 4.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.896 -1.128 . . . . 0.0 111.375 170.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.76 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.035 0.921 . . . . 0.0 111.472 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.498 HD13 HG11 ' A' ' 44' ' ' VAL . 39.6 mm -98.39 137.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.522 2.329 . . . . 0.0 107.787 172.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.473 HD12 ' CA ' ' A' ' 26' ' ' GLY . 59.3 mt . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 116.827 -1.559 . . . . 0.0 108.426 176.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.58 -33.68 75.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.459 2.762 . . . . 0.0 118.459 -171.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.0 -35.25 80.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.088 -2.882 . . . . 0.0 111.014 171.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -74.34 0.54 14.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -72.48 -51.72 18.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.672 -1.893 . . . . 0.0 109.941 168.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.09 -73.76 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.798 158.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.96 -19.24 63.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -166.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.5 133.06 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 121.748 2.067 . . . . 0.0 115.575 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -129.49 178.71 6.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.555 1.542 . . . . 0.0 111.718 172.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -83.03 124.75 30.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.213 -1.555 . . . . 0.0 109.523 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.15 52.98 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 121.118 -0.989 . . . . 0.0 113.933 -173.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -81.83 165.04 21.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.588 1.185 . . . . 0.0 111.896 176.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -107.69 131.15 54.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.678 -172.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 42' ' ' ILE . 2.3 p -106.43 120.49 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.092 -1.63 . . . . 0.0 107.541 163.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.24 -37.59 9.61 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.618 -1.301 . . . . 0.0 112.308 -179.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.13 156.87 43.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 119.467 1.03 . . . . 0.0 113.217 -177.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.71 123.34 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 111.646 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 53.46 32.8 14.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.218 1.372 . . . . 0.0 114.566 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.4 20.65 76.72 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.899 -1.126 . . . . 0.0 114.49 -175.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -115.23 102.61 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.7 m -59.46 135.83 57.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.883 -1.136 . . . . 0.0 112.457 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.95 70.71 2.69 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.0 111.897 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.82 101.26 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.387 1.875 . . . . 0.0 112.349 -174.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.49 38.02 95.65 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.119 -0.988 . . . . 0.0 112.978 -175.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.05 140.52 35.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.417 -1.049 . . . . 0.0 109.706 176.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -114.48 -168.78 1.42 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 103.892 -2.632 . . . . 0.0 103.892 174.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -56.45 -52.88 63.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.91 -1.744 . . . . 0.0 114.168 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -74.14 -41.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.707 1.14 . . . . 0.0 112.315 -174.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -59.45 -47.1 86.77 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 119.957 -1.714 . . . . 0.0 114.449 172.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.41 -29.9 70.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.459 -1.401 . . . . 0.0 114.597 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.5 -56.86 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.43 166.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -51.56 -42.4 61.83 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -61.17 -29.81 70.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.933 2.093 . . . . 0.0 115.012 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -97.74 -33.43 11.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.104 2.162 . . . . 0.0 115.263 173.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -49.44 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.168 2.587 . . . . 0.0 114.147 -169.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -92.91 30.92 1.48 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.564 1.65 . . . . 0.0 111.548 -169.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -87.14 -174.57 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.628 2.771 . . . . 0.0 111.175 -176.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.37 173.44 51.22 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.337 158.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -61.53 -41.22 97.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.691 1.596 . . . . 0.0 113.07 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.23 126.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.939 1.352 . . . . 0.0 111.043 169.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -120.51 105.22 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.607 1.563 . . . . 0.0 107.394 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -77.83 103.55 7.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.605 -1.309 . . . . 0.0 109.542 165.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -89.17 118.4 28.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.744 -1.222 . . . . 0.0 110.429 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.38 95.34 10.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.12 145.61 26.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.885 2.074 . . . . 0.0 110.196 -177.333 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.62 139.23 52.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.772 1.273 . . . . 0.0 110.048 163.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? . . . . . 0 N--CA 1.429 -1.497 0 C-N-CA 126.686 1.994 . . . . 0.0 113.267 177.195 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 28' ' ' SER 0.395 2.3 t 77.09 121.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 163.093 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 20.5 m -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 10.8 p -80.99 122.95 27.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.795 1.638 . . . . 0.0 110.661 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.261 1.664 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 -170.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 121.764 0.792 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -114.01 121.8 44.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.449 1.5 . . . . 0.0 108.806 179.041 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -101.32 75.14 1.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.511 1.524 . . . . 0.0 111.375 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.58 121.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.193 -1.567 . . . . 0.0 114.817 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.72 122.24 39.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.774 -1.829 . . . . 0.0 111.328 175.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.23 170.64 16.33 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.439 1.096 . . . . 0.0 108.578 175.079 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.0 133.49 55.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.423 1.089 . . . . 0.0 109.501 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 155.03 34.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.992 -1.068 . . . . 0.0 111.42 -174.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 t -100.9 100.03 10.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.838 -1.164 . . . . 0.0 109.052 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.265 2.4 m-20 37.81 60.23 1.2 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.536 2.735 . . . . 0.0 117.141 -172.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.6 54.66 5.37 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.969 -1.082 . . . . 0.0 114.198 178.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 m 179.22 109.91 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.237 1.415 . . . . 0.0 107.354 -172.148 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.9 mt -76.84 -44.86 30.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.39 45.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.806 1.193 . . . . 0.0 110.768 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.16 136.94 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 121.553 0.692 . . . . 0.0 110.793 169.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB3' HG13 ' B' ' 207' ' ' VAL . 71.1 m -80.09 110.52 15.57 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.091 1.757 . . . . 0.0 112.442 167.603 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.8 123.47 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -172.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -121.72 171.08 9.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.574 2.349 . . . . 0.0 109.98 176.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.63 -131.01 10.29 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.238 1.399 . . . . 0.0 112.606 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.65 168.73 44.84 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.271 0.939 . . . . 0.0 111.895 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.468 0 C-N-CA 126.161 1.784 . . . . 0.0 115.006 -171.824 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.706 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -110.15 157.71 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -137.01 153.1 50.75 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.016 -1.678 . . . . 0.0 108.056 -169.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.55 HG11 HD13 ' A' ' 47' ' ' ILE . 14.3 t -90.85 117.89 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.41 -1.431 . . . . 0.0 112.074 178.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -81.66 -33.98 31.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.844 -1.16 . . . . 0.0 112.102 177.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.93 146.15 18.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.803 0.811 . . . . 0.0 109.776 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.55 HD13 HG11 ' A' ' 44' ' ' VAL . 44.2 mm -100.76 121.67 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 120.55 -1.344 . . . . 0.0 112.547 -176.069 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.502 0.668 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.72 72.74 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.946 1.698 . . . . 0.0 113.625 -176.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.91 -36.19 62.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.4 -1.437 . . . . 0.0 113.424 165.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 t -75.36 2.31 11.59 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.325 -2.11 . . . . 0.0 107.923 153.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.71 -28.12 1.46 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 170.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 36.8 mtt85 -81.77 -27.61 33.66 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mt -67.02 133.82 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 119.235 0.925 . . . . 0.0 113.436 178.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.23 -178.43 4.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.734 -1.229 . . . . 0.0 109.424 166.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -76.6 103.34 6.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.517 -1.989 . . . . 0.0 111.132 174.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.7 -17.72 1.82 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.783 -1.198 . . . . 0.0 115.505 -173.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.49 156.65 36.69 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 119.918 1.859 . . . . 0.0 115.226 -172.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.19 122.31 45.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.655 1.582 . . . . 0.0 109.513 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.48 114.39 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.94 -38.89 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.403 -1.435 . . . . 0.0 112.939 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.16 160.18 44.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.022 1.283 . . . . 0.0 114.147 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 92' ' ' VAL . 47.0 t -134.3 113.32 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 111.49 -175.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 10.2 p30 43.44 33.98 0.7 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 -163.708 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.07 22.29 59.51 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.575 -1.328 . . . . 0.0 113.383 -177.032 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.99 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 172.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -70.38 144.26 51.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.475 1.131 . . . . 0.0 113.248 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.79 56.38 3.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.727 1.211 . . . . 0.0 110.037 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.27 24.56 0.18 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 128.588 2.755 . . . . 0.0 114.654 -163.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.1 40.21 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.085 1.802 . . . . 0.0 111.173 -176.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.47 148.39 25.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.287 -1.125 . . . . 0.0 111.81 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.609 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 46.6 p -95.91 -159.7 0.74 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.727 2.811 . . . . 0.0 109.872 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -63.96 -54.88 27.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.831 -1.793 . . . . 0.0 112.228 163.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -68.05 -38.7 82.78 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 114.446 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB2' ' H ' ' A' ' 77' ' ' THR . 35.2 mt-30 -68.52 -38.84 81.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.975 -1.703 . . . . 0.0 113.128 174.391 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.41 87.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.79 -1.819 . . . . 0.0 113.597 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.634 1.173 . . . . 0.0 110.751 175.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -51.93 -41.07 61.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 174.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -70.64 -24.66 62.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.705 1.602 . . . . 0.0 113.984 -175.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.85 -40.18 11.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.008 -1.683 . . . . 0.0 114.141 167.288 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -46.76 44.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.181 1.792 . . . . 0.0 114.786 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.88 34.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.935 -1.728 . . . . 0.0 113.496 -170.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.0 p -103.03 153.35 20.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.416 2.286 . . . . 0.0 114.158 -170.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.31 62.08 4.52 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.321 1.439 . . . . 0.0 115.888 -175.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.321 9.8 tt0 64.63 -50.68 0.31 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.354 3.462 . . . . 0.0 116.929 178.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.19 127.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.263 1.506 . . . . 0.0 109.8 173.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 68' ' ' VAL . 47.9 t -120.11 104.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -79.09 102.78 8.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 165.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.526 ' HG ' HG12 ' A' ' 92' ' ' VAL . 14.9 mt -87.59 113.85 23.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 110.39 -175.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.12 95.78 10.28 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.7 141.21 36.46 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.543 2.337 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.79 139.02 45.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.813 1.245 . . . . 0.0 109.287 167.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? . . . . . 0 N--CA 1.43 -1.455 0 C-N-CA 127.467 2.307 . . . . 0.0 114.387 178.393 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 28' ' ' SER 0.374 15.6 t 67.59 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 124.352 2.025 . . . . 0.0 114.732 171.108 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 98.3 m -138.29 133.65 33.34 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 43.7 m -74.47 118.87 17.92 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.436 1.494 . . . . 0.0 109.509 171.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.572 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -176.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.277 0.0 OUTLIER -131.2 132.61 44.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.749 1.22 . . . . 0.0 108.247 170.473 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -106.71 87.18 2.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.217 1.007 . . . . 0.0 109.102 175.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.4 t -90.68 122.84 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.205 2.202 . . . . 0.0 113.044 -174.73 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -105.73 118.36 36.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.005 -2.309 . . . . 0.0 113.22 -179.762 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 mt -120.12 160.85 22.04 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.943 -1.098 . . . . 0.0 111.161 -173.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.26 102.65 8.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.001 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.604 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.86 143.83 57.22 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -173.045 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 t -104.39 93.99 5.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.425 1.49 . . . . 0.0 109.627 -168.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.62 56.44 7.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.674 2.39 . . . . 0.0 114.156 -173.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.39 60.01 7.17 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.792 -1.193 . . . . 0.0 114.231 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -175.81 104.47 0.08 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 20' ' ' LYS . 9.2 mt -72.33 -49.98 30.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 164.884 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.03 37.63 0.3 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 113.307 -1.77 . . . . 0.0 111.605 165.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.05 130.69 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.324 1.059 . . . . 0.0 112.127 179.814 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -73.32 111.22 8.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.217 1.007 . . . . 0.0 111.954 160.575 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.8 m -84.12 124.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.44 169.7 9.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.459 1.904 . . . . 0.0 110.04 175.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.46 -121.51 5.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.481 1.515 . . . . 0.0 113.613 178.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.31 147.71 22.13 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -175.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -171.363 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.776 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -108.85 155.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 168.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.002 -1.686 . . . . 0.0 107.292 -171.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 47' ' ' ILE . 8.7 t -79.9 130.68 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.375 -1.453 . . . . 0.0 110.432 173.384 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -90.3 -49.47 6.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.235 -1.541 . . . . 0.0 110.327 168.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.99 37.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.128 0.971 . . . . 0.0 109.824 -173.097 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.461 HD13 HG11 ' A' ' 44' ' ' VAL . 45.3 mm -95.15 137.45 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 170.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 N--CA 1.43 -1.431 0 O-C-N 120.869 -1.145 . . . . 0.0 113.215 -179.118 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 118.989 2.959 . . . . 0.0 118.989 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 -28.89 61.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.184 -1.572 . . . . 0.0 114.991 179.07 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.14 -37.3 83.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.179 -1.576 . . . . 0.0 110.942 168.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -69.93 -1.7 10.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -178.373 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -71.56 -83.4 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.062 -2.274 . . . . 0.0 109.793 165.568 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.88 -41.08 0.93 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.957 -1.089 . . . . 0.0 111.561 174.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -84.94 -18.6 34.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.31 127.22 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.843 1.257 . . . . 0.0 110.836 176.303 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.8 -179.42 5.07 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.634 1.574 . . . . 0.0 110.359 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -76.52 70.55 3.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.326 1.45 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.68 -13.03 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.384 -1.447 . . . . 0.0 116.561 179.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -71.34 157.4 38.15 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -92.92 130.33 38.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.392 1.477 . . . . 0.0 110.216 -177.171 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.26 122.3 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.123 1.369 . . . . 0.0 107.754 167.809 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -32.84 8.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.993 -1.067 . . . . 0.0 113.155 175.101 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 159.72 44.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.763 -1.211 . . . . 0.0 112.811 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 t -141.08 123.66 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 111.863 -174.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.09 30.43 19.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.28 -1.512 . . . . 0.0 112.687 -178.26 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.84 78.06 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 125.73 1.633 . . . . 0.0 114.557 -174.245 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.92 109.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -177.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 m -60.57 146.21 45.98 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.124 1.44 . . . . 0.0 113.677 175.087 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -79.28 65.01 4.33 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.52 -1.362 . . . . 0.0 110.303 172.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.38 98.77 9.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.242 -1.536 . . . . 0.0 111.019 -176.307 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.93 66.43 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.361 -0.837 . . . . 0.0 112.896 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.82 129.15 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.955 1.836 . . . . 0.0 115.087 -170.178 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.5 p -93.4 -165.19 1.29 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.645 2.378 . . . . 0.0 107.741 -179.745 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.6 -49.99 75.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.085 -1.635 . . . . 0.0 112.737 164.735 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -69.83 -45.38 67.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 77' ' ' THR . 58.9 tt0 -69.22 -32.86 72.4 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.979 -1.076 . . . . 0.0 112.97 177.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.1 89.97 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.394 -1.441 . . . . 0.0 114.312 173.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.89 -52.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.398 -0.811 . . . . 0.0 110.146 171.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.24 -40.81 78.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.2 m -62.4 -28.78 70.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 175.054 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.27 -40.79 11.94 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.824 1.65 . . . . 0.0 115.057 172.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -75.69 -44.33 42.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.912 2.885 . . . . 0.0 113.483 -173.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -87.93 38.61 0.85 Allowed 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.336 -1.477 . . . . 0.0 111.471 -169.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.0 p -109.26 166.45 10.85 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.722 2.009 . . . . 0.0 112.125 -173.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.13 -89.09 0.19 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.199 -1.563 . . . . 0.0 115.564 -172.699 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.64 -62.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.602 -0.94 . . . . 0.0 110.177 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.2 t -75.09 125.79 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 122.961 1.362 . . . . 0.0 110.707 172.346 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.7 t -114.37 103.99 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -83.12 103.88 12.88 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 108.622 172.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.73 118.76 26.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.025 -1.047 . . . . 0.0 111.483 178.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 102.53 15.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.75 144.49 30.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.588 1.955 . . . . 0.0 110.427 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.98 132.15 54.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 163.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 tptt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 123.961 0.905 . . . . 0.0 112.258 179.738 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.507 28.0 m 54.41 98.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 169.314 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 31.2 m -133.76 124.51 26.75 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 -174.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -69.83 128.78 37.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.488 1.115 . . . . 0.0 110.672 171.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.259 1.594 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -170.744 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.431 -1.396 0 CA-C-O 122.055 0.931 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -131.11 137.55 49.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.558 1.143 . . . . 0.0 108.004 178.22 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.39 76.36 0.97 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.032 1.333 . . . . 0.0 109.364 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.74 121.71 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.044 1.738 . . . . 0.0 114.942 -169.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -99.54 116.56 31.95 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.512 -1.992 . . . . 0.0 110.46 174.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.29 170.68 15.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.51 141.06 49.53 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.967 -1.083 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -63.99 145.98 54.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.573 1.949 . . . . 0.0 112.593 174.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -101.73 101.65 12.18 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.392 1.091 . . . . 0.0 109.495 179.708 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.95 -20.77 0.06 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.704 2.802 . . . . 0.0 117.522 -173.226 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.16 43.81 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.799 -1.813 . . . . 0.0 111.97 179.572 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.9 p -174.12 129.07 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.3 mt -78.99 -40.55 31.31 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.716 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 117.56 43.19 0.59 Allowed Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.39 169.235 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 pt -120.21 134.73 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.695 0.76 . . . . 0.0 109.886 167.238 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.6 m -96.12 117.13 30.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.162 0.985 . . . . 0.0 111.042 169.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.67 142.09 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -167.339 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 159.51 40.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.855 1.662 . . . . 0.0 109.448 168.384 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.98 -141.79 16.3 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.839 1.209 . . . . 0.0 114.593 173.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -175.54 48.6 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.668 1.127 . . . . 0.0 115.252 -178.689 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 N--CA 1.429 -1.478 0 C-N-CA 127.634 2.374 . . . . 0.0 114.085 178.126 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 N-CA-C 112.779 -0.128 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -107.64 162.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.338 -170.479 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.852 -1.78 . . . . 0.0 107.777 -173.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.586 HG11 HD13 ' A' ' 47' ' ' ILE . 6.2 t -96.68 125.16 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 120.558 -1.339 . . . . 0.0 111.469 176.505 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 -33.55 14.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.373 -1.454 . . . . 0.0 112.261 175.049 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.14 137.58 24.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 110.977 177.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.586 HD13 HG11 ' A' ' 44' ' ' VAL . 43.9 mm -96.23 140.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.581 1.952 . . . . 0.0 107.411 173.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.671 HD12 ' HA2' ' A' ' 26' ' ' GLY . 68.1 mt . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 116.853 -1.546 . . . . 0.0 109.521 169.249 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 121.524 0.678 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.05 66.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.267 -1.521 . . . . 0.0 114.729 -175.16 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.56 -32.91 69.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.114 -1.616 . . . . 0.0 111.343 167.665 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -73.76 5.69 3.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 177.323 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.64 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.101 -2.249 . . . . 0.0 107.733 151.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.77 -42.14 0.6 Allowed Glycine 0 N--CA 1.431 -1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 112.712 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.512 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 2.5 mpt_? -79.7 -17.85 52.64 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.067 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -72.59 143.8 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.013 1.725 . . . . 0.0 112.457 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.13 -178.87 5.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.376 -1.452 . . . . 0.0 109.278 159.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.25 135.25 36.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.1 -1.625 . . . . 0.0 111.861 177.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.22 -21.53 17.39 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.619 1.104 . . . . 0.0 112.725 -170.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -71.55 159.65 34.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.217 1.407 . . . . 0.0 114.232 -172.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -101.53 134.88 43.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.753 1.263 . . . . 0.0 110.916 -177.47 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 t -112.6 111.75 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.063 2.545 . . . . 0.0 105.055 178.215 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.82 -33.66 9.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.422 -1.424 . . . . 0.0 113.64 -175.266 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.64 158.05 39.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.75 1.159 . . . . 0.0 113.361 -179.198 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.2 t -129.9 129.5 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.043 -1.036 . . . . 0.0 110.606 174.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.385 0.5 OUTLIER 39.25 43.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.927 2.491 . . . . 0.0 116.081 -171.879 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.87 12.26 81.54 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.452 1.501 . . . . 0.0 114.649 178.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.9 t -109.32 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.606 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 p -71.36 153.77 42.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.314 1.53 . . . . 0.0 113.301 174.038 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.56 74.15 7.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.452 1.12 . . . . 0.0 112.253 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -84.28 107.95 16.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.016 1.389 . . . . 0.0 110.052 176.242 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.84 11.18 84.8 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.339 -1.476 . . . . 0.0 116.373 -177.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.95 141.78 34.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 123.478 1.609 . . . . 0.0 114.909 -169.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 66.9 p -99.22 -156.74 0.56 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.067 2.147 . . . . 0.0 109.455 -175.555 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -53.48 19.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.129 -1.607 . . . . 0.0 110.563 164.458 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -69.8 -38.63 76.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 77' ' ' THR . 10.5 tt0 -65.42 -37.5 87.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.957 -1.714 . . . . 0.0 113.79 171.371 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.34 -36.22 83.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.678 -1.889 . . . . 0.0 114.397 172.747 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.11 -57.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.028 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -48.46 -38.89 21.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 175.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.4 m -65.3 -33.3 75.66 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.879 2.471 . . . . 0.0 113.759 177.077 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mt -90.87 -29.62 17.41 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.702 -1.874 . . . . 0.0 114.577 171.846 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.15 -48.62 7.91 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.676 2.39 . . . . 0.0 114.739 -168.738 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -87.2 37.92 0.79 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.034 -1.666 . . . . 0.0 111.531 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 35.7 p -95.59 159.47 14.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.435 2.694 . . . . 0.0 112.087 -175.678 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.03 63.32 3.77 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.796 -1.19 . . . . 0.0 114.251 -174.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.289 28.3 tt0 68.69 -51.51 0.57 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.377 2.671 . . . . 0.0 115.423 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.34 125.97 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.673 1.225 . . . . 0.0 110.513 170.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.67 107.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -89.53 96.63 10.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 124.26 34.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 111.825 -169.023 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.14 100.89 13.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.3 1.048 . . . . 0.0 108.286 165.372 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.9 147.54 26.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.221 2.208 . . . . 0.0 109.378 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.62 138.43 54.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.521 1.153 . . . . 0.0 108.481 166.206 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 tptt . . . . . 0 N--CA 1.431 -1.397 0 O-C-N 120.968 -1.083 . . . . 0.0 112.2 -178.281 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.454 1.1 t 69.68 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 125.051 2.358 . . . . 0.0 115.69 154.313 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.0 m -130.5 122.3 27.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -170.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.8 p -74.27 130.03 38.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.609 1.563 . . . . 0.0 110.319 176.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' LEU . 11.7 p . . . . . 0 C--O 1.259 1.579 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -164.178 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 122.148 0.975 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.62 122.47 24.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.369 1.468 . . . . 0.0 109.088 176.734 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -88.35 86.41 7.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.384 1.564 . . . . 0.0 110.34 168.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.17 143.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.3 1.44 . . . . 0.0 108.876 176.177 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 117.92 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.894 -1.754 . . . . 0.0 109.65 174.668 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.1 mt -120.84 161.23 21.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.513 1.125 . . . . 0.0 109.916 -173.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.13 117.43 26.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 166.318 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -63.9 145.33 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.1 1.36 . . . . 0.0 114.303 -173.96 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.6 t -97.62 104.09 16.08 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 120.511 -1.368 . . . . 0.0 110.474 178.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 49.83 39.82 19.08 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.157 2.183 . . . . 0.0 115.28 -174.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 65.54 1.98 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 121.107 -0.996 . . . . 0.0 115.004 -173.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.487 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 46.6 t 177.98 114.01 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -175.305 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.8 mt -76.52 -38.25 55.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.528 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.5 27.65 2.32 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.122 169.067 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HB ' HG13 ' A' ' 44' ' ' VAL . 40.1 pt -124.37 127.36 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.684 0.754 . . . . 0.0 109.96 -174.232 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -79.12 110.69 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.028 1.331 . . . . 0.0 114.003 173.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.46 129.39 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -176.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -124.27 167.88 13.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.727 . . . . 0.0 109.939 172.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.7 -152.03 42.06 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.975 1.274 . . . . 0.0 113.61 -177.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.0 165.7 19.65 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.288 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.43 -1.447 0 O-C-N 120.634 -1.509 . . . . 0.0 114.372 -171.332 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 CA-C-O 121.554 0.53 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 5.4 tp -140.92 163.0 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -135.72 155.32 50.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.292 -1.505 . . . . 0.0 107.356 -173.177 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 47' ' ' ILE . 21.9 t -96.96 121.39 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.758 -1.214 . . . . 0.0 111.611 -178.497 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.31 -34.48 18.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.246 -1.534 . . . . 0.0 113.21 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.21 132.68 18.64 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -177.743 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.476 ' CD1' HG11 ' A' ' 44' ' ' VAL . 38.6 mm -93.48 126.3 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 166.561 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 121.631 -0.668 . . . . 0.0 111.859 179.442 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.439 0 CA-C-O 121.07 0.462 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.8 -41.1 79.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.668 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.77 -30.5 56.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.234 -1.541 . . . . 0.0 112.996 174.395 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -72.29 2.22 6.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 175.762 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.13 -99.86 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.874 -2.391 . . . . 0.0 109.045 162.519 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 -47.36 0.14 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.654 -1.904 . . . . 0.0 113.404 175.475 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 mtm-85 -69.2 -33.83 73.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.92 1.288 . . . . 0.0 113.143 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -52.13 129.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.062 2.945 . . . . 0.0 116.016 -175.386 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.87 177.79 8.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.57 -1.331 . . . . 0.0 110.93 167.38 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -72.16 121.26 19.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.475 -2.641 . . . . 0.0 112.445 175.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.06 0.95 11.55 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -176.264 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.95 158.69 29.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.528 2.164 . . . . 0.0 112.836 176.206 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -100.62 129.92 46.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.244 1.418 . . . . 0.0 108.971 178.453 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.52 117.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.03 -39.12 8.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.875 -1.765 . . . . 0.0 113.332 176.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.55 159.18 44.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 119.993 1.269 . . . . 0.0 113.721 -177.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 92' ' ' VAL . 67.0 t -133.28 115.78 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 123.881 0.872 . . . . 0.0 111.271 179.905 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 52.49 27.11 4.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.066 -1.646 . . . . 0.0 115.305 -168.184 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 4.52 72.97 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 114.25 -173.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.39 93.5 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -177.636 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.5 p -71.42 135.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.34 1.067 . . . . 0.0 113.634 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.2 mt -80.12 56.67 2.48 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.081 2.152 . . . . 0.0 112.354 -174.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -73.35 82.04 1.4 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.289 2.236 . . . . 0.0 112.643 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.27 29.41 19.79 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 120.711 -1.243 . . . . 0.0 113.446 -178.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.29 149.85 35.32 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.687 1.232 . . . . 0.0 112.238 176.037 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -104.66 -163.27 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.503 1.921 . . . . 0.0 109.121 -176.013 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -66.72 -54.11 26.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 111.511 169.24 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -64.35 -46.54 82.98 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.499 1.12 . . . . 0.0 112.659 177.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -63.38 -41.76 98.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.417 -1.427 . . . . 0.0 113.654 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.21 -38.4 87.88 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.295 -1.503 . . . . 0.0 114.918 174.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.79 -56.34 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 118.7 0.682 . . . . 0.0 110.494 170.298 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 36.0 mt-10 -64.18 -25.45 68.08 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -65.13 -35.05 79.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.357 1.863 . . . . 0.0 111.186 173.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.95 -40.85 13.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.241 1.816 . . . . 0.0 114.507 174.123 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 83' ' ' GLU 0.356 0.0 OUTLIER -82.33 -35.59 27.75 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -174.457 . . . . . . . . 4 4 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -81.33 41.58 0.62 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.559 -1.963 . . . . 0.0 113.333 178.101 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -105.42 -169.02 1.53 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.087 2.155 . . . . 0.0 110.488 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.86 -117.02 3.99 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.194 1.378 . . . . 0.0 110.736 176.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -66.35 0.93 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.877 -1.367 . . . . 0.0 111.438 178.098 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.46 129.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.907 -174.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 68' ' ' VAL . 30.1 t -121.28 105.99 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 172.277 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -77.43 100.43 5.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.653 1.581 . . . . 0.0 108.844 165.368 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -84.6 111.83 19.89 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.462 1.505 . . . . 0.0 108.065 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 99.61 12.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 171.596 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.5 144.1 32.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.286 1.434 . . . . 0.0 109.802 -177.672 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.62 125.26 53.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 166.301 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptm . . . . . 0 N--CA 1.429 -1.491 0 C-N-CA 124.808 1.243 . . . . 0.0 113.567 -171.306 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 120.351 0.119 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER 85.8 112.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 123.981 1.848 . . . . 0.0 113.466 165.823 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.6 m -139.4 118.8 12.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 -172.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 85.8 p -73.14 129.1 37.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.383 0.992 . . . . 0.0 109.426 170.084 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.0 p . . . . . 0 C--O 1.261 1.697 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -161.306 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.43 -1.471 0 CA-C-O 122.244 1.021 . . . . 0.0 108.842 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 124.58 31.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.18 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.01 82.23 3.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.687 1.232 . . . . 0.0 108.567 176.27 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.54 153.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.301 1.44 . . . . 0.0 109.709 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -129.31 122.35 29.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.177 -1.577 . . . . 0.0 107.807 166.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -119.89 153.25 36.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.936 -1.103 . . . . 0.0 108.336 -173.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.07 8.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.63 123.9 15.61 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.85 1.66 . . . . 0.0 113.303 -168.873 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.259 11.1 t -85.7 104.45 15.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.303 -1.498 . . . . 0.0 110.978 -169.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.61 16.71 9.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 127.2 2.2 . . . . 0.0 116.019 -173.835 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.99 84.58 1.35 Allowed Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.262 -1.524 . . . . 0.0 111.041 -175.566 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.254 79.2 p 151.51 109.31 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.346 2.658 . . . . 0.0 107.447 -169.023 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.13 -40.94 82.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.239 2.216 . . . . 0.0 107.369 161.047 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 110.74 32.23 2.73 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 124.953 1.263 . . . . 0.0 110.765 173.038 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 pt -121.37 130.7 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 121.86 -0.788 . . . . 0.0 109.484 174.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -87.04 119.33 27.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.026 0.917 . . . . 0.0 111.096 168.249 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 29' ' ' VAL . 15.9 m -86.08 133.65 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -126.22 170.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.534 1.534 . . . . 0.0 110.83 176.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.91 -121.73 5.69 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 125.23 1.395 . . . . 0.0 113.461 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.39 155.05 30.78 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.624 1.107 . . . . 0.0 112.236 -177.884 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.488 -1.418 0 C-N-CA 126.312 1.845 . . . . 0.0 114.154 -175.462 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.693 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 42' ' ' ILE . 4.1 tp -116.13 155.87 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.488 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -132.66 152.3 51.72 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.236 -1.54 . . . . 0.0 107.904 -169.308 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.36 107.42 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.846 -1.158 . . . . 0.0 111.397 -170.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -86.93 -42.09 13.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.631 -1.918 . . . . 0.0 113.416 -177.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.55 133.13 47.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 113.576 176.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.9 128.93 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.884 2.474 . . . . 0.0 109.777 175.622 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.601 HD12 ' HA2' ' A' ' 26' ' ' GLY . 72.9 mt . . . . . 0 N--CA 1.429 -1.502 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.692 174.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 121.42 0.629 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.57 -40.5 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.509 1.924 . . . . 0.0 113.652 -176.545 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -62.6 -33.57 75.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.286 -1.508 . . . . 0.0 111.227 170.122 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.35 1.66 7.45 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 174.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.25 -70.98 0.28 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.636 -1.915 . . . . 0.0 108.751 157.097 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -11.46 5.74 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 123.462 0.553 . . . . 0.0 112.984 164.278 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -94.78 -12.71 26.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.25 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -86.32 138.0 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.935 1.694 . . . . 0.0 112.746 -173.835 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -128.24 -171.95 2.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.858 1.263 . . . . 0.0 110.65 170.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -94.78 36.07 1.21 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.397 -2.064 . . . . 0.0 115.182 -163.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.9 16.85 1.07 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.372 -1.455 . . . . 0.0 111.749 175.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -92.62 151.5 20.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.894 0.854 . . . . 0.0 111.949 -162.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -96.64 124.67 40.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.073 0.949 . . . . 0.0 110.526 -176.242 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.2 108.67 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 167.488 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -39.69 11.51 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.949 -1.72 . . . . 0.0 112.09 178.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.63 38.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 119.509 1.049 . . . . 0.0 113.47 -176.355 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 92' ' ' VAL . 11.2 t -133.36 118.21 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 123.58 0.752 . . . . 0.0 111.432 -175.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 61.72 29.6 18.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.049 1.295 . . . . 0.0 111.808 -173.549 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.18 4.35 89.78 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.509 -1.37 . . . . 0.0 115.278 -171.523 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.8 107.33 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 118.639 1.219 . . . . 0.0 108.081 -172.501 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 m -70.41 138.22 51.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.206 -0.934 . . . . 0.0 113.333 -178.042 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.46 37.95 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.298 1.839 . . . . 0.0 111.727 -178.055 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -84.53 74.29 10.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.669 1.988 . . . . 0.0 110.227 -169.794 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.63 9.6 6.94 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 124.175 0.893 . . . . 0.0 112.985 -170.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.49 140.46 32.3 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.147 1.473 . . . . 0.0 112.953 177.763 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.473 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.2 p -92.12 -160.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.706 2.002 . . . . 0.0 109.912 -178.735 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -66.5 -56.42 10.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.031 -1.668 . . . . 0.0 111.317 165.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -69.38 -38.4 77.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 121.355 -0.841 . . . . 0.0 112.673 -177.127 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' A' ' 77' ' ' THR . 9.0 tt0 -65.96 -36.91 84.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 174.867 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.24 96.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.563 -1.96 . . . . 0.0 113.929 171.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 t -56.21 -49.8 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.74 1.216 . . . . 0.0 111.933 174.827 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.006 -1.684 . . . . 0.0 114.029 176.163 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.2 m -66.31 -24.72 66.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.303 1.841 . . . . 0.0 113.216 -179.313 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.44 -46.39 8.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.848 1.259 . . . . 0.0 114.138 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -85.47 -33.62 21.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.045 -1.66 . . . . 0.0 115.376 -169.969 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.53 34.23 0.98 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.901 -1.75 . . . . 0.0 111.032 -174.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.3 p -88.48 -166.15 1.52 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.368 2.667 . . . . 0.0 110.429 177.404 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.89 -123.92 3.79 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.019 -1.676 . . . . 0.0 110.138 170.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.8 -50.61 4.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.184 -1.186 . . . . 0.0 109.8 177.142 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.19 123.63 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 123.22 1.486 . . . . 0.0 110.776 176.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 68' ' ' VAL . 6.4 t -114.58 112.48 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.833 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -78.51 116.11 18.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.72 110.08 22.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.027 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.72 99.91 12.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.532 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.55 142.89 36.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.37 1.868 . . . . 0.0 110.207 -173.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -121.81 151.61 40.41 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.004 1.722 . . . . 0.0 109.514 177.329 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 174.483 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 16.1 tp . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.448 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.45 2.9 m 52.61 88.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.132 2.173 . . . . 0.0 115.077 170.302 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 61.7 m -126.77 118.21 24.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -168.88 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.3 p -79.59 120.45 23.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.4 1.08 . . . . 0.0 110.304 -179.37 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -169.155 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.43 -1.454 0 CA-C-O 122.461 1.124 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.2 117.28 14.37 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.562 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.53 76.65 3.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.887 1.327 . . . . 0.0 109.601 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.03 116.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.706 2.402 . . . . 0.0 112.472 -169.211 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.332 0.2 OUTLIER -104.56 118.36 36.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.834 -1.791 . . . . 0.0 112.078 -173.999 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 mt -127.72 178.38 6.18 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.768 -1.207 . . . . 0.0 109.216 -171.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.28 119.33 22.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 162.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HB3' ' H ' ' A' ' 24' ' ' SER . 2.1 mtpt -62.31 128.6 36.83 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.576 -1.328 . . . . 0.0 113.09 -174.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -88.72 121.02 30.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.505 -1.372 . . . . 0.0 109.392 179.105 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.26 4.59 3.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.845 2.058 . . . . 0.0 114.743 178.182 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.93 86.24 0.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 125.527 1.537 . . . . 0.0 110.581 -164.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.55 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 37.3 m 163.57 119.81 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 128.192 2.597 . . . . 0.0 106.584 -169.697 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 92' ' ' VAL . 23.6 mt -72.7 -37.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.785 1.755 . . . . 0.0 109.095 162.778 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 102.58 34.66 4.05 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.141 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HB ' HG13 ' A' ' 44' ' ' VAL . 41.9 pt -119.99 136.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 122.031 -0.688 . . . . 0.0 109.683 173.287 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.2 m -84.46 122.35 28.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 123.307 0.643 . . . . 0.0 109.754 160.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 m -85.13 132.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.617 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -122.85 161.83 23.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.538 -1.976 . . . . 0.0 109.691 174.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.72 -148.62 30.69 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.764 1.174 . . . . 0.0 113.998 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.83 146.91 5.46 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.431 -1.419 0 C-N-CA 126.525 1.93 . . . . 0.0 114.996 -178.242 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.683 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.27 2.1 tp -116.04 157.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 119.644 1.722 . . . . 0.0 110.7 -173.976 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -140.5 152.79 45.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -170.511 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' A' ' 47' ' ' ILE . 14.7 t -87.99 131.66 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.698 -1.877 . . . . 0.0 111.506 -178.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -96.98 -52.38 3.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.908 -1.12 . . . . 0.0 111.213 175.75 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.81 118.07 17.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.074 -1.016 . . . . 0.0 111.163 -171.671 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 44' ' ' VAL . 32.2 mm -88.92 129.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 126.28 1.832 . . . . 0.0 109.346 177.222 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' HA2' ' A' ' 26' ' ' GLY . 79.9 mt . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.449 174.51 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.515 0 CA-C-O 120.643 0.259 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.05 80.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.352 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -51.72 -35.83 44.61 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.107 1.363 . . . . 0.0 113.548 167.984 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 -16.18 46.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.97 -77.15 0.07 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.019 0.927 . . . . 0.0 110.281 164.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.36 -20.95 3.9 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 114.804 160.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.76 -13.62 60.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 118.778 1.289 . . . . 0.0 113.479 178.002 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 141.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 125.082 1.353 . . . . 0.0 113.542 -176.328 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.69 -174.24 3.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.697 -1.252 . . . . 0.0 110.372 169.055 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -81.69 56.25 2.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.388 -1.445 . . . . 0.0 112.914 -175.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -172.56 -8.91 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.248 -0.908 . . . . 0.0 114.58 -176.443 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.68 157.67 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.663 1.732 . . . . 0.0 114.855 -177.1 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -93.7 123.8 37.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.42 1.088 . . . . 0.0 110.412 -176.722 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.78 110.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.588 -1.32 . . . . 0.0 107.983 174.104 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.45 -26.59 12.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.64 172.0 17.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.62 2.009 . . . . 0.0 113.239 176.336 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 HD23 ' A' ' 94' ' ' LEU . 9.7 p -142.89 120.51 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 177.019 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.501 0.0 OUTLIER 30.22 43.77 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.0 2.963 . . . . 0.0 119.0 -151.501 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.48 10.31 86.03 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 126.452 1.977 . . . . 0.0 115.366 -175.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.16 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.472 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -63.72 130.43 44.21 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.063 1.745 . . . . 0.0 115.576 -170.318 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mt -89.42 -6.65 56.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.969 2.108 . . . . 0.0 110.366 171.694 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.94 108.74 9.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.988 -1.695 . . . . 0.0 109.202 172.047 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.62 28.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.181 -0.95 . . . . 0.0 113.421 -163.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 142.07 34.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.791 -1.417 . . . . 0.0 113.08 -179.506 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.57 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 60.4 p -91.1 -162.0 0.87 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.868 2.467 . . . . 0.0 109.746 -177.89 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -62.87 -51.62 66.3 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.647 -1.908 . . . . 0.0 111.47 167.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -65.26 -50.62 65.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.339 1.055 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.57 ' HB2' ' H ' ' A' ' 77' ' ' THR . 2.3 mp0 -63.03 -33.37 75.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.607 -1.308 . . . . 0.0 113.856 177.471 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.85 89.61 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 120.263 1.392 . . . . 0.0 114.185 174.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -59.12 -51.21 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 121.58 -0.7 . . . . 0.0 111.212 176.058 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -63.44 -32.58 74.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.346 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.4 m -60.72 -45.18 95.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.886 1.674 . . . . 0.0 112.332 172.27 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.6 -41.3 12.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 113.323 -174.476 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -44.12 56.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -88.47 42.32 1.06 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.654 -1.904 . . . . 0.0 112.421 -169.711 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 p -99.5 -171.0 1.99 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.407 3.483 . . . . 0.0 109.496 177.13 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.93 -132.95 4.53 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.533 -1.354 . . . . 0.0 111.681 175.106 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -93.37 -52.17 4.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.403 -1.645 . . . . 0.0 112.563 178.136 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.59 130.98 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 122.0 0.905 . . . . 0.0 111.308 176.596 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 25' ' ' LEU . 3.9 m -122.23 113.45 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.405 1.082 . . . . 0.0 108.086 172.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -81.57 94.26 6.87 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.552 -1.343 . . . . 0.0 108.826 160.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 68' ' ' VAL . 4.8 mt -73.3 110.49 7.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.034 1.333 . . . . 0.0 110.053 178.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.38 100.43 11.84 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.455 -0.778 . . . . 0.0 110.358 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.71 149.07 28.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.986 1.714 . . . . 0.0 109.585 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -124.44 147.49 48.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.94 1.296 . . . . 0.0 108.36 167.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 176.093 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' B' B ' 206' ' ' LEU . . . . . 0.674 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.674 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.378 15.4 m 23.14 100.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.155 3.782 . . . . 0.0 119.663 161.87 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -130.55 123.05 28.71 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 -176.42 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.5 p -72.17 129.02 37.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.093 0.949 . . . . 0.0 110.068 169.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.26 1.619 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 -158.466 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 45.4 ttp . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.949 0.881 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -139.77 146.97 49.63 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.553 -1.342 . . . . 0.0 108.891 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.72 163.37 35.91 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 122.657 1.985 . . . . 0.0 111.618 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.47 30.67 76.93 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.786 1.184 . . . . 0.0 115.353 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.18 131.19 54.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.955 -1.32 . . . . 0.0 110.786 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.78 133.86 52.99 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.177 1.791 . . . . 0.0 110.143 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.18 118.1 33.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.963 1.305 . . . . 0.0 109.093 174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.23 92.06 7.05 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.051 1.405 . . . . 0.0 110.078 170.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.2 t -89.45 127.91 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 C-N-CA 126.315 1.846 . . . . 0.0 112.454 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.267 0.0 OUTLIER -108.35 122.54 47.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.012 -2.305 . . . . 0.0 110.238 174.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.4 mt -125.84 157.64 37.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.005 -173.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.05 113.22 22.89 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 163.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.1 ptpt -56.41 132.45 51.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.262 1.425 . . . . 0.0 113.953 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.5 t -97.74 110.13 22.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.605 -1.31 . . . . 0.0 109.138 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 46.07 55.43 7.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.896 2.478 . . . . 0.0 115.457 -173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.98 51.22 19.72 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.714 -1.241 . . . . 0.0 114.828 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.3 p -178.24 111.57 0.07 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.3 mt -66.63 -53.51 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.408 2.283 . . . . 0.0 108.15 166.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.796 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 133.96 26.73 0.56 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.261 -1.336 . . . . 0.0 111.911 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 44' ' ' VAL . 11.2 pt -126.27 137.61 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.306 1.05 . . . . 0.0 111.171 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -87.27 119.82 27.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.982 1.713 . . . . 0.0 111.649 164.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 29' ' ' VAL . 21.8 m -84.63 140.59 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -174.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.02 178.25 7.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.463 1.905 . . . . 0.0 109.291 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.4 -118.2 4.73 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.27 1.414 . . . . 0.0 113.105 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.79 162.2 36.01 Favored Glycine 0 N--CA 1.429 -1.814 0 O-C-N 121.432 -1.04 . . . . 0.0 112.502 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 p -61.6 -20.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.66 -22.4 60.93 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.467 1.507 . . . . 0.0 112.346 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 m -100.28 158.29 15.98 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.25 2.22 . . . . 0.0 106.114 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 p -78.35 67.53 4.17 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.691 -2.505 . . . . 0.0 114.958 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.1 m -89.75 -160.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.049 2.14 . . . . 0.0 110.397 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -81.03 43.85 0.73 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.236 -2.165 . . . . 0.0 113.588 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 m170 53.56 33.13 15.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.45 115.97 1.15 Allowed Glycine 0 N--CA 1.43 -1.739 0 O-C-N 119.883 -1.76 . . . . 0.0 110.939 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 156.51 140.7 3.02 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.458 ' H ' HD13 ' A' ' 73' ' ' LEU . 6.3 tp -107.25 156.41 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 170.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -135.94 157.54 46.6 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.877 -1.764 . . . . 0.0 106.416 -170.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' ILE . 9.6 t -87.32 131.29 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.141 -1.599 . . . . 0.0 111.9 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.29 -41.48 9.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.367 -1.458 . . . . 0.0 110.816 171.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.45 136.03 25.7 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.032 -1.042 . . . . 0.0 111.102 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.509 HD13 HG11 ' A' ' 44' ' ' VAL . 36.2 mm -97.43 137.33 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 127.017 2.127 . . . . 0.0 108.597 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.796 HD12 ' HA2' ' A' ' 26' ' ' GLY . 50.1 mt -77.22 132.67 69.69 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 110.151 171.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.04 93.88 0.46 Allowed 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.968 2.445 . . . . 0.0 112.192 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.256 30.4 mmtp 82.57 53.32 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.938 2.495 . . . . 0.0 113.725 174.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.92 -179.08 30.53 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 151.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.9 -39.11 68.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.056 1.742 . . . . 0.0 115.348 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.2 -53.73 54.19 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.181 2.192 . . . . 0.0 115.104 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.53 -26.93 68.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.923 -1.736 . . . . 0.0 112.292 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -70.11 -18.73 63.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.033 -1.667 . . . . 0.0 115.066 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.74 -71.57 0.24 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.036 -2.29 . . . . 0.0 107.368 157.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.0 5.63 62.4 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 161.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -80.75 -19.37 45.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.298 -1.119 . . . . 0.0 110.115 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.08 149.29 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.298 1.839 . . . . 0.0 114.253 162.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -131.44 -161.23 1.11 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.62 1.568 . . . . 0.0 107.464 157.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -88.3 45.45 1.28 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.959 -2.338 . . . . 0.0 112.549 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.73 -20.13 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 O-C-N 120.609 -1.307 . . . . 0.0 114.807 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -78.76 161.06 27.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -166.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -104.07 124.65 49.44 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.64 1.576 . . . . 0.0 110.411 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.26 117.24 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 107.248 166.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 -36.19 9.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.824 -1.797 . . . . 0.0 112.754 175.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.26 154.22 38.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.82 -1.175 . . . . 0.0 111.401 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.04 121.23 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 121.065 -1.022 . . . . 0.0 111.259 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.8 t30 63.77 21.33 12.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.643 -1.285 . . . . 0.0 113.389 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.94 20.38 63.34 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.665 -1.272 . . . . 0.0 113.492 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.0 t -119.9 110.67 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 121.079 -1.248 . . . . 0.0 107.99 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.7 m -58.13 141.18 51.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.383 1.873 . . . . 0.0 114.543 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 42' ' ' ILE . 4.3 mt -81.08 47.62 1.03 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.284 1.516 . . . . 0.0 111.889 170.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -81.76 117.03 21.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.196 1.799 . . . . 0.0 109.707 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.86 72.02 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.064 -1.023 . . . . 0.0 114.734 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.21 132.76 36.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.529 1.633 . . . . 0.0 112.639 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -110.46 -164.92 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.006 2.523 . . . . 0.0 105.517 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -58.18 -52.17 66.68 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.557 -1.965 . . . . 0.0 112.947 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -70.53 -44.63 67.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.121 0.968 . . . . 0.0 112.583 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -38.83 92.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.05 1.34 . . . . 0.0 113.807 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.32 97.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 0.0 114.312 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.6 t -58.37 -54.51 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 118.127 0.421 . . . . 0.0 110.247 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -50.77 -37.12 40.42 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 126.085 1.754 . . . . 0.0 115.351 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 73.7 m -72.22 -31.46 65.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.68 2.392 . . . . 0.0 113.898 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -89.02 -37.94 14.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.242 1.817 . . . . 0.0 114.102 173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -82.97 -45.45 14.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.624 1.97 . . . . 0.0 113.378 -166.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -90.88 37.32 0.92 Allowed 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.038 1.399 . . . . 0.0 112.623 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.8 p -90.1 173.51 8.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.949 2.1 . . . . 0.0 114.058 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.71 51.39 4.45 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.673 -1.892 . . . . 0.0 113.972 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 68.27 -51.78 0.54 Allowed 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.299 3.04 . . . . 0.0 115.673 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.6 t -76.86 128.46 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 123.144 1.449 . . . . 0.0 109.844 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -120.03 100.22 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -82.26 98.49 8.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.875 1.67 . . . . 0.0 107.987 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -87.51 112.75 22.55 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.322 1.449 . . . . 0.0 109.878 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.26 100.52 12.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.84 136.97 44.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.413 1.885 . . . . 0.0 110.881 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.28 158.23 17.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.134 1.774 . . . . 0.0 109.37 171.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 131.71 31.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.98 14.3 64.7 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.624 -1.923 . . . . 0.0 113.961 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -111.73 121.66 45.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.392 1.877 . . . . 0.0 109.997 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.6 m -75.04 154.94 86.64 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.327 -1.483 . . . . 0.0 113.531 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.3 -1.983 0 C-N-CA 122.546 2.164 . . . . 0.0 113.369 169.78 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 N--CA 1.431 -1.416 0 CA-C-O 121.328 0.585 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.551 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.6 tp 61.37 179.8 0.11 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.634 2.374 . . . . 0.0 114.819 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.551 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.419 16.0 m 33.12 89.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 129.934 3.294 . . . . 0.0 116.775 171.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 64.5 m -125.11 121.83 35.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 101.944 -3.354 . . . . 0.0 101.944 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.0 p -71.62 121.1 18.18 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 124.574 1.15 . . . . 0.0 109.779 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.636 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 33.5 ttm . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -119.69 140.26 29.2 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 120.119 -1.613 . . . . 0.0 107.156 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -68.96 115.26 3.89 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 123.888 2.424 . . . . 0.0 113.057 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.69 50.44 42.5 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 115.185 0.834 . . . . 0.0 115.185 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.52 128.14 33.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.354 -1.086 . . . . 0.0 109.238 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 p -91.68 130.63 37.44 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.911 0.862 . . . . 0.0 110.566 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.58 121.54 37.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.517 1.127 . . . . 0.0 108.599 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -88.74 87.63 7.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.965 1.364 . . . . 0.0 111.021 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.9 t -85.82 110.77 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.941 1.696 . . . . 0.0 111.493 -176.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.58 123.21 40.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.621 -1.924 . . . . 0.0 108.24 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.11 172.36 12.48 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.13 128.77 55.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 158.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.3 137.17 52.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.578 1.151 . . . . 0.0 110.565 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -89.35 92.2 9.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.015 -1.678 . . . . 0.0 110.67 -174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.5 -18.82 0.11 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.52 61.07 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 119.983 -1.698 . . . . 0.0 110.028 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 p -179.97 119.64 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.875 1.797 . . . . 0.0 107.266 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' CD2' HG21 ' A' ' 92' ' ' VAL . 16.9 mt -74.87 -47.54 29.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.001 1.857 . . . . 0.0 106.575 162.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 112.01 39.94 1.23 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.426 1.489 . . . . 0.0 111.4 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.421 ' HB ' HG13 ' A' ' 44' ' ' VAL . 42.9 pt -124.85 136.65 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.812 0.815 . . . . 0.0 109.713 172.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 m -88.31 121.57 30.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.342 1.457 . . . . 0.0 111.398 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.11 138.41 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -174.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.2 t -138.6 175.9 9.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.16 2.584 . . . . 0.0 108.581 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 -128.34 9.02 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 113.123 177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.8 163.49 39.44 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.796 -1.414 . . . . 0.0 114.525 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -59.94 -24.08 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 126.697 1.999 . . . . 0.0 114.615 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.36 6.8 24.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.133 -1.604 . . . . 0.0 114.297 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.7 p -123.16 174.66 7.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.231 -1.543 . . . . 0.0 107.907 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.4 m -87.98 60.08 5.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.581 -1.95 . . . . 0.0 114.257 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -83.1 -164.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.213 1.805 . . . . 0.0 110.937 174.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -77.26 63.61 2.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.127 -2.233 . . . . 0.0 111.841 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.31 30.7 p80 30.64 31.0 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 132.316 4.246 . . . . 0.0 120.647 -179.694 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.92 111.98 0.45 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 119.801 -1.812 . . . . 0.0 110.29 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.01 147.08 4.45 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.101 -2.0 . . . . 0.0 108.101 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -105.57 160.33 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.9 160.31 38.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.926 -1.734 . . . . 0.0 107.017 -171.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' ILE . 4.0 t -92.07 134.46 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.429 -1.42 . . . . 0.0 112.219 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -99.56 -36.64 9.46 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.72 -1.237 . . . . 0.0 111.441 171.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.05 129.95 16.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.216 -1.553 . . . . 0.0 111.654 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.509 HD13 HG11 ' A' ' 44' ' ' VAL . 38.6 mm -95.25 136.86 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.261 1.824 . . . . 0.0 108.816 177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.695 HD12 ' HA2' ' A' ' 26' ' ' GLY . 62.4 mt -80.46 134.55 54.59 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 119.919 -1.738 . . . . 0.0 110.176 172.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -59.18 96.57 0.09 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 123.683 2.922 . . . . 0.0 114.667 168.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' H ' ' HG2' ' A' ' 54' ' ' GLU . 37.5 mmtm 65.0 57.88 0.95 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.152 2.181 . . . . 0.0 114.429 173.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.19 -113.13 0.53 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 158.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.45 -44.99 3.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.16 -1.2 . . . . 0.0 110.71 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.87 63.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.081 1.753 . . . . 0.0 114.656 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 50' ' ' LYS . 5.9 tp10 -59.73 -28.37 67.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.44 -1.412 . . . . 0.0 112.956 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.83 -14.54 63.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.69 -70.52 0.34 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.163 -1.586 . . . . 0.0 108.685 159.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.47 6.64 56.42 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 114.206 169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -78.83 -27.62 44.32 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.301 -1.705 . . . . 0.0 109.102 164.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -69.27 143.74 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.873 1.669 . . . . 0.0 114.198 179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -132.61 172.81 12.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.696 -1.252 . . . . 0.0 110.049 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -82.62 58.39 4.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.686 -1.884 . . . . 0.0 113.458 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.55 31.4 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 171.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -103.75 159.19 15.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.184 0.994 . . . . 0.0 109.567 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -100.73 130.22 46.73 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.713 1.205 . . . . 0.0 109.772 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.21 114.35 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 168.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.98 -34.11 11.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.575 -1.328 . . . . 0.0 112.225 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.08 165.34 37.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.217 1.371 . . . . 0.0 113.327 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.409 HG21 HD23 ' A' ' 85' ' ' LEU . 14.9 t -134.27 119.17 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 121.375 -0.828 . . . . 0.0 110.552 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.89 27.1 8.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 121.101 1.773 . . . . 0.0 115.247 -171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.67 17.82 74.55 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 120.88 -1.137 . . . . 0.0 114.5 -172.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.9 98.29 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.6 t -68.64 137.12 53.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.277 1.431 . . . . 0.0 114.642 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.93 30.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.855 2.062 . . . . 0.0 111.702 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.06 10.49 1.19 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -167.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.62 36.59 0.39 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 120.829 -1.17 . . . . 0.0 110.401 166.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.32 37.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.059 0.943 . . . . 0.0 113.31 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 t -108.73 -161.59 0.77 Allowed 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.415 2.286 . . . . 0.0 106.859 176.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -55.09 -55.97 25.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.637 1.975 . . . . 0.0 114.09 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -64.64 -54.45 31.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.082 0.944 . . . . 0.0 112.724 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -41.09 71.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.132 1.773 . . . . 0.0 114.256 177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.25 -41.51 89.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.208 -1.558 . . . . 0.0 114.844 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.1 t -57.52 -52.5 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 119.196 0.907 . . . . 0.0 110.333 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -59.03 -35.9 74.08 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.6 m -64.58 -34.65 78.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.966 1.706 . . . . 0.0 113.772 175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 68' ' ' VAL . 16.5 mt -87.98 -39.48 14.66 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.258 -1.526 . . . . 0.0 113.481 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -50.81 10.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.409 2.284 . . . . 0.0 113.986 -173.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -84.59 43.03 0.94 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 124.023 1.868 . . . . 0.0 112.044 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 62.4 p -99.08 174.64 6.24 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.93 2.892 . . . . 0.0 108.35 172.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -79.24 -131.22 0.76 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.646 -1.284 . . . . 0.0 112.743 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -97.19 -49.78 4.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 121.023 -1.281 . . . . 0.0 110.45 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.4 t -79.6 129.88 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.184 1.468 . . . . 0.0 110.977 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.573 HG21 ' CD2' ' A' ' 25' ' ' LEU . 13.9 m -121.37 110.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.821 1.648 . . . . 0.0 107.062 170.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -82.84 96.15 8.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 161.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.3 mt -76.38 122.42 24.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.748 -1.22 . . . . 0.0 110.817 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.8 103.58 15.48 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 108.664 173.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -112.83 144.54 42.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.155 1.382 . . . . 0.0 110.219 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -119.29 133.63 55.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.013 1.325 . . . . 0.0 109.519 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.21 119.58 11.74 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.068 1.347 . . . . 0.0 114.386 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.99 73.54 0.7 Allowed Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 125.731 1.634 . . . . 0.0 111.282 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -135.64 160.28 39.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.473 -1.016 . . . . 0.0 109.828 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.52 139.69 26.64 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.819 -1.563 . . . . 0.0 110.222 -172.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo . . . . . 0 N--CA 1.434 -2.029 0 C-N-CA 123.027 2.485 . . . . 0.0 116.845 178.32 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 42.9 t80 . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 120.94 0.4 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.19 172.65 12.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.885 1.274 . . . . 0.0 114.371 -169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.517 17.4 m 61.92 98.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.001 2.521 . . . . 0.0 116.531 171.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.2 m -129.43 120.99 26.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 -173.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.4 p -71.36 135.72 47.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.168 0.987 . . . . 0.0 109.796 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.259 1.604 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 -166.062 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.525 ' N ' ' HZ3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 122.387 1.089 . . . . 0.0 109.963 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -121.83 153.12 60.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 C-N-CA 125.326 1.45 . . . . 0.0 107.773 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.9 126.57 12.69 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.527 2.151 . . . . 0.0 112.148 -172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.97 19.15 77.92 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 123.778 0.704 . . . . 0.0 113.619 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.1 88.96 5.96 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.996 -1.297 . . . . 0.0 109.526 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -75.84 132.47 40.38 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 125.328 1.451 . . . . 0.0 112.15 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.94 134.42 54.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.77 1.228 . . . . 0.0 107.947 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -115.21 68.49 0.71 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 122.94 1.352 . . . . 0.0 108.819 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.4 t -75.97 112.77 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.522 2.329 . . . . 0.0 112.21 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.29 3.0 pm0 -100.74 120.84 40.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.879 -1.763 . . . . 0.0 111.708 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 94' ' ' LEU . 13.4 mt -133.73 174.34 10.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.56 1.144 . . . . 0.0 108.802 -171.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.03 125.52 52.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 160.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -75.93 143.82 41.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 113.117 179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -91.15 87.28 6.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.965 1.364 . . . . 0.0 110.69 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 67.58 6.88 5.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.947 2.099 . . . . 0.0 115.404 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.47 72.88 0.53 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.8 t 167.97 99.62 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.332 1.853 . . . . 0.0 108.447 -166.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.3 mt -70.14 -45.13 67.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 154.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.12 40.67 0.95 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 124.848 1.213 . . . . 0.0 110.68 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -127.84 134.22 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.962 0.887 . . . . 0.0 109.862 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.5 m -85.07 120.46 26.6 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 123.677 0.791 . . . . 0.0 111.553 163.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.54 142.35 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -173.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -142.8 170.72 15.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.316 1.446 . . . . 0.0 110.0 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.84 -130.96 10.55 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.053 1.311 . . . . 0.0 112.368 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.32 157.62 31.56 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.598 1.094 . . . . 0.0 111.421 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.2 t -45.19 -40.72 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.391 1.877 . . . . 0.0 113.193 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -68.28 -26.23 65.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.596 1.958 . . . . 0.0 115.006 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.9 m -80.88 -33.31 34.44 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.656 -1.278 . . . . 0.0 111.481 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.268 3.8 t 96.04 87.62 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.959 2.904 . . . . 0.0 110.208 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 m -119.75 -156.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.729 2.012 . . . . 0.0 109.334 -170.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -83.36 79.38 9.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.401 -2.062 . . . . 0.0 110.77 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 71.8 -80.05 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.311 1.844 . . . . 0.0 112.047 -169.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -151.65 -121.3 0.94 Allowed Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 126.378 1.942 . . . . 0.0 108.677 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.35 -170.18 53.67 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.013 -1.287 . . . . 0.0 111.946 -168.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.421 HG22 HG13 ' A' ' 65' ' ' VAL . 6.2 tp -143.31 160.93 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.289 -1.712 . . . . 0.0 106.79 160.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -125.56 166.74 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.092 -1.63 . . . . 0.0 107.291 -177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.4 t -83.89 141.35 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.085 -1.634 . . . . 0.0 110.216 170.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -97.09 -57.69 2.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.803 -1.185 . . . . 0.0 109.535 160.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.69 145.11 49.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.879 0.872 . . . . 0.0 111.135 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.1 mm -101.07 131.94 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.279 1.831 . . . . 0.0 106.706 173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 pt -88.92 163.86 33.37 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.339 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -66.38 103.5 0.66 Allowed 'Trans proline' 0 C--N 1.298 -2.082 0 C-N-CA 122.923 2.416 . . . . 0.0 114.279 176.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 50.5 70.72 0.48 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 170.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.65 -92.4 0.76 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 164.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.06 -36.82 1.74 Allowed 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 124.811 1.244 . . . . 0.0 109.981 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.93 -48.18 59.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 126.213 1.805 . . . . 0.0 114.443 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.7 -32.54 67.48 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.032 -1.668 . . . . 0.0 113.06 173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -70.54 -0.62 8.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -73.69 -96.98 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.209 -2.182 . . . . 0.0 107.553 156.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.93 -14.42 0.77 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 120.75 -1.219 . . . . 0.0 113.067 172.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -84.63 -23.45 29.52 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.939 -1.33 . . . . 0.0 110.733 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.39 135.22 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.181 2.592 . . . . 0.0 113.965 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.58 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 4.1 t-80 -143.98 -173.72 4.07 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.419 1.58 . . . . 0.0 114.343 167.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.58 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 78.4 mttt -89.22 81.16 6.76 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.185 1.794 . . . . 0.0 111.348 -164.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.98 -14.28 0.77 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.17 -0.956 . . . . 0.0 113.029 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.84 170.26 8.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -106.3 143.83 33.87 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.232 1.413 . . . . 0.0 109.643 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.421 HG13 HG22 ' A' ' 42' ' ' ILE . 3.9 p -110.48 129.38 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 164.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.05 -32.84 8.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.878 -1.764 . . . . 0.0 112.211 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.03 156.89 42.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.729 -1.232 . . . . 0.0 112.441 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.539 HG21 HD23 ' A' ' 85' ' ' LEU . 3.6 t -136.15 120.77 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.083 -1.01 . . . . 0.0 110.784 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.3 t30 65.3 19.21 11.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.892 1.277 . . . . 0.0 112.736 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.93 26.17 46.25 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.601 -1.312 . . . . 0.0 113.284 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -122.95 104.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.3 p -65.56 138.51 58.1 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.323 1.449 . . . . 0.0 114.32 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 mt -80.71 49.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.31 1.844 . . . . 0.0 111.247 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.44 107.96 6.91 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.584 1.554 . . . . 0.0 110.643 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 29.61 62.48 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 121.436 -0.79 . . . . 0.0 114.025 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.84 137.25 33.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.567 1.651 . . . . 0.0 113.555 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.6 p -93.66 -165.74 1.38 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.365 1.866 . . . . 0.0 108.341 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -64.71 -50.07 68.38 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 119.547 -1.971 . . . . 0.0 111.371 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -64.28 -49.04 73.38 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.393 1.077 . . . . 0.0 113.194 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -67.69 -30.95 70.6 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.603 -1.311 . . . . 0.0 114.332 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.14 93.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.126 -1.609 . . . . 0.0 114.48 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.4 t -53.68 -51.77 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.609 1.163 . . . . 0.0 111.574 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -58.4 -43.4 88.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.512 -1.368 . . . . 0.0 114.463 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 88.0 m -65.53 -30.79 71.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.551 1.54 . . . . 0.0 114.508 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.539 HD23 HG21 ' A' ' 68' ' ' VAL . 19.9 mt -88.62 -49.23 7.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.946 1.298 . . . . 0.0 112.096 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.18 -33.22 44.17 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -91.63 37.75 0.97 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.071 -1.643 . . . . 0.0 110.898 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 42.5 p -94.06 170.09 9.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.053 2.141 . . . . 0.0 108.125 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.1 -79.24 1.04 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 119.83 -1.794 . . . . 0.0 112.693 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -137.75 -57.7 0.68 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.653 -0.91 . . . . 0.0 108.979 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.5 t -78.07 130.47 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 123.114 1.435 . . . . 0.0 111.833 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.482 HG21 HD22 ' A' ' 25' ' ' LEU . 13.3 m -115.26 117.88 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.464 1.106 . . . . 0.0 108.157 167.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -85.72 97.54 10.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.258 -1.527 . . . . 0.0 107.349 161.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 18' ' ' LEU . 9.8 mt -85.19 112.57 20.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 110.762 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.07 105.19 17.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.168 0.987 . . . . 0.0 108.719 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mt -117.9 144.26 45.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.589 1.555 . . . . 0.0 111.352 -165.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -123.07 138.67 54.61 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.462 1.505 . . . . 0.0 109.637 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 27.1 mmtp -75.0 136.02 41.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.731 1.212 . . . . 0.0 113.735 -172.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.96 61.34 3.39 Favored Glycine 0 N--CA 1.431 -1.651 0 O-C-N 120.772 -1.205 . . . . 0.0 111.555 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -126.01 -172.65 2.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.103 1.761 . . . . 0.0 110.687 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.41 156.62 79.28 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.89 1.676 . . . . 0.0 108.953 -168.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo . . . . . 0 N--CA 1.433 -2.045 0 C-N-CA 122.822 2.348 . . . . 0.0 114.887 167.258 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 N--CA 1.429 -1.496 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 5.5 tp 54.73 -148.69 0.47 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.76 2.024 . . . . 0.0 113.35 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.619 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.411 1.9 t 38.22 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 129.81 3.244 . . . . 0.0 116.281 152.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 46.7 m -138.04 122.61 18.52 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 102.941 -2.985 . . . . 0.0 102.941 -164.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -83.52 127.91 34.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.006 0.908 . . . . 0.0 111.255 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.261 1.678 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 -163.097 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 121.418 0.628 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.1 151.07 41.45 Favored Pre-proline 0 N--CA 1.429 -1.478 0 C-N-CA 125.109 1.364 . . . . 0.0 111.388 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.06 114.35 3.95 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.922 2.415 . . . . 0.0 114.332 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.37 28.65 61.37 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 121.481 -0.762 . . . . 0.0 114.702 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.66 133.67 34.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.502 -0.999 . . . . 0.0 110.485 -175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.3 p -91.0 138.19 31.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.724 -1.235 . . . . 0.0 112.559 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.04 120.01 33.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 173.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -94.85 74.41 3.58 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.359 1.064 . . . . 0.0 108.617 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.94 153.12 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 127.187 2.195 . . . . 0.0 110.02 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -130.33 123.03 29.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.945 -1.722 . . . . 0.0 109.501 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.7 mt -122.89 174.85 6.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.516 1.126 . . . . 0.0 109.29 -176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.51 136.87 54.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 153.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HB2' ' H ' ' A' ' 24' ' ' SER . 7.7 ptpt -66.85 130.25 42.54 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.067 1.747 . . . . 0.0 113.365 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 101.52 13.3 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.527 -1.358 . . . . 0.0 109.649 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.2 t70 51.37 64.95 1.64 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.733 2.013 . . . . 0.0 114.01 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.48 72.64 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.869 -1.144 . . . . 0.0 115.234 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.42 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 35.9 t -172.75 99.01 0.14 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -169.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -64.62 -41.99 95.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.363 2.265 . . . . 0.0 107.075 164.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 106.29 46.32 1.16 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.359 171.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -123.36 136.9 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 124.358 0.681 . . . . 0.0 110.108 165.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.3 m -84.72 120.0 25.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.3 1.04 . . . . 0.0 110.677 162.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -90.01 129.82 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -126.54 165.33 19.35 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.232 -2.167 . . . . 0.0 110.958 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.12 -130.58 10.37 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.333 1.444 . . . . 0.0 113.221 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.2 158.69 24.15 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.756 1.646 . . . . 0.0 110.897 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.3 p -60.42 -20.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 125.098 1.359 . . . . 0.0 114.12 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -55.35 -49.63 71.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.654 1.982 . . . . 0.0 114.379 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -166.1 164.21 18.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.318 10.5 p 85.74 -21.02 0.23 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.284 2.698 . . . . 0.0 118.284 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -92.5 -170.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 120.024 -1.672 . . . . 0.0 110.238 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.6 ttm180 -76.49 -62.54 1.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.444 -1.41 . . . . 0.0 110.22 171.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -165.83 5.18 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.98 107.14 0.2 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.527 -2.608 . . . . 0.0 113.657 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.79 171.35 26.63 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 65' ' ' VAL . 3.8 tp -115.99 151.03 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 167.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -128.14 153.69 46.59 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.282 -2.137 . . . . 0.0 105.512 -168.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.458 HG11 HD13 ' A' ' 47' ' ' ILE . 15.5 t -82.69 127.03 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.593 -1.942 . . . . 0.0 111.535 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -84.43 -54.49 4.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.497 -1.377 . . . . 0.0 109.977 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.56 137.82 34.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 123.292 0.637 . . . . 0.0 110.321 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.458 HD13 HG11 ' A' ' 44' ' ' VAL . 44.9 mm -90.62 144.98 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.271 1.828 . . . . 0.0 107.582 175.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 26' ' ' GLY . 59.8 mt -87.2 117.15 68.2 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 119.725 -1.859 . . . . 0.0 108.326 164.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.3 65.93 8.86 Favored 'Trans proline' 0 N--CA 1.433 -2.06 0 CA-C-N 124.161 2.522 . . . . 0.0 111.938 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.259 0.7 OUTLIER 152.29 45.76 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 131.45 3.9 . . . . 0.0 111.342 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -108.15 -121.38 4.58 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.777 -2.452 . . . . 0.0 110.383 167.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -127.61 -31.1 2.5 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.972 1.709 . . . . 0.0 110.362 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -46.88 60.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.824 -1.798 . . . . 0.0 113.072 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.11 -32.87 56.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.803 1.287 . . . . 0.0 113.576 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 p -59.24 -20.98 58.72 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.18 -79.35 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.435 1.094 . . . . 0.0 110.939 167.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.88 -19.32 6.15 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 121.463 -0.773 . . . . 0.0 113.913 168.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -30.16 60.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.816 -1.402 . . . . 0.0 112.319 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.81 140.79 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -134.83 -164.08 1.47 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -73.42 150.73 41.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.479 -2.013 . . . . 0.0 110.725 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.38 74.75 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 120.57 -1.331 . . . . 0.0 115.445 174.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.09 148.86 41.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 118.896 1.348 . . . . 0.0 111.891 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.45 112.33 25.18 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.88 1.272 . . . . 0.0 110.036 -168.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 42' ' ' ILE 0.26 3.5 p -84.47 116.03 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 119.963 -1.71 . . . . 0.0 108.36 173.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 -37.18 12.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.181 -1.574 . . . . 0.0 111.436 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.14 28.31 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.166 0.984 . . . . 0.0 112.906 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.35 128.94 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.75 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 52.61 18.97 1.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.86 -2.4 . . . . 0.0 117.408 -170.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.1 6.15 63.4 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.425 -1.422 . . . . 0.0 114.945 -171.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -108.03 101.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 125.726 1.611 . . . . 0.0 109.786 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.8 m -68.72 145.02 54.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -82.16 43.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.033 2.533 . . . . 0.0 112.848 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.55 117.33 23.06 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.928 -1.733 . . . . 0.0 110.72 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.03 6.5 86.55 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 123.926 0.774 . . . . 0.0 113.436 -170.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.87 133.96 33.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.939 1.37 . . . . 0.0 113.434 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.6 p -97.14 -160.35 0.8 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.402 2.681 . . . . 0.0 108.228 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -63.77 -55.96 19.15 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.045 -1.659 . . . . 0.0 111.771 164.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -64.98 -38.76 92.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.86 -37.31 73.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.789 -1.819 . . . . 0.0 114.149 174.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.62 76.42 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.2 -1.563 . . . . 0.0 114.22 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.3 t -58.93 -56.37 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 118.167 -0.921 . . . . 0.0 110.729 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.97 -43.23 63.46 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 m -56.18 -45.55 79.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.188 2.195 . . . . 0.0 114.629 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.5 mt -91.91 -32.38 15.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.746 -1.846 . . . . 0.0 115.26 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -79.34 -50.08 11.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.488 1.515 . . . . 0.0 113.145 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -92.19 52.23 1.92 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.126 -1.609 . . . . 0.0 111.922 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.1 p -95.04 -164.96 1.23 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.303 2.241 . . . . 0.0 110.656 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.25 -75.43 1.19 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.089 -1.632 . . . . 0.0 112.365 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -150.6 -60.21 0.19 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.822 -1.399 . . . . 0.0 110.225 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -72.35 125.04 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.219 1.485 . . . . 0.0 110.614 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.97 103.57 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -73.85 110.35 8.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.917 -1.114 . . . . 0.0 110.38 165.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.2 mt -91.79 110.67 22.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.367 0.985 . . . . 0.0 108.681 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.66 95.41 10.25 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.906 0.86 . . . . 0.0 108.769 173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -105.14 138.91 40.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.102 1.761 . . . . 0.0 110.273 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -107.91 137.02 46.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.59 1.956 . . . . 0.0 108.088 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -79.75 126.2 30.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.01 56.58 5.01 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 113.859 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -111.0 151.15 28.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.983 1.713 . . . . 0.0 110.902 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.94 145.05 31.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 116.125 -1.893 . . . . 0.0 107.432 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--N 1.3 -2.018 0 CA-C-N 124.381 2.6 . . . . 0.0 115.285 -176.53 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.43 -1.473 0 CA-C-O 121.918 0.866 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.53 -149.57 0.31 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.337 -1.477 . . . . 0.0 109.355 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.416 2.3 t 67.79 104.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 124.395 2.045 . . . . 0.0 113.484 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 59.5 m -135.84 123.82 22.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -70.44 121.64 18.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.627 1.171 . . . . 0.0 108.549 167.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.259 1.589 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -166.567 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 121.31 0.576 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -147.86 147.75 28.01 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.1 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.79 137.9 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 123.484 2.28 . . . . 0.0 112.442 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.54 76.67 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 116.285 1.274 . . . . 0.0 116.285 172.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -82.72 130.83 35.19 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.777 -1.425 . . . . 0.0 110.773 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.58 129.68 45.12 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.754 -1.217 . . . . 0.0 110.748 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.94 116.97 24.48 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.615 1.166 . . . . 0.0 109.39 177.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.71 86.61 7.31 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.273 1.035 . . . . 0.0 110.279 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.12 121.13 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 126.874 2.069 . . . . 0.0 109.722 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -123.07 116.8 24.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.547 -1.971 . . . . 0.0 111.448 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.13 167.79 27.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.223 -1.548 . . . . 0.0 112.279 -167.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.22 138.8 40.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.378 1.071 . . . . 0.0 110.212 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -75.67 160.91 29.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.717 -1.24 . . . . 0.0 112.539 -171.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 m -92.6 71.8 5.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.276 -1.515 . . . . 0.0 109.343 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 53.57 63.58 2.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.158 2.183 . . . . 0.0 114.959 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.45 38.57 14.25 Favored Glycine 0 N--CA 1.431 -1.657 0 CA-C-N 115.444 -0.798 . . . . 0.0 114.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -177.54 108.59 0.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.201 1.4 . . . . 0.0 107.932 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 9.4 mt -66.0 -48.04 72.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.279 2.632 . . . . 0.0 108.2 169.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.07 34.41 0.78 Allowed Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.094 1.33 . . . . 0.0 112.645 172.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.0 pt -121.76 129.66 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 121.454 0.645 . . . . 0.0 110.514 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.257 5.5 m -78.68 122.9 26.56 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 111.81 162.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.9 m -90.19 134.29 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -130.61 168.08 17.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.115 1.366 . . . . 0.0 109.069 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.59 -146.99 21.06 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.237 0.923 . . . . 0.0 113.28 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.69 169.65 43.98 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 121.314 -1.11 . . . . 0.0 112.02 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.73 -21.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -71.76 -20.78 61.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -111.39 166.51 11.06 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.509 -1.369 . . . . 0.0 109.976 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.8 m -84.51 99.17 10.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.991 -1.068 . . . . 0.0 108.716 172.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 p -146.21 54.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 123.987 1.851 . . . . 0.0 107.586 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 70.73 -72.41 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.119 2.168 . . . . 0.0 112.655 -168.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -138.23 -85.25 0.28 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.569 1.147 . . . . 0.0 109.657 -171.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.95 16.6 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -168.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.69 176.2 54.76 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 119.056 1.428 . . . . 0.0 110.296 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.289 2.7 tp -112.61 151.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.804 -1.41 . . . . 0.0 107.459 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.98 155.13 50.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 -167.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.487 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.0 t -82.52 136.7 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 119.48 -2.012 . . . . 0.0 111.387 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -92.59 -51.71 4.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.025 0.93 . . . . 0.0 110.507 166.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.82 141.78 38.71 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.594 -0.691 . . . . 0.0 111.574 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.487 ' CD1' HG11 ' A' ' 44' ' ' VAL . 44.2 mm -103.66 128.63 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.259 1.823 . . . . 0.0 109.676 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.6 139.74 41.07 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -82.35 68.84 7.64 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.523 2.149 . . . . 0.0 112.233 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -117.28 -87.12 0.62 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.158 0.983 . . . . 0.0 109.11 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.04 45.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . -109.46 -77.07 0.6 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.006 1.903 . . . . 0.0 109.112 157.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.86 88.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -53.5 -40.06 65.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.16 1.457 . . . . 0.0 112.889 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 t -79.58 -16.14 56.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.25 -54.05 14.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.753 2.524 . . . . 0.0 111.365 -164.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -167.58 -77.78 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 118.925 -1.607 . . . . 0.0 113.476 153.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -81.74 -7.8 59.63 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -164.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mt -73.29 126.47 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.039 -1.663 . . . . 0.0 114.196 -173.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 74.9 t60 -128.81 -160.1 1.0 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 163.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 20.6 pttp -92.95 67.09 4.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.349 -2.72 . . . . 0.0 114.442 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.35 42.83 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.461 -2.649 . . . . 0.0 116.717 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -116.17 174.67 5.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.987 1.393 . . . . 0.0 111.213 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.44 129.7 56.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.868 1.667 . . . . 0.0 107.435 176.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.269 9.4 p -100.13 119.86 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.061 1.3 . . . . 0.0 107.892 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.16 -39.01 10.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.524 -1.36 . . . . 0.0 111.547 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.23 150.36 42.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.403 -0.919 . . . . 0.0 113.03 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.0 t -133.14 116.94 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.19 31.1 20.39 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.974 1.31 . . . . 0.0 112.92 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.16 30.92 54.18 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.192 -0.943 . . . . 0.0 112.939 -174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.7 t -129.12 100.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.2 t -70.37 137.31 50.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 112.814 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.12 57.1 3.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.515 1.526 . . . . 0.0 112.562 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -86.23 94.69 9.38 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.538 -1.976 . . . . 0.0 110.729 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.04 45.58 4.12 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 121.349 -0.844 . . . . 0.0 111.521 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.18 147.56 37.17 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 122.592 1.187 . . . . 0.0 109.202 171.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -126.21 -165.35 1.43 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.464 ' O ' HG23 ' A' ' 82' ' ' VAL . 10.3 t-80 -52.58 -55.16 24.2 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.216 -1.553 . . . . 0.0 114.292 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -62.5 -50.55 70.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.672 1.225 . . . . 0.0 113.491 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -42.58 99.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.546 1.138 . . . . 0.0 113.426 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.98 89.36 Favored 'General case' 0 N--CA 1.431 -1.377 0 O-C-N 120.442 -1.411 . . . . 0.0 114.431 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 78' ' ' HIS . 52.1 t -54.94 -56.59 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.328 0.967 . . . . 0.0 110.676 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -69.41 -27.38 65.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 89.6 m -65.78 -26.6 67.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.78 2.032 . . . . 0.0 112.623 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.93 -46.46 8.52 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.14 1.376 . . . . 0.0 112.587 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' B' ' 210' ' ' VAL 0.45 0.0 OUTLIER -71.74 -45.78 60.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -172.048 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -93.7 45.4 1.15 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.323 1.535 . . . . 0.0 110.344 -171.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.4 p -98.13 157.23 16.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.512 2.325 . . . . 0.0 108.256 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -63.53 4.19 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.21 -0.931 . . . . 0.0 115.418 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -155.22 -59.93 0.11 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.687 -0.89 . . . . 0.0 109.03 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.83 124.72 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.212 1.482 . . . . 0.0 110.6 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.5 t -112.27 104.83 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 113.643 -1.617 . . . . 0.0 107.24 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -78.33 104.81 9.16 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 120.894 -1.129 . . . . 0.0 108.903 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mt -90.83 107.37 19.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.401 1.481 . . . . 0.0 107.783 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.35 95.92 10.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 173.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.22 142.9 32.73 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.068 2.147 . . . . 0.0 110.362 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -115.07 136.58 52.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.436 1.094 . . . . 0.0 109.029 167.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -62.56 117.88 6.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.918 1.687 . . . . 0.0 113.543 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.42 61.56 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.789 -1.194 . . . . 0.0 114.095 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -117.4 152.31 35.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.697 1.599 . . . . 0.0 109.64 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.1 m -86.76 149.91 49.38 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 121.305 -0.872 . . . . 0.0 112.367 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo . . . . . 0 C--N 1.299 -2.073 0 C-N-CA 122.729 2.286 . . . . 0.0 116.226 179.033 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.3 -156.28 0.69 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.398 -0.813 . . . . 0.0 109.807 174.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.434 2.6 t 69.93 96.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 124.969 2.318 . . . . 0.0 113.393 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 79.6 m -149.1 121.8 8.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 -165.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.7 m -72.41 139.67 47.93 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.952 0.901 . . . . 0.0 111.169 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 86' ' ' ARG . 7.7 p . . . . . 0 C--O 1.26 1.639 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 122.415 1.103 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -106.71 111.28 63.95 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 164.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -72.04 119.45 6.19 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 123.272 2.204 . . . . 0.0 111.977 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.94 16.41 61.27 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.91 126.57 31.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.216 1.008 . . . . 0.0 111.841 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -94.64 130.41 41.12 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.419 1.104 . . . . 0.0 110.627 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.275 0.1 OUTLIER -114.96 113.81 24.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.712 -1.243 . . . . 0.0 108.697 174.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.29 81.85 5.47 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.108 0.956 . . . . 0.0 109.342 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.68 143.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.769 2.028 . . . . 0.0 109.466 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.52 130.49 55.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.413 -2.054 . . . . 0.0 110.643 166.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.57 157.58 33.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 124.225 1.01 . . . . 0.0 108.314 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.77 105.78 13.43 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.957 0.884 . . . . 0.0 109.181 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.37 135.12 45.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.509 1.924 . . . . 0.0 112.992 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 t -101.88 108.62 20.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.791 -1.193 . . . . 0.0 108.869 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 42.76 49.12 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.619 2.368 . . . . 0.0 116.162 -166.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 45.84 26.81 Favored Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.808 -1.183 . . . . 0.0 115.248 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.1 p -161.06 117.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.899 1.809 . . . . 0.0 106.138 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.08 -36.05 66.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.292 1.837 . . . . 0.0 107.732 169.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.03 2.14 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.478 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 47' ' ' ILE . 8.4 pt -127.67 135.36 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 122.674 1.226 . . . . 0.0 109.566 171.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' HG22 ' B' ' 207' ' ' VAL . 75.6 m -78.94 112.02 15.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.937 1.695 . . . . 0.0 112.507 172.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.86 131.67 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.5 t -132.88 174.05 10.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.956 2.502 . . . . 0.0 108.325 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.87 45.18 76.05 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 118.608 2.203 . . . . 0.0 118.608 166.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.54 169.81 47.67 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 120.592 -1.534 . . . . 0.0 111.227 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 m -55.74 -19.42 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -48.89 -64.76 0.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -170.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 p -143.97 -70.19 0.31 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.212 -0.93 . . . . 0.0 110.092 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 m -42.22 -49.19 4.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.89 2.876 . . . . 0.0 117.67 -168.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -92.34 -1.22 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.943 -1.098 . . . . 0.0 113.769 -170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 64.65 49.93 2.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.317 1.447 . . . . 0.0 111.745 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 72.12 164.99 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.495 2.318 . . . . 0.0 113.07 -164.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.92 -96.7 0.11 Allowed Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.206 -2.808 . . . . 0.0 118.965 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 171.59 -117.5 0.68 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 -168.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.5 tp -145.79 162.15 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 159.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.9 165.62 27.02 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.41 -1.431 . . . . 0.0 108.642 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -80.31 138.19 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.574 1.95 . . . . 0.0 110.643 167.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -95.24 -57.47 2.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.395 -1.441 . . . . 0.0 109.542 159.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.78 134.74 52.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.879 1.272 . . . . 0.0 111.301 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 27' ' ' ILE . 48.7 mm -93.33 133.46 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.8 pt -93.25 147.22 33.36 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 121.113 -0.992 . . . . 0.0 111.637 172.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 111.79 3.2 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.952 2.434 . . . . 0.0 112.156 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 67.98 64.2 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.43 -96.92 2.21 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 166.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.61 -38.34 0.66 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 110.342 171.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.53 -42.0 65.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.41 -36.8 61.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.942 1.829 . . . . 0.0 112.535 169.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -74.56 6.49 3.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -74.12 -79.26 0.09 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.894 -2.379 . . . . 0.0 106.357 152.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.51 -31.6 1.66 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.271 -0.893 . . . . 0.0 111.179 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -89.07 -20.87 23.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.533 -0.98 . . . . 0.0 111.335 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mt -66.46 130.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 124.859 1.264 . . . . 0.0 110.106 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -155.34 169.79 23.41 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -161.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -80.03 77.04 6.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.74 -1.225 . . . . 0.0 111.864 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.78 60.05 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.376 0.989 . . . . 0.0 110.839 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -95.57 -151.52 0.34 Allowed 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.895 2.078 . . . . 0.0 110.222 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -160.04 121.04 3.08 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 149.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.56 122.73 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.034 -1.667 . . . . 0.0 107.728 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.19 -30.3 9.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.888 -1.133 . . . . 0.0 113.275 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.26 159.01 41.07 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 120.244 1.383 . . . . 0.0 113.64 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 t -137.19 119.67 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 C-N-CA 123.997 0.919 . . . . 0.0 111.856 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.99 34.4 22.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.876 -1.765 . . . . 0.0 113.473 -167.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.17 -5.13 73.33 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.627 1.584 . . . . 0.0 113.834 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -93.61 106.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 121.008 -1.289 . . . . 0.0 108.297 -170.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.8 p -60.71 137.21 58.21 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.244 1.018 . . . . 0.0 113.612 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -70.27 -48.8 55.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.4 1.08 . . . . 0.0 111.143 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 34.5 41.83 0.06 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.248 3.425 . . . . 0.0 120.248 160.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.37 -16.85 2.49 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.129 -1.607 . . . . 0.0 111.88 -165.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.29 132.35 44.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.042 1.877 . . . . 0.0 115.119 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -175.45 2.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -48.03 -52.77 18.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.585 -1.947 . . . . 0.0 115.455 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -74.16 -43.95 55.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.309 -0.869 . . . . 0.0 112.161 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -57.58 -43.6 84.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.11 1.364 . . . . 0.0 114.328 172.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -40.68 95.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.452 -1.405 . . . . 0.0 114.292 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.4 -42.95 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 121.076 -1.015 . . . . 0.0 111.593 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.91 -44.22 97.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.943 -1.723 . . . . 0.0 114.697 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.8 m -58.93 -26.51 64.44 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.688 1.995 . . . . 0.0 114.83 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -91.24 -46.52 8.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.634 1.574 . . . . 0.0 112.679 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -79.35 -34.9 41.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.999 -1.688 . . . . 0.0 114.569 -172.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.82 35.22 0.68 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.455 1.598 . . . . 0.0 111.888 -172.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.4 p -99.67 -176.81 3.38 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.564 3.146 . . . . 0.0 108.203 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.42 -115.02 0.57 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.264 -1.522 . . . . 0.0 112.069 173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -105.62 -44.88 4.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.246 1.018 . . . . 0.0 110.868 176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.48 125.01 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 123.041 1.4 . . . . 0.0 110.462 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.8 t -114.0 106.49 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 170.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -83.36 101.66 11.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.575 1.55 . . . . 0.0 109.155 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.27 115.91 26.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.421 1.489 . . . . 0.0 108.659 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.73 99.52 12.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.08 148.62 25.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.696 1.999 . . . . 0.0 111.776 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -111.91 145.14 40.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.32 1.448 . . . . 0.0 109.608 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -78.26 99.42 6.27 Favored 'General case' 0 CA--C 1.489 -1.371 0 O-C-N 120.179 -1.575 . . . . 0.0 110.982 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.18 64.57 4.29 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.781 1.182 . . . . 0.0 114.134 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -135.99 137.39 41.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.967 1.307 . . . . 0.0 108.2 176.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 m -75.77 158.61 82.58 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 120.832 -1.168 . . . . 0.0 112.024 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo . . . . . 0 N--CA 1.434 -1.994 0 C-N-CA 122.801 2.334 . . . . 0.0 115.433 -179.5 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 49.9 p90 . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.88 0.847 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 9.3 tp -145.58 159.5 43.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 28' ' ' SER 0.46 3.5 t 64.26 106.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 117.455 2.391 . . . . 0.0 117.455 162.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 88.4 m -143.92 120.82 11.31 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 103.039 -2.948 . . . . 0.0 103.039 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 89.1 p -76.39 119.91 20.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.604 1.093 . . . . 0.0 109.62 173.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.26 1.634 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -167.082 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 122.999 1.38 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 2.9 mptt -63.65 138.71 97.45 Favored Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.533 1.933 . . . . 0.0 115.184 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 9' ' ' LYS . 82.8 Cg_exo -71.27 112.47 3.34 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 123.693 2.355 . . . . 0.0 116.629 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 33.32 9.84 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 123.679 0.657 . . . . 0.0 113.363 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.72 14.81 0.07 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -142.15 128.63 20.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.774 -1.204 . . . . 0.0 108.171 155.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.259 0.1 OUTLIER -132.56 115.14 15.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 166.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.88 91.41 8.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.591 1.186 . . . . 0.0 110.282 166.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.12 154.1 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 126.71 2.004 . . . . 0.0 108.494 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -130.99 113.24 13.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.212 -2.18 . . . . 0.0 110.322 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.5 mt -119.62 152.15 37.53 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.587 -1.32 . . . . 0.0 111.001 -170.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.96 117.87 35.1 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 165.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.54 138.01 54.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.952 -1.092 . . . . 0.0 112.581 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -89.83 103.34 16.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.648 1.213 . . . . 0.0 109.075 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 51.71 44.62 29.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.788 2.435 . . . . 0.0 115.248 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 48.72 26.9 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 119.888 -1.757 . . . . 0.0 114.398 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -161.81 111.55 1.56 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' CD1' HD22 ' A' ' 85' ' ' LEU . 7.2 mt -73.44 -45.19 55.83 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 167.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.52 31.65 0.76 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.089 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.5 pt -120.43 124.98 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 122.278 1.037 . . . . 0.0 110.647 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 114.44 17.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.385 1.074 . . . . 0.0 111.481 166.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 127.63 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -173.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -128.16 -179.7 5.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.834 2.453 . . . . 0.0 108.702 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.58 -125.22 7.05 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.346 -1.471 . . . . 0.0 111.928 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.51 162.64 35.05 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.477 -1.014 . . . . 0.0 114.164 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.03 -32.25 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.399 1.48 . . . . 0.0 113.667 -177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -72.92 -19.75 61.2 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.53 -1.356 . . . . 0.0 114.569 -173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.4 p -100.21 -6.09 26.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.763 -1.211 . . . . 0.0 111.803 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t 67.24 83.8 0.16 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.695 2.398 . . . . 0.0 113.817 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.22 27.32 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.671 -1.268 . . . . 0.0 112.708 -167.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.274 32.5 ttp180 73.92 71.43 0.11 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.933 1.693 . . . . 0.0 110.874 -168.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 79.75 -61.35 0.3 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.931 2.093 . . . . 0.0 113.299 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.75 -149.28 6.52 Favored Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.18 155.84 22.7 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -157.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tp -115.56 161.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -133.94 162.08 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.299 -2.125 . . . . 0.0 106.646 -170.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -83.98 132.57 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.391 -1.443 . . . . 0.0 110.61 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -90.37 -53.44 4.44 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.44 -1.413 . . . . 0.0 109.161 163.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.96 135.68 31.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.897 0.879 . . . . 0.0 109.49 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 mm -90.82 128.66 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 pt -76.32 156.87 83.4 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.749 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.38 95.41 0.86 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 122.237 1.958 . . . . 0.0 113.346 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.252 46.9 mtmt 83.88 77.89 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.612 2.365 . . . . 0.0 114.287 166.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.5 -157.68 8.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 168.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.32 1.048 . . . . 0.0 113.719 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.16 -41.25 86.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.674 1.589 . . . . 0.0 114.226 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -60.3 -38.19 82.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.906 -1.121 . . . . 0.0 111.253 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -70.95 0.52 7.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.45 -74.23 0.19 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.524 -2.61 . . . . 0.0 108.205 156.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.61 -26.22 3.5 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 121.638 -0.664 . . . . 0.0 111.518 167.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -80.52 -24.84 39.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.739 -0.859 . . . . 0.0 112.149 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 132.6 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.011 1.324 . . . . 0.0 112.392 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.57 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 41.5 t60 -138.28 -178.44 5.28 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 173.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.57 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 27.0 mttm -78.35 69.21 4.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.573 -1.329 . . . . 0.0 113.157 -168.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 3.31 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -80.37 171.76 14.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.197 1.999 . . . . 0.0 114.005 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.3 ttt-85 -108.24 139.11 43.39 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.843 1.257 . . . . 0.0 109.942 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.28 115.27 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.384 1.874 . . . . 0.0 107.662 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.45 -34.41 10.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.832 -1.792 . . . . 0.0 113.846 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.11 152.68 39.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.773 1.17 . . . . 0.0 113.696 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.63 HG13 HG13 ' A' ' 92' ' ' VAL . 70.0 t -135.72 122.75 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.43 0.692 . . . . 0.0 111.129 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 t30 58.98 28.04 17.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.25 1.02 . . . . 0.0 113.409 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 23.35 46.06 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.737 1.636 . . . . 0.0 114.015 -176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.8 t -124.95 96.5 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 118.761 1.28 . . . . 0.0 110.275 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 80.3 p -67.49 142.49 56.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.6 mt -85.78 68.39 10.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.28 128.01 33.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 121.05 -1.031 . . . . 0.0 109.247 162.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.99 -2.28 65.57 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.754 1.862 . . . . 0.0 117.754 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.79 135.96 33.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.422 2.111 . . . . 0.0 113.586 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.0 t -109.35 -169.61 1.51 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.5 2.72 . . . . 0.0 106.143 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -49.16 -58.89 4.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.933 2.093 . . . . 0.0 115.103 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -72.23 -42.09 66.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.165 1.46 . . . . 0.0 111.077 -171.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -59.19 -47.34 85.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.954 1.702 . . . . 0.0 113.84 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.1 -36.55 79.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.94 -51.85 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 121.134 -0.979 . . . . 0.0 111.221 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -56.8 -36.65 70.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.7 m -69.43 -24.24 63.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.607 1.563 . . . . 0.0 114.309 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 68' ' ' VAL . 9.8 mt -89.82 -44.41 9.97 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.534 -1.978 . . . . 0.0 111.877 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -78.6 -44.17 24.68 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 127.743 2.417 . . . . 0.0 116.037 -168.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -81.31 13.35 2.96 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 123.941 1.829 . . . . 0.0 114.503 -168.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -84.15 -176.37 6.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.457 3.103 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.33 -123.88 2.1 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 120.131 -1.605 . . . . 0.0 112.762 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -95.33 -60.26 1.71 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 121.298 -1.119 . . . . 0.0 111.091 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.0 t -76.26 120.99 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 123.051 1.405 . . . . 0.0 112.109 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.63 HG13 HG13 ' A' ' 68' ' ' VAL . 2.4 t -111.13 110.68 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.054 1.742 . . . . 0.0 107.816 168.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.55 102.82 7.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.929 -1.107 . . . . 0.0 110.312 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.67 113.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.899 1.279 . . . . 0.0 109.132 -177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.92 105.36 17.63 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.359 -0.838 . . . . 0.0 109.197 171.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.78 145.78 29.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.457 1.503 . . . . 0.0 111.403 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.71 145.96 42.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.48 1.912 . . . . 0.0 106.694 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -72.64 143.48 48.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.18 -71.62 0.74 Allowed Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 126.126 1.822 . . . . 0.0 113.428 167.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -163.91 -35.41 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 169.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 12.6 m -78.81 152.57 77.57 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 120.648 -1.283 . . . . 0.0 114.171 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 C--N 1.299 -2.033 0 C-N-CA 122.757 2.305 . . . . 0.0 113.121 178.369 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.92 -161.32 0.83 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.663 1.585 . . . . 0.0 112.372 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.412 2.3 t 79.8 112.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 124.221 1.962 . . . . 0.0 113.319 174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 38.9 m -145.02 124.99 13.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.515 -3.143 . . . . 0.0 102.515 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.4 p -80.83 131.42 35.39 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.257 0.935 . . . . 0.0 110.865 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 -160.143 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 122.42 1.105 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.89 131.9 22.9 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.681 -1.262 . . . . 0.0 107.739 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 135.4 22.76 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 123.461 2.272 . . . . 0.0 111.947 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.77 16.63 80.53 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.868 1.107 . . . . 0.0 115.868 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.58 123.31 27.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.865 1.266 . . . . 0.0 111.942 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.0 p -90.04 141.92 28.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.519 1.152 . . . . 0.0 113.636 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.14 119.6 12.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.432 1.493 . . . . 0.0 107.871 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.42 66.88 1.5 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.576 1.15 . . . . 0.0 111.265 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.32 111.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.113 2.165 . . . . 0.0 114.426 -168.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.31 0.2 OUTLIER -96.31 111.95 23.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.781 -1.824 . . . . 0.0 112.86 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.3 mt -117.75 159.75 22.5 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.546 1.138 . . . . 0.0 107.984 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.38 24.08 10.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.398 1.094 . . . . 0.0 111.142 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' HB3' ' H ' ' A' ' 24' ' ' SER . 30.3 mttt 52.29 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.984 2.914 . . . . 0.0 114.515 -171.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -122.42 81.3 1.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.35 -2.094 . . . . 0.0 106.506 159.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.1 t0 55.73 64.05 1.86 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.938 2.095 . . . . 0.0 115.15 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.47 46.79 9.53 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.85 -1.156 . . . . 0.0 114.987 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.529 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 47.7 t 178.53 113.36 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 8.2 mt -75.54 -38.34 59.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.426 1.89 . . . . 0.0 107.368 169.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.22 14.83 4.38 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 113.944 -1.48 . . . . 0.0 111.941 168.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.22 125.32 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 122.263 1.03 . . . . 0.0 110.732 -175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.446 ' HB3' HG13 ' B' ' 207' ' ' VAL . 45.9 m -78.35 109.27 12.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.717 1.207 . . . . 0.0 110.504 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -82.35 127.19 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -125.31 167.9 14.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.424 1.49 . . . . 0.0 110.406 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.03 -125.6 7.07 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.564 1.554 . . . . 0.0 113.183 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.3 167.34 30.12 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.71 -12.87 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.163 -1.787 . . . . 0.0 113.554 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -60.27 -31.54 70.33 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.83 2.052 . . . . 0.0 113.969 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 m -100.2 -33.14 10.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.217 -1.552 . . . . 0.0 109.633 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.288 8.1 t 97.47 119.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.408 2.683 . . . . 0.0 109.474 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG13 ' CZ ' ' A' ' 43' ' ' TYR . 14.6 t -126.41 70.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -168.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.4 ttt-85 69.85 -68.78 0.19 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.491 1.916 . . . . 0.0 113.32 -172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -136.92 -11.79 1.73 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.351 1.461 . . . . 0.0 111.202 172.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.59 130.13 1.99 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 -162.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.82 170.49 33.52 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.42 167.31 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.406 ' CZ ' HG13 ' A' ' 37' ' ' VAL . 13.9 m-85 -136.14 156.5 48.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.559 -1.963 . . . . 0.0 107.12 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 47' ' ' ILE . 3.4 t -80.57 130.46 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.262 -1.524 . . . . 0.0 112.015 165.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -91.89 -38.68 12.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.417 -1.427 . . . . 0.0 112.531 168.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.3 136.08 22.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.7 -1.25 . . . . 0.0 112.129 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 HD13 HG11 ' A' ' 44' ' ' VAL . 25.3 mm -96.75 143.32 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.026 2.131 . . . . 0.0 108.008 175.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 pt -107.59 146.5 33.47 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 120.72 -1.238 . . . . 0.0 113.827 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.64 69.22 8.05 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -103.76 -68.77 0.83 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 110.753 170.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.6 23.19 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.741 0 O-C-N 120.845 -1.159 . . . . 0.0 115.422 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . -118.38 -82.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.29 -1.123 . . . . 0.0 109.047 174.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -34.52 78.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.66 -35.6 81.07 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.6 -1.938 . . . . 0.0 111.741 170.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.27 2.58 24.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.569 2.062 . . . . 0.0 116.569 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -70.15 -90.42 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.859 -1.776 . . . . 0.0 108.476 160.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 -41.79 0.29 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.783 -1.198 . . . . 0.0 111.186 170.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.9 mtm-85 -87.42 -17.35 32.46 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -170.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -70.58 133.45 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.676 -1.265 . . . . 0.0 112.293 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.505 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 21.9 t-80 -129.24 -165.18 1.48 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 123.939 0.896 . . . . 0.0 108.604 170.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 43.2 pttt -102.71 44.79 0.99 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.852 -1.78 . . . . 0.0 112.229 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.68 33.97 0.16 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -97.74 178.19 5.23 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 124.358 1.063 . . . . 0.0 109.667 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -114.33 128.63 56.45 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.745 -1.847 . . . . 0.0 108.698 174.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.36 110.22 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.378 -1.452 . . . . 0.0 107.27 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.02 -48.58 7.65 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.507 -1.996 . . . . 0.0 112.348 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -136.79 160.87 37.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.882 -1.136 . . . . 0.0 113.479 -173.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.451 HG13 HG13 ' A' ' 92' ' ' VAL . 47.4 t -134.0 112.94 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 123.964 0.905 . . . . 0.0 111.285 -175.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 58.74 26.82 15.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.138 -1.601 . . . . 0.0 113.536 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 12.98 83.66 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.702 -1.249 . . . . 0.0 113.705 -171.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.85 100.27 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 t -68.14 148.46 50.88 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 121.109 -0.995 . . . . 0.0 110.091 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.561 2.059 . . . . 0.0 116.561 -166.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 61.29 51.63 4.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.334 1.54 . . . . 0.0 112.314 169.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.58 35.0 80.03 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.087 -1.633 . . . . 0.0 115.617 -173.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.65 151.99 23.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.541 1.639 . . . . 0.0 113.13 174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.503 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 64.5 p -104.2 -158.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.161 2.585 . . . . 0.0 109.381 -169.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -60.21 -51.3 70.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.191 -1.568 . . . . 0.0 112.471 161.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -70.69 -46.14 63.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.126 0.971 . . . . 0.0 111.983 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.503 ' HB2' ' H ' ' A' ' 77' ' ' THR . 65.9 mt-30 -66.57 -34.38 77.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.993 -1.067 . . . . 0.0 113.454 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.57 -41.11 93.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.313 1.87 . . . . 0.0 114.288 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.8 -50.48 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.909 0.884 . . . . 0.0 111.596 174.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -59.26 -40.53 86.33 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.346 -1.471 . . . . 0.0 113.874 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.3 m -59.78 -30.36 68.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.623 1.969 . . . . 0.0 113.428 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.5 mt -89.96 -42.05 11.4 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.342 1.857 . . . . 0.0 113.78 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.97 -24.87 24.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -90.05 24.5 2.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.276 -2.14 . . . . 0.0 112.907 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.3 p -94.38 162.39 13.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.655 2.782 . . . . 0.0 112.409 -173.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.37 65.02 3.44 Favored Glycine 0 N--CA 1.431 -1.695 0 O-C-N 120.528 -1.358 . . . . 0.0 113.718 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.271 28.1 tt0 68.33 -55.24 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.0 115.368 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.8 t -74.75 132.6 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 122.381 1.086 . . . . 0.0 110.625 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.451 HG13 HG13 ' A' ' 68' ' ' VAL . 23.1 t -126.3 108.84 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -77.35 108.04 10.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.906 -1.121 . . . . 0.0 108.445 163.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.0 105.29 12.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.538 -1.351 . . . . 0.0 109.486 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.07 93.96 8.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mt -98.59 139.71 33.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.877 2.071 . . . . 0.0 109.703 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -109.47 135.96 49.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 106.798 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -69.1 115.27 8.2 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.755 1.222 . . . . 0.0 112.021 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.89 37.23 3.43 Favored Glycine 0 N--CA 1.432 -1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 115.041 -167.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -115.03 151.93 33.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.801 1.24 . . . . 0.0 111.221 -172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -86.72 140.11 33.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 125.561 1.544 . . . . 0.0 110.501 -166.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo . . . . . 0 N--CA 1.434 -2.024 0 C-N-CA 122.919 2.413 . . . . 0.0 115.273 -179.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 122.896 1.331 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.441 ' CD2' ' H ' ' B' ' 206' ' ' LEU . 0.3 OUTLIER -83.94 -143.18 0.08 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.093 1.757 . . . . 0.0 112.721 178.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' A' ' 28' ' ' SER 0.418 2.1 t 76.02 106.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.56 2.124 . . . . 0.0 113.358 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -141.31 122.26 14.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.795 -3.039 . . . . 0.0 102.795 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 41.5 m -78.0 129.26 35.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.261 1.684 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -163.213 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.43 -1.433 0 CA-C-O 122.465 1.126 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -106.86 119.41 51.48 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.378 -1.451 . . . . 0.0 109.765 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -64.79 124.17 12.77 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.462 2.108 . . . . 0.0 113.568 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.21 19.97 50.92 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.394 1.473 . . . . 0.0 115.082 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -76.78 116.77 17.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 119.444 1.622 . . . . 0.0 111.89 -176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 p -90.42 142.08 28.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.091 1.424 . . . . 0.0 112.715 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.82 116.51 18.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -89.57 83.99 6.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.911 1.339 . . . . 0.0 109.741 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.4 t -80.84 110.97 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 126.947 2.099 . . . . 0.0 112.99 -173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.64 121.67 41.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.101 -2.249 . . . . 0.0 109.531 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.6 mt -122.04 172.81 7.96 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.089 0.956 . . . . 0.0 109.9 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.23 122.17 23.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 161.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 10.7 ptpt -67.02 160.46 26.48 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.442 1.897 . . . . 0.0 114.805 -177.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -115.75 106.94 14.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.163 1.385 . . . . 0.0 108.924 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 48.88 55.0 9.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.641 2.376 . . . . 0.0 114.503 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.62 48.55 61.63 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 119.974 -1.704 . . . . 0.0 114.982 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.6 m -172.01 111.05 0.28 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 -172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -72.73 -36.68 67.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.876 2.07 . . . . 0.0 108.101 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.04 38.15 1.73 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.425 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 pt -126.45 130.41 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 121.838 0.828 . . . . 0.0 110.222 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.413 ' HB3' HG13 ' B' ' 207' ' ' VAL . 74.7 m -85.27 114.11 22.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 171.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.16 129.27 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 t -121.25 164.27 17.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.769 2.428 . . . . 0.0 111.023 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.51 -145.85 18.22 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 125.397 1.475 . . . . 0.0 111.854 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.64 153.87 23.71 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.062 1.315 . . . . 0.0 111.929 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -67.05 -2.67 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.779 1.631 . . . . 0.0 115.315 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -69.42 -20.97 63.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.766 -1.834 . . . . 0.0 111.869 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -123.07 172.48 8.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 167.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 p -86.72 68.47 10.14 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.919 -1.738 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.46 -39.83 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 124.821 1.248 . . . . 0.0 109.339 -173.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -162.34 -101.58 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -128.32 -12.31 5.09 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.637 -1.289 . . . . 0.0 112.914 163.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.17 115.58 0.6 Allowed Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 173.82 168.4 34.76 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 104.577 -3.409 . . . . 0.0 104.577 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 65' ' ' VAL 0.256 4.4 tp -129.13 163.0 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -138.84 160.94 38.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 47' ' ' ILE . 88.5 t -80.69 130.34 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 120.302 -1.499 . . . . 0.0 110.393 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -88.13 -55.85 3.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.136 -1.602 . . . . 0.0 110.208 166.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.42 139.64 25.72 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.103 0.954 . . . . 0.0 110.782 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD11 HG11 ' A' ' 44' ' ' VAL . 36.4 mm -91.23 137.82 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.552 1.541 . . . . 0.0 107.042 173.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.7 pt -85.75 166.83 27.64 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 121.435 -0.79 . . . . 0.0 112.505 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.12 93.71 1.08 Allowed 'Trans proline' 0 N--CA 1.433 -2.06 0 C-N-CA 122.58 2.187 . . . . 0.0 113.457 166.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.334 48.6 mtmt 74.12 84.33 0.11 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.354 2.262 . . . . 0.0 116.59 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -110.01 -107.35 3.05 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 158.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.36 -40.44 0.73 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.746 1.219 . . . . 0.0 112.606 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.44 83.52 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -173.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -48.09 -36.85 13.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.716 1.606 . . . . 0.0 114.172 167.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 t -73.14 4.25 4.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.66 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.462 -2.024 . . . . 0.0 108.249 155.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.37 -23.69 2.04 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.323 -0.86 . . . . 0.0 112.562 164.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 mtt85 -77.56 -31.78 53.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.806 1.242 . . . . 0.0 112.18 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -67.49 143.72 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.244 1.818 . . . . 0.0 113.966 -179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.533 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 44.6 t60 -142.44 -167.03 2.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.975 -1.078 . . . . 0.0 109.628 170.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 58.3 mttp -80.06 53.97 1.82 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.859 -1.776 . . . . 0.0 113.255 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.28 -35.08 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.823 -1.798 . . . . 0.0 114.998 -169.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -65.38 156.29 32.71 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -167.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 117.37 33.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.292 1.437 . . . . 0.0 110.19 -170.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 42' ' ' ILE . 2.7 p -93.46 125.23 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.255 1.503 . . . . 0.0 109.504 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -37.16 9.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.967 1.307 . . . . 0.0 112.214 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.12 157.11 44.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.68 115.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 124.36 1.064 . . . . 0.0 111.541 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.94 23.13 6.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -168.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.8 12.7 68.36 Favored Glycine 0 N--CA 1.429 -1.792 0 O-C-N 120.795 -1.19 . . . . 0.0 113.859 -171.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.33 99.27 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.6 p -61.95 139.12 58.42 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 125.832 1.653 . . . . 0.0 113.573 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.26 47.32 1.32 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.708 -1.245 . . . . 0.0 112.66 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -74.59 115.04 13.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.663 -1.898 . . . . 0.0 110.695 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.85 84.92 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.793 -1.192 . . . . 0.0 115.07 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.98 136.3 33.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.847 1.823 . . . . 0.0 112.95 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -95.44 -161.37 0.86 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.087 2.155 . . . . 0.0 109.836 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' B' ' 205' ' ' TYR . 79.3 t60 -64.3 -56.25 15.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.008 -1.682 . . . . 0.0 111.628 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -66.96 -38.73 86.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -67.12 -36.17 81.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.971 -1.706 . . . . 0.0 113.908 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.23 90.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.487 -2.008 . . . . 0.0 113.782 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.38 -55.93 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 124.0 0.92 . . . . 0.0 110.461 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -54.06 -33.48 57.56 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.5 m -68.67 -36.47 78.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.827 2.051 . . . . 0.0 112.006 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.4 mt -89.29 -34.57 16.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.808 1.643 . . . . 0.0 114.934 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -45.29 17.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.965 1.706 . . . . 0.0 112.445 -172.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -90.0 47.48 1.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.858 -1.777 . . . . 0.0 112.227 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.6 p -107.31 -166.62 1.17 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.988 2.115 . . . . 0.0 110.524 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.73 -93.92 1.25 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.078 -1.639 . . . . 0.0 114.647 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -132.91 -53.01 0.92 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.072 1.349 . . . . 0.0 109.519 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -77.06 139.84 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 120.472 -1.392 . . . . 0.0 110.89 174.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.21 121.82 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 164.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.5 m170 -86.46 105.82 17.04 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.66 1.184 . . . . 0.0 109.969 166.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mt -87.24 110.8 20.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.333 -1.48 . . . . 0.0 109.652 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 97.94 11.16 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.728 -1.232 . . . . 0.0 108.44 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -101.54 141.33 34.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.075 2.15 . . . . 0.0 110.901 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -108.27 141.09 40.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.461 1.904 . . . . 0.0 107.488 166.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -59.42 119.58 7.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.236 1.814 . . . . 0.0 113.917 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 65.5 4.12 Favored Glycine 0 N--CA 1.431 -1.685 0 O-C-N 120.671 -1.268 . . . . 0.0 114.457 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.34 151.44 44.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.199 1.399 . . . . 0.0 111.83 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.6 m -92.39 157.4 40.44 Favored Pre-proline 0 N--CA 1.431 -1.419 0 C-N-CA 124.734 1.214 . . . . 0.0 109.323 164.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.3 -2.008 0 C-N-CA 122.624 2.216 . . . . 0.0 114.022 -179.429 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 41.5 p90 . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 122.251 1.024 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp -99.34 155.8 17.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.907 -1.121 . . . . 0.0 109.145 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 28' ' ' SER 0.417 2.1 t 70.82 104.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 124.553 2.12 . . . . 0.0 114.633 164.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.8 m -142.48 121.99 13.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.325 -2.842 . . . . 0.0 103.325 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 7.4 m -76.21 126.43 30.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 171.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.626 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.431 -1.401 0 CA-C-O 122.04 0.924 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -122.74 151.71 60.99 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 121.069 -1.019 . . . . 0.0 111.991 -171.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.61 154.73 27.36 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 122.913 2.076 . . . . 0.0 113.109 171.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.72 53.02 41.83 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 125.654 1.597 . . . . 0.0 114.544 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -116.91 98.5 6.52 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 121.569 -0.959 . . . . 0.0 108.433 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -94.81 131.5 40.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.222 -0.923 . . . . 0.0 109.762 168.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.61 121.4 35.49 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 124.823 1.249 . . . . 0.0 108.353 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -98.7 79.36 2.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.317 1.532 . . . . 0.0 108.836 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -79.91 115.55 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.323 2.249 . . . . 0.0 111.581 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.266 3.1 pt-20 -105.87 115.45 30.25 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.221 -2.174 . . . . 0.0 110.276 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.5 mt -117.28 160.66 20.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.885 1.274 . . . . 0.0 109.568 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.92 105.3 11.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -66.84 145.88 55.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -173.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 t -99.48 110.64 23.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.563 1.545 . . . . 0.0 109.068 -173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t70 58.11 20.41 6.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.57 1.948 . . . . 0.0 116.017 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 57.6 2.02 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.008 -1.682 . . . . 0.0 112.654 -171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -173.93 112.72 0.19 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 126.207 1.803 . . . . 0.0 106.823 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.6 mt -74.88 -40.15 61.09 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.413 1.885 . . . . 0.0 106.219 165.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 112.45 40.63 1.11 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.474 170.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 47' ' ' ILE . 21.8 pt -131.68 127.92 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.298 1.047 . . . . 0.0 110.585 175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 m -80.41 123.28 27.9 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.644 1.177 . . . . 0.0 111.515 167.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.72 145.79 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.8 t -140.98 170.74 15.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.349 1.46 . . . . 0.0 109.074 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.12 -133.29 11.71 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.882 1.229 . . . . 0.0 113.615 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.47 161.57 34.82 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 124.753 1.168 . . . . 0.0 112.551 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.15 -14.36 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.45 -1.618 . . . . 0.0 115.03 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -63.69 -47.48 81.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.724 1.609 . . . . 0.0 114.447 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 m -161.73 120.15 2.33 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.375 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t 69.08 77.25 0.23 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 164.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 m -137.11 -165.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.285 1.834 . . . . 0.0 108.386 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -76.64 -63.26 1.38 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.969 -1.707 . . . . 0.0 109.298 162.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -157.35 -15.0 0.09 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.43 94.66 0.1 Allowed Glycine 0 N--CA 1.431 -1.639 0 O-C-N 119.273 -2.142 . . . . 0.0 112.69 -174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.64 41.92 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 105.153 -3.179 . . . . 0.0 105.153 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.49 HG22 HG13 ' A' ' 65' ' ' VAL 0.262 3.8 tp -118.73 158.09 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 166.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -134.94 158.05 45.29 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.564 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.7 t -86.76 138.6 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 120.227 -1.546 . . . . 0.0 110.732 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -101.51 -74.05 0.63 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.509 -1.369 . . . . 0.0 109.955 167.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.21 124.82 50.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.142 0.972 . . . . 0.0 111.534 -175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.564 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.0 mm -90.21 133.92 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.274 1.83 . . . . 0.0 108.562 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' HA2' ' A' ' 26' ' ' GLY . 73.4 mt -79.88 136.47 54.6 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 116.047 -1.93 . . . . 0.0 109.771 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -59.98 107.41 0.4 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.181 2.587 . . . . 0.0 112.853 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.256 83.0 mttt 31.52 73.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.013 2.968 . . . . 0.0 119.013 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.97 -76.96 1.02 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 164.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.56 -45.33 0.49 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.435 1.094 . . . . 0.0 109.649 166.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.03 -45.71 69.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -174.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -56.15 -36.08 67.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.132 -1.605 . . . . 0.0 111.933 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 t -71.31 3.04 4.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.67 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.982 1.719 . . . . 0.0 108.83 159.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.77 -41.49 0.19 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.562 -1.336 . . . . 0.0 111.903 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -84.92 -26.82 27.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.9 mt -65.69 129.09 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 125.174 1.39 . . . . 0.0 114.6 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -132.95 177.71 7.44 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.731 2.013 . . . . 0.0 110.683 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -71.01 77.03 0.66 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.376 -1.452 . . . . 0.0 113.463 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.81 19.18 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -85.58 165.0 17.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 119.175 1.488 . . . . 0.0 112.147 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 120.72 43.32 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.679 1.191 . . . . 0.0 110.598 -171.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.49 HG13 HG22 ' A' ' 42' ' ' ILE . 5.8 p -95.84 122.63 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.178 -1.577 . . . . 0.0 110.658 171.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.0 -36.42 11.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.304 -1.497 . . . . 0.0 111.366 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.55 155.82 43.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.993 -1.067 . . . . 0.0 113.049 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.9 t -131.42 118.52 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.328 -0.857 . . . . 0.0 111.504 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.34 30.78 20.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.266 1.426 . . . . 0.0 112.77 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.51 79.82 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.444 -1.41 . . . . 0.0 114.251 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.35 104.91 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.462 1.505 . . . . 0.0 107.661 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.8 p -64.27 144.76 56.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.21 40.22 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.217 1.407 . . . . 0.0 112.793 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.54 118.48 16.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.117 -1.615 . . . . 0.0 111.305 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.24 88.64 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.063 -1.023 . . . . 0.0 114.846 -174.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.17 140.81 29.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.736 1.732 . . . . 0.0 113.262 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.04 -174.17 2.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -45.93 -50.9 14.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.086 2.154 . . . . 0.0 114.863 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -70.04 -44.31 69.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.787 0.835 . . . . 0.0 112.428 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.89 -37.75 76.11 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.005 -1.059 . . . . 0.0 112.459 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.4 97.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.702 -1.249 . . . . 0.0 113.71 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.3 t -57.0 -53.63 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 123.45 0.7 . . . . 0.0 111.388 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -58.37 -31.39 67.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.8 m -71.6 -26.21 62.5 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.774 2.029 . . . . 0.0 112.896 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.52 -46.65 8.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.007 1.723 . . . . 0.0 114.275 168.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 -32.9 22.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.31 1.844 . . . . 0.0 115.064 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -91.4 41.66 1.07 Allowed 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.999 -2.313 . . . . 0.0 111.589 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.9 p -102.84 160.86 14.23 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.681 1.992 . . . . 0.0 108.975 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.5 -70.36 1.11 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.31 -1.494 . . . . 0.0 113.906 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -153.57 -52.73 0.1 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.968 -0.724 . . . . 0.0 109.407 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -72.14 130.53 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.658 1.218 . . . . 0.0 112.049 171.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.24 109.8 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.425 1.09 . . . . 0.0 108.063 172.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -83.02 109.75 17.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.777 -1.202 . . . . 0.0 109.418 169.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -89.54 110.1 20.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.55 1.14 . . . . 0.0 108.506 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.15 93.49 9.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -98.96 144.13 28.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.335 1.854 . . . . 0.0 110.577 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -111.54 144.02 41.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.901 1.68 . . . . 0.0 107.075 164.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 100' ' ' GLN . 1.1 pptt? -53.64 130.39 36.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.482 1.913 . . . . 0.0 115.089 172.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.64 43.76 3.2 Favored Glycine 0 N--CA 1.428 -1.842 0 O-C-N 118.807 -2.433 . . . . 0.0 112.003 171.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.429 ' H ' ' HD2' ' A' ' 98' ' ' LYS . 4.2 tp-100 -118.11 143.33 46.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.176 1.79 . . . . 0.0 110.995 -163.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -82.9 126.88 71.71 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 125.233 1.413 . . . . 0.0 110.727 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.3 -2.003 0 C-N-CA 122.467 2.111 . . . . 0.0 114.795 171.158 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 123.068 1.413 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.525 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 6.8 tp -161.59 -154.39 0.34 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.828 -3.397 . . . . 0.0 101.828 176.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.525 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.443 29.4 m 53.74 82.06 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.159 2.184 . . . . 0.0 116.667 166.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 94.6 m -118.7 114.31 22.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 -170.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.3 m -83.09 124.52 30.54 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 122.907 0.483 . . . . 0.0 110.118 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.26 1.628 0 N-CA-C 103.099 -2.926 . . . . 0.0 103.099 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 N--CA 1.43 -1.454 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -136.76 161.84 59.4 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 149.43 64.7 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 CA-C-N 121.913 1.719 . . . . 0.0 111.534 169.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.06 9.29 60.88 Favored Glycine 0 N--CA 1.429 -1.785 0 O-C-N 121.523 -0.735 . . . . 0.0 114.831 171.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -86.76 104.75 16.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.62 -1.518 . . . . 0.0 110.252 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p -96.1 147.09 24.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.56 1.544 . . . . 0.0 112.785 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.48 116.49 14.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.859 1.263 . . . . 0.0 109.107 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.52 81.61 5.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.311 1.529 . . . . 0.0 112.677 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.1 t -74.63 114.68 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 126.651 1.98 . . . . 0.0 112.219 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -103.55 113.05 26.26 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.762 -1.836 . . . . 0.0 110.744 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.24 161.49 25.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.78 -1.2 . . . . 0.0 110.28 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.89 117.04 29.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 163.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -49.27 130.76 19.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.33 1.852 . . . . 0.0 114.711 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 t -96.95 109.9 22.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.775 1.63 . . . . 0.0 107.955 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.57 26.84 11.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.21 2.204 . . . . 0.0 115.3 -171.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.71 64.74 2.09 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.115 -1.616 . . . . 0.0 112.437 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 174.58 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.8 mt -75.72 -45.52 36.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.347 2.022 . . . . 0.0 106.472 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.0 32.02 0.89 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 113.672 -1.604 . . . . 0.0 111.568 169.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.0 pt -113.0 129.93 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.884 0.849 . . . . 0.0 109.74 174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -83.07 112.45 19.8 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.286 1.035 . . . . 0.0 110.031 161.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.93 138.32 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.3 t -131.26 167.83 18.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.111 -1.618 . . . . 0.0 108.763 172.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.52 -140.49 18.96 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 124.641 1.115 . . . . 0.0 113.62 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.2 155.43 31.69 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 124.476 1.036 . . . . 0.0 110.56 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.6 t -43.19 -38.67 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 126.853 2.061 . . . . 0.0 114.959 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.59 -41.19 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.811 2.044 . . . . 0.0 114.697 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.0 m -87.62 -13.64 42.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.404 1.882 . . . . 0.0 112.335 -165.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.305 22.4 m 84.65 80.36 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.581 1.952 . . . . 0.0 112.762 175.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.89 57.31 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.814 1.246 . . . . 0.0 110.393 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.44 -67.09 0.23 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.747 1.619 . . . . 0.0 112.532 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -131.41 -79.23 0.52 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.351 1.86 . . . . 0.0 106.784 171.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.38 -126.86 1.41 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 173.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.31 168.75 24.15 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.574 -0.956 . . . . 0.0 112.014 -164.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.551 HG22 HG13 ' A' ' 65' ' ' VAL . 3.3 tp -124.95 160.26 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -142.55 153.89 43.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -168.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.456 HG11 HD13 ' A' ' 47' ' ' ILE . 8.5 t -84.37 138.28 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.159 -2.213 . . . . 0.0 111.789 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -94.47 -58.48 2.19 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.778 -1.201 . . . . 0.0 109.603 166.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.17 51.01 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.377 -0.827 . . . . 0.0 111.647 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.456 HD13 HG11 ' A' ' 44' ' ' VAL . 37.4 mm -96.17 125.43 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.074 1.35 . . . . 0.0 108.439 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.0 pt -85.37 154.58 59.78 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 120.733 -1.23 . . . . 0.0 112.772 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.7 70.69 7.26 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 C-N-CA 122.479 2.119 . . . . 0.0 112.641 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -115.82 -86.76 0.61 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 110.469 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.29 48.79 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 117.107 1.603 . . . . 0.0 117.107 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.86 -63.41 1.27 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 118.946 1.373 . . . . 0.0 108.554 153.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -45.73 75.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.062 -1.649 . . . . 0.0 113.451 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -19.63 65.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.524 -1.36 . . . . 0.0 112.977 172.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 t -69.11 -22.18 63.99 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.5 -89.94 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.199 -1.563 . . . . 0.0 110.32 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.84 -3.79 9.22 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.916 -1.115 . . . . 0.0 113.197 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpp_? -84.57 -27.94 26.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.013 -1.287 . . . . 0.0 108.399 161.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.13 128.6 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.619 1.567 . . . . 0.0 112.761 166.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -133.74 -155.82 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -90.36 81.73 6.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.201 -2.187 . . . . 0.0 112.894 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.06 39.97 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 118.854 2.301 . . . . 0.0 118.854 164.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -98.19 163.57 12.68 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.539 1.536 . . . . 0.0 110.943 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -89.26 125.48 35.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.569 -1.332 . . . . 0.0 108.395 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.551 HG13 HG22 ' A' ' 42' ' ' ILE 0.26 2.9 p -102.48 120.16 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 165.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.8 -28.93 11.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.796 -1.19 . . . . 0.0 112.124 -173.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.46 161.69 42.26 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 121.635 -0.666 . . . . 0.0 112.459 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -139.6 122.82 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 121.269 -0.895 . . . . 0.0 110.54 -176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 60.61 26.8 16.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.439 1.927 . . . . 0.0 113.353 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.04 -0.57 89.39 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 125.713 1.625 . . . . 0.0 114.085 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.03 101.88 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.805 1.242 . . . . 0.0 108.132 -172.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -62.6 136.92 58.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.852 -1.155 . . . . 0.0 113.659 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.85 -43.81 91.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.065 0.946 . . . . 0.0 113.512 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 28.22 79.6 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.361 2.664 . . . . 0.0 117.939 158.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.66 -22.32 30.55 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.021 1.296 . . . . 0.0 114.69 -170.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.37 141.43 57.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -98.93 -153.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.814 2.046 . . . . 0.0 110.061 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -73.28 -50.68 20.88 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.8 -1.813 . . . . 0.0 110.918 167.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -64.32 -44.74 90.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 123.531 0.732 . . . . 0.0 112.757 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -31.87 72.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.641 -1.287 . . . . 0.0 114.25 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.09 94.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.319 -2.113 . . . . 0.0 114.756 170.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 86' ' ' ARG . 73.3 t -55.08 -56.24 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.197 0.999 . . . . 0.0 110.049 170.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 28.3 tt0 -48.04 -46.99 33.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.379 1.992 . . . . 0.0 116.379 175.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.5 m -62.47 -31.92 72.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.821 2.448 . . . . 0.0 113.58 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.5 mt -88.25 -40.78 13.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.53 -1.981 . . . . 0.0 113.668 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 82' ' ' VAL . 4.4 ppt_? -80.01 -38.74 31.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -166.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.64 29.7 1.12 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.87 -1.769 . . . . 0.0 111.705 -169.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 60.7 p -96.43 151.47 19.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.748 2.819 . . . . 0.0 109.854 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.25 -58.12 4.44 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.687 -1.258 . . . . 0.0 114.643 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -150.93 -67.52 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.651 -0.911 . . . . 0.0 112.297 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.96 128.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.643 1.211 . . . . 0.0 111.086 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.0 t -124.11 103.93 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.92 1.688 . . . . 0.0 106.977 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -81.37 103.61 11.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.768 -1.207 . . . . 0.0 109.379 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.04 115.8 22.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.461 -1.4 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.25 95.1 9.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 173.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.09 151.31 19.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.825 2.05 . . . . 0.0 110.708 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.37 147.67 49.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.522 1.129 . . . . 0.0 108.402 164.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -50.02 117.78 2.52 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.814 1.646 . . . . 0.0 114.511 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.36 70.46 3.15 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.803 -1.186 . . . . 0.0 113.073 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -124.75 158.85 32.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.646 1.178 . . . . 0.0 110.382 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.06 143.62 43.01 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 117.718 -1.134 . . . . 0.0 109.749 168.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo . . . . . 0 N--CA 1.433 -2.057 0 CA-C-N 123.293 2.212 . . . . 0.0 114.913 176.23 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 15.2 tp 78.74 -147.59 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.238 2.615 . . . . 0.0 109.343 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.678 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.341 8.8 m 21.72 80.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 130.948 3.699 . . . . 0.0 117.636 160.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 44.2 m -118.94 121.38 39.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 19.8 p -79.14 127.89 32.6 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.563 1.145 . . . . 0.0 110.508 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 86' ' ' ARG . 14.9 p . . . . . 0 C--O 1.26 1.655 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 -160.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 121.532 0.682 . . . . 0.0 109.299 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -129.06 163.06 48.34 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 126.778 2.031 . . . . 0.0 109.055 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.05 159.36 47.92 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.047 2.124 . . . . 0.0 113.175 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.71 0.16 87.87 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 115.752 1.061 . . . . 0.0 115.752 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.06 98.83 9.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.038 1.419 . . . . 0.0 113.618 -164.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p -91.51 155.58 18.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.474 -1.392 . . . . 0.0 110.948 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.51 121.48 16.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.398 1.079 . . . . 0.0 108.908 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -98.88 77.83 2.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.278 1.031 . . . . 0.0 109.729 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.4 t -84.4 132.24 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.871 2.868 . . . . 0.0 113.316 -171.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -110.51 124.75 52.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.886 -2.384 . . . . 0.0 111.8 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.52 150.87 48.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.576 -1.327 . . . . 0.0 110.375 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.11 104.97 12.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 122.181 0.991 . . . . 0.0 108.74 170.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.709 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.72 140.51 49.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.257 1.576 . . . . 0.0 115.257 -172.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 t -99.38 95.19 6.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.412 1.577 . . . . 0.0 110.138 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t70 56.73 58.11 4.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.753 2.021 . . . . 0.0 113.936 -174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.94 52.21 49.75 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.04 -1.038 . . . . 0.0 114.392 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -167.73 98.08 0.47 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.491 1.615 . . . . 0.0 107.647 -171.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.709 HD23 ' HB3' ' A' ' 20' ' ' LYS . 7.3 mt -73.53 -42.22 62.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.364 1.866 . . . . 0.0 106.753 168.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.7 43.65 0.95 Allowed Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.295 172.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 47' ' ' ILE . 32.3 pt -125.4 136.37 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-O 121.754 0.788 . . . . 0.0 109.462 169.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.402 ' HB3' HG22 ' B' ' 207' ' ' VAL . 4.1 m -82.25 118.09 22.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.941 -1.1 . . . . 0.0 111.716 161.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 m -89.48 120.46 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 116.744 2.128 . . . . 0.0 116.744 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.2 t -119.21 163.23 17.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.694 2.798 . . . . 0.0 109.796 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.1 -147.75 19.8 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 124.627 1.108 . . . . 0.0 112.412 -175.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.27 158.48 19.67 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.104 1.335 . . . . 0.0 111.01 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -61.6 -18.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 120.425 -1.633 . . . . 0.0 114.752 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -70.77 -26.87 63.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.365 -0.835 . . . . 0.0 112.298 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.15 12.45 30.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.242 1.017 . . . . 0.0 110.792 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.279 99.2 p 47.08 79.55 0.06 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 117.784 2.512 . . . . 0.0 117.784 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -110.23 116.43 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 120.643 -1.286 . . . . 0.0 108.206 -174.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 36.97 -103.36 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.875 2.07 . . . . 0.0 115.167 -163.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -132.16 38.74 3.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.786 -1.196 . . . . 0.0 112.145 171.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.78 107.51 3.06 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-O 122.926 1.292 . . . . 0.0 116.263 166.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -175.83 179.77 46.78 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 42' ' ' ILE . 3.6 tp -118.3 162.41 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -141.81 165.1 28.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -172.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 47' ' ' ILE . 6.3 t -89.02 135.93 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.494 -1.379 . . . . 0.0 112.338 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -73.04 0.55 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.98 -1.075 . . . . 0.0 108.929 164.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.57 126.01 51.72 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.444 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.443 HD13 HG22 ' A' ' 27' ' ' ILE . 25.9 mm -82.69 125.57 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 161.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -88.91 153.74 49.62 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.248 175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.34 106.6 1.05 Allowed 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.592 2.195 . . . . 0.0 113.754 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.322 30.4 pttt 45.5 62.8 2.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.241 3.016 . . . . 0.0 117.893 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.06 -81.9 0.82 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 120.822 -1.174 . . . . 0.0 111.064 172.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 -38.58 0.4 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.347 1.059 . . . . 0.0 110.365 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.6 57.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.469 1.908 . . . . 0.0 115.753 -176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -53.6 -43.28 68.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.864 1.316 . . . . 0.0 111.353 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -69.02 5.91 1.05 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.22 -78.15 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.385 -1.447 . . . . 0.0 108.944 156.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -39.51 0.45 Allowed Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -93.86 -19.6 20.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 mt -72.57 127.49 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.109 -1.619 . . . . 0.0 113.018 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -125.64 -178.32 4.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.949 1.3 . . . . 0.0 109.045 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -79.06 82.98 5.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 0.0 112.114 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.12 -8.71 0.33 Allowed Glycine 0 N--CA 1.431 -1.655 0 O-C-N 120.122 -1.611 . . . . 0.0 115.815 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.12 157.03 36.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 119.205 1.503 . . . . 0.0 114.266 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -91.65 132.51 36.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.911 1.284 . . . . 0.0 109.374 -178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 t -92.39 117.47 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 160.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.46 -31.53 11.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.666 -1.896 . . . . 0.0 112.218 172.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.56 160.51 43.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.341 -0.849 . . . . 0.0 112.13 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -136.62 118.58 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.047 -1.033 . . . . 0.0 111.037 -177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 58.52 26.77 14.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.178 -1.577 . . . . 0.0 113.946 -172.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.56 4.59 85.46 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 121.165 -0.959 . . . . 0.0 113.765 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -98.04 101.23 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 121.25 -1.147 . . . . 0.0 108.205 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 p -56.97 124.1 17.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.748 2.019 . . . . 0.0 112.759 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.12 -46.29 78.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.934 -1.104 . . . . 0.0 113.664 -171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 6.01 78.55 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.922 3.689 . . . . 0.0 117.68 167.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.8 -23.05 5.08 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.562 -1.336 . . . . 0.0 113.461 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.77 141.82 39.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.1 p -98.13 -161.6 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.789 1.635 . . . . 0.0 108.422 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -59.62 -48.0 83.37 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 119.874 -1.766 . . . . 0.0 112.511 164.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -71.04 -45.1 64.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.285 1.434 . . . . 0.0 111.68 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.52 -33.35 72.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.366 -1.459 . . . . 0.0 114.262 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.65 -37.85 88.89 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.663 -1.898 . . . . 0.0 114.402 172.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.7 t -54.48 -54.3 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 123.919 0.888 . . . . 0.0 111.047 171.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 55.0 mt-10 -59.06 -37.56 77.34 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.0 m -61.97 -27.72 69.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.358 1.863 . . . . 0.0 112.204 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.25 -41.93 10.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.473 1.509 . . . . 0.0 114.525 169.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HG3' ' HA ' ' A' ' 83' ' ' GLU 0.293 0.0 OUTLIER -88.7 -32.25 18.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -165.52 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -88.6 39.54 0.92 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.666 1.222 . . . . 0.0 111.647 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.0 p -105.81 170.81 7.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.696 1.999 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.22 -92.17 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.892 -1.13 . . . . 0.0 114.101 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -133.44 -48.22 0.83 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.552 -1.558 . . . . 0.0 109.263 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.31 121.12 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.976 1.37 . . . . 0.0 111.242 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.1 t -109.61 104.03 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -87.16 99.97 12.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.769 2.027 . . . . 0.0 107.486 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.06 124.59 31.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.363 -1.461 . . . . 0.0 109.892 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.39 100.55 13.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 167.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 146.32 26.91 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.47 1.908 . . . . 0.0 111.431 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -124.02 144.1 50.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.244 1.417 . . . . 0.0 108.807 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 130.52 15.05 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.69 72.05 2.46 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 119.767 -1.833 . . . . 0.0 113.538 168.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -162.14 157.76 23.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.75 152.46 37.81 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.176 -1.578 . . . . 0.0 110.418 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.3 -2.016 0 CA-C-N 123.527 2.295 . . . . 0.0 113.973 166.407 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 50.0 t80 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.57 -173.41 3.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 121.224 -0.923 . . . . 0.0 112.394 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 28' ' ' SER 0.405 3.8 t 71.33 114.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 124.22 1.962 . . . . 0.0 113.567 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 54.2 m -153.3 129.18 10.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 81.1 p -74.54 129.08 37.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.864 1.266 . . . . 0.0 110.079 172.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 86' ' ' ARG . 11.6 p . . . . . 0 C--O 1.26 1.608 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -161.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.431 -1.419 0 CA-C-O 121.296 0.57 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -148.54 158.36 40.44 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.61 135.9 22.66 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 C-N-CA 122.721 2.281 . . . . 0.0 112.867 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.43 27.2 73.01 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 125.133 1.349 . . . . 0.0 114.516 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.69 114.13 20.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.962 1.305 . . . . 0.0 111.268 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.8 p -88.33 145.67 25.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.024 1.392 . . . . 0.0 112.41 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.4 113.23 16.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 173.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -87.14 85.68 7.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 123.265 1.507 . . . . 0.0 109.949 170.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.16 152.91 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.133 2.173 . . . . 0.0 109.844 175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -128.32 131.67 48.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.103 -1.623 . . . . 0.0 108.716 164.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 167.99 16.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.64 134.47 51.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 157.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.569 ' HB3' ' H ' ' A' ' 24' ' ' SER . 24.0 mttt -61.61 136.49 58.03 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.077 1.351 . . . . 0.0 113.848 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -84.68 84.37 7.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.417 -1.427 . . . . 0.0 110.047 170.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.16 60.09 2.18 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.358 2.263 . . . . 0.0 114.602 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.72 48.72 60.11 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 120.714 -1.241 . . . . 0.0 115.044 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.569 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 40.3 t 176.96 106.7 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -166.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 7.7 mt -66.02 -47.27 74.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.898 2.285 . . . . 0.0 106.283 164.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.34 38.02 0.7 Allowed Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.296 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.15 127.87 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 121.796 0.808 . . . . 0.0 110.52 176.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -78.36 104.91 9.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.632 1.973 . . . . 0.0 113.149 165.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.4 m -83.08 125.11 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 t -118.57 161.43 20.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.757 2.423 . . . . 0.0 111.457 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.86 -145.3 21.59 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.129 1.347 . . . . 0.0 113.453 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.68 169.5 20.18 Favored Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 124.602 1.096 . . . . 0.0 111.017 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -66.95 -7.81 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -61.8 -27.2 68.59 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -138.76 -163.28 1.44 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.457 -0.777 . . . . 0.0 110.474 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.2 m -85.16 92.31 8.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.942 1.697 . . . . 0.0 111.673 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -103.48 -129.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -88.54 -99.71 0.09 Allowed 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.774 -1.829 . . . . 0.0 107.19 162.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -134.19 22.8 3.79 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.891 -1.755 . . . . 0.0 112.148 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.77 129.25 3.2 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.438 -1.414 . . . . 0.0 110.934 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.7 176.79 31.15 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 105.403 -3.079 . . . . 0.0 105.403 174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 65' ' ' VAL . 4.7 tp -116.17 157.17 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -131.57 161.7 32.03 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.649 -1.907 . . . . 0.0 106.562 -170.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 47' ' ' ILE . 85.4 t -86.67 128.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.962 1.305 . . . . 0.0 111.512 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -99.17 -35.6 9.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.735 -1.853 . . . . 0.0 111.739 173.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.02 133.85 11.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.569 0.699 . . . . 0.0 110.446 -175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.436 HD11 HG11 ' A' ' 44' ' ' VAL . 46.9 mm -100.44 115.78 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.7 pt -81.45 144.22 52.9 Favored Pre-proline 0 N--CA 1.43 -1.45 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.4 71.4 6.81 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 122.95 2.433 . . . . 0.0 112.189 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -111.86 -89.06 0.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 123.58 0.752 . . . . 0.0 108.973 164.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 50.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.724 -0.61 . . . . 0.0 113.855 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . -127.03 -72.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.895 -1.356 . . . . 0.0 108.479 164.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.94 85.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.068 -1.645 . . . . 0.0 113.102 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.07 -33.85 76.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.702 -1.249 . . . . 0.0 112.516 168.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.2 t -63.75 -20.43 65.75 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -68.78 -76.16 0.1 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.552 -1.342 . . . . 0.0 109.429 162.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.15 7.91 56.96 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.317 -0.864 . . . . 0.0 113.788 170.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -88.55 -18.69 27.57 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.91 -1.347 . . . . 0.0 109.711 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.97 153.34 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.634 1.574 . . . . 0.0 112.632 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 65.7 t60 -147.89 176.59 10.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 166.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 24.6 pttm -81.16 57.06 3.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 -169.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -166.48 0.94 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.552 -1.342 . . . . 0.0 114.841 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -80.11 166.47 21.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 118.982 1.391 . . . . 0.0 114.415 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -103.87 132.08 50.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.95 1.3 . . . . 0.0 109.234 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.483 HG13 HG22 ' A' ' 42' ' ' ILE . 2.8 p -105.37 125.0 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.719 -1.238 . . . . 0.0 107.809 167.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.99 -28.69 9.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.468 -1.395 . . . . 0.0 113.401 -175.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.22 161.0 42.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 120.007 1.276 . . . . 0.0 112.777 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 92' ' ' VAL . 65.7 t -133.63 116.76 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.264 1.026 . . . . 0.0 110.532 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 58.77 24.0 11.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.197 -1.564 . . . . 0.0 114.164 -173.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.71 4.93 84.78 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 124.573 1.083 . . . . 0.0 114.132 -171.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 t -96.29 102.21 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.8 p -55.35 135.27 50.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.761 2.024 . . . . 0.0 115.168 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 mt -74.74 -54.51 7.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.837 -1.165 . . . . 0.0 110.8 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -5.07 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.262 3.825 . . . . 0.0 117.897 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.22 -19.02 6.46 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -163.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.26 138.98 37.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 120.675 -1.486 . . . . 0.0 114.748 -176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.8 t -110.71 -161.0 0.73 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.279 2.231 . . . . 0.0 106.391 177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -61.57 -51.83 66.92 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.466 -2.021 . . . . 0.0 112.793 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -66.51 -49.97 64.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.015 -1.053 . . . . 0.0 112.239 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 177.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.22 93.67 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.291 -2.13 . . . . 0.0 114.4 173.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.2 t -59.45 -50.72 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 118.434 -0.793 . . . . 0.0 111.03 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -47.22 -47.58 24.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.594 1.543 . . . . 0.0 115.03 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.7 m -62.99 -36.45 83.57 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.456 2.702 . . . . 0.0 114.533 -177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -90.98 -44.36 9.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.817 1.247 . . . . 0.0 113.73 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -52.12 13.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.81 2.044 . . . . 0.0 112.599 -170.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -89.17 38.31 0.89 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.489 1.614 . . . . 0.0 112.531 -166.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.5 p -91.57 -168.91 2.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.097 2.959 . . . . 0.0 108.944 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -89.6 -116.89 1.63 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.122 -1.611 . . . . 0.0 110.542 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -105.65 -47.7 3.84 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.72 -0.871 . . . . 0.0 109.951 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.61 129.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.111 -0.993 . . . . 0.0 111.77 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.621 HG13 HG13 ' A' ' 68' ' ' VAL . 79.6 t -122.64 108.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 40.8 m80 -78.99 109.78 13.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.786 -1.196 . . . . 0.0 108.585 163.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -89.02 120.23 30.25 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.643 -1.286 . . . . 0.0 110.536 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.33 97.26 11.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.23 142.14 35.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.544 1.938 . . . . 0.0 110.52 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -115.34 140.4 49.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.786 1.634 . . . . 0.0 108.912 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.07 115.44 4.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.858 1.663 . . . . 0.0 113.853 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.44 48.32 3.56 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.321 -1.487 . . . . 0.0 112.428 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -120.02 137.71 53.93 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.079 1.351 . . . . 0.0 109.179 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -84.35 156.91 62.57 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 124.965 1.306 . . . . 0.0 111.765 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 N--CA 1.434 -2.021 0 C-N-CA 123.065 2.51 . . . . 0.0 114.458 178.766 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.0 tp 75.98 155.3 0.16 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.831 2.453 . . . . 0.0 115.026 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.356 4.9 t 74.46 120.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 123.936 1.826 . . . . 0.0 114.813 167.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.3 m -143.15 132.17 22.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.9 p -82.93 129.99 35.09 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.882 1.273 . . . . 0.0 109.244 173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.642 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -164.653 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.431 -1.412 0 CA-C-O 121.1 0.476 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -127.32 -159.1 0.03 OUTLIER Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -63.71 112.47 1.81 Allowed 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 124.359 2.592 . . . . 0.0 111.536 155.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 137.34 57.63 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -166.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -159.0 163.06 36.77 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -68.82 152.65 45.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.951 -1.718 . . . . 0.0 113.824 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 96' ' ' LEU 0.299 0.1 OUTLIER -136.25 129.15 31.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.648 1.179 . . . . 0.0 108.681 171.384 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -105.97 79.8 1.46 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.626 1.203 . . . . 0.0 109.64 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.6 t -76.21 159.37 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 126.986 2.114 . . . . 0.0 110.796 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 0.1 OUTLIER -125.74 129.91 50.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 119.949 -1.72 . . . . 0.0 108.386 164.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.3 mt -125.88 164.95 19.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.102 1.761 . . . . 0.0 110.096 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.15 112.92 14.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.274 1.03 . . . . 0.0 109.587 167.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -56.51 144.71 30.44 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.225 2.21 . . . . 0.0 115.849 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -113.08 117.94 33.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.992 1.317 . . . . 0.0 108.253 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 36.05 51.73 0.79 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.422 2.689 . . . . 0.0 117.522 -166.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.86 48.05 22.97 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.276 -1.515 . . . . 0.0 114.565 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -172.48 111.25 0.25 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.082 1.42 . . . . 0.0 107.298 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.32 -45.3 73.34 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.322 2.249 . . . . 0.0 108.057 167.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 123.68 41.0 0.44 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.176 167.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.64 135.83 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.983 0.896 . . . . 0.0 110.646 170.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -85.68 114.21 22.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.263 1.025 . . . . 0.0 109.666 163.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -83.02 137.2 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.0 t -127.98 165.77 19.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.652 1.981 . . . . 0.0 110.075 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.84 -149.11 39.2 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.888 1.233 . . . . 0.0 112.893 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' H ' HG11 ' A' ' 37' ' ' VAL . . . 121.66 168.11 13.31 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 177.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.77 -21.71 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.837 -1.39 . . . . 0.0 113.759 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -71.34 -29.22 64.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.577 -1.327 . . . . 0.0 113.64 176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 m -117.51 74.6 0.94 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.5 m -25.09 106.81 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.072 2.949 . . . . 0.0 118.366 -167.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.466 HG11 ' H ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -92.91 -98.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.975 1.71 . . . . 0.0 111.34 -166.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -123.08 -79.55 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 163.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -125.9 144.05 50.83 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 158.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 24.8 -69.44 0.0 OUTLIER Glycine 0 N--CA 1.43 -1.712 1 C-N-CA 132.742 4.973 . . . . 0.0 121.267 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -30.24 141.28 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 130.038 3.685 . . . . 0.0 119.998 -173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 tp -94.08 167.51 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 0.0 109.768 -170.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -136.4 158.79 43.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.228 -2.17 . . . . 0.0 107.722 -176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.624 HG11 ' CD1' ' A' ' 47' ' ' ILE . 4.2 t -89.5 128.82 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.813 -1.179 . . . . 0.0 111.12 175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -88.51 -63.08 1.35 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.01 -1.056 . . . . 0.0 110.07 170.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.21 133.83 54.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.206 1.402 . . . . 0.0 110.125 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.624 ' CD1' HG11 ' A' ' 44' ' ' VAL . 30.4 mm -97.83 135.89 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.281 1.832 . . . . 0.0 108.274 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.741 HD12 ' HA2' ' A' ' 26' ' ' GLY . 55.8 mt -75.34 132.36 76.24 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 117.323 -1.322 . . . . 0.0 111.213 174.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -61.66 94.4 0.12 Allowed 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 123.409 2.739 . . . . 0.0 114.575 168.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 74.4 51.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.871 2.069 . . . . 0.0 113.983 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -83.82 -119.33 0.74 Allowed Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 161.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.44 -40.73 4.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.228 -1.16 . . . . 0.0 111.221 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.77 60.93 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.55 -34.4 70.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.057 1.408 . . . . 0.0 111.71 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -72.09 1.27 7.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -72.51 -74.15 0.17 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.615 -1.928 . . . . 0.0 107.541 156.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.79 -18.5 2.58 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.521 -0.737 . . . . 0.0 113.486 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -92.99 -15.73 25.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 123.474 0.71 . . . . 0.0 112.48 -173.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -80.86 133.79 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.048 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.29 177.45 8.61 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 122.188 0.994 . . . . 0.0 111.031 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -63.91 104.15 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.932 1.693 . . . . 0.0 112.441 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.44 -31.31 2.34 Favored Glycine 0 N--CA 1.429 -1.818 0 O-C-N 120.696 -1.253 . . . . 0.0 115.191 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -72.73 161.18 31.06 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 118.507 1.154 . . . . 0.0 113.71 -170.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -98.69 134.44 41.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.48 1.112 . . . . 0.0 110.894 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.38 114.11 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.771 1.628 . . . . 0.0 107.072 171.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.78 -27.86 12.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.699 -1.876 . . . . 0.0 113.973 -173.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -159.35 166.68 30.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 119.073 0.851 . . . . 0.0 112.501 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 HG22 ' A' ' 84' ' ' THR . 4.1 p -146.31 135.35 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 112.077 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.0 m120 56.41 20.22 4.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.382 -2.074 . . . . 0.0 115.93 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.1 11.1 79.35 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.255 -1.528 . . . . 0.0 115.383 -168.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 t -109.43 106.26 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.107 1.763 . . . . 0.0 109.485 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.8 p -62.16 141.51 58.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.0 mt -85.41 34.31 0.57 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.227 -1.546 . . . . 0.0 113.214 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -72.74 103.19 3.56 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.5 -2.0 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.1 13.58 58.72 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 121.376 -0.827 . . . . 0.0 114.079 -175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.35 140.03 29.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.673 -1.486 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -95.05 -163.62 1.07 Allowed 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.131 1.772 . . . . 0.0 110.408 -175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -59.97 -54.42 46.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.973 -1.704 . . . . 0.0 112.749 164.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -67.35 -44.79 78.18 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.25 -0.906 . . . . 0.0 111.951 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -68.2 -33.89 75.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.84 -39.32 93.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.695 -1.878 . . . . 0.0 113.727 170.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.4 -53.98 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 122.995 0.518 . . . . 0.0 111.135 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -69.45 -20.13 63.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.464 HG22 HG12 ' A' ' 68' ' ' VAL . 95.7 m -63.81 -36.08 82.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.686 1.595 . . . . 0.0 110.756 168.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.27 -40.0 12.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.312 1.445 . . . . 0.0 114.717 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.459 0.0 OUTLIER -72.83 -43.42 62.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.874 -2.391 . . . . 0.0 116.546 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -87.87 47.41 1.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.007 1.384 . . . . 0.0 111.102 -174.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.0 p -102.09 175.29 5.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.39 2.676 . . . . 0.0 111.417 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -109.34 75.51 0.21 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 124.802 1.191 . . . . 0.0 111.654 175.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 69.22 -50.61 0.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.068 2.547 . . . . 0.0 117.382 169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.86 135.21 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 125.631 1.572 . . . . 0.0 109.772 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.457 HG13 ' CG2' ' A' ' 68' ' ' VAL . 2.1 t -119.32 107.31 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.4 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.594 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 75.5 m80 -79.02 103.03 8.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.729 -1.232 . . . . 0.0 109.329 162.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -85.39 117.36 24.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.386 1.474 . . . . 0.0 109.343 -174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.78 102.94 15.64 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 121.694 0.759 . . . . 0.0 109.39 167.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.445 HD13 ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -104.82 145.32 30.55 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.521 1.928 . . . . 0.0 110.862 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.76 120.79 43.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 163.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -76.65 126.18 30.53 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.73 -1.231 . . . . 0.0 107.691 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -46.58 -76.25 0.14 Allowed Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 116.4 1.32 . . . . 0.0 116.4 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.291 13.5 pt20 178.34 45.21 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.844 1.657 . . . . 0.0 111.837 149.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.2 t -95.31 118.95 66.21 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 120.202 -1.561 . . . . 0.0 110.844 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo . . . . . 0 N--CA 1.434 -2.011 0 C-N-CA 123.141 2.561 . . . . 0.0 111.613 160.699 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 8.3 tp 70.38 172.03 0.31 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.625 1.97 . . . . 0.0 113.831 -176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.445 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.461 19.5 m 46.68 91.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 128.12 2.568 . . . . 0.0 117.023 170.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 22.5 m -128.88 126.58 40.06 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 42.4 m -62.78 123.36 18.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.868 2.467 . . . . 0.0 109.239 170.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--O 1.26 1.651 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 -172.544 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.43 -1.468 0 CA-C-O 122.39 1.091 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -124.78 150.46 65.75 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 126.632 1.973 . . . . 0.0 106.729 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -67.56 112.02 2.5 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-N 123.829 2.403 . . . . 0.0 116.082 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.08 18.99 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.231 0.919 . . . . 0.0 114.162 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -72.4 123.19 22.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.207 1.403 . . . . 0.0 111.799 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 p -96.67 132.97 41.79 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.508 -1.37 . . . . 0.0 111.299 174.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 111.4 16.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.169 1.388 . . . . 0.0 108.94 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -87.96 75.0 8.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.344 1.458 . . . . 0.0 110.842 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.42 121.26 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.397 -1.439 . . . . 0.0 114.033 -171.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -100.89 132.41 46.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.758 -1.839 . . . . 0.0 112.192 170.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.61 178.57 8.72 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.13 148.56 43.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.53 -1.356 . . . . 0.0 109.845 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 146.29 24.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 113.021 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 t -96.63 85.2 3.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.911 1.338 . . . . 0.0 108.91 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 55.71 72.96 0.45 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.253 1.821 . . . . 0.0 115.015 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.0 50.54 60.96 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.267 1.413 . . . . 0.0 114.324 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.6 t -169.96 98.08 0.29 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -169.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.54 HD11 HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -75.16 -47.05 30.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.054 1.883 . . . . 0.0 105.956 164.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.587 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 116.11 46.39 0.55 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.114 171.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 pt -118.09 134.85 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.003 0.921 . . . . 0.0 109.429 166.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -88.99 112.66 23.63 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.574 1.15 . . . . 0.0 109.951 166.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 m -79.23 143.65 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -138.08 171.33 14.56 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.699 -1.876 . . . . 0.0 109.001 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.98 -133.4 11.78 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 125.011 1.291 . . . . 0.0 112.815 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.36 154.71 29.89 Favored Glycine 0 N--CA 1.429 -1.769 0 C-N-CA 123.985 0.803 . . . . 0.0 112.566 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.8 p -58.81 -28.57 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.402 1.481 . . . . 0.0 113.751 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -79.5 -15.36 57.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.814 -1.179 . . . . 0.0 112.276 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 m -91.14 -23.58 20.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.716 -1.24 . . . . 0.0 109.379 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.0 m 74.01 93.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.228 2.611 . . . . 0.0 111.402 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.01 49.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.123 0.969 . . . . 0.0 110.542 -168.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 72.02 -52.24 0.7 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.531 2.333 . . . . 0.0 113.396 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 40' ' ' GLY . 38.4 t-80 -114.07 -140.92 0.38 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.241 1.416 . . . . 0.0 107.328 160.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' H ' ' CG ' ' A' ' 39' ' ' HIS . . . -140.5 43.18 1.14 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 120.086 -1.634 . . . . 0.0 113.378 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 -175.69 31.11 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 124.0 0.81 . . . . 0.0 111.972 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.281 2.4 tp -111.54 159.1 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.257 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -139.48 157.45 45.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 47' ' ' ILE . 53.9 t -82.33 137.9 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.552 -1.967 . . . . 0.0 110.592 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -100.31 -53.29 3.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.941 -1.1 . . . . 0.0 109.851 165.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.52 146.65 48.3 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.939 0.876 . . . . 0.0 111.231 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 44' ' ' VAL . 47.1 mm -110.79 133.63 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.465 1.906 . . . . 0.0 109.21 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.587 HD12 ' HA2' ' A' ' 26' ' ' GLY . 62.3 mt -74.71 133.65 76.39 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.522 -1.704 . . . . 0.0 110.762 174.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.75 95.67 0.24 Allowed 'Trans proline' 0 N--CA 1.433 -2.032 0 C-N-CA 123.543 2.829 . . . . 0.0 114.047 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp 63.23 47.33 4.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 127.743 2.417 . . . . 0.0 116.008 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.24 -70.25 1.33 Allowed Glycine 0 N--CA 1.431 -1.657 0 O-C-N 120.932 -1.105 . . . . 0.0 112.34 170.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.31 -48.43 0.27 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.659 -0.906 . . . . 0.0 110.86 170.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.62 -45.11 72.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.936 1.694 . . . . 0.0 115.513 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.62 -33.64 68.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.927 -1.733 . . . . 0.0 111.737 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t -72.7 6.33 2.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -63.84 -88.55 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.001 -1.687 . . . . 0.0 106.888 149.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.33 -21.78 0.95 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.893 -1.129 . . . . 0.0 112.122 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -85.82 -35.56 20.59 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 121.365 -1.079 . . . . 0.0 111.145 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 mt -60.4 125.22 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.524 1.53 . . . . 0.0 113.102 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.49 -177.06 4.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.586 1.154 . . . . 0.0 109.412 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -76.62 89.89 3.35 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.086 -1.634 . . . . 0.0 111.434 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.95 -21.17 0.37 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.707 -1.246 . . . . 0.0 114.964 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -68.2 155.32 39.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 114.71 29.03 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.711 2.004 . . . . 0.0 109.43 -168.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.27 112.68 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.225 -1.547 . . . . 0.0 108.743 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.61 -31.75 11.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.451 -1.406 . . . . 0.0 112.962 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.76 160.25 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.637 1.108 . . . . 0.0 112.553 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 t -137.2 127.32 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 56.85 27.02 12.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.027 1.74 . . . . 0.0 114.608 -174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.1 18.73 79.78 Favored Glycine 0 N--CA 1.43 -1.766 0 O-C-N 120.598 -1.314 . . . . 0.0 113.644 -172.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.35 102.22 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.7 t -60.76 138.06 58.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.2 mt -86.19 82.12 8.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -110.09 42.09 1.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.315 2.007 . . . . 0.0 110.308 -170.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.17 55.44 0.18 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.01 141.94 43.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.013 0.911 . . . . 0.0 108.581 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.8 p -96.09 -163.84 1.09 Allowed 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 125.757 1.623 . . . . 0.0 109.572 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -62.04 -54.67 38.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.47 -1.394 . . . . 0.0 111.713 165.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -67.8 -42.9 80.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.6 tt0 -63.97 -46.49 84.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 -34.8 77.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.91 -53.74 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 121.709 -0.619 . . . . 0.0 111.285 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.41 -30.87 71.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 59.4 m -60.3 -28.92 68.49 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.465 1.506 . . . . 0.0 112.303 171.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.54 HD22 HD11 ' A' ' 25' ' ' LEU . 14.0 mt -88.34 -47.0 8.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.02 -1.675 . . . . 0.0 113.355 168.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -88.07 -27.88 21.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -162.097 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -86.9 18.98 3.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.627 -1.296 . . . . 0.0 113.217 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.0 p -88.29 170.49 10.94 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.978 2.511 . . . . 0.0 111.396 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.15 -90.13 0.21 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.373 -1.455 . . . . 0.0 115.238 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -129.44 -57.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.598 -1.531 . . . . 0.0 110.321 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.24 136.82 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 122.041 0.924 . . . . 0.0 111.028 173.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.3 t -121.69 109.66 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 168.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -85.54 102.67 13.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.644 1.178 . . . . 0.0 109.284 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -87.65 120.03 28.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.769 -1.832 . . . . 0.0 110.439 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.85 97.72 11.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.911 -1.118 . . . . 0.0 108.663 169.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.38 145.8 28.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.466 1.906 . . . . 0.0 110.41 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.62 144.18 46.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.769 1.228 . . . . 0.0 108.971 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.97 120.0 11.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -172.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.94 56.72 5.07 Favored Glycine 0 N--CA 1.429 -1.798 0 O-C-N 120.77 -1.206 . . . . 0.0 113.643 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -139.74 158.39 44.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.356 1.862 . . . . 0.0 108.299 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.67 171.39 4.84 Favored Pre-proline 0 N--CA 1.429 -1.475 0 C-N-CA 125.517 1.527 . . . . 0.0 110.433 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo . . . . . 0 C--N 1.299 -2.034 0 C-N-CA 123.122 2.548 . . . . 0.0 113.645 164.237 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.4 tp 64.78 -157.17 0.3 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.897 2.079 . . . . 0.0 111.871 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.576 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.359 13.5 m 29.27 101.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.781 3.232 . . . . 0.0 119.071 157.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -132.57 123.68 26.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.0 p -75.5 119.93 20.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.692 1.597 . . . . 0.0 110.793 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.566 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.431 -1.399 0 CA-C-O 121.737 0.78 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -119.91 177.53 1.37 Allowed Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 163.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -68.02 94.21 0.4 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 CA-C-N 124.799 2.75 . . . . 0.0 112.186 168.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.87 50.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -149.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.607 1.563 . . . . 0.0 108.821 -175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 p -78.33 125.94 30.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -173.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.06 126.12 51.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.385 2.674 . . . . 0.0 109.147 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.24 67.16 1.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.222 1.409 . . . . 0.0 110.83 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.38 112.64 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -165.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 93' ' ' HIS . 5.5 tt0 -93.1 118.81 31.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.432 -2.043 . . . . 0.0 111.418 175.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.6 169.65 17.18 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.612 1.165 . . . . 0.0 109.351 175.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.31 150.13 32.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.783 1.633 . . . . 0.0 110.006 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.96 174.2 9.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.163 -0.961 . . . . 0.0 112.101 -170.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.8 t -110.89 103.87 12.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.124 -1.61 . . . . 0.0 107.361 168.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t70 34.42 67.48 0.22 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.523 2.729 . . . . 0.0 117.18 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.36 48.35 45.7 Favored Glycine 0 N--CA 1.429 -1.808 0 O-C-N 119.961 -1.712 . . . . 0.0 115.069 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 m -175.98 111.15 0.1 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -69.56 -45.56 68.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.153 1.781 . . . . 0.0 108.094 167.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.501 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 106.01 45.13 1.31 Allowed Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.774 1.178 . . . . 0.0 110.799 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -125.8 141.96 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 163.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 m -90.37 126.17 35.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 110.505 164.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.47 148.83 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -149.38 167.8 25.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.341 -1.475 . . . . 0.0 108.743 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.19 -138.21 14.21 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.854 -1.154 . . . . 0.0 112.704 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.86 167.57 28.3 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.218 0.913 . . . . 0.0 113.776 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -49.85 -37.45 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.609 1.964 . . . . 0.0 113.3 171.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -55.02 -40.99 70.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.819 2.448 . . . . 0.0 116.289 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.9 t -93.71 -6.31 46.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.545 -1.347 . . . . 0.0 110.923 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 m 64.62 90.8 0.08 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.288 1.835 . . . . 0.0 112.862 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 m -93.25 -142.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 125.029 1.331 . . . . 0.0 107.791 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 ttm-85 -88.77 91.38 8.79 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.627 -1.921 . . . . 0.0 108.46 166.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 66.58 -65.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.188 2.595 . . . . 0.0 115.524 -171.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.34 118.49 0.62 Allowed Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 106.529 -2.628 . . . . 0.0 106.529 -162.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.7 150.24 8.69 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 42' ' ' ILE . 3.9 tp -107.93 156.86 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -131.7 161.09 33.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 -173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.548 HG11 HD13 ' A' ' 47' ' ' ILE . 35.4 t -91.87 134.17 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.577 -1.327 . . . . 0.0 109.497 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -85.48 -57.26 3.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.586 172.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.85 129.23 25.76 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 123.919 0.888 . . . . 0.0 110.628 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.548 HD13 HG11 ' A' ' 44' ' ' VAL . 35.0 mm -91.7 122.86 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.698 1.599 . . . . 0.0 109.181 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.501 HD12 ' CA ' ' A' ' 26' ' ' GLY . 54.2 mt -67.49 133.98 92.9 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.018 176.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.31 91.45 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 123.314 2.676 . . . . 0.0 112.166 171.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.268 10.8 mmmm 68.48 78.85 0.22 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.13 2.572 . . . . 0.0 115.203 -173.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.15 -134.16 8.25 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 106.336 -2.706 . . . . 0.0 106.336 148.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.34 -39.36 12.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.655 -1.497 . . . . 0.0 111.468 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.46 -48.19 67.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.503 1.921 . . . . 0.0 115.876 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.32 -30.47 66.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.126 -1.608 . . . . 0.0 112.344 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 t -71.34 3.94 3.31 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.351 1.982 . . . . 0.0 116.351 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -59.41 -84.23 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.438 -1.414 . . . . 0.0 109.378 155.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.67 -45.81 0.26 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 121.174 -0.953 . . . . 0.0 111.551 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -86.54 -39.9 15.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -53.68 130.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 -163.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 53.0 t60 -127.38 175.17 8.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.543 1.937 . . . . 0.0 110.833 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 51.0 mttp -86.11 40.96 0.9 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.058 1.743 . . . . 0.0 113.558 -169.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.26 38.58 0.09 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.258 -1.526 . . . . 0.0 110.864 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -103.45 158.1 16.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.07 1.348 . . . . 0.0 109.719 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.69 134.07 42.12 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 123.79 0.836 . . . . 0.0 109.229 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -97.12 110.54 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 163.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.75 -27.86 15.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.96 -1.713 . . . . 0.0 112.187 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.25 160.21 41.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 111.39 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.6 t -137.37 121.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.938 -1.101 . . . . 0.0 110.297 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.373 0.8 OUTLIER 43.02 34.29 0.61 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.415 2.376 . . . . 0.0 117.415 -173.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.34 60.64 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 124.284 0.945 . . . . 0.0 114.008 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.83 98.64 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.629 1.572 . . . . 0.0 107.225 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.6 p -62.36 142.52 57.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.854 -1.154 . . . . 0.0 113.352 173.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.9 mt -87.28 30.74 0.76 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.56 -1.337 . . . . 0.0 112.726 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.38 97.43 2.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.489 1.916 . . . . 0.0 109.061 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.16 -3.21 33.28 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.337 0.97 . . . . 0.0 114.986 -173.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -92.73 140.95 29.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.943 1.872 . . . . 0.0 114.378 -176.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.511 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 80.6 p -101.99 -163.0 0.97 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.503 2.321 . . . . 0.0 109.863 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.01 -53.21 53.65 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.214 -1.554 . . . . 0.0 111.343 166.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.1 -45.19 82.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.605 -0.684 . . . . 0.0 112.727 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.511 ' HB2' ' H ' ' A' ' 77' ' ' THR . 1.6 mm-40 -61.05 -43.07 99.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.79 -1.194 . . . . 0.0 113.253 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.22 94.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.956 -1.715 . . . . 0.0 115.411 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.4 t -59.43 -48.67 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 121.481 -0.762 . . . . 0.0 111.365 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.05 -36.69 84.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.643 -1.286 . . . . 0.0 114.104 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.5 m -63.59 -26.56 68.74 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 125.897 1.679 . . . . 0.0 113.351 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.33 -42.58 11.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.974 -1.704 . . . . 0.0 113.596 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.57 -22.77 23.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.054 -1.654 . . . . 0.0 115.291 -169.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.71 37.51 1.92 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.61 -1.931 . . . . 0.0 111.28 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.5 p -87.76 -171.58 3.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.627 2.371 . . . . 0.0 111.207 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.42 62.54 0.3 Allowed Glycine 0 N--CA 1.431 -1.693 0 O-C-N 120.508 -1.37 . . . . 0.0 112.52 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 72.88 -54.05 0.7 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.301 2.641 . . . . 0.0 114.567 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 t -82.49 132.07 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-O 123.071 1.415 . . . . 0.0 109.98 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.1 t -117.76 109.72 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 17' ' ' GLU . 8.4 m80 -84.62 102.01 12.58 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.902 -1.123 . . . . 0.0 108.434 170.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.5 110.89 21.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.424 -1.422 . . . . 0.0 111.56 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.9 89.31 7.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.398 1.094 . . . . 0.0 108.318 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.9 mt -103.79 148.61 25.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.88 2.472 . . . . 0.0 111.633 -173.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -135.37 140.69 45.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.824 -1.173 . . . . 0.0 109.528 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -82.7 61.8 5.98 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.358 -1.464 . . . . 0.0 113.134 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.2 -88.34 0.15 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.069 -1.644 . . . . 0.0 113.135 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 179.2 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.457 2.303 . . . . 0.0 110.393 163.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.5 m -93.06 165.45 18.5 Favored Pre-proline 0 N--CA 1.43 -1.473 0 C-N-CA 124.696 1.198 . . . . 0.0 111.656 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 N--CA 1.434 -1.998 0 C-N-CA 122.502 2.135 . . . . 0.0 115.762 -179.466 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 47.5 p90 . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 121.705 0.764 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 3.3 tp -88.4 -156.96 0.4 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.353 1.461 . . . . 0.0 110.161 -178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.495 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.52 33.4 m 66.65 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 127.823 2.449 . . . . 0.0 117.543 174.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 99.6 m -152.55 118.45 5.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 91.1 p -78.65 128.62 33.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 122.403 1.097 . . . . 0.0 109.935 171.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.261 1.658 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 -156.386 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 18.1 mmt . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.26 138.94 33.27 Favored Pre-proline 0 N--CA 1.429 -1.484 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.55 121.01 5.78 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 122.552 2.168 . . . . 0.0 112.204 -165.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.45 38.1 79.55 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 121.438 -0.789 . . . . 0.0 114.3 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -80.51 129.88 34.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.849 1.26 . . . . 0.0 111.138 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -82.97 124.31 30.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 120.943 -1.098 . . . . 0.0 112.654 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.05 129.38 56.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.5 1.52 . . . . 0.0 107.483 170.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.46 84.44 3.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.929 1.292 . . . . 0.0 108.815 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.8 107.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 127.215 2.206 . . . . 0.0 111.662 -171.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.27 112.75 24.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.826 -1.796 . . . . 0.0 109.643 -174.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.8 mt -122.94 150.75 42.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 -172.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.43 110.5 20.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 164.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 148.34 37.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.544 1.138 . . . . 0.0 113.709 -173.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 t -102.33 97.18 7.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.427 -1.421 . . . . 0.0 109.96 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 60.49 50.12 6.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.787 2.035 . . . . 0.0 112.57 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.81 55.69 25.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 120.352 -1.467 . . . . 0.0 113.934 -172.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -165.87 112.33 0.89 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.236 1.493 . . . . 0.0 107.005 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.697 HD21 HG21 ' A' ' 92' ' ' VAL . 6.9 mt -67.33 -49.61 63.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.482 1.913 . . . . 0.0 106.258 162.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.96 39.06 0.66 Allowed Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.954 -1.476 . . . . 0.0 111.562 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.446 ' HB ' HG13 ' A' ' 44' ' ' VAL . 44.8 pt -123.9 132.28 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 121.673 0.749 . . . . 0.0 109.817 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -77.22 117.4 18.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.443 -0.785 . . . . 0.0 111.742 159.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.36 128.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 115.724 1.749 . . . . 0.0 115.724 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t -130.19 169.69 15.04 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.379 1.471 . . . . 0.0 108.898 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.82 58.87 7.67 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.472 2.149 . . . . 0.0 118.472 169.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.52 -176.63 34.18 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.34 -1.683 . . . . 0.0 109.604 172.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.43 -29.95 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -68.6 -34.57 76.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.4 p -94.68 14.76 20.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.478 -1.389 . . . . 0.0 113.58 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.3 m 67.82 63.27 0.4 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.216 1.806 . . . . 0.0 114.244 173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.8 m -87.52 -133.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 124.339 1.056 . . . . 0.0 111.343 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -82.92 -57.15 3.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.577 -1.952 . . . . 0.0 110.258 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -136.3 -89.66 0.29 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 156.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.54 -131.71 6.88 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 164.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.71 -172.27 34.01 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-O 121.911 0.728 . . . . 0.0 111.904 -168.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.5 tp -148.05 161.35 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 161.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -135.71 161.24 36.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.528 -1.982 . . . . 0.0 106.739 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.61 HG11 HD13 ' A' ' 47' ' ' ILE . 10.9 t -92.44 129.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.031 -1.668 . . . . 0.0 111.643 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -88.67 -49.31 6.94 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.808 -1.182 . . . . 0.0 111.429 169.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.47 126.92 28.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.845 -1.159 . . . . 0.0 110.626 -170.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.61 HD13 HG11 ' A' ' 44' ' ' VAL . 34.3 mm -96.07 119.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 pt -84.37 145.66 45.84 Favored Pre-proline 0 N--CA 1.431 -1.407 0 O-C-N 120.841 -1.162 . . . . 0.0 112.735 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.94 77.83 3.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.877 2.385 . . . . 0.0 113.254 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -125.34 -89.43 0.57 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 121.386 -0.821 . . . . 0.0 109.06 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.25 58.54 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.72 0 O-C-N 120.306 -1.496 . . . . 0.0 116.262 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.64 -62.45 1.02 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 153.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.57 -50.96 65.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.715 1.606 . . . . 0.0 114.454 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -56.96 -34.43 68.04 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.683 -1.26 . . . . 0.0 111.915 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 t -72.51 -6.33 43.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -73.54 -75.45 0.15 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.632 -1.918 . . . . 0.0 108.552 164.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.76 -10.19 12.43 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.399 -0.813 . . . . 0.0 114.238 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 -81.74 -23.74 36.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.78 -0.835 . . . . 0.0 111.395 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.99 139.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.165 1.786 . . . . 0.0 112.868 176.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -138.32 -167.91 2.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.248 1.023 . . . . 0.0 108.758 166.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -80.78 75.95 7.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.328 -1.483 . . . . 0.0 111.967 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.38 13.3 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.747 -1.221 . . . . 0.0 116.126 173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -81.97 158.95 23.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.488 1.644 . . . . 0.0 113.18 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.65 114.17 27.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.236 1.415 . . . . 0.0 110.616 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.96 117.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.383 -1.448 . . . . 0.0 108.075 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -97.21 -39.46 9.26 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 121.003 -1.061 . . . . 0.0 112.163 173.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.524 ' HB3' HD12 ' A' ' 95' ' ' LEU . . . -156.2 166.21 34.12 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.118 1.326 . . . . 0.0 114.279 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG21 HD23 ' A' ' 85' ' ' LEU . 9.1 t -135.16 122.56 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 121.053 -1.029 . . . . 0.0 110.644 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 49.13 30.77 3.12 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -167.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.85 27.79 57.97 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 120.503 -1.373 . . . . 0.0 113.813 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.83 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 56.7 m -60.53 136.76 58.15 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 125.123 1.369 . . . . 0.0 114.59 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.97 53.11 1.9 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.169 1.788 . . . . 0.0 113.446 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.44 117.95 23.41 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.654 1.582 . . . . 0.0 108.198 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.86 9.53 86.51 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 120.87 -1.144 . . . . 0.0 115.727 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.76 140.29 29.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.865 1.317 . . . . 0.0 112.659 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 p -100.6 -164.89 1.15 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.968 1.707 . . . . 0.0 109.222 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -60.17 -57.33 13.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.446 -1.409 . . . . 0.0 112.651 163.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.61 -43.82 95.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.159 -0.963 . . . . 0.0 112.968 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.3 -37.04 86.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.759 -1.213 . . . . 0.0 113.471 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.87 89.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.314 -1.491 . . . . 0.0 114.986 170.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.3 t -57.84 -53.21 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 121.69 -0.631 . . . . 0.0 112.108 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -57.76 -37.93 74.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.3 m -64.23 -30.17 71.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.53 2.332 . . . . 0.0 113.294 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.42 HD23 HG21 ' A' ' 68' ' ' VAL . 24.8 mt -88.47 -43.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.99 -1.694 . . . . 0.0 113.771 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -48.46 11.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.784 1.634 . . . . 0.0 114.976 -162.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -81.12 18.98 0.96 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.719 1.208 . . . . 0.0 113.723 -169.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.1 p -85.02 177.1 8.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.182 2.593 . . . . 0.0 112.08 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.87 -77.82 0.28 Allowed Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.167 -1.583 . . . . 0.0 115.217 -175.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -154.29 -54.33 0.1 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 121.529 -0.983 . . . . 0.0 108.982 171.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.44 128.08 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.846 1.308 . . . . 0.0 111.006 170.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.697 HG21 HD21 ' A' ' 25' ' ' LEU . 2.7 m -118.42 112.2 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.977 1.711 . . . . 0.0 107.53 166.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -78.85 95.22 5.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.685 -1.259 . . . . 0.0 107.71 164.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 117.3 15.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.791 -1.193 . . . . 0.0 113.063 175.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.524 HD12 ' HB3' ' A' ' 67' ' ' ALA . 7.1 mt -86.04 95.64 9.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.8 mt -104.19 130.64 51.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.902 2.881 . . . . 0.0 111.688 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -105.94 140.24 39.25 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.778 -1.202 . . . . 0.0 110.24 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -70.89 111.35 6.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.111 1.364 . . . . 0.0 113.121 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.82 70.43 2.55 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 120.708 -1.245 . . . . 0.0 113.394 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.97 164.47 28.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.286 -1.126 . . . . 0.0 110.766 -177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.3 t -79.27 140.25 56.59 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 126.737 2.015 . . . . 0.0 112.328 -175.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo . . . . . 0 N--CA 1.433 -2.078 0 C-N-CA 123.934 3.089 . . . . 0.0 115.116 169.408 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.43 -1.449 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 0.7 OUTLIER -125.01 -121.6 0.26 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.266 1.027 . . . . 0.0 110.831 -176.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.451 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.521 30.1 m 66.46 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 127.571 2.348 . . . . 0.0 116.932 171.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 80.3 m -152.82 125.6 8.37 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 78.7 p -76.91 126.43 30.96 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.592 1.157 . . . . 0.0 108.404 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.26 1.613 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 -161.575 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.598 ' N ' ' HZ3' ' A' ' 98' ' ' LYS . 63.5 ttp . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -99.03 144.21 27.79 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 124.88 1.272 . . . . 0.0 108.412 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -64.5 116.52 3.81 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 123.389 2.246 . . . . 0.0 115.494 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.1 36.48 40.52 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 124.062 0.839 . . . . 0.0 114.671 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -76.17 130.52 38.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.892 -1.358 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.48 117.14 31.07 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 120.139 -1.6 . . . . 0.0 112.019 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.312 0.0 OUTLIER -106.62 136.88 45.65 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.591 1.556 . . . . 0.0 110.075 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -117.64 76.72 1.08 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.068 1.347 . . . . 0.0 108.423 -173.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.68 137.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 126.851 2.06 . . . . 0.0 111.233 -172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.13 127.64 53.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.354 2.343 . . . . 0.0 110.093 167.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.5 128.8 49.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.207 1.003 . . . . 0.0 110.156 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.1 90.88 6.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.219 1.009 . . . . 0.0 109.313 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.08 137.52 58.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -104.05 105.19 15.28 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.82 1.295 . . . . 0.0 109.413 -160.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 54.78 37.33 28.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.198 2.199 . . . . 0.0 114.958 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.62 88.62 0.25 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.794 -1.191 . . . . 0.0 112.371 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.284 51.9 p 149.32 112.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.727 2.411 . . . . 0.0 109.519 -173.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 20' ' ' LYS . 8.0 mt -73.28 -43.16 61.51 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 156.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.94 17.81 3.31 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.545 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.3 pt -105.8 126.22 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 122.013 0.911 . . . . 0.0 111.09 -173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -79.31 109.68 13.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.06 1.344 . . . . 0.0 111.469 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.64 127.62 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.4 t -134.07 178.93 6.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.697 2.399 . . . . 0.0 108.699 173.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.11 39.94 35.96 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 119.881 -1.762 . . . . 0.0 117.26 168.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.48 -179.88 49.31 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.092 -1.828 . . . . 0.0 113.606 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.81 -8.69 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.288 1.835 . . . . 0.0 114.345 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -65.51 -33.18 75.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.764 -1.835 . . . . 0.0 114.314 170.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -99.23 -166.7 1.38 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.931 -1.106 . . . . 0.0 108.685 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 57.8 m -103.25 92.32 4.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.871 -1.768 . . . . 0.0 109.354 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -104.9 179.0 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -53.97 -64.34 0.86 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -161.28 59.89 0.28 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.684 -1.26 . . . . 0.0 110.009 167.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.16 130.44 4.3 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-O 123.295 1.497 . . . . 0.0 110.728 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 179.04 -169.98 41.54 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 169.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 42' ' ' ILE . 6.4 tp -136.32 156.18 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 155.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -137.12 154.56 50.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -171.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 47' ' ' ILE . 11.9 t -84.08 131.94 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 119.694 -1.879 . . . . 0.0 111.067 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -86.33 -52.66 5.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 109.956 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.43 140.43 41.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.224 -0.922 . . . . 0.0 111.696 -174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 44' ' ' VAL . 46.3 mm -97.61 127.57 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 126.503 1.921 . . . . 0.0 106.789 169.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 pt -78.74 157.15 77.17 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 121.194 -0.941 . . . . 0.0 112.092 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.61 84.59 0.62 Allowed 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 121.922 1.748 . . . . 0.0 115.575 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.287 0.0 OUTLIER 86.29 82.71 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.506 2.322 . . . . 0.0 112.978 165.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.96 -116.12 3.09 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.57 -37.55 4.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.462 1.105 . . . . 0.0 112.282 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.73 72.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.121 -1.612 . . . . 0.0 113.228 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.68 -26.84 64.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.618 1.567 . . . . 0.0 112.424 165.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -80.93 -9.49 59.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.437 -2.039 . . . . 0.0 115.788 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -76.22 -62.45 1.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.748 2.067 . . . . 0.0 106.049 156.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.62 -9.68 62.45 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 121.499 -0.75 . . . . 0.0 112.935 162.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -74.23 -28.77 61.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 123.66 0.784 . . . . 0.0 109.174 166.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.7 mt -61.71 128.08 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 126.938 2.095 . . . . 0.0 110.716 165.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.598 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 70.9 t60 -127.7 -161.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.109 0.963 . . . . 0.0 109.665 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.598 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 95.1 mttt -92.45 66.27 4.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.555 -2.59 . . . . 0.0 111.12 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.92 53.5 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.45 -0.781 . . . . 0.0 114.911 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -109.83 173.68 6.22 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.778 1.231 . . . . 0.0 108.898 168.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -103.89 136.43 43.56 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.034 0.934 . . . . 0.0 110.377 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.63 119.39 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.41 -34.21 8.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.864 -1.772 . . . . 0.0 113.161 177.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.58 153.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.119 1.327 . . . . 0.0 112.9 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.6 t -133.92 111.96 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 112.102 -174.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.74 31.19 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.437 -1.415 . . . . 0.0 113.744 -166.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.42 80.7 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.123 1.344 . . . . 0.0 113.921 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.75 102.04 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.992 -1.299 . . . . 0.0 107.584 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 m -65.75 137.1 57.04 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 126.136 1.774 . . . . 0.0 114.359 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.2 mt -86.99 26.39 1.16 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.561 1.544 . . . . 0.0 113.009 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -68.21 118.16 10.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.573 -1.955 . . . . 0.0 110.023 171.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.28 6.53 86.1 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 120.954 -1.091 . . . . 0.0 115.201 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.37 137.94 32.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 118.945 1.372 . . . . 0.0 111.744 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 t -113.64 -168.15 1.3 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.916 -2.624 . . . . 0.0 103.916 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -54.62 -52.0 63.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.603 -1.936 . . . . 0.0 114.647 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -67.31 -46.24 74.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.242 -0.912 . . . . 0.0 112.978 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -60.99 -46.44 90.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.497 1.519 . . . . 0.0 114.809 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.29 -34.63 78.57 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.371 -1.456 . . . . 0.0 114.404 177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.12 -54.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.151 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -55.48 -47.71 75.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.2 m -52.56 -33.16 44.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 126.283 1.833 . . . . 0.0 115.182 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 mt -92.2 -46.7 7.61 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.176 1.79 . . . . 0.0 115.449 173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.11 -37.05 55.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.592 2.357 . . . . 0.0 114.586 -172.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -86.54 30.49 0.71 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.157 -1.59 . . . . 0.0 112.363 -170.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.6 p -106.19 176.78 5.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.761 2.424 . . . . 0.0 109.361 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.42 -74.63 1.28 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 119.444 -2.035 . . . . 0.0 113.954 -173.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -139.91 -66.36 0.45 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.966 -1.314 . . . . 0.0 110.068 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -73.59 115.35 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.17 1.462 . . . . 0.0 110.605 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.8 t -105.74 103.56 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.23 97.77 8.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.594 1.158 . . . . 0.0 109.133 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.29 114.01 22.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.829 1.652 . . . . 0.0 108.993 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.96 103.85 16.42 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mt -108.97 142.84 39.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.317 1.847 . . . . 0.0 110.408 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -114.04 129.45 56.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.564 1.146 . . . . 0.0 108.034 171.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.598 ' HZ3' ' N ' ' A' ' 8' ' ' MET . 17.3 tptm -71.76 122.81 21.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.539 1.936 . . . . 0.0 113.264 -171.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.94 66.88 3.04 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 117.196 1.638 . . . . 0.0 117.196 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -127.88 154.3 45.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.261 1.424 . . . . 0.0 109.278 166.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.12 144.4 28.56 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.117 1.367 . . . . 0.0 110.28 -172.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo . . . . . 0 N--CA 1.434 -1.992 0 C-N-CA 122.346 2.031 . . . . 0.0 114.903 171.854 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 123.081 1.42 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.72 -156.06 0.68 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.389 2.7 t 66.86 91.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 124.943 2.306 . . . . 0.0 113.016 173.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 90.4 m -136.61 128.62 29.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.193 -2.891 . . . . 0.0 103.193 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 57.7 m -72.89 120.03 17.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.261 1.668 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 -175.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 17.0 ptm . . . . . 0 N--CA 1.431 -1.384 0 CA-C-O 122.307 1.051 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -130.59 159.01 72.93 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.271 -1.518 . . . . 0.0 109.845 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 147.12 25.65 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.478 2.118 . . . . 0.0 111.694 163.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.31 61.53 2.78 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 124.566 1.079 . . . . 0.0 113.496 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -142.42 99.28 3.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.881 1.273 . . . . 0.0 108.198 -169.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -84.01 132.32 34.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.558 -1.339 . . . . 0.0 111.93 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -115.72 126.57 54.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.8 1.64 . . . . 0.0 107.739 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -99.69 85.39 3.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.979 1.371 . . . . 0.0 108.312 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.7 t -81.1 115.52 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.668 1.987 . . . . 0.0 111.594 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.05 118.53 36.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.289 -2.132 . . . . 0.0 110.761 -174.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.4 mt -126.02 -178.86 4.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.557 1.143 . . . . 0.0 108.973 -170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.43 126.86 30.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 162.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.57 53.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 120.9 -1.125 . . . . 0.0 112.755 -174.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.8 t -97.23 92.8 6.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.439 1.59 . . . . 0.0 109.543 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.38 25.82 12.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.004 1.722 . . . . 0.0 114.31 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.3 65.46 1.32 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 124.677 1.132 . . . . 0.0 112.662 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.3 t 179.33 113.94 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -175.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.3 mt -78.58 -36.26 44.64 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.357 2.027 . . . . 0.0 106.466 162.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.545 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 101.82 43.93 2.02 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -128.3 133.64 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.5 m -89.34 108.03 19.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.683 1.593 . . . . 0.0 111.736 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 m -77.89 137.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -171.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.1 t -133.07 166.32 22.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.316 -1.49 . . . . 0.0 110.37 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.49 -130.86 10.27 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 125.106 1.336 . . . . 0.0 112.645 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.52 160.68 30.35 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 124.529 1.061 . . . . 0.0 112.049 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 m -70.87 11.89 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.808 -1.995 . . . . 0.0 115.729 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -70.08 -39.37 75.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.312 -1.492 . . . . 0.0 111.367 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.2 p -99.55 -155.53 0.51 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.883 1.273 . . . . 0.0 110.101 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.0 m -119.06 81.99 1.79 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.008 -1.683 . . . . 0.0 108.069 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -118.03 81.61 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 123.757 1.741 . . . . 0.0 110.305 -167.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 67.41 -109.4 0.12 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.788 1.635 . . . . 0.0 109.267 -168.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -146.83 52.24 1.1 Allowed 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.58 -1.325 . . . . 0.0 111.264 160.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.37 122.82 4.45 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-O 122.845 1.247 . . . . 0.0 114.921 166.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 164.11 177.24 36.69 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 105.936 -2.865 . . . . 0.0 105.936 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tp -115.34 154.94 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 119.489 1.645 . . . . 0.0 106.936 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -138.79 148.75 44.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.315 -2.116 . . . . 0.0 105.853 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 47' ' ' ILE . 69.9 t -73.39 127.56 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 O-C-N 120.622 -1.299 . . . . 0.0 111.505 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -88.23 -66.05 0.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.725 -1.235 . . . . 0.0 108.722 166.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.93 133.53 53.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.527 1.131 . . . . 0.0 111.711 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 44' ' ' VAL . 51.0 mm -93.44 137.1 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 169.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.545 HD12 ' CA ' ' A' ' 26' ' ' GLY . 54.5 mt -78.59 143.09 62.74 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.525 -1.703 . . . . 0.0 110.726 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -63.4 94.66 0.17 Allowed 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.486 2.79 . . . . 0.0 112.946 166.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.325 48.9 mtmt 43.84 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.446 2.698 . . . . 0.0 117.346 -169.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.22 -136.18 9.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 151.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.52 -44.69 18.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.255 -1.733 . . . . 0.0 113.732 178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 120.786 1.63 . . . . 0.0 113.314 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 p -55.18 -27.28 44.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.644 2.09 . . . . 0.0 116.644 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.17 -73.8 0.06 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.872 1.269 . . . . 0.0 111.173 170.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.44 -9.92 14.8 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 121.667 -0.646 . . . . 0.0 112.95 164.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -79.17 -27.69 42.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.135 -1.215 . . . . 0.0 110.557 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.408 HG13 ' H ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -69.98 146.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.549 1.939 . . . . 0.0 114.434 179.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -148.58 -171.59 3.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.833 -1.167 . . . . 0.0 109.317 166.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -78.12 93.74 4.59 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.902 -2.373 . . . . 0.0 112.569 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.38 -19.24 0.26 Allowed Glycine 0 N--CA 1.429 -1.782 0 O-C-N 121.023 -1.048 . . . . 0.0 114.467 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -70.05 153.43 43.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -172.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 0.0 OUTLIER -105.51 121.3 43.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.407 1.575 . . . . 0.0 111.325 -172.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.22 109.48 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.418 2.687 . . . . 0.0 106.232 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.09 -37.07 9.48 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.192 -0.943 . . . . 0.0 112.488 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.93 166.5 33.35 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.979 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' A' ' 92' ' ' VAL . 4.8 p -142.54 123.57 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 121.311 -0.868 . . . . 0.0 113.023 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.24 30.89 3.32 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.82 22.4 66.45 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.608 -1.308 . . . . 0.0 114.329 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.81 98.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -67.0 137.59 56.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 125.106 1.362 . . . . 0.0 112.554 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -75.63 61.16 1.32 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.069 1.748 . . . . 0.0 113.679 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -71.1 110.18 5.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.192 1.397 . . . . 0.0 111.56 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.65 30.53 78.18 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.717 1.151 . . . . 0.0 115.6 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.54 140.45 29.73 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.762 1.281 . . . . 0.0 112.821 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.5 p -97.96 -157.44 0.6 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.698 1.999 . . . . 0.0 109.934 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -72.0 -45.23 61.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.421 -2.049 . . . . 0.0 109.754 168.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -53.21 55.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.327 1.051 . . . . 0.0 111.645 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -70.07 -26.9 64.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.06 -40.07 78.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.481 -2.012 . . . . 0.0 113.644 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG12 ' HG2' ' A' ' 86' ' ' ARG . 24.0 t -57.88 -52.56 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.16 -0.963 . . . . 0.0 110.184 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.406 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 62.1 mt-10 -54.02 -41.19 67.73 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 60.5 m -57.25 -39.31 75.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.905 2.082 . . . . 0.0 114.452 175.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mt -92.21 -28.4 17.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.842 1.257 . . . . 0.0 113.252 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG2' HG12 ' A' ' 82' ' ' VAL . 4.4 ppt_? -86.6 -47.98 8.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -91.02 43.98 1.17 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.667 1.699 . . . . 0.0 110.473 -171.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 57.8 p -95.94 -152.8 0.38 Allowed 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.103 2.961 . . . . 0.0 109.609 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.14 -137.42 9.56 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.144 -1.598 . . . . 0.0 110.43 172.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -92.9 -51.48 5.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.522 1.129 . . . . 0.0 109.055 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.76 132.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.976 1.37 . . . . 0.0 110.139 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 68' ' ' VAL . 4.5 t -124.01 111.76 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 168.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -80.66 103.55 10.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.126 1.371 . . . . 0.0 107.772 160.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -83.27 108.77 16.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.716 2.007 . . . . 0.0 108.284 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.7 102.57 11.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 110.722 169.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -109.6 147.97 32.1 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.392 2.277 . . . . 0.0 110.228 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -128.88 152.21 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.172 1.789 . . . . 0.0 106.425 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.64 141.53 46.51 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.87 -6.36 85.29 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 125.975 1.75 . . . . 0.0 113.243 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -80.14 65.52 5.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.805 1.642 . . . . 0.0 110.381 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.91 164.12 49.87 Favored Pre-proline 0 N--CA 1.431 -1.422 0 C-N-CA 126.678 1.991 . . . . 0.0 113.001 -172.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo . . . . . 0 C--N 1.3 -1.984 0 CA-C-N 121.782 1.672 . . . . 0.0 115.586 -173.342 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 43.1 t80 . . . . . 0 N--CA 1.43 -1.437 0 CA-C-O 121.442 0.639 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.606 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.0 tp -138.89 -162.13 1.28 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.104 0.962 . . . . 0.0 109.331 -172.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.606 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.394 10.9 m 31.71 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 130.308 3.443 . . . . 0.0 118.213 164.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 82.2 m -119.47 124.15 45.79 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 36.9 t -67.98 112.43 4.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.519 1.128 . . . . 0.0 108.562 164.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 25' ' ' LEU . 13.1 p . . . . . 0 C--O 1.26 1.624 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 -167.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 121.074 0.464 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -101.92 139.02 19.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 CA-C-O 116.968 -1.491 . . . . 0.0 107.479 166.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -58.57 115.55 2.62 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 123.472 2.276 . . . . 0.0 116.835 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.36 2.49 6.39 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.214 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -89.63 109.72 20.66 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 120.079 1.94 . . . . 0.0 110.121 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -96.69 155.81 16.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 111.575 172.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -133.87 133.43 41.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -111.4 76.03 0.95 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.967 1.307 . . . . 0.0 108.939 -177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.72 118.91 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 C-N-CA 125.712 1.605 . . . . 0.0 114.543 -169.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.268 6.3 pm0 -99.68 126.39 45.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.466 -2.021 . . . . 0.0 111.977 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 169.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.62 148.17 33.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.519 1.128 . . . . 0.0 110.697 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 146.88 28.42 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 111.005 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -94.45 93.07 7.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.528 -1.357 . . . . 0.0 108.244 170.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 45.81 67.72 0.7 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.257 2.623 . . . . 0.0 115.861 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.82 42.7 77.97 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 121.507 -0.746 . . . . 0.0 113.862 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.4 p -167.89 106.18 0.51 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.848 1.785 . . . . 0.0 108.49 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.13 -47.23 59.1 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 162.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.87 27.77 1.67 Allowed Glycine 0 N--CA 1.431 -1.686 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.186 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.9 pt -109.13 122.93 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 122.998 1.38 . . . . 0.0 109.541 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -84.51 110.54 18.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.176 1.39 . . . . 0.0 109.209 171.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 m -80.9 138.43 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.477 ' HA ' HD11 ' B' ' 206' ' ' LEU . 9.2 t -133.51 171.63 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.017 1.727 . . . . 0.0 108.281 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.42 -143.73 18.05 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 124.985 1.279 . . . . 0.0 113.163 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.6 159.39 28.82 Favored Glycine 0 N--CA 1.431 -1.661 0 O-C-N 121.562 -0.963 . . . . 0.0 111.808 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -54.33 -32.75 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.052 1.741 . . . . 0.0 114.503 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -89.59 -11.43 42.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.492 -1.38 . . . . 0.0 113.253 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 m -88.82 -96.24 0.1 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.93 -1.106 . . . . 0.0 110.01 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.8 t -159.82 80.81 0.72 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.74 -1.85 . . . . 0.0 109.528 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.38 -167.73 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.807 -1.183 . . . . 0.0 108.834 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -72.92 -69.06 0.44 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.005 1.322 . . . . 0.0 110.875 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.03 -1.64 0.24 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.276 -1.515 . . . . 0.0 114.289 165.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.51 117.52 0.48 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.555 -1.966 . . . . 0.0 109.667 -175.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.05 145.44 4.3 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 tp -102.88 158.8 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 167.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -133.94 158.73 42.74 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.576 -1.952 . . . . 0.0 105.914 -171.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 47' ' ' ILE . 3.3 t -89.7 134.49 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.578 -1.951 . . . . 0.0 109.873 174.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.44 -39.16 10.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.356 -1.465 . . . . 0.0 110.923 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.67 20.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.555 -0.716 . . . . 0.0 111.265 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.506 HD13 HG11 ' A' ' 44' ' ' VAL . 30.9 mm -99.01 135.02 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.6 1.96 . . . . 0.0 107.3 171.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt -100.71 147.47 33.69 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.6 73.08 6.19 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 123.101 2.534 . . . . 0.0 113.189 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -110.17 -85.91 0.54 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.065 -1.022 . . . . 0.0 111.732 170.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.53 38.66 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.311 -1.493 . . . . 0.0 114.236 -173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.23 -75.66 0.52 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.82 -36.69 82.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.141 -1.599 . . . . 0.0 115.114 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.36 -29.77 70.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.496 -1.378 . . . . 0.0 111.583 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.35 -0.86 15.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 115.405 1.632 . . . . 0.0 115.405 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.73 -84.83 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.735 -1.853 . . . . 0.0 108.447 158.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.57 -1.54 15.81 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.759 -1.213 . . . . 0.0 113.353 168.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -95.05 -31.9 13.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.023 -1.281 . . . . 0.0 110.237 169.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.36 139.54 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.131 -1.605 . . . . 0.0 114.594 174.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -127.54 177.47 6.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.982 0.896 . . . . 0.0 109.213 160.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -74.63 50.78 0.44 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.25 -1.53 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.154 -2.216 . . . . 0.0 115.666 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -76.01 161.73 28.65 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 118.567 1.183 . . . . 0.0 114.175 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -96.0 131.9 41.9 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.736 1.214 . . . . 0.0 109.869 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.48 115.36 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 168.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.35 -35.83 12.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.196 -1.565 . . . . 0.0 111.915 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.98 156.8 41.91 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.009 0.822 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.16 119.94 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 121.007 -1.058 . . . . 0.0 109.948 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.74 28.12 16.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.119 -1.613 . . . . 0.0 114.186 -168.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.91 0.7 90.41 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 125.035 1.302 . . . . 0.0 113.486 -173.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.6 t -97.33 104.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.155 -1.203 . . . . 0.0 109.163 -172.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -53.4 137.17 36.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.357 2.263 . . . . 0.0 115.697 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.24 25.55 1.6 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.736 -1.227 . . . . 0.0 112.584 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -75.7 111.57 11.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.011 -1.68 . . . . 0.0 110.574 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.45 -1.67 72.92 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.777 -0.577 . . . . 0.0 113.039 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.22 138.66 31.4 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.552 1.644 . . . . 0.0 111.59 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.486 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 3.8 t -117.57 -171.7 2.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.677 2.391 . . . . 0.0 104.836 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 t-160 -48.96 -52.65 23.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.844 1.658 . . . . 0.0 114.856 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -70.42 -47.74 59.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.755 1.161 . . . . 0.0 113.188 -175.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' HB2' ' H ' ' A' ' 77' ' ' THR . 5.1 mm100 -50.67 -49.35 57.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.554 1.542 . . . . 0.0 114.474 168.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.61 84.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.436 -1.415 . . . . 0.0 114.5 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.417 HG13 HG11 ' B' ' 210' ' ' VAL . 65.1 t -62.53 -48.19 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 121.339 -0.851 . . . . 0.0 111.512 175.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -58.14 -39.0 77.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.212 -1.555 . . . . 0.0 113.592 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.5 m -64.56 -26.81 68.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.518 2.327 . . . . 0.0 113.715 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.46 -47.02 7.67 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.349 1.459 . . . . 0.0 114.087 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.269 0.1 OUTLIER -79.62 -35.09 39.98 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -169.361 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.75 40.31 1.03 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.436 -2.04 . . . . 0.0 111.61 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.1 p -101.2 159.07 15.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.75 2.42 . . . . 0.0 111.663 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.09 65.09 4.17 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 121.165 -0.959 . . . . 0.0 112.103 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 67.46 -48.09 0.5 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 129.319 3.048 . . . . 0.0 116.133 -178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.2 t -80.5 131.66 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.775 1.274 . . . . 0.0 110.874 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.415 HG12 ' HG ' ' A' ' 94' ' ' LEU . 60.9 t -117.73 109.18 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -88.4 101.15 13.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.935 -1.103 . . . . 0.0 109.153 171.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.415 ' HG ' HG12 ' A' ' 92' ' ' VAL . 15.2 mt -90.37 122.62 33.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.864 -1.148 . . . . 0.0 111.627 -173.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.07 102.95 14.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.7 mt -112.47 142.52 44.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.507 1.923 . . . . 0.0 110.583 -171.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.65 142.09 50.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.207 2.203 . . . . 0.0 108.512 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -67.79 127.12 31.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.4 69.69 1.5 Allowed Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 125.154 1.359 . . . . 0.0 111.671 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -130.42 166.21 20.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.944 1.298 . . . . 0.0 110.164 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.24 160.41 42.77 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.362 1.465 . . . . 0.0 110.479 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 N--CA 1.434 -2.006 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 176.798 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.477 HD11 ' HA ' ' A' ' 30' ' ' THR . 10.5 tp 77.15 173.43 0.21 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.288 2.635 . . . . 0.0 114.2 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.407 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.491 5.9 m 52.82 100.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.103 2.961 . . . . 0.0 117.827 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 53.5 m -130.62 118.93 21.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 76.2 p -77.67 122.83 25.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.575 1.15 . . . . 0.0 109.244 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.633 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 -175.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 121.764 0.793 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -138.2 147.45 55.9 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 175.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.71 105.23 1.27 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.66 2.343 . . . . 0.0 116.19 -168.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.47 39.81 97.82 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 124.762 1.172 . . . . 0.0 113.739 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.01 135.75 44.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.146 0.978 . . . . 0.0 111.727 -172.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 p -89.52 120.68 31.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.37 1.081 . . . . 0.0 111.23 174.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 114.74 26.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 174.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -92.29 83.45 5.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 174.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.24 153.39 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 127.761 2.425 . . . . 0.0 110.339 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.15 129.52 50.96 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.513 -1.992 . . . . 0.0 108.321 167.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.8 mt -128.75 161.72 29.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 123.998 0.919 . . . . 0.0 109.689 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.74 117.13 26.67 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.032 0.92 . . . . 0.0 108.863 163.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' H ' ' HG2' ' A' ' 20' ' ' LYS . 1.2 ptmm? -62.84 126.25 26.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.051 1.74 . . . . 0.0 113.087 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -96.48 118.27 32.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.989 -1.069 . . . . 0.0 108.709 -171.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 64.34 -19.93 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.29 2.236 . . . . 0.0 117.006 -171.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.75 53.26 0.11 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.971 1.748 . . . . 0.0 110.682 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 m -177.81 126.87 0.13 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.623 -2.732 . . . . 0.0 103.623 -173.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' B' ' 210' ' ' VAL . 8.2 mt -84.02 -39.4 19.68 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.393 2.277 . . . . 0.0 106.724 172.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA2' HD11 ' A' ' 48' ' ' ILE . . . 131.97 6.17 3.28 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 124.298 0.951 . . . . 0.0 113.22 170.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.9 pt -102.0 127.55 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 122.428 1.108 . . . . 0.0 111.13 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -81.49 109.8 16.29 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.075 1.35 . . . . 0.0 112.102 168.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -84.91 125.95 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -172.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.5 t -120.22 160.84 22.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.938 2.095 . . . . 0.0 110.843 175.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.08 -125.14 8.24 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.668 1.604 . . . . 0.0 112.441 176.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.15 140.72 11.43 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 177.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 40' ' ' GLY . 9.1 m -56.5 -27.56 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.898 1.279 . . . . 0.0 114.28 -167.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' HB2' HG22 ' A' ' 77' ' ' THR . 63.1 t30 -47.22 -55.34 8.76 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 128.064 2.545 . . . . 0.0 116.275 -167.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 p -140.96 -77.75 0.29 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -168.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -41.82 -46.75 4.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.575 3.15 . . . . 0.0 117.648 -171.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.8 m -91.31 -6.9 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 O-C-N 119.934 -1.729 . . . . 0.0 112.854 -174.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 61.34 52.75 3.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.031 2.132 . . . . 0.0 112.751 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.367 17.9 m-70 59.51 132.46 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.395 2.278 . . . . 0.0 116.174 -164.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.418 ' H ' HG12 ' A' ' 33' ' ' VAL . . . -178.23 -107.09 0.21 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.976 -2.328 . . . . 0.0 113.776 -162.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -172.92 -157.03 13.65 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 107.354 -2.298 . . . . 0.0 107.354 -177.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.517 HG22 HG13 ' A' ' 65' ' ' VAL 0.287 2.3 tp -114.61 157.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.043 1.421 . . . . 0.0 108.701 175.432 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -140.6 157.25 45.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.892 -1.755 . . . . 0.0 106.614 -171.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 47' ' ' ILE . 6.2 t -88.73 127.37 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.305 -1.497 . . . . 0.0 112.2 174.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -83.27 -50.42 8.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.656 -1.277 . . . . 0.0 109.907 171.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.06 138.87 37.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -174.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.539 HD13 HG11 ' A' ' 44' ' ' VAL . 29.1 mm -97.03 145.58 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 126.121 1.768 . . . . 0.0 107.184 171.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.542 HD11 ' HA2' ' A' ' 26' ' ' GLY . 2.2 pt -99.05 138.97 20.69 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 110.776 169.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.3 67.31 8.63 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.491 2.127 . . . . 0.0 110.895 171.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 168.16 73.63 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.866 2.066 . . . . 0.0 110.098 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 177.04 164.98 31.7 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 118.628 -2.545 . . . . 0.0 109.453 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.14 84.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.746 2.019 . . . . 0.0 114.475 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.13 72.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.322 -1.486 . . . . 0.0 113.916 -177.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.74 -32.99 72.26 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.274 1.43 . . . . 0.0 112.195 169.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -61.62 -28.54 69.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.32 -75.04 0.05 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.932 1.242 . . . . 0.0 111.797 176.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.16 -30.71 2.42 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 112.1 168.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 -86.58 -20.97 27.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.14 -1.212 . . . . 0.0 113.644 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.6 mt -71.75 133.89 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.159 1.784 . . . . 0.0 112.073 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -150.33 -159.75 1.08 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.638 -1.288 . . . . 0.0 110.557 165.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -75.76 129.03 36.41 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.215 -1.553 . . . . 0.0 112.1 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.75 23.24 56.42 Favored Glycine 0 N--CA 1.428 -1.839 0 O-C-N 120.151 -1.593 . . . . 0.0 114.965 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -94.85 148.14 22.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.289 -1.124 . . . . 0.0 109.821 168.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -90.99 129.8 36.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 121.04 -1.038 . . . . 0.0 109.976 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG13 HG22 ' A' ' 42' ' ' ILE . 1.5 p -104.19 119.91 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 165.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.87 -31.57 11.43 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.754 -1.216 . . . . 0.0 112.852 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.34 158.2 43.48 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 119.04 0.836 . . . . 0.0 112.418 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 HG13 ' A' ' 92' ' ' VAL . 61.1 t -135.49 120.86 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 121.189 -0.945 . . . . 0.0 111.027 -177.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 54.94 29.79 12.82 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.412 1.485 . . . . 0.0 114.44 -170.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.77 22.36 77.15 Favored Glycine 0 N--CA 1.431 -1.659 0 O-C-N 121.037 -1.039 . . . . 0.0 114.117 -173.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.48 101.94 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.619 1.567 . . . . 0.0 107.86 177.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -66.19 143.49 57.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.843 -1.16 . . . . 0.0 113.915 177.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.39 62.0 3.61 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.902 1.681 . . . . 0.0 112.783 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.33 123.33 37.67 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.837 1.655 . . . . 0.0 108.539 177.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.5 -7.6 57.11 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.626 -1.296 . . . . 0.0 114.487 -171.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.93 129.26 34.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.128 1.918 . . . . 0.0 114.755 -169.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 34' ' ' ASN . 73.1 p -96.17 -163.48 1.05 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.471 1.909 . . . . 0.0 108.415 -175.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.4 -51.66 66.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.986 -1.696 . . . . 0.0 112.374 163.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -66.61 -42.19 87.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.122 -0.986 . . . . 0.0 112.723 -177.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 77' ' ' THR . 5.9 tt0 -69.84 -34.32 73.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 175.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.73 -33.43 75.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.217 -2.177 . . . . 0.0 114.097 171.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.59 -53.01 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 121.429 -0.794 . . . . 0.0 110.832 169.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -52.13 -41.36 62.46 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.418 1.463 . . . . 0.0 114.837 175.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.7 m -62.41 -29.95 70.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.65 2.38 . . . . 0.0 114.542 178.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.47 -40.95 9.21 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 172.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -50.55 15.06 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.534 2.334 . . . . 0.0 112.73 -171.262 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -91.44 42.55 1.11 Allowed 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.977 1.37 . . . . 0.0 110.622 -168.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 32.1 p -102.44 164.7 11.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.51 2.324 . . . . 0.0 111.341 -174.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -86.04 58.23 4.77 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.759 -1.213 . . . . 0.0 113.125 178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 71.16 -48.23 0.67 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.945 2.898 . . . . 0.0 116.858 172.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.49 128.29 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.596 1.188 . . . . 0.0 109.478 171.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.429 HG13 HG13 ' A' ' 68' ' ' VAL . 95.3 t -117.63 99.27 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -78.92 105.89 10.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.807 -1.183 . . . . 0.0 107.964 166.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.0 mt -88.89 125.49 34.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.187 -1.571 . . . . 0.0 110.544 -177.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.42 102.09 14.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.967 -1.083 . . . . 0.0 108.567 166.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.32 148.29 24.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.2 1.8 . . . . 0.0 111.713 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -116.37 138.75 51.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 162.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -67.86 126.1 28.38 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 123.618 0.767 . . . . 0.0 112.982 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -21.57 76.0 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 124.883 1.23 . . . . 0.0 114.497 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -84.32 104.89 14.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.149 1.78 . . . . 0.0 109.641 172.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.2 105.12 49.45 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 121.258 -0.901 . . . . 0.0 111.637 -173.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--N 1.299 -2.042 0 N-CA-C 118.04 2.284 . . . . 0.0 118.04 162.98 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 20.2 tp -86.82 157.55 19.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.301 -1.499 . . . . 0.0 111.087 172.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.41 2.2 t 78.92 122.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.077 1.894 . . . . 0.0 114.565 166.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 93.1 m -147.21 125.11 11.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.097 -2.927 . . . . 0.0 103.097 176.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.7 p -75.52 128.99 36.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.013 0.925 . . . . 0.0 109.61 169.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 25' ' ' LEU . 9.3 p . . . . . 0 C--O 1.259 1.588 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 -162.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -87.09 156.43 54.72 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 120.042 -1.661 . . . . 0.0 110.692 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -58.3 129.73 34.25 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 120.045 3.056 . . . . 0.0 120.045 -155.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.73 12.65 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 125.733 1.635 . . . . 0.0 112.727 178.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.55 16.39 0.65 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.493 3.516 . . . . 0.0 120.493 -160.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.17 114.59 7.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 156.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -130.66 113.69 14.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.089 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.75 71.55 3.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.867 1.317 . . . . 0.0 110.637 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.95 121.58 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.702 2.401 . . . . 0.0 111.721 -171.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -105.24 115.34 30.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.423 -2.048 . . . . 0.0 109.398 -174.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -115.83 146.4 42.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.836 0.827 . . . . 0.0 110.003 -171.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.81 109.58 21.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 165.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -53.7 151.99 5.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.842 2.057 . . . . 0.0 112.77 175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -110.12 104.74 13.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.9 56.73 5.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.133 2.173 . . . . 0.0 116.086 -175.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.62 61.2 5.19 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 120.49 -1.381 . . . . 0.0 115.897 -177.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.6 t 175.08 112.64 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.792 1.637 . . . . 0.0 106.77 -173.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.3 mt -76.42 -41.93 45.93 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 126.233 1.813 . . . . 0.0 107.388 169.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.45 33.76 1.28 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.034 171.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.7 pt -118.19 133.74 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 121.845 -0.797 . . . . 0.0 111.062 175.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -82.95 113.13 20.34 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.245 1.018 . . . . 0.0 111.088 164.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.555 HG23 ' CE1' ' A' ' 78' ' ' HIS . 21.0 m -85.26 128.98 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -124.11 167.15 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.448 1.899 . . . . 0.0 110.865 176.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.39 -137.65 15.6 Favored Glycine 0 N--CA 1.428 -1.846 0 C-N-CA 125.103 1.335 . . . . 0.0 112.915 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.11 161.88 21.81 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 124.433 1.015 . . . . 0.0 111.293 177.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.7 t -56.05 -32.7 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -70.48 -27.84 64.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 -171.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 p -103.95 3.37 33.49 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.454 -1.404 . . . . 0.0 112.433 -175.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t 68.11 84.68 0.15 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.011 1.725 . . . . 0.0 113.094 179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.2 m -88.04 -159.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.848 1.659 . . . . 0.0 110.014 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -56.29 -66.93 0.35 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.1 -1.625 . . . . 0.0 112.852 175.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -167.07 116.75 0.86 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 156.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 60.36 105.59 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.415 2.126 . . . . 0.0 118.415 170.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 129.69 -167.96 21.34 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 121.513 -0.993 . . . . 0.0 113.491 162.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.7 tp -116.59 164.39 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.189 0.995 . . . . 0.0 110.093 -166.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -140.72 156.75 46.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.028 -1.67 . . . . 0.0 106.786 -172.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.591 HG11 ' CD1' ' A' ' 47' ' ' ILE . 3.4 t -91.37 119.87 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.644 -1.285 . . . . 0.0 111.782 177.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -83.71 -40.49 18.81 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.732 -1.23 . . . . 0.0 111.065 177.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.42 131.8 17.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.964 0.905 . . . . 0.0 109.988 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.591 ' CD1' HG11 ' A' ' 44' ' ' VAL . 50.4 mm -97.33 120.23 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 171.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.9 pt -77.56 152.46 80.88 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 121.163 -0.961 . . . . 0.0 113.018 -175.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.77 92.54 0.96 Allowed 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 122.159 1.906 . . . . 0.0 113.243 -177.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.308 46.7 mtpt 92.64 88.33 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 127.129 2.172 . . . . 0.0 110.641 169.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.41 -172.96 20.8 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 103.284 -3.926 . . . . 0.0 103.284 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.72 82.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -175.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.24 -40.53 67.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.81 -28.7 69.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.469 -1.394 . . . . 0.0 111.796 168.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.7 t -73.33 -12.9 60.99 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -64.92 -85.03 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.923 2.147 . . . . 0.0 110.403 176.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.82 -30.22 0.82 Allowed Glycine 0 N--CA 1.431 -1.697 0 O-C-N 120.622 -1.299 . . . . 0.0 111.469 172.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.401 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 1.2 mpt_? -83.87 -43.08 15.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.55 -0.971 . . . . 0.0 111.287 -176.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.2 134.83 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 124.765 1.226 . . . . 0.0 114.046 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -133.5 -172.69 3.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 164.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -84.52 122.3 28.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.308 -2.12 . . . . 0.0 112.084 -178.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.71 -30.71 2.73 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.495 -1.378 . . . . 0.0 112.395 -169.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -73.12 162.88 28.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.279 1.514 . . . . 0.0 113.768 -172.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -105.01 129.9 53.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.98 0.912 . . . . 0.0 109.884 -173.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.34 114.72 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.12 1.438 . . . . 0.0 107.984 167.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.41 -32.02 11.71 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 120.231 -1.543 . . . . 0.0 113.176 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.14 159.32 43.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.611 1.096 . . . . 0.0 111.867 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 t -136.0 126.2 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 121.474 -0.766 . . . . 0.0 110.415 -178.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 m120 58.59 22.14 9.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.919 1.691 . . . . 0.0 114.828 -174.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.69 -2.72 80.61 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.629 1.109 . . . . 0.0 114.267 -172.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.81 103.01 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.115 1.366 . . . . 0.0 108.53 -172.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -62.77 141.39 58.62 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.599 1.56 . . . . 0.0 113.18 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -80.56 72.46 7.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.475 1.131 . . . . 0.0 111.098 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -91.65 111.18 22.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.769 1.228 . . . . 0.0 108.621 174.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.3 -3.86 85.15 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.988 -1.07 . . . . 0.0 115.349 -176.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.41 133.35 38.69 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 123.942 1.83 . . . . 0.0 114.745 -172.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 80.0 p -99.53 -155.82 0.52 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.558 2.343 . . . . 0.0 109.881 -169.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 29' ' ' VAL . 85.2 t60 -72.4 -50.47 26.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.612 -1.93 . . . . 0.0 111.19 168.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -42.82 80.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 77' ' ' THR . 17.8 tt0 -65.68 -35.87 82.01 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.12 -1.612 . . . . 0.0 113.902 174.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.78 96.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.671 -1.893 . . . . 0.0 115.05 172.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.03 -56.39 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 123.594 0.757 . . . . 0.0 110.406 172.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -51.28 -46.49 62.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.06 1.344 . . . . 0.0 113.602 177.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.5 m -59.58 -30.39 68.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.384 1.874 . . . . 0.0 114.422 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.6 mt -89.34 -38.65 14.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.161 -1.587 . . . . 0.0 113.366 173.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -36.44 39.16 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.575 2.35 . . . . 0.0 114.863 -172.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.02 15.13 0.58 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -172.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.5 p -91.68 158.86 16.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.287 2.635 . . . . 0.0 111.013 -169.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.55 -61.67 3.08 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 121.414 -0.804 . . . . 0.0 114.286 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -151.52 -64.84 0.18 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 121.236 -1.155 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -73.09 129.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 123.153 1.454 . . . . 0.0 111.541 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -115.58 105.3 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.834 1.654 . . . . 0.0 107.749 172.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -78.74 106.17 10.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.572 -1.33 . . . . 0.0 109.284 169.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mt -87.41 110.37 20.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.067 1.747 . . . . 0.0 108.677 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.9 101.86 13.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 172.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.89 143.26 34.28 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.642 1.577 . . . . 0.0 110.758 -175.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -114.16 143.16 45.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.888 2.075 . . . . 0.0 106.226 171.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -78.54 129.48 34.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 123.564 0.746 . . . . 0.0 110.892 178.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.96 -74.13 0.55 Allowed Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 123.628 0.633 . . . . 0.0 113.811 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -159.38 8.6 0.11 Allowed 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t -99.12 118.39 62.68 Favored Pre-proline 0 N--CA 1.431 -1.406 0 O-C-N 119.953 -1.717 . . . . 0.0 110.096 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 C--N 1.3 -2.018 0 CA-C-N 124.784 2.744 . . . . 0.0 115.419 -176.982 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.429 -1.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp 74.73 -175.68 0.14 Allowed 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.648 2.379 . . . . 0.0 112.618 -178.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.404 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.412 5.7 m 45.23 92.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 162.925 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 97.6 m -128.34 125.05 37.93 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 -171.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.3 m -74.23 123.84 25.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.293 1.837 . . . . 0.0 108.575 177.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.657 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 -163.15 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 121.209 0.528 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -113.09 160.94 29.18 Favored Pre-proline 0 N--CA 1.43 -1.454 0 O-C-N 120.92 -1.112 . . . . 0.0 110.39 -175.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -66.28 132.79 30.6 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 122.333 2.022 . . . . 0.0 113.607 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.46 -32.0 4.84 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 123.712 0.672 . . . . 0.0 113.638 174.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.42 132.13 41.68 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -169.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -104.13 143.84 32.38 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.1 1.36 . . . . 0.0 107.408 157.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.264 0.1 OUTLIER -125.22 120.94 32.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.52 74.83 1.91 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.893 1.277 . . . . 0.0 107.734 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.99 151.23 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.302 2.241 . . . . 0.0 109.355 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' HB3' ' CD2' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -128.27 128.68 45.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.435 -2.041 . . . . 0.0 111.165 168.266 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.5 mt -126.0 141.16 52.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 124.553 1.141 . . . . 0.0 109.058 -171.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.66 111.47 23.83 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.65 124.06 18.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.45 1.1 . . . . 0.0 111.7 -177.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.9 t -94.37 108.58 20.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.92 1.343 . . . . 0.0 108.982 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 60.23 34.86 20.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.823 2.049 . . . . 0.0 114.686 -179.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.46 60.57 2.47 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.742 -1.224 . . . . 0.0 114.367 178.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.7 m 172.34 120.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.868 2.067 . . . . 0.0 105.574 -175.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.85 -41.44 78.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.217 1.484 . . . . 0.0 107.966 161.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 120.11 22.95 3.08 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 113.962 -1.472 . . . . 0.0 111.471 170.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' A' ' 44' ' ' VAL . 36.7 pt -111.39 130.24 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.213 -1.169 . . . . 0.0 111.224 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -79.67 112.53 17.03 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 124.201 1.0 . . . . 0.0 110.576 167.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 m -84.15 131.15 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -123.11 166.73 14.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.618 -1.927 . . . . 0.0 109.824 176.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.69 -150.83 31.61 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 124.787 1.185 . . . . 0.0 113.857 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.458 ' H ' HG11 ' A' ' 37' ' ' VAL . . . 113.49 166.05 16.16 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 125.49 1.519 . . . . 0.0 110.556 -177.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -66.78 -6.55 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -72.49 -39.88 67.32 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.211 -1.555 . . . . 0.0 112.674 171.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.5 p -109.96 174.19 5.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.337 -1.477 . . . . 0.0 110.858 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.4 m -80.65 90.52 5.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.492 -2.005 . . . . 0.0 112.864 -175.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG11 ' H ' ' A' ' 32' ' ' GLY . 19.7 m -94.68 -165.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.458 1.503 . . . . 0.0 109.803 172.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -72.76 -69.52 0.41 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.774 -1.829 . . . . 0.0 110.005 173.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 119.9 3.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.098 -1.002 . . . . 0.0 109.216 163.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 46.64 87.95 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 127.564 2.507 . . . . 0.0 118.797 166.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.72 -171.91 39.48 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 120.477 -1.602 . . . . 0.0 111.098 169.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.268 1.8 tp -115.3 162.04 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.776 0.798 . . . . 0.0 109.454 -172.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -142.69 154.07 43.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -169.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG11 ' CD1' ' A' ' 47' ' ' ILE . 6.6 t -90.1 126.98 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.965 -1.709 . . . . 0.0 111.988 179.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -90.47 -48.37 7.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.519 -1.363 . . . . 0.0 111.169 176.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.05 128.72 18.2 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 122.003 0.906 . . . . 0.0 112.217 -172.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.535 ' CD1' HG11 ' A' ' 44' ' ' VAL . 43.7 mm -92.68 134.24 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.205 2.202 . . . . 0.0 109.175 178.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.553 HD12 ' CA ' ' A' ' 26' ' ' GLY . 29.6 mt -76.06 143.87 74.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 125.132 1.373 . . . . 0.0 109.911 175.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -60.75 88.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.379 2.719 . . . . 0.0 115.053 161.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 mttt 66.6 63.06 0.52 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 170.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.46 -120.56 2.77 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 158.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.29 -44.64 7.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 121.532 -0.981 . . . . 0.0 112.307 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.55 -41.31 72.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.93 -31.36 71.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.152 -2.217 . . . . 0.0 110.862 170.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.04 5.79 6.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -72.52 -87.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.296 -2.128 . . . . 0.0 105.9 149.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.0 1.0 Allowed Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.862 163.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -79.55 -17.48 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 117.172 0.486 . . . . 0.0 112.309 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.49 133.85 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.174 2.19 . . . . 0.0 111.67 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.93 -178.94 5.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.895 -1.128 . . . . 0.0 108.763 169.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -86.23 60.42 6.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.923 -2.361 . . . . 0.0 113.258 -174.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.91 -7.52 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 O-C-N 121.086 -1.009 . . . . 0.0 114.787 176.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -76.05 154.12 35.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.399 1.571 . . . . 0.0 114.92 -172.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -102.64 105.83 16.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.406 1.882 . . . . 0.0 108.79 -173.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.37 113.14 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.8 -1.813 . . . . 0.0 108.949 -179.391 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.42 -29.0 13.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.137 1.375 . . . . 0.0 113.41 -173.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 155.18 38.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 119.984 1.266 . . . . 0.0 112.745 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 92' ' ' VAL . 13.5 t -132.98 119.0 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.595 -0.691 . . . . 0.0 111.175 -177.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 56.09 31.98 19.19 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 120.409 1.459 . . . . 0.0 114.027 -168.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.29 9.9 85.62 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.809 -1.182 . . . . 0.0 114.301 -173.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -100.26 101.97 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -178.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.4 p -60.42 138.1 58.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.83 31.77 0.84 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.76 -1.213 . . . . 0.0 112.15 -178.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.72 76.13 1.55 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.201 2.201 . . . . 0.0 110.941 -177.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.99 5.79 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 125.047 1.308 . . . . 0.0 114.44 -170.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -90.59 139.08 31.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.021 1.911 . . . . 0.0 112.587 177.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t -112.13 -165.26 0.98 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.458 2.303 . . . . 0.0 105.95 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -53.9 -57.68 10.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.391 1.876 . . . . 0.0 113.641 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -69.62 -46.99 64.96 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 111.987 -174.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.61 -48.64 66.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.918 1.687 . . . . 0.0 113.572 173.272 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.61 86.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.208 -1.558 . . . . 0.0 114.609 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.79 -47.97 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.35 1.06 . . . . 0.0 112.193 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -68.47 -29.23 67.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.251 -1.531 . . . . 0.0 114.158 177.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 96.6 m -68.55 -26.3 65.35 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.948 1.699 . . . . 0.0 113.194 174.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -91.51 -48.66 6.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.341 1.457 . . . . 0.0 113.58 172.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -82.61 -36.97 25.63 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 -172.103 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -89.01 29.26 1.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.31 1.868 . . . . 0.0 112.594 -172.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.4 p -88.76 -168.35 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.373 3.069 . . . . 0.0 109.933 175.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.52 -110.85 3.02 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 120.211 -1.555 . . . . 0.0 111.547 175.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -102.12 -61.17 1.42 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 117.863 0.831 . . . . 0.0 112.567 -176.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.64 125.86 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 122.765 1.269 . . . . 0.0 110.45 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 68' ' ' VAL . 8.1 t -109.92 111.51 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 C-N-CA 125.395 1.478 . . . . 0.0 107.833 165.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 17' ' ' GLU . 78.5 m80 -79.87 112.26 16.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 120.773 -1.204 . . . . 0.0 108.643 166.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.8 mt -94.28 112.96 24.79 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.054 1.342 . . . . 0.0 109.015 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.45 101.01 13.69 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mt -107.05 143.61 34.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.489 2.315 . . . . 0.0 110.182 -175.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -122.66 143.57 49.69 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.197 1.399 . . . . 0.0 109.95 173.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.52 113.87 0.56 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.807 3.262 . . . . 0.0 119.807 -175.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.87 64.31 3.41 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.952 -2.343 . . . . 0.0 113.144 172.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -141.59 169.13 18.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.443 1.097 . . . . 0.0 111.76 -178.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.63 129.18 32.13 Favored Pre-proline 0 N--CA 1.43 -1.436 0 C-N-CA 125.959 1.704 . . . . 0.0 110.577 -172.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 C--N 1.3 -2.009 0 C-N-CA 123.072 2.514 . . . . 0.0 117.177 174.951 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.43 -1.439 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.6 tp -156.34 173.31 17.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.466 6.9 m 43.57 87.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 128.789 2.836 . . . . 0.0 117.439 170.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 77.1 m -129.37 120.82 26.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.385 -3.191 . . . . 0.0 102.385 -176.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.4 m -78.86 121.98 25.51 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.314 1.446 . . . . 0.0 109.501 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 -171.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -119.79 140.29 29.36 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.506 -1.371 . . . . 0.0 108.026 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.21 138.08 19.83 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 123.574 2.312 . . . . 0.0 111.764 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.64 25.65 71.69 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 117.538 1.775 . . . . 0.0 117.538 175.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -99.28 104.06 15.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 118.592 1.196 . . . . 0.0 111.916 -169.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 p -76.66 143.49 40.07 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.554 -1.341 . . . . 0.0 113.804 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.35 132.69 48.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.562 1.145 . . . . 0.0 108.489 174.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.7 84.86 2.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.207 1.003 . . . . 0.0 109.569 175.279 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.96 155.0 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.479 1.911 . . . . 0.0 109.644 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -130.54 118.82 21.64 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.287 -2.133 . . . . 0.0 110.097 165.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.3 mt -122.36 154.47 37.63 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.937 -1.102 . . . . 0.0 109.975 -174.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -105.95 119.64 39.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.1 0.952 . . . . 0.0 109.223 162.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 123.43 19.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.992 1.317 . . . . 0.0 113.025 177.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -90.1 115.12 27.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.777 -1.202 . . . . 0.0 109.501 -175.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 52.43 42.63 31.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.317 1.847 . . . . 0.0 114.915 -172.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.57 43.17 53.41 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.271 0.938 . . . . 0.0 115.342 178.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.1 t -166.74 113.49 0.82 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 -170.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' B' ' 210' ' ' VAL . 6.0 mt -75.07 -28.79 60.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.118 -1.614 . . . . 0.0 107.443 169.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.35 13.09 11.02 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.988 168.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.0 pt -114.75 125.76 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 118.226 1.013 . . . . 0.0 110.454 -171.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -80.86 121.77 26.38 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.509 1.124 . . . . 0.0 113.536 176.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.19 132.47 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -127.96 170.57 12.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.509 1.524 . . . . 0.0 109.045 169.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.43 -123.08 6.31 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.291 1.424 . . . . 0.0 113.734 178.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.15 155.17 27.53 Favored Glycine 0 N--CA 1.431 -1.689 0 O-C-N 121.681 -0.893 . . . . 0.0 112.993 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -61.1 -24.88 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.881 -1.364 . . . . 0.0 112.794 -177.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -65.19 -32.41 74.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.173 2.189 . . . . 0.0 113.542 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.8 m -79.84 -48.87 12.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.591 1.156 . . . . 0.0 109.462 176.564 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . 0.377 66.1 p 102.39 106.57 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.111 3.364 . . . . 0.0 109.582 -174.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.62 56.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.993 1.317 . . . . 0.0 109.064 -163.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.267 70.9 ttt180 71.02 -62.98 0.44 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.809 2.044 . . . . 0.0 114.972 -171.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -137.57 -50.95 0.62 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.643 -1.286 . . . . 0.0 110.365 178.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.08 -137.21 3.42 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 105.743 -2.943 . . . . 0.0 105.743 -178.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.93 173.23 27.76 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 121.714 -0.874 . . . . 0.0 112.492 -168.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -123.32 161.73 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 170.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -132.71 152.03 51.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.78 -1.825 . . . . 0.0 106.647 -171.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 47' ' ' ILE . 47.6 t -91.27 119.43 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 120.04 -1.663 . . . . 0.0 108.973 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -82.91 -60.33 2.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.605 -1.309 . . . . 0.0 110.833 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.91 132.28 56.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.26 1.029 . . . . 0.0 110.838 -176.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.492 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.3 mm -94.6 131.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 164.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt -101.52 157.74 33.1 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 111.685 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.48 109.37 2.03 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.56 2.173 . . . . 0.0 113.149 171.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt 68.89 61.05 0.34 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 167.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -97.41 -100.29 2.04 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 162.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.07 -38.74 0.77 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.51 1.124 . . . . 0.0 110.569 170.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.74 -32.9 64.08 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -170.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.48 -41.43 80.68 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.306 -1.496 . . . . 0.0 111.468 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -73.6 6.27 3.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.348 2.259 . . . . 0.0 116.496 -177.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.55 -82.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.405 -2.06 . . . . 0.0 107.742 152.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.55 -32.64 1.11 Allowed Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 170.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -83.92 -15.8 46.6 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 124.072 0.949 . . . . 0.0 113.162 -172.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.87 133.01 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.941 1.696 . . . . 0.0 110.989 173.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 61' ' ' LYS . 4.3 t-160 -131.55 -172.71 2.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.285 1.434 . . . . 0.0 109.936 173.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' H ' ' CD2' ' A' ' 60' ' ' HIS . 55.5 mtmt -85.95 113.06 21.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.876 -1.765 . . . . 0.0 109.898 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.23 10.8 12.98 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.354 0.978 . . . . 0.0 114.946 -175.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.25 164.09 20.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.465 1.506 . . . . 0.0 112.826 176.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -116.3 121.39 41.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.668 2.387 . . . . 0.0 111.647 -173.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.6 t -93.07 122.06 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.512 1.525 . . . . 0.0 107.895 174.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.94 -39.88 8.34 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 120.255 -1.528 . . . . 0.0 112.309 175.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.98 159.94 42.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 119.787 1.176 . . . . 0.0 113.783 -176.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 92' ' ' VAL . 79.7 t -132.01 119.8 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 124.378 1.071 . . . . 0.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 56.82 25.11 9.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.258 -1.527 . . . . 0.0 115.034 -171.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.74 -2.98 84.88 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.12 1.343 . . . . 0.0 114.6 -171.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.6 t -93.86 100.46 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 0.0 108.361 -174.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.6 t -70.29 137.37 50.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.315 1.446 . . . . 0.0 113.497 -178.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 mt -79.92 52.16 1.45 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.099 2.16 . . . . 0.0 112.403 -177.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -79.25 119.06 21.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.005 1.322 . . . . 0.0 109.925 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.76 14.03 75.31 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.886 -1.134 . . . . 0.0 114.959 -175.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.51 138.78 31.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.855 1.312 . . . . 0.0 112.299 -177.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.3 p -101.11 -162.55 0.95 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.682 1.993 . . . . 0.0 109.699 -174.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -59.84 -54.07 50.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.977 -1.702 . . . . 0.0 112.001 164.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -71.59 -41.13 69.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.498 -0.751 . . . . 0.0 112.869 -176.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -40.5 96.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 175.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.85 -41.37 95.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.888 -1.758 . . . . 0.0 114.584 173.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -53.8 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 119.123 0.874 . . . . 0.0 111.189 173.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 85.5 m -64.58 -36.73 85.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.878 2.471 . . . . 0.0 113.643 176.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mt -91.94 -26.96 18.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.305 1.842 . . . . 0.0 115.269 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HB2' HG21 ' B' ' 210' ' ' VAL . 3.7 tmt_? -83.97 -52.8 6.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.423 1.889 . . . . 0.0 112.489 -176.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -93.68 63.77 3.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.76 -1.213 . . . . 0.0 110.695 -175.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.2 p -96.14 -129.65 0.16 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.006 1.322 . . . . 0.0 111.815 177.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.29 57.36 0.43 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 64.08 -54.4 0.25 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.785 3.234 . . . . 0.0 114.47 -170.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.35 124.99 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.572 1.177 . . . . 0.0 110.156 175.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.601 HG13 HG13 ' A' ' 68' ' ' VAL . 85.0 t -110.92 106.57 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 168.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -77.97 102.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.942 -1.099 . . . . 0.0 108.952 166.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -85.43 118.31 24.88 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.577 -1.327 . . . . 0.0 110.475 -176.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.96 100.92 13.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 148.86 25.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.481 1.512 . . . . 0.0 109.991 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.2 -164.04 1.08 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.038 2.135 . . . . 0.0 107.562 173.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.05 106.54 11.28 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.259 -2.151 . . . . 0.0 112.282 159.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.09 66.63 3.82 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.331 -1.48 . . . . 0.0 112.265 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -144.76 168.74 19.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.52 1.528 . . . . 0.0 108.584 175.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.83 165.85 44.7 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 125.275 1.43 . . . . 0.0 112.791 -173.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 C--N 1.299 -2.043 0 C-N-CA 123.91 3.073 . . . . 0.0 110.656 153.598 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 122.662 1.22 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 13.3 tp -124.0 -147.13 0.37 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.673 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.38 2.4 t 25.52 101.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.188 4.195 . . . . 0.0 118.568 163.604 . . . . . . . . 4 3 . 1 . 024 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 2.6 p -144.92 116.02 7.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -172.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.4 p -75.25 130.2 38.73 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.382 1.073 . . . . 0.0 110.424 174.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 86' ' ' ARG . 2.8 p . . . . . 0 C--O 1.261 1.682 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 -171.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.431 -1.405 0 CA-C-O 122.755 1.264 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -117.39 155.72 49.77 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 158.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -65.29 131.02 26.95 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.013 2.112 . . . . 0.0 113.308 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 50.67 20.12 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 178.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -77.9 123.12 26.38 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.844 -1.386 . . . . 0.0 110.923 176.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.9 p -82.59 144.04 30.61 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.085 -1.635 . . . . 0.0 112.321 177.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.26 1.6 m-30 -107.67 144.01 35.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 166.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -118.51 77.41 1.17 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 158.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.47 112.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.917 2.087 . . . . 0.0 107.098 -168.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.71 135.36 54.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.935 -1.728 . . . . 0.0 112.719 -175.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -161.15 178.3 9.42 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.344 -0.847 . . . . 0.0 108.9 -171.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.05 139.2 52.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.841 -1.162 . . . . 0.0 111.461 179.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.77 144.22 28.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.18 -1.575 . . . . 0.0 111.305 -177.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.6 t -96.89 102.22 13.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.771 -1.206 . . . . 0.0 109.317 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.32 61.98 2.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -171.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.53 49.74 63.14 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.845 -1.159 . . . . 0.0 114.201 178.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.4 t -168.3 96.58 0.41 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.732 1.73 . . . . 0.0 107.319 -170.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mt -72.02 -46.52 56.85 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.048 2.139 . . . . 0.0 106.514 166.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.66 39.93 0.96 Allowed Glycine 0 N--CA 1.429 -1.826 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.708 175.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.52 130.0 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.946 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -84.65 113.76 21.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.09 1.356 . . . . 0.0 112.072 170.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.81 125.65 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -175.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -122.71 164.04 19.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.656 1.982 . . . . 0.0 109.367 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.41 17.26 Favored Glycine 0 N--CA 1.431 -1.683 0 C-N-CA 124.71 1.148 . . . . 0.0 112.547 178.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.93 165.26 34.14 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 124.246 0.926 . . . . 0.0 111.565 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.64 -13.94 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.467 -1.607 . . . . 0.0 113.492 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -67.36 -39.81 85.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.316 1.846 . . . . 0.0 113.803 171.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.9 m -84.3 -33.37 23.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.88 -1.137 . . . . 0.0 109.931 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 t 81.29 86.24 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.862 2.065 . . . . 0.0 109.97 -177.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.8 73.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 125.034 1.333 . . . . 0.0 108.867 -167.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.5 mtp85 68.95 -49.65 0.59 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.996 2.118 . . . . 0.0 113.714 -168.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -145.77 -102.44 0.1 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.431 1.893 . . . . 0.0 105.926 164.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.3 -131.88 4.34 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 167.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.22 156.35 15.01 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.902 -1.351 . . . . 0.0 111.529 -166.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 42' ' ' ILE 0.274 4.0 tp -110.3 163.07 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.973 -1.31 . . . . 0.0 108.181 173.423 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -137.39 161.91 35.02 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.915 -1.74 . . . . 0.0 107.0 -174.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.55 HG11 ' CD1' ' A' ' 47' ' ' ILE . 2.2 t -89.91 125.86 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.296 -1.503 . . . . 0.0 111.841 173.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -82.13 -51.84 7.58 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.732 -1.23 . . . . 0.0 109.948 166.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.62 32.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.763 1.225 . . . . 0.0 110.443 -177.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.55 ' CD1' HG11 ' A' ' 44' ' ' VAL . 46.4 mm -91.51 121.57 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 pt -76.97 142.41 69.12 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 110.229 179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.7 106.94 1.93 Allowed 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.578 2.186 . . . . 0.0 113.285 -164.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 64.89 64.11 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.465 1.506 . . . . 0.0 113.44 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -99.08 -146.29 20.05 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 167.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.6 -41.16 21.93 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.659 -1.495 . . . . 0.0 111.151 175.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.11 -51.49 57.5 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.741 2.016 . . . . 0.0 115.119 -176.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.72 -41.87 82.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.276 1.036 . . . . 0.0 111.373 173.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -69.19 -5.52 23.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -178.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -82.89 -101.22 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.329 2.331 . . . . 0.0 110.457 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.31 -97.71 0.96 Allowed Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.211 -1.556 . . . . 0.0 112.805 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 72.0 mtm-85 -133.99 26.08 3.93 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 121.999 -0.706 . . . . 0.0 112.744 -156.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 mt -87.11 127.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.86 -1.775 . . . . 0.0 113.427 -170.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -143.85 155.02 43.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 163.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -62.78 148.76 45.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 -153.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.73 23.61 7.07 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 172.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -103.02 172.95 6.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.725 1.762 . . . . 0.0 112.693 174.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -98.34 136.5 38.41 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.368 1.067 . . . . 0.0 110.738 178.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.35 101.89 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.034 2.934 . . . . 0.0 105.01 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.253 0.9 OUTLIER -98.02 -38.18 9.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.235 -2.166 . . . . 0.0 114.827 -173.946 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 145.21 27.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.236 1.38 . . . . 0.0 113.49 -176.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 36.6 t -131.23 116.02 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 O-C-N 120.994 -1.066 . . . . 0.0 111.914 -171.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 55.59 33.99 22.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.222 1.409 . . . . 0.0 113.677 -170.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.42 25.71 62.82 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.455 -0.778 . . . . 0.0 113.495 -176.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.9 t -123.63 100.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.7 m -76.42 136.43 39.45 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -175.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.82 38.34 0.7 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.913 1.685 . . . . 0.0 114.189 -173.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -82.81 111.1 18.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.486 -2.009 . . . . 0.0 110.718 175.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.85 8.95 68.87 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.947 -1.095 . . . . 0.0 113.083 -175.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -94.12 155.02 17.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.985 1.374 . . . . 0.0 110.067 171.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.567 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 71.2 p -106.87 -170.34 1.7 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.426 1.89 . . . . 0.0 108.718 -172.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -57.29 -49.95 74.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.762 -1.211 . . . . 0.0 112.903 161.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -69.9 -43.8 71.0 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.031 -1.043 . . . . 0.0 112.215 -176.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.567 ' HB2' ' H ' ' A' ' 77' ' ' THR . 4.7 mp0 -67.19 -34.3 77.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.633 -1.292 . . . . 0.0 112.947 175.177 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.92 87.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.9 -1.75 . . . . 0.0 114.475 172.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -57.47 -49.19 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 121.379 -0.825 . . . . 0.0 111.923 172.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.9 -31.28 71.56 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.012 -1.68 . . . . 0.0 114.901 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 90.6 m -74.93 -27.75 60.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.558 1.943 . . . . 0.0 112.714 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.89 -43.69 10.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.297 1.839 . . . . 0.0 112.892 174.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.3 0.0 OUTLIER -84.24 -34.38 23.88 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -172.612 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -86.1 35.31 0.64 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.512 -1.992 . . . . 0.0 112.309 -176.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.6 p -93.69 163.25 13.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 128.142 2.577 . . . . 0.0 113.483 -176.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.75 59.57 4.9 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 125.065 1.317 . . . . 0.0 114.268 -176.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.259 46.4 tt0 68.09 -53.5 0.52 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.617 2.767 . . . . 0.0 114.634 -174.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.8 t -76.37 136.33 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.169 1.388 . . . . 0.0 110.721 174.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.15 101.39 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.65 1.98 . . . . 0.0 107.165 171.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -82.29 97.61 8.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.815 2.446 . . . . 0.0 108.58 170.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.04 113.24 21.97 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.913 0.863 . . . . 0.0 111.462 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -84.47 102.73 13.03 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 163.347 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.16 152.8 24.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.991 1.316 . . . . 0.0 108.053 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.0 125.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.036 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -65.9 123.05 18.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 124.849 1.26 . . . . 0.0 112.148 -178.124 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.4 70.22 2.66 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.472 1.034 . . . . 0.0 112.64 -174.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.94 137.02 50.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.852 1.661 . . . . 0.0 109.674 -176.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.6 m -117.38 161.43 33.39 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 127.083 2.153 . . . . 0.0 107.482 176.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 C--N 1.3 -2.019 0 CA-C-N 123.102 2.143 . . . . 0.0 113.799 -175.576 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 19.9 tp -86.34 165.11 16.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.081 0.952 . . . . 0.0 109.206 163.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.397 2.7 t 72.58 115.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.768 2.223 . . . . 0.0 115.511 164.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 73.0 m -141.53 123.23 15.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -77.14 124.06 27.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 169.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--O 1.26 1.615 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -162.566 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 122.216 1.007 . . . . 0.0 108.644 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -97.18 148.1 33.9 Favored Pre-proline 0 N--CA 1.43 -1.442 0 C-N-CA 124.406 1.082 . . . . 0.0 109.707 176.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.78 129.21 14.16 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 122.826 2.045 . . . . 0.0 113.346 -175.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.59 25.09 75.17 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 125.376 1.465 . . . . 0.0 115.321 176.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -79.59 129.98 34.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.002 -1.293 . . . . 0.0 113.137 -173.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 p -93.69 143.12 26.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.409 -1.432 . . . . 0.0 113.802 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.1 OUTLIER -132.02 118.86 20.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.874 1.27 . . . . 0.0 108.921 173.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.92 86.45 5.88 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.268 1.427 . . . . 0.0 109.146 173.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.2 t -80.97 156.85 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.211 2.204 . . . . 0.0 109.982 178.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 93' ' ' HIS . 0.8 OUTLIER -126.85 132.77 50.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.616 -1.927 . . . . 0.0 107.159 166.728 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 83.6 mt -129.46 153.37 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.013 -1.054 . . . . 0.0 109.572 -177.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.52 110.01 17.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.434 1.094 . . . . 0.0 109.067 166.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 24' ' ' SER . 15.5 ptpt -60.04 141.31 55.92 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 127.77 2.428 . . . . 0.0 114.746 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 t -101.57 113.76 27.17 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.698 -1.251 . . . . 0.0 109.344 -174.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 58.76 -18.02 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 129.189 2.995 . . . . 0.0 118.171 -169.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.19 59.32 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.847 1.689 . . . . 0.0 109.27 -178.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.491 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 95.4 p -178.2 120.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 -173.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' B' ' 210' ' ' VAL . 9.8 mt -79.45 -40.02 30.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.436 1.894 . . . . 0.0 106.586 168.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' HA2' HD11 ' A' ' 48' ' ' ILE . . . 118.06 29.3 2.02 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.035 1.303 . . . . 0.0 111.988 171.304 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 pt -114.78 131.03 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.632 174.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.8 m -83.91 117.07 23.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 123.236 0.614 . . . . 0.0 111.04 162.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.67 132.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -173.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -128.28 163.55 24.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.102 2.161 . . . . 0.0 109.608 174.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.35 -137.36 13.26 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 125.279 1.419 . . . . 0.0 111.788 -177.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 155.63 28.07 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 -17.2 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 120.546 -1.561 . . . . 0.0 114.06 -178.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -55.91 -37.45 68.92 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.987 1.715 . . . . 0.0 114.292 169.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 m -128.13 71.71 1.39 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -28.27 116.78 0.1 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.496 3.517 . . . . 0.0 120.496 -162.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.06 95.41 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.181 1.392 . . . . 0.0 109.78 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 65.08 -96.79 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.584 1.954 . . . . 0.0 111.885 -174.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -124.65 10.28 8.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.652 -1.28 . . . . 0.0 112.645 172.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.53 86.36 1.9 Allowed Glycine 0 N--CA 1.43 -1.747 0 O-C-N 121.11 -0.994 . . . . 0.0 114.288 174.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.51 -172.75 20.67 Favored Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 175.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.464 HG22 HG13 ' A' ' 65' ' ' VAL 0.255 2.2 tp -120.49 162.1 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 118.049 0.924 . . . . 0.0 109.078 -166.621 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -142.08 162.11 36.31 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 -171.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 47' ' ' ILE . 3.3 t -88.36 132.31 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.679 -1.263 . . . . 0.0 111.769 172.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -88.52 -46.85 8.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.529 -1.357 . . . . 0.0 110.554 170.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.02 134.02 24.08 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.067 -1.021 . . . . 0.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.471 HD13 HG11 ' A' ' 44' ' ' VAL . 27.3 mm -93.84 128.92 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.433 1.493 . . . . 0.0 108.725 173.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.428 HD11 ' HA2' ' A' ' 26' ' ' GLY . 2.6 pt -83.26 133.44 47.63 Favored Pre-proline 0 N--CA 1.43 -1.454 0 O-C-N 121.184 -0.948 . . . . 0.0 110.836 172.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.08 64.75 7.08 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 121.558 1.592 . . . . 0.0 111.064 178.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt 173.04 77.61 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.456 1.502 . . . . 0.0 109.781 -175.268 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.46 4.92 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.728 -1.857 . . . . 0.0 111.061 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -113.87 -39.26 4.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.447 1.099 . . . . 0.0 111.603 -172.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.78 66.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.009 1.323 . . . . 0.0 113.84 -178.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -56.76 -34.17 67.31 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.968 1.307 . . . . 0.0 112.504 167.124 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 t -70.27 -5.46 27.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 176.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.97 -79.27 0.06 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 118.643 -2.536 . . . . 0.0 108.061 159.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.33 -20.14 3.36 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 169.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -85.31 -32.99 22.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.887 -0.772 . . . . 0.0 111.537 177.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.6 mt -65.86 125.89 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.735 1.614 . . . . 0.0 113.097 178.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.465 ' CG ' ' H ' ' A' ' 61' ' ' LYS . 17.3 t60 -136.71 177.9 7.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.319 1.056 . . . . 0.0 109.954 171.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' H ' ' CG ' ' A' ' 60' ' ' HIS . 30.1 pttt -79.74 58.9 2.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.852 -1.78 . . . . 0.0 115.347 -172.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.32 -10.32 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 125.188 1.375 . . . . 0.0 113.238 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -78.62 154.35 30.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 118.611 1.206 . . . . 0.0 113.427 -173.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.29 138.74 32.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.408 1.483 . . . . 0.0 107.465 175.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -113.42 115.68 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 161.654 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.76 -30.53 11.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 121.006 -1.059 . . . . 0.0 113.412 -172.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.92 153.52 38.11 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.02 0.827 . . . . 0.0 112.584 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 92' ' ' VAL . 11.6 t -135.75 120.26 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 123.453 0.701 . . . . 0.0 112.173 -175.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 55.5 33.87 21.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.432 -1.417 . . . . 0.0 114.203 -168.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.67 11.72 85.06 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 120.68 -1.263 . . . . 0.0 113.538 -175.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -105.64 100.3 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.5 p -60.75 135.2 57.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.078 1.751 . . . . 0.0 113.306 174.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.6 mt -68.96 -49.35 58.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.445 -0.785 . . . . 0.0 112.476 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 46.39 27.79 0.64 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.939 2.94 . . . . 0.0 118.939 166.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.61 27.91 0.93 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.268 -1.52 . . . . 0.0 112.885 -169.033 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.86 146.05 26.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.803 -1.41 . . . . 0.0 110.702 175.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -94.83 -167.7 1.69 Allowed 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 125.719 1.608 . . . . 0.0 109.148 -178.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -61.52 -50.2 73.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.029 -1.669 . . . . 0.0 112.151 165.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.19 -49.41 74.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -38.11 89.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.1 -1.0 . . . . 0.0 113.286 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.23 96.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.034 -1.666 . . . . 0.0 114.983 172.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.55 -54.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.465 173.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -49.72 -43.11 47.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.245 1.384 . . . . 0.0 114.555 175.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 83.6 m -68.22 -27.45 66.38 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.272 2.229 . . . . 0.0 114.882 -178.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.3 -41.43 10.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.87 -1.769 . . . . 0.0 113.78 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 -53.89 6.89 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.557 2.343 . . . . 0.0 114.214 -169.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -87.51 36.43 0.75 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.509 1.623 . . . . 0.0 111.96 -168.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.2 p -93.44 -172.48 2.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.588 2.755 . . . . 0.0 109.636 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.11 -90.48 0.48 Allowed Glycine 0 N--CA 1.429 -1.818 0 O-C-N 119.86 -1.775 . . . . 0.0 112.599 174.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -142.99 -50.15 0.34 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.747 1.219 . . . . 0.0 110.013 -175.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.64 131.52 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.173 -1.579 . . . . 0.0 110.129 172.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 68' ' ' VAL . 2.4 t -122.3 112.54 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 71.1 m80 -76.52 113.28 13.96 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.647 -1.283 . . . . 0.0 108.806 163.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mt -94.83 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.978 -1.077 . . . . 0.0 108.766 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.43 102.77 15.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.07 150.67 23.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.049 2.139 . . . . 0.0 111.358 -177.458 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -127.38 136.35 51.74 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.261 1.024 . . . . 0.0 108.878 169.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -61.51 128.24 35.33 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.234 2.214 . . . . 0.0 114.445 -175.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.92 65.49 0.3 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.983 -1.073 . . . . 0.0 114.403 175.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -116.05 161.93 18.15 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.952 1.301 . . . . 0.0 109.602 174.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.0 p -82.91 129.78 60.35 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.755 -1.215 . . . . 0.0 112.901 -178.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--N 1.3 -2.002 0 C-N-CA 123.09 2.527 . . . . 0.0 114.125 167.573 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 6.5 t80 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.3 tp 77.25 160.05 0.21 Allowed 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.879 2.871 . . . . 0.0 112.572 -168.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.422 1.4 t 77.6 102.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-O 124.584 2.135 . . . . 0.0 113.311 171.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 89.4 m -136.72 119.68 16.41 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 -171.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 33.5 p -75.1 129.23 37.21 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.984 1.313 . . . . 0.0 109.253 174.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 25' ' ' LEU . 8.5 p . . . . . 0 C--O 1.26 1.63 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 -162.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 121.709 0.766 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -135.21 133.42 20.67 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -67.41 115.99 3.98 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 122.861 2.057 . . . . 0.0 112.937 172.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.82 78.7 0.31 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 124.183 0.897 . . . . 0.0 114.412 -175.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.48 140.04 45.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 121.482 -1.011 . . . . 0.0 109.276 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.3 p -97.29 141.25 30.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.84 -1.162 . . . . 0.0 113.077 177.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.69 137.79 53.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.744 1.618 . . . . 0.0 107.823 176.046 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -114.44 82.9 1.79 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.216 1.484 . . . . 0.0 108.802 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.5 t -80.12 142.6 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.0 2.12 . . . . 0.0 109.083 -178.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.34 123.53 44.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.037 -2.289 . . . . 0.0 109.2 170.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.35 162.06 19.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.064 0.946 . . . . 0.0 108.778 -176.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 125.0 53.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 157.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' HB2' ' H ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -61.48 136.69 58.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.038 1.335 . . . . 0.0 112.025 169.224 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -90.71 95.45 10.15 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 123.354 1.55 . . . . 0.0 108.682 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 62.54 -17.71 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.724 2.861 . . . . 0.0 118.724 -171.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.2 62.56 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.846 -1.784 . . . . 0.0 109.919 -178.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 20' ' ' LYS . 45.7 t 167.8 104.46 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -162.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.8 mt -75.17 -41.59 57.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 161.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.95 41.44 1.09 Allowed Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.676 171.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 47' ' ' ILE . 6.5 pt -119.45 129.04 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-O 121.653 0.74 . . . . 0.0 110.297 171.211 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' HG13 ' B' ' 207' ' ' VAL . 63.6 m -82.29 113.95 20.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.294 1.037 . . . . 0.0 110.481 167.251 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.38 129.78 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -128.82 166.37 19.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 126.004 1.722 . . . . 0.0 110.373 176.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.35 -157.35 46.21 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 125.118 1.342 . . . . 0.0 111.463 -170.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.35 151.68 8.95 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.869 178.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -3.58 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -170.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -72.06 -28.49 63.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.187 -1.57 . . . . 0.0 114.042 177.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.2 p -116.66 176.38 5.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 t -81.9 111.63 18.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.604 -1.935 . . . . 0.0 108.781 173.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -110.62 -65.49 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.213 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -179.88 -47.54 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.96 2.104 . . . . 0.0 106.539 164.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -142.29 154.91 45.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 167.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.74 56.02 4.75 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.85 -168.93 26.27 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 163.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.6 tp -125.26 155.84 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 173.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -139.14 156.43 47.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -166.073 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 t -78.6 137.87 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 119.096 -2.252 . . . . 0.0 111.21 175.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -86.08 -64.65 1.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.414 -1.429 . . . . 0.0 108.529 160.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.44 136.62 50.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.245 1.018 . . . . 0.0 110.785 -175.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 27' ' ' ILE . 36.5 mm -89.81 118.99 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.667 1.587 . . . . 0.0 107.424 169.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.3 pt -79.23 157.78 75.14 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 117.728 -1.13 . . . . 0.0 111.776 -177.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -69.87 89.79 0.53 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.435 2.09 . . . . 0.0 114.974 -172.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 70.09 65.38 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.797 1.639 . . . . 0.0 114.967 166.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.75 -95.02 1.54 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 168.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.2 -39.16 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.291 -1.123 . . . . 0.0 111.698 173.125 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.58 -48.86 36.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.463 1.905 . . . . 0.0 114.639 -174.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -51.22 -39.51 56.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.071 1.415 . . . . 0.0 111.789 169.07 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.5 m -67.83 -2.76 7.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -67.72 -90.99 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.2 2.273 . . . . 0.0 109.145 164.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.79 -35.34 0.5 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.976 -1.077 . . . . 0.0 111.615 173.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.61 -25.85 35.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.791 -0.829 . . . . 0.0 113.113 -179.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.06 131.26 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.068 -1.645 . . . . 0.0 112.339 177.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -136.58 179.25 6.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.983 -1.073 . . . . 0.0 108.795 167.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -84.54 49.15 1.63 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.231 -1.543 . . . . 0.0 114.905 -167.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -165.41 19.64 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.899 -1.75 . . . . 0.0 114.057 176.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.33 179.99 4.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.028 -1.277 . . . . 0.0 112.425 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -113.01 142.54 45.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.768 2.027 . . . . 0.0 109.088 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.2 p -117.78 133.9 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.324 -1.485 . . . . 0.0 108.126 165.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.59 -30.48 5.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.556 -1.34 . . . . 0.0 113.93 -173.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 157.25 42.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.162 1.346 . . . . 0.0 113.452 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 92' ' ' VAL . 92.8 t -137.99 123.27 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 123.821 0.848 . . . . 0.0 110.955 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 52.67 33.89 14.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.61 1.564 . . . . 0.0 114.641 -173.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.89 23.46 69.29 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.065 -1.022 . . . . 0.0 113.512 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.12 100.07 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 C-N-CA 124.333 1.053 . . . . 0.0 108.392 -179.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.8 p -57.09 142.61 41.75 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.928 2.091 . . . . 0.0 115.468 173.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.45 -56.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.624 -1.297 . . . . 0.0 111.555 176.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 43.24 43.97 4.3 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 169.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.99 45.16 0.97 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 120.819 -1.176 . . . . 0.0 110.679 -168.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.57 144.69 28.37 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.443 -1.033 . . . . 0.0 108.918 171.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.6 p -97.01 -160.98 0.84 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.481 1.512 . . . . 0.0 109.946 -175.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -66.42 -49.9 65.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.951 -1.718 . . . . 0.0 110.802 167.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -66.5 -46.93 74.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.484 -0.76 . . . . 0.0 112.775 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -69.71 -33.01 71.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.48 91.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.465 -2.022 . . . . 0.0 113.533 170.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.59 -52.38 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 118.885 -0.579 . . . . 0.0 111.314 172.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -47.24 -45.16 23.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 171.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -73.64 -27.47 61.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.95 1.3 . . . . 0.0 112.368 -171.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.8 mt -90.27 -48.12 7.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.077 1.751 . . . . 0.0 114.51 172.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -48.24 17.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.956 2.103 . . . . 0.0 113.402 -173.287 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -88.38 31.41 0.82 Allowed 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.859 -1.776 . . . . 0.0 112.426 -166.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 45.3 p -83.04 -168.06 1.92 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.283 3.433 . . . . 0.0 109.388 171.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.5 -108.08 0.53 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.383 -1.448 . . . . 0.0 110.723 170.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -120.18 -44.87 2.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.567 1.147 . . . . 0.0 110.436 174.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -72.72 129.89 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 122.449 1.119 . . . . 0.0 112.116 173.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 68' ' ' VAL . 45.8 t -129.76 99.87 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 126.415 1.886 . . . . 0.0 108.116 179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -78.02 98.62 5.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.552 1.941 . . . . 0.0 110.312 168.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mt -84.79 113.16 21.14 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.455 1.902 . . . . 0.0 109.911 -175.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.55 98.36 11.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 168.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.06 147.97 25.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.364 1.865 . . . . 0.0 109.717 -177.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -118.97 132.97 56.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.702 1.239 . . . . 0.0 108.236 167.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -74.24 139.88 44.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.862 1.265 . . . . 0.0 109.79 176.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.2 -80.93 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 112.475 165.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -157.83 -40.33 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 159.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . 0.346 11.6 p -4.72 82.11 0.03 OUTLIER Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 129.658 3.183 . . . . 0.0 118.819 -156.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 C--N 1.299 -2.036 0 C-N-CA 122.225 1.95 . . . . 0.0 116.829 -151.263 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 tp -146.13 179.17 7.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.951 -1.093 . . . . 0.0 108.068 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 28' ' ' SER 0.398 2.2 t 67.86 104.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-O 124.924 2.297 . . . . 0.0 114.378 169.819 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 34.1 m -140.24 122.76 16.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 102.612 -3.107 . . . . 0.0 102.612 -171.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.3 p -80.55 121.29 25.62 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 123.984 0.914 . . . . 0.0 109.986 175.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 3.0 m . . . . . 0 C--O 1.259 1.579 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -169.488 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.8 mpt? . . . . . 0 N--CA 1.43 -1.469 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -118.43 118.24 33.99 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-O 117.612 -1.185 . . . . 0.0 108.987 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -69.9 96.53 0.61 Allowed 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 123.115 2.148 . . . . 0.0 116.317 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.85 55.82 0.57 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 126.155 1.836 . . . . 0.0 111.747 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -133.99 124.24 25.95 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 118.099 0.949 . . . . 0.0 110.04 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.7 p -95.54 147.07 23.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.521 1.153 . . . . 0.0 110.743 170.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.38 128.25 41.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -103.25 81.24 1.92 Allowed 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.609 1.195 . . . . 0.0 108.316 177.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.95 109.11 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 126.926 2.091 . . . . 0.0 112.543 -173.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 124.64 44.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.92 -1.738 . . . . 0.0 109.384 -177.061 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.1 mt -134.93 158.73 43.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 109.045 -171.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.1 121.28 43.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 162.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -63.18 146.51 53.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.885 -1.134 . . . . 0.0 113.37 -175.136 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.7 t -92.41 88.66 6.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.963 1.364 . . . . 0.0 107.381 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 t0 44.99 64.98 1.2 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.18 2.592 . . . . 0.0 117.108 -177.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.13 52.8 6.02 Favored Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.634 -1.291 . . . . 0.0 114.119 179.154 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 3.9 m 177.33 109.67 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.166 1.386 . . . . 0.0 108.618 -169.354 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.39 -45.68 45.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.248 1.819 . . . . 0.0 107.426 163.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.88 47.06 0.85 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 125.444 1.497 . . . . 0.0 111.054 177.1 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 pt -128.8 131.65 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 121.39 0.614 . . . . 0.0 109.429 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.1 m -91.05 113.03 25.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 124.434 1.094 . . . . 0.0 111.95 171.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.6 m -80.85 140.13 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -172.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 t -130.67 168.18 17.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.098 1.759 . . . . 0.0 109.602 172.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.85 -150.23 34.02 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 124.977 1.275 . . . . 0.0 114.08 -177.1 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.09 161.44 21.76 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 125.439 1.495 . . . . 0.0 109.602 -179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -71.44 11.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.094 -1.827 . . . . 0.0 115.136 -171.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -58.71 -37.81 76.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.741 -2.474 . . . . 0.0 115.711 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.3 p -116.92 -172.68 2.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.76 1.224 . . . . 0.0 107.902 166.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 t -73.56 89.3 1.7 Allowed 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.61 -1.931 . . . . 0.0 112.478 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 174.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 104.192 -2.522 . . . . 0.0 104.192 176.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -69.78 78.98 0.45 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.545 -1.972 . . . . 0.0 112.653 176.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.9 t60 69.91 -38.45 0.41 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.59 3.556 . . . . 0.0 116.282 -178.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.59 -129.1 1.7 Allowed Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.35 -3.5 . . . . 0.0 104.35 -178.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.78 164.73 4.52 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 124.702 1.144 . . . . 0.0 113.584 -173.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 65' ' ' VAL 0.287 3.9 tp -124.33 156.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 120.103 -1.821 . . . . 0.0 106.826 170.659 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.09 151.63 52.01 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -170.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 47' ' ' ILE . 16.0 t -85.87 130.91 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.403 -2.061 . . . . 0.0 110.524 176.252 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -90.23 -45.96 8.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.035 -1.666 . . . . 0.0 110.379 168.192 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.85 143.87 33.58 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 122.605 1.193 . . . . 0.0 112.784 -178.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.601 ' CD1' HG11 ' A' ' 44' ' ' VAL . 47.8 mm -105.02 116.97 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.513 2.725 . . . . 0.0 108.001 -176.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.7 pt -84.08 154.69 63.94 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.539 -1.351 . . . . 0.0 112.653 -177.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -67.92 106.55 1.34 Allowed 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.734 2.289 . . . . 0.0 115.36 -169.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.9 mttm 41.39 65.02 0.9 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.044 2.537 . . . . 0.0 117.701 175.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.62 -90.13 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 169.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.54 -41.58 2.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.728 -0.866 . . . . 0.0 111.093 169.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.96 -49.0 50.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.955 1.702 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.17 -29.98 70.74 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.454 -1.403 . . . . 0.0 111.929 173.023 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.7 m -69.72 -2.36 11.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 176.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.95 -80.9 0.05 Allowed 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 120.872 1.669 . . . . 0.0 107.427 157.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.62 -33.94 0.82 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 121.25 -0.906 . . . . 0.0 111.413 165.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.8 mtm-85 -72.25 -26.49 62.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -169.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.02 141.3 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.706 1.202 . . . . 0.0 114.125 -174.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -134.21 -166.93 1.87 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.607 -1.308 . . . . 0.0 110.783 165.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -80.84 135.34 35.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.041 -1.662 . . . . 0.0 110.337 -176.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.65 2.34 72.8 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.076 -1.64 . . . . 0.0 114.642 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.21 151.52 39.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.437 1.119 . . . . 0.0 111.682 176.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -106.19 114.46 28.6 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.419 1.087 . . . . 0.0 109.357 -167.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 42' ' ' ILE . 3.3 p -92.89 120.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.132 -1.605 . . . . 0.0 108.814 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.04 -39.84 9.95 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.651 -1.281 . . . . 0.0 111.544 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.63 149.23 34.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 92' ' ' VAL . 10.7 t -129.59 117.73 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 O-C-N 120.804 -1.185 . . . . 0.0 113.061 -173.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 0.4 OUTLIER 46.62 37.54 4.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.277 2.231 . . . . 0.0 115.754 -169.863 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.24 5.88 57.93 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 114.201 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -121.87 105.77 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 118.346 1.073 . . . . 0.0 110.366 -168.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 t -60.74 139.24 57.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 124.818 1.247 . . . . 0.0 112.759 172.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.84 60.33 2.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.911 2.084 . . . . 0.0 111.614 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.01 105.26 10.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.081 2.153 . . . . 0.0 111.796 -169.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.93 21.03 79.15 Favored Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.813 -1.179 . . . . 0.0 114.026 -175.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.27 141.07 29.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.161 -1.2 . . . . 0.0 113.165 -175.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -104.57 -156.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.591 2.356 . . . . 0.0 109.66 -174.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -68.97 -50.94 44.63 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.707 -1.871 . . . . 0.0 111.384 168.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -60.72 -51.76 68.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 112.337 174.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.83 -36.07 82.71 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.006 -1.059 . . . . 0.0 113.846 -175.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.15 92.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.156 -1.59 . . . . 0.0 114.953 171.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.05 -49.7 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 110.764 174.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -65.36 -26.12 67.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.891 -1.756 . . . . 0.0 114.902 178.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 91.8 m -75.97 -27.98 57.7 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.158 1.783 . . . . 0.0 113.172 176.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.6 mt -89.63 -47.72 7.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.227 -1.545 . . . . 0.0 113.963 173.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.31 -37.1 22.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.695 1.598 . . . . 0.0 114.072 -170.277 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.55 37.58 0.92 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.979 -1.701 . . . . 0.0 111.274 -172.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.5 p -100.17 179.41 4.49 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.132 3.373 . . . . 0.0 111.555 -179.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -85.94 -136.68 4.22 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.611 -1.306 . . . . 0.0 112.871 173.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -85.06 -62.42 1.54 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.802 -1.411 . . . . 0.0 111.869 -177.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.1 t -75.75 124.28 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.89 1.329 . . . . 0.0 111.787 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 68' ' ' VAL . 13.5 t -114.99 114.94 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 167.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -87.35 110.66 20.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 168.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.4 mt -87.12 111.14 20.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.585 -1.322 . . . . 0.0 110.253 174.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 98.36 10.97 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.4 mt -104.97 137.92 41.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.968 2.507 . . . . 0.0 110.759 -173.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.6 148.05 42.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.235 1.814 . . . . 0.0 108.545 170.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.0 133.56 55.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 176.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.72 19.7 53.64 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.422 -2.048 . . . . 0.0 113.465 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -96.71 130.95 43.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.085 1.754 . . . . 0.0 110.503 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.4 p -82.47 146.05 52.89 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 116.891 -1.528 . . . . 0.0 110.008 172.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 N--CA 1.433 -2.041 0 CA-C-N 124.966 2.809 . . . . 0.0 114.672 179.463 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.351 0.596 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 7.8 tp 66.82 168.48 0.24 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.215 2.206 . . . . 0.0 114.006 -161.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.462 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.452 5.7 m 46.06 76.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 128.058 2.543 . . . . 0.0 117.311 171.107 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.1 m -117.78 117.86 30.48 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 -168.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 69.3 p -78.86 117.98 20.47 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.017 1.327 . . . . 0.0 111.323 178.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 104.115 -2.55 . . . . 0.0 104.115 -171.567 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -145.43 164.41 26.52 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 175.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -63.51 139.29 69.64 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.687 2.258 . . . . 0.0 112.621 160.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.77 35.45 50.78 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 174.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.7 103.99 6.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.41 1.605 . . . . 0.0 110.994 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 p -94.57 119.54 33.41 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.439 1.114 . . . . 0.0 110.907 170.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.68 117.46 33.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.218 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -90.53 89.05 7.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.985 1.85 . . . . 0.0 109.513 170.4 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.36 150.77 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.388 1.875 . . . . 0.0 108.358 176.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -135.79 130.7 34.45 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.799 -1.813 . . . . 0.0 109.164 168.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.08 165.42 36.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.223 1.011 . . . . 0.0 111.718 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.18 132.77 45.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.578 1.151 . . . . 0.0 110.355 170.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HB3' HD23 ' A' ' 25' ' ' LEU . 5.5 ptpt -70.49 164.27 25.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 0.0 112.374 177.189 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 t -114.64 96.94 5.99 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.532 -1.355 . . . . 0.0 109.36 -179.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 53.08 55.08 9.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.011 2.125 . . . . 0.0 115.399 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.74 48.75 16.06 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 114.001 179.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 p -178.58 119.32 0.08 Allowed 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 20' ' ' LYS . 10.8 mt -74.66 -38.19 62.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.91 2.084 . . . . 0.0 106.449 164.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.473 ' CA ' HD12 ' A' ' 48' ' ' ILE . . . 120.52 18.25 4.11 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 125.253 1.406 . . . . 0.0 110.864 168.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.2 pt -107.93 129.19 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.715 1.245 . . . . 0.0 110.541 -176.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.421 ' HB3' HG22 ' B' ' 207' ' ' VAL . 28.0 m -85.96 113.61 22.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.513 1.125 . . . . 0.0 110.864 173.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -85.13 131.59 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 -171.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -126.24 164.96 19.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.118 2.167 . . . . 0.0 110.83 177.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.59 -136.18 13.69 Favored Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 125.877 1.703 . . . . 0.0 114.009 174.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.52 176.84 49.59 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 124.662 1.125 . . . . 0.0 114.457 -179.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 p -60.42 -16.39 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.521 2.328 . . . . 0.0 115.343 -172.263 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.2 -39.88 80.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.542 -1.349 . . . . 0.0 113.627 171.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.1 t -113.18 167.68 10.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.452 1.501 . . . . 0.0 109.556 -178.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -80.85 88.08 5.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.781 -1.824 . . . . 0.0 111.441 176.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.79 77.47 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 123.266 1.507 . . . . 0.0 107.9 177.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.02 -95.91 0.06 Allowed 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 126.387 1.875 . . . . 0.0 112.605 -167.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -115.4 -57.84 2.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.568 1.147 . . . . 0.0 111.119 176.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.1 -115.73 0.35 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -178.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.08 -165.03 53.2 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 121.178 -1.189 . . . . 0.0 114.716 -178.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.42 HG22 HG13 ' A' ' 65' ' ' VAL 0.264 3.1 tp -145.52 164.53 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 161.121 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -145.53 157.49 43.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -168.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.498 HG11 HD13 ' A' ' 47' ' ' ILE . 7.8 t -90.06 130.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.015 -1.678 . . . . 0.0 113.208 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -87.73 -53.56 4.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.896 -1.128 . . . . 0.0 111.375 170.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.97 132.76 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.035 0.921 . . . . 0.0 111.472 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.498 HD13 HG11 ' A' ' 44' ' ' VAL . 39.6 mm -98.39 137.22 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 127.522 2.329 . . . . 0.0 107.787 172.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.473 HD12 ' CA ' ' A' ' 26' ' ' GLY . 59.3 mt -85.5 141.04 36.24 Favored Pre-proline 0 N--CA 1.43 -1.46 0 CA-C-O 116.827 -1.559 . . . . 0.0 108.426 176.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.31 92.65 0.34 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.367 2.711 . . . . 0.0 112.911 171.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt 59.13 60.62 2.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.797 2.039 . . . . 0.0 114.964 177.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.16 -68.72 1.32 Allowed Glycine 0 N--CA 1.429 -1.769 0 O-C-N 120.333 -1.479 . . . . 0.0 110.008 170.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.59 -52.74 0.44 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 123.653 0.781 . . . . 0.0 109.043 163.523 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.58 -33.68 75.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.459 2.762 . . . . 0.0 118.459 -171.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.0 -35.25 80.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.088 -2.882 . . . . 0.0 111.014 171.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -74.34 0.54 14.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -177.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -72.48 -51.72 18.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.672 -1.893 . . . . 0.0 109.941 168.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 158.09 -73.76 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.798 158.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -69.96 -19.24 63.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 -166.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -66.5 133.06 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 121.748 2.067 . . . . 0.0 115.575 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -129.49 178.71 6.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.555 1.542 . . . . 0.0 111.718 172.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -83.03 124.75 30.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.213 -1.555 . . . . 0.0 109.523 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.64 2.15 52.98 Favored Glycine 0 N--CA 1.429 -1.819 0 O-C-N 121.118 -0.989 . . . . 0.0 113.933 -173.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -81.83 165.04 21.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.588 1.185 . . . . 0.0 111.896 176.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -107.69 131.15 54.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.678 -172.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 42' ' ' ILE . 2.3 p -106.43 120.49 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 120.092 -1.63 . . . . 0.0 107.541 163.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.24 -37.59 9.61 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.618 -1.301 . . . . 0.0 112.308 -179.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.13 156.87 43.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 119.467 1.03 . . . . 0.0 113.217 -177.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.71 123.34 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 121.335 -0.853 . . . . 0.0 111.646 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 53.46 32.8 14.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.218 1.372 . . . . 0.0 114.566 -171.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.4 20.65 76.72 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.899 -1.126 . . . . 0.0 114.49 -175.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -115.23 102.61 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.7 m -59.46 135.83 57.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.883 -1.136 . . . . 0.0 112.457 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.95 70.71 2.69 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.0 111.897 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.82 101.26 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.387 1.875 . . . . 0.0 112.349 -174.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.49 38.02 95.65 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 121.119 -0.988 . . . . 0.0 112.978 -175.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.05 140.52 35.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.417 -1.049 . . . . 0.0 109.706 176.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 t -114.48 -168.78 1.42 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 103.892 -2.632 . . . . 0.0 103.892 174.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -56.45 -52.88 63.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.91 -1.744 . . . . 0.0 114.168 -178.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tmtp? -74.14 -41.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.707 1.14 . . . . 0.0 112.315 -174.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -59.45 -47.1 86.77 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 119.957 -1.714 . . . . 0.0 114.449 172.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.41 -29.9 70.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.459 -1.401 . . . . 0.0 114.597 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.5 t -55.5 -56.86 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.43 166.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -51.56 -42.4 61.83 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 174.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -61.17 -29.81 70.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.933 2.093 . . . . 0.0 115.012 177.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -97.74 -33.43 11.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.104 2.162 . . . . 0.0 115.263 173.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -49.44 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.168 2.587 . . . . 0.0 114.147 -169.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.7 t-20 -92.91 30.92 1.48 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.564 1.65 . . . . 0.0 111.548 -169.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -87.14 -174.57 4.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.628 2.771 . . . . 0.0 111.175 -176.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.37 173.44 51.22 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 120.848 -1.158 . . . . 0.0 111.337 158.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -61.53 -41.22 97.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.691 1.596 . . . . 0.0 113.07 178.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.23 126.47 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 122.939 1.352 . . . . 0.0 111.043 169.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.0 t -120.51 105.22 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.607 1.563 . . . . 0.0 107.394 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -77.83 103.55 7.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.605 -1.309 . . . . 0.0 109.542 165.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -89.17 118.4 28.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.744 -1.222 . . . . 0.0 110.429 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.38 95.34 10.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.12 145.61 26.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.885 2.074 . . . . 0.0 110.196 -177.333 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -119.62 139.23 52.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.772 1.273 . . . . 0.0 110.048 163.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.61 124.73 24.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.686 1.994 . . . . 0.0 113.267 177.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.05 73.21 2.67 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.316 -1.49 . . . . 0.0 113.09 172.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.05 160.41 14.35 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.319 2.247 . . . . 0.0 111.403 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.76 113.53 44.71 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.942 -1.504 . . . . 0.0 108.628 173.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 C--N 1.3 -2.014 0 CA-C-N 123.802 2.394 . . . . 0.0 116.53 -175.168 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.625 1.202 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 14.7 tp -107.78 158.47 17.27 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.333 1.453 . . . . 0.0 109.957 176.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 28' ' ' SER 0.395 2.3 t 77.09 121.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 163.093 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 20.5 m -150.63 126.62 10.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 10.8 p -80.99 122.95 27.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.795 1.638 . . . . 0.0 110.661 174.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.261 1.664 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 -170.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.476 0.655 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.62 138.35 19.57 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 109.838 177.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.18 147.46 42.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 122.037 1.825 . . . . 0.0 110.516 172.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.58 19.19 74.5 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -78.86 123.68 27.48 Favored 'General case' 0 CA--C 1.489 -1.395 0 O-C-N 120.903 -1.351 . . . . 0.0 111.452 -176.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -102.25 126.25 49.19 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.678 -1.264 . . . . 0.0 111.112 -178.055 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -114.01 121.8 44.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.449 1.5 . . . . 0.0 108.806 179.041 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -101.32 75.14 1.6 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.511 1.524 . . . . 0.0 111.375 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.58 121.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 120.193 -1.567 . . . . 0.0 114.817 -169.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.72 122.24 39.45 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.774 -1.829 . . . . 0.0 111.328 175.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.23 170.64 16.33 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.439 1.096 . . . . 0.0 108.578 175.079 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.0 133.49 55.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.423 1.089 . . . . 0.0 109.501 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.53 155.03 34.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.992 -1.068 . . . . 0.0 111.42 -174.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 t -100.9 100.03 10.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.838 -1.164 . . . . 0.0 109.052 178.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.265 2.4 m-20 37.81 60.23 1.2 Allowed 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.536 2.735 . . . . 0.0 117.141 -172.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.6 54.66 5.37 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.969 -1.082 . . . . 0.0 114.198 178.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 m 179.22 109.91 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.237 1.415 . . . . 0.0 107.354 -172.148 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.9 mt -76.84 -44.86 30.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 165.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.39 45.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.806 1.193 . . . . 0.0 110.768 174.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.16 136.94 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 121.553 0.692 . . . . 0.0 110.793 169.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.444 ' HB3' HG13 ' B' ' 207' ' ' VAL . 71.1 m -80.09 110.52 15.57 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.091 1.757 . . . . 0.0 112.442 167.603 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -88.8 123.47 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -172.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.5 t -121.72 171.08 9.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.574 2.349 . . . . 0.0 109.98 176.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.63 -131.01 10.29 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.238 1.399 . . . . 0.0 112.606 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.65 168.73 44.84 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 124.271 0.939 . . . . 0.0 111.895 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.5 -12.87 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.161 1.784 . . . . 0.0 115.006 -171.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -74.55 -24.55 58.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 119.84 -1.788 . . . . 0.0 111.18 173.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -97.08 -173.9 2.81 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.513 1.525 . . . . 0.0 109.396 174.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -96.85 91.12 5.5 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.405 -2.059 . . . . 0.0 112.372 178.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 40' ' ' GLY . 15.1 m -112.82 -172.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.794 -175.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.48 45.43 0.39 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.529 2.332 . . . . 0.0 115.44 -173.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.282 1.5 t-160 62.06 40.34 12.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.373 1.869 . . . . 0.0 114.023 -169.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' H ' HG23 ' A' ' 37' ' ' VAL . . . 104.93 116.92 4.28 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.126 1.346 . . . . 0.0 112.197 -175.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.53 153.12 9.98 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.721 -1.751 . . . . 0.0 108.721 173.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 tp -110.15 157.71 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 174.133 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -137.01 153.1 50.75 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.016 -1.678 . . . . 0.0 108.056 -169.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.55 HG11 HD13 ' A' ' 47' ' ' ILE . 14.3 t -90.85 117.89 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.41 -1.431 . . . . 0.0 112.074 178.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -81.66 -33.98 31.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.844 -1.16 . . . . 0.0 112.102 177.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.93 146.15 18.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.803 0.811 . . . . 0.0 109.776 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.55 HD13 HG11 ' A' ' 44' ' ' VAL . 44.2 mm -100.76 121.67 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 15.3 pt -78.34 148.41 74.05 Favored Pre-proline 0 N--CA 1.429 -1.48 0 O-C-N 120.55 -1.344 . . . . 0.0 112.547 -176.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -85.92 66.54 5.36 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 C-N-CA 122.593 2.195 . . . . 0.0 112.221 167.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.276 23.7 pttm 170.86 65.94 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.592 2.357 . . . . 0.0 110.243 166.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -158.7 179.6 34.24 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.211 -2.18 . . . . 0.0 111.336 -178.696 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.19 17.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.336 2.654 . . . . 0.0 111.869 -172.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.37 -41.72 72.74 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.946 1.698 . . . . 0.0 113.625 -176.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.91 -36.19 62.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.4 -1.437 . . . . 0.0 113.424 165.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 t -75.36 2.31 11.59 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.325 -2.11 . . . . 0.0 107.923 153.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.71 -28.12 1.46 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 170.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 36.8 mtt85 -81.77 -27.61 33.66 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mt -67.02 133.82 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 119.235 0.925 . . . . 0.0 113.436 178.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -127.23 -178.43 4.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.734 -1.229 . . . . 0.0 109.424 166.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -76.6 103.34 6.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.517 -1.989 . . . . 0.0 111.132 174.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.7 -17.72 1.82 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 120.783 -1.198 . . . . 0.0 115.505 -173.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.49 156.65 36.69 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 119.918 1.859 . . . . 0.0 115.226 -172.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.19 122.31 45.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.655 1.582 . . . . 0.0 109.513 -175.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.48 114.39 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.94 -38.89 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.403 -1.435 . . . . 0.0 112.939 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.16 160.18 44.01 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.022 1.283 . . . . 0.0 114.147 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 92' ' ' VAL . 47.0 t -134.3 113.32 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 121.405 -0.809 . . . . 0.0 111.49 -175.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.437 10.2 p30 43.44 33.98 0.7 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.33 2.345 . . . . 0.0 117.33 -163.708 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.07 22.29 59.51 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.575 -1.328 . . . . 0.0 113.383 -177.032 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.99 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 172.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 73.4 p -70.38 144.26 51.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.475 1.131 . . . . 0.0 113.248 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.79 56.38 3.87 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.727 1.211 . . . . 0.0 110.037 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -77.27 24.56 0.18 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 128.588 2.755 . . . . 0.0 114.654 -163.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.1 40.21 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.085 1.802 . . . . 0.0 111.173 -176.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.47 148.39 25.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.287 -1.125 . . . . 0.0 111.81 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.609 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 46.6 p -95.91 -159.7 0.74 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.727 2.811 . . . . 0.0 109.872 -174.384 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -63.96 -54.88 27.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.831 -1.793 . . . . 0.0 112.228 163.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -68.05 -38.7 82.78 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 114.446 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.609 ' HB2' ' H ' ' A' ' 77' ' ' THR . 35.2 mt-30 -68.52 -38.84 81.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.975 -1.703 . . . . 0.0 113.128 174.391 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.41 87.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.79 -1.819 . . . . 0.0 113.597 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 t -55.52 -54.77 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.634 1.173 . . . . 0.0 110.751 175.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -51.93 -41.07 61.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 174.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.3 m -70.64 -24.66 62.75 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.705 1.602 . . . . 0.0 113.984 -175.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -90.85 -40.18 11.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.008 -1.683 . . . . 0.0 114.141 167.288 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -46.76 44.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.181 1.792 . . . . 0.0 114.786 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -83.88 34.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.935 -1.728 . . . . 0.0 113.496 -170.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.0 p -103.03 153.35 20.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.416 2.286 . . . . 0.0 114.158 -170.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -81.31 62.08 4.52 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.321 1.439 . . . . 0.0 115.888 -175.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.321 9.8 tt0 64.63 -50.68 0.31 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.354 3.462 . . . . 0.0 116.929 178.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -80.19 127.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.263 1.506 . . . . 0.0 109.8 173.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 68' ' ' VAL . 47.9 t -120.11 104.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -79.09 102.78 8.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 165.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.526 ' HG ' HG12 ' A' ' 92' ' ' VAL . 14.9 mt -87.59 113.85 23.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.503 -0.748 . . . . 0.0 110.39 -175.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.12 95.78 10.28 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.7 141.21 36.46 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.543 2.337 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -109.79 139.02 45.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.813 1.245 . . . . 0.0 109.287 167.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -65.17 110.13 2.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.467 2.307 . . . . 0.0 114.387 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.06 52.76 2.21 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 120.218 -1.552 . . . . 0.0 112.001 175.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -119.41 147.23 44.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.649 1.579 . . . . 0.0 107.962 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.4 m -82.21 152.75 68.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 120.673 -1.267 . . . . 0.0 110.25 176.131 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 N--CA 1.433 -2.056 0 CA-C-N 122.486 1.924 . . . . 0.0 111.503 175.756 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 36.8 t80 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 12.8 tp -158.08 152.55 24.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.891 -1.131 . . . . 0.0 109.544 -176.317 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.444 HG13 ' HB3' ' A' ' 28' ' ' SER 0.374 15.6 t 67.59 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 124.352 2.025 . . . . 0.0 114.732 171.108 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 98.3 m -138.29 133.65 33.34 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 -179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 43.7 m -74.47 118.87 17.92 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.436 1.494 . . . . 0.0 109.509 171.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.572 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 -176.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.429 -1.505 0 CA-C-O 121.741 0.781 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -132.14 150.0 74.81 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 120.633 -1.292 . . . . 0.0 107.881 179.457 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.85 148.35 40.76 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 122.496 2.131 . . . . 0.0 112.224 173.613 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.27 28.7 55.27 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.4 1.72 . . . . 0.0 117.4 171.241 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -87.06 125.76 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.206 -1.173 . . . . 0.0 112.79 -163.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 p -78.55 133.72 37.32 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.597 -1.314 . . . . 0.0 112.697 177.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.277 0.0 OUTLIER -131.2 132.61 44.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.749 1.22 . . . . 0.0 108.247 170.473 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -106.71 87.18 2.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.217 1.007 . . . . 0.0 109.102 175.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.4 t -90.68 122.84 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.205 2.202 . . . . 0.0 113.044 -174.73 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -105.73 118.36 36.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.005 -2.309 . . . . 0.0 113.22 -179.762 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 mt -120.12 160.85 22.04 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.943 -1.098 . . . . 0.0 111.161 -173.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.26 102.65 8.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 171.001 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.604 ' HB3' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.86 143.83 57.22 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -173.045 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.2 t -104.39 93.99 5.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.425 1.49 . . . . 0.0 109.627 -168.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.62 56.44 7.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.674 2.39 . . . . 0.0 114.156 -173.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.39 60.01 7.17 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.792 -1.193 . . . . 0.0 114.231 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.1 t -175.81 104.47 0.08 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -172.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 20' ' ' LYS . 9.2 mt -72.33 -49.98 30.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 164.884 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.03 37.63 0.3 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 113.307 -1.77 . . . . 0.0 111.605 165.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.05 130.69 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.324 1.059 . . . . 0.0 112.127 179.814 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.2 m -73.32 111.22 8.24 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.217 1.007 . . . . 0.0 111.954 160.575 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.8 m -84.12 124.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.44 169.7 9.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.459 1.904 . . . . 0.0 110.04 175.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.46 -121.51 5.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.481 1.515 . . . . 0.0 113.613 178.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.31 147.71 22.13 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -175.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 m -64.08 -11.23 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -171.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -48.57 -67.82 0.24 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.887 2.075 . . . . 0.0 115.574 -171.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 p -135.7 -82.67 0.4 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 111.469 -174.745 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -52.44 -24.38 7.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.02 2.97 . . . . 0.0 119.02 -166.159 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 m -85.28 -3.1 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.156 -1.59 . . . . 0.0 113.371 -178.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 21.3 mtp-105 71.38 23.95 3.82 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.15 2.18 . . . . 0.0 113.197 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.252 2.4 t-80 78.08 125.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.97 2.908 . . . . 0.0 112.554 -170.063 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.03 -111.18 0.24 Allowed Glycine 0 N--CA 1.431 -1.686 0 O-C-N 119.526 -1.983 . . . . 0.0 114.203 -160.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.42 -150.22 5.76 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.006 -2.037 . . . . 0.0 108.006 178.762 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -108.85 155.37 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 168.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -136.68 152.94 50.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.002 -1.686 . . . . 0.0 107.292 -171.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 47' ' ' ILE . 8.7 t -79.9 130.68 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 120.375 -1.453 . . . . 0.0 110.432 173.384 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -90.3 -49.47 6.52 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.235 -1.541 . . . . 0.0 110.327 168.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.99 37.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.128 0.971 . . . . 0.0 109.824 -173.097 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.461 HD13 HG11 ' A' ' 44' ' ' VAL . 45.3 mm -95.15 137.45 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 170.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.3 pt -95.17 152.37 39.39 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 120.869 -1.145 . . . . 0.0 113.215 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -80.09 68.21 8.38 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 122.865 2.377 . . . . 0.0 112.397 168.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -121.51 -73.54 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.833 0.853 . . . . 0.0 111.254 171.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.42 -99.61 0.12 Allowed Glycine 0 N--CA 1.431 -1.678 0 O-C-N 121.303 -0.873 . . . . 0.0 113.331 -169.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -49.04 -52.87 22.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 118.989 2.959 . . . . 0.0 118.989 -152.49 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 -28.89 61.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.184 -1.572 . . . . 0.0 114.991 179.07 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -67.14 -37.3 83.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.179 -1.576 . . . . 0.0 110.942 168.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.9 m -69.93 -1.7 10.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 -178.373 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -71.56 -83.4 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.062 -2.274 . . . . 0.0 109.793 165.568 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.88 -41.08 0.93 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.957 -1.089 . . . . 0.0 111.561 174.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -84.94 -18.6 34.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.31 127.22 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.843 1.257 . . . . 0.0 110.836 176.303 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.8 -179.42 5.07 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.634 1.574 . . . . 0.0 110.359 177.467 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -76.52 70.55 3.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.326 1.45 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.68 -13.03 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.384 -1.447 . . . . 0.0 116.561 179.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -71.34 157.4 38.15 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -173.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -92.92 130.33 38.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.392 1.477 . . . . 0.0 110.216 -177.171 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.26 122.3 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 125.123 1.369 . . . . 0.0 107.754 167.809 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.38 -32.84 8.85 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.993 -1.067 . . . . 0.0 113.155 175.101 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.05 159.72 44.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.763 -1.211 . . . . 0.0 112.811 179.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.6 t -141.08 123.66 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.105 -0.997 . . . . 0.0 111.863 -174.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 58.09 30.43 19.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.28 -1.512 . . . . 0.0 112.687 -178.26 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.84 78.06 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 125.73 1.633 . . . . 0.0 114.557 -174.245 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.92 109.76 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -177.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.2 m -60.57 146.21 45.98 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.124 1.44 . . . . 0.0 113.677 175.087 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -79.28 65.01 4.33 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.52 -1.362 . . . . 0.0 110.303 172.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.38 98.77 9.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.242 -1.536 . . . . 0.0 111.019 -176.307 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.93 66.43 Favored Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.361 -0.837 . . . . 0.0 112.896 -177.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.82 129.15 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.955 1.836 . . . . 0.0 115.087 -170.178 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 73.5 p -93.4 -165.19 1.29 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.645 2.378 . . . . 0.0 107.741 -179.745 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -58.6 -49.99 75.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.085 -1.635 . . . . 0.0 112.737 164.735 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -69.83 -45.38 67.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 77' ' ' THR . 58.9 tt0 -69.22 -32.86 72.4 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.979 -1.076 . . . . 0.0 112.97 177.7 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.01 -39.1 89.97 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.394 -1.441 . . . . 0.0 114.312 173.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.89 -52.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.398 -0.811 . . . . 0.0 110.146 171.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.24 -40.81 78.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 177.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.2 m -62.4 -28.78 70.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 175.054 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.27 -40.79 11.94 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.824 1.65 . . . . 0.0 115.057 172.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -75.69 -44.33 42.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.912 2.885 . . . . 0.0 113.483 -173.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -87.93 38.61 0.85 Allowed 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.336 -1.477 . . . . 0.0 111.471 -169.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.0 p -109.26 166.45 10.85 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.722 2.009 . . . . 0.0 112.125 -173.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.13 -89.09 0.19 Allowed Glycine 0 N--CA 1.429 -1.772 0 O-C-N 120.199 -1.563 . . . . 0.0 115.564 -172.699 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.64 -62.53 0.6 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.602 -0.94 . . . . 0.0 110.177 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.2 t -75.09 125.79 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 122.961 1.362 . . . . 0.0 110.707 172.346 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.7 t -114.37 103.99 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 174.507 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -83.12 103.88 12.88 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 108.622 172.856 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.73 118.76 26.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.025 -1.047 . . . . 0.0 111.483 178.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.76 102.53 15.22 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 170.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.75 144.49 30.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.588 1.955 . . . . 0.0 110.427 -177.769 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -110.98 132.15 54.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 163.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -74.33 121.86 22.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 123.961 0.905 . . . . 0.0 112.258 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.05 68.24 3.47 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -169.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -131.03 150.58 52.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.42 1.088 . . . . 0.0 110.892 174.388 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 p -98.5 131.93 25.08 Favored Pre-proline 0 N--CA 1.431 -1.39 0 C-N-CA 126.437 1.895 . . . . 0.0 110.14 -172.723 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo . . . . . 0 N--CA 1.433 -2.035 0 CA-C-N 123.326 2.223 . . . . 0.0 114.446 178.348 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 121.664 0.745 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 11.3 tp -144.04 166.13 25.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.831 -1.168 . . . . 0.0 110.041 -174.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.507 28.0 m 54.41 98.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 118.015 2.598 . . . . 0.0 118.015 169.314 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 31.2 m -133.76 124.51 26.75 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 -174.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 16.4 m -69.83 128.78 37.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.488 1.115 . . . . 0.0 110.672 171.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.259 1.594 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -170.744 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 59.2 mtm . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -129.61 155.87 79.61 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 120.825 -1.172 . . . . 0.0 109.129 178.573 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -75.66 129.67 11.97 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.82 2.347 . . . . 0.0 111.517 167.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.52 40.41 96.14 Favored Glycine 0 N--CA 1.429 -1.811 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 170.687 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.84 118.49 22.4 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 121.207 -1.173 . . . . 0.0 109.48 177.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 p -90.83 135.42 33.74 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.728 -1.233 . . . . 0.0 111.202 174.033 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -131.11 137.55 49.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.558 1.143 . . . . 0.0 108.004 178.22 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.39 76.36 0.97 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.032 1.333 . . . . 0.0 109.364 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.74 121.71 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.044 1.738 . . . . 0.0 114.942 -169.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -99.54 116.56 31.95 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.512 -1.992 . . . . 0.0 110.46 174.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.29 170.68 15.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -119.51 141.06 49.53 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.967 -1.083 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -63.99 145.98 54.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.573 1.949 . . . . 0.0 112.593 174.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -101.73 101.65 12.18 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.392 1.091 . . . . 0.0 109.495 179.708 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.95 -20.77 0.06 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.704 2.802 . . . . 0.0 117.522 -173.226 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.16 43.81 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 O-C-N 119.799 -1.813 . . . . 0.0 111.97 179.572 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.9 p -174.12 129.07 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' B' ' 210' ' ' VAL . 7.3 mt -78.99 -40.55 31.31 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 169.716 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 117.56 43.19 0.59 Allowed Glycine 0 N--CA 1.429 -1.825 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.39 169.235 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.0 pt -120.21 134.73 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.695 0.76 . . . . 0.0 109.886 167.238 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.6 m -96.12 117.13 30.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.162 0.985 . . . . 0.0 111.042 169.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.67 142.09 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -167.339 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 t -133.89 159.51 40.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.855 1.662 . . . . 0.0 109.448 168.384 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.98 -141.79 16.3 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.839 1.209 . . . . 0.0 114.593 173.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -175.54 48.6 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.668 1.127 . . . . 0.0 115.252 -178.689 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.56 -15.74 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 127.634 2.374 . . . . 0.0 114.085 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.867 1.667 . . . . 0.0 112.942 174.707 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -126.98 -163.6 1.26 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.841 1.657 . . . . 0.0 107.547 174.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.9 p -107.78 105.67 15.62 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.899 -2.376 . . . . 0.0 110.669 174.085 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 m -106.08 -130.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 124.275 1.03 . . . . 0.0 110.598 -176.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -92.17 -67.0 0.88 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.071 -1.643 . . . . 0.0 108.755 168.151 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -156.81 62.64 0.52 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.298 -0.876 . . . . 0.0 109.675 178.545 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.11 8.24 87.96 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 117.619 1.808 . . . . 0.0 117.619 174.123 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.65 159.99 29.82 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 119.762 1.781 . . . . 0.0 112.779 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.9 tp -107.64 162.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.338 -170.479 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -139.19 162.13 35.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.852 -1.78 . . . . 0.0 107.777 -173.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.586 HG11 HD13 ' A' ' 47' ' ' ILE . 6.2 t -96.68 125.16 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 120.558 -1.339 . . . . 0.0 111.469 176.505 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.56 -33.55 14.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.373 -1.454 . . . . 0.0 112.261 175.049 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.14 137.58 24.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 110.977 177.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.586 HD13 HG11 ' A' ' 44' ' ' VAL . 43.9 mm -96.23 140.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.581 1.952 . . . . 0.0 107.411 173.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.671 HD12 ' HA2' ' A' ' 26' ' ' GLY . 68.1 mt -82.76 131.95 53.05 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.853 -1.546 . . . . 0.0 109.521 169.249 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.64 101.41 0.15 Allowed 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.106 2.537 . . . . 0.0 114.04 168.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt 68.88 50.2 0.63 Allowed 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.994 1.718 . . . . 0.0 114.669 170.573 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.48 -98.18 0.49 Allowed Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 162.167 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -126.09 -38.79 2.13 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.689 1.195 . . . . 0.0 110.965 171.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.25 -44.05 66.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.267 -1.521 . . . . 0.0 114.729 -175.16 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -58.56 -32.91 69.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.114 -1.616 . . . . 0.0 111.343 167.665 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t -73.76 5.69 3.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 177.323 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.64 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.101 -2.249 . . . . 0.0 107.733 151.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.77 -42.14 0.6 Allowed Glycine 0 N--CA 1.431 -1.669 0 O-C-N 120.86 -1.15 . . . . 0.0 112.712 178.739 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.512 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 2.5 mpt_? -79.7 -17.85 52.64 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -174.067 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.8 mt -72.59 143.8 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 126.013 1.725 . . . . 0.0 112.457 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.13 -178.87 5.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.376 -1.452 . . . . 0.0 109.278 159.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.25 135.25 36.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.1 -1.625 . . . . 0.0 111.861 177.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.22 -21.53 17.39 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 124.619 1.104 . . . . 0.0 112.725 -170.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -71.55 159.65 34.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.217 1.407 . . . . 0.0 114.232 -172.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -101.53 134.88 43.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.753 1.263 . . . . 0.0 110.916 -177.47 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.1 t -112.6 111.75 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.063 2.545 . . . . 0.0 105.055 178.215 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -102.82 -33.66 9.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.422 -1.424 . . . . 0.0 113.64 -175.266 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.64 158.05 39.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.75 1.159 . . . . 0.0 113.361 -179.198 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.2 t -129.9 129.5 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 121.043 -1.036 . . . . 0.0 110.606 174.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.385 0.5 OUTLIER 39.25 43.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.927 2.491 . . . . 0.0 116.081 -171.879 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.87 12.26 81.54 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 125.452 1.501 . . . . 0.0 114.649 178.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.9 t -109.32 95.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.606 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 p -71.36 153.77 42.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.314 1.53 . . . . 0.0 113.301 174.038 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.2 mt -80.56 74.15 7.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 122.452 1.12 . . . . 0.0 112.253 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -84.28 107.95 16.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.016 1.389 . . . . 0.0 110.052 176.242 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.84 11.18 84.8 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.339 -1.476 . . . . 0.0 116.373 -177.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.95 141.78 34.14 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 123.478 1.609 . . . . 0.0 114.909 -169.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 66.9 p -99.22 -156.74 0.56 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.067 2.147 . . . . 0.0 109.455 -175.555 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.14 -53.48 19.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.129 -1.607 . . . . 0.0 110.563 164.458 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -69.8 -38.63 76.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -177.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 77' ' ' THR . 10.5 tt0 -65.42 -37.5 87.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.957 -1.714 . . . . 0.0 113.79 171.371 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.34 -36.22 83.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.678 -1.889 . . . . 0.0 114.397 172.747 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.11 -57.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.028 169.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -48.46 -38.89 21.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 175.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.4 m -65.3 -33.3 75.66 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.879 2.471 . . . . 0.0 113.759 177.077 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mt -90.87 -29.62 17.41 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.702 -1.874 . . . . 0.0 114.577 171.846 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.15 -48.62 7.91 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.676 2.39 . . . . 0.0 114.739 -168.738 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -87.2 37.92 0.79 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.034 -1.666 . . . . 0.0 111.531 -174.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 35.7 p -95.59 159.47 14.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.435 2.694 . . . . 0.0 112.087 -175.678 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.03 63.32 3.77 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.796 -1.19 . . . . 0.0 114.251 -174.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . 0.289 28.3 tt0 68.69 -51.51 0.57 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.377 2.671 . . . . 0.0 115.423 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.34 125.97 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.673 1.225 . . . . 0.0 110.513 170.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.67 107.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 166.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -89.53 96.63 10.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 171.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 124.26 34.37 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 111.825 -169.023 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.14 100.89 13.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.3 1.048 . . . . 0.0 108.286 165.372 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.9 147.54 26.01 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.221 2.208 . . . . 0.0 109.378 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.62 138.43 54.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.521 1.153 . . . . 0.0 108.481 166.206 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.2 tptt -74.59 118.78 17.93 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 120.968 -1.083 . . . . 0.0 112.2 -178.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.82 4.07 Favored Glycine 0 N--CA 1.43 -1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 114.664 -164.568 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -129.66 140.06 51.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 124.762 1.225 . . . . 0.0 108.019 172.147 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.8 156.29 39.56 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 125.134 1.374 . . . . 0.0 110.054 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--N 1.299 -2.067 0 C-N-CA 122.529 2.153 . . . . 0.0 113.119 -179.026 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 123.092 1.425 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 17.5 tp -97.96 179.59 4.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.913 1.685 . . . . 0.0 109.745 -179.054 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.454 1.1 t 69.68 90.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 125.051 2.358 . . . . 0.0 115.69 154.313 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.0 m -130.5 122.3 27.38 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 -170.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.8 p -74.27 130.03 38.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.609 1.563 . . . . 0.0 110.319 176.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' LEU . 11.7 p . . . . . 0 C--O 1.259 1.579 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -164.178 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 122.943 1.354 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -113.49 147.33 37.27 Favored Pre-proline 0 N--CA 1.429 -1.52 0 C-N-CA 124.283 1.033 . . . . 0.0 109.204 178.208 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.96 149.77 37.38 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 123.198 2.178 . . . . 0.0 110.649 169.131 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.01 31.85 65.73 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 117.031 1.572 . . . . 0.0 117.031 173.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -97.99 120.48 38.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.836 -1.39 . . . . 0.0 111.068 -168.864 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -79.82 134.44 36.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.108 -1.62 . . . . 0.0 112.116 172.472 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . 0.253 0.0 OUTLIER -132.62 122.47 24.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.369 1.468 . . . . 0.0 109.088 176.734 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -88.35 86.41 7.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.384 1.564 . . . . 0.0 110.34 168.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.3 t -81.17 143.32 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.3 1.44 . . . . 0.0 108.876 176.177 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 117.92 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.894 -1.754 . . . . 0.0 109.65 174.668 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.1 mt -120.84 161.23 21.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.513 1.125 . . . . 0.0 109.916 -173.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.13 117.43 26.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 166.318 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' HB3' ' H ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -63.9 145.33 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.1 1.36 . . . . 0.0 114.303 -173.96 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.6 t -97.62 104.09 16.08 Favored 'General case' 0 CA--C 1.489 -1.398 0 O-C-N 120.511 -1.368 . . . . 0.0 110.474 178.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 49.83 39.82 19.08 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.157 2.183 . . . . 0.0 115.28 -174.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.47 65.54 1.98 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 121.107 -0.996 . . . . 0.0 115.004 -173.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.487 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 46.6 t 177.98 114.01 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 -175.305 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' B' ' 210' ' ' VAL . 5.8 mt -76.52 -38.25 55.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 169.528 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.5 27.65 2.32 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.122 169.067 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HB ' HG13 ' A' ' 44' ' ' VAL . 40.1 pt -124.37 127.36 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 121.684 0.754 . . . . 0.0 109.96 -174.232 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -79.12 110.69 14.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.028 1.331 . . . . 0.0 114.003 173.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.46 129.39 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -176.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -124.27 167.88 13.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.727 . . . . 0.0 109.939 172.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.7 -152.03 42.06 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.975 1.274 . . . . 0.0 113.61 -177.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.0 165.7 19.65 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.288 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.07 -27.54 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.634 -1.509 . . . . 0.0 114.372 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -80.7 -11.68 59.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.848 -1.782 . . . . 0.0 113.402 179.338 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.9 m -88.52 -22.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 120.452 -1.405 . . . . 0.0 110.729 173.063 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m 77.74 87.85 0.07 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.324 2.25 . . . . 0.0 111.141 -177.195 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.19 -116.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -170.605 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.1 mmt-85 -82.7 -98.35 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.24 -1.538 . . . . 0.0 107.78 161.144 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -105.77 -35.06 7.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.978 2.111 . . . . 0.0 112.171 176.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.51 -127.48 1.11 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 104.121 -3.591 . . . . 0.0 104.121 178.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.61 -175.16 53.51 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 121.501 -0.999 . . . . 0.0 112.004 -167.738 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 5.4 tp -140.92 163.0 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -135.72 155.32 50.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.292 -1.505 . . . . 0.0 107.356 -173.177 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 47' ' ' ILE . 21.9 t -96.96 121.39 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.758 -1.214 . . . . 0.0 111.611 -178.497 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.31 -34.48 18.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.246 -1.534 . . . . 0.0 113.21 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.21 132.68 18.64 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.631 -0.668 . . . . 0.0 109.708 -177.743 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.476 ' CD1' HG11 ' A' ' 44' ' ' VAL . 38.6 mm -93.48 126.3 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 166.561 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 pt -79.7 160.78 68.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 121.631 -0.668 . . . . 0.0 111.859 179.442 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.04 106.06 2.14 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 122.136 1.89 . . . . 0.0 112.178 168.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.524 0.1 OUTLIER 57.98 98.38 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.064 2.546 . . . . 0.0 117.521 179.385 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.15 -110.22 1.89 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 164.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -117.55 -42.06 2.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.302 1.441 . . . . 0.0 111.265 170.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.8 -41.1 79.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.668 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -54.77 -30.5 56.88 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.234 -1.541 . . . . 0.0 112.996 174.395 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t -72.29 2.22 6.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 175.762 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.13 -99.86 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.874 -2.391 . . . . 0.0 109.045 162.519 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 -47.36 0.14 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.654 -1.904 . . . . 0.0 113.404 175.475 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 mtm-85 -69.2 -33.83 73.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.92 1.288 . . . . 0.0 113.143 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -52.13 129.08 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.062 2.945 . . . . 0.0 116.016 -175.386 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.87 177.79 8.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.57 -1.331 . . . . 0.0 110.93 167.38 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -72.16 121.26 19.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.475 -2.641 . . . . 0.0 112.445 175.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.06 0.95 11.55 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 116.091 1.196 . . . . 0.0 116.091 -176.264 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -77.95 158.69 29.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.528 2.164 . . . . 0.0 112.836 176.206 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -100.62 129.92 46.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.244 1.418 . . . . 0.0 108.971 178.453 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -96.52 117.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 174.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.03 -39.12 8.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.875 -1.765 . . . . 0.0 113.332 176.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.55 159.18 44.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 119.993 1.269 . . . . 0.0 113.721 -177.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 92' ' ' VAL . 67.0 t -133.28 115.78 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 123.881 0.872 . . . . 0.0 111.271 179.905 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 52.49 27.11 4.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.066 -1.646 . . . . 0.0 115.305 -168.184 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 4.52 72.97 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.737 -1.227 . . . . 0.0 114.25 -173.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -94.39 93.5 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -177.636 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.5 p -71.42 135.08 47.06 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.34 1.067 . . . . 0.0 113.634 179.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.2 mt -80.12 56.67 2.48 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.081 2.152 . . . . 0.0 112.354 -174.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -73.35 82.04 1.4 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.289 2.236 . . . . 0.0 112.643 -177.437 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.27 29.41 19.79 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 120.711 -1.243 . . . . 0.0 113.446 -178.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.29 149.85 35.32 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.687 1.232 . . . . 0.0 112.238 176.037 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.2 p -104.66 -163.27 0.95 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.503 1.921 . . . . 0.0 109.121 -176.013 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -66.72 -54.11 26.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 111.511 169.24 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -64.35 -46.54 82.98 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 124.499 1.12 . . . . 0.0 112.659 177.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -63.38 -41.76 98.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.417 -1.427 . . . . 0.0 113.654 178.883 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.21 -38.4 87.88 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.295 -1.503 . . . . 0.0 114.918 174.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.79 -56.34 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 118.7 0.682 . . . . 0.0 110.494 170.298 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 86' ' ' ARG . 36.0 mt-10 -64.18 -25.45 68.08 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 87.8 m -65.13 -35.05 79.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.357 1.863 . . . . 0.0 111.186 173.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.95 -40.85 13.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.241 1.816 . . . . 0.0 114.507 174.123 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 83' ' ' GLU 0.356 0.0 OUTLIER -82.33 -35.59 27.75 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -174.457 . . . . . . . . 4 4 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -81.33 41.58 0.62 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.559 -1.963 . . . . 0.0 113.333 178.101 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 55.4 p -105.42 -169.02 1.53 Allowed 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.087 2.155 . . . . 0.0 110.488 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -108.86 -117.02 3.99 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.194 1.378 . . . . 0.0 110.736 176.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -66.35 0.93 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.877 -1.367 . . . . 0.0 111.438 178.098 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.46 129.53 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 122.63 1.205 . . . . 0.0 111.907 -174.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.516 HG13 HG13 ' A' ' 68' ' ' VAL . 30.1 t -121.28 105.99 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 172.277 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -77.43 100.43 5.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.653 1.581 . . . . 0.0 108.844 165.368 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mt -84.6 111.83 19.89 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.462 1.505 . . . . 0.0 108.065 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 99.61 12.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 171.596 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mt -104.5 144.1 32.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.286 1.434 . . . . 0.0 109.802 -177.672 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.62 125.26 53.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 166.301 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -65.41 122.12 16.44 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.808 1.243 . . . . 0.0 113.567 -171.306 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.84 71.53 2.19 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 124.756 1.169 . . . . 0.0 112.622 -173.048 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -138.34 147.4 43.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -87.06 145.53 38.45 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 124.927 1.291 . . . . 0.0 110.001 -172.81 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo . . . . . 0 C--N 1.3 -2.025 0 CA-C-N 123.252 2.197 . . . . 0.0 114.25 173.321 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.54 -148.9 0.41 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.912 -1.117 . . . . 0.0 110.928 174.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER 85.8 112.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 123.981 1.848 . . . . 0.0 113.466 165.823 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 91.6 m -139.4 118.8 12.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 -172.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 85.8 p -73.14 129.1 37.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.383 0.992 . . . . 0.0 109.426 170.084 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' LEU . 12.0 p . . . . . 0 C--O 1.261 1.697 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 -161.306 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 120.782 0.325 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.55 148.3 38.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 174.439 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -72.93 161.9 42.42 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 122.902 2.401 . . . . 0.0 111.484 171.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.74 -4.49 74.06 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 115.618 1.007 . . . . 0.0 115.618 -173.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -90.72 97.28 11.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.24 -1.741 . . . . 0.0 112.192 -172.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p -100.77 148.83 24.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.814 -1.179 . . . . 0.0 108.842 159.579 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.72 124.58 31.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 175.18 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.01 82.23 3.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.687 1.232 . . . . 0.0 108.567 176.27 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.54 153.71 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 125.301 1.44 . . . . 0.0 109.709 179.244 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -129.31 122.35 29.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.177 -1.577 . . . . 0.0 107.807 166.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt -119.89 153.25 36.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.936 -1.103 . . . . 0.0 108.336 -173.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.07 8.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 169.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.63 123.9 15.61 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.85 1.66 . . . . 0.0 113.303 -168.873 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.259 11.1 t -85.7 104.45 15.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.303 -1.498 . . . . 0.0 110.978 -169.815 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.61 16.71 9.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 127.2 2.2 . . . . 0.0 116.019 -173.835 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.99 84.58 1.35 Allowed Glycine 0 N--CA 1.431 -1.673 0 O-C-N 120.262 -1.524 . . . . 0.0 111.041 -175.566 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.254 79.2 p 151.51 109.31 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 128.346 2.658 . . . . 0.0 107.447 -169.023 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.13 -40.94 82.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.239 2.216 . . . . 0.0 107.369 161.047 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 110.74 32.23 2.73 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 124.953 1.263 . . . . 0.0 110.765 173.038 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 pt -121.37 130.7 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 121.86 -0.788 . . . . 0.0 109.484 174.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -87.04 119.33 27.15 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.026 0.917 . . . . 0.0 111.096 168.249 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 29' ' ' VAL . 15.9 m -86.08 133.65 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 -171.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -126.22 170.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.534 1.534 . . . . 0.0 110.83 176.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.91 -121.73 5.69 Favored Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 125.23 1.395 . . . . 0.0 113.461 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.39 155.05 30.78 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 124.624 1.107 . . . . 0.0 112.236 -177.884 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.58 -19.05 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 0 C-N-CA 126.312 1.845 . . . . 0.0 114.154 -175.462 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -65.75 -42.39 90.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.189 2.596 . . . . 0.0 113.554 178.386 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.7 m -131.63 -97.7 0.32 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 123.166 0.587 . . . . 0.0 110.659 -171.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.9 m -100.85 78.03 1.91 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.025 -1.672 . . . . 0.0 114.102 -164.966 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.42 -176.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 165.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -80.78 -54.71 5.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.597 -1.314 . . . . 0.0 108.9 161.547 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.64 -2.09 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 168.384 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.86 126.96 0.92 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 119.018 -2.301 . . . . 0.0 110.898 -173.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.99 169.42 16.18 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 172.151 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 42' ' ' ILE . 4.1 tp -116.13 155.87 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.488 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -132.66 152.3 51.72 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.236 -1.54 . . . . 0.0 107.904 -169.308 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -93.36 107.42 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 120.846 -1.158 . . . . 0.0 111.397 -170.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -86.93 -42.09 13.44 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.631 -1.918 . . . . 0.0 113.416 -177.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.55 133.13 47.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 113.576 176.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -99.9 128.93 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.884 2.474 . . . . 0.0 109.777 175.622 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.601 HD12 ' HA2' ' A' ' 26' ' ' GLY . 72.9 mt -95.94 113.37 61.99 Favored Pre-proline 0 N--CA 1.429 -1.502 0 CA-C-O 117.628 -1.177 . . . . 0.0 110.692 174.779 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -79.68 66.19 8.81 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.311 2.575 . . . . 0.0 113.45 171.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' H ' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER 175.59 15.3 0.0 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.576 2.35 . . . . 0.0 112.341 171.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 50' ' ' LYS . . . -94.17 -108.67 2.07 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 119.528 -1.982 . . . . 0.0 111.667 174.267 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 -39.45 0.27 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.63 -0.924 . . . . 0.0 110.781 -175.108 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.57 -40.5 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.509 1.924 . . . . 0.0 113.652 -176.545 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -62.6 -33.57 75.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.286 -1.508 . . . . 0.0 111.227 170.122 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.35 1.66 7.45 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 174.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.25 -70.98 0.28 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.636 -1.915 . . . . 0.0 108.751 157.097 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -11.46 5.74 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 123.462 0.553 . . . . 0.0 112.984 164.278 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -94.78 -12.71 26.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.25 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.3 mt -86.32 138.0 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.935 1.694 . . . . 0.0 112.746 -173.835 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -128.24 -171.95 2.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.858 1.263 . . . . 0.0 110.65 170.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -94.78 36.07 1.21 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.397 -2.064 . . . . 0.0 115.182 -163.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.9 16.85 1.07 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.372 -1.455 . . . . 0.0 111.749 175.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -92.62 151.5 20.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.894 0.854 . . . . 0.0 111.949 -162.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -96.64 124.67 40.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.073 0.949 . . . . 0.0 110.526 -176.242 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.2 108.67 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 167.488 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -39.69 11.51 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.949 -1.72 . . . . 0.0 112.09 178.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.95 152.63 38.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 119.509 1.049 . . . . 0.0 113.47 -176.355 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 92' ' ' VAL . 11.2 t -133.36 118.21 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 123.58 0.752 . . . . 0.0 111.432 -175.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 61.72 29.6 18.13 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.049 1.295 . . . . 0.0 111.808 -173.549 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.18 4.35 89.78 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 120.509 -1.37 . . . . 0.0 115.278 -171.523 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.8 107.33 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 118.639 1.219 . . . . 0.0 108.081 -172.501 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.6 m -70.41 138.22 51.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.206 -0.934 . . . . 0.0 113.333 -178.042 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.46 37.95 0.59 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.298 1.839 . . . . 0.0 111.727 -178.055 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -84.53 74.29 10.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.669 1.988 . . . . 0.0 110.227 -169.794 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.63 9.6 6.94 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 124.175 0.893 . . . . 0.0 112.985 -170.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.49 140.46 32.3 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.147 1.473 . . . . 0.0 112.953 177.763 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.473 ' H ' ' HB3' ' A' ' 80' ' ' GLN . 68.2 p -92.12 -160.78 0.77 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.706 2.002 . . . . 0.0 109.912 -178.735 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -66.5 -56.42 10.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.031 -1.668 . . . . 0.0 111.317 165.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -69.38 -38.4 77.99 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 121.355 -0.841 . . . . 0.0 112.673 -177.127 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' A' ' 77' ' ' THR . 9.0 tt0 -65.96 -36.91 84.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 174.867 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.24 96.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.563 -1.96 . . . . 0.0 113.929 171.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 t -56.21 -49.8 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.74 1.216 . . . . 0.0 111.933 174.827 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.006 -1.684 . . . . 0.0 114.029 176.163 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.2 m -66.31 -24.72 66.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.303 1.841 . . . . 0.0 113.216 -179.313 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.8 mt -91.44 -46.39 8.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.848 1.259 . . . . 0.0 114.138 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -85.47 -33.62 21.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.045 -1.66 . . . . 0.0 115.376 -169.969 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -91.53 34.23 0.98 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.901 -1.75 . . . . 0.0 111.032 -174.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.3 p -88.48 -166.15 1.52 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.368 2.667 . . . . 0.0 110.429 177.404 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.89 -123.92 3.79 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.019 -1.676 . . . . 0.0 110.138 170.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -98.8 -50.61 4.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.184 -1.186 . . . . 0.0 109.8 177.142 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.19 123.63 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 123.22 1.486 . . . . 0.0 110.776 176.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.482 HG13 HG13 ' A' ' 68' ' ' VAL . 6.4 t -114.58 112.48 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 166.833 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -78.51 116.11 18.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.72 110.08 22.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.027 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.72 99.91 12.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 171.532 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.55 142.89 36.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.37 1.868 . . . . 0.0 110.207 -173.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -121.81 151.61 40.41 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.004 1.722 . . . . 0.0 109.514 177.329 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 123.86 10.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 174.483 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.18 57.52 3.2 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.788 -1.82 . . . . 0.0 113.15 171.383 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -151.88 151.22 30.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 122.038 -0.683 . . . . 0.0 109.217 177.333 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.98 155.39 64.33 Favored Pre-proline 0 N--CA 1.43 -1.474 0 C-N-CA 125.182 1.393 . . . . 0.0 111.612 -178.186 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.299 -2.048 0 C-N-CA 122.438 2.092 . . . . 0.0 115.657 -174.775 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 N--CA 1.429 -1.499 0 CA-C-O 122.879 1.323 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 16.1 tp -141.21 -170.26 3.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 179.184 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.448 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.45 2.9 m 52.61 88.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.132 2.173 . . . . 0.0 115.077 170.302 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 61.7 m -126.77 118.21 24.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -168.88 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.3 p -79.59 120.45 23.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.4 1.08 . . . . 0.0 110.304 -179.37 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.259 1.592 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -169.155 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.474 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -130.73 142.83 46.95 Favored Pre-proline 0 N--CA 1.431 -1.412 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.576 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.22 142.49 30.59 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 123.139 2.157 . . . . 0.0 112.204 -179.408 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.82 17.22 73.08 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 124.398 0.999 . . . . 0.0 115.491 178.672 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -76.63 111.15 11.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.326 -1.103 . . . . 0.0 111.765 -174.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -81.81 146.47 29.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.461 1.124 . . . . 0.0 111.753 172.633 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.2 117.28 14.37 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.562 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -94.53 76.65 3.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.887 1.327 . . . . 0.0 109.601 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.03 116.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.706 2.402 . . . . 0.0 112.472 -169.211 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.332 0.2 OUTLIER -104.56 118.36 36.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.834 -1.791 . . . . 0.0 112.078 -173.999 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.9 mt -127.72 178.38 6.18 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.768 -1.207 . . . . 0.0 109.216 -171.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.28 119.33 22.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 162.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.55 ' HB3' ' H ' ' A' ' 24' ' ' SER . 2.1 mtpt -62.31 128.6 36.83 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.576 -1.328 . . . . 0.0 113.09 -174.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 t -88.72 121.02 30.65 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.505 -1.372 . . . . 0.0 109.392 179.105 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 67.26 4.59 3.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.845 2.058 . . . . 0.0 114.743 178.182 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.93 86.24 0.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 125.527 1.537 . . . . 0.0 110.581 -164.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.55 ' H ' ' HB3' ' A' ' 20' ' ' LYS . 37.3 m 163.57 119.81 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 128.192 2.597 . . . . 0.0 106.584 -169.697 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 92' ' ' VAL . 23.6 mt -72.7 -37.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.785 1.755 . . . . 0.0 109.095 162.778 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.646 ' HA2' HD12 ' A' ' 48' ' ' ILE . . . 102.58 34.66 4.05 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.141 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.433 ' HB ' HG13 ' A' ' 44' ' ' VAL . 41.9 pt -119.99 136.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 122.031 -0.688 . . . . 0.0 109.683 173.287 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.2 m -84.46 122.35 28.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 123.307 0.643 . . . . 0.0 109.754 160.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.4 m -85.13 132.98 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.617 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -122.85 161.83 23.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.538 -1.976 . . . . 0.0 109.691 174.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.72 -148.62 30.69 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 124.764 1.174 . . . . 0.0 113.998 -175.203 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.83 146.91 5.46 Favored Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.78 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.415 ' HA ' ' H ' ' A' ' 40' ' ' GLY . 4.9 p -54.1 -21.36 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 126.525 1.93 . . . . 0.0 114.996 -178.242 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -51.01 -60.15 3.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.593 1.957 . . . . 0.0 114.618 -174.858 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.0 t -152.18 -57.96 0.15 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.356 -1.465 . . . . 0.0 112.694 -172.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.9 p -67.53 -13.78 62.36 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 -162.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.2 7.07 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 120.685 -1.259 . . . . 0.0 113.106 -178.163 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 58.97 59.82 2.66 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.392 1.477 . . . . 0.0 113.022 -172.189 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.1 m170 52.11 82.65 0.06 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 33' ' ' VAL . . . -142.15 -117.18 1.27 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.095 -1.628 . . . . 0.0 113.781 -177.613 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -137.35 2.98 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -177.931 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . 0.27 2.1 tp -116.04 157.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 119.644 1.722 . . . . 0.0 110.7 -173.976 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -140.5 152.79 45.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -170.511 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.51 HG11 ' CD1' ' A' ' 47' ' ' ILE . 14.7 t -87.99 131.66 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.698 -1.877 . . . . 0.0 111.506 -178.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -96.98 -52.38 3.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.908 -1.12 . . . . 0.0 111.213 175.75 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.81 118.07 17.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.074 -1.016 . . . . 0.0 111.163 -171.671 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.51 ' CD1' HG11 ' A' ' 44' ' ' VAL . 32.2 mm -88.92 129.14 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 126.28 1.832 . . . . 0.0 109.346 177.222 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' HA2' ' A' ' 26' ' ' GLY . 79.9 mt -78.16 121.19 83.59 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.449 174.51 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . 54.9 Cg_endo -81.29 66.85 8.66 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.653 2.34 . . . . 0.0 113.062 -178.301 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt 170.47 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.43 1.892 . . . . 0.0 115.055 175.256 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.18 -74.33 0.57 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -159.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.32 -56.09 0.09 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.324 -1.104 . . . . 0.0 111.114 -178.165 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.05 80.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.352 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 18.7 tp10 -51.72 -35.83 44.61 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.107 1.363 . . . . 0.0 113.548 167.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -61.7 -16.18 46.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 178.422 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.97 -77.15 0.07 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.019 0.927 . . . . 0.0 110.281 164.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.36 -20.95 3.9 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.555 -1.341 . . . . 0.0 114.804 160.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -74.76 -13.62 60.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 118.778 1.289 . . . . 0.0 113.479 178.002 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.29 141.98 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 125.082 1.353 . . . . 0.0 113.542 -176.328 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -136.69 -174.24 3.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.697 -1.252 . . . . 0.0 110.372 169.055 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -81.69 56.25 2.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.388 -1.445 . . . . 0.0 112.914 -175.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -172.56 -8.91 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 O-C-N 121.248 -0.908 . . . . 0.0 114.58 -176.443 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.68 157.67 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.663 1.732 . . . . 0.0 114.855 -177.1 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -93.7 123.8 37.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.42 1.088 . . . . 0.0 110.412 -176.722 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.78 110.51 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.588 -1.32 . . . . 0.0 107.983 174.104 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.45 -26.59 12.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -176.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.64 172.0 17.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.62 2.009 . . . . 0.0 113.239 176.336 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 HD23 ' A' ' 94' ' ' LEU . 9.7 p -142.89 120.51 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 177.019 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.501 0.0 OUTLIER 30.22 43.77 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.0 2.963 . . . . 0.0 119.0 -151.501 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.48 10.31 86.03 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 126.452 1.977 . . . . 0.0 115.366 -175.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.16 103.16 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 177.472 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.7 t -63.72 130.43 44.21 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.063 1.745 . . . . 0.0 115.576 -170.318 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mt -89.42 -6.65 56.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.969 2.108 . . . . 0.0 110.366 171.694 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -75.94 108.74 9.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.988 -1.695 . . . . 0.0 109.202 172.047 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.62 28.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.181 -0.95 . . . . 0.0 113.421 -163.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 142.07 34.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.791 -1.417 . . . . 0.0 113.08 -179.506 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.57 ' H ' ' HB2' ' A' ' 80' ' ' GLN . 60.4 p -91.1 -162.0 0.87 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.868 2.467 . . . . 0.0 109.746 -177.89 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -62.87 -51.62 66.3 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.647 -1.908 . . . . 0.0 111.47 167.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -65.26 -50.62 65.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.339 1.055 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' HB2' ' H ' ' A' ' 77' ' ' THR . 2.3 mp0 -63.03 -33.37 75.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.607 -1.308 . . . . 0.0 113.856 177.471 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.92 -42.85 89.61 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 120.263 1.392 . . . . 0.0 114.185 174.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.5 t -59.12 -51.21 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 121.58 -0.7 . . . . 0.0 111.212 176.058 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -63.44 -32.58 74.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 178.346 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.4 m -60.72 -45.18 95.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.886 1.674 . . . . 0.0 112.332 172.27 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.6 -41.3 12.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.935 -1.103 . . . . 0.0 113.323 -174.476 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -44.12 56.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -88.47 42.32 1.06 Allowed 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.654 -1.904 . . . . 0.0 112.421 -169.711 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 29.9 p -99.5 -171.0 1.99 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.407 3.483 . . . . 0.0 109.496 177.13 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.93 -132.95 4.53 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 120.533 -1.354 . . . . 0.0 111.681 175.106 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -93.37 -52.17 4.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.403 -1.645 . . . . 0.0 112.563 178.136 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.9 t -79.59 130.98 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 122.0 0.905 . . . . 0.0 111.308 176.596 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 25' ' ' LEU . 3.9 m -122.23 113.45 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.405 1.082 . . . . 0.0 108.086 172.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -81.57 94.26 6.87 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.552 -1.343 . . . . 0.0 108.826 160.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 68' ' ' VAL . 4.8 mt -73.3 110.49 7.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 125.034 1.333 . . . . 0.0 110.053 178.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.38 100.43 11.84 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 121.455 -0.778 . . . . 0.0 110.358 175.794 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.71 149.07 28.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.986 1.714 . . . . 0.0 109.585 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -124.44 147.49 48.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.94 1.296 . . . . 0.0 108.36 167.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -58.37 115.35 2.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 176.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.92 61.93 0.94 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.639 1.114 . . . . 0.0 110.686 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -144.02 156.57 44.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.52 166.39 39.97 Favored Pre-proline 0 N--CA 1.429 -1.486 0 C-N-CA 124.344 1.057 . . . . 0.0 111.917 176.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo . . . . . 0 C--N 1.299 -2.049 0 C-N-CA 123.058 2.505 . . . . 0.0 112.759 168.514 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' B' B ' 206' ' ' LEU . . . . . 0.674 ' HG ' ' H ' ' B' ' 207' ' ' VAL . 12.4 tp 65.92 -147.55 0.21 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.532 1.933 . . . . 0.0 113.076 -178.842 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.674 ' H ' ' HG ' ' B' ' 206' ' ' LEU 0.378 15.4 m 23.14 100.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.155 3.782 . . . . 0.0 119.663 161.87 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 52.9 m -130.55 123.05 28.71 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 -176.42 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 32.5 p -72.17 129.02 37.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.093 0.949 . . . . 0.0 110.068 169.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.26 1.619 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 -158.466 . . . . . . . . 0 0 . 1 stop_ save_